cell_line_id,drug_id,response,predictions
MOLP-8,11612883,2.388158793316403,2.173229423029197
MDST8,654092,-1.4293910300938224,-0.29661726888028467
RKO,52947716,-6.611161073849914,-3.257517786860836
RKO,56963564,0.5825206420774123,-0.18327334846591742
Granta-519,107970,1.5911312599666134,1.9248519764588226
HEL,12003241,-0.3954740832299299,-1.3122894605619957
SK-HEP-1,445091,4.514173662724111,4.406133376559697
SK-CO-1,vorinostat-carboplatin (1-1 mol-mol),2.626947191906058,3.09501691902732
SU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),1.047000957100153,1.010754834329742
PaTu 8902,selumetinib-navitoclax (8-1 mol-mol),2.7909772109313677,2.0114915118491488
HCC15,24775005,4.257174534281358,3.7449943210938623
HuP-T3,6450551,3.7588607556856006,2.9968844646504498
SaOS-2,72376,-1.862865015628177,-1.6606152688014801
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749,2.735656114936556
Panc 02.03,3062316,2.5231792980774,0.9075319475218648
MOLP-8,6918837,-6.2821371699611515,-4.415265897576397
SW48,1242560,3.5610164041067645,3.394675762066046
RCC10RGB,3062316,3.7206614033239833,0.11010144104223393
IA-LM,25262965,-3.1838216959830796,-1.6480589217056838
BICR 22,3038522,1.9324211832044784,2.965727234138431
SW1573,4096211,3.236722527011662,2.406128584091834
LS180,navitoclax-pluripotin (1-1 mol-mol),-0.4771322903655018,-1.054373017495552
NCI-H2452,2733526,3.4563089712221,3.853754570022736
WM115,44197249,3.814304480361476,4.123215022885685
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487,0.7803482334099582
Granta-519,JQ-1-UNC0638 (2-1 mol-mol),-1.2323689665878552,-0.2048932757107715
SW948,216345,3.8478701746280506,3.311883113560463
RKN,2858523,3.2318364946727653,3.1613178345707076
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913,1.7215463452381885
LCLC-97TM1,17759555,4.8791087487812606,3.5183341138877573
ALL-SIL,24771867,-3.516684419884963,-1.5357858614291728
WM115,11455910,0.9860510612095932,1.179328762498458
MOLP-8,11485656,1.8270206697288176,1.5997485357506394
MOLM-13,9866186,-0.4750218873797177,-0.027202268142528584
Daudi,445091,3.707432883595851,3.5897376448178755
RERF-LC-MS,9907093,3.840365222907794,4.385410593959016
LCLC-97TM1,selumetinib-decitabine (4-1 mol-mol),4.710076676704391,2.2196150148780442
IA-LM,49836020,4.225846480888235,3.59824283048963
IA-LM,JQ-1-navitoclax (2-1 mol-mol),0.4623829149690596,0.6042267563297838
HuP-T3,445643,4.0158423100173986,3.954977919761991
RKO,5351362,1.5688417029382893,1.3980116007736296
SU-DHL-1,25262965,-0.1887460090186497,-1.82023951993045
MOLP-8,3552672,2.5417747800161483,2.621964056449201
Daudi,selumetinib-UNC0638 (4-1 mol-mol),2.5339399670169827,2.8272206998377247
HCC15,24771867,-1.1106317715549263,2.9162494065533666
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335,-3.8453674559510205
COR-L95,25161177,5.647598761093448,3.9522811962740003
BFTC-909,16219061,3.736019824418232,3.399065076261633
LCLC-97TM1,3503,2.904492448420953,2.5293569236794577
RKN,5287620,-2.679516494579474,-2.046630150311813
IA-LM,5281321,-0.2514769440259956,-2.3225361673511817
SK-HEP-1,24964624,3.121305411780932,2.8388123122330478
SaOS-2,9884685,-0.6485333929619777,0.7498045897341409
MOLP-8,44566777,0.3680572795114795,-0.009213818345137494
K-562,3081361,1.217245739162405,2.115970266009191
HuP-T3,53392493,2.0684681956337654,2.756046707339699
SW48,11404337,-1.6842588085779022,-0.3765086496934364
RKO,24771867,6.323343540042099,-0.0885662688925829
MDST8,11497983,4.366208744407351,3.8833343228837616
Daudi,6918638,-1.8107043721369585,-0.38223212136719786
RERF-LC-MS,107970,3.001301355490032,2.506771767168499
NCI-H2452,56963564,2.315469414243469,0.7616914268006987
MOLP-8,JQ-1-UNC0638 (2-1 mol-mol),-1.954296009625891,0.4524226721787673
MOLM-13,4259181,-1.5110532495146267,-0.3160269682406662
RERF-LC-MS,5566,3.05978093065268,3.061418748444282
HEL,44607531,1.529117499700861,1.0958636483973465
BFTC-909,25262965,-1.7887871070762158,-1.1294640717050828
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588,-0.8742753430165989
BICR 31,46191454,1.7584497327325264,1.9036276816900275
UACC-812,426756,4.999419351863596,4.213611336746564
SW1271,9911463,3.695583497273472,3.7597166900172585
COR-L105,219104,4.205860409291191,4.024838021578785
MOLP-8,46943432,-0.8980695552897974,0.800671940644528
MOLM-13,11626560,-0.3289224093786886,0.7027151432622243
SU-DHL-1,73707398,0.2992121771474305,1.0590600527374743
HCC15,doxorubicin-navitoclax (2-1 mol-mol),-1.4188615279170478,-0.8720772174845511
HCC1500,9907093,4.182225492860836,4.273361466120202
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559,1.4132874996010407
LS180,serdemetan-SCH-529074 (1-1 mol-mol),1.4143670518957836,2.0435150870919925
NCI-H1568,5746,-0.0019321539800122,0.930656227300483
SW1271,navitoclax-birinapant (1-1 mol-mol),0.1602834101021188,1.0875371446150144
HEL,10385095,1.0320529067741009,0.857351482038351
P31/FUJ,374536,-2.654779926412406,0.9299437884143745
KU-19-19,119607,4.136898976237774,5.303181439064879
HCC1500,11656518,1.3375266797474916,1.4475606764722668
NCI-H1568,44819697,-2.651253194329211,-0.27422471342315957
COR-L105,6918328,0.8369476830507139,0.35966500729652723
PaTu 8988t,1750826,2.46453979570572,-1.0518127087655262
NCI-H1568,vorinostat-navitoclax (4-1 mol-mol),0.9474025116898376,1.167530049056035
HCC1500,6438330,2.8683818740810088,1.8894758522003472
HEL,11214940,0.9295508638766669,1.3328401262569083
HCC15,104842,-2.640027553911029,-3.013255988496927
BICR 22,53495165,-1.022289455565369,0.1799536025665396
SK-HEP-1,JQ-1-vorinostat (2-1 mol-mol),1.4434630535263555,1.596587422772977
SW948,11167602,-0.1815305116238505,2.3597755368384457
SaOS-2,119607,5.401113896800015,5.351128490818649
SW1271,444795,4.935671262335122,4.730421332270338
LS411N,107970,2.4864618038552724,1.9152012856204812
RERF-LC-MS,3025944,4.157794890121567,4.378256020839988
IGROV-1,5282054,3.614574021382022,3.687556865905678
MOLP-8,5284373,1.9803114216772224,2.09358521998283
SW1271,46907787,1.639327018501732,2.443300546500413
K-562,tretinoin-carboplatin (2-1 mol-mol),5.512334561910439,3.763342934941188
IA-LM,carboplatin-UNC0638 (2-1 mol-mol),4.065848381548882,3.5638277162100196
ALL-SIL,5351362,0.9273092220520184,0.9183971575850468
MDST8,docetaxel-tanespimycin (2-1 mol-mol),-2.250770682375198,-2.1253783055734594
LCLC-97TM1,54618164,4.1848187977728,4.05189964700078
SK-HEP-1,123631,3.617013696107864,2.487406929565488
LS180,1641662,3.031869457755623,3.4331312757541856
LCLC-97TM1,46199207,3.402623883365983,3.2102890373444173
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.46540278587711575
ALL-SIL,168312962,1.491579787235829,0.5028869311185892
IGROV-1,135398516,1.9751898057484376,2.2229824683205717
SK-OV-3,4261,3.2658157069367615,1.8203445528033944
Panc 02.03,11707110,-0.717341284128793,-0.07722367530699815
P31/FUJ,4261,-0.12536828191131,0.25168912763449036
Daudi,53481919,2.490259403593742,2.5686925999072447
MDST8,navitoclax-birinapant (1-1 mol-mol),-0.9553214738186762,1.4281045558810388
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186,2.032062919779619
SW1573,12003241,-0.6702221198842615,-0.8031590560448132
COR-L95,11238147,1.8523673489534709,2.6728084306634456
SW48,452548,-3.152923699933953,0.0891828265622245
ALL-SIL,46224516,1.508509192124363,1.835631876115338
COR-L105,selumetinib-MK-2206 (8-1 mol-mol),1.6265269022274589,2.310052869111169
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998,3.205367942160649
UACC-812,docetaxel-tanespimycin (2-1 mol-mol),-4.467025086254145,-3.141395884516614
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778,1.0209125820260083
Daudi,6918837,-6.333799665630375,-4.330774341919082
K-562,57330099,5.557476297558147,3.9401668568581774
MOLM-13,3038522,-2.559283473550591,1.8527042132841434
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841,-0.3997060679695835
SU-DHL-6,9903786,1.8029536633965553,2.002580364020205
Daudi,151289,0.3893937359913983,0.558761472449168
MOLP-8,51037431,3.96461280344528,3.0498763351535962
BICR 31,11152667,-0.7818812516610519,-0.5645502198975305
LS180,46907787,-0.2837252988913812,1.8485109965511668
PaTu 8902,16725315,5.393152185048805,4.34004725907741
Panc 02.03,6914657,-4.005158687469553,-3.9740619103861463
HuP-T3,54613361,5.307179038572215,0.1276845743072683
PaTu 8902,107970,2.826401466277882,2.416900569071939
RKO,25183872,-1.1635703485572924,-1.3276944991594943
RCC10RGB,135659046,5.776465120313546,3.8052344899830906
BICR 31,16725315,5.360398456728244,4.3101716290761445
IA-LM,216239,1.6797579071033788,2.336522039999129
LCLC-97TM1,selumetinib-navitoclax (8-1 mol-mol),3.8256626967827385,1.8821125704784785
COR-L105,6610216,4.21117605455994,4.282255674664165
COR-L105,10427712,4.508625829006449,4.426016648759818
NCI-H2452,6610355,4.992583267176856,4.6026922717150285
PaTu 8988t,11364421,0.0778741703331701,-1.5734443868696582
RKN,3552672,1.948192158503618,2.739359083444
Granta-519,46174525,4.2506809125564615,3.263108072010668
SW1271,44819697,-0.8585090240358869,-0.7480395326632143
WM115,44486219,4.206639028474801,4.31747843420132
MOLP-8,6918736,-3.613498069188207,-2.189882937517173
LS411N,navitoclax-pluripotin (1-1 mol-mol),0.0808011312818899,-0.910897136751122
LS411N,49836020,4.501659667614969,2.841865903225082
WM115,9927531,5.125567810288171,4.6498174046404515
SW1271,24797083,1.5469513987685792,1.3280524842428645
HCC1500,1566236,1.5057997400762737,2.3251177805862393
SK-OV-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3877296872918334,2.2698087008116232
LCLC-97TM1,5566,3.3253657103683976,2.839768499765011
NCI-H1568,1242560,2.6554382745340046,3.5616079485392533
RKO,11717001,3.92417498432234,3.9867732150723585
SW1271,11612883,2.3755529899406604,2.9413319660659725
Daudi,11396600,1.6595042173405945,2.34347741301729
P31/FUJ,60700,-1.8341903870446763,-1.8146328130252565
MOLM-13,JQ-1-MK-0752 (1-1 mol-mol),-1.5133138249776965,-0.28718243030171725
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649,0.85331780791181
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516,3.09280721286494
IGROV-1,3552672,2.134472496867482,3.047149937925773
Granta-519,637858,1.0013506713179747,0.9175147217231792
RERF-LC-MS,24753719,5.208830602571573,4.371767417524751
BICR 22,10385095,0.7738978245677988,1.5803110159494338
IA-LM,216468,5.467489395679956,1.8275567218076325
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912,2.578764684182241
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295,1.1144604941512122
SK-HEP-1,5738263,4.7811273930471065,3.51838566232326
SU-DHL-1,44632017,-0.1440136540504316,0.8579850849696657
HEL,selumetinib-navitoclax (8-1 mol-mol),-0.2593426680751931,0.461058983162345
PaTu 8902,11152667,1.2355675895718252,-0.4027983370797412
RCC10RGB,53245473,3.741106102916085,3.073711312780921
RERF-LC-MS,637858,3.156110522031532,2.2318976336319367
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.9739085260517184
HuP-T3,selumetinib-MK-2206 (8-1 mol-mol),2.743935040601299,2.1731392157378036
MOLP-8,23635314,-4.658988245687028,-2.883211341594266
HCC1500,241158,4.347158152842418,4.120222915761907
NCI-H1568,16065773,2.3280951044534923,2.6006427970711683
COR-L105,24771867,3.297975412837562,3.1872727727755126
COR-L105,11625818,4.2515796910784385,4.565156963843471
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445,1.6230631932658357
IGROV-1,2841722,3.834853118277962,4.321023900318734
SaOS-2,51039095,1.985897726070115,2.5878475102540426
LS180,navitoclax-sorafenib (1-1 mol-mol),3.51212583776398,1.7537091025255194
COR-L105,44589607,3.154557065472522,3.243457095432019
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187,4.658918714251167
LS411N,9911463,4.267700407985282,2.822860906654767
IGROV-1,4378219,2.016502068118561,2.7218933208678187
Daudi,135659046,3.1156448500687923,3.152504184245384
KU-19-19,16722836,2.3762239171314894,1.8121861961421377
IGROV-1,10410894,3.2660402181528263,3.0808623279266065
Panc 02.03,49793307,-1.288996397670963,-2.189165267921135
HuP-T3,SNX-2112-bortezomib (250-1 mol-mol),0.0780901353743998,-1.0779150129496002
MOLM-13,3136844,3.815118683612459,3.534599292601015
MOLP-8,6914657,-3.275680842626438,-4.71268888543057
K-562,9887053,4.062685534067952,2.6477769093080736
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028,1.1119016913680493
NCI-H1568,52947716,-4.502411459776945,-0.04961330795380656
BFTC-909,11178236,-2.4757289909406683,-2.871968419975561
Daudi,6610355,3.6984054922795906,3.8610489326463475
HuP-T3,10184653,2.026243337908569,1.333373182647307
IA-LM,36462,3.5803800151684384,1.9305154218916634
SU-DHL-6,46907787,-0.6700724490980451,-0.5303255185956409
HCC15,10231331,4.227224330005602,2.4009897718684265
LS180,135398516,1.9815935031047112,2.085728181309802
MDST8,53495165,-1.6914230136545845,0.8942040577097649
SW48,135411,0.1882785626851766,0.7357373365754445
COR-L105,11485656,1.8131666015075352,2.4144693819862395
HCC15,1239801,5.074899811919598,4.183335713430958
SK-CO-1,11497983,-2.036472499029009,4.335726392306616
Granta-519,2742550,3.255820788990773,3.1115800940371936
ALL-SIL,16720766,-0.6951675656481376,-0.6297002912784428
COR-L105,11175137,3.2551565890936165,2.8155314894335843
RCC10RGB,decitabine-navitoclax (2-1 mol-mol),2.143538063867694,1.976262970797722
BICR 22,ISOX-bortezomib (250-1 mol-mol),1.660291867951594,0.5402046962088969
IGROV-1,409805,5.990596261907717,4.658136259646809
Panc 02.03,11485656,5.602754460209725,2.5333575536737287
Granta-519,54619267,3.910643053444693,3.1838778521609696
COR-L95,navitoclax-gemcitabine (1-1 mol-mol),-4.597005855092225,-0.835104159916797
BICR 22,6252,-0.1324642168432157,1.2060607222250463
MDST8,11404337,0.5498361952050128,-0.09270873648770507
SaOS-2,60750,-3.1697993298632183,-2.393314712175867
SW948,11717001,4.275182691709766,3.718645368208168
MDST8,11175137,2.5746086097463974,2.5963731776502215
IGROV-1,322968,4.140599241163106,3.728338389891758
HCC1500,1242560,3.704354238917139,3.656150423898845
MOLM-13,9911830,-0.5537570191991712,1.8994966409852732
COR-L105,16038120,1.5247864010803889,1.2377289854661773
COR-L105,45279963,3.905008730311125,3.89296711981654
WM115,148198,-2.543343591950365,-3.153999985528373
IGROV-1,2749,2.0319044408234954,1.9900050357347525
K-562,4477,-0.1635303329058878,0.4401203740405388
SK-HEP-1,25227462,1.4628952719758763,0.5876432722583783
Panc 02.03,23582824,1.3457270338170706,0.9310650822950555
SK-HEP-1,241158,4.116654148222159,4.040669865449392
SK-CO-1,168313047,0.9150038640573646,2.357930352739612
Granta-519,9823820,3.571742016367909,2.4789837663720924
SK-CO-1,159324,2.1120355222347738,3.0353050860610313
SK-CO-1,10385095,1.4661007046294967,1.4528825307227524
NCI-H2452,71304818,2.7948147605911218,2.7003248984433323
MOLP-8,4578,4.125075782233611,4.034821254492469
NCI-H2452,11455910,0.7111396076654327,1.233022117562126
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785,-5.342227920553838
LS180,10074640,3.3464344717087333,3.1754455030852733
MDST8,71466578,3.80352554053155,4.496358261618617
LS411N,6184667,3.0967158778150465,2.291462420343546
SW948,11317348,1.1175502037929408,2.0377766172815313
MDST8,119607,4.705186592802013,5.112433828197174
SW48,11507802,0.6466338181730511,1.6702838784778884
IA-LM,alisertib-navitoclax (2-1 mol-mol),-2.012462769104639,0.5804891522188795
WM115,5702613,3.6693021536028367,2.8349117863023814
SK-CO-1,23725625,2.337747507524157,5.252762601869134
K-562,2749,1.8349792189296796,1.2250967301648656
IA-LM,3825829,4.571991496451351,3.503771545597607
KU-19-19,104842,-1.861779032385676,-2.31053829418676
SK-HEP-1,12001922,2.448252559355595,2.09160197340268
HEL,135440466,1.1488755358131115,1.6825553569448974
Panc 02.03,6918328,1.3018368822202735,0.14345544260237741
SaOS-2,72734382,4.901362762899978,4.624542066931252
HuP-T3,135421197,1.625440100707307,1.8751315124643029
HCC1500,3384730,2.626558190955656,2.8754487784296106
IGROV-1,51037431,5.669320749085174,2.981000446729866
BFTC-909,4917,2.929839520827846,3.1776002882357814
WM115,637858,1.77843641117838,1.9736461967726238
MDST8,44589607,2.007770745404649,2.935356353049245
LCLC-97TM1,5282054,3.1900504557345664,3.391798017508618
HuP-T3,46199207,3.4499209547515433,3.4129517446992588
BICR 31,25262965,-3.4333038857773093,-1.7626336320013893
LCLC-97TM1,6914657,-1.7973267784986633,-3.914057938143036
MOLM-13,9823820,-0.5140029045699521,2.6653586752216523
RCC10RGB,327653,3.228661308812885,3.364439178851061
NCI-H1568,4705,2.022283964907955,3.1819517320017616
SW948,selumetinib-MK-2206 (8-1 mol-mol),-0.5060345185709773,2.1137823290145925
RKO,6914657,-2.9196237708628505,-4.253738207829607
WM115,72734382,5.455243998512052,4.757563665242649
SW48,46398810,2.2376864399879,2.443546568141873
LS411N,2945648,3.381909997555915,2.4872785553801693
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517,1.3840961094063688
SaOS-2,selumetinib-PLX-4032 (8-1 mol-mol),4.990111037976576,3.519763077345719
ALL-SIL,421610,2.937759224643201,2.4227844659653757
COR-L95,11404337,0.1032061359669597,-0.26087717100723756
WM115,11427553,3.734660617826416,2.729279674807604
HCC15,122327,4.313110702061898,4.753455338397794
Daudi,9444,3.424690286905087,3.7360056662257817
Granta-519,4521392,4.382822475618979,3.995449075654725
SW48,31703,-4.626106549902408,-1.2281517752280466
RKN,10127622,5.371150210721622,4.165275419205644
ALL-SIL,71466445,2.2002248480614925,2.233460449719907
MDST8,656346,0.9697505348816438,1.3351187249385204
Daudi,71680916,3.7291665773697,3.7499304003532377
HEL,135398516,1.4688857829361923,1.1430681887209793
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412,1.4321098316082195
P31/FUJ,9936388,-7.166815071220185,-4.894739100105605
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716,3.316648277105417
HCC15,11625818,4.624206979967606,4.666993009350232
LCLC-97TM1,42611257,3.4642891468760957,3.1908207052880324
LCLC-97TM1,5311,1.9621633752287055,1.109899283399187
RERF-LC-MS,52912189,3.970931922009392,2.542299597003069
BICR 22,9915743,0.3047863731286212,-0.07757820568244167
Granta-519,11612883,3.2575401906490895,1.8501486783652006
LCLC-97TM1,vorinostat-carboplatin (1-1 mol-mol),3.53516680468747,2.790508192374401
NCI-H2452,3543504,4.306818718463235,4.642086338384888
SK-CO-1,676352,2.6575015884388704,2.1773574975733445
COR-L105,docetaxel-tanespimycin (2-1 mol-mol),0.3286281168811693,-2.4537899945319226
RKN,71304818,2.008207131108322,2.626619817897112
IGROV-1,67156097,0.1763939852409119,-0.280327761385355
IGROV-1,51039095,1.7163430299301403,2.916173355754493
P31/FUJ,JQ-1-MK-0752 (1-1 mol-mol),-0.1535880671922636,-0.38309107209953963
IGROV-1,72193861,2.0623829231433293,1.6775082838917037
Daudi,tretinoin-navitoclax (4-1 mol-mol),3.599991807714322,1.0546774999279427
NCI-H1568,11167602,1.5259281753697294,2.558685419616023
NCI-H1568,52912189,3.4016367932827563,2.41594304516218
SU-DHL-1,107985,-3.306496987383706,-3.7292832192209717
P31/FUJ,73707386,2.311695228129917,2.345904939781665
WM115,9884685,-1.925323313513864,0.7872145660329437
SaOS-2,16722836,0.8662367041162377,1.6580768493194282
PaTu 8902,46843906,4.340257675131653,3.0002174901639567
BFTC-909,656346,-0.1018552101429806,0.967749771756826
COR-L95,54618305,4.5292428127427575,4.360145482129474
PaTu 8988t,selumetinib-MK-2206 (8-1 mol-mol),3.0176221561167096,2.331117789864416
Daudi,24772860,-3.9771177154169304,-2.683981967456613
BFTC-909,9911463,4.114346930944119,3.9099909014817364
LCLC-97TM1,44197249,3.7483906325702545,3.2914342462444885
BFTC-909,6918837,-1.9878509916437357,-2.6025291891511757
RERF-LC-MS,24797083,0.2985814331764478,1.3487341489400289
P31/FUJ,135928012,4.893710575363991,3.7487367949396213
P31/FUJ,53232,3.343897726239282,2.5144026427713073
K-562,navitoclax-MST-312 (1-1 mol-mol),0.8745280332695038,0.334827583217146
MOLP-8,25062766,1.6722099464266416,1.8421170432213958
PaTu 8902,JQ-1-vorinostat (2-1 mol-mol),2.024407809701968,1.2453299647042606
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308,-0.4999511516937408
SK-CO-1,262093,3.1807391377127376,2.9309021811301146
LS180,72376,-2.8322202153843703,-2.072003134570874
SK-CO-1,carboplatin-etoposide (40-17 mol-mol),1.570074747334896,2.9703594061129532
KU-19-19,6918328,0.0154884073180988,0.4307562898988024
SK-HEP-1,107985,-2.2891993358893856,-3.491681137704436
PaTu 8988t,216239,1.832862266271042,2.3514422470798046
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453,1.5379499206206424
PaTu 8902,156414,2.7243668654536206,1.4930790018942621
Daudi,16659841,2.946181230411034,2.622220238974043
LS180,123631,2.1427319304120624,2.093178560745719
BFTC-909,10385095,0.9839595624316404,1.3301730659480366
NCI-H1568,241158,1.943489424131273,3.7613427302468354
UACC-812,44589607,1.3537953197929582,2.8964845533059083
Granta-519,11960529,3.2261057296158593,3.3899760402011907
LCLC-97TM1,25062766,2.2139494005881293,2.133595231015189
LCLC-97TM1,5291,3.6350350305332424,3.7137816721873707
MOLM-13,44491742,3.7695621371445975,3.4635016119859166
P31/FUJ,3025986,-2.3655111331800067,-1.728727946355647
PaTu 8988t,2749,1.558615062570056,1.8583431409311328
IGROV-1,2113511,5.982902824257526,5.636842023568634
Daudi,54639126,5.221444108043,2.611763430786788
HuP-T3,selumetinib-PLX-4032 (8-1 mol-mol),4.085577653340594,3.3824726656887587
HCC15,9868037,2.5640614102548556,3.1976385997754324
PaTu 8902,6918837,-2.118913626513807,-2.410491318346108
ALL-SIL,23725625,2.2136327630148736,3.3134335216615822
COR-L105,11455910,0.425998653780944,1.323450222690174
K-562,16013152,3.768503882504226,3.179865146753218
Daudi,67156097,-2.7448600083467163,-2.0748745518535308
SW48,6610216,4.461301788418361,4.034559275580596
BICR 22,11977753,-1.1105881150796446,-1.2476047276640032
Daudi,753704,2.787779434331829,3.910781973501008
COR-L105,46943432,2.471907312248233,2.912738782970917
IA-LM,16736978,1.926640001137528,1.5688161283923785
IGROV-1,176870,1.8349827429681411,3.0756323353059347
SK-CO-1,148198,-1.1611262776602205,-3.3265385909671674
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119,3.9249956862385162
IGROV-1,46943432,4.105714883822214,2.5151388106769543
LS411N,168312962,3.224541058203402,0.9287663013064287
LS411N,1641662,3.6634193785306337,3.0059326547461405
HEL,vorinostat-navitoclax (4-1 mol-mol),-0.226382947191329,-0.1364331518124755
LCLC-97TM1,26596,-2.266692800551727,-1.344774475714048
HEL,151289,0.2321343459174182,0.45520328520234116
Daudi,1285940,3.7558538743643792,2.2693479965569248
MOLP-8,2749,1.3302247490678565,1.0531412773474162
RERF-LC-MS,10427712,4.250983789220692,4.316842630734275
WM115,16725315,4.630500047502962,4.1101323123740325
Granta-519,9840324,5.864872193260208,5.581688354054247
HuP-T3,25262965,3.989652761156405,-1.5728579054675023
NCI-H2452,11719255,2.41462187851326,3.736682424351434
COR-L105,1641662,3.72017777917812,3.761694280940966
SaOS-2,89928392,1.2892186505806515,1.4155210776148466
LS411N,969516,3.2917111714105647,2.2241859672090327
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474,2.8522802420750897
NCI-H2452,327653,3.049758242791241,3.278598648103338
LS180,4521392,3.9983682640735094,4.297891695132347
IA-LM,2113511,5.955012720035456,5.406119636854619
HCC15,11167602,2.587200682435675,2.816004844688428
RCC10RGB,9911830,4.5526597563763795,2.6927765865141158
P31/FUJ,168312962,2.530788243280419,0.5190097288973187
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422,4.0728685651879895
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203,3.0369916844741334
Granta-519,9933475,1.54115480203428,1.3585134370521892
HuP-T3,73707398,1.153693297692098,1.4540009329057526
SaOS-2,409805,5.764413924489168,4.834663979813425
KU-19-19,984333,-0.867877464903324,0.49423680492690425
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272,1.4786847908353007
LCLC-97TM1,selumetinib-PLX-4032 (8-1 mol-mol),3.0304859741823944,3.3509069777569316
P31/FUJ,navitoclax-pluripotin (1-1 mol-mol),-1.7547710657643,-2.085590197667804
SW48,6918837,-4.354568378072889,-2.7819150054063173
LCLC-97TM1,16741245,5.12826814210941,4.079583100525606
NCI-H2452,11507802,3.578778888517491,1.6566157499744594
HEL,11175137,3.15338888234114,1.8684641380778186
BICR 22,60750,-4.532323865382038,-0.5117229346733583
Granta-519,44491742,4.018752292224149,3.5581000585394413
SK-HEP-1,12003241,-1.7510835313415607,-0.9126284457028839
SU-DHL-6,36314,1.1358641594844867,-2.4848401097931614
HuP-T3,11152667,0.3145958176635,-0.2166433721634594
Granta-519,15547703,2.599412791530534,2.5454258455774847
IA-LM,25126798,4.097105087874825,3.6986119982613457
MOLP-8,119182,-1.11255726511749,-2.2162770469506503
BICR 31,65064,5.259646525120305,5.153102524454938
COR-L105,6917907,-5.504495586582428,-5.127150997431057
LCLC-97TM1,11238147,1.840896458617422,2.653717927386123
HEL,51039095,2.698396554100347,2.085638073804581
PaTu 8902,44185566,2.9137350944736653,2.582061283400456
Daudi,53495165,-3.885820769064659,-2.0166541329253334
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976,4.0195257906202
MOLP-8,439501,-2.9296652389863267,-2.3639192952550654
Panc 02.03,4259181,2.0313571914007604,0.5380449421978508
PaTu 8902,126941,-2.2828817630557228,-2.650610530305402
RKN,5328940,2.201806852003849,1.7463708573338073
PaTu 8988t,SNX-2112-bortezomib (250-1 mol-mol),-1.5745385961478635,-1.334346829620791
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592,1.9193178205418204
COR-L95,246676,4.317733637680926,3.8742517711665783
K-562,135928012,4.4390204871751004,4.132577149172699
MOLP-8,56946209,-6.528820954061854,-4.644708350278073
SW948,selumetinib-decitabine (4-1 mol-mol),0.3455932815007744,1.6401244974529123
COR-L105,135421197,1.9442341701951136,2.205940867051592
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567,2.257479522413264
IA-LM,selumetinib-MK-2206 (8-1 mol-mol),3.1087327611966185,2.220078972513593
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391,3.628898417357671
RCC10RGB,5280436,4.525748645562069,3.520565148512465
NCI-H1568,31703,-1.6950574450364193,-0.9347072806440644
SW1271,148198,-2.630785543453804,-3.3355548202614727
Granta-519,11964036,1.5223427206827596,0.40518177847439096
MOLM-13,16725315,3.788691115651132,3.6588964602799154
Panc 02.03,1716436,3.766168811644757,2.9643213897505856
SaOS-2,JQ-1-UNC0638 (2-1 mol-mol),1.2943206739427773,1.7372821308729376
K-562,1566236,1.8179642124055264,1.7391730939809242
RCC10RGB,409805,6.020159348453613,5.159674529973183
HuP-T3,navitoclax-MST-312 (1-1 mol-mol),0.8342028342455182,0.8739944630308483
HCC1500,11175137,2.755904594476177,2.799379193482126
HCC1500,11494412,1.8019649514762912,2.223960087704359
HCC15,10127622,3.735977541508184,3.592928916467632
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579,2.1766243130585035
SK-HEP-1,168312962,-1.3309808369359073,1.799198119633719
COR-L105,24180719,3.693037976394381,3.694994431574543
Daudi,46943432,0.8866201698678313,1.228924806272184
HCC15,BRD-K27188169-navitoclax (2-1 mol-mol),-0.2430288225821102,2.6104350150769453
Granta-519,24180125,1.2477770260094014,2.217086252972888
RKN,9967941,2.6996754619948065,3.8713922806409533
RKN,135398516,1.9656218312143572,2.082864531856849
KU-19-19,16115403,-3.194116920729502,-3.453484609699944
SW948,56949517,5.5880132005349505,4.378879651051508
NCI-H1568,44632017,0.9967277604489184,1.424502573972942
COR-L95,11175137,2.52315362607855,2.268678187834959
NCI-H1568,676352,1.7505105304855018,2.157929145790653
NCI-H2452,126941,-2.0674603287446964,-3.0368366917006977
NCI-H2452,4477,0.2060981637085811,0.6285360313905276
SaOS-2,vorinostat-navitoclax (4-1 mol-mol),1.3300754000959574,1.1778711298915066
LS411N,vorinostat-carboplatin (1-1 mol-mol),2.115093899053651,2.1435155168826445
BICR 31,11647372,2.8607835505972035,1.1283140915150385
WM115,52912189,2.2242444616857417,2.5543975324823776
COR-L105,2729026,3.0417945234466863,2.907164701553954
COR-L95,65064,3.24172080303354,4.299761633402821
IGROV-1,54613361,1.0826132998561049,0.18487801733483789
NCI-H1568,53232,2.5527200815554587,3.0466599757009534
IGROV-1,9884685,-0.088911709267569,0.540235778141885
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614,-2.7635479253996698
SW948,16720766,3.3510678765666517,0.47502827266461495
ALL-SIL,135928012,2.5698772014589992,3.474209080894846
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.7111154169241413
COR-L95,56946209,-6.902335125637694,-4.267900809077331
IA-LM,49867926,4.185996432673056,3.454159071044125
SW948,11625818,3.962309646097391,3.7270346380184054
IA-LM,4259181,2.3536383664390734,-0.08015645253668646
NCI-H1568,4259181,0.5766231269303183,0.0856978405943533
SW948,6438330,3.286047925562068,2.1477307787517814
P31/FUJ,15547703,2.950164329068843,2.652911647825674
COR-L95,1750826,-0.7485912803642704,-1.6846312360808517
HEL,51037431,1.91843497941606,2.8404051510147896
BICR 22,vorinostat-navitoclax (4-1 mol-mol),0.9224898382798205,0.9792331700835529
Granta-519,462382,0.1364457210972633,0.3619412005275602
LCLC-97TM1,11719255,2.8064116850649774,2.9710168652560567
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.14249234774721
MOLP-8,1242560,2.9421278446513393,2.7890633938606366
WM115,9911463,2.5241618652619007,3.9584305995332403
RKO,3025986,-0.6013959236761957,-1.5308922099487827
PaTu 8902,5335621,4.440333682211631,4.8349248935861535
NCI-H2452,19582717,3.9299005055458793,4.5567644385614265
NCI-H2452,171352865,2.832902682703541,3.043062320470187
COR-L105,5566,3.258554573596101,3.0688889641957373
BFTC-909,11647372,1.2423847125416496,1.3650376370685313
Daudi,3503,0.8148417795144576,1.9762301243908118
COR-L105,25183872,-0.7403581245059931,-0.7386517525667615
ALL-SIL,375860,-1.552794194023853,-0.5657877840630247
HuP-T3,72193861,3.3106720937076233,1.6808091039201827
NCI-H1568,ISOX-bortezomib (250-1 mol-mol),0.1016439372832729,0.5686995393283898
SW1271,6438330,2.1351654373433764,1.9799734539877327
SU-DHL-6,25262965,-2.983432395440536,-2.2445956365707604
SU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.762662031403703,1.7709585607015146
BICR 22,JQ-1-UNC0638 (2-1 mol-mol),1.3883099593452988,1.6462321592775444
SU-DHL-1,44489367,4.533806271256096,4.207570305506686
MDST8,31703,-1.4422735490012837,-0.791672315175871
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685,0.5611045504315211
IA-LM,10302451,4.177351274859187,2.860244035403886
SW48,11214940,3.1705360221414134,2.4006147419608026
RCC10RGB,10074640,3.4095283906874956,3.1715720068814046
HCC1500,carboplatin-UNC0638 (2-1 mol-mol),3.485346920824326,3.171665715813099
COR-L105,25227462,0.5095099099095757,1.0208982717419333
COR-L95,66577038,3.0490878420221934,2.7850545945344694
LS180,46191454,1.5509574675684803,1.5077139986946235
RCC10RGB,65064,5.251967206688168,4.996821871318449
IGROV-1,72376,-2.111352545322758,-1.8608142155205758
MOLM-13,89183176,2.661461024404157,3.1791901375883445
LCLC-97TM1,doxorubicin-navitoclax (2-1 mol-mol),-1.1891183752031609,-0.9501690200553113
RKO,3384730,1.0492755436091918,1.6914394813909006
SW948,11656518,-0.9054812480406104,1.378135400286487
ALL-SIL,2949965,1.286096946783907,2.2525310706713864
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936,3.528487821638251
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068,3.9757507290063194
K-562,5287620,-0.244838249137823,-2.002486518587023
Granta-519,3825829,3.4773445434270243,3.259426308321464
MOLP-8,10385095,0.909191851453096,0.938000603892867
COR-L95,135928012,3.4969711227856397,3.9970332061048164
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.0062889762455312
UACC-812,25161177,3.457735095549926,4.1007776451273665
SK-HEP-1,11178236,-5.847785565222589,-3.1081380685818742
SW1573,16741245,2.047879460545898,4.004610435416652
K-562,vorinostat-navitoclax (4-1 mol-mol),0.9167311998987592,0.7939170866900495
K-562,89183176,3.981701702250952,3.2911712206910746
P31/FUJ,9915743,-0.8907797257006451,0.4035037155904022
WM115,3503,1.3325075362119865,2.3538842919001146
PaTu 8988t,44202524,3.9754310935930968,2.164382782116624
SW948,9952709,2.6604018004594514,2.830760234468657
Granta-519,56946209,-6.359988120178517,-4.919547446050345
NCI-H1568,navitoclax-piperlongumine (1-1 mol-mol),1.526760839095053,1.4241360024246914
Daudi,613000,1.9882519691431488,2.151034222504768
RERF-LC-MS,374536,3.716253113618047,2.5752531123682023
LS180,72734382,4.032476699930466,4.702144856989156
Daudi,1566236,1.0534301581716357,1.43925766325763
BFTC-909,9868037,3.24226767674478,3.4112879773172384
HuP-T3,107985,-4.90392348596967,-3.4513323245229377
BICR 22,crizotinib-PLX-4032 (2-1 mol-mol),2.04605335326416,2.059808350068741
IGROV-1,168312962,3.022863957843741,1.6536811668986993
IGROV-1,3081361,0.99973562532788,2.337253718044572
BFTC-909,5311,1.6846521587280363,1.6265742653126491
NCI-H2452,2841722,4.2339337769073175,4.35681235072289
NCI-H1568,navitoclax-gemcitabine (1-1 mol-mol),-4.7036832419339865,-0.5521437221624638
RERF-LC-MS,5278396,3.382202757419261,3.6149037351593085
COR-L95,44607531,1.1147625805359247,1.5420937538988708
SaOS-2,135440466,1.1747227113697256,2.3301013905206083
RCC10RGB,285033,2.114091727684993,-1.2443436415633053
SW1573,448949,2.6434946381292703,2.300626283372654
SK-CO-1,11964036,1.41955554287601,1.476981823011944
SK-HEP-1,24901704,5.545234809796251,3.4338477170063983
RERF-LC-MS,71751553,4.213964581210796,4.595644135196002
SW1573,11178236,-2.507507612037206,-3.0625429057527804
HCC15,6450551,1.6627728253820353,2.920060960603101
SU-DHL-1,54619267,3.144461009217004,3.722152251531398
P31/FUJ,11626560,0.2148563033664798,0.5965248978323813
COR-L105,119607,5.370152891195211,5.43078998244774
NCI-H2452,11427553,2.818972077820031,2.7986775525734733
HuP-T3,2871966,0.5817483683031975,0.7892681436518946
Granta-519,439501,-6.00499370561019,-2.6311610951323856
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425,1.575066855051618
SW948,navitoclax-sorafenib (1-1 mol-mol),1.76041571963915,1.4829990214704836
BICR 22,2945648,3.5832925483527625,2.756489273528625
NCI-H1568,11228183,4.140816994678141,2.5632056653658113
COR-L95,89928392,1.3878824566143364,0.9453502946770601
BICR 22,2871966,0.0284401826322965,0.8959333813510575
HEL,46199207,2.3973871372245372,2.650395388967457
HCC1500,52912189,2.5783780690097857,2.1270287077476486
KU-19-19,52947716,-4.518413756843173,-0.3562502823341053
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565,3.626270088472536
NCI-H1568,7326481,2.864470016727109,3.085862869078121
RKN,53232,2.2291100881655037,2.440883497420887
KU-19-19,4477,-0.0533500132034658,0.4486264521284531
SK-OV-3,107970,2.5604111984812152,2.3666193187914377
BICR 22,1242560,3.7933374150058015,3.1757489605144804
ALL-SIL,5738263,2.854339564213428,2.684812945120722
HEL,5329102,1.6539669706420914,1.390664807817503
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577,3.275611802442977
SaOS-2,3854666,0.6354016080385003,1.8653033761780466
P31/FUJ,107985,-4.114404549725097,-3.864231807919974
SK-HEP-1,54619267,4.307302877095537,4.043549565960614
MOLP-8,11213558,1.2108381509164672,0.8647537269838758
LS180,6914657,-4.58065814502937,-3.6571739597299775
HEL,71466380,3.121887792191312,3.8186227643755033
COR-L105,25154868,4.769445801979145,4.457507083229003
LCLC-97TM1,25105715,3.527934306265534,3.265242313981289
SW1271,16013152,5.485365595141675,4.164395082866404
ALL-SIL,1750826,-2.8707446972397483,-3.654203882298814
SW48,44632017,-0.021210675828241,1.312158663138613
NCI-H1568,4578,4.166510450069308,4.570251964019782
SW948,24180125,1.460789729891403,2.4394568096605966
COR-L105,25161177,3.712985248467103,4.323175944016712
P31/FUJ,57519531,1.451496749892495,1.313745073639224
ALL-SIL,6918837,-4.772645295536399,-4.869321464531357
RKO,16720766,-1.2722083569090707,0.12591811915013307
Daudi,11707110,2.6257952816009498,0.9883332176253148
PaTu 8988t,24785538,3.127280515757933,1.878838956528991
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316,2.6942011555333942
HEL,46174525,3.393297616528365,2.8513607990771193
MDST8,17759555,5.018522859633252,3.5954995040417415
SW1271,53392493,2.79081275696651,2.662911323890154
COR-L95,carboplatin-UNC0638 (2-1 mol-mol),3.064030034312791,3.2209008112185007
SU-DHL-1,9927531,2.969590320438058,4.022597701855535
Daudi,445455,3.7530002864178416,3.6807356439287493
SW948,24951314,0.7675285489701543,0.779230117152972
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053,0.6372076293484462
SK-CO-1,9866186,-0.7388742913087788,0.8073986705853519
RERF-LC-MS,60700,0.497286081450591,0.03595197393083846
BFTC-909,11364421,-5.034674750215906,-1.4501539716233887
SW1573,49766530,-2.79322841384178,-0.05830366435438275
COR-L105,vorinostat-carboplatin (1-1 mol-mol),4.069993227019241,3.3368730107445783
MDST8,25126798,3.890491738661291,3.8625437599891326
HCC1500,3543504,4.272332537756205,4.29901725607278
COR-L95,25062766,3.209944577871265,1.8766931173062418
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418,1.616688581350808
SK-CO-1,44632017,0.9847861620501556,1.258162425578227
NCI-H2452,navitoclax-piperlongumine (1-1 mol-mol),2.2697751233857058,1.715090646537896
NCI-H2452,445455,4.8000860101003235,4.8767979448405825
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766,2.665976896772296
HuP-T3,439501,-2.469428626730465,-2.1564732566272102
RERF-LC-MS,9884685,0.4531053665233772,0.7476320865223047
RKO,5281321,1.9988379902215376,-2.224706224455494
NCI-H2452,10410894,4.350169635958685,3.4887055127614746
HuP-T3,24951314,1.4235135044150102,1.3494316565233182
SaOS-2,71466445,4.363709574185696,3.8634618013824253
BICR 31,44185566,3.0664042381745946,2.721495417124474
NCI-H1568,11625818,3.359978935972883,4.476478552330389
BICR 31,3552672,2.13577451695998,2.6953619791007255
P31/FUJ,decitabine-carboplatin (1-1 mol-mol),1.8939659397992608,-0.04857417962501247
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983,3.606892493067974
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936,2.973989347286915
LCLC-97TM1,119182,-0.294501899208461,-0.8047296370785932
ALL-SIL,52947716,-0.7216046839402591,-2.422845978679218
RKO,11640390,5.295981617059328,2.251550070188237
RKO,25150857,2.5785304193211247,1.8430630986257859
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124,2.8818118139917255
ALL-SIL,1716436,3.0252724323132374,2.393931861039023
RCC10RGB,262093,2.8343922904091134,3.1281333964497016
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045,0.8334608912664139
SK-HEP-1,439501,-2.4482777943885856,-2.128829152309607
RKN,71466380,6.199959456698308,4.471674057376927
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211,4.28364524751211
RERF-LC-MS,1242560,3.610791422912421,3.5091804475494293
SK-CO-1,ISOX-bortezomib (250-1 mol-mol),-0.2509608033573304,0.5904653493924454
Panc 02.03,66577038,3.3089612685646985,3.070972616675119
LCLC-97TM1,52947716,-3.0616129604635565,-0.9565715331390793
SU-DHL-1,20959075,-3.3128713931491087,-2.855899790699685
BICR 22,2113511,7.552062733189383,5.334424739010651
SW948,25126798,3.357341035223679,3.685715124995598
HEL,3854666,0.8085723321900852,0.7039336691165055
HCC15,168313047,3.1265794948701338,2.1566200082099067
WM115,107985,-2.5041726579949857,-3.2779109803781483
WM115,42611257,-0.3600732192588895,2.897836339773603
HCC15,60700,-1.3823438115431317,-0.21928746117754058
COR-L95,alisertib-navitoclax (2-1 mol-mol),-1.2067075871406427,-0.808419230554148
PaTu 8902,navitoclax-MST-312 (1-1 mol-mol),2.8235677032410873,1.0839652525253698
SW48,60750,-4.2221568193195225,-1.5827011450553927
NCI-H1568,262093,2.8880881470868585,3.002691681125375
PaTu 8902,53392493,3.316041661234319,2.7950556872541377
Granta-519,11647372,1.7523915142224398,0.14656779878554332
SK-HEP-1,8515,5.0523689066797495,4.083876923406378
SW1271,decitabine-navitoclax (2-1 mol-mol),4.244493551272361,1.637487729493392
LS180,702558,5.586038369213652,5.1436950653432305
IGROV-1,15983966,1.7101486625531308,-1.6646425410632844
SK-CO-1,6505803,-2.970063061644963,-0.6341235745571004
SaOS-2,navitoclax-piperlongumine (1-1 mol-mol),1.6017048786640289,1.774752671161727
PaTu 8988t,11485656,1.82057121616084,2.519072732171173
KU-19-19,2874250,6.302627434426347,4.38700799487452
MOLM-13,11175137,0.3158641445144168,1.6128302734100775
WM115,644241,2.021542714802758,2.0936213536990196
SW48,52947716,1.8444935422046616,-1.369947886615032
NCI-H1568,10302451,3.040030486332468,3.0340958781312013
COR-L95,44185566,2.2555949878605484,2.095186307297292
LS411N,16725315,5.1123164266785714,3.574853861739224
BICR 22,25195348,4.085059979970886,3.3836918821557647
SaOS-2,5311281,0.944453452900516,2.211288476861024
SW1271,613753,3.197731710568041,3.492660149006348
IA-LM,9840324,5.344700856558617,5.631744349475862
LCLC-97TM1,439501,-2.367039612081251,-2.153966050576845
LS180,9825149,2.508714096118433,2.1811225142996515
COR-L105,9911830,1.908645944756667,2.612197580762416
Granta-519,25126798,3.857539921377872,3.585618314651809
K-562,11238147,1.4367734907149323,2.104780834433977
SK-CO-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6721111669479054,-1.4930319259588827
IGROV-1,4705,3.3098412390054603,3.0122575854065
RERF-LC-MS,1716436,4.437154842045929,3.228760843668776
COR-L95,6918638,0.5429028056483723,-0.06060742748117496
BICR 22,11507802,1.0844954054416946,2.11671035537442
Daudi,54626689,2.8292455243221264,4.343311929766186
COR-L105,148124,3.589067174421039,-1.2401691258799463
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383,-0.4167870362668967
IGROV-1,9825149,2.5588021380929553,2.3366122552188724
LS180,2113511,7.0742493322433955,5.637794002168737
MOLP-8,16038120,-1.6086793301450355,-0.133958185168694
KU-19-19,67291369,2.2261044123877656,3.1105103265987055
COR-L105,carboplatin-etoposide (40-17 mol-mol),5.23047829437091,3.3798771652296384
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029,-0.7353598245304938
MDST8,navitoclax-gemcitabine (1-1 mol-mol),0.2783653553106409,-1.4933230949772105
Granta-519,44462760,4.300929542453815,2.9100423624176828
MDST8,tretinoin-navitoclax (4-1 mol-mol),1.0614057430446846,2.283545855459942
KU-19-19,17755052,6.06318579738538,1.8077168327242783
MDST8,11214940,-0.3312007430689519,2.0549762887518996
SaOS-2,57519531,1.7793183342968584,2.5118485173106664
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644,3.062358366085056
LCLC-97TM1,44493528,4.18527882332477,4.357145199793305
LS180,decitabine-navitoclax (2-1 mol-mol),3.265284502098727,1.5503047755422579
SW48,10231331,-2.95597966611556,1.6851898118956075
SW948,24797083,1.9027092264791332,1.4536624350204028
IGROV-1,11238147,2.1723642292765084,2.7207574728359822
COR-L95,17755052,2.817022282186957,1.1880456789860216
LS180,25126798,3.79328534931886,3.627781311506606
IGROV-1,71304818,2.4878074097553378,2.6365421535047777
SK-HEP-1,10302451,4.165168773877425,3.2139214795619626
HCC15,25102847,1.68346873279249,2.531036362848436
SK-OV-3,15983966,-3.6834707194333927,-0.9258184728691287
HCC1500,54143018,1.195335139641603,1.0707966669510007
COR-L105,11364421,-0.5536252833264237,-0.754625311878953
RKN,148198,-1.0178445286580065,-3.283844088055917
KU-19-19,400769,-0.482585358097733,-0.5579873298666106
COR-L105,7326481,3.3886978035876547,3.0258634729692915
COR-L105,44819697,1.466179589978979,-0.4345657712926916
SW1271,5281672,5.179464513143849,4.5626501529257455
PaTu 8988t,3634881,3.651211463421112,3.291531429765264
IA-LM,11404337,0.4340662777154989,-0.2754748501441041
NCI-H1568,5287969,-2.4053225408736405,-1.5956940753506836
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745,-1.6479553656286
COR-L105,54619267,4.07987987500145,4.198916847906886
SK-OV-3,9907093,4.994966956142975,4.24251220909513
ALL-SIL,11167602,0.1759872916057691,1.5565863334994023
MOLM-13,49836020,-0.1965532240483963,3.476440600304281
HCC15,52947716,3.127529556956005,-0.5278686031702656
SW1573,4261,3.544037815747042,1.7326190417767537
MOLM-13,6184667,1.666374934082413,2.101911628069072
SK-HEP-1,3854666,3.0622551399292264,2.4507621908815227
Granta-519,241158,3.1692083740262373,2.383219385584511
MOLP-8,5978,-7.284134927472065,-2.61115055736647
LS180,10302451,1.4669812473297774,2.4829391504668266
RKO,16065773,3.3120716405166615,2.0094431699938156
MOLM-13,24964624,0.892926396159225,1.435074352706788
KU-19-19,11427553,3.4053411651543035,3.117128228086389
SK-CO-1,44137675,3.0714779264964074,3.399253987414425
P31/FUJ,6852167,1.016015239887951,1.7095787982743575
HCC1500,5351362,1.2955308259083285,1.7509656032116157
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081,1.5825900695631558
MOLM-13,252682,7.80657372951634,6.380983594780238
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619,4.254636354929318
HCC1500,44607530,1.2894809747133489,1.6378001528327888
SW1271,3025944,4.184087558749553,4.2692708797251555
HCC15,44493528,4.34604946513687,4.399398894534342
P31/FUJ,6918736,-1.9353169891324984,-2.370400268410968
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805,5.098031643078334
K-562,24856436,0.0017034666231649,-0.32316838172926976
LS180,216468,-0.2416288368660945,3.0421937462041173
SU-DHL-6,11507802,0.7208159532280615,0.8002638443491434
SW948,5291,4.046310039203204,3.633291969357803
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344,2.774152815747272
HCC15,11152667,0.1037945221143532,-0.11474012285295761
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284,1.0459561419592707
Daudi,piperlongumine-MST-312 (1-1 mol-mol),0.9306925214047892,1.2502117379037738
SaOS-2,49766530,0.3706728408995327,-0.6086298822742686
SU-DHL-1,168313016,5.361416197440646,4.5721798821828905
HCC15,168312962,2.4994502868710677,2.1467965927933697
IGROV-1,24797083,1.5319862293819655,1.3454469056061729
WM115,71751553,4.133313051647094,4.596547045881036
SW1271,24951314,2.0404240106098723,1.2978977879723994
Granta-519,SNX-2112-bortezomib (250-1 mol-mol),-3.1352941908416243,-2.8021902977873294
SaOS-2,676352,2.2074841133021432,2.0479120282627763
P31/FUJ,322968,1.4419696378870497,2.090765383382737
SU-DHL-1,10127622,2.7675483211751466,2.888668519721183
COR-L105,44137675,1.808161252080405,3.5738258958603346
PaTu 8988t,11625818,4.482422780967983,4.611704223737493
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054,1.2092415784376325
Panc 02.03,16038120,1.606654693103348,1.2446713928362687
BICR 22,3854666,0.9977305103930704,2.161222226182717
Daudi,46398810,1.6020476162665716,1.8871817538553213
COR-L95,984333,1.162546188419483,0.4315732107923575
WM115,1317464,3.7806694387813753,2.731353981422518
K-562,71680916,4.727537128358906,4.060117266705219
BICR 31,25183872,-0.4870171412848909,-0.5167274615917536
COR-L105,11626560,2.2911739511823503,1.9385110971853612
SW1271,9936388,2.2656701786136315,-1.2308668241911798
MOLM-13,135421197,0.945680487717708,1.1932692548253225
SK-HEP-1,136227924,3.6301481247272287,3.118419813595575
K-562,375860,-0.3542925626582329,-0.33830078939298686
SK-OV-3,9887053,4.42879128381072,4.394537896949892
LS180,9936388,-5.017955750811216,-1.874386376881488
SW48,9935249,1.3330175828473068,2.4465821376403394
SW1271,11214940,1.5931636594582963,1.773871231570492
BICR 31,serdemetan-SCH-529074 (1-1 mol-mol),3.0027631707479467,2.2838488942200157
RKO,67156097,-1.3338800856316015,-1.7529500548101273
LCLC-97TM1,51039095,2.799665973949055,2.82462376260685
MOLM-13,54143018,-1.3895840664016086,-0.36477632910748825
Granta-519,5738263,2.4520737989935246,2.4456288052356396
SW1271,2828334,6.430891789984985,6.169653540762497
COR-L105,salermide-PLX-4032 (12-1 mol-mol),5.562133960836907,4.898028706346716
HCC15,3136844,4.306118753112888,4.471968070832789
IGROV-1,54454,2.453541831966438,2.742562064281504
BICR 22,9935249,5.2884064452137585,2.886805071713304
BICR 22,72376,-2.4643814155147634,-1.717443141499139
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147,2.4285575272272957
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786,2.2679886404355436
SK-OV-3,25022340,0.9085118587340768,3.0769046997584737
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823,2.504748107355207
P31/FUJ,11238147,2.0504580426090286,1.9417941743069589
NCI-H2452,44607531,1.7526351480007742,1.7227494665121401
SW48,selumetinib-navitoclax (8-1 mol-mol),-2.7874089121789662,1.8232863088199451
WM115,119607,3.834781850796951,5.295262806084369
IGROV-1,71466445,2.3758001916617797,3.777743454192611
SaOS-2,54618164,4.337585482929099,4.120515240753325
SaOS-2,46843906,2.56299568717197,2.9948320469784333
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782,2.1200794348686625
LCLC-97TM1,2841722,4.284298549740087,4.109885222491163
LS411N,36462,3.380504085081747,1.6284869355382665
COR-L95,637858,1.3348673917451612,1.3901887402995756
HuP-T3,10113978,4.191114511390656,3.4040884887958356
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372,1.635557092248166
MOLM-13,24772860,-4.1681928866236415,-2.9439189033437354
WM115,9823820,4.472944540337913,4.077814068030452
MOLM-13,3676137,4.483658238026924,3.9143005005932427
MOLP-8,49766530,-0.668776240648524,-1.6506548503787641
SW1271,107970,2.3235168881670285,2.4452742731760377
PaTu 8988t,16065773,3.154821962511545,2.4029272212706565
Daudi,tretinoin-carboplatin (2-1 mol-mol),4.019264736178175,3.4831930292192412
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717,1.63847596650161
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955,3.0768755740744784
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413,3.7177916619373086
NCI-H2452,11364421,-0.8742390414707,-1.5534358765700578
NCI-H2452,4788,5.30317679490816,5.792618528059981
P31/FUJ,11396600,3.188193103342261,2.8521587022833526
SW48,2130404,2.4705566813277215,3.185363465738791
SU-DHL-6,322968,0.8712022459195665,1.9752332522022151
BICR 22,107985,-3.867593954539223,-3.326778535545298
COR-L105,46215462,2.588599789838095,2.1226116113581504
PaTu 8988t,5287969,-2.0890298278516513,-1.8714557762943553
SaOS-2,9866186,1.0217998308229927,0.9087385560267665
SW948,16065773,2.2305150921307653,2.076751892496718
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819,4.957381206982476
WM115,10127622,-0.9383410403940764,3.1468276238426567
WM115,2733526,4.043531113233861,3.844664478775635
PaTu 8902,49850262,5.593248228762752,3.7283378660872106
HCC1500,54613361,2.498230028210423,0.18185628222071323
SaOS-2,ISOX-bortezomib (250-1 mol-mol),1.126416426166952,0.4894191874073303
Daudi,5746,-2.3170879531966273,-0.2973578074529982
MDST8,6610355,3.7892287954147457,4.472312915027541
SK-OV-3,219104,6.736269406359778,3.9564587416130927
MOLP-8,49793307,-5.094504062696007,-4.08978033659663
NCI-H1568,54626689,4.298451601405369,4.659531340195565
IGROV-1,156414,1.4212019235656712,1.240787372330667
Daudi,4477,-0.8111056564008632,0.5190982116069855
K-562,135398738,1.706304792848783,2.410856347955523
MOLM-13,57330099,4.105312173478173,3.7293592509336704
SW1271,42642645,0.8738549597199083,0.9034486852203588
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823,-0.9274784383190803
NCI-H1568,decitabine-carboplatin (1-1 mol-mol),4.2821372470380545,4.153030432707298
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883,2.460894010056089
Granta-519,16725315,3.130545070245978,3.52783613516584
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384,2.6086289546608494
RKO,3854666,1.2691133577357363,1.1668629520251912
SaOS-2,119182,-1.602754826097209,-0.38615271791222233
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024,-2.1713597059569385
Granta-519,9843750,4.294258272153345,3.2413047103511032
MDST8,5329102,2.639161266907228,2.121153470817788
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578,0.12070631976008431
SW48,36314,-6.6979677874770065,-2.437963861015198
RKO,9825149,2.459088339864112,1.7865596984563896
MOLM-13,9911463,2.5287579203643986,3.038468320644102
RERF-LC-MS,44566777,0.4059341966526995,0.7646473249026875
SK-OV-3,10184653,1.9718742380811307,0.8539818236208511
HCC1500,16219061,2.7461663809715375,3.2250346264185925
SK-HEP-1,9926054,1.934364320328667,2.073773793604639
IGROV-1,24901704,3.0789156375765936,3.2583830733961268
BICR 31,9933475,1.7480026685414405,1.9086258237778906
COR-L95,3552672,1.407232830890507,2.5402541929012132
NCI-H2452,ISOX-bortezomib (250-1 mol-mol),1.6045376494936,0.812043178751246
COR-L105,66577038,3.4359280481345755,3.1112813280714926
COR-L105,24753719,4.356648297258706,4.447670576360414
ALL-SIL,24978538,-2.389127379896269,-0.928169288626262
SU-DHL-1,3025986,-2.176216514163443,-1.302437500602326
IA-LM,3062316,1.9598487648076035,1.2608953995975625
MOLP-8,448949,2.0087568721459146,1.190547931780555
HCC15,89928392,2.045660123087396,1.8303369766224145
SK-CO-1,16720766,-0.9325558438762483,0.8931095799063171
IGROV-1,11485656,1.900409616013456,2.1453319685172354
HCC15,44137675,4.493981948720765,3.646390374849022
SaOS-2,5284373,3.659507244236858,2.896507653602003
COR-L95,44589607,1.7004659608333377,2.1849863588891454
PaTu 8988t,16659841,4.413190590676007,3.825670741107991
MDST8,5311,1.1196330054843209,1.2140775868067908
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787,4.077318920385315
K-562,168313200,4.769830643466651,2.6042891796773397
SU-DHL-1,36314,4.070517798024083,-2.1037892971723307
COR-L95,219104,2.3748233222255144,2.90073800527084
Granta-519,44566777,1.2837383493022634,-0.31330362226745967
WM115,45279963,3.6868070952026506,3.8180822711237408
HuP-T3,10127622,4.169685865232827,3.7199321406783237
SaOS-2,54454,3.299905279612609,2.62459860188243
COR-L105,71466445,5.452991683251573,4.332413090019591
SK-HEP-1,crizotinib-PLX-4032 (2-1 mol-mol),2.841663753001873,2.0996960101105056
COR-L105,19582717,3.403236730524823,4.5531109560152245
K-562,11625818,4.129982389727392,3.4851742233799547
LCLC-97TM1,3384730,2.793888789676347,2.3188452139436135
BICR 31,4917,3.733916426719056,3.2128513817113356
PaTu 8902,54619267,4.2510877724746585,4.199978066615471
ALL-SIL,25102847,-0.1309610459144975,1.7166429939522656
MOLM-13,23939,5.7894293981406,3.4441968433507304
COR-L95,2828334,5.963676169995917,5.830627399035694
PaTu 8988t,44137675,4.243997881661858,3.5636106527413154
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166,4.617845287146432
SW948,5978,-3.22198817122066,-1.7150125912720897
RKN,375860,0.0559819210079563,-0.08696164779452502
NCI-H1568,49836020,3.1231470101883336,2.1990570528251836
NCI-H1568,12001922,1.1909466973303815,2.0333402557387155
HuP-T3,135411,0.8125735513868637,0.7598130295688271
NCI-H1568,119607,3.825066299684422,5.195724967441195
WM115,9825149,1.8328544820090609,2.143500848081265
WM115,104842,-0.2362637011987665,-2.601032298660186
P31/FUJ,327653,2.543614095842417,2.6624660350742437
RKO,11396600,3.504834935214814,2.539851495395539
SK-CO-1,135440466,-1.3303352220830715,2.060590446827233
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885,0.6508205368677202
P31/FUJ,23635314,-1.6494447832357666,-2.7612239569800745
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411,2.9428348840946192
SW1271,46215462,2.0233113088179406,1.933114720605941
MOLP-8,969516,1.8716619229833695,2.079860462858658
K-562,135999136,3.657737204061429,2.595181849804435
SW1271,9866186,1.0057234740027048,1.0284327302501546
BICR 31,5278396,4.450921628721945,3.8295880753978118
HuP-T3,462382,0.4397112913332706,0.5856415725743044
SW48,44202524,0.7134579720144102,2.341020820430148
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-0.9481542057234915
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952,4.282113927121928
LCLC-97TM1,3025944,4.079230434060959,4.129864598785023
SW48,46174525,4.111785915347283,4.182118533878378
HCC15,11396600,3.725702968544969,3.9169031244260655
SaOS-2,2949965,2.5764816921436067,2.7420808518753232
COR-L95,selumetinib-navitoclax (8-1 mol-mol),1.0752689694736437,1.728215890761605
NCI-H1568,10296883,3.9462373745058863,3.989933358008545
COR-L105,SNX-2112-bortezomib (250-1 mol-mol),-1.6644703388391169,-0.9766652734828766
Panc 02.03,216345,4.682043945218969,4.1559231276989115
Daudi,26596,-3.612902475241139,-2.3891633700505017
NCI-H2452,262093,3.2163720661137942,3.1909568471188328
PaTu 8902,9936388,2.1491039356268966,-0.5172925730869563
SaOS-2,4477,0.5134457679146515,0.5619786288600159
RERF-LC-MS,4096211,1.8582313750529689,2.1643696292108974
SK-HEP-1,53232,2.505434368946379,2.5988803814051873
SaOS-2,crizotinib-PLX-4032 (2-1 mol-mol),1.6526017036303646,1.8329416546568242
KU-19-19,439501,-2.2192304341921205,-1.9319182942418458
SW48,11222830,1.1015320686905217,1.5863971429253183
P31/FUJ,71680916,4.420716560192731,3.9245818509485026
IGROV-1,73707398,0.8848064516600974,1.2422793991487897
BICR 31,176870,3.2718013899021607,3.3195958314406493
PaTu 8902,72193861,3.6637635590803384,1.9729062034709879
SW48,10427712,4.323791553226545,4.157777414814746
HuP-T3,5470400,-0.4965810223867313,-0.25281092740791405
BFTC-909,3385,6.578023483143935,4.046914676923899
LS411N,5278396,4.113687735714835,3.085426697516579
WM115,carboplatin-etoposide (40-17 mol-mol),5.807621476943687,2.5432105985761444
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.6989189323282723
P31/FUJ,36462,-0.6599401629031103,-0.2560464162552983
IA-LM,24964624,2.660053298461781,1.5328842145702157
Granta-519,4477,0.7960263088071861,0.4354882230116417
WM115,675434,4.127717546006753,4.6655082505371
SW48,2708,3.1864056833879726,4.557390129184464
P31/FUJ,11964036,1.0580497047985076,0.34263713678290275
SK-CO-1,4096211,1.2314360568652074,2.247355418909819
Granta-519,24748573,3.0643863299071668,1.6013899653366226
HCC1500,salermide-PLX-4032 (12-1 mol-mol),5.277831355050616,4.609072778051166
MDST8,6918736,-3.3936356144084066,-0.6000597504062338
IGROV-1,3062316,-2.2361832227909075,1.1590967608679237
Daudi,136227331,3.813653547789358,3.040189659145268
MDST8,3385,6.506797592159471,3.902468071469493
MOLP-8,3101542,4.39402228569031,1.989426869548042
PaTu 8988t,19582717,5.440280671607156,4.380863270069214
ALL-SIL,54618771,-0.3818526805852408,0.05952279795268143
SW948,9911463,3.099005262739027,3.3642651540166257
NCI-H1568,navitoclax-pluripotin (1-1 mol-mol),-0.6791877741589081,-0.6888944547002712
HEL,4259181,-1.3539346499127438,-0.49309722488895
Panc 02.03,702558,5.477624163348055,5.448102029863172
RCC10RGB,9911463,4.415558893727306,4.014157531555887
P31/FUJ,2828334,6.241721397046506,5.67536474839644
BFTC-909,53232,2.9810373365160316,2.763899663243872
KU-19-19,1750826,-1.6748688873644846,-1.3288289314284176
WM115,54454,3.1744679186495963,2.7889615537005294
LS180,5329102,2.7428602070947266,1.9611747943286604
K-562,25102847,1.0686863962440132,2.0645029126783587
NCI-H2452,51039095,3.311280338748592,2.8448559608221102
SaOS-2,107985,-4.209612864808627,-3.4268600958450897
RERF-LC-MS,24180719,3.6010609924552455,3.7080569992194357
P31/FUJ,9967941,3.859476565836545,2.912689199594581
ALL-SIL,19582717,3.9660864037028793,2.8758506325547257
BICR 31,448949,3.395825088667814,2.142798613733954
IGROV-1,9926054,1.8111808945519428,1.9581098809236983
MOLM-13,44632017,0.3571286974750209,0.6368770966721632
RKO,984333,1.1849980625737155,0.5235623800744784
BICR 31,tretinoin-carboplatin (2-1 mol-mol),5.271330190091957,4.967892780681243
LS180,5311281,2.3621140012684014,2.4011486636146615
IGROV-1,5328940,0.347812751869877,1.6919335441483232
SU-DHL-1,126941,-4.504729002827146,-3.079956717252101
LS180,49850262,4.041689005821524,3.5152319836375843
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435,1.0496556371214962
SW48,10113978,2.97157913395206,3.1393105397027044
COR-L95,227681,2.232633220711044,2.897103064041537
P31/FUJ,carboplatin-etoposide (40-17 mol-mol),0.2579285765316561,0.2063457448022695
SW1271,65064,3.2018268639765908,4.764398375766054
Daudi,2733487,3.89488184101632,5.64927381056568
MDST8,4096211,1.945430248625456,2.302420787610021
MOLM-13,56963564,-0.6687647359934185,-0.1943453223559556
HEL,navitoclax-birinapant (1-1 mol-mol),-0.6071790485634636,0.23718344469948746
Daudi,216468,0.1519487612341026,0.9590048924679226
COR-L105,11494412,3.277457630260471,2.2701932574045087
BICR 31,31703,-0.4867862372580436,-0.6452577977741163
P31/FUJ,49793307,-4.015617000908982,-4.142269812302117
ALL-SIL,6450551,-1.4599471288533186,1.0501669952500392
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206,0.19590191955686173
SW1271,36462,1.4389686814792042,2.042591218716397
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.0062889762455312
SW1271,17755052,4.188603356762487,1.7849628072594248
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085,4.265904088844627
Granta-519,9967941,4.009641048767512,3.120806403596343
HCC1500,25105715,3.368057340132644,3.4517465042996647
Daudi,ISOX-bortezomib (250-1 mol-mol),-0.1612683603405773,0.19634670480997468
HEL,2858523,2.985624119180162,2.5596077082684996
SaOS-2,3543504,4.845259948636094,4.544253428018056
HEL,71466578,3.2881122758034413,2.513527623649022
MOLM-13,44185566,-0.1979234147827578,1.5052828970872627
RKO,46215462,1.869666408515056,1.2851521867545466
PaTu 8988t,16720766,0.7633491404380248,0.5622919304793917
MDST8,17755052,0.7758841708349149,1.8730661992481423
SW948,doxorubicin-navitoclax (2-1 mol-mol),-0.3830277458226139,-0.678489944579152
Granta-519,16741245,4.459375532286075,3.4730448152485986
LCLC-97TM1,36462,0.8347023875377979,2.0571735542208534
HEL,24785538,4.025400084811953,0.11542892348929629
SU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.8193437205412945,1.7797617270521762
SK-CO-1,54613361,-1.1953747905350511,0.044182575971841186
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034,1.3964251831481869
Daudi,25105715,2.455657378323054,2.8871688436062084
SK-CO-1,3038522,3.74499401693701,3.045974476224867
LS411N,11625818,4.428513603720294,3.0296723637520877
SW948,445643,4.022773961540602,4.137952373243456
COR-L105,135984461,4.336047626093702,3.913963987676726
NCI-H1568,71466578,4.264938806787537,4.540992877987878
HuP-T3,11364421,1.6783982807514195,-1.1270183589735923
Daudi,49867926,3.659415180241599,2.5777968138267853
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512,-0.9219626596825462
SW948,11404337,1.0073661261070797,-0.3290116577809315
SU-DHL-6,5278396,3.0928075812605123,3.194453347057996
SW48,JQ-1-vorinostat (2-1 mol-mol),0.3555995079043024,0.6454592756385894
PaTu 8988t,24964624,3.238300662516523,2.464470854606214
Granta-519,135411,0.2246473977843227,-0.14839636868411962
LS411N,3025986,-2.0648766502168843,-0.7803916090290847
HEL,BRD-K58730230,4.651487565209977,2.5220277950024066
K-562,148124,-7.41486725283878,-3.2131653435451613
K-562,10302451,0.1323934402367818,2.5698976918105827
K-562,1641662,2.591871767435193,2.862317866625345
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924,4.158525600509294
Daudi,156422,2.1936092532092295,2.685406192788082
BFTC-909,44491742,4.0640318167931255,4.445846185999103
PaTu 8988t,doxorubicin-navitoclax (2-1 mol-mol),-0.3664110079346409,-0.884759124971306
MOLP-8,135398744,7.476327693514706,4.690609198537342
IGROV-1,54618164,4.2184521751950115,3.9111310060069746
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282,1.9759527336258993
PaTu 8988t,4259181,-1.3402011211504403,0.42027337656924096
RCC10RGB,selumetinib-navitoclax (8-1 mol-mol),2.731385168920209,2.3317877669648945
KU-19-19,31703,-0.69897788572983,-0.8253824773926951
SK-HEP-1,5460769,6.10306620405049,2.662102263846242
K-562,11404337,1.5978316825317844,-0.6934750932634755
NCI-H2452,9840324,6.282829349463256,5.897789381576458
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079,-0.4293076250617142
KU-19-19,11214940,3.3843502872937106,2.095212519138166
MOLM-13,3815108,3.4784839929418343,2.224761240844353
IGROV-1,16065773,3.3717508464278585,2.5227662138697005
Daudi,6252,0.2227136884944618,-2.0861158718585124
SK-OV-3,1641662,4.382504296977698,3.66599485200609
MOLP-8,11238147,1.6731293567937424,2.1850720642432044
K-562,44462760,3.6560426907742896,3.043739297642122
RKO,9911463,3.963116579454927,3.389847591854779
KU-19-19,387447,-3.0100561484626738,-4.156976657771798
LS180,219104,3.901138037988577,3.701649081743331
SaOS-2,selumetinib-UNC0638 (4-1 mol-mol),4.750362941139615,3.4193123166978876
LS180,11609586,3.254650235567635,2.7461713368543825
RKO,3025944,4.391654014934833,4.077853483531521
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819,0.9365736999744414
SW1573,11640390,3.5338327701281176,3.7694757459088506
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426,-3.6557263897581422
NCI-H2452,navitoclax-pluripotin (1-1 mol-mol),-1.4411429928004444,-0.6476825446826343
LCLC-97TM1,2708,5.63991197078878,4.34406017316904
HuP-T3,262093,3.018266583248783,3.022483166755926
PaTu 8902,3503,3.0706473844938422,2.263865524487068
HCC15,6918328,-0.0257689511183662,0.11309729122529262
COR-L105,24797083,1.0360227961267732,1.517854192465085
P31/FUJ,9887053,2.876589254443052,2.366554275297514
WM115,446155,1.535185995815247,2.5677378223599643
COR-L105,613753,3.1601590793812,3.279713720632033
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021,-0.5843084725583764
IGROV-1,10385095,1.0670946713416192,1.3194036582551225
NCI-H2452,6252,4.582294901932163,1.002541599494385
MOLP-8,72193861,1.011292170776,0.38354722512146094
LS411N,JQ-1-vorinostat (2-1 mol-mol),0.7731890132640523,-0.17951183328976872
IGROV-1,26596,2.910298792762654,-0.5359137703128236
RERF-LC-MS,11640390,2.8932892314821927,3.8560244124893988
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568,3.751142563366705
ML-1 [Human thyroid carcinoma],9444,3.622178437751676,4.268175577490879
MOLP-8,carboplatin-etoposide (40-17 mol-mol),0.4522049028656168,1.1292611713432377
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276,3.506903700973768
SK-OV-3,168313047,2.892407732266751,2.4224778298805445
Daudi,9926054,1.7776420054693636,1.7606458772000462
COR-L105,2749,1.1758378373045044,2.2337554935291153
SK-CO-1,6918837,-2.3986996753086305,-2.800375329687627
IGROV-1,12003241,-2.0122972114546904,-1.0724594763195507
HCC15,9866186,0.9811967871114916,1.1347501451074613
MOLP-8,selumetinib-decitabine (4-1 mol-mol),-1.0628389373049278,0.6580099515882045
WM115,9887053,3.7520086754622657,4.196882243849224
COR-L105,9933475,1.7212192557919994,1.9692445401418734
MDST8,9967941,4.864965348465847,3.5705526655734077
KU-19-19,5566,3.5813761109507154,2.9934166283638364
MDST8,navitoclax-pluripotin (1-1 mol-mol),-0.7687489339577367,-0.8130860904893297
ALL-SIL,168313016,2.945013463521221,3.9288034504162765
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636,1.269259666065695
LCLC-97TM1,216239,3.3274661005628636,2.1352839438151516
UACC-812,9935249,3.1921366544842,2.749577467029169
KU-19-19,46398810,3.059016393641159,2.697863229917287
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866,2.4239333550542956
Daudi,24901704,1.6931015271472445,2.0857042479747956
UACC-812,navitoclax-sorafenib (1-1 mol-mol),2.1784288698451473,1.7640794747374773
SU-DHL-1,135440466,0.4118800450630493,1.9087315865430188
IGROV-1,5311,1.0068816368200209,1.4471634589531788
RERF-LC-MS,5329102,2.8374518121885637,1.9981942083847317
LS180,selumetinib-UNC0638 (4-1 mol-mol),1.869156071766359,2.664003383930336
Granta-519,10302451,3.667767303482806,2.526100680719422
HCC1500,alisertib-navitoclax (2-1 mol-mol),-1.6435253227103,-0.07991636585266744
NCI-H1568,4096211,1.8643847121139272,2.2026388926692944
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722,3.054653156675459
LS180,44487872,4.564049669792266,4.428921961205367
ALL-SIL,JQ-1-vorinostat (2-1 mol-mol),0.0034804556832889,-0.5642746228721668
SW948,135411,1.551236240082995,0.3650132071204038
PaTu 8988t,216345,4.148994433618168,4.134126914026331
LS180,9935249,3.57280690269837,3.0688489322706305
UACC-812,46926350,-4.425607795744521,-3.978524092080459
K-562,46224516,3.0237589268452396,2.305141163247828
SW948,16013152,4.211275799279611,3.332247341725635
BICR 22,10074640,3.373223414806136,3.033720680024443
Granta-519,54618164,3.794628352719798,3.287497658412283
K-562,49793307,-5.346924391172112,-4.203672536669699
IGROV-1,54678924,1.4704159748793169,1.933058995294996
COR-L105,selumetinib-tretinoin (2-1 mol-mol),2.682328410307197,3.6177108683714803
IA-LM,24785538,2.950939703376364,0.41683034968654775
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869,3.575232017883172
ALL-SIL,262093,0.6753795238054565,1.6525294119748384
SK-HEP-1,49793307,-1.6219654789172164,-2.361934453885172
UACC-812,9915743,-6.921665690083625,-0.030267843761583348
MOLP-8,24964624,0.5129160642166024,0.972438999522383
SW48,16725315,4.089936042929296,4.133792787546067
P31/FUJ,25102847,1.6695774391929423,1.785230994560813
MOLM-13,216468,0.0785275755512733,1.0266476138847422
HCC1500,135421197,1.2704457907642457,2.0004726255995644
COR-L95,445643,4.015431140089913,3.7555248401894046
Granta-519,9826308,-1.279512827450026,-0.3213960061964993
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185,2.6047418011190886
HCC15,44589607,3.4730057914725005,3.0041036570125392
SK-CO-1,73707398,0.894037962240185,1.6387887736442257
RERF-LC-MS,46191454,1.934559197398404,2.0982118965839995
PaTu 8902,44491742,4.263402068757711,4.304227643782252
PaTu 8902,53481919,4.066569856261274,3.971918811740057
HCC1500,4521392,5.662319691471263,4.246508869510494
BICR 22,11364421,-5.708558910936986,-1.4905233371383344
LCLC-97TM1,6610216,4.478615539127516,4.069600473174354
BICR 22,52912189,1.443997008169696,2.3304427955100873
SW1271,11404337,-3.6050810245472382,-0.1767302913974921
IGROV-1,969516,2.460805405371151,2.7675635093528204
LS411N,25062766,1.7796504921777256,1.6768935008883938
IGROV-1,11977753,-2.2284230058029433,-0.9636030774763291
SW48,JQ-1-UNC0638 (2-1 mol-mol),0.4200169651809782,1.3602760695955984
IA-LM,54618164,4.43488746250501,4.020128407744752
SU-DHL-1,135398738,3.5570959576905983,4.04821823632643
HCC1500,23725625,5.012282150953445,5.169024321965294
SW948,56973724,2.5267361451247647,2.2680354378570295
COR-L105,2742550,3.8597521863519257,4.17252111995886
HCC1500,selumetinib-navitoclax (8-1 mol-mol),0.8768646792211049,1.850821028450625
SW948,11485656,1.7814283284456571,1.8824339829292887
LS180,56963564,-0.4927248320174067,0.946806136291506
RKO,9866186,0.3829002704071885,0.27344446119112076
Daudi,44202524,1.1056351253600936,1.5708391342122678
NCI-H1568,11964036,0.8982081488420575,1.4593130824963385
MOLM-13,9915743,0.7456385275428815,0.401162225405237
Panc 02.03,4788,6.040807258084593,5.7352111661150555
SU-DHL-1,10410894,1.885737679840171,2.907079642301771
WM115,3062316,1.2654694678882143,1.2282048674515773
HuP-T3,148198,-3.5090934063696153,-3.2814334626277706
HCC1500,24748573,2.217224851211772,2.116143355264135
RKN,44185566,3.394049733904779,2.6038594961053914
WM115,73707371,4.316198918387243,4.825370987524773
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286,2.0892501822481924
COR-L95,119607,5.444677320305195,4.73488339178312
SW1271,3543504,5.279434126076659,4.395922061507017
RKN,613753,3.037549827357118,3.3075621925169436
MOLP-8,9933475,1.6461417731910544,1.6889589109693675
SU-DHL-1,374536,2.32669265560356,1.6495348961663228
NCI-H2452,11222830,1.0864314168284432,1.6792545671559842
BICR 31,16736978,1.5520316002325725,2.1321693705667797
BFTC-909,11656518,3.71751997684089,2.018737995638138
SW48,49793307,-4.357023521296349,-2.707257914399781
HCC15,676352,2.734399334153108,2.2175740558186727
K-562,9933475,1.5582186007451084,1.7786396366891253
COR-L105,1716436,2.5827881779858797,3.265848352911234
MOLP-8,71751553,4.257415338539138,3.7320284948251117
MOLP-8,11427553,-1.470461076327197,1.318016855668447
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336,2.142274938615409
HCC1500,65064,3.4319990575629484,4.76965558490748
BICR 22,54678924,2.835542995017498,2.3505030368463324
SaOS-2,52947716,3.1327874038156636,-0.25751924462933207
RERF-LC-MS,327653,4.17889189356682,3.2521840332285836
RERF-LC-MS,216468,3.2358353560937267,3.5186585273651168
LS180,637858,2.1359320280537704,1.7740055964144623
ALL-SIL,navitoclax-PLX-4032 (1-1 mol-mol),-1.20714893159784,-0.5717835014553916
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.5442292916999816
HCC15,25154868,4.699010678354358,4.406854051604481
BFTC-909,1716436,3.115342072857748,3.1128326494525926
WM115,208908,3.0871953707393662,2.102579375987395
COR-L95,5287969,-1.974656124599848,-2.026486347456565
MOLP-8,9907093,3.7363465424365567,3.5390326403506465
RCC10RGB,5738263,4.593697299478501,3.699472436516699
SU-DHL-1,446155,1.7989638936827528,2.2816715948498576
Granta-519,51037431,4.032962229357369,2.9236918150831492
BFTC-909,24771867,4.730369684143592,2.3839353743449685
SW1271,9926054,1.9992649208496855,2.1146089459147235
IA-LM,46843906,4.034671652936036,1.8469365975029048
PaTu 8902,3634881,3.736044150449037,3.216447465984432
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217,2.334696015291197
COR-L105,89928392,1.7234999745886912,1.666656447515376
Panc 02.03,6917907,-5.450554920776264,-4.687099218970369
ALL-SIL,216345,2.7239648031314108,2.9230441839653993
Granta-519,5311281,1.2060114833285496,1.6457820303251265
RKN,25150857,2.829513348324473,2.5501768704174603
RERF-LC-MS,702558,6.005509402748126,5.292364324452751
Granta-519,44202524,0.8355806814666445,1.1413085698874683
IGROV-1,65064,4.920352624378345,4.740642021489295
HCC15,82146,4.430619158397189,3.934388065337684
IGROV-1,135984461,4.285945029851472,3.7105518460418327
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024,2.708076119822503
RKN,25183872,-1.1518449365963386,-0.8404823109587939
SW1271,6450551,2.703162256598128,2.501949266991
COR-L95,SNX-2112-bortezomib (250-1 mol-mol),-1.5926355912839212,-1.4976298694470862
RKN,656346,1.677354805367284,1.2065555481979309
MOLP-8,3503,1.781914224283778,1.9421520051579708
COR-L105,2828334,6.248355208389406,6.261863692169502
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305,-3.2252070454568633
MOLP-8,135875424,3.0291075959050233,3.1447864427985035
HCC15,24748573,2.004363812639911,2.4272958469694705
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076,2.187020098960847
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517,1.4600015505025323
IGROV-1,56649450,0.515518984822669,3.339763381593775
KU-19-19,9444,4.28834999434395,4.168251235670184
Granta-519,3552672,2.198733357723822,2.5942071509186286
SW948,66577038,2.9537896679300655,2.8401506334902047
NCI-H2452,119607,5.591396796149955,5.429881942182316
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864,3.479458879456112
HuP-T3,2729026,2.9922624267509317,2.7548370560650404
SK-HEP-1,71466578,6.341226391578653,4.915050976820327
Daudi,24785538,-0.3082535888445589,0.3758541823727385
IGROV-1,5280436,3.2616766817665086,3.0794214574849685
RERF-LC-MS,7251185,3.4578262740878976,2.848032041416387
HCC15,156414,2.365134958139565,1.4142618694460998
BICR 22,piperlongumine-MST-312 (1-1 mol-mol),1.342404351806,1.755059472124235
BICR 31,10127622,3.719060323270891,4.13264459366961
SaOS-2,15547703,3.066966974063678,3.1889080686514455
Daudi,decitabine-carboplatin (1-1 mol-mol),0.1639659484946293,0.33357851362653357
HCC15,alisertib-navitoclax (2-1 mol-mol),-2.6533611611755177,1.0253771632486242
SU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.028973070586865,3.7990006643165217
SU-DHL-1,3689413,-2.511818154735677,-0.1385610133647133
COR-L105,56946209,-4.798718381888378,-3.8899825533534806
IGROV-1,5978,-1.5618214380165825,-2.157515139010329
BFTC-909,11222830,1.7098036316197358,1.6348422059575205
IGROV-1,216239,2.21703825410177,2.5403342687126824
MDST8,135440466,3.3221976295713342,2.2622789508273784
P31/FUJ,44632017,0.6534437162154956,0.8371603422517806
IGROV-1,219104,3.803083685328391,3.6586956768099332
SaOS-2,637858,1.716758511666406,1.8765545673970392
WM115,crizotinib-PLX-4032 (2-1 mol-mol),-0.0688201401017855,1.7582521482133868
COR-L95,24753719,4.203119149122614,3.8536711469206746
HCC1500,3025944,3.928139296588046,4.327799539094612
Panc 02.03,56946209,-4.513446270471167,-3.817815851354267
HuP-T3,25126798,3.926602492728053,3.7425387144306073
PaTu 8988t,3011155,4.341218756124128,4.0411144150933636
SW48,20959075,-3.67297247887529,-2.790989772830313
HCC1500,JQ-1-navitoclax (2-1 mol-mol),-0.2605650300766051,0.35717084381560604
BICR 22,44486219,3.936553836391045,4.067900942092072
RERF-LC-MS,6918736,-1.8242544668906209,-1.4575143584285006
NCI-H2452,selumetinib-PLX-4032 (8-1 mol-mol),3.036066268275686,4.036662097555858
RKO,44137675,4.282234128328841,2.912212196090749
IA-LM,11626560,2.8197095065502515,1.1936737984792996
SW948,2746,1.2183078272507333,2.3597737524341493
NCI-H1568,168313200,3.516432771095034,2.8267802317652335
IA-LM,262093,2.9896562434219627,2.136249049754814
MOLP-8,4261,-0.435327551985223,0.7972259570373574
HEL,2708,3.2519957529556716,3.410305460987635
BICR 31,selumetinib-tretinoin (2-1 mol-mol),0.9632535907950592,3.466930744274158
LCLC-97TM1,erlotinib-PLX-4032 (2-1 mol-mol),2.856806725221915,2.8658399977930844
MOLM-13,51039095,-0.7255439577713276,1.8081173174853455
IGROV-1,426756,6.142776526139055,4.385713100416311
NCI-H2452,25154868,4.866167054223791,4.646931065033939
PaTu 8902,4705,3.6244040622068256,3.110627732262516
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671,3.492195470245816
Daudi,135421197,0.2989842149032058,1.4515899032411987
IGROV-1,10427712,3.944243047938238,4.536459987082317
COR-L95,24978538,-1.547703636473998,0.5064148600152856
SaOS-2,52912189,2.036463757447864,2.516584890174986
PaTu 8902,452548,0.9739796251952438,0.27793994504051944
IGROV-1,52912189,2.3966568144845666,2.4522768054746447
SU-DHL-1,387447,-5.562438756444553,-4.480390489076253
HCC15,135398516,2.1695814103654696,2.2271586045827148
SK-CO-1,6610216,4.838209270425191,4.186550534065046
MOLM-13,5351362,0.6925875902125201,1.0584110969285079
HCC15,46191454,1.8626809755345697,1.7917062368781753
SW948,9825149,1.8114941973110277,2.001175067727495
Daudi,54639665,4.383406013207389,3.192933623692875
HEL,2828334,6.1216048061751795,5.514868274216424
BICR 22,71466445,3.433479198461154,3.8099893806294625
ALL-SIL,9826308,-0.8056632694679019,-0.3030069345444236
NCI-H2452,57519531,1.3990882913061125,2.5399697888043544
BICR 22,54613361,0.4978505675466737,0.18192917475584722
SK-OV-3,135440466,2.5162908691834405,2.4312147233350503
SW48,JQ-1-MK-0752 (1-1 mol-mol),-0.7749163681319219,1.7147653693628147
SW48,6852167,2.2630322871527913,2.6932118419248248
RKO,11404337,-0.3534280477619294,-0.74788176974541
ALL-SIL,5291,-1.9713425457655045,2.8385845066715802
K-562,salermide-PLX-4032 (12-1 mol-mol),5.074335009677914,4.749299986233255
IGROV-1,24771867,1.9944882740161016,2.099055289458151
MOLM-13,46224516,1.6904951862054391,1.5578198049351275
SW48,119607,5.387394946551996,5.103488065436503
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613,0.9202898759780712
BICR 22,49836020,2.6142262300183305,2.10938117824021
BICR 22,16720766,0.4876582946813295,1.2039719715944186
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937,3.1385766238623303
SK-CO-1,123631,1.846760097113305,2.1503991874955606
BFTC-909,36462,4.374665451212183,2.2479318499210312
LS180,vorinostat-carboplatin (1-1 mol-mol),3.0396864380779327,2.990301878055839
RKO,5328940,1.7974237645790871,1.3106641094571956
RCC10RGB,ISOX-bortezomib (250-1 mol-mol),1.8255695347909304,0.7332449469691408
ALL-SIL,5281321,-2.461016259028612,-2.427322787774221
P31/FUJ,568763,-0.9310646254211032,-0.340802651850718
HuP-T3,selumetinib-UNC0638 (4-1 mol-mol),3.11768337000848,3.252602920405285
HCC15,crizotinib-PLX-4032 (2-1 mol-mol),0.980759868979001,2.0919243442812046
WM115,3081361,1.7542351340434374,2.4389646404082295
Panc 02.03,676352,3.0262590525496895,2.211235107851889
Panc 02.03,44462760,5.147948611944762,3.9588951562756596
COR-L95,11228183,-1.8408108773608771,0.7992291807864338
WM115,56973724,4.208743527700851,3.3653322522262177
KU-19-19,vorinostat-carboplatin (1-1 mol-mol),2.5196906513135913,3.2522007887424547
HEL,65628,4.10911337005638,3.2369652511190314
Daudi,11612883,1.1925703345745973,2.0566906428772502
RCC10RGB,24856436,4.070420512574028,0.8360634723068603
COR-L105,46199207,3.6604959991625825,3.2883703398396977
Granta-519,25195348,3.9328442274761217,2.2079968661733984
NCI-H1568,1750826,-3.116085482779225,-0.9742400669063614
IA-LM,12001922,1.9531449792239188,1.7552165313405517
IGROV-1,19582717,6.764352444432722,3.993266826804882
HCC15,10113978,2.260363506948615,3.55491714907695
SK-HEP-1,10074640,3.7857764861964935,3.313776681461025
PaTu 8988t,6918328,1.905296387062238,0.3932373502416157
HuP-T3,24785538,1.540895569713237,1.716929826812075
BICR 31,5281321,1.1837918014475457,-0.9344787133438522
MOLM-13,216345,0.0865178974102724,2.8662947671096064
HCC15,448949,2.8674184346568414,1.9865403013435705
K-562,44566777,1.311822236929868,-0.1804615703213436
HEL,452548,-1.769607447996444,-2.6548157258680294
SU-DHL-1,11507802,0.9378608618407872,1.771648484072031
SU-DHL-6,2113511,5.89050983447184,4.597162319199361
SaOS-2,54613361,0.0035364978270003,-0.12360788063507396
SaOS-2,24748573,1.7294478830476196,2.344763386434948
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713,3.527351955984678
HuP-T3,49766530,1.2218451996302029,-0.5091386332881757
HEL,262093,2.3252232523203995,1.508893162954804
SaOS-2,tretinoin-navitoclax (4-1 mol-mol),2.244909484198112,2.5696934154642754
MOLP-8,675434,3.835070621627746,3.9785788558580304
RKN,16725315,3.256745916563384,4.2345600044841625
RERF-LC-MS,5746,1.1068525081764873,1.1012125428907082
SaOS-2,11964036,0.5086023979470407,1.4631242627901613
COR-L105,selumetinib-navitoclax (8-1 mol-mol),1.996235021345007,2.402447141927257
LCLC-97TM1,126941,-2.218385477362075,-2.559293883560004
HCC15,54618771,1.6567762934530044,1.3101794951215158
RKO,2113511,4.623772297498578,5.110463410773228
RKN,9929138,7.419607622812729,5.525383452553598
HCC1500,5460769,5.1304942195737935,2.3991728167879134
COR-L95,31703,-3.0462560513884203,-1.4891393941874247
HCC1500,46224516,1.0534131743048871,2.6194835180983995
Panc 02.03,5328940,2.397017671249583,1.6293299765086666
LCLC-97TM1,11404337,-1.4043223473519348,-0.32938356567296195
HCC1500,42642645,1.451455976812008,1.098743027523305
IGROV-1,51037431,5.669320749085174,2.981000446729866
SW1573,107970,2.0608182724975266,2.513897794255267
SW948,46191454,4.338482378206047,1.2686414877307013
Granta-519,11455910,0.302072347623865,0.25138321091053006
COR-L105,2113511,6.080993735084838,5.662446563879995
SW948,ISOX-bortezomib (250-1 mol-mol),0.2235113953706366,0.8107717284655784
IGROV-1,448949,2.098499309472767,2.149839136295482
NCI-H1568,107970,1.680617581032042,2.334442909894908
SK-OV-3,24797083,1.6169926593639932,1.4831926792227288
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033,1.3887915159077955
SW948,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.798210383310514,3.334081510864923
IGROV-1,4259181,0.1937358171291443,0.22252156091263828
LS180,135875424,4.384751932486372,3.9025238807582054
UACC-812,54765302,2.961863639252158,4.01432977305977
SW1271,49867926,6.0238397416149345,4.275970331627971
SU-DHL-1,3025944,3.851371371046294,4.0930341348005435
SW48,9967941,4.423983829284398,3.5545354164891245
SW1573,11609586,3.686627979451031,2.9830782735029198
Panc 02.03,16065773,3.1661848504472023,2.740118769395015
RCC10RGB,135421197,4.393109316582631,2.1473561148151656
IGROV-1,24785538,1.106246320450551,1.5298150893727835
HuP-T3,5278396,4.193223405360703,3.7765750402418576
IA-LM,24901704,3.940918836251392,2.693693576919788
SK-HEP-1,11214940,1.8009666315936252,2.186194545526866
K-562,11364421,-5.792707438494169,-4.434561579243824
LS411N,3384730,4.573317632228089,1.6211440166110302
LCLC-97TM1,568763,-0.0784771886342085,0.18547867045476538
HCC1500,9936388,-2.5304598124234365,-1.2017688227309187
HCC15,5311,0.7792586953300233,1.7180445278135832
SU-DHL-1,54686904,3.5039759810509676,2.555357159100586
PaTu 8988t,11626560,2.010870886496287,1.9270792416355775
HuP-T3,2749,2.009482044490881,2.104188815755174
RKO,60750,-2.2331483998906654,-2.2798826167426913
HCC15,5287620,-1.6098111318920385,-1.9635718406526415
HEL,654092,-1.523294365181231,-0.8728988269173388
SK-HEP-1,71304818,1.6350171624170464,2.6925625946578085
SU-DHL-1,448949,1.2808073887625644,1.7447495314929113
K-562,5281321,0.5422415972342122,-2.2875453621735913
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178,1.7931868497439638
LCLC-97TM1,5351362,1.316382729979947,1.4251238276364426
MOLP-8,5460769,1.8843864880791628,2.2044160371642882
SaOS-2,56963564,-0.1924881408966614,0.7609092048103928
RKN,446155,3.7628691651204234,2.306861056218045
HEL,doxorubicin-navitoclax (2-1 mol-mol),-1.6523771973343595,-2.1237078082277203
NCI-H1568,16038120,0.8714631615296456,0.8827747725888968
Daudi,25102847,1.3031740879242997,1.8815283514706436
LS411N,25154868,4.929077040033465,3.9008621587932324
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796,1.9859298211280345
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948,3.9578577564619137
LS411N,9915743,2.8294092926119028,0.47633455151858733
Panc 02.03,BRD-K55473186,4.513191364064351,3.96446412655401
SW1271,JQ-1-vorinostat (2-1 mol-mol),1.5175672893366323,1.4573719864091654
SK-HEP-1,selumetinib-navitoclax (8-1 mol-mol),3.029292695644022,2.0054748699425864
SU-DHL-6,4917,2.9501994456287792,2.8759872666539423
Daudi,16741245,3.410771008602035,3.393726859820583
MOLP-8,3062316,1.3489297980566397,0.9414559668231012
NCI-H2452,selumetinib-UNC0638 (4-1 mol-mol),4.804967854809725,3.84239553385542
RERF-LC-MS,25183872,-0.4545636564638026,-0.5484462075256283
HEL,JQ-1-UNC0638 (2-1 mol-mol),-0.0647820501822815,-0.05693115372915201
MOLP-8,60700,-2.8082015295780858,-1.0962607474458326
NCI-H2452,637858,1.8545349692582156,2.191975876428552
LCLC-97TM1,11626560,0.938916298027116,1.5134171417393603
HuP-T3,136227924,2.888640375816574,3.067230762824433
IA-LM,5284329,5.1954673618886655,2.6341259502843424
RKO,104842,-2.5196749638548,-2.8686285492075787
SaOS-2,11494412,0.4895123820960489,1.948301924238487
IA-LM,9926054,3.212619063516659,1.84837084785585
MOLM-13,doxorubicin-navitoclax (2-1 mol-mol),-5.382475006616194,-2.7998562822106634
MDST8,23635314,-2.200660522590374,-1.0331271594392284
SaOS-2,alisertib-navitoclax (2-1 mol-mol),-0.6198148244275179,0.4401590907386808
RKN,4261,1.529955054772996,1.584170064832429
SW48,11396600,3.829401994456863,3.6648111576940745
LS411N,JQ-1-navitoclax (2-1 mol-mol),0.3997266798331875,0.5583379270184312
HCC1500,16659841,5.303826701580757,3.7743481454635113
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447,3.403405213466145
BICR 31,JQ-1-vorinostat (2-1 mol-mol),1.378421076759701,1.1591906860026788
MOLP-8,10231331,1.2198029486879254,0.7663951639150849
COR-L95,16725315,5.004914745056217,3.804608752827179
HEL,16115403,-4.756245139541522,-4.621364386672867
WM115,11717001,-1.1241138002933555,3.8384911187211177
SaOS-2,11626560,1.1465195781021866,1.8784693122709033
BFTC-909,9907093,4.635414583134371,4.336698321296495
HCC1500,66577038,2.9555971550997935,3.0076636404233597
IA-LM,285033,0.5092837727748464,-1.6942597329677935
IA-LM,4917,4.737499942891754,2.8211104863349585
BICR 22,44632017,0.9263322393180023,1.0230544105756503
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713,-1.034329910223881
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656,-2.89724802565168
SW1573,89928392,2.032641459256584,1.8637455192973524
MOLP-8,119607,5.472499710124238,4.389162614672051
COR-L105,46398810,3.2483226376094194,2.741264354892442
HCC15,decitabine-navitoclax (2-1 mol-mol),0.0974547037094189,2.13580122329506
HCC1500,135999136,4.086589117257826,3.8107208206028393
WM115,11497983,4.51521868458229,4.2508129118987945
SK-HEP-1,46926350,-4.110479335135347,-3.8823666980262987
RKO,322968,3.8471310775605216,2.38993012458005
LS180,25262965,-0.0916364033105869,-1.6923943981617333
HCC1500,246676,4.424448695399937,4.3574357843408364
COR-L105,104842,-0.9230389281504464,-2.377102751932307
SK-HEP-1,navitoclax-piperlongumine (1-1 mol-mol),1.24584260367843,1.8891573573331164
SK-CO-1,6610355,4.767157937449789,4.447633496927342
IGROV-1,676352,2.310492141650647,2.1914866389208236
SW48,262093,2.726859331273406,2.6660102856669785
HCC15,55508,3.481008151195261,3.499035387890837
HCC1500,2126,3.801078614960916,4.526634480939837
PaTu 8988t,24951314,3.0808050806085188,1.4275415478187228
RKN,11455910,3.815213247766997,1.1129562009399028
SW1573,3062316,2.075650426956439,1.1319998500273911
SK-HEP-1,5287620,-1.0463187584720948,-1.9874982971816133
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555,2.675090563631993
MOLP-8,24779724,4.381900106399647,2.6237773584676063
Panc 02.03,107985,-4.238430695688479,-3.528636576075114
IA-LM,322968,2.7570489193637018,2.81178274065146
K-562,448949,1.070656561881704,1.2977108431861282
LS180,54649381,3.823257143411622,3.789402123549777
IGROV-1,5281321,-1.4962463697398798,-0.7891091126965071
NCI-H1568,42642645,1.4281976900349445,0.8302277544981869
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083,1.56120687429545
K-562,44185566,1.8580861510177096,1.6664143639539848
SW48,637858,1.3097623359774897,1.763869059552771
SK-HEP-1,613753,3.3794099216210203,3.3407551038307326
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766,3.6769331957836986
COR-L105,11234052,4.539846823478364,4.368954798344502
IGROV-1,72193861,2.0623829231433293,1.6775082838917037
SW1271,3503,3.0280256153278606,2.266936852386897
NCI-H1568,57330099,4.373464200171548,4.258311961778859
MOLM-13,1750826,-3.2515027143289728,-2.8424516320230526
SW1271,11222830,1.3106603955640226,1.531359969103203
RERF-LC-MS,445091,4.218142840499499,4.46955449011441
BICR 31,3062316,-1.406162609577698,0.3801758233248691
HEL,25126798,0.3968700607761156,3.2279258124960517
COR-L95,5738263,2.419040765220329,3.0630221566498084
SK-CO-1,36462,0.7476665664464673,2.309970215628574
WM115,49766530,-0.6421157759153451,-0.0013372775154914518
SW1271,ISOX-bortezomib (250-1 mol-mol),1.0601498198738095,0.48166841984801345
BFTC-909,46901937,4.445112058189045,3.185471696535503
SW1271,136227331,4.376300443457216,3.795719346664736
COR-L95,25262965,1.4716002732306153,-1.5935995425049796
COR-L105,5281672,4.46136628199001,4.558282856457761
WM115,73707398,1.178086440828875,1.1893104566535955
Granta-519,6852167,2.2648312753409887,1.506481255516023
RERF-LC-MS,46174525,5.020740506928848,4.765507636715739
SW48,navitoclax-PLX-4032 (1-1 mol-mol),2.4409762203438117,1.7937377341665168
RCC10RGB,44202524,4.922768729279552,2.5228520225393223
BFTC-909,BRD-K27188169,5.152610673434624,3.594636691922636
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355,1.8059451671960136
IA-LM,439501,-4.16745845294267,-2.2036591795706633
RKN,25262965,-0.5506090189051945,-1.202468517930237
SW48,3385,1.919145280274203,3.619525248658984
RERF-LC-MS,12001922,2.43602915295576,2.0511525513720263
IGROV-1,568763,0.665047061839467,0.852575529983506
P31/FUJ,10385095,1.5135865779060806,0.5178674395181502
HuP-T3,12001922,2.3367896101102907,1.9850782879874171
HCC1500,1641662,3.3816027924522487,3.717684995387822
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828,3.3513990170114947
P31/FUJ,1242560,3.8275456086274127,2.934277363566647
NCI-H1568,57519531,1.3161148530355309,2.7529613503731216
SW1271,42611257,4.308869978455437,3.4402212049221386
Daudi,10184653,1.026270071695755,0.5091222440215644
K-562,2858523,2.745068324935018,2.820573363210168
IA-LM,crizotinib-PLX-4032 (2-1 mol-mol),2.5646441197957555,1.2881720206375027
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631,-0.577740264726155
BICR 22,12001922,2.2523981699696165,1.918944425234799
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719,-0.24855032429953655
UACC-812,5978,-2.554443854158195,-1.6288449767014368
MOLP-8,753704,3.0200894206550877,4.093748741099543
ALL-SIL,5394,4.4345454375843625,3.2650324996610633
RCC10RGB,navitoclax-PLX-4032 (1-1 mol-mol),2.769034348653669,1.8889483931075983
WM115,selumetinib-navitoclax (8-1 mol-mol),-2.2824841087283954,1.4895652013283054
NCI-H2452,44137675,2.6709050374584846,3.749752989143926
BICR 31,52912189,2.5113420173615464,2.541842610800818
WM115,72199292,4.562209520612744,0.3204327736447422
BICR 22,25154868,5.114547534217177,4.430106478463073
SW48,25262965,-0.5589271325062998,-1.241799172237695
IGROV-1,4705,3.3098412390054603,3.0122575854065
LS180,SNX-2112-bortezomib (250-1 mol-mol),-0.5067570232278682,-1.6794874305757526
COR-L95,11955716,-2.3894028875885778,-1.4248449597336843
BICR 31,241158,4.31214680273537,4.108083085115701
RCC10RGB,25062766,2.0619451400109265,2.1869463305710157
HCC1500,25262965,-5.244904140838402,-1.0611953161347405
PaTu 8988t,285033,-2.1993510069972215,-1.7516710973258567
PaTu 8988t,44566777,-0.8532538772982161,0.7102023703857147
SW948,71466445,3.954398511848749,2.848161465898703
IGROV-1,6610216,4.310938387105607,4.106228975424988
PaTu 8902,11497983,4.394920409770125,4.359201915019131
SW48,11612883,0.3553002535249436,2.5971940776126137
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188,-0.3123319942497211
HEL,9868037,2.50949616555346,1.7271234213410918
HEL,11178236,-0.8324730036537664,-3.7747672146847564
RERF-LC-MS,60750,-4.1612389836176,-2.0106688071680603
Granta-519,carboplatin-etoposide (40-17 mol-mol),-0.2598184919405968,0.07752988940633838
SaOS-2,24901704,3.518814077302041,3.236585075823198
COR-L95,6914657,-4.192308975603822,-4.541193677292525
COR-L105,262093,2.940873643596252,3.228742075685935
LS180,44486219,4.325065743764261,4.2121894081819375
RKN,10074640,3.313081701902331,3.275781161420757
BFTC-909,5746,0.5111824642409613,1.1240816952444284
K-562,8515,4.039482215632923,3.3128077711167525
PaTu 8988t,31703,0.1373281877500042,-0.5453653571151178
MDST8,135984461,4.124255066625015,3.4330239003067873
WM115,107970,1.780812210779262,2.376930301597506
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112,2.6829260145629363
IGROV-1,327653,3.667792542405671,3.1018572951675334
P31/FUJ,89183176,3.539325961528454,3.0479569500472263
RCC10RGB,6438330,2.9900078425794385,2.4210240870449415
RKN,5280436,4.161667428331563,3.563539214739499
COR-L105,445455,4.3186388426275535,4.809243768972703
LS411N,24785538,0.7817075732213645,0.5669131997258287
Daudi,11152667,-2.9472151872913104,-1.948937776287309
P31/FUJ,448949,2.0159916590055067,1.3374713282774653
Daudi,11609586,-0.3532025604686024,1.53296188820519
SW948,46926350,-4.641976408237662,-4.246569645714526
SW1271,72193861,2.914678902909763,1.7044949090162893
PaTu 8902,25126798,4.210533326596683,3.8496214408854654
COR-L105,11955716,-2.257823880116287,-1.1617779659444223
HCC15,46224516,2.679221759698836,2.8846330554590183
HCC15,135423438,2.37991378319322,2.376515847090132
Daudi,421610,1.7509728437935097,2.301694511616768
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.0837817777729475
SaOS-2,11238147,2.85636627636287,2.8868276608153036
IGROV-1,374536,0.7022324251593053,2.441048546590101
SU-DHL-1,51039095,1.7422871999086744,2.3093910543148617
IA-LM,72193861,3.820444995189443,0.5997301317529206
HEL,5738263,3.378820716395454,2.4539533491587964
RCC10RGB,BRD9876-MK-1775 (4-1 mol-mol),3.486807022828034,0.8797781131564801
SW948,6852167,2.188206161672083,2.597258440770515
K-562,71751553,5.367911183247371,3.6679791218885054
BFTC-909,71304818,3.116417285157316,2.542800779839557
SW948,25227462,-0.2382390684396511,0.0378343951640093
SK-OV-3,637858,3.830307013284548,2.022864030766431
RKN,49766530,-3.8574490235665584,-0.6070268114950134
NCI-H1568,9933475,1.8521331470520848,1.8779015132310979
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857,1.9993367852409383
KU-19-19,17759555,3.7275461226555566,3.663051185182919
LS411N,44589607,3.372730635507476,2.0898497845336106
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757,2.138474517941556
SW1271,5278396,3.101008990901291,3.600855560272515
LCLC-97TM1,46398810,1.8633773855233131,2.284525367183483
SK-CO-1,6852167,2.111498553552754,2.7957755884423743
SW1573,5479543,3.675213844165782,3.698505807024377
COR-L95,12003241,2.921570030601445,-0.7197309492945265
Panc 02.03,9911463,4.953148943637795,4.001420079558155
P31/FUJ,crizotinib-PLX-4032 (2-1 mol-mol),0.7828925550397006,1.0601441167543706
RERF-LC-MS,3384730,3.247206310046507,3.020479579177265
IGROV-1,51039095,1.7163430299301403,2.916173355754493
KU-19-19,89928392,2.8864230284497747,1.6334900865553599
SK-CO-1,216468,0.6363757446548435,3.4356630993877144
LCLC-97TM1,3038522,2.979698040139259,3.153984864177593
BICR 22,6914657,-3.057028291966878,-2.8453212108590593
MDST8,3815108,3.655140825789689,2.6558935166319624
HEL,11364421,-3.0976744543470067,-4.459792143007023
SW1573,10074640,3.956421484938757,3.1756572317222678
LS180,6610355,3.640469161520063,4.254504819736511
Daudi,2858523,2.224035136584194,2.8614920767015404
BICR 22,135875424,4.925705128316808,3.938296077133444
SK-OV-3,23582824,0.9299959314677436,0.6902086110862306
K-562,5282054,3.5952240521498062,2.8212128078582435
NCI-H2452,44589607,3.0010828964799208,3.260707304738269
LS180,638278,3.5544678930796656,3.0036356607024266
MOLP-8,426756,3.5390437920539117,4.010951198547024
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614,1.441624926924402
SaOS-2,selumetinib-MK-2206 (8-1 mol-mol),3.420103401204114,2.56801360144221
SK-HEP-1,selumetinib-PLX-4032 (8-1 mol-mol),4.995301598954557,3.5305071705765845
BICR 31,71466380,5.422644788319504,4.492930511240387
PaTu 8988t,53392493,3.5279637137541524,2.697739452008675
UACC-812,6610216,4.947422623598504,4.258496278454066
SW1271,16038120,0.5203426502283315,1.18846615281893
IGROV-1,67156097,0.1763939852409119,-0.280327761385355
UACC-812,216239,2.3945159107119767,2.1854739084625656
HCC15,serdemetan-SCH-529074 (1-1 mol-mol),2.4880259252589543,2.1909436725847176
ALL-SIL,36462,-1.376242093473402,-0.30195063245203846
BICR 31,1750826,0.6511109819152475,-1.0365137522735355
IGROV-1,56649450,0.515518984822669,3.339763381593775
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445,3.0279731228342883
PaTu 8988t,6918837,-0.8891471976747255,-2.2802506641280975
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507,-0.2551665995723191
NCI-H1568,2828334,5.9155051642717,6.1909830662405545
MOLP-8,56973724,1.5171827826362807,1.8531919554997804
MOLP-8,2729026,2.779201693602774,2.2983702135996085
P31/FUJ,753704,3.2802738483106766,4.008516980944079
SaOS-2,25183872,-0.102413301755783,-0.849122033432814
NCI-H2452,decitabine-navitoclax (2-1 mol-mol),4.538424362545292,2.0546518348217173
LCLC-97TM1,9825149,1.404394440199107,2.257059468397382
WM115,9929138,6.7694003006369226,5.380114517212971
RERF-LC-MS,2746,3.2731211053052647,3.3940008332570333
COR-L95,5351362,0.837381680047442,1.1316375656166147
HCC15,ISOX-bortezomib (250-1 mol-mol),1.036560789961647,0.8229165337634082
RCC10RGB,3101542,4.48788654191394,3.6103419011063043
BICR 31,44566777,1.4466588952743178,0.8101670186563714
WM115,5746,-0.962904812763719,1.1792737028386766
HEL,9903786,1.206049982415758,1.7384111234520188
NCI-H1568,44486219,3.435494584556288,4.365020220088485
SK-CO-1,124202324,2.795373404058925,2.5039277709966443
MOLM-13,5329102,-5.212236525427112,1.238379551512087
SaOS-2,10427712,4.893681366378875,4.403322603185657
SW48,409805,3.4729287041870127,4.6830936755812385
HCC15,216345,4.3772403070959705,4.089072689261743
NCI-H2452,46215462,2.291566037713401,1.8914155015977292
SU-DHL-1,55283,1.0511806970329092,2.265925842698005
SW48,navitoclax-birinapant (1-1 mol-mol),1.0401381719181744,0.8960002205547162
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182,-3.8370989169810574
MDST8,24821094,3.627663013095859,2.8500962131659486
HCC15,9911463,3.642862209488471,3.8839599729846572
BICR 31,navitoclax-gemcitabine (1-1 mol-mol),3.844959889456845,-0.5635159020098671
SW948,11178236,-0.7120713487548671,-2.894041872845773
HCC1500,5329102,1.6369795361395487,2.056503458226743
SU-DHL-1,11364421,-4.160715855029451,-1.9407198661076392
SU-DHL-1,176870,3.225718242496366,3.449773901313272
WM115,2742550,3.774256401917875,3.9529864254499527
SW48,12003241,-0.9746028071684796,-0.9533068343519013
NCI-H1568,11494412,0.631822071405162,2.018384835881453
WM115,25102847,1.9091464851380515,2.380568233044731
COR-L105,23725625,5.8274909459435165,5.271406108080007
Granta-519,9956119,4.186560294974692,2.6558615519644597
COR-L95,72193861,1.6807669427950571,0.8428035840247696
IA-LM,6917907,0.442667441503668,-4.664704318699655
SW1573,53232,-0.4627324496874346,2.6420666237280153
Panc 02.03,19582717,5.117031119305748,4.437640924407849
RCC10RGB,227681,3.758665689171896,3.5224075814525206
WM115,24901704,3.629786211252992,3.3631068239729704
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061,0.3858141400887347
K-562,637858,1.3097643671251342,0.9414871384397706
SW948,613753,3.0653891790249617,3.021249437522091
Granta-519,9926054,1.8135939424605243,1.6233595647389647
SK-CO-1,55508,3.57241133457179,3.252291480859974
HCC1500,5426,4.174536858194301,3.514561214896811
IGROV-1,4521392,5.131794979216607,4.196224175305276
UACC-812,6918878,3.827620339158657,2.8323144330177707
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906,0.6822996336415738
KU-19-19,72193861,2.401782330602402,1.8360264295992936
WM115,5281321,0.1495893125543727,-1.0533584247978678
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901,3.1262138443550396
P31/FUJ,31703,-2.5575864334968976,-2.6295744492876763
HEL,decitabine-navitoclax (2-1 mol-mol),-1.4855622179945482,-0.8675089354473781
ALL-SIL,44589607,0.5481515481681011,1.707754928428047
PaTu 8988t,11955716,-2.6731660557009267,-1.783712642279513
IGROV-1,5738263,4.037832478240785,3.45112555997276
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382,-2.5304348668966528
BFTC-909,650361,3.8112149600795706,3.889746125505086
SW948,16725315,5.2631267850751335,4.0770552039594445
Panc 02.03,25102847,3.3458680072040603,2.6884843729092545
BICR 31,216239,4.655547148927136,2.4870662529347634
SK-HEP-1,51039095,3.60670356936783,2.8432678914358167
IGROV-1,9907093,2.687959785702283,3.9878764421102137
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902,-1.8098821631279043
LCLC-97TM1,49766530,0.6419783818490065,-0.756896027503002
Granta-519,2113511,5.634502761977105,4.397911386547884
COR-L95,322968,2.331837213900703,2.7955173963592093
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549,0.5075512754738543
SW48,60700,-1.9747801062936423,-0.3511411133778475
SaOS-2,46907787,1.5905885991562354,2.509360780039279
LS411N,5311,1.0830647686053458,0.7593398360282254
NCI-H1568,5278396,3.684546625455108,3.6085570198423085
P31/FUJ,2858523,2.921593087757198,2.7841814598501533
MOLP-8,25102847,1.798391543473315,1.863409712194083
HCC15,57330099,4.175732386995395,4.339163712849091
LCLC-97TM1,16013152,5.423690206414697,3.8136289237612853
SW1271,16065773,2.6188234772001886,2.391799509511559
RERF-LC-MS,52947716,-5.597592816818683,0.08943707374316733
MOLM-13,11167602,-1.7638454235436123,1.7802970525385273
NCI-H2452,vorinostat-carboplatin (1-1 mol-mol),3.5311802496777576,3.341617291177526
Granta-519,3038522,1.8764454398289976,2.539837264274888
SW1573,54626689,3.958399976383255,4.599943477949549
K-562,445455,4.202279962055385,3.810038289646653
SK-CO-1,25262965,-3.291258197582341,-1.1209071612502641
Granta-519,54618771,-0.1786557603441652,0.22671748555876026
ML-1 [Human thyroid carcinoma],216345,4.790115930225849,4.105650973605141
HuP-T3,42642645,1.566786855324099,0.9915670105018424
MOLM-13,44589607,2.917529465117915,1.9425939675714594
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862,1.4058736024173784
SU-DHL-6,753704,4.418086475877281,4.05715303181505
SU-DHL-6,6918837,-4.716152603392634,-4.706124150567929
P31/FUJ,46199207,2.4446101047156215,2.6819702088833286
SaOS-2,156422,4.313289259132858,4.024100796606657
BFTC-909,5282054,4.21714099973987,3.8818284179645777
RCC10RGB,9803433,4.221770064596342,4.526994454392497
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455,-0.1666457401729744
RKN,89183176,6.327700475537756,4.500137556016966
BFTC-909,16038120,1.74161234898449,1.1951825332226422
HCC1500,71466445,3.970736335461394,4.100602799054868
Granta-519,25062766,1.8322611726564384,1.5587582244891762
SK-OV-3,216345,4.761928129554225,3.951262745482972
Granta-519,11609586,-2.485330170292811,1.126193855403497
SK-HEP-1,6918878,4.4325993547595655,3.290502040176906
P31/FUJ,676352,1.6175160353980318,1.5995388227468859
UACC-812,25227462,-0.2916299121927669,0.2601071609329326
RERF-LC-MS,54596558,4.400747096440468,4.5080244139190135
Daudi,9911830,-0.0057102646081846,1.8833232696840028
COR-L95,72376,-2.5853838467146493,-2.570187854790845
LCLC-97TM1,135875424,3.9585615026829823,3.534976596670698
P31/FUJ,49850262,2.7073676452568427,2.7379627494493493
HEL,10410894,1.686960620182283,2.7557195774980316
LS180,10127622,1.4423864514133429,2.8383072288377855
LS411N,16038120,1.458068935835204,0.46303936310550375
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506,3.2484964421408233
IGROV-1,11214940,1.360660548899077,2.271828951228982
Panc 02.03,969516,3.806573436208542,2.9116426776172846
BICR 22,JQ-1-navitoclax (2-1 mol-mol),1.0465005615278271,0.94053706687312
SW48,656346,-0.2718986936332406,1.2093779398840792
SW948,285033,-0.875487938395224,-1.8222282892585762
Panc 02.03,4261,3.516583077320981,1.70295197945042
SW48,49766530,3.606492941369466,0.44395214513881986
SW48,16038120,-1.7922421690180796,0.48324048460337043
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128,0.9248932805537126
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024,3.309205564475213
WM115,2945648,2.5851994154769025,3.043538472588273
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999,3.192166374259136
BICR 22,25227462,-3.180570489875023,0.5231042061033604
IGROV-1,5460769,1.6083174601829917,2.869405595440461
K-562,753704,4.7227938780788525,4.254783565857282
K-562,ISOX-bortezomib (250-1 mol-mol),0.3376370593793573,0.3622521411864132
HuP-T3,4788,5.894927949545096,5.76044280173571
SK-OV-3,42642645,1.640931292575566,0.8855499713289653
PaTu 8988t,11222830,1.761666424308375,1.6134406196880153
BFTC-909,448949,2.818327130228084,2.09389769130221
HEL,serdemetan-SCH-529074 (1-1 mol-mol),2.278758279722759,1.424580435658954
WM115,5281672,6.287836255113029,4.354811013665593
Daudi,3384730,1.441294292217556,1.3976916768350702
SaOS-2,navitoclax-pluripotin (1-1 mol-mol),-0.5587106095561101,-0.9210167848431747
LS180,6252,-0.5438897009285958,0.7873275061994341
SaOS-2,3025944,4.435896212894107,4.237179057460174
SaOS-2,25161177,4.43427627730954,4.100383040238606
LS180,JQ-1-UNC0638 (2-1 mol-mol),0.673634242684319,0.9874768201245476
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892,0.047572248091362915
BFTC-909,11228183,3.298719229946038,2.4246938825651245
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286,2.032064670349136
Granta-519,135659046,3.900512348834848,3.3321993626493036
LS180,126941,-2.6871715133008385,-2.092536693005397
MOLM-13,3081361,0.9632978577503784,1.7117378159898617
WM115,9936388,-1.175666523167262,-0.799388148789427
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197,-0.610787427936044
IGROV-1,15953870,2.712793598656007,3.638670784638731
RKN,10410894,1.511663597063748,3.2727910548989105
IA-LM,6918638,0.61198230609435,0.5460076649245544
SW1271,56946209,-4.174123648346971,-3.7036242828267927
BICR 22,67156097,-1.5899611273150889,-0.20990049443381456
SW1271,2749,2.846909316544141,1.9807997730204976
KU-19-19,65628,4.405271017285275,4.603888956523448
MOLM-13,5566,2.591289759721003,2.782224606985175
HCC1500,89928392,1.0051530188155344,1.7713262429111827
SW948,25102847,1.6816963863778185,2.091082150330368
ALL-SIL,10427712,3.5706749567785625,3.5992020009421073
IGROV-1,2749,2.0319044408234954,1.9900050357347525
LS411N,selumetinib-piperlongumine (8-1 mol-mol),1.1466452951203283,2.109661403453865
HCC15,SNX-2112-bortezomib (250-1 mol-mol),-3.246727097806559,-1.308088940123853
SaOS-2,1242560,3.6046854082724034,3.6363113051336495
RCC10RGB,123631,3.672101761387351,2.453469801725248
SaOS-2,JQ-1-MK-0752 (1-1 mol-mol),2.214313979092396,1.7754022408258792
SW48,carboplatin-etoposide (40-17 mol-mol),-0.9429596789262168,2.4070549082266073
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139,-0.4947348604924182
MOLM-13,23725625,2.3173082013566204,3.380489205845345
SK-CO-1,15547703,3.920131639479481,3.074567904704543
SK-CO-1,navitoclax-pluripotin (1-1 mol-mol),-0.9841338872717872,-1.1125821564196157
SaOS-2,71729975,2.29546286795302,2.1774797778975876
KU-19-19,12003241,-0.0608702413973226,-0.9569574833314997
SK-CO-1,568763,0.0338205510733868,0.7420585030143108
SU-DHL-1,984333,1.5848171755072842,0.28078100664311095
RERF-LC-MS,49766530,0.7744144603938863,-0.27591382633819544
SU-DHL-6,11152667,-4.5064226702829,-1.6654099549337391
HCC15,2130404,2.6093174666871293,3.342269514238312
RKN,11626560,2.593417875894138,1.9446203798722743
NCI-H1568,navitoclax-MST-312 (1-1 mol-mol),0.8258625122307741,0.7988568086507801
Daudi,44137675,1.0044684727898117,2.7056798253702126
SW948,54619267,3.654776559833868,3.920969731248032
MOLP-8,selumetinib-UNC0638 (4-1 mol-mol),0.7931432464838661,2.6145818593776737
RCC10RGB,4259181,1.719089746142662,0.37747609291239975
SU-DHL-1,9887053,2.0473441666614156,3.914903532550186
SK-OV-3,9911463,4.2249846626647125,3.9174332578381357
HCC15,49766530,0.5190445493569186,0.019015982541263972
Granta-519,3385,2.090684083959823,2.6584226762556087
RKO,54613361,0.2998145946125954,-0.14019946420573492
HEL,3384730,1.593743887858678,1.409091869467413
NCI-H1568,11977753,-3.4091025242198696,-1.084082950115555
SK-OV-3,285033,-0.1977879636486448,-1.5987357266763396
Daudi,3385,1.70419989930712,2.3205786995700923
NCI-H1568,9825149,1.6639399446813206,2.099195001495102
IGROV-1,654092,-1.340387623873854,-0.005734850945298391
SW1271,126941,-2.215477966101826,-2.435556573376334
IGROV-1,6852167,1.5305143027352028,2.8760236503936234
HEL,11626560,1.0872099702081388,0.6476786465060604
SW948,126941,-3.436390914894009,-2.5915810740493344
RKN,107985,-3.0900461086436404,-3.2130633808868185
P31/FUJ,12001922,1.6134382673725098,1.3845575118148827
Daudi,11404337,-3.064654238522792,-1.0306789149260887
SaOS-2,6438330,2.0981522234577064,2.0277533556582363
LS411N,126941,-2.790198017582557,-2.749707851513812
HCC1500,10302451,3.7658874637842135,3.0303524197583784
BICR 31,4259181,2.3774772051226685,0.41708922657290404
MOLM-13,11656518,1.5202718128538335,0.4192431714664414
COR-L95,148124,-0.3758104123213183,-2.8946748266908418
MOLP-8,53232,1.5052202963885184,2.602077195783352
NCI-H2452,3038522,3.3601174997652725,3.0513184984651933
HCC1500,erlotinib-PLX-4032 (2-1 mol-mol),3.588293308391856,2.726253415814513
SW948,16722836,1.2939108289094092,1.2603211064773736
HEL,439501,-2.350875236844296,-2.48557161858273
NCI-H2452,445091,5.08182727911324,4.531814187061827
RKO,9840324,5.302067215897717,5.464760341924695
SaOS-2,44489675,3.960447273667139,3.9851983638422
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691,2.414419603089016
BICR 22,46901937,4.667354689676901,3.1030097231393468
LCLC-97TM1,2746,2.92478275020961,2.6396599947477775
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273,-0.1210748425101053
Daudi,44491742,3.5549145676591314,3.933083882468168
BICR 31,374536,2.383890315264743,2.784795467623304
NCI-H2452,17759555,4.398260875691204,3.700824597212675
LS411N,25183872,0.0970121311419586,-0.589933882071731
Panc 02.03,23725625,6.172373492037936,5.213349601231857
Granta-519,65064,2.9178387202883735,3.781885894455053
COR-L105,11222830,1.704570553497338,1.6196281976667268
NCI-H1568,5394,4.198509108960074,4.094289758567367
P31/FUJ,135984461,4.1454221372139894,2.8622024491856717
K-562,49836020,4.414855158615189,3.0155706807103257
HEL,4788,5.03605552733545,4.86779005419342
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062,0.6169213507997403
LS411N,6610216,4.962940577428159,3.9000839874341193
NCI-H1568,23635314,-3.8228905075414055,-0.8652570462096505
HCC1500,5328940,1.924598719414512,1.7538996268303426
BFTC-909,44589607,3.3115887945185496,3.135264745397923
MOLM-13,5281321,-2.338854439084819,-2.447735382351399
MOLP-8,71466380,3.4619880715079603,3.747458967608578
K-562,439501,-2.3563528898814905,-2.406785631929733
LCLC-97TM1,44819697,0.4394946813834864,-0.8241099678399444
HCC1500,9956119,4.194319271525248,3.5426048067996176
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.583978337786103
HCC1500,6505803,-1.3038553273576796,-0.7133651626702293
SK-CO-1,16038120,-1.5377645940979283,0.9523595520705247
MOLP-8,46398810,1.7248083632166018,1.9417078884353898
RKN,73707386,3.296207724675486,2.552853189935543
HuP-T3,6918638,1.0959798369911515,0.6121907204828355
SK-CO-1,72734382,5.327408257337546,4.517003900773582
P31/FUJ,alisertib-navitoclax (2-1 mol-mol),-2.72541188794455,-1.4957881907267412
SU-DHL-1,23725625,3.354193732931358,4.659727703133046
SW948,4378219,2.7444419460246716,2.2177513329367726
Granta-519,6610216,4.381057854502396,3.7688117383659905
SaOS-2,25126798,4.16568157244383,3.9658484203121365
MOLP-8,11719255,2.3085103352777057,2.1689296195196985
SU-DHL-1,969516,2.44648475018104,2.7813801973708623
HuP-T3,9884685,1.9355517940144655,0.9624379785913924
SU-DHL-1,54618164,3.660876980117255,3.7989682727040837
P31/FUJ,4788,5.1911977113578285,4.94171912372144
IGROV-1,10074640,3.2681490579824426,3.1625051790981447
LS180,46224516,3.8200366067107714,2.7761118395809903
K-562,24753719,4.107201496626299,3.6729981358615538
HCC1500,46926350,-3.99988450675712,-3.7346769302467875
LS411N,11175137,2.6624545374598,2.1026717434129947
IGROV-1,71466578,4.017291197092763,4.448235705858479
Granta-519,10184653,0.998312657126817,0.7045635572693777
MDST8,selumetinib-MK-2206 (8-1 mol-mol),0.7033297936486181,2.243355313657754
MOLP-8,6918328,-3.583816044173495,-1.3426655502000395
SW948,56649450,1.940604714075546,2.972911517825921
BFTC-909,374536,2.594742723017773,2.2671476918945648
KU-19-19,44185566,3.361767971446376,2.6151001810709467
NCI-H2452,1750826,0.2631697114156899,-1.6886606648285167
LCLC-97TM1,24180719,3.1823264447338837,3.408883768936894
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077,-2.6681562359389517
KU-19-19,navitoclax-piperlongumine (1-1 mol-mol),2.9388781180521124,1.98041392630931
RKO,675434,4.252493680505022,4.488720650124804
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955,1.420382971924846
HCC15,25105715,3.3758270019314147,3.3552062671899034
HuP-T3,6610216,4.722811341582641,4.343456961132137
MOLP-8,156422,3.6985484587412394,3.3056414146769955
SK-HEP-1,6917907,-0.2672796642005143,-4.349430826704706
SW948,984333,0.954004982504914,0.782767307329846
PaTu 8988t,51039095,3.672985699080835,2.9383456650019326
Granta-519,selumetinib-BRD-A02303741 (4-1 mol-mol),7.197937797796196,3.532052019661791
MOLM-13,10385095,0.2048351805935088,0.7461366980107527
WM115,2842253,4.366205978966029,5.156662531117562
NCI-H1568,navitoclax-birinapant (1-1 mol-mol),1.7942101393430023,1.0883254581339359
IGROV-1,135423438,0.764137689665023,2.4798559373188183
RKO,16725315,5.119694523443236,3.5918510149201586
MDST8,11609586,4.829072296940778,2.9345393614717006
COR-L95,7251185,1.1216187825494426,2.0467487682196897
RERF-LC-MS,51039095,3.2453184174795324,2.7939263782499903
P31/FUJ,17759555,3.626728737883383,3.3905007663019067
HCC1500,5113032,4.590685122922873,4.948997075189813
P31/FUJ,16741245,4.043144814115882,3.3713744142705058
HCC15,5746,0.6503914795852271,1.1404010816535153
RKO,10074640,2.8357111382750646,2.914533075597552
WM115,10322450,3.651827454662003,3.713487937322027
LS180,11404337,-0.0678179476465551,-0.4604042159934697
Daudi,46191454,-0.8094751773550651,0.36960226419476255
P31/FUJ,selumetinib-tretinoin (2-1 mol-mol),-0.8330243559244562,1.9579725116232123
P31/FUJ,44202524,1.0280075167408849,1.1361062166017124
ALL-SIL,44185566,1.0410692737439569,1.4771783502728377
PaTu 8902,54618164,4.284638344065584,4.22944994539505
COR-L95,46224516,1.2687748324677306,2.453345168390686
COR-L105,56949517,4.666554440626914,4.5756786237940545
BICR 31,piperlongumine-MST-312 (1-1 mol-mol),1.564015805040982,2.0248957043792655
BICR 22,45279963,3.757910341256097,3.381018497656574
HEL,9911463,3.4775133545177774,3.055848609586974
HCC1500,navitoclax-PLX-4032 (1-1 mol-mol),-0.625964193644412,0.889546650642895
BICR 22,JQ-1-MK-0752 (1-1 mol-mol),2.0389244155422577,1.3438561562869333
Granta-519,5287969,-2.420005986832857,-2.120476576972569
IGROV-1,71466578,4.017291197092763,4.448235705858479
Daudi,1323703,3.9745876209629354,2.266550589800605
COR-L95,9956119,3.960527548011759,3.2769932934570596
SW48,15953870,2.1672009909649415,3.7827734471907593
SW48,5278396,2.530949009900888,3.5767255167248475
WM115,10296883,3.9273376390568138,3.981693883657053
NCI-H2452,10302451,4.286596307748033,3.558356902798743
SW948,9915743,1.1952390119197474,0.3858177707473228
SW1271,9903786,4.005340236032604,2.969773004023976
LS411N,49793307,-3.1894754739686455,-3.058709454465175
Daudi,126941,-4.413815937813151,-2.9227225859979353
SU-DHL-1,89183176,5.662525063156772,3.7490171928188714
BICR 31,SNX-2112-bortezomib (250-1 mol-mol),-2.620347476140509,-1.1135792378974192
SK-CO-1,216239,2.5779715954988656,2.252897189049915
SaOS-2,24889392,3.914866726590468,3.8850098890251648
LS180,3025944,4.8838055311701805,4.1504231383983585
SW48,11626560,-0.4765255311776857,1.7093047145519171
RKN,168313047,2.366456695786382,2.3257990934017845
NCI-H1568,4788,5.820003751306211,5.487975457490662
RKN,65628,4.337575078598336,4.428961904985013
LS411N,5311281,3.759327828108219,2.4703626967155468
RKN,23725625,4.172652901782409,5.16341524742409
BFTC-909,168312962,2.436518653578315,1.9280736779523284
K-562,56946209,-4.819463057676977,-4.765673222850928
K-562,navitoclax-piperlongumine (1-1 mol-mol),1.084720053726158,1.25665258135642
Daudi,11647372,-0.1839602824658907,0.23090690210110623
SW948,5479543,0.3482839273666757,2.750286424592178
SU-DHL-1,11626560,-1.697644171575415,1.5636781228286554
BICR 22,71466380,4.042212978424107,4.368129937178345
HCC1500,selumetinib-UNC0638 (4-1 mol-mol),3.968035032331931,2.730604042637686
MOLP-8,BRD-A02303741-navitoclax (2-1 mol-mol),3.766843844868067,1.3649375707721936
MOLP-8,9967941,2.6295638429027206,3.082622374115171
SW1271,piperlongumine-MST-312 (1-1 mol-mol),2.322149279280664,1.7046405171911951
NCI-H2452,25183872,0.970145395005522,-0.7347527327833725
RCC10RGB,navitoclax-MST-312 (1-1 mol-mol),1.0881941253840328,0.9831968448554771
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996,0.7183619852884761
HCC15,8515,2.8931769079597767,3.791138059443096
SK-HEP-1,7251185,3.0945137710223687,2.7899000856217846
HuP-T3,3689413,-1.422602865458103,0.07906050395053323
HCC1500,2113511,4.626117550925971,5.259408933055588
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043,4.303307088317065
SW1573,5351362,2.395315345585997,1.594369737472238
SaOS-2,16725315,3.258166087647875,3.9161046547640934
SK-HEP-1,44566777,0.1035402456781041,0.7166116067086095
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694,4.229745011253387
NCI-H2452,54618771,2.226699645078912,1.3815276528285734
RKN,5329102,3.127163305072316,2.0098275297843724
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943,1.3193612787649278
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.0837817777729475
NCI-H1568,5287620,-3.0605655272876104,-2.020625157874902
IGROV-1,5329102,1.2794664511054334,2.0132615963717315
SU-DHL-1,71680916,6.473574001994787,4.6020446845484235
COR-L105,25262965,-4.3344847799771,-1.3125613649049344
SW48,3503,2.2068347221848605,2.1654556862692433
BICR 31,36462,3.088359748996336,2.445706985695631
SK-HEP-1,24753719,4.401042857593667,4.296844495013346
RCC10RGB,navitoclax-gemcitabine (1-1 mol-mol),-0.0681716439191075,-0.49965662442063136
IA-LM,16659841,3.92216274325252,2.8708562439560326
WM115,24771867,3.628628048718056,2.923174026315743
SK-CO-1,67156097,0.6545128366700663,-0.18839686423043267
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934,2.8013252677075555
SaOS-2,navitoclax-sorafenib (1-1 mol-mol),2.1552340524690843,1.6749038435669297
IGROV-1,71466380,4.863636874274779,4.269614038310135
HCC1500,selumetinib-piperlongumine (8-1 mol-mol),2.4825259194039173,2.994486524554087
Daudi,5281321,-4.970506938945455,-2.5969963349549294
BFTC-909,12003241,-0.8371396827795129,-1.0814033800515188
SaOS-2,44185566,3.018169617675811,2.7553853728172584
SW48,54619238,4.554849733994691,4.462941410795349
Granta-519,25227462,-6.0432717278136066,-2.4021271719744908
HCC1500,72376,-0.7270592073375387,-1.4892621775907404
SK-OV-3,3689413,0.6002437290843657,-0.24742078160441616
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279,4.714927996914883
COR-L105,71466380,4.962997689396809,4.609826540102186
K-562,56649450,4.352548214039191,2.7260991431455137
ALL-SIL,2828334,5.780519190951295,5.524891631213389
MOLP-8,5746,-0.9490954024297016,0.017493619215271407
LS411N,9935249,3.5378716054356927,1.4039384938053845
KU-19-19,148198,-3.572091199224797,-3.5201185478961423
Granta-519,navitoclax-piperlongumine (1-1 mol-mol),-0.8573381901716745,-0.14107558180872862
Granta-519,navitoclax-MST-312 (1-1 mol-mol),-0.2022371646874937,-0.2525653753102544
RERF-LC-MS,54619267,3.9836959677109354,4.179004178681534
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864,1.265638713718659
SK-CO-1,445455,4.388752059403359,4.792424177382946
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032,3.534749756937298
BFTC-909,6914657,-4.61933610547547,-3.5661092741364855
IGROV-1,54619267,3.9701367924453455,3.916677424866417
NCI-H2452,6918289,-3.5458030779688277,2.718459068681004
SW48,654092,0.3720639788768654,0.06963223326714402
LS180,10184653,1.1411409682713576,0.9997535258465655
SW1573,4259181,2.0061423198913766,0.3554704618899192
BICR 22,5978,-3.054007840707858,-1.8730064872551548
SK-CO-1,446155,2.509492168961503,2.601497035896266
HuP-T3,piperlongumine-MST-312 (1-1 mol-mol),1.4346079723069378,1.8438631186769374
MOLP-8,6917907,-6.199761218038622,-5.543646062817982
WM115,6610216,3.675624927368402,4.225250161248005
BICR 22,11964036,1.4111698106068242,1.4135991094931903
IGROV-1,135440466,0.9791523710816318,2.283322810681581
SU-DHL-1,46224516,1.9664047258697153,2.2649113610077687
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185,1.173221912992942
NCI-H2452,156422,4.888821376667332,4.20983588507965
BICR 22,446155,3.7361559304721106,2.5799418140063097
BFTC-909,3038522,3.685618431455981,3.19934756583773
RKO,46907787,4.104881837237831,0.28672332880146567
IGROV-1,123631,1.7694522866439453,2.187533608867449
LS411N,5280436,4.183720769167266,2.789217507333081
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121,-1.5697506707016968
HEL,5311,0.0816485968486221,0.4350427934478383
SU-DHL-1,327653,2.51842673185387,2.785207934039397
MOLM-13,8515,0.8268618162227004,3.045453836526605
MOLP-8,25183872,-1.6811002192977054,-1.7709628689014076
Granta-519,11228183,-2.3490545548585335,0.37925494068082977
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776,0.7016635232484113
SaOS-2,5470400,4.204063595869918,0.22832711364855562
BFTC-909,5738263,3.1091802601858185,3.426866467678611
SK-CO-1,20959075,-3.269929661945314,-2.636829351552927
SK-OV-3,9956119,5.08600620496794,3.794870662023834
WM115,tretinoin-navitoclax (4-1 mol-mol),3.8155470378280008,2.638736904177153
BICR 31,5978,2.6862960741960693,-2.1651506033138816
RERF-LC-MS,375860,-0.2896823379882159,-0.10990804174051667
SK-OV-3,selumetinib-piperlongumine (8-1 mol-mol),4.999927979817729,3.0631398732761532
COR-L105,44202524,4.8543272504702895,2.2182028219739776
MOLP-8,44137675,1.775364766844489,3.1386465291564916
IGROV-1,9907093,2.687959785702283,3.9878764421102137
LCLC-97TM1,10385095,1.2595894653665305,1.2673581037799437
HCC1500,serdemetan-SCH-529074 (1-1 mol-mol),0.9549823890456136,1.914334606589922
P31/FUJ,3038522,3.230912995410489,2.7499294636319864
PaTu 8988t,5281321,0.6032906637165831,-0.8606150572224527
HEL,9866186,-1.054303819018661,0.022400931282450517
HCC15,carboplatin-etoposide (40-17 mol-mol),1.5999978710207647,3.1767869229367194
SW948,2708,5.7755473109613265,3.9985443346787486
PaTu 8988t,3025944,4.261130932115319,4.391555284586968
SK-HEP-1,3689413,-2.4602386660304143,-0.3658025553877524
SU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3225967046124065,3.079828645208552
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865,3.10336889304566
RKO,6252,0.5352436981906653,-0.6206178971548078
SU-DHL-1,4521392,5.192178694848648,4.02188767183648
Daudi,72376,-4.854665282210012,-3.718986444445554
RKN,4259181,0.9508926940780028,0.2873147939159477
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647,2.2683176733089683
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264,-0.476217978122082
SW1271,36314,-4.053350989931705,-1.0533792024839148
COR-L105,1750826,-1.9007119452090728,-1.1608012091478728
HuP-T3,salermide-PLX-4032 (12-1 mol-mol),5.718732466752557,4.734666349286876
Granta-519,46215462,0.9491023197189584,1.2571676585094307
SW1271,3676137,4.713113076263269,4.4476190389233174
IA-LM,5278396,3.9030690758091904,3.4115036985154603
NCI-H2452,24775005,5.579264227156813,3.696043302544589
K-562,23635314,-4.3400265171433725,-2.820640110772164
COR-L105,6852167,2.71981320036177,2.9970400325280964
Panc 02.03,16741245,4.354855972582246,4.01977624467445
SU-DHL-1,2733487,6.186604270067288,5.9683173951967845
Granta-519,26596,-3.6955660538224784,-2.667208179044687
SW1271,JQ-1-UNC0638 (2-1 mol-mol),1.8151113798618133,1.5298171150100504
ALL-SIL,176870,2.444675771693443,2.6078021674654703
LCLC-97TM1,19582717,4.783105330370089,3.7791400809231925
HuP-T3,119607,5.841541098284191,5.440521235805287
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676,3.5889924200203493
P31/FUJ,637858,0.7903103947120294,0.8740295523928495
COR-L95,5329102,1.6379635813529434,1.6583490896060509
BICR 31,5291,3.978522058600436,3.831557471909929
LS180,6852167,2.255231171645259,2.7178859800367223
IA-LM,89928392,1.436934436501384,0.722091215150295
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177,-3.1848279779379656
BICR 22,9903786,3.2901982519836213,3.0605935503376753
SK-CO-1,3384730,3.2619898650330272,2.985014141257772
SW48,17755052,-0.4852421045975616,1.332906988672476
COR-L105,568763,0.9810834095142736,0.53377515043451
HCC1500,9866186,3.137309558941867,0.9839844228173084
HCC15,124202324,2.163317754038658,2.469458288646127
HCC1500,6917907,-5.345696307345718,-5.045467893151039
HCC1500,23635314,-1.1425681705854864,-0.15505890417925053
Granta-519,126941,-4.311277898608593,-3.2282323060460545
SU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),3.205630539300333,4.231410810886596
SW948,24771867,-2.1331828785420166,0.2543606597543854
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307,3.0168645183218894
LCLC-97TM1,10410894,3.7243046596553344,3.255578246276927
COR-L95,11609586,-0.6075050167057128,2.208745981804904
MOLM-13,9952709,2.652499766566874,2.1627393513108655
HCC15,24951314,1.20775234306688,1.684539130893734
BFTC-909,11175137,1.859642091823866,2.785336420772607
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567,-0.7666145034923225
SaOS-2,9444,4.299296809659387,4.210537858398443
Daudi,71576739,4.751042411789338,2.62036299560065
SU-DHL-1,6505803,-0.92520479323989,-0.5787998742433641
SU-DHL-1,11214940,-0.4959690036226346,1.8876216508412045
IA-LM,71466578,5.490140561499378,3.2255223539613387
RERF-LC-MS,262093,3.104487938727744,3.0484188898107347
SW1271,71466380,4.990835020791986,4.487587971457025
Panc 02.03,135411,0.8368106867561712,0.8761371196599385
RERF-LC-MS,8515,3.770178660744851,4.150982541016542
HCC15,45100309,5.717971650422449,2.7676978320699925
COR-L95,54618771,1.9587299059916856,1.2001093217959582
LCLC-97TM1,16736978,1.4629436365964008,1.795116259457859
IGROV-1,9825149,2.5588021380929553,2.3366122552188724
IGROV-1,227681,3.5439813498262347,3.4424002319720803
RERF-LC-MS,44489675,3.7548789887197183,4.057596776295082
MOLP-8,3136844,3.797428854524256,3.3787078626621185
COR-L95,5746,-1.1189080553056585,0.19368786218522108
BICR 22,135398516,2.7677082767193117,1.9616897565314708
KU-19-19,tanespimycin-gemcitabine (1-1 mol-mol),1.208542786585586,-0.4021346887073561
ALL-SIL,57330099,4.126515702027515,3.7443726633954286
SW48,135398738,2.3509294796071454,4.335492330302002
WM115,2113511,5.303490143807845,5.376371606277989
Daudi,2729026,1.2833432455886875,1.9604565269740268
P31/FUJ,100016,5.4217002529902185,4.813174541247687
IGROV-1,71466445,2.3758001916617797,3.777743454192611
ALL-SIL,6918878,-0.682122479171039,0.43088559037520113
Daudi,73707371,3.866210661620395,3.3677918281152994
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059,0.14572029652213314
SW48,11364421,-4.967269122022574,-1.718332468526522
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805,1.5462241531126697
LS411N,135411,0.7383506227122603,0.17087140582649038
K-562,3634881,3.4419902111623473,2.735917707186729
KU-19-19,969516,2.8919422545546043,2.9535924479003093
Daudi,135999136,4.063293138043838,2.369127723930079
SU-DHL-1,12001922,1.0574025128990867,1.8115995948231345
HCC15,carboplatin-UNC0638 (2-1 mol-mol),3.871381279129182,3.4943153959236897
MDST8,11427553,3.108888701151444,2.9845061201414156
COR-L95,navitoclax-pluripotin (1-1 mol-mol),-0.7248049337705845,-1.0110361829561194
HuP-T3,9840324,6.187364891887578,5.921398162177135
RERF-LC-MS,5281321,-2.2570738048063257,-1.2805844859240714
UACC-812,16725315,4.601797708491857,4.106229831390686
WM115,53481919,3.625694730030069,3.9060424081537763
WM115,3136844,4.4781621433894925,4.423090059206297
SK-HEP-1,135999136,5.290710201924687,3.8881766090854324
SK-OV-3,72734382,4.397767647147488,4.7272289251617785
SU-DHL-1,4096211,0.0680701310214702,2.056439377944963
SK-CO-1,2749,0.8616454488616467,2.0283322927193677
COR-L105,4477,0.3499366832640422,0.5405566487768659
SW948,24785538,-1.2786696026485709,0.5594064820503479
BICR 22,25161177,4.685384367036766,3.8728945727630006
Granta-519,11955716,-3.0537796337487064,-1.9977906894903799
ALL-SIL,10127622,5.469150259822909,3.5597128148896413
SK-CO-1,11238147,1.2924304468719774,3.0540290278915654
IGROV-1,11427553,2.926316692603687,2.9345320689945633
BICR 22,54618164,4.171441086739322,3.9256893013545944
BFTC-909,57519531,3.2286550647211025,2.6283685363773683
SaOS-2,1750826,-1.0374385524430834,-1.8856984240979637
SU-DHL-1,71466445,3.7763473385017994,3.200148213416343
SW1271,6852167,3.737297660761554,2.8032160688307295
SW948,9549297,1.722924191719054,2.134231878844279
BICR 31,72376,-0.802396523967939,-1.6372505587840394
SK-HEP-1,56946209,-4.57873882670014,-3.855793345540566
RKO,24964624,3.0430796891613903,1.6609389862151267
NCI-H2452,54143018,0.9899128272921088,0.6033125886497396
SU-DHL-6,60750,-4.821248170588626,-3.2240336701889487
HEL,44259,1.31343744649104,0.45484254760065207
MDST8,3038522,4.546677862508445,2.9103279273704263
Daudi,72193861,0.2314245956601211,0.345517064418043
NCI-H2452,4096211,2.487981551988898,2.2086734118173057
LCLC-97TM1,carboplatin-etoposide (40-17 mol-mol),1.252125961208134,2.8493056783647903
Daudi,208908,1.616008502166041,1.8432390885916496
LS411N,46191454,1.665967132338862,1.0991784722300249
Panc 02.03,262093,3.467425891303458,2.9277614420348748
COR-L95,462382,0.8255977399878551,0.6223890464057508
IGROV-1,16736978,0.1982875499977011,1.8999857577282335
MDST8,107985,-3.301997074358414,-3.419746087942646
COR-L105,navitoclax-gemcitabine (1-1 mol-mol),-0.9402734681791266,-0.4729865020294124
ML-1 [Human thyroid carcinoma],65064,4.907366569161651,5.005275885577143
RKO,54618164,4.0326978900214705,3.767208423782263
MOLP-8,5311,0.4432260076750803,0.4788928860179382
SK-HEP-1,5291,4.1108608913621545,3.7510027453101116
SaOS-2,107970,2.235066344736828,2.2911874053227734
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.0338101341566786
Granta-519,6252,-5.172240666242431,-1.7351879517814424
IGROV-1,285033,-1.3538783590767758,-1.6946390524905846
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006,1.5530760579927188
NCI-H1568,46191454,1.7726304550427152,1.8112658682118206
PaTu 8902,24856436,4.585148807200659,0.8054839481573056
WM115,5351362,0.9981168658111552,1.7877353562129208
IA-LM,387447,-4.406032561698067,-4.231820747386275
MOLM-13,656346,-0.3431029585418202,0.3839599212890329
COR-L105,637858,2.3247583240908405,2.2193534910375705
Daudi,448949,1.1283153338590814,1.2983863675466694
SW948,42642645,-0.386998084672917,0.5243801799724865
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845,2.238921755724699
HCC1500,52947716,-7.376885049387286,-1.107875317314274
MDST8,439501,-2.351670240427255,-2.2114614450116785
RERF-LC-MS,25161177,4.303824118845859,4.199195111781406
SU-DHL-1,3634881,1.9377929493272257,3.1780865454304323
RKO,46398810,2.934390735401444,2.047758870005042
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253,2.77195646884065
HCC15,159324,2.6315252421023536,3.1554818763114376
PaTu 8988t,serdemetan-SCH-529074 (1-1 mol-mol),3.002094874495684,2.139835257283981
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783,2.8425901440540517
Daudi,2949965,1.2926680931891954,2.168513842489036
RKO,23725625,3.9986828157613616,3.701074175803108
HEL,16722836,0.561669465799647,0.8471471524141293
Panc 02.03,11175137,3.7353172411310696,2.8679105789342696
KU-19-19,6918878,0.8609723302141853,3.263431499152527
Granta-519,docetaxel-tanespimycin (2-1 mol-mol),-8.26947994699302,-4.865530845740724
SW48,3854666,0.5343434371102147,2.0201905503848154
SK-HEP-1,11626560,2.7034566874481745,2.189163896154715
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954,1.9342156507359902
NCI-H2452,3825829,3.8827569930751937,4.180350913078282
BFTC-909,126941,-2.0975077483758415,-2.5157024886848696
NCI-H2452,24951314,1.9717681393720747,1.6152593435238516
HCC15,54454,0.5186235809490349,2.688987067880203
BICR 31,4096211,1.2121831781068038,2.1911686617057553
SK-CO-1,6914657,-1.8836208914019363,-3.599031124164172
SW48,44493528,3.8128145383765992,4.17414154714204
COR-L95,BRD-A02303741-navitoclax (2-1 mol-mol),0.0270607892224954,1.4881357446196797
SW1271,168312962,3.6054980890180746,1.6194337144458069
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584,3.073583298558193
Panc 02.03,135440466,3.0724615257354153,2.2891239972219144
PaTu 8988t,navitoclax-piperlongumine (1-1 mol-mol),3.1694697801552025,1.7964356759937525
BFTC-909,11427553,2.7610941057010754,2.672694906065317
LS411N,ISOX-bortezomib (250-1 mol-mol),0.5408045393266885,0.5899544003087541
SW1271,44493528,4.286060334293371,4.514428317198906
Granta-519,JQ-1-MK-0752 (1-1 mol-mol),-0.0004173872761687,-0.15708333119906864
LS180,49836020,0.6204023867713871,2.2502441187024784
HEL,148198,-3.399100076616297,-4.12874174784969
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857,4.437680160106364
Granta-519,3543504,5.0961511485487705,3.407226137617613
HCC1500,3038522,2.0060085934463108,2.6785865111853293
RKO,4917,3.097539294413192,2.675750172127021
RCC10RGB,168312962,4.335962117924443,2.5418515851698307
SaOS-2,104842,-4.966916923279438,-2.8711123173868005
Panc 02.03,753704,5.09544361232119,5.136386209714134
PaTu 8988t,439501,-3.4446792284706347,-2.0827485870629
LS180,5282054,4.115839158247494,3.734599463332557
IA-LM,5287620,-0.8479822353163541,-1.9400976504847054
RCC10RGB,6610216,4.531223922644925,4.275279202870865
SK-OV-3,vorinostat-carboplatin (1-1 mol-mol),3.580838266034329,3.2339310755986417
HuP-T3,selumetinib-tretinoin (2-1 mol-mol),3.9566869559335585,3.260040702119334
SW1271,9911830,2.7072275961126997,2.511338063453327
WM115,11719255,3.1992621528929166,3.5694903190655145
RCC10RGB,42642645,2.104174802814935,1.1517866902865912
K-562,72376,-2.627875463605781,-3.22998869486178
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337,2.5544598076126657
HCC1500,9549297,1.8848953505663728,2.0224857196860997
HCC1500,44241473,4.374636754710865,4.679570828862933
HuP-T3,2708,5.229598766149438,5.141085311085691
P31/FUJ,9866186,-0.5408158091236333,0.14576523017409795
RERF-LC-MS,11657048,4.330866638894723,4.086290784773334
HEL,119182,-2.1951032337756935,-2.9796440920560254
RCC10RGB,10296883,4.350673741830848,4.001937902567733
MDST8,10385095,1.2575537617816142,1.250369652732328
SK-CO-1,23635314,-1.3218098525260824,-0.9894147392212159
BICR 22,72199289,4.441607504718354,3.243853792120727
MOLP-8,9911830,1.992368688928045,1.989193931837403
SW48,24772860,-4.097111396936187,-1.5038268179217262
COR-L105,8515,4.561371818511258,3.990017606861406
IGROV-1,15547703,3.339928221860449,3.116359769216088
SU-DHL-1,656346,-0.4085927723055031,1.11957428840186
COR-L105,168313200,3.683873258385797,3.003396344343106
Daudi,46224516,0.8162026590632436,2.2853143808491647
Granta-519,5287620,-2.8216901996678985,-2.2565505065494738
P31/FUJ,JQ-1-vorinostat (2-1 mol-mol),-0.2741289026450685,-0.47329397909407267
UACC-812,11640390,4.086462739167014,3.1783357399902563
K-562,17755052,3.8994339695870326,1.1628252524652556
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139,1.63964010251946
LS180,656346,-0.0089884994203474,1.3100448992443214
LS411N,selumetinib-UNC0638 (4-1 mol-mol),2.4499191002493315,3.0125130066588786
SU-DHL-1,5311281,2.996662642824561,2.1593999863598006
RCC10RGB,25161177,5.612412997721579,4.188830623681403
K-562,3854666,0.2872946014041473,0.9680362608781737
P31/FUJ,9825149,2.400010374644864,1.4835452170561194
SW1271,11964036,1.1602803966527862,1.489255132394469
LCLC-97TM1,176870,1.9757247403033509,2.5855166473432867
K-562,168313016,4.482960220744853,4.03519295612244
BICR 22,selumetinib-PLX-4032 (8-1 mol-mol),3.113612897977895,2.8883166237067877
SW1573,285033,-0.3175288260868649,-1.5360863165872503
BICR 31,4788,6.181654669045445,5.8331029725167305
LS411N,11404337,-0.9351547419605356,-0.5420930159024085
RERF-LC-MS,9967941,1.5454786965180345,3.800097385745172
Granta-519,56973724,1.8473061894805545,1.845985191193575
K-562,11507802,0.4095176942133114,0.7988298961116093
SW1271,1750826,-3.093550008900348,-1.1286473924175875
P31/FUJ,135398738,-0.0291234665218711,1.9730193244840015
WM115,5329102,1.7959886386080517,1.8302123788975475
MOLM-13,5470400,-0.3466627309634489,-0.20436004648322792
WM115,navitoclax-PLX-4032 (1-1 mol-mol),-0.9695757520165332,1.7799054664245995
Granta-519,44607531,0.7355881041308102,1.0954571866032279
RCC10RGB,5566,3.997570642857795,3.0309789206823416
KU-19-19,24964624,3.8522438290321768,2.581635490775803
WM115,1641662,3.4019570651475557,3.607799809809263
BICR 22,5282054,4.223594396310054,3.8727358662793017
BICR 31,10231331,3.776464743887352,2.515393340778249
RKO,3825829,4.017808531984142,3.2095172414236863
Daudi,10322450,2.3131627402631905,2.8444901879966604
BICR 22,285033,-4.068757657270757,-1.7256194862043321
SU-DHL-1,5281321,-1.7372628502658949,-1.0914111995412987
RKO,5287620,-1.9975210326345276,-1.9317122765975732
Panc 02.03,53232,6.367991743549877,2.934679171205722
SaOS-2,9826308,0.4955218987390744,0.2450856799856628
HuP-T3,10074640,3.8159838645365807,3.19928789244101
SW948,4259181,0.2292867461834122,0.056496667477821186
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872,1.6077982226193674
IGROV-1,568763,0.665047061839467,0.852575529983506
ALL-SIL,decitabine-carboplatin (1-1 mol-mol),-0.0286812837112609,-0.3612880339323554
MOLM-13,322968,2.556875190594409,2.2900107876916773
ALL-SIL,9903786,1.532435199339551,1.805699667497749
SW1573,409805,6.568626512075582,5.066196095309896
LS180,1750826,1.061711606063746,-0.7115737582503856
HuP-T3,46191454,1.9484889201022677,1.957321756640267
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743,3.421750999930668
HEL,216345,3.87635579429504,2.882426846465318
BICR 31,2749,2.2358137088107033,2.3143170671271127
SaOS-2,3385,7.1536746080698395,4.1557563560281725
WM115,11626560,1.643291568999912,1.8606772770838982
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922,1.7796205821314575
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192,2.434649389014344
Granta-519,24964624,2.975569692960617,1.161903335947644
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783,1.1274053423135306
COR-L105,6918638,0.8528151020185122,0.8149859402305547
RCC10RGB,9825149,2.634802111166888,2.6722605365223746
HCC1500,44493528,4.240662848371031,4.423407553873279
COR-L105,44489675,3.747818158649104,4.089274573041148
SK-CO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1356145956067642,2.71636269944412
P31/FUJ,selumetinib-piperlongumine (8-1 mol-mol),0.6855922532418997,1.867098512561248
BICR 31,2746,4.041774334142006,3.6605627725597776
MDST8,51037431,3.453193232905579,3.2596832727847995
K-562,676352,1.515837042857868,1.880286027038351
LCLC-97TM1,73707386,3.587652793939767,2.883078017585008
SK-CO-1,54618164,4.180915062416914,3.952452717769848
SaOS-2,5329102,1.942826181308244,2.0063853831198504
SU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.969153330724774,-1.973906956720978
LCLC-97TM1,151289,0.9235530786043882,1.1253033939777282
BICR 22,400769,0.1100780529561809,-0.363380227470903
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704,-2.6085851733778833
SK-CO-1,400769,-0.6897300489229926,-0.5653422895972888
SW1271,56973724,2.58013716529859,3.3187083112263607
LCLC-97TM1,2945648,2.6479910997037934,2.6900269902391356
SU-DHL-1,439501,-2.3864560258185916,-2.226891196106986
NCI-H1568,148198,-4.9953315451672005,-3.4716244562952983
RKO,11507802,1.7455765117352984,0.7751795997275509
Panc 02.03,216239,3.7763245170365183,2.6313564427684866
HCC1500,9825149,1.9829642871568696,2.0530808700590994
NCI-H2452,53232,3.5381177646863837,2.839689108686647
MOLP-8,11494412,0.4734092912657368,0.19070867774665984
Granta-519,9911463,3.5000933341892733,2.9419240893580185
SK-CO-1,10410894,3.775604170297083,3.1044366091747584
Granta-519,navitoclax-pluripotin (1-1 mol-mol),-1.5381813072816537,-2.491109812235593
MDST8,5328940,2.138158341424683,1.8806135023277213
SaOS-2,1716436,3.427239396926117,2.9797839872443204
HuP-T3,9887053,4.07990532641299,4.325240463459594
NCI-H1568,24772860,2.3104914540479324,-1.5784533594339916
LCLC-97TM1,135999136,4.356650968290631,3.451698975422864
IGROV-1,4378219,2.016502068118561,2.7218933208678187
BICR 22,46199207,3.899734747403315,2.9437556638685978
BICR 31,9915743,-0.3251640044425866,0.6772607155650561
NCI-H2452,613753,2.817247196569438,3.2822080777958935
P31/FUJ,46174525,2.51911302821391,2.987489420770418
P31/FUJ,5335621,3.2282922271331613,4.1274599322992
IGROV-1,5278396,3.119031774261392,3.4479049184805257
HuP-T3,16038120,1.51216352382263,1.0910157124554696
LCLC-97TM1,17755052,0.1986775459223547,1.5711987306185475
PaTu 8988t,66577038,3.1818565141070625,2.973567346379738
PaTu 8988t,54618771,0.599962301527202,1.3503835942819118
SK-CO-1,46191454,1.747962727561699,1.732721369534687
SW48,46907787,-1.5740012638710297,2.066737640608152
ALL-SIL,11485656,1.390704841990788,1.5576643857145567
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808,3.4764993347980955
SK-CO-1,4788,5.843658659854095,5.693473259784606
IGROV-1,16725315,4.890680859998698,4.143152939705725
SW1271,24821094,3.627509655063773,2.861814137034651
Daudi,navitoclax-pluripotin (1-1 mol-mol),-3.474702671481659,-2.1514559313630697
WM115,216468,3.848857711215856,3.4385127797598183
SaOS-2,24779724,4.377738848523283,4.413125740888097
HCC15,675434,4.852455641097197,4.580400023022481
SK-CO-1,46398810,2.9216967746168625,2.755783180347633
LS180,JQ-1-vorinostat (2-1 mol-mol),0.4669519655203766,0.8359317314197555
Panc 02.03,123631,3.5560371664842325,2.400018731109596
SK-CO-1,448949,1.9523830928265349,1.9775730114813073
RKO,285033,-2.0365968290915393,-2.5366189463294107
SW48,2749,0.8385534684858028,1.7916458868459606
IA-LM,navitoclax-gemcitabine (1-1 mol-mol),-0.1598122581920494,-1.2956164322672075
HCC1500,54618164,3.7944844711277264,4.084322093232758
Panc 02.03,2858523,3.458791746781272,3.0903933515283897
PaTu 8902,piperlongumine-MST-312 (1-1 mol-mol),2.709357535529884,2.0434617867153033
COR-L95,4261,0.3666433774913241,1.0674721810030716
HEL,126941,-3.7945695708983664,-3.2871274980078384
HCC1500,54596490,4.413271545106012,4.611809474964633
BFTC-909,375860,-1.1901103647211757,-0.02572205755110649
COR-L95,9866186,0.0204391385842873,0.5521782385633033
BICR 22,66577038,2.5300885228037813,2.666010783475508
SW948,9826308,0.2428169991227084,-0.0639361024298292
MOLM-13,73707440,5.976327057082507,4.201938808626504
PaTu 8902,5291,3.72219732976082,3.767044585232785
RERF-LC-MS,5470400,2.5584942331402623,0.466798759160516
SW1573,16725315,3.253832365815957,4.0510847661476
SU-DHL-1,3552672,1.9257473882600096,2.7643870209597874
HCC15,60750,0.68669542572171,-1.4518970638574478
SW48,5328940,0.1162920415883012,1.5205120051928263
PaTu 8988t,4378219,1.99751885903338,2.6551367629804945
HEL,241158,3.370113308144609,2.34155196708016
MOLP-8,53495165,-2.6639864548579535,-2.0610507617425626
LS411N,46943432,5.879073426568822,1.205068302905369
LS180,ISOX-bortezomib (250-1 mol-mol),0.5409757723847333,0.6253678165887522
SK-HEP-1,selumetinib-UNC0638 (4-1 mol-mol),4.697700742307761,3.1691431608397
Panc 02.03,4521392,4.25988041093388,4.312915870491739
SW1271,5951923,6.143368489838077,4.367457511156193
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.4698336102755327
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552,2.470937113409627
RERF-LC-MS,11717001,4.567893424272946,4.2975518967977555
NCI-H1568,25102847,1.8020479238639409,2.681616518498605
MOLM-13,44137675,1.768154079183361,2.6350623987992394
RKO,10427712,4.823698606341804,3.7481915922297486
BICR 22,6852167,2.9570859917106533,2.62254712021049
ALL-SIL,vorinostat-navitoclax (4-1 mol-mol),-1.3745471945547945,-0.40210534123281905
SW1271,124202324,3.327062905972079,2.6755268375092616
WM115,400769,0.2375153529743729,-0.5042535805121972
RKN,3038522,4.332475047921768,3.4386319702126
SW1271,4096211,3.040458805184357,1.9722026315303356
BICR 31,60700,1.4006980690412227,0.0819084680346299
Granta-519,448949,1.64880276038625,1.3703470832278735
HEL,11964036,0.787171767074348,0.2785900356273663
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881,2.2438901446831068
BICR 22,11485656,1.7887481250962165,2.2121174567237643
HEL,44202524,1.7623585771552046,1.2763289426495996
COR-L105,3503,2.4932686195421625,2.5004966125555934
LS180,4788,5.917574515812926,5.617187280197059
IGROV-1,219104,3.803083685328391,3.6586956768099332
IGROV-1,11152667,-1.4116509977729443,-0.47513339005627614
LCLC-97TM1,JQ-1-MK-0752 (1-1 mol-mol),0.5638595279312849,1.579580261069493
HuP-T3,11485656,3.0565489144797224,2.377958499501782
NCI-H1568,9907093,3.7800753982052697,4.1435082984968155
LCLC-97TM1,10184653,1.174063194948861,1.290664534302421
MDST8,16038120,1.9679009346440888,1.1234998071773155
MDST8,navitoclax-PLX-4032 (1-1 mol-mol),-1.0125849451326647,1.609401150080005
NCI-H1568,216239,1.54277692538335,2.433394198063431
LCLC-97TM1,5280436,3.0011603005672804,3.159503820932067
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.075005952505135
Granta-519,5281321,-3.900138103622144,-2.7616202660831397
NCI-H2452,6917907,-3.4621989648593696,-5.060117755574379
HCC1500,135659046,2.9858139057826905,3.8581178857080944
P31/FUJ,3825829,3.1586120375796516,3.278742269487605
NCI-H1568,selumetinib-piperlongumine (8-1 mol-mol),3.9234194964704185,3.5427028437536916
SW1271,JQ-1-navitoclax (2-1 mol-mol),1.3503657606474289,0.7748839594502642
SK-HEP-1,7326481,2.0213225214426505,3.197655485039092
PaTu 8988t,JQ-1-navitoclax (2-1 mol-mol),1.798415555135888,1.2003019423790746
HCC1500,3634881,3.181593200231373,3.3092200368617024
HuP-T3,5311,2.274555641774389,1.4939405137917605
P31/FUJ,969516,2.490551298955204,2.1329478946112435
LCLC-97TM1,25183872,-1.9138026924081315,-0.7058915769087196
WM115,54619267,3.5599503094850244,4.092627601317685
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545,2.7612225469439733
SaOS-2,17755052,-0.5339241699834809,2.075827235060099
SW948,decitabine-navitoclax (2-1 mol-mol),2.8681609289857155,0.959653880857351
SaOS-2,19582717,4.316823865856345,4.158813019100392
COR-L105,25105715,3.731140483220641,3.5021923752658792
SK-HEP-1,5278396,4.037206436677834,3.743711883882054
HCC15,erlotinib-PLX-4032 (2-1 mol-mol),4.047611661511117,2.8343297162093535
COR-L105,6918837,-2.1114263163326177,-2.4824339635043033
IGROV-1,25262965,-3.18785020602057,-1.2187312310954874
HuP-T3,6505803,1.3238670991795596,-0.6983780731780663
NCI-H1568,11214940,1.6761106979183067,1.9726311165733206
HCC15,44543605,4.452652862359365,4.11186462305458
SW48,46199207,2.9489751610364405,2.981840091157718
P31/FUJ,104842,-4.465734156959207,-3.403371176606911
MOLM-13,24180719,3.226510234308061,3.1683579449774193
HCC15,12003241,-1.0460858766179792,-0.9147992471122088
IGROV-1,10231331,1.9104831176724932,1.645513785781561
IGROV-1,107970,2.287061680908213,2.2188506069441782
LCLC-97TM1,46907787,1.8795083111860824,1.2760722813209864
IGROV-1,5278396,3.119031774261392,3.4479049184805257
SK-CO-1,5329102,2.034917542642271,2.1792742946806434
SK-HEP-1,11152667,2.375581084403437,-0.28137224364569097
WM115,2126,3.806678244062894,4.603026954511338
SW1271,selumetinib-decitabine (4-1 mol-mol),1.699127774006886,3.927753077834313
K-562,6918736,-3.666344542032524,-2.0402047657033844
Granta-519,6450551,1.162651959279597,1.1815940146659512
NCI-H2452,5479543,3.804245584293823,3.762642363323024
Daudi,11497983,1.6119133198716458,0.27315868177993624
WM115,4521392,4.32247006400087,4.355223893591877
MOLM-13,24901704,-2.733844077576574,2.401932256064205
Daudi,56973724,1.9677776982823123,2.0009338764000044
HCC1500,613753,3.153964202511791,3.2910334406137673
Granta-519,5460769,2.1422187145203897,2.1622466222399437
RCC10RGB,53495165,3.554009618530711,0.8372482376526585
PaTu 8902,3854666,4.137852419807088,2.503973799515913
Granta-519,151289,0.2062194994497177,0.6164467696791843
MOLP-8,5479543,3.0970965636903327,2.576054687116544
LCLC-97TM1,4096211,1.6170661636178802,1.670265398421729
LCLC-97TM1,SNX-2112-bortezomib (250-1 mol-mol),-1.5766290939625012,-1.341883488549506
SW48,9907093,2.826389946725867,3.8075170791390867
MOLP-8,5281672,3.2641398124752063,4.2213230967161595
SW948,6610355,3.913576061403015,4.233864226825906
SU-DHL-1,5746,-2.2023974745237815,-0.041665388406442495
MOLM-13,10410894,3.311191932806664,2.822857678997755
SW1573,3384730,1.5192292760027193,3.1114133552668006
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.708464522380885
NCI-H2452,54649381,5.966732082850981,3.938572096522445
COR-L105,JQ-1-navitoclax (2-1 mol-mol),0.1739680576486409,1.173474126908762
BFTC-909,9444,3.603329432205708,4.2394382734654865
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671,-1.2064746023779747
SW1271,9952709,3.6093754742197706,3.1430851294082776
IGROV-1,4788,5.801051990484709,5.415890965787957
K-562,3825829,2.9396673791475587,3.446185144429695
COR-L105,53232,1.738169806280081,2.926142881705506
Daudi,25195348,1.3194617548918357,2.3369230122777527
NCI-H1568,46199207,1.8853593558521984,3.105219394723525
RCC10RGB,135440466,4.497503570362309,2.1605522687260668
SU-DHL-1,navitoclax-birinapant (1-1 mol-mol),1.3479254816656925,0.4520332309810959
NCI-H1568,3062316,1.133797551734723,1.0940958777968952
Panc 02.03,56649450,3.905458120664549,3.409293604558663
RKN,44589607,3.09715941328701,2.9258270463180533
MOLM-13,568763,-0.9067431163570788,-0.25903702668988127
MOLP-8,444795,3.9342801961368417,2.9249305089430244
RCC10RGB,navitoclax-piperlongumine (1-1 mol-mol),1.8990680206310235,1.4012458298500825
COR-L95,selumetinib-piperlongumine (8-1 mol-mol),2.799372777395438,2.438388599543273
COR-L105,vorinostat-navitoclax (4-1 mol-mol),0.9761778131002136,1.4123753882407408
IGROV-1,6918878,1.6706182189896102,2.9137512619480965
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112,2.024405548610658
BICR 22,5280436,0.2666608642372045,3.353763085053684
BFTC-909,3081361,3.110656330811392,2.5718144231497666
PaTu 8988t,45279963,4.21642269895433,3.603478245743746
MDST8,613753,3.2461287764543085,3.157920245433698
LS411N,6917907,-5.419583860239815,-4.484250119928659
HCC15,5335621,5.428336568471036,4.923145337207306
SW48,71466380,4.3724837890251935,4.269819502370231
SK-OV-3,66577038,3.416512813520814,3.1858623411583937
RCC10RGB,49766530,-1.6086406954404375,-0.32821448498514855
HuP-T3,16722836,1.72068374216493,1.7624537742361692
MOLM-13,168313016,3.5509192860421592,3.924468689851796
SU-DHL-1,675434,3.83709506639581,4.159147916229894
P31/FUJ,9911463,3.6551866379259743,3.1141001684508023
P31/FUJ,445455,5.725867195241275,3.6570883164008343
MOLP-8,285033,-4.447286141218139,-2.909949896008296
RKN,107970,2.600341318615175,2.3436099149737313
IA-LM,4788,5.899787929501101,5.565180634804492
RKO,71680916,5.910552922648844,3.760225757129319
K-562,9825149,1.660902694463834,1.954291467577007
RCC10RGB,4261,3.441062261939301,1.8906318552643466
IGROV-1,387447,-3.9508602289798658,-4.1711251647710785
WM115,54618164,3.776567993994872,4.085434873795552
LS180,44607531,1.744731406430345,1.0971406356435964
NCI-H2452,123631,2.1406097245383062,2.7760967250148423
K-562,262093,3.1056763935044813,1.7619435449759038
MDST8,24180719,2.4870372971011374,2.8900273010422763
WM115,66577038,2.911239385644133,3.0620228407510246
SU-DHL-1,6918328,-0.7249486298416586,-1.3114445020485448
NCI-H2452,135999136,4.5117873079445205,4.027792329464695
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111,4.190139283052198
PaTu 8902,11609586,3.6092581559147185,2.9814266834730914
IGROV-1,11497983,4.37450324471555,3.551788650510249
RKN,387447,-2.9807645129134066,-4.092173401060992
LS180,6184667,4.288388758455988,2.8592557699137835
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432,0.10599622707584931
NCI-H1568,5460769,1.1324377767406906,2.6125525689115006
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956,2.5709350967469953
HuP-T3,3025986,0.0333046209415895,-0.8070384327524444
IGROV-1,11625818,2.877471533668122,4.639095978662588
SaOS-2,122327,5.211292969638739,4.804284018373913
BICR 31,46943432,4.176233154169203,2.7164057341636543
HCC1500,10427712,5.196976599700856,4.239674502965311
K-562,9866186,0.7861847855254385,0.34458306426552016
RKO,10231331,2.816804700080647,0.9625626297067268
NCI-H1568,126941,-1.411149621431801,-2.331874665053243
HCC1500,9933475,1.9677534910437375,1.7917972272403548
ALL-SIL,53245473,2.8781179496967666,2.408869904255139
K-562,135423438,0.8826240773524879,1.6181944124454208
BFTC-909,9956119,4.255413767268681,3.6857648539205354
HCC1500,9884685,1.9086372211674376,0.46874851834354186
P31/FUJ,71304818,2.235751993715144,1.8274390411952088
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.9804258170851865
MOLP-8,5470400,0.1664110443814662,-0.08889499098840023
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183,4.067859699455101
SW48,44819697,-2.186530212001632,-0.24940066305042985
SW48,12001922,1.4259296039497584,1.7918261343335664
NCI-H1568,24951314,0.6613293075425478,1.329719369920798
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.2226685318165216
SW1573,51039095,4.568767182944777,2.7196629528100775
BFTC-909,46224516,1.8849058086882595,2.820963181731504
SU-DHL-1,52947716,-4.8688827763192135,-1.9379118696441886
IGROV-1,262093,3.169376516915595,3.173323523606832
MOLM-13,selumetinib-PLX-4032 (8-1 mol-mol),2.341131850097057,3.058827903952657
WM115,24821094,1.6911725066550027,3.289517805536073
COR-L105,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9364869385558905,3.866591001033025
SaOS-2,53325874,4.45514535643454,4.634430850170329
SaOS-2,4261,1.4562926555721387,1.5515896411851857
Daudi,selumetinib-BRD-A02303741 (4-1 mol-mol),4.766499662103581,3.6484273565799015
SK-CO-1,9907093,3.652313916117519,4.07147791420081
SaOS-2,613753,3.192322830330122,3.1348714222945193
BFTC-909,148198,-2.03933057080943,-3.238183000158383
MOLM-13,49793307,-4.691237884437231,-4.244424522473644
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763,-0.6853297828224559
COR-L105,135411,0.974173137304268,0.864090519220812
RERF-LC-MS,135411,0.496828330774242,0.7278401982473109
SK-OV-3,16725315,5.283554915030345,4.103612292945132
SK-CO-1,3854666,3.8596661393399927,2.3100610129984083
LS180,51039095,2.999333495393298,2.89344424592836
RERF-LC-MS,135440466,2.007932851474071,2.254592323682286
SW1271,SNX-2112-bortezomib (250-1 mol-mol),-1.3790138823522573,-1.6392890108955709
LS411N,446155,3.6642844723827266,2.9926097748425375
HCC15,72193861,-0.2523453521741511,1.7950756095854035
BFTC-909,52947716,3.1995758728854224,0.23521232541519155
SK-HEP-1,9933475,2.440596541444364,1.9597517259119066
MOLM-13,702558,4.671896667990455,3.847209726833625
P31/FUJ,375860,-1.2092771030706315,-0.48953209557339156
Panc 02.03,57519531,5.330694472788803,2.7036429549997676
COR-L105,selumetinib-decitabine (4-1 mol-mol),2.222127008727221,4.01407973114001
HCC1500,11238147,3.2515653100317023,2.876622012770813
RKO,11427553,3.456895276763714,1.6985326546524022
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675,2.7363978618581313
HCC15,9927531,3.758901572486559,4.779174216010873
Panc 02.03,107970,3.0394503344184214,2.4240393055158096
BICR 22,6917907,-5.724798000333263,-3.128336859891229
P31/FUJ,219104,1.0946129740431632,2.270205889096585
MOLP-8,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9308410221976412,3.8171989395691917
ML-1 [Human thyroid carcinoma],421610,2.367130129227347,3.1307831223356044
P31/FUJ,SNX-2112-bortezomib (250-1 mol-mol),-3.0882098716957223,-2.486930862788504
COR-L105,23582824,0.3539942370445449,0.5788714337161137
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865,2.6201116832830196
NCI-H1568,135999136,4.3721543597322405,3.979278966422439
HuP-T3,11404337,1.0495167124251128,-0.16188324839526164
MOLM-13,2729026,2.3347481789683564,2.1877758735363595
IGROV-1,9935249,3.330117761231163,2.9720913651531258
IGROV-1,16038120,0.2864038103759729,0.9801423510508538
NCI-H2452,11167602,2.565240148317103,2.549380440121469
Granta-519,4788,5.939837006566146,4.86138754491752
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349,3.1385766238623303
Daudi,2842253,3.640131040983124,3.5332835264019975
PaTu 8988t,9911463,4.367264855700764,3.9325583483184623
IA-LM,613753,3.1957676281974328,2.894695808223
HCC1500,168312962,0.9454061370050444,1.94076647376174
Granta-519,52912189,-1.096728840522365,0.26057640374048974
K-562,67291369,1.5957287334193675,0.961086867652612
HuP-T3,1750826,-1.878047057258104,-1.480434430082413
RCC10RGB,24180125,2.398663234613943,2.9180092836155858
SW1271,5566,3.0013167075914344,3.009804711377403
P31/FUJ,126941,-4.476387704672624,-2.910649325616136
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629,2.081798680250244
HCC1500,44486219,3.883233561942222,4.444427050203512
SW1573,24964624,5.100144587499453,2.564208454176621
LCLC-97TM1,crizotinib-PLX-4032 (2-1 mol-mol),1.007977471964547,1.5582297268842242
Daudi,42642645,-0.8700738631175318,0.20226572773335674
COR-L95,carboplatin-etoposide (40-17 mol-mol),-0.214243666427535,1.506541773891308
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758,1.0990107818086754
SW1271,969516,2.705669665349302,2.8868950431842
COR-L95,6918837,-4.56092327324237,-3.7548405580429933
SK-CO-1,25154868,4.619527339846263,4.273473096047528
RKO,159324,3.5523933893017583,1.3931500963782744
HCC1500,168313200,1.6452616775244175,2.695304516778404
IGROV-1,4788,5.801051990484709,5.415890965787957
KU-19-19,5746,1.6270456089520258,1.3245714698271458
RERF-LC-MS,46398810,3.3112335021243977,2.7144372171425655
IGROV-1,6438330,2.7487580937365683,2.5352764823954432
PaTu 8988t,123631,3.803217986992814,2.6957589717980763
LCLC-97TM1,5278396,4.167561166456711,3.288185684583317
WM115,71680916,4.535911767348542,4.796302359628848
NCI-H2452,322968,3.869715934392993,4.2503859198863605
NCI-H1568,2708,3.449118605167301,5.0455731849657415
Daudi,5470400,3.6690588756853706,-0.6078146629215033
NCI-H1568,3038522,2.281352774411324,2.9579851873141814
K-562,24951314,0.9405452740645998,0.25825529818462317
BICR 31,44137675,3.031084694210408,3.5563267614286804
SaOS-2,82146,4.466197629976123,3.8685877712436167
ALL-SIL,BRD-A02303741-navitoclax (2-1 mol-mol),-0.9236991288199824,-0.011422747461367564
HuP-T3,5738263,4.055810266621769,3.4556391161595816
COR-L95,11494412,1.7619372096243109,0.7339161435255069
Granta-519,11507802,0.4974969144595386,0.7796780257762468
WM115,2949965,2.619280368742809,2.888357482999936
HCC15,613753,3.363668001401703,3.4517612610780217
HCC1500,107985,-3.8501888791364034,-3.4280717473003004
WM115,54678924,1.8194282087981308,2.2539144682671695
Daudi,135398516,-0.2737475793919353,1.0619451125482835
PaTu 8902,5280436,5.000479378124589,3.4452340614066657
RKN,439501,-1.5558449248177562,-2.44544459751473
RCC10RGB,5287620,-0.3857243809023412,-1.8127841204169917
Daudi,5566,2.2518803351891616,2.942935261061354
COR-L105,31703,0.0245204691354453,-0.7180493190789022
LS180,44507138,3.917968702075208,2.4408545892923077
Daudi,11964036,0.3747037141940179,0.3348604654681728
K-562,16659841,3.212428083743772,2.6712800213428185
MOLM-13,54618771,-0.6841479707721928,-0.11778864803807206
NCI-H1568,49793307,-3.5648882234860895,-2.398533337429038
SK-HEP-1,navitoclax-gemcitabine (1-1 mol-mol),-0.1291553978520299,-1.22969848323306
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863,1.188118941007032
KU-19-19,selumetinib-decitabine (4-1 mol-mol),2.1660518976484853,3.86590080825301
SW1271,107985,-2.924919788256343,-3.225575591598828
COR-L95,2746,2.78697970441755,2.0698697798073082
IGROV-1,104842,-1.6690343627553987,-2.837050359366107
COR-L95,16038120,0.5843691628917023,0.5096090502871755
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783,1.3560651460307096
HCC1500,123631,1.5682585338280497,2.2641419753417935
PaTu 8902,322968,4.547287257097872,3.8809602515309063
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335,2.0400736197442426
Daudi,11167602,1.0022899570414256,1.650421311163083
ALL-SIL,10074640,-0.3353589360570669,2.2928344175738204
COR-L95,57519531,1.325264870307383,1.9701456494796181
LCLC-97TM1,46191454,0.3820919964810073,1.5552995400705563
ALL-SIL,439501,-2.349752310116714,-2.8293574680671636
IGROV-1,25126798,3.9275606774720817,3.756445003546894
WM115,24753719,4.6734048968266775,4.346843460055803
HCC15,36314,-6.084589216701663,-1.9082255694090022
HEL,16720766,-1.3120587580234824,-0.6036700573025889
SU-DHL-1,11222830,1.179409628644554,1.7350990153294665
HuP-T3,3634881,3.0028113890745707,3.350001077210639
K-562,5738263,2.3545721599917027,2.6906031910610726
SK-CO-1,16725315,3.5012946679092853,4.297197283112937
RKN,327653,3.2518035953304434,3.283406103097745
RKO,24772860,-3.046302255649564,-2.1528304715706934
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616,-0.8612294755428976
NCI-H1568,piperlongumine-MST-312 (1-1 mol-mol),1.2489252589958966,2.141860259002677
SK-CO-1,15953870,2.1343083972614725,3.538752762992461
BICR 22,71751553,4.276876209585518,4.466167032228669
K-562,24964624,2.9615918690112717,1.5217049197487975
RKO,11222830,1.6656419736189183,1.3563024963865795
RCC10RGB,25105715,3.76392637454814,3.4708233880697343
ALL-SIL,54618164,3.625474128679928,3.485844414757236
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196,-0.6725433987105022
SU-DHL-1,49793307,-4.256389272054101,-3.737013673998047
SK-HEP-1,9915743,2.4580731883892293,1.3485543344229751
SaOS-2,10410894,2.56650375580144,3.3177723288891747
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056,2.059882528322589
COR-L95,44491742,4.146782751375218,4.138161727647515
SK-OV-3,44137675,2.687297746540291,3.437453125978164
SU-DHL-1,4477,-0.6876815909262691,0.5754213043289325
RKN,5311,1.8833679583763572,1.680749688089668
COR-L105,11640390,3.408966388045623,3.7537167796482604
RCC10RGB,637858,2.3286326267725084,2.1001578248008297
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595,1.6511254590127382
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422,2.6031750578943873
NCI-H1568,serdemetan-SCH-529074 (1-1 mol-mol),1.1632168234026012,2.0474068491265625
SU-DHL-1,6852167,2.266746993939426,2.5228635245983453
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316,2.92473434717832
HuP-T3,49793307,-5.3581383477853555,-2.416883570939202
SK-CO-1,5282054,3.655593178279643,3.9073714275377442
RKO,2841722,4.522769482159767,3.8487509148028263
Granta-519,65628,2.6603144373939154,2.9713254322142415
SU-DHL-1,637858,0.6782178889909583,1.8406285985817135
RKN,9911830,3.6623648245681744,2.449897549066274
ALL-SIL,tretinoin-navitoclax (4-1 mol-mol),0.1560826957318693,-0.38447112767147007
MDST8,ISOX-bortezomib (250-1 mol-mol),1.0361241685592786,0.5798548073721733
BICR 22,9884685,0.2149660223226223,0.7205105702515595
COR-L105,46907787,0.7742744471044445,2.663940498823988
RCC10RGB,navitoclax-sorafenib (1-1 mol-mol),2.209619948834929,1.7653888696058908
RKO,54618771,2.3159310195777985,0.6991697576879256
HCC1500,6450551,2.2317386689521816,2.853263431551395
BICR 22,10296883,3.888864516393213,3.960844827751755
Daudi,10302451,1.2926011902861492,2.389302863896807
Daudi,tanespimycin-gemcitabine (1-1 mol-mol),-4.635562978503933,-2.4482773205177337
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994,2.485240917202837
Granta-519,216239,2.502983600228736,1.7068973323979568
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815,1.4478834071745121
NCI-H2452,4521392,4.554150979099382,4.307410414688673
IGROV-1,123631,1.7694522866439453,2.187533608867449
IGROV-1,5566,3.174346862827938,3.0950961490949527
MDST8,72193861,1.790495642839322,2.000203174922983
COR-L95,400769,-0.6446482680437077,-0.542330822741532
SaOS-2,5287620,-1.8033063725700844,-1.8820570484299213
COR-L95,6917907,-5.619348954097505,-5.224973279312746
WM115,9840324,5.544544164897635,5.871702249785003
COR-L105,selumetinib-UNC0638 (4-1 mol-mol),1.9595144972930605,3.0559687053594002
SW948,10322450,3.138867511839475,3.2671591429979503
K-562,25126798,3.746183025237492,3.533707776688611
LS180,5335621,4.412574333730147,4.653844286375068
SK-CO-1,9911830,2.5560928673864676,2.5969547045018486
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237,2.8137031162249158
SK-CO-1,9825149,2.4273154495027147,2.0743528331572865
HuP-T3,tretinoin-navitoclax (4-1 mol-mol),4.772875046445671,2.370027277011263
KU-19-19,10074640,3.725362653690234,3.131680039962644
NCI-H1568,24901704,3.012455129702266,3.3455121957452936
PaTu 8902,216345,4.855612410794221,4.1849487454920045
LCLC-97TM1,44202524,1.0559659544617075,2.406132299455521
MOLP-8,9884685,-1.6145757941110517,-0.13828170721295963
SaOS-2,11656518,3.53164758658959,1.8684585543728491
ALL-SIL,5280436,2.610850174870569,2.744366179092597
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677,2.3503842147736758
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848,1.0775484772513828
COR-L105,16659841,4.469572921203622,4.087272088430833
SW48,11625818,2.5740084903132914,4.249911790865209
COR-L95,135875424,3.0866900102445816,3.398279959239901
NCI-H2452,10074640,3.4255764700713685,3.2701087513075344
SK-CO-1,60750,-4.4937571478067495,-1.302329530369429
BICR 22,374536,2.9550889228261386,2.110955282934742
MOLP-8,2126,5.134995770793403,3.605233074743861
NCI-H2452,5566,2.960608772215372,3.1692655754219152
Daudi,54618771,-0.114332288085178,0.3168109843880363
NCI-H1568,44137675,2.485428235347338,3.4629994379505407
BICR 31,24771867,6.325583215176513,2.970599225950685
HCC1500,135875424,3.5744445956281483,3.896158380510195
K-562,vorinostat-carboplatin (1-1 mol-mol),2.490945525629646,2.0770937758912664
IGROV-1,753704,6.461140333581179,4.951316208300307
SW48,11497983,-4.007853458767396,3.3626312329155548
MOLM-13,25195348,1.114215790958376,2.3840684466549806
Daudi,441298,1.3514709590925575,2.0523999003283366
SK-OV-3,124202324,3.0713957973247186,2.4643739363688426
BFTC-909,23635314,-1.3241610546701814,-1.5076817227360937
COR-L95,71304818,2.943301589855332,2.069573079813909
SW1271,44607530,2.17277245139498,1.8398812225256214
RERF-LC-MS,219104,4.628133490361187,4.016900034722185
NCI-H2452,31703,-0.2834256058580119,-0.717715401842407
Daudi,462382,-0.0525304302162242,0.37715003257348384
SU-DHL-1,25183872,-2.297532702486321,-1.8789649002626794
K-562,54618164,3.946994253297547,3.6830164210488925
SK-HEP-1,568763,1.0235069184223942,0.6809409120377132
SW48,docetaxel-tanespimycin (2-1 mol-mol),-8.123886258687621,-3.014483010784371
Daudi,BRD-A02303741-navitoclax (2-1 mol-mol),3.127125631555358,0.8107284138661731
Panc 02.03,2828334,6.385741192046609,6.185157550451844
HCC15,5702613,2.8473188935914835,2.978511777830322
PaTu 8902,11625818,4.430115392870615,4.6033898314080615
COR-L105,53392493,2.0389615313780256,2.8935301406410345
RKN,3062316,2.6330403907451863,1.4384135660281023
UACC-812,6505803,-4.59801553223132,-0.6615816610459853
UACC-812,16736978,0.0217391388778129,2.077005875996039
BFTC-909,5278396,3.473037688340168,3.744469970529558
SW948,73707398,1.7510146080607218,0.9751518363848493
BICR 22,107970,2.71438120007047,2.4029916536160076
SW1271,984333,0.5174855517327741,0.8524368747063993
IGROV-1,9967941,2.9735049794712545,3.7727462684070914
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693,-0.7611251849367571
SW948,135984461,4.375312800732864,3.6045791032396233
LS180,5280436,4.14000298943632,3.3337006375620497
MOLP-8,219104,2.0853040324344536,2.3342914140619015
MOLP-8,1716436,2.7387406442001287,2.629904100613607
MOLM-13,171352865,4.594115651620468,1.889499756421071
KU-19-19,10127622,1.068304480617998,3.8474225370812962
KU-19-19,5460769,4.3332822587900255,2.3481481887077993
LS180,675434,4.417044491450032,4.347575293435963
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286,3.3004465327173973
SK-HEP-1,66577038,3.45712203265648,3.0775441936444956
SW1271,3689413,-1.2412691685690602,-0.42794219854664284
COR-L95,10296883,4.074268886544182,3.477854721759753
HCC1500,5287620,-3.8084705838741306,-1.5835331719461214
RCC10RGB,JQ-1-navitoclax (2-1 mol-mol),1.088443536961304,0.7446512429215183
WM115,serdemetan-SCH-529074 (1-1 mol-mol),1.0432203411705916,2.0665320854933125
SW948,vorinostat-navitoclax (4-1 mol-mol),1.0335682598311662,1.0780086325734233
SW1271,46843906,3.0036733058278298,2.9727771690420495
SW1271,10184653,2.439662406391272,1.3857168194269451
SK-CO-1,31703,-2.259601900898513,-0.6669304494857458
COR-L105,10074640,3.626128603914542,3.20413631644288
MOLP-8,11152667,-1.9226575172330305,-1.7302714450057104
SW948,56646779,5.261847054930003,2.477081455584296
MOLP-8,9825149,0.6088991704164435,1.519201057654976
ALL-SIL,piperlongumine-MST-312 (1-1 mol-mol),1.1188007214876046,1.209624465485572
RKN,1641662,3.781184529562369,3.5649858615342294
Daudi,1750826,-5.008838903624334,-2.882007456191654
RERF-LC-MS,24856436,0.2419222597799965,0.737260618097073
COR-L105,6184667,3.4155069342084916,2.9895891910434558
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443,1.1191917816548789
MOLP-8,568763,-0.8505432933185847,-0.02073102587207695
Granta-519,piperlongumine-MST-312 (1-1 mol-mol),1.116794346695572,1.1257570252874565
SK-OV-3,54618771,2.5849230632376923,1.7628301546737122
SW1271,135398516,2.256973153183445,2.421850859362842
MOLM-13,44819697,-1.7672663076184636,-1.8540804984624535
LCLC-97TM1,24748573,2.1629406196043894,1.80614491241482
NCI-H1568,10113978,1.8126489257310032,3.2749596783212183
ALL-SIL,SNX-2112-bortezomib (250-1 mol-mol),-3.319111432428944,-2.844393580922126
COR-L95,1566236,1.7351682171374878,2.0362254432547258
PaTu 8988t,54619267,4.243668204976347,4.273926718925806
BICR 31,73707398,2.635299985295534,1.2937241494614893
P31/FUJ,24978538,-1.1674360999825653,-0.5143723723706944
HuP-T3,25227462,0.1487181406442073,0.979806040003257
Daudi,439501,-2.973914496380735,-2.3135279956011896
NCI-H1568,67156097,-1.7914617240991686,-0.7661073796848566
WM115,36314,3.85550299796777,-0.8748400242681658
MOLP-8,409805,3.552664043240888,3.7702363773177554
SW48,24753719,4.052743892866938,3.881820577069494
SW48,3825829,3.1303188593692854,3.6851109133114806
PaTu 8988t,54613361,0.5051194448617704,0.12750152225538702
SK-CO-1,44493528,4.973545843770428,4.345501340952299
MOLP-8,44202524,1.1617664844294235,1.2363200574327284
P31/FUJ,11656518,-0.8295634521320199,0.5637258055126967
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981,4.492020788207983
LS180,36314,2.4476112429633403,-1.740138279697849
SK-CO-1,119182,-2.3548964470523974,-0.640689584724854
LS411N,72376,-2.6969507034435236,-2.8711104616993155
BICR 31,51037431,4.633533363663127,3.4502897259658964
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246,-1.6285686968237372
HCC1500,46907787,2.786329845885891,2.3078382598882494
MOLP-8,2708,2.5820066460748015,3.5364080292784283
HEL,10113978,2.6394190696879662,2.3184438420661713
HEL,1641662,3.192273244328466,2.7578799504716858
LS411N,12001922,2.0246848718715604,1.5742573678805718
ALL-SIL,56963564,-1.2928564241979046,-0.2996622902770891
ALL-SIL,168313047,1.973173862571291,1.7040190726678395
COR-L95,3038522,2.051786867518871,2.8078449905219713
LS411N,25102847,2.9606059837222767,1.82584629888285
SW48,5566,2.216391660090734,2.648801049842667
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728,1.894550550653625
SW48,6917907,-5.957551707769467,-4.143929650216222
RKN,246676,4.414592383854902,4.468032406370659
IGROV-1,285033,-1.3538783590767758,-1.6946390524905846
PaTu 8988t,11609586,2.9135578891851233,2.8926028884978545
P31/FUJ,19582717,2.23583270668625,2.8476458890824223
SK-OV-3,71304818,3.289226671933847,2.636360482266235
SW48,9903786,0.6824641791663469,2.533233392493612
SW48,107985,-4.220376672084107,-3.508609673501191
ALL-SIL,49836020,-3.56746653346715,3.2335163765304378
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333,-1.9723001848039803
MOLM-13,7326481,3.309466894819375,2.7061146216744767
PaTu 8988t,387447,-4.215036300164339,-3.582782639258665
IGROV-1,10231331,1.9104831176724932,1.645513785781561
NCI-H1568,salermide-PLX-4032 (12-1 mol-mol),5.036103452561945,4.943238343194552
WM115,6852167,1.3860811523021286,2.840762932898829
SW48,11175137,0.8049020199472112,2.5505822289885565
NCI-H1568,6918837,-3.937828464321892,-2.5995481676699934
ALL-SIL,409805,3.511042482554543,3.7805133891812726
BFTC-909,11485656,2.882750602975944,2.3954094237760333
HCC1500,6610216,3.984830656845064,4.2614717552707395
MDST8,46191454,-0.3052251724831438,2.094546159173262
NCI-H2452,52947716,2.3907771066336543,1.1203975230747663
COR-L95,135411,0.6709946332822974,0.5379465417501426
RERF-LC-MS,11497983,4.204546577264711,4.4910056183404965
MDST8,3025986,-2.3601391308628368,-0.6020172465182221
K-562,10113978,1.9599198523990544,2.5004337488752917
MDST8,66577038,3.4472401917824387,2.971524301343614
RCC10RGB,6917907,3.54732574828972,-3.6503999181351516
SU-DHL-1,54618305,4.34503505735179,3.7315218194316877
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552,2.3087139993734747
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644,2.0354300678810286
WM115,448949,1.6539360415615445,2.057862739017497
ALL-SIL,216239,1.0502640873271551,1.732007815552243
HuP-T3,docetaxel-tanespimycin (2-1 mol-mol),1.3630986120545014,-3.191109806339233
IA-LM,53325874,6.131967715828746,3.7046288378903323
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821,3.617138598038525
P31/FUJ,119182,-2.8125390579467244,-3.007061098813333
SU-DHL-1,11717001,3.585470860794662,3.671054893915791
MOLP-8,168313016,3.7646553629166304,3.9528911030420493
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816,2.5693091111870014
SW1271,9823820,4.369434873409536,4.082127199875199
SK-CO-1,51037431,2.025162533854422,3.3828085802801007
SW48,11964036,-0.90016316876993,1.1524454054791746
Granta-519,702558,4.9740995052838874,3.8532805252746702
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213,-0.4356878398530608
NCI-H1568,6918328,-2.169641972219076,0.17116212047649804
Daudi,637858,0.7785119720749748,0.7769735714383523
SW948,53495165,0.2015090818079991,-1.3705433933293285
SW1573,46398810,3.5765453048302933,2.487495115079109
MOLP-8,637858,0.6022882265593398,1.0759545693721784
NCI-H1568,3825829,3.749474944576795,4.012648146195628
MOLM-13,4788,4.00969340257961,5.092404727836106
SU-DHL-1,135398516,1.716785738144405,1.8390668008814588
HCC1500,2945648,3.001490751925554,3.1293520868963394
SaOS-2,SNX-2112-bortezomib (250-1 mol-mol),-2.769432838518552,-1.1717004371767645
HEL,46943432,0.8947528664895825,0.8016507595217943
RKN,3689413,-4.085525957083088,-0.6201593584319065
COR-L95,45279963,4.007720953160328,3.317808423405463
LS180,11364421,-2.9792456594346945,-1.6152351096250144
SW948,51039095,-2.1737453378627567,2.9925994007643872
HEL,135421197,2.810551353794614,1.2951037557682092
SK-OV-3,doxorubicin-navitoclax (2-1 mol-mol),-0.6082867931514424,-1.1363872183591963
HuP-T3,5351362,1.4959503226370765,1.6532847701230577
P31/FUJ,selumetinib-decitabine (4-1 mol-mol),-0.417260560947631,0.7704975856969635
SU-DHL-1,6623618,1.9512254956144048,2.0396217635704947
BICR 22,31703,-2.104947288409208,-0.9869759483620898
P31/FUJ,BRD-A02303741-navitoclax (2-1 mol-mol),0.458289206697817,0.40242961751288936
IA-LM,17755052,4.247702528352723,1.9968338293226398
IGROV-1,17755052,-1.0246415273055465,1.4541191896690517
WM115,navitoclax-birinapant (1-1 mol-mol),2.982568846631371,1.544195169185582
IGROV-1,3503,2.453392942972796,2.443928277144516
BICR 31,10302451,2.0763164615496232,3.0869455067462974
COR-L95,JQ-1-vorinostat (2-1 mol-mol),1.1858087423050925,0.6851259580027148
MOLM-13,2841722,4.084965304911922,3.763410267717098
COR-L105,9549297,5.541569761250669,2.553314784725118
COR-L95,4705,3.007858501345706,2.9262774848611293
SK-HEP-1,54626689,5.252317432323977,4.611267875416524
BICR 22,24964624,2.8366894332481127,2.242190039947719
K-562,3384730,2.2830550335302555,1.7316864303225652
RKN,46224516,3.695788234754723,2.898946092475205
Panc 02.03,44607531,1.9299895981807216,1.3967468914488586
MOLM-13,11317348,-4.1893096196029465,0.949902041006454
LS411N,60700,1.793788628592944,-0.5341831609079994
ALL-SIL,9967941,3.4348481015027628,3.0996524762215483
SK-HEP-1,46907787,5.1061569205326505,2.7190929599509066
RKN,5351362,2.529766574998156,1.5394794492472545
HuP-T3,31703,0.4675615226322689,-0.8396431617599218
SaOS-2,6610355,4.596244040557677,4.636796959339371
BICR 31,25195348,4.130650271984148,3.5008660422130173
MOLP-8,73707438,3.908454567487333,3.897208534499545
MDST8,3503,3.3556251865549065,2.4639606008209882
COR-L95,439501,-1.1523844892623298,-2.490295683663841
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097,3.404469167608503
P31/FUJ,5281321,-2.503740446113486,-2.4584602626548153
BICR 22,selumetinib-piperlongumine (8-1 mol-mol),3.0599254943264116,3.015750838178606
BICR 22,2729026,3.062923067871907,2.453276754664639
SW1573,51037431,1.8928004764191728,3.1662153337876218
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971,-1.3574957780542507
RERF-LC-MS,16741245,3.282184197465347,3.4094235642651456
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957,4.6199071906112295
SK-HEP-1,11427553,3.604603983851784,3.0250659344531527
SW948,alisertib-navitoclax (2-1 mol-mol),-1.9206127672365017,0.41455041603134923
SaOS-2,36462,1.0480120523183942,1.834033041282785
IGROV-1,124202324,2.2563058955522157,2.1628348600216594
P31/FUJ,54618771,-0.1557090961755644,0.24295989088836945
HCC15,6918837,-3.491973763742546,-2.656678508523147
RERF-LC-MS,10302451,4.085913110869725,3.281123281305054
WM115,9866186,1.4274901944164853,1.1152204515694095
RCC10RGB,3634881,4.1231622503065495,3.58999262179357
MOLP-8,tretinoin-carboplatin (2-1 mol-mol),4.454701733266676,3.488722905771801
SK-OV-3,56946209,-2.3996417591607235,-3.763305811070911
Daudi,9907093,2.3595872536278977,3.289592236204232
UACC-812,135421197,0.8848266315498433,1.851249922234955
COR-L105,11707110,-2.3960237918310967,0.41485648384244983
NCI-H2452,crizotinib-PLX-4032 (2-1 mol-mol),2.3217431804401607,2.0363816310146587
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172,1.6780307064958138
BICR 22,5287620,-2.2777736835755076,-1.8349957739406415
HEL,135398738,1.3240045179008624,2.331534978348444
SK-CO-1,3825829,3.015639513793665,4.041925176716856
BFTC-909,135398516,3.047749913114312,2.423592583340423
Granta-519,252682,6.242071482699392,6.446244216040445
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159,1.9411725449906958
SU-DHL-1,241158,1.6235055790866513,3.7025118365454768
PaTu 8988t,8515,4.36808886077581,4.095370762102305
NCI-H1568,44489675,3.7863062268563064,4.037145421510206
MDST8,135875424,6.383148165610491,3.902246471731441
IA-LM,24771867,1.1290385026114922,0.3323649641431684
PaTu 8902,12001922,1.8953174279693872,1.9290838655664602
HCC1500,8515,5.3989297102528715,3.911578052595344
MDST8,4259181,0.8851574645315519,0.4198132156601855
SK-OV-3,16038120,1.745962946040546,1.0936315989212537
SK-CO-1,25126798,3.6561952188996503,3.822006365524659
HCC1500,4261,0.9221319619811188,1.3111534719335458
WM115,613753,3.1291419252746877,3.321700381937765
IGROV-1,6505803,-0.2382223795960626,-0.7995475613560213
KU-19-19,49766530,0.1366302187334878,-0.05589305351835834
BICR 22,11494412,0.8036857209518554,1.8827186149484563
HCC1500,11955716,2.281516197797272,-0.9690021954432112
MOLP-8,71680916,4.479993680298279,4.067129781867206
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773,4.38580284676274
BICR 22,15983966,-4.391384426150851,-0.45829425527840056
SK-HEP-1,selumetinib-tretinoin (2-1 mol-mol),6.787404934084747,3.756224931633602
RERF-LC-MS,9866186,0.0636323256725951,0.9776364329726859
IGROV-1,54613361,1.0826132998561049,0.18487801733483789
K-562,4259181,-0.7813149193344907,-0.07918777631312207
SW48,6438330,1.214777505056659,2.2601362819009463
LS180,54618305,4.3130332958468385,4.183647775483749
K-562,5746,1.9738407973257048,0.21961319906270318
COR-L95,3081361,3.577896308939448,1.943663816300028
KU-19-19,ISOX-bortezomib (250-1 mol-mol),0.6477518582997711,0.7211747651629213
MOLM-13,navitoclax-sorafenib (1-1 mol-mol),-4.200053856490793,0.3584834125073432
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764,5.459487535796992
NCI-H2452,alisertib-navitoclax (2-1 mol-mol),-1.045230676490147,0.6729178228585936
K-562,53495165,-1.204911447319433,-1.6321486266062237
SK-CO-1,JQ-1-vorinostat (2-1 mol-mol),1.937629549480178,1.0180480388957074
HCC15,3676137,4.952150033317278,4.325167478938009
PaTu 8988t,46398810,3.220252132938068,2.692553214155347
IA-LM,ISOX-bortezomib (250-1 mol-mol),0.3247346059672509,0.4666175691748227
BFTC-909,9927531,5.31835549136936,4.894708821980584
Panc 02.03,16722836,2.9028860212849565,1.8744620250454453
NCI-H1568,doxorubicin-navitoclax (2-1 mol-mol),-2.631367093813306,-1.3086061048855937
Granta-519,3011155,5.044202810550695,2.28768125915114
IGROV-1,3825829,4.144093606877803,4.089634186682881
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891,-0.52652871395824
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014,-1.5299779679976513
WM115,11238147,1.7518250261640556,2.9022628531280033
HEL,6610355,4.700351008256091,3.754596216806492
COR-L105,10410894,5.46795970795096,3.5655757454520343
K-562,135421197,2.032823128578147,1.4254530356683799
HuP-T3,25105715,3.756943800954468,3.4951860589441663
BICR 22,11717001,4.533318725499836,4.042743188208607
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303,2.4108939759212826
BICR 22,176870,3.0604023761484154,2.669287834801401
COR-L105,9823820,3.977631180290917,4.364105819441269
P31/FUJ,66577038,3.0536576112540916,2.591769913882178
HuP-T3,11612883,3.639610964764467,2.973558552728775
PaTu 8988t,12001922,2.536714978511883,1.9308396074080474
P31/FUJ,24771867,-2.604308550432203,-0.8632893162092214
P31/FUJ,3634881,2.159990781463395,2.593309973409365
SW1271,11640390,3.706316930576478,3.752193705727413
Granta-519,984333,0.7513060576966085,-0.5736315432880024
COR-L95,46398810,2.3153378536205036,2.0724185414255856
NCI-H2452,4259181,1.4154165902225178,0.46535257574548844
HCC15,docetaxel-tanespimycin (2-1 mol-mol),-6.454135481670954,-3.2131902563465657
RERF-LC-MS,3503,1.2198018250646854,2.289020833051509
BFTC-909,168313047,1.967772312792883,2.3549639008633547
NCI-H1568,49766530,-3.205306991379519,-0.007354816447954238
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569,0.7965533820358313
IGROV-1,44491742,4.406671418311328,4.173323265636984
SaOS-2,54596490,5.687426160237218,4.06768823024527
Granta-519,46843906,0.846372381562089,1.532817656800824
SK-OV-3,46398810,2.6339706660379205,2.586864423927661
WM115,25154868,2.4497388117539773,4.416694645114019
K-562,navitoclax-gemcitabine (1-1 mol-mol),-0.2101297783462078,-1.7420135691734873
BICR 31,123631,1.818021308876907,2.3780113073625984
HuP-T3,60750,3.212181181151216,-2.077565512438964
WM115,71304818,2.065667497969779,2.551866005609085
SU-DHL-1,11964036,1.0253922980362349,1.4154414048930752
SW1271,9444,4.046685913234064,4.136895213157154
IA-LM,1716436,3.827820678542469,2.6520797414830275
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175,2.0178930981429093
Granta-519,selumetinib-decitabine (4-1 mol-mol),1.299817261369256,0.5829943490569138
SW48,44137675,1.8984167228990951,3.207195224045819
IGROV-1,11364421,-2.1205062036040982,-1.8205991388783707
PaTu 8902,3465537,3.540732953494624,2.576988500236014
HCC1500,54618771,1.4039271563223086,1.128403161546683
NCI-H1568,23725625,5.336887169251221,5.260721470494794
BICR 31,9936388,2.7244047649519074,-0.12006504274944914
IGROV-1,49850262,4.068828647042517,3.6702588512290584
HCC15,5280436,4.320878094694944,3.4818300369873003
COR-L95,46215462,1.6156782364555438,1.2894134021587593
SW948,25022340,4.946878477600784,1.3965930658513779
P31/FUJ,3025944,3.8644283212627895,3.8467721229575473
SK-CO-1,5978,-3.732613512446313,-1.5503823405610788
LS411N,19582717,5.192972758226466,3.3012438300994713
SaOS-2,26596,-1.8442798913702467,-1.172405692987323
MOLM-13,6610216,4.131122051839403,3.8783377043943457
KU-19-19,3025944,4.41555498235696,4.334678262056117
HCC15,11497983,1.686538707374479,4.038949774076488
HCC1500,216468,3.3608861469702735,3.1980941457863774
NCI-H2452,56649450,2.972344092085675,3.7950891824790496
SK-OV-3,25262965,0.4953902890441227,-1.6063317173850382
HCC15,10184653,1.3258142209068642,1.3846867343740012
SU-DHL-1,3825829,2.249840075454991,3.867044021179812
WM115,49867926,3.8689880289876446,4.456937858410992
K-562,285033,-3.792012978388577,-2.912410926880371
Granta-519,53495165,-2.785106410212646,-2.0939322818040336
SU-DHL-1,5335621,3.5965276677583846,4.228816935194844
NCI-H1568,1566236,1.6523344134899465,2.6766245101547113
HCC15,25195348,3.62058364960133,3.4895960158835244
LCLC-97TM1,7326481,3.961997196958484,2.926461331595355
SU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),2.5998168320155712,0.4126637814470074
LS411N,9887053,4.348393626170801,3.0204706455132584
LS180,208908,2.3350670945107783,1.6696623144353513
IA-LM,54454,3.681506421747591,2.4804933199741415
RKN,4378219,1.9905206425028277,2.4820085758504256
WM115,selumetinib-tretinoin (2-1 mol-mol),-1.0607687385354925,2.175337039512215
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402,2.861133026507716
IGROV-1,216345,3.498629789107092,3.4890272552306065
SW948,5282054,2.5738720751419746,3.0718555329942974
PaTu 8902,66577038,3.2739824602509304,3.0965986985331413
COR-L105,1566236,2.352597865521479,2.705195969324121
MDST8,selumetinib-piperlongumine (8-1 mol-mol),2.2463644977006423,2.798427325047023
MOLM-13,46191454,-2.5774836063329905,-0.01693623896158022
HCC15,72734382,4.010055800269774,4.580445998373852
SU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),0.7019716882253797,0.2496035749507912
SaOS-2,53232,1.3253237607162072,2.702066539548523
KU-19-19,9936388,2.972521935644637,-0.7501845106093904
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386,1.7276258032400134
PaTu 8988t,selumetinib-PLX-4032 (8-1 mol-mol),6.546714585900996,3.796405427695743
SU-DHL-6,445643,2.4790626422724107,3.4290583112961723
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193,4.585349684560758
HCC1500,208908,1.6399748300125228,1.8058002845338479
P31/FUJ,4917,2.744589019426067,2.768077883203445
HuP-T3,241158,3.8412641522091144,3.9551913610504705
SaOS-2,46224516,2.521923040225463,2.5853246968707624
LS180,54618771,0.643112685351952,0.8916523724219038
Daudi,23725625,2.2816125857144978,3.4118345179756777
Panc 02.03,25227462,-1.0518848939229315,0.7647718338970502
WM115,462382,0.0353255606914336,0.5356270220612624
SaOS-2,135875424,3.0421388786055727,3.754380529879551
Granta-519,10113978,3.360346958971763,2.1866529189755015
SU-DHL-1,51037431,2.2415500634191763,2.5228430546047607
SW1271,135440466,1.7072517695379112,2.548262488943798
BICR 31,208908,2.9880095911503983,2.0964030994840175
NCI-H1568,11719255,3.5544275615483087,3.5973579251337253
SU-DHL-1,4259181,-1.4222017445817885,0.195748631853805
NCI-H1568,135984461,4.216726883570129,4.018302614736804
Daudi,navitoclax-piperlongumine (1-1 mol-mol),0.8768236288563281,0.4691702187929906
K-562,25195348,2.6278567451650394,2.7414861453958554
SW948,6918638,-0.8188756331889222,0.1840743958999461
UACC-812,216345,3.8515167014354152,3.6933951606086084
PaTu 8988t,446155,5.325372031764619,2.7164655761121406
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397,3.2877030215677663
NCI-H1568,54618771,0.8004506686595156,1.490566863611944
HCC15,9823820,3.975711917882334,4.25819051854488
RCC10RGB,9935249,3.9754060705766943,3.214234357128332
SK-OV-3,3854666,3.321518045263264,2.223228461565363
Daudi,135928012,2.6114481479622516,3.422858570624821
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433,3.098630292415873
HCC1500,44491742,3.6723474636183537,4.337712182004081
K-562,54626689,4.3954029102592145,4.2625478269753
SW948,11152667,-0.307089718187717,-0.9788463581942295
NCI-H1568,984333,0.7198134332239758,0.8477450359689306
Granta-519,selumetinib-tretinoin (2-1 mol-mol),5.148474908350203,2.58698906548974
IGROV-1,44507138,2.359177395411688,2.5845051771022396
COR-L105,44566777,0.9614143121394376,0.8770455642061644
HCC1500,25126798,3.9309577641895137,3.892321855803027
LS411N,5470400,-0.4509258648896809,-0.68239386674315
PaTu 8902,11427553,3.388107623793881,2.9873481006937084
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876,2.4410767871337815
LS411N,11364421,-0.88941081068058,-3.575357816537407
Panc 02.03,6918638,1.5939476449475074,0.5190996752814641
IA-LM,73707398,1.4255919606814562,0.7867406911794471
Granta-519,54613361,-0.5306815642640709,-0.8453084425922297
IGROV-1,176870,1.8349827429681411,3.0756323353059347
SK-OV-3,24821094,3.4952627197751744,2.788446047108002
SaOS-2,5566,3.2892304449964125,2.8188399311648795
BFTC-909,44486219,4.380685277356905,4.450173012205502
SW1271,52947716,2.875834451056303,-1.4486244941300432
LS180,20959075,-3.038194424999374,-2.848678729652747
BICR 22,2708,5.160276397343071,4.934867721589818
LS411N,24856436,0.7977520405714393,0.6135336588223573
RKO,3062316,2.656751778030552,0.906485417073079
IGROV-1,2841722,3.834853118277962,4.321023900318734
SW948,9967941,3.223093544556301,3.021539349699097
WM115,5291,3.6779708977342263,3.6308023785629366
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737,3.164627289562859
NCI-H2452,11152667,-1.2581393219211725,-0.1758699170873459
SK-HEP-1,54454,2.662573207119838,2.4494433547928125
PaTu 8902,46398810,2.87785673961289,2.698269119140712
MOLM-13,4096211,0.3628379797080729,1.0307033635073375
SaOS-2,31703,-1.4545352226195103,-0.9192295670150373
NCI-H2452,89928392,1.3829077368930702,1.7574877831063784
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482,0.7763533471593259
SU-DHL-1,216468,2.865615091111303,2.5003288455743875
BFTC-909,5335621,5.263558209813896,4.787829205938545
IGROV-1,984333,0.6618578113050116,0.6354090225640696
SaOS-2,53393127,5.00574224434263,3.7930547614788135
LS180,26596,-1.3053249122689552,-0.7713725683683572
PaTu 8902,216239,3.2515461693373946,2.4040584003407637
RERF-LC-MS,216239,1.5111459083459036,2.3591875504841697
IGROV-1,327653,3.667792542405671,3.1018572951675334
MDST8,25062766,1.7641764997703038,2.159348855535383
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853,-0.27412434195942653
SW948,9911830,2.1163810502856344,2.313793698606358
SW948,25262965,-4.786935998048743,-1.5915210766159213
Granta-519,17755052,3.698735089058188,0.8133669170617688
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836,2.9972189949488706
SW1271,navitoclax-MST-312 (1-1 mol-mol),1.6729617215063168,0.838845306157943
BICR 31,65628,4.368112552275168,4.565225137823547
LS411N,1716436,3.6051806229528394,2.6466239909538554
HEL,31703,-1.5815868160580933,-2.597941149750732
ALL-SIL,46191454,0.8221974593607395,-0.19931873074463272
IGROV-1,46843906,3.392503571349757,2.896333877313046
MDST8,52912189,0.1558018738717314,2.4045684461879766
SK-HEP-1,73707398,1.730256970360003,1.5631511508988414
NCI-H2452,969516,2.821538204226011,3.0788932045698716
Daudi,9825149,1.5190393381512124,1.4319963321285458
HEL,49766530,-2.395534265113236,-1.9631291398479938
SU-DHL-1,445643,3.1136870030048116,3.666174919559479
Granta-519,25102847,2.235988678650905,1.9798088110823662
SU-DHL-1,8515,3.677486404661737,3.542067005767371
SK-CO-1,decitabine-carboplatin (1-1 mol-mol),2.301340396249523,4.213034632431764
NCI-H1568,73707398,1.0000031751048108,1.483308219364956
RKN,44607531,3.612700906890815,1.5175647493104683
RKO,448949,2.722052887717566,1.5775680618042267
SaOS-2,123631,3.143555798261004,2.3913447681215767
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557,-2.6423548069763427
HCC15,445455,6.40486213649735,4.837753252044217
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324,3.9739957160613626
MOLM-13,16720766,-3.0154852550238473,-0.9386055749966138
SU-DHL-1,52912189,2.819399061651446,2.351082445404022
IGROV-1,6918328,-0.5330006254346346,0.15790899945039044
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937,-0.6768779226481166
Granta-519,168312962,2.8455100129937447,0.5269599108024425
RCC10RGB,24748573,3.544482176439233,2.322723841682544
NCI-H1568,71576739,4.4464222538448075,4.054933721642883
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.7111154169241413
MOLP-8,3025944,3.977744021049233,4.022967023655816
MDST8,navitoclax-sorafenib (1-1 mol-mol),0.2125187849150193,1.8040314151427677
SW48,3025944,3.8378875325919513,4.287971321066771
P31/FUJ,5460769,2.718083541162644,1.781616943331792
PaTu 8902,56946209,-3.5225671286307585,-4.038722776772441
IGROV-1,11964036,-0.1609353030421705,1.4382878575304994
HCC1500,327653,2.623652361439541,3.1159862736272714
BICR 22,11640390,3.3009766271386014,3.199929838269046
IGROV-1,400769,-0.5589612210030486,-0.47957617837387084
HuP-T3,24821094,3.9398095537443023,3.1045315128016284
HuP-T3,BRD-A02303741-navitoclax (2-1 mol-mol),4.136817383870447,2.858910828659175
RKN,54618771,1.93479648501244,1.3668680485867586
Daudi,BRD-A02303741-carboplatin (1-1 mol-mol),4.3065470056962765,4.028849372642977
PaTu 8988t,73707398,1.170719580837983,1.3140069429445813
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383,3.4228743236926165
Panc 02.03,10231331,3.962628244123872,1.9946266268466213
HCC1500,387447,-5.435802195710178,-4.2781961618794195
K-562,25150857,2.2256112733235978,1.759976688875844
COR-L95,135398516,3.161482452438301,2.035383597247009
MOLP-8,46191454,-2.2442719810217984,0.4622315760687187
HEL,BRD-A02303741-navitoclax (2-1 mol-mol),-1.272488077546847,0.5609671567108989
BICR 22,4259181,0.3497439952553443,0.4654156689732003
SU-DHL-1,49836020,5.336381428124731,2.5781750288703917
P31/FUJ,246676,3.344572915959865,3.7073521633812208
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539,0.646333105420018
WM115,JQ-1-MK-0752 (1-1 mol-mol),1.4273161009607245,1.8975228389427545
WM115,carboplatin-UNC0638 (2-1 mol-mol),3.608353626656174,3.2319969367379984
SK-CO-1,135875424,3.678629656731489,3.8828136340047674
SW948,3552672,1.903682389315955,2.5353366424395745
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436,3.715229560585422
NCI-H2452,JQ-1-navitoclax (2-1 mol-mol),0.3722844908497442,1.0577371592261235
HCC15,selumetinib-decitabine (4-1 mol-mol),4.297917027036863,3.841037610595627
P31/FUJ,6610355,3.438139996915945,3.741124265431762
NCI-H1568,446155,2.3736727750277455,3.045241843773293
HCC15,107985,-2.9906891972859415,-3.2823308014089285
Daudi,6918328,-3.006382851838594,-1.4520799037064216
Daudi,25161177,4.237474374185298,3.1913134718367644
LS180,selumetinib-navitoclax (8-1 mol-mol),0.5338849490491672,1.3556980677633756
RCC10RGB,vorinostat-carboplatin (1-1 mol-mol),4.3210323450827275,3.362824481626033
HCC1500,374536,2.8802619944250765,2.31160887382579
SU-DHL-1,400769,-1.357151076144479,-0.9825720449850565
MOLP-8,16725315,4.20287759788283,3.8866269713734827
K-562,SNX-2112-bortezomib (250-1 mol-mol),-3.0816368014715434,-2.3612815288567384
MDST8,24753719,4.799692184779076,4.284980065858571
Panc 02.03,25195348,3.9334722209588735,3.3537548809542157
IA-LM,5328940,2.67230513268953,1.227376961723745
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688,-4.238151770921436
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.0338101341566786
Granta-519,676352,1.633141874861156,1.657645071012958
HCC15,49793307,-2.657858659953827,-2.601478859577978
K-562,16065773,1.923835638804153,2.1166860125352995
RERF-LC-MS,23582824,0.1470987082457378,0.6474538727768143
SW948,9907093,4.923675844906718,3.597979237345407
HuP-T3,374536,4.193584653265312,2.5116958253158783
WM115,11396600,2.8854117577089378,3.646588005535936
IGROV-1,16722836,0.856484234547582,1.5958903130915807
LS411N,89183176,4.7846004508379085,3.107405881335026
LS411N,selumetinib-MK-2206 (8-1 mol-mol),1.1332062725089502,1.9219367514018126
HCC15,6917907,-3.7751611818797897,-3.845630977394045
NCI-H1568,637858,1.7833024505225796,2.108479550570964
PaTu 8902,5329102,2.5341846500240246,2.2602399886431463
Daudi,54765302,2.540510911033338,3.428676138326001
RERF-LC-MS,100016,6.56071523320666,6.407892842165307
NCI-H1568,387447,-3.95080818095812,-3.863327054232172
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574,2.5341430970540317
SaOS-2,11612883,2.0316436721768087,2.8204498071094197
SK-OV-3,135411,1.6318689765112546,0.792034243625209
IGROV-1,208908,2.822483792004996,1.8249590634002573
RKN,51037431,2.467401650082352,3.066280182541874
MOLM-13,3025944,3.8428716966726992,3.8107165874584195
PaTu 8902,135421197,2.3024316473658004,1.970275817193829
MDST8,969516,2.598297465814476,3.0178689230364153
MOLM-13,60750,-4.5529472050787545,-2.9549630463879875
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872,0.9705225385451012
IGROV-1,9915743,-0.4757488934941289,0.562821725359728
BICR 31,56946209,-4.213875977630207,-3.742353878193971
MDST8,124202324,2.333625526818204,2.634380166895019
BFTC-909,46907787,2.3649992203474515,2.1634739066516673
Daudi,12003241,-4.903510386182724,-0.8966743978975127
PaTu 8902,969516,4.108056616445131,2.935849650979504
RKO,24951314,1.467797052763695,0.613723890288524
SW48,439501,-2.266376314928653,-1.9631532762000665
IGROV-1,5311281,3.3250623444804206,2.5510222373111615
BFTC-909,9825149,2.463033939289578,2.4131704987113167
LS180,2858523,3.002923184305197,3.0815865181364797
HEL,decitabine-carboplatin (1-1 mol-mol),0.001071059904297,0.27930502652827977
ALL-SIL,selumetinib-navitoclax (8-1 mol-mol),-0.8393067870593486,0.13989599807896752
PaTu 8902,10074640,3.6154267469790304,3.2512723528206697
LS180,135421197,1.2375553911833763,1.8221506384268287
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102,2.5630222553042876
HuP-T3,4259181,1.3598984416642497,0.24616226739123287
MOLM-13,9840324,5.573129737038137,5.509111402916203
NCI-H2452,docetaxel-tanespimycin (2-1 mol-mol),0.4791468482228301,-2.9593740138796756
RCC10RGB,7251185,2.312506998895348,2.699299485754293
LCLC-97TM1,23725625,2.954034200595367,4.362049701240635
RKO,24797083,0.8657042008278414,1.3792090587584367
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658,3.658300439317439
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825,2.727946588807088
ALL-SIL,24951314,0.1921049921473096,0.19358676061086796
NCI-H1568,tretinoin-navitoclax (4-1 mol-mol),4.46686431300974,2.4245530422650616
K-562,16725315,4.409558206085648,3.837338532243268
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117,2.397588747928074
SU-DHL-1,9915743,1.482861419138649,0.5575743282263254
SW1271,4917,2.7806051488376293,3.143745724446518
Granta-519,vorinostat-carboplatin (1-1 mol-mol),1.7690430171361815,1.970779697641648
COR-L95,3062316,3.2830028596837217,1.5578230998693567
MDST8,10074640,3.541716125988611,2.9746137646534696
IGROV-1,44185566,2.2104732991243248,2.424391646793461
SU-DHL-6,57519531,1.2127003418717253,1.5810968196500854
SK-CO-1,241158,4.831010946536929,3.874467688866684
SW948,46843906,2.6248020109336023,1.9555062514383326
RERF-LC-MS,6610216,4.063402980130349,4.31596591251792
RERF-LC-MS,46843906,4.323049782377064,3.3903494524269346
NCI-H1568,selumetinib-UNC0638 (4-1 mol-mol),2.7760221243911016,3.13290860827448
LCLC-97TM1,piperlongumine-MST-312 (1-1 mol-mol),1.3069230942291734,1.895186707532326
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756,2.4162261168870938
HCC15,24180719,4.303391195547382,3.4060919620643015
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885,1.7096400921693873
MOLP-8,6505803,0.6382990348001342,-0.9219248974105001
Daudi,5278396,2.816567405543214,2.6965327560112744
RKO,66577038,3.1469091340303637,2.3950131998978836
MOLP-8,54143018,0.5860183196437395,-0.4349254158391627
SaOS-2,24856436,0.4386880001360848,0.3719935702417259
BICR 31,9866186,1.254760755448308,0.9194247688552525
RCC10RGB,11257553,3.6405008146732434,1.5318112036861722
SW48,JQ-1-navitoclax (2-1 mol-mol),-0.920123495664676,0.7418177732879091
RKO,57330099,4.8516025997257275,3.8585708557559104
P31/FUJ,54649500,4.423311343715707,3.03518196125776
SW948,10302451,4.082058519290096,2.80664469204863
WM115,2746,3.2273654457979957,3.338359448083301
KU-19-19,654092,0.6096416345891582,-0.14109442928179042
PaTu 8988t,10296883,3.999790485906541,3.9688867301787827
BICR 22,54143018,1.1733542553992964,0.9229051173440587
MDST8,71466445,2.0942740576673593,3.6857511543831736
PaTu 8902,36462,3.471634301287976,2.350172850486501
LS411N,44632017,5.0127460000138,1.1530631937360143
COR-L95,9911830,2.1813921058815553,2.178137743597433
ALL-SIL,9911830,-2.857836139869332,1.8195814570955815
WM115,3465537,1.2344570371137795,2.4978029220642384
NCI-H2452,navitoclax-birinapant (1-1 mol-mol),2.13598555906201,1.915048462116025
SU-DHL-1,54454,0.0220955119836291,2.3096488616388826
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245,4.657775107076719
MOLP-8,24821094,3.654707766369703,2.6493984280644907
MOLP-8,6852167,0.8455390099609336,1.716927297227247
Panc 02.03,11222830,1.865607722872823,1.615287017808687
MDST8,2746,2.514425635914287,3.2532274805653025
Granta-519,1716436,2.7310795448836904,2.5538331018506564
Daudi,selumetinib-tretinoin (2-1 mol-mol),4.819941209079035,3.0576755603213654
RERF-LC-MS,11625818,4.251014876931036,4.479337588589261
P31/FUJ,4378219,1.2412027933720209,1.7029932416875406
HCC15,3062316,2.729530034687651,0.9644178519109317
LS180,9903786,2.2166672873522857,2.6877914177831745
PaTu 8902,16065773,3.37985868216597,2.700523411216883
LS411N,9911830,3.118029057589745,2.1914476254875908
LCLC-97TM1,6438330,3.0238187505324885,2.6030119936719553
KU-19-19,25062766,2.9321374053838807,1.949656175915899
HCC1500,10074640,2.968051262406446,2.8540758591738906
P31/FUJ,6505803,0.2535639265329721,-0.8149756978948453
NCI-H2452,387447,-3.2957708741809975,-4.202857994118283
MOLM-13,11228183,-2.7074565632423546,0.5472132016050066
SU-DHL-6,5566,0.7122829809928822,2.9172378856359003
COR-L95,24785538,1.0654849938174582,1.11026194651189
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009,0.6474371705128852
WM115,4578,4.221194502857287,4.6217730146091816
COR-L105,4578,4.590840204947243,4.585164549737886
K-562,374536,0.780579010414565,1.1066778872643377
COR-L105,60700,0.1425021915553204,0.1607536548103406
K-562,46926350,-4.162486097405079,-4.493560642764043
SW1573,4705,3.887877577681455,3.4753039072705136
LCLC-97TM1,637858,1.4157632634757724,1.6453607526439618
WM115,46926350,-4.284670953339827,-3.889319282202217
RERF-LC-MS,15547703,2.8085711207925015,3.2855300660644544
NCI-H1568,11497983,3.872384435522252,4.442876400898132
MDST8,4788,5.889593740712007,5.6710618298248665
IGROV-1,8515,2.1861539315976053,3.784894226218016
RKN,24772860,-0.333409077824626,-1.4497649791688405
PaTu 8988t,322968,4.849886698333752,3.961702942150586
RERF-LC-MS,16720766,0.5604118097796991,0.737267023502219
SW948,6505803,-1.4287073835677784,-0.7814961227114832
BICR 22,462382,1.3729135623232431,0.8303491616222005
LS180,322968,4.435040308321651,3.576908464004179
SaOS-2,11152667,-0.1732170298835725,-0.354546546066554
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709,2.036820722898042
HCC1500,227681,1.895909952215359,3.622011001270571
SU-DHL-1,57330099,3.736750567984075,4.020472250567971
PaTu 8902,crizotinib-PLX-4032 (2-1 mol-mol),2.4716529657314252,2.072270727327962
COR-L95,11977753,-0.4790698517891548,-1.6869051387350646
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388,2.851592708164812
SW1573,11427553,4.057369297610019,2.8266826054157574
LS411N,selumetinib-decitabine (4-1 mol-mol),2.113542613262742,1.106297934894553
LS180,12001922,1.7594619366424422,1.9922158561261947
SaOS-2,12001922,2.1147367002170494,1.905396144191609
SU-DHL-1,3543504,3.7817510655567625,4.140850021502141
BICR 31,24901704,3.914024172074534,3.482813723276095
MOLM-13,5287620,-2.884996470216499,-2.301868945694865
BICR 31,25102847,2.842271629600241,2.568076748054618
COR-L95,10113978,3.7452762075447104,2.6305658966921275
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306,0.9639259376360472
MOLP-8,vorinostat-navitoclax (4-1 mol-mol),0.8660372331148116,0.5021825377064836
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189,-1.3319985712298372
MOLP-8,decitabine-carboplatin (1-1 mol-mol),0.1349258094123646,0.49957484822967524
COR-L105,168312962,3.0410731046381065,2.495335160521681
LCLC-97TM1,10322450,3.85878970197106,3.608059056953781
HCC1500,25161177,4.357780519617112,3.985560598595577
SK-CO-1,9967941,1.837567054996146,3.579716703184493
COR-L95,5311,1.4789786210040632,0.9725964759241578
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785,3.746956902656412
LCLC-97TM1,72193861,0.688846554638978,1.0637714795889635
SW48,4096211,0.1208358665406906,2.1676066060377104
LS411N,135875424,4.300305751936665,3.2087096630033174
SK-CO-1,42642645,0.466262192383588,0.9985109713668291
IGROV-1,1566236,2.765820903157784,2.463719793922751
HCC15,10410894,4.508285516741203,3.2613245927226817
IGROV-1,6450551,2.579641476451469,2.777602567511325
IGROV-1,452548,0.0422661560146271,0.33527077791150167
COR-L95,216345,3.729430833860697,3.3722872201519745
Daudi,navitoclax-gemcitabine (1-1 mol-mol),-4.251556973738435,-2.2278014574490017
LS180,2945648,3.723684880750219,3.011053293898166
RKO,9936388,0.8183869926163714,-4.267689545277724
HuP-T3,10231331,2.6811135289001236,1.7307890565236261
PaTu 8902,44493528,4.360494725244959,4.411215611130819
Panc 02.03,45279963,4.323488067826322,3.865784619585879
MDST8,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2819787508049554,2.4395727153395934
BFTC-909,44507138,2.8704731321552734,2.7099185611299
ALL-SIL,49766530,-2.347000417785464,-1.9624437869114257
SU-DHL-1,6918289,4.3249644726818275,0.65980900686557
NCI-H2452,54626689,4.879011133008654,4.635145988200443
HCC1500,4917,1.9149154714535184,2.8931645774285277
LCLC-97TM1,15547703,3.011827246330581,3.0321068159391356
MOLM-13,71304818,2.1544936448447873,2.114499180015782
SU-DHL-1,4917,2.4666047815714154,2.936904063453517
NCI-H2452,56946209,-3.558178980562316,-3.973354182584757
RKN,1750826,-6.055252220387113,-1.848512960266838
RKO,25105715,3.388469834531371,3.223360816972821
RCC10RGB,46191454,4.887818963424851,1.9177779463262785
LS411N,3815108,3.549037613932863,2.437387040414091
HEL,56946209,-4.040477533762366,-4.7225715957205745
BICR 22,122327,5.571410232221064,4.250970860553869
BFTC-909,969516,2.723005004244225,2.7884367308496096
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706,1.6159887466649059
RKO,24856436,0.2423564692967549,0.39927924593676567
SU-DHL-6,5746,-1.2123840023346684,-0.5516946966905253
SU-DHL-1,135411,-2.10627226052293,0.4959346638024893
SK-OV-3,1716436,3.636442167288748,2.839978572086758
IGROV-1,44543605,3.88270235241076,3.6668230214493702
K-562,6914657,-3.91828110768511,-4.905174641148415
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229,0.8508793826905032
NCI-H2452,25262965,-3.6663688304344695,-1.814264505372558
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816,1.1358182113097814
MOLM-13,11404337,-1.791363376051536,-1.2377089922653548
RKO,36462,3.4370564574699185,1.4848672923141022
IGROV-1,446155,3.750396425244744,2.6277176356742693
COR-L95,72734382,4.117898969233179,4.015518959021523
K-562,11396600,3.7562155275673415,2.6887693869606917
LCLC-97TM1,4705,3.0319662392534057,2.725877083032321
Daudi,2130404,3.4806417402967993,1.9914133378326977
UACC-812,vorinostat-navitoclax (4-1 mol-mol),1.8866466886365112,1.3145555534628335
MDST8,327653,3.1544218347658375,3.1549384913767526
SK-CO-1,11656518,0.968890652064466,1.9236731345463465
K-562,5311281,3.9022564066083967,2.1938237554015676
ALL-SIL,carboplatin-etoposide (40-17 mol-mol),-0.158708138675103,0.08106882473288986
MOLP-8,selumetinib-PLX-4032 (8-1 mol-mol),1.1163083218110827,3.380938647585091
RKO,445091,4.342692134156949,3.8696673647860638
MOLM-13,9935249,2.7939558009041283,1.264876561396391
SK-CO-1,selumetinib-navitoclax (8-1 mol-mol),-1.2361376975305869,1.8203815601527464
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386,1.8203743875889105
SU-DHL-1,124202324,2.3695119203399906,2.4268678028989696
COR-L105,9884685,2.6443959528770167,0.8286313275457
BICR 31,10113978,4.990782635230478,3.492158010440873
HEL,crizotinib-PLX-4032 (2-1 mol-mol),1.5778515450818191,0.5412563659415031
MOLP-8,6610355,3.5622833697709178,3.9282439741569743
LCLC-97TM1,2749,2.4194398786749067,1.6707956668651525
Daudi,5311,0.1794409230409946,0.4190752381478094
HuP-T3,2113511,6.036487802507154,5.637400768427269
P31/FUJ,452548,-2.598049093653093,-2.441997896711579
SaOS-2,16065773,3.691866894593861,2.252145054340156
RERF-LC-MS,65064,5.274588293813746,4.961878802773614
HuP-T3,89928392,1.747135585577409,1.5631707058445345
P31/FUJ,56963564,-0.6738396792941169,-0.2711142432387375
LS180,5746,0.8609008276830991,0.777758174944086
BICR 22,11707110,-2.2145574606059912,0.06155800087369703
Daudi,9952709,2.2307089742515713,2.07931771634563
SW48,3543504,4.30466926238752,4.207349722743057
SW48,11427553,0.5193301330840923,2.736929488785388
WM115,56649450,1.7070260970326938,3.3931062958739684
IGROV-1,89928392,1.4824233552493276,1.4310066296703057
SW1271,72376,-1.909620961604672,-1.862423832624434
SaOS-2,5278396,3.8495121754699686,3.6519577004577384
K-562,42642645,-0.9952706094252596,0.2550534514091809
Panc 02.03,446155,2.721578883226381,2.925516131394173
RERF-LC-MS,44462760,4.251912039026111,3.987795930506079
BFTC-909,3503,3.411270469206907,2.407907413790743
MOLM-13,104842,-5.846939346357726,-3.7386047318216447
K-562,11656518,1.1460195934444493,1.0286209463102516
HCC15,76446078,6.244123044550032,3.782358163927725
COR-L95,6438330,1.555078701387849,1.6540499607712398
COR-L95,9926054,2.0133423062539726,1.8158898686552132
BICR 31,462382,1.217928478873545,1.085125675540793
UACC-812,46199207,3.606176782545976,3.1330744150107823
SW1271,16725315,3.214819296898604,3.933561290344514
BICR 22,3385,1.594485383262216,3.932051128252478
HEL,11234052,1.6482548628813194,3.0853095233484074
SW1271,49793307,-1.6735159246770874,-2.3857298760608368
HEL,3025944,4.107185950107739,3.8109169526391935
SK-CO-1,1641662,2.678789461404506,3.6653566537423496
RKN,71680916,6.446363106372924,4.809197524411285
IA-LM,25183872,-0.4633226224219731,-0.846131778191084
IGROV-1,6918837,-2.9804518885508635,-2.4544872691238897
HEL,252682,5.808471376099282,6.259621398253663
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351,-1.0819665752164358
MOLM-13,374536,0.9670025892080272,1.0720276058103213
NCI-H2452,168313047,2.588327036215806,2.4256592022121084
Granta-519,4917,3.021022166883331,2.6495352269897396
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167,1.8961084120015068
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189,-0.01272212912777385
BICR 31,262093,3.397835562493394,2.9860839669787937
LS411N,12003241,-0.0946051023392001,-1.0350774576581094
HCC1500,5282054,2.2651950194203323,3.805222788849794
HCC15,322968,4.854333863324092,3.839483312903167
RCC10RGB,9936388,2.3235560801623465,-0.5101916080195069
NCI-H2452,46199207,3.026577128215497,3.3543717127060275
Granta-519,9444,3.3091580955395146,3.5420195240777623
IGROV-1,53392493,2.352084848618059,2.5716803691717147
COR-L95,151289,3.0372683791028705,0.9346804508260296
NCI-H1568,216468,4.700562763036761,3.4733324573662565
WM115,25195348,4.859937697346287,3.3814881814952087
SaOS-2,2858523,3.094677154220442,3.1154187837697735
SW1271,421610,4.471416490511734,3.226238703219612
BICR 31,637858,2.611871003184785,2.082251530544742
SW948,11175137,1.686043515242534,2.26184596517377
MDST8,11625818,2.7981930885976705,4.316499902170951
Panc 02.03,11609586,3.3931905350155915,3.0517549849178867
Granta-519,selumetinib-UNC0638 (4-1 mol-mol),2.20466638812085,2.436893676063184
PaTu 8902,9825149,2.767587999144615,2.273659086500888
HCC1500,6918837,-4.362896894201754,-3.2121511980351523
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153,2.115447074201953
SaOS-2,5282054,3.07206551989859,3.581886686470288
SK-OV-3,navitoclax-birinapant (1-1 mol-mol),-5.0727238052406705,1.6870216805471925
SK-CO-1,72376,-3.2194985981528808,-1.409720247118044
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772,3.5597959308886518
WM115,10302451,3.6553280898048905,3.2565795753167714
Granta-519,613000,2.2510291651452143,2.411406732031334
SaOS-2,11222830,1.0878926350484104,1.5701280841986398
IA-LM,54678924,1.6007306497128662,1.7253620941485182
HEL,119607,4.922739390517752,4.219875552144944
HCC1500,6918328,-0.2689126411143879,-0.3439277610405869
HuP-T3,crizotinib-PLX-4032 (2-1 mol-mol),2.5650363225974315,1.9543679972898889
LS180,3062316,2.327440880417239,0.9785570369490211
LCLC-97TM1,11317348,1.7152030009838672,2.4189796200259552
SaOS-2,6918736,-1.8799034133096575,-1.7206211381714198
SaOS-2,12003241,-0.699813042979073,-1.1558645585078704
LS180,10113978,3.7861477365363383,3.060598611489585
SW48,54618359,4.4319552735559,1.8585689945142467
PaTu 8902,ISOX-bortezomib (250-1 mol-mol),1.241492124971151,0.8682388484703576
HEL,387447,-4.961191552031455,-4.987385820582976
RKN,6610216,4.220445612403551,4.3758318423819
P31/FUJ,656346,-0.3707458386499477,0.2225207297024713
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659,0.07395505406639674
PaTu 8902,navitoclax-gemcitabine (1-1 mol-mol),4.2969329187245,-0.5713924403236073
MOLP-8,9952709,2.638563783306324,2.1454122004322294
SaOS-2,11455910,0.8777485884783317,0.9713015358648187
K-562,10184653,1.719293175029272,1.2432459485172291
Granta-519,4259181,-0.7648884727300508,-0.550075865732433
BICR 22,4521392,3.4098909359208625,3.9296596350686626
HCC15,2874250,4.519421691404506,4.050842150153791
SaOS-2,6918638,1.2055090485954645,0.5222538868729152
MOLM-13,9868037,0.9756233042827712,1.8175067502236448
HCC15,navitoclax-sorafenib (1-1 mol-mol),0.4047669070332462,2.2137503024098155
MOLP-8,16659841,2.203571056365997,2.4061752644962877
LS411N,656346,4.206497662771029,0.6742767008850046
RKO,5460769,5.660789679983863,1.7475711572427932
BICR 31,6610355,4.797647038745592,4.524918925515297
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629,2.1172186521636074
RKO,11964036,1.8153618806471208,0.6063405573651638
NCI-H2452,7326481,3.286880233884326,3.012972533706652
RCC10RGB,44491742,5.1484686760969645,4.5236098688060835
IGROV-1,50905018,6.092412272559071,4.44937114132383
BICR 31,9884685,0.303781088019613,0.9655115756171763
Panc 02.03,3081361,3.1546648300373357,2.4740918438881003
BFTC-909,25126798,3.8219929141120166,3.7909725063631505
MOLM-13,66890843,1.9738756301734208,0.9436828006504726
HCC1500,24180125,3.164669305988548,3.045739951194795
SK-HEP-1,53392493,3.66906541895257,2.7849171971372977
RERF-LC-MS,2945648,2.437954541344266,3.0665166261191876
HEL,25150857,2.447529551071105,1.3887654175396869
BICR 22,65064,5.333446499438452,4.909464315112185
PaTu 8988t,carboplatin-UNC0638 (2-1 mol-mol),3.665220724432894,3.432945669315316
P31/FUJ,123631,2.0303759233077017,2.013942311954945
HCC1500,tanespimycin-gemcitabine (1-1 mol-mol),2.493780816473477,-0.9779682383273596
IGROV-1,11175137,1.8411496230681277,2.337217203083792
KU-19-19,44241473,5.030815161961597,4.8984924244365065
SW48,72193861,-0.4534629909928462,1.7255570318999225
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398,2.8578600848261972
MOLM-13,5311281,1.6146001182421037,1.7549100105712716
HCC1500,9915743,1.9340540182592263,0.14460452553409128
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392,-0.3670799573119546
SW1271,crizotinib-PLX-4032 (2-1 mol-mol),1.7792866548085249,1.795464688310438
LS180,4096211,2.1975503712063604,1.8168984510042367
NCI-H2452,66577038,3.355972963473848,3.1166936832952916
WM115,JQ-1-UNC0638 (2-1 mol-mol),1.9415560976310364,1.728312236296538
HCC15,11175137,3.485795641541794,2.6194261053287335
K-562,navitoclax-pluripotin (1-1 mol-mol),-4.5842278555306395,-1.815184811038634
HuP-T3,2945648,2.5475895191101197,3.099305493200208
Panc 02.03,6450551,4.166761052507323,3.0864468708239134
K-562,2708,5.362475494708341,3.6423184282658063
RKN,219104,3.4277527780329096,3.904738104446766
RKO,16722836,2.0172870973895085,1.158978365166693
UACC-812,439501,-1.4243957864326813,-2.048977065679242
MOLP-8,11222830,0.9410853080031706,1.2196361620858847
WM115,1239801,4.563824386797348,4.114970370095528
Daudi,11717001,4.763561920962392,3.8373777599137693
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333,1.8349592264789196
COR-L95,16736978,-0.5228132160938015,1.7853617378706346
IGROV-1,11213558,0.52356811652227,1.6566500002624296
MDST8,44202524,1.4033794041893788,2.5176536871148514
SU-DHL-6,10113978,2.1190356124222194,2.5042264687725457
SK-HEP-1,4917,3.764636353681369,3.1491971831223644
HCC15,452548,-2.1001752731425727,0.4728090242680561
SW48,46191454,-0.9829938197758128,1.6071808627834283
MOLM-13,4521392,4.5803067712490115,3.8737623128074388
HuP-T3,25062766,2.4453672011464023,1.8636488904230781
COR-L105,107985,-4.244896937866387,-3.2985790586125243
SU-DHL-1,89928392,0.4021872915525221,1.4797678281772557
BICR 22,55508,4.44611517999926,3.0350199845728865
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243,3.692889810249613
MOLM-13,675434,3.665195693175508,3.787937402487618
SK-HEP-1,6610216,4.694225049802747,4.345165157347882
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.708464522380885
SU-DHL-1,49766530,-4.824875359994143,-0.5803403877069906
HEL,12001922,1.658840092002429,1.6359571176770258
HCC15,46398810,2.6134237903958093,2.605256779331398
NCI-H1568,3136844,4.658915015928919,4.3893535840859945
NCI-H2452,24821094,3.1123469452418537,3.1596422430270694
LS180,3543504,4.376890558116308,4.482466975756223
ALL-SIL,9927531,4.600523700119875,3.939313330767598
BICR 31,11167602,4.451308398956488,2.754500796146214
SW1271,16219061,4.25548468975063,3.314805497686544
PaTu 8988t,448949,1.751499890417066,2.066986122604982
WM115,2858523,2.9957579985597467,3.0221022834385702
RCC10RGB,11364421,1.2845393833467151,-0.7636017855814612
SK-CO-1,984333,1.8899562330111348,0.9178193330623787
COR-L105,72376,-1.002534224494363,-1.2731544049427137
NCI-H1568,168312962,2.190321562510239,2.2253596823295028
SaOS-2,2746,3.4161371679978436,3.31184294921687
Panc 02.03,51039095,3.661030142872421,3.024179038812577
SK-CO-1,65628,3.554197618459022,4.415967925523436
COR-L105,16725315,5.297524124299076,4.3180748332601535
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644,1.4863017912432488
RCC10RGB,46224516,2.231293839634299,2.839636110908068
RKN,9956119,4.4432647969313,3.779315793936801
RKN,16065773,2.958619348149216,2.517282147360097
WM115,17755052,0.4002517605741686,1.7381777631860489
WM115,168313200,2.1363369230808593,2.7864056747303763
BICR 31,ISOX-bortezomib (250-1 mol-mol),1.0654896454992784,0.7029793468992009
WM115,navitoclax-MST-312 (1-1 mol-mol),0.1056862983661574,0.7166980529269961
LCLC-97TM1,9903786,1.8016114643921617,2.6572847957005092
SaOS-2,49867926,4.146129188416838,4.223956341931007
RKO,25126798,4.002843113400742,3.578907986194937
ALL-SIL,219104,1.1543769867483644,2.0688253861573282
Granta-519,tretinoin-navitoclax (4-1 mol-mol),0.0394078475475117,0.2689923350683285
SK-OV-3,3062316,0.5292744016150154,0.8431298389776789
SK-OV-3,11178236,-2.424602318267421,-3.2665160022528696
LS180,9887053,3.1718141126704618,4.094991671403071
BFTC-909,25183872,0.7872065650622051,-0.8034392755849189
NCI-H1568,2945648,2.136721092573253,2.8850132468809604
RKO,1716436,3.795795915163565,2.5635748562548315
SW948,65064,5.291153994733523,4.910967023023153
PaTu 8988t,salermide-PLX-4032 (12-1 mol-mol),5.538923116384137,4.810131703240557
SK-CO-1,16115403,-4.417233339728943,-3.4539744706535473
SaOS-2,400769,-0.6660591873157414,-0.5977646835988449
SW1271,2733526,3.2893803459487594,3.8669367343318273
BICR 31,4521392,4.267019749412992,4.459877508042734
P31/FUJ,25154868,4.728907139536709,4.140986622074813
HEL,676352,2.4086189638079643,1.9300617850474464
PaTu 8902,BRD-K27188169,4.434214541500356,3.8709147756266646
KU-19-19,44607531,3.044914521934579,1.5902065814227613
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609,2.889356740100104
SK-CO-1,72193861,-0.1340038294528125,1.9738817880079407
HCC15,selumetinib-UNC0638 (4-1 mol-mol),3.167456472626372,3.3310892401523637
WM115,135423438,3.926483426744841,2.534263018393283
RERF-LC-MS,135875424,2.839581382146162,4.00409979401052
PaTu 8988t,46926350,-4.145321949318386,-3.862887013984067
Daudi,23582824,-0.638376916275564,0.36786227757289075
Panc 02.03,168313200,4.226618217059218,3.0644959088410015
NCI-H1568,11175137,2.3278621292073067,2.6294969145605056
COR-L105,11152667,-0.3968124554752262,-0.3206696584187346
IA-LM,5281672,4.428935042775787,4.489366506375294
IGROV-1,3062316,-2.2361832227909075,1.1590967608679237
SU-DHL-1,5281672,4.30860315799997,4.196613530667369
HuP-T3,tretinoin-carboplatin (2-1 mol-mol),5.021357813866161,5.125141068799468
BICR 31,11625818,3.9395546041344858,4.704783654657387
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236,2.3923387039849113
NCI-H1568,445643,3.6093957886383814,3.992734862408729
NCI-H1568,4477,0.3996701755478256,0.5532781402381672
RKO,36314,-4.63858923378885,-1.1056093191267125
Daudi,675434,3.694219652985114,3.9064050502346355
MDST8,60750,-4.217127024403589,-0.7719831760798518
WM115,9903786,3.894434750277636,2.695301498122741
RCC10RGB,5282054,3.6705963985990993,3.935945023843093
HCC1500,262093,2.85046563878574,2.818197096980943
BFTC-909,4259181,-0.0277162117211437,0.2801695944101903
COR-L95,252682,6.347695054422412,6.5419526048397465
LS180,9911463,3.681535048080384,3.8464733655888206
SK-HEP-1,1566236,1.7725788045776691,2.2260931418074357
LCLC-97TM1,6918736,-2.1743152466595626,-1.8731434602652937
SW948,10231331,-0.4116197219649379,1.5032221673860675
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188,2.7551321561456605
KU-19-19,52912189,3.155674258646967,2.695616342888497
PaTu 8988t,44185566,3.1955818251601493,2.793932544208784
ALL-SIL,31703,-2.84181702758724,-2.9163557190700504
MOLP-8,67156097,-2.505693621695456,-2.1616073672261136
P31/FUJ,12003241,-0.93015536828776,-1.5969638148843188
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324,1.48936484809361
HuP-T3,72376,-1.771653200109272,-1.824532300530908
COR-L95,vorinostat-carboplatin (1-1 mol-mol),3.640391778924097,2.6028881364956034
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351,1.531490345049168
SK-CO-1,54649381,3.727346200170898,3.9881049017309387
BICR 31,4578,4.306546690441069,4.455638621225029
HEL,24856436,0.2549549224561803,-0.9861954653042534
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777,1.762932466371123
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094,1.4471200261335335
NCI-H1568,568763,0.1547040002068053,0.6439649601600285
SaOS-2,10184653,1.5674189620168135,1.453223264017264
BICR 22,carboplatin-etoposide (40-17 mol-mol),1.4257688352427802,3.114313297770985
SK-CO-1,10127622,-1.7782095442547816,2.845098711098077
RKO,6450551,2.9764230599456782,1.6016030302702484
RCC10RGB,11222830,2.1708629162803654,1.7387637813802175
MOLM-13,439501,-2.531564352317227,-2.587928762640873
KU-19-19,5328940,2.592216165266187,1.664873326282664
SK-CO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7439599678595026,2.019141611519118
KU-19-19,navitoclax-pluripotin (1-1 mol-mol),-0.1990402991745543,-0.8594060590252677
LS411N,46224516,2.772468105753273,2.7508906942737066
COR-L95,3465537,1.5360689669151406,2.383723735354516
NCI-H2452,650361,3.725817753027947,3.80509330612598
MOLP-8,135423438,1.7176055832456645,1.6880708161388815
Daudi,15953870,2.3174310256528017,3.0007907835417718
HEL,25062766,1.0860006913119025,1.4043636842557516
LS411N,9866186,0.9541786681011424,0.3343922095919815
NCI-H2452,72193861,1.1802568558602904,1.9063133531999907
SW1573,104842,-2.57352069349058,-2.3868517611244426
SW48,1750826,1.3136286655933227,-0.37400175894768944
HCC15,25262965,-1.0400697166295236,-1.5401249542771154
SW948,156414,1.6424995325300082,1.1448513863518688
HEL,49793307,-3.822273429090704,-4.255770270305985
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.570509240579035
KU-19-19,15983966,3.017543110767297,-0.8225753482059723
Granta-519,445643,4.101892829369416,3.182362703255754
WM115,44462760,-6.607584862322745,2.447956493592114
COR-L95,16722836,1.6737270586986386,1.3483071372311233
HuP-T3,19582717,-4.617931701404403,4.424958312913553
MOLP-8,135984461,3.690365922940533,2.7361510615140783
WM115,25105715,3.143290836206988,3.3687505521411496
SU-DHL-1,6610355,4.337111630655639,4.170982348584929
P31/FUJ,107970,2.0437014771117425,1.7401157642901304
BICR 31,9903786,2.10396775229317,2.829759298281713
HCC15,119607,5.6213928119464285,5.296565166159757
K-562,53392493,1.9280012389180945,1.7753351142284783
Granta-519,erlotinib-PLX-4032 (2-1 mol-mol),4.2552857521313925,2.8728022152414834
ML-1 [Human thyroid carcinoma],4788,6.371899932480547,5.807132491576731
SaOS-2,6184667,2.75971928345779,3.0559151883912454
HCC1500,49867930,4.391361036771465,4.713717191367945
HCC1500,156422,3.756088196252004,3.806444703393787
LS180,2729026,2.858515315971793,2.62451534663837
UACC-812,9926054,1.7122964049751828,1.9980531226573028
BFTC-909,2945648,3.347829093032643,3.032510592672835
RCC10RGB,piperlongumine-MST-312 (1-1 mol-mol),2.4761046612469944,2.2389147138287195
COR-L95,10427712,3.3507411292398315,4.077172700011925
HCC1500,73707371,6.057238887548947,4.800175608819358
SU-DHL-1,5566,2.363543718324467,3.0180006373200503
RCC10RGB,navitoclax-pluripotin (1-1 mol-mol),0.1501865832808995,-0.5999178052974802
SW1271,44137675,2.993655891868926,3.511989705496084
PaTu 8988t,10385095,1.1295524511895831,1.252904513288059
IGROV-1,107970,2.287061680908213,2.2188506069441782
LCLC-97TM1,3081361,3.200154540210029,2.306594300756304
MDST8,24797083,1.659668465713326,1.4085458167939169
MOLM-13,100016,3.967621300341963,4.81818432833009
SW48,6914657,-5.582748420606011,-3.6224521842085404
RKN,54454,2.1815674244706407,2.636230827148408
SW1271,54686904,4.077781574312711,3.623858856816514
MDST8,tanespimycin-gemcitabine (1-1 mol-mol),1.2757210463641129,0.031319902063737894
LCLC-97TM1,11152667,-1.9849905525936635,-0.5596414781544586
RKO,6610355,5.147293026177706,4.23967051780184
HuP-T3,11234052,4.425621489915021,4.218218689180734
BICR 31,11485656,2.9684140094972387,2.5274807606414753
HCC15,445643,3.643779771767104,4.126040262243741
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635,0.8629760189907699
Granta-519,6918878,0.9437787040623058,0.33713035270501357
SU-DHL-1,16720766,-1.7997333167058054,0.37696470007931215
COR-L95,navitoclax-MST-312 (1-1 mol-mol),0.0334777259745642,0.13781373965172283
RKO,11626560,1.596896929931414,1.1347051632323093
IGROV-1,44589607,3.0909001492794377,2.653358202721837
HEL,168313047,1.7739787927154282,1.781595902155769
IGROV-1,11964036,-0.1609353030421705,1.4382878575304994
SK-HEP-1,969516,2.3030983588134917,2.9889921097454693
LS411N,68056272,3.648680202626129,3.2235726984297632
WM115,navitoclax-piperlongumine (1-1 mol-mol),2.2126166903364037,1.3784350606698683
HEL,2749,1.5352641298417238,1.0233311502144984
MOLM-13,135398516,0.1807695197937267,1.547332368201942
Daudi,176870,1.9898427065198672,2.5127708986150483
HEL,10427712,4.076538081897971,3.656217587243578
SW948,24772860,-2.2115718578693495,-1.8077187363907208
Granta-519,2729026,1.8472912754822493,2.2650318308950106
COR-L95,5394,4.313147278509764,3.6257035973978535
LS411N,46907787,0.8939335106347707,0.04933289607463348
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474,4.417243702528712
KU-19-19,11485656,2.7576201496249264,2.452293130159579
IGROV-1,2858523,3.196384505087132,3.09519315657488
SW948,702558,5.163408425848839,4.430975316953475
RERF-LC-MS,72734382,4.885789692793362,4.780120073943456
NCI-H1568,JQ-1-navitoclax (2-1 mol-mol),1.9826778797664537,1.1307106970345968
RERF-LC-MS,11964036,1.6707185338079893,1.727764650565054
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317,4.614934747152449
SW48,3038522,2.575519148977434,2.812182895631377
IGROV-1,11364421,-2.1205062036040982,-1.8205991388783707
Daudi,24753719,1.7041863717102288,3.1570796578735822
MOLM-13,selumetinib-BRD-A02303741 (4-1 mol-mol),2.2135360458532216,3.2296697899259525
SW1271,73707438,3.2742940196229022,4.055320565552041
MOLM-13,44487061,4.373293273870424,3.2036095636266073
SaOS-2,568763,0.7449819257203903,0.5799320309083559
SaOS-2,168313200,1.7182390433527042,2.9932966887706236
K-562,15547703,3.09098547046412,2.84486943699922
BICR 22,24785538,-0.3286106781648999,1.707464441119734
IGROV-1,9936388,2.10108466287406,-1.4638110917399119
BICR 22,4477,1.559722374810713,0.5484023867879609
LCLC-97TM1,navitoclax-birinapant (1-1 mol-mol),-0.5917483578052505,1.7082045940009178
BICR 22,16038120,1.2563245393113998,1.4067213839748387
PaTu 8988t,56649450,4.324867884259214,3.6126962680189534
PaTu 8988t,135411,1.3050507330755643,0.7479912022838533
NCI-H2452,12001922,2.2907278374018296,2.080753246698868
RKO,44185566,2.4837284923488063,1.6279492440705257
K-562,9826308,0.1842141800186153,-0.18432150862953015
RCC10RGB,5311281,4.058856975975892,2.434608663747442
WM115,5460769,2.9023963298546507,2.4952260798129005
HCC15,119182,0.1055567812373319,-0.20182142812162135
BICR 22,44607531,1.5270609291983028,1.22566930305519
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245,-1.0314225327720772
NCI-H1568,25262965,-4.225307409424958,-1.5393084987517793
SW948,5328940,1.2304763256018572,1.3853299437461664
IA-LM,10296883,4.25848729020474,3.160235837946447
LCLC-97TM1,11964036,0.9095700511944136,1.1873195807569685
SK-OV-3,10074640,3.759507235638381,3.2710586101849977
BFTC-909,25062766,1.7422044094415416,1.966632672473958
MOLM-13,44202524,0.8413416322030352,1.4247694844757601
P31/FUJ,44137675,3.225768708166513,2.8803398667121245
PaTu 8902,42642645,2.254917267204718,0.9439515696107977
RKO,53232,4.485666667988006,2.6004782735421657
MDST8,51039095,3.753808380930837,2.4393759707708176
ALL-SIL,25150857,1.7729123360103365,1.4831609055367105
KU-19-19,136227924,3.1447471190609217,3.103769076253869
BICR 22,9911830,2.5765146499323497,2.5099932397093694
SW48,26596,-2.356334812614481,-0.7296191296213363
WM115,8515,4.149615392892544,3.97583106078241
SaOS-2,3025986,-1.3703894596366477,-0.9060953857865108
LS411N,6623618,2.410312404439064,2.18167273010373
RKO,2749,1.3580925102381314,1.6530232636702202
SW1271,9915743,1.6128868969613257,0.9999276878277596
SaOS-2,44589607,3.1014372869468736,2.959301774618893
BICR 31,9908783,4.390198834476992,5.142778677032643
RERF-LC-MS,1641662,3.403538628142178,3.797184782417085
SW948,168313200,2.3052543991742933,2.913210881995627
BFTC-909,16720766,-0.0189955240044846,0.5424385774393315
HCC1500,46843906,3.5664723036358703,3.212053872620246
BFTC-909,5291,3.495280995080932,3.837299851222569
PaTu 8902,5287620,-1.817962379422155,-2.22409309793525
Granta-519,24772860,-2.616849709254195,-2.8422758664942602
SW48,selumetinib-decitabine (4-1 mol-mol),-2.392622848847121,2.9888981145909956
MOLM-13,2858523,2.990787770243497,2.1773710570451965
MOLP-8,73707398,-1.5200522985211378,0.45566501288121075
WM115,4788,5.364989483250021,5.6448873595984015
KU-19-19,11717001,1.9129980214779312,4.031814374260409
PaTu 8988t,3854666,2.839522644305469,2.227363922359902
MOLM-13,vorinostat-navitoclax (4-1 mol-mol),-0.987195893966014,-0.20158809734516328
RKN,11222830,1.5707482267531538,1.650048990353798
SK-HEP-1,5978,1.689065603838291,-1.1132454569080432
LS180,374536,-1.6764778169414856,2.706287713296975
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286,0.9873505289415289
RCC10RGB,46199207,3.760684270246491,3.3495989750983615
SW1271,49836020,-1.4027167140646708,2.0388300462039566
BFTC-909,2130404,3.366307483642889,3.2394117987113287
SW1271,3384730,3.1846503121443144,2.8617969901025577
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676,2.5520486696360734
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005,3.929935924982394
SaOS-2,285033,-3.099559966451384,-1.7639189902326455
LS180,71466578,4.68838045718991,4.40560726393954
LCLC-97TM1,2126,5.523539990092585,4.032328007833382
NCI-H1568,9936388,-8.53108348301746,-1.0255783126883709
Panc 02.03,6505803,-1.93196111296706,-0.9085134748199478
BICR 22,9926054,1.8271931211135617,2.185561723601862
SW1573,54618164,4.339091959582753,4.181558588322544
COR-L95,9907093,4.309721999642839,3.7652733836919317
LCLC-97TM1,9911830,3.2250615193472085,2.1855125387690744
K-562,151289,0.3703020531314545,0.46680448121729756
HCC1500,24821094,2.4557115965701257,2.7306115113608933
ALL-SIL,11222830,0.8263932665864424,0.929884155671382
ALL-SIL,44490293,5.541636788423512,1.5682468501449702
BFTC-909,15547703,3.647732910564925,3.3398417028565546
PaTu 8988t,11175137,3.61207596874577,2.96066310680215
COR-L95,44566777,1.612039010223373,0.5340790266325931
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083,1.389388671448635
SW48,9444,3.3118033011757806,4.1273618455113965
COR-L105,52947716,1.1539739817838972,-0.20227803118741733
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105,2.438895625792014
SW1573,16013152,3.6979705228045354,4.242655081381247
SW1573,17759555,4.342323370433329,3.7416428150620633
SW1271,11609586,3.768986685585146,2.910913870284402
K-562,3552672,6.190745251508109,2.3141771416270536
ML-1 [Human thyroid carcinoma],151289,2.136095657957592,1.247837104587552
SW48,vorinostat-carboplatin (1-1 mol-mol),1.7573438485405597,3.124093374315953
COR-L95,selumetinib-BRD-A02303741 (4-1 mol-mol),6.0949369940274645,3.4094844409324474
IGROV-1,57519531,2.639098862164858,2.6533642835309985
IGROV-1,1716436,3.2816872421007375,3.072483195237116
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457,1.69322239620293
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308,-0.4059438125209151
IGROV-1,2828334,6.070696247039626,6.1181813078833205
SW1271,53495165,2.774319130141937,0.02534233842130703
SW948,67291369,3.8063591597957593,1.4279568974380548
Daudi,11507802,0.3815953316544085,0.6334583938439543
RERF-LC-MS,2708,5.106155932743474,5.0480173457997815
SW1573,52912189,3.9296893768173065,2.160663320682603
SU-DHL-1,25154868,3.5324679540942165,4.088278254064745
BICR 31,24772860,-2.497965982707089,-1.7043986155488022
K-562,11719255,4.077642177046201,2.2738407729051064
WM115,5470400,-1.5377493662522326,0.20530721215626802
KU-19-19,44589607,3.6813877406069246,2.8758664317523808
LS180,11626560,1.7567799331145733,1.8166060102045494
Daudi,11427553,0.4642664556868584,1.1232175653582417
HCC1500,44607531,1.3781074542184104,1.330915408796832
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528,0.3710132387106339
PaTu 8902,4259181,0.9791956381618654,0.2145754016892346
SaOS-2,216345,4.363902597199754,3.9689712449834422
BFTC-909,100016,5.8134150302243865,6.346853928220988
BICR 22,56963564,0.2615280103832354,0.8961724117791394
COR-L95,selumetinib-MK-2206 (8-1 mol-mol),3.988992383923742,2.155668304374899
LS180,613753,3.1711720082363337,3.386219485125096
BICR 22,3825829,4.259881935728516,3.8116858488509426
P31/FUJ,25262965,-1.897985536240049,-2.0094249014449463
RKO,15953870,3.3462063589818034,3.2332377963381536
ALL-SIL,26596,-3.0181503922951674,-2.5913303397539234
SW1271,4788,5.888244914590778,5.617244654257069
COR-L105,25150857,2.68968810352953,2.6317573524797586
RKO,24753719,3.882573791668401,3.2542019281374257
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453,3.699977104472106
Granta-519,selumetinib-PLX-4032 (8-1 mol-mol),6.800610624755647,3.1829471176170143
P31/FUJ,selumetinib-PLX-4032 (8-1 mol-mol),0.7192847011043231,3.242385863948806
PaTu 8902,613753,4.768885644214674,3.323948864156849
PaTu 8902,44589607,3.762990171329796,3.1257584554132554
MOLP-8,176870,4.692998654081846,2.7106638505653278
MOLP-8,216468,0.300035377459394,0.9983744233086138
NCI-H1568,1641662,3.419317894706959,3.634284127888563
HCC1500,11626560,1.5792444837322512,1.8972717194552589
HCC1500,3689413,-1.6712109221216571,-0.01631671024675961
RKN,984333,1.094463938199557,0.8899896702244877
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405,3.9034972849936254
COR-L105,4788,5.897633886873905,5.7978965331240735
HuP-T3,carboplatin-etoposide (40-17 mol-mol),4.278227331004969,3.263942298490579
PaTu 8988t,136227924,2.49705731140334,3.1582923916520502
LCLC-97TM1,3634881,2.947438100526324,3.1348580984584076
RCC10RGB,53392493,3.4706572822964072,2.7896821609237725
Panc 02.03,10385095,1.3097039910351371,1.4820354303760532
RERF-LC-MS,445455,4.41080153827665,4.880239918795753
PaTu 8988t,6918638,2.256433939948275,0.753747226654782
KU-19-19,24951314,1.2793314486163916,1.475548987172919
MDST8,25183872,-0.5549651899708961,-0.6849591158671499
COR-L95,JQ-1-MK-0752 (1-1 mol-mol),5.448110634286577,1.2053188300390714
WM115,navitoclax-sorafenib (1-1 mol-mol),1.4633730841087864,1.7491914112992435
COR-L95,9908783,4.358103020890871,4.157198016316369
COR-L105,3552672,2.0991572824292435,2.800831525105119
SK-CO-1,5566,2.706069596509063,3.055190945662762
RERF-LC-MS,969516,2.2498421794663095,2.9260400173391354
HCC15,JQ-1-UNC0638 (2-1 mol-mol),2.9546017932515256,1.7557417521309042
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725,2.323752355882355
NCI-H2452,452548,0.0358025934468,0.3972219598297563
Daudi,409805,3.686040208403983,3.6399855415080804
BFTC-909,5287620,-2.871557478653834,-1.8015902872445795
UACC-812,25183872,-0.2383295665292847,-0.6114449319002927
SW48,36462,-1.5563073788110886,1.855410513565624
SK-CO-1,327653,3.1822308576162692,3.2386223518467325
MOLP-8,11507802,0.9747707839930404,0.7136255247396869
SW48,55508,1.9258231187784565,3.153513664402696
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895,2.258576527184621
COR-L105,16065773,2.993283969068687,2.6679327842990688
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624,0.6867875814720705
LS180,451668,4.827094473942733,3.9171786687285675
IGROV-1,36462,2.313632721410001,2.157524946181313
RCC10RGB,selumetinib-piperlongumine (8-1 mol-mol),4.460336891472633,3.6307407320985217
COR-L95,navitoclax-piperlongumine (1-1 mol-mol),-0.3992176902442844,0.4927531890284966
MDST8,11719255,3.580824685094748,3.326844830917706
BICR 22,135984461,4.376718251500639,3.9907906846184016
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091,2.4138888189934207
Granta-519,2871966,-2.0442685638601947,-0.09961459664795705
Panc 02.03,136227924,3.0839082623333387,3.1856627816247705
IA-LM,10074640,3.892343788144062,3.268383755857998
HuP-T3,navitoclax-piperlongumine (1-1 mol-mol),2.1493116178026157,1.8322370831861354
BICR 22,10231331,2.1949493731732095,2.200567444971312
PaTu 8902,carboplatin-UNC0638 (2-1 mol-mol),3.7190209158995273,3.470113818031738
NCI-H2452,10127622,4.466077980380041,4.250549469719231
PaTu 8902,11178236,-2.9840755573739943,-3.307752641719424
MDST8,6918837,-2.3764765121755,-2.506495714117827
HCC15,1716436,2.8917896521916537,3.0075988134087637
Daudi,5351362,0.314899635949887,1.1155818383036018
IGROV-1,1750826,-3.124548162001242,-0.7400359222419632
SW1271,24779724,6.290779023739936,4.430518456849984
SW948,216468,0.513065020542466,1.7748587669998113
HCC15,5738263,4.375256926251463,3.5720978078978503
Granta-519,25183872,-2.24080905771406,-2.2389268655733634
MOLM-13,selumetinib-navitoclax (8-1 mol-mol),-1.2398703731830696,-0.15776189879831187
SaOS-2,46926350,-4.2820912559124995,-4.030646167116134
COR-L105,49766530,-0.5480688242609842,-0.44007605368588365
HEL,2874250,-2.245656223692803,3.9454567055777954
K-562,45279963,2.402740503794971,3.0512278664038615
SW1271,441298,2.7117876410913073,2.2094675021515258
Daudi,46215462,1.1016280052611975,1.1079366002314566
BFTC-909,9915743,2.0959000942543025,1.32023772590066
Granta-519,55508,1.5366901224911111,2.789139507575274
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354,1.8782503727577313
SU-DHL-1,445455,4.339452591135178,4.327894190489825
Granta-519,11222830,0.944926764715042,0.9570395380220763
SK-HEP-1,135421197,3.339831791709741,2.1230727409329186
COR-L105,11719255,5.177770829400177,3.5936544376975816
SaOS-2,49793307,-3.0698778362667807,-2.306057355460722
SU-DHL-1,54618771,0.3433661921186922,0.5179974049331841
SaOS-2,navitoclax-PLX-4032 (1-1 mol-mol),2.865443862493463,1.9525402633297058
IGROV-1,54618164,4.2184521751950115,3.9111310060069746
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206,2.7546612841721134
HCC15,4259181,-0.5021574884501439,0.10745668098128687
PaTu 8902,5311,1.4468060231693458,1.6881820518536488
SaOS-2,11609586,3.464015551213678,2.9863786674676205
BFTC-909,26596,-1.7437210940555867,-0.8109954965117976
RKO,3385,4.410917651107157,2.9763782996712513
SW48,5282054,3.4229655251352984,3.5812094882569987
HEL,3025986,1.4059985389197358,-1.6052228588744146
HCC15,2749,2.6993987110059456,2.1422245055097293
RCC10RGB,serdemetan-SCH-529074 (1-1 mol-mol),2.3426493996230424,2.2672883947907803
MOLM-13,2733526,3.3430267495988693,3.365975801750605
HCC1500,71466380,5.203984730888507,4.486874680456352
SK-HEP-1,104842,-1.0887000355540395,-2.560992410353237
SW948,5566,3.1149649258053107,2.9450619826581397
Daudi,11234052,2.508646185471885,2.9516210472945126
WM115,tanespimycin-gemcitabine (1-1 mol-mol),-2.08510571323105,-0.12122445292548875
SW48,208908,0.7661322887377208,1.693851014752332
SW48,24978538,0.0148337391131729,0.8406870265357491
P31/FUJ,9926054,1.2698752833949425,1.6791781248226005
Daudi,5287620,-2.5355659158885167,-2.2858413648181797
BICR 31,53325874,4.467091056736401,4.611049624248585
LS411N,400769,-0.3072623933562745,-0.7628983174722537
HCC15,7326481,6.13295321500094,3.0528550592988943
LS180,6610216,4.524725364990245,4.273410410173697
BICR 31,11609586,2.804864928293696,2.9921149284020623
NCI-H1568,5351362,0.9370615420718584,1.591935393205146
NCI-H1568,selumetinib-PLX-4032 (8-1 mol-mol),3.6289743773432463,3.723247589011006
HCC1500,26596,-0.8174609850015592,-0.88590982105782
Daudi,JQ-1-UNC0638 (2-1 mol-mol),-1.821496210426365,0.18864780699176842
Granta-519,salermide-PLX-4032 (12-1 mol-mol),5.521121579042541,4.587298354241976
BICR 31,5311281,1.899563489561116,2.6298491317911106
HuP-T3,11964036,1.9148977928601396,1.5948030633324088
HuP-T3,6918328,0.6989696425214073,0.17651248055455313
IA-LM,56963564,0.8197284064300991,0.06327416594912526
K-562,25227462,-1.535473545694956,-1.2627444297066044
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857,3.511750622190613
P31/FUJ,6438330,0.60015264799364,0.9845276976686591
NCI-H1568,54143018,1.7330311939537375,0.9293873781195039
MOLM-13,10184653,-1.0304513474260102,0.5895690442881469
COR-L105,3081361,0.7591954413754667,2.579640984472421
SW48,3465537,3.829258919586145,2.403261797279679
SK-CO-1,135398516,1.0451560562277196,2.2333678429877946
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826,1.8403973007408687
BICR 31,11222830,2.7999268343872603,1.6394882360631637
P31/FUJ,1750826,-3.787471607079622,-2.76154906049123
MOLM-13,124202324,0.9453642044256088,1.4851247004658155
LS180,445091,4.461419397707798,4.271584587033672
K-562,4578,4.401657334703153,3.8369273111860105
BFTC-909,31703,-0.9928331583982526,-0.7624631406193723
Daudi,54618164,3.154466747848232,3.4434106016559864
HCC1500,375860,0.1348683063529126,0.08072582112028949
MOLM-13,3385,-0.0516453787728095,2.3430042043054202
Daudi,123631,1.6174763425926726,1.854304064093117
SW1573,6610355,4.129027118562099,4.662534055290369
K-562,44589607,2.662527895237601,1.9602603825993343
SW948,24964624,1.7910099631647045,1.845503747132431
LS180,387447,-4.2321913932512185,-3.754935742766997
SW1271,445091,4.3767610709371025,4.4018817468755005
LS411N,5328940,2.1913370268343324,1.3166546855130565
ALL-SIL,46199207,2.4207183231317826,2.4454067932513697
BFTC-909,644241,3.062866082016443,1.9845312312510677
SK-CO-1,5738263,3.1381077819263954,3.5180014041682313
HCC1500,selumetinib-BRD-A02303741 (4-1 mol-mol),5.277663522211575,3.5560402354357286
PaTu 8902,3385,6.504553614083827,4.224481007468052
SW1271,5328940,1.739297434861375,1.8838893317440386
Daudi,444795,4.05018196872557,2.998434084294489
SaOS-2,9887053,4.468769125876902,4.092073045118362
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464,4.7897490655773005
MOLP-8,9936388,3.4211096692910052,-4.996447382748678
SaOS-2,5746,3.648398890023908,1.2442542705201143
PaTu 8988t,135875424,4.8815767191826325,3.8445235695775644
SaOS-2,25195348,4.111342507306749,3.2679897869842645
NCI-H1568,135398738,4.732110826035958,4.704744028487784
RKO,5329102,2.192208184281935,1.6312680640283816
ML-1 [Human thyroid carcinoma],122327,4.584045367066115,4.929616023583373
WM115,11612883,3.668907379861532,2.9469579040165605
HCC1500,24785538,2.8337652504333817,1.5665591290678014
ALL-SIL,3854666,-1.067048731148745,0.6598422370703011
WM115,11494412,2.975341542339242,2.090623696705596
Granta-519,9884685,-0.5481626961732873,-0.2842973047066593
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532,1.722718909561325
KU-19-19,5287620,-2.913600334543538,-2.0283040819997153
HCC1500,25227462,-1.134185511373382,0.11593716418162935
SK-OV-3,9936388,2.038842599711319,-1.1525325171317475
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557,4.902892337894971
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309,1.7591819271569458
COR-L95,9840324,5.902997789616562,5.553889094800751
SK-OV-3,159324,5.082712026660022,3.4265951718143195
COR-L105,5426,4.419968019169297,4.011509964381172
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662,3.4907826446005203
HuP-T3,44491742,4.372770131484514,4.327166969476336
HEL,navitoclax-gemcitabine (1-1 mol-mol),-3.418603962504733,-2.6246267121416818
MOLM-13,5978,-4.923441638627742,-3.377026922153062
KU-19-19,9911463,4.338553857034003,3.9555001273199855
LS411N,SNX-2112-bortezomib (250-1 mol-mol),-2.160208901072175,-1.3880397186427578
MDST8,9956119,3.20428794924567,3.5136068630684254
IGROV-1,44137675,1.8406125640672395,3.247209208502524
NCI-H1568,24771867,2.7621066837370156,3.0181636110165293
SW1573,3503,1.662872296112478,2.1484244174348706
ALL-SIL,54143018,-1.6646130342073118,-0.5250895230099418
KU-19-19,9903786,4.470072542277405,3.260180586775965
Granta-519,67291369,2.669151289874282,0.5791074000291498
HuP-T3,126941,-4.07371973001698,-2.334657479924047
IGROV-1,11175137,1.8411496230681277,2.337217203083792
LCLC-97TM1,3543504,4.4040963352609825,4.033222823485144
PaTu 8988t,10184653,1.9115764380070437,1.4266267607749352
BICR 31,10184653,-1.3652350776002238,0.7518049295813501
PaTu 8988t,4917,3.9515789700022728,3.184340691830818
LS411N,9967941,4.95978669187673,3.055270384614212
SW948,6918837,-5.2716912634433815,-3.2980426122715145
Granta-519,19582717,3.2223711893143796,2.7797607686773462
HuP-T3,753704,5.56041062328625,5.294470004960074
SW948,BRD-A02303741-navitoclax (2-1 mol-mol),3.1746461495638867,1.826207032831434
HuP-T3,44819697,0.7007171788005963,-0.5639565948489078
Daudi,49766530,-5.535187194073846,-1.7812231876521292
RKO,168313047,1.9322709085928884,2.039844648374572
HEL,451668,-1.9900462993769088,-0.5957270734640028
BICR 22,selumetinib-tretinoin (2-1 mol-mol),2.504585066651982,2.7601795127280333
ALL-SIL,637858,0.2842777242368783,0.908862707722061
SW48,375860,-0.9823609780883206,0.08954799139140114
Granta-519,426756,3.1337304970475865,3.764140523427625
LS411N,3038522,4.360410119835835,3.1495468754756506
BICR 22,SNX-2112-bortezomib (250-1 mol-mol),-1.3459249311621435,-1.5304701892184003
NCI-H2452,11626560,1.8431584922948163,1.9973606160688675
SW48,135398516,1.3232406127849534,1.9231627160607965
SW48,5329102,0.4162536894409948,1.892729392642936
ML-1 [Human thyroid carcinoma],322968,3.685498672876688,4.170986359977536
BICR 22,11427553,3.133254296040306,3.2343899788419206
NCI-H2452,72376,-3.519434001557919,-1.5885035031250971
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434,2.9044707938985237
K-562,135984461,3.2548026411837787,3.1969935823089846
SaOS-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.697295369553163,2.0440363115477327
Daudi,73707398,-0.7942959168982594,0.2746592518370417
NCI-H2452,46398810,2.3683678826725387,2.743925546114427
PaTu 8902,5738263,4.741832860910815,3.5997556653486833
MOLP-8,10322450,4.082153801594249,3.1571061343647604
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708,4.160225506383136
SW48,5287620,-2.9796019172473747,-1.8253677098078558
COR-L95,navitoclax-birinapant (1-1 mol-mol),-1.5627413747354164,0.25140147735601254
MOLP-8,56963564,0.2564931281605764,0.0520142572467154
Granta-519,375860,-0.9367901929922506,-0.4339558696531135
SK-CO-1,656346,-0.6691405855346803,1.3283221165994405
RCC10RGB,44607531,1.912198544747903,1.505073406130121
RKO,9823820,5.913042612438718,2.75504843563799
SW1271,25262965,-0.6695626057691765,-1.3100827070089491
SaOS-2,2742550,4.001711578380083,4.124784599503315
SW948,44491742,3.910317363967626,4.075252245822866
K-562,25105715,3.3934107563871088,3.2880410641701996
K-562,3689413,1.0071697658281389,-1.4779016976250605
NCI-H1568,9911830,1.3917537385715242,2.6785199279913012
IGROV-1,42642645,0.3750175292659389,1.1560339403199644
MOLP-8,53392493,1.8438027475223988,1.690098734214362
BICR 22,4788,5.9489186959823845,5.590519324759253
IGROV-1,5287620,-1.5394168430569777,-1.9703421548359026
IGROV-1,446155,3.750396425244744,2.6277176356742693
LS180,15983966,-3.417830365026362,-0.9443215479888185
MDST8,5566,3.234550965497495,2.755803742645642
K-562,644241,-4.86229706466587,0.4396105024578092
SU-DHL-1,135421197,1.1384736779813156,1.8187458735790043
KU-19-19,44507138,1.5611189443326865,2.457731604828337
Panc 02.03,5281321,1.7682996743542674,-0.7593910462829996
SW948,44607531,1.464462944366021,1.2527803121576344
KU-19-19,54649381,3.8760376098429616,4.08109559042647
Daudi,25062766,1.1734245449662122,1.636572208092965
IGROV-1,56946209,-4.416985130578084,-3.8501457410305253
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904,-0.346306157125487
NCI-H2452,11238147,5.37150149846425,3.0775612128708154
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552,1.1525927070225264
HEL,3689413,-2.191477482826257,-1.7251371404958697
WM115,285033,-0.1832916587196474,-1.5251903644769027
SaOS-2,piperlongumine-MST-312 (1-1 mol-mol),1.0729634254150997,1.61641645087066
SU-DHL-1,426756,3.3694285311129777,4.090312891653107
WM115,135999136,1.8466122948256136,4.045750421552236
IA-LM,45279963,4.638115534107364,3.1273280949002267
MDST8,JQ-1-UNC0638 (2-1 mol-mol),2.369730621007783,1.554755519261773
SW948,4917,3.7157271581620166,2.9252808317917
Granta-519,119182,-4.107570420442856,-3.1226766022411994
MDST8,56946209,-2.145438357732055,-3.4875670910123815
HuP-T3,9927531,4.952379772704904,4.711703848020452
RCC10RGB,72967,3.7162805539485775,3.5622202113730106
P31/FUJ,vorinostat-carboplatin (1-1 mol-mol),1.4493920018144175,1.978976046154209
COR-L105,25126798,3.974391104898093,3.930200411520141
IGROV-1,676352,2.310492141650647,2.1914866389208236
MOLM-13,11640390,3.605079146985929,2.4496749076721165
SW1271,10302451,1.5832525718610488,3.2706035599507937
HEL,123631,2.2046071754004553,1.846034875893551
Daudi,9887053,0.4273795924431001,2.4319619475315126
HCC15,53232,1.2438342439906054,2.8385066607881515
KU-19-19,crizotinib-PLX-4032 (2-1 mol-mol),2.7637212964945745,1.993505378454194
MOLP-8,107970,1.7976582890286323,1.889978874657488
COR-L105,12003241,-1.8759508779616432,-0.9248585193206215
SW948,11222830,1.2602033369542562,1.3970281281425065
LS411N,60750,3.4958773713368725,-2.275644497526807
SK-HEP-1,selumetinib-decitabine (4-1 mol-mol),7.187577119098816,3.761787663838703
COR-L95,11152667,-1.0192155235937173,-0.721155045386257
RCC10RGB,136227924,3.611686331312014,3.1209871138704877
Granta-519,46398810,1.929291860170987,1.710484284169197
SW1271,135999136,4.614562085611917,3.5780317903991543
IGROV-1,53232,2.4872106086763393,2.8598711974991757
SW1271,5329102,1.7502689549650896,1.8513905789199165
Granta-519,136227924,1.3333863896282263,2.183863736791846
HCC15,11213558,1.313690011959325,1.9524263034452582
BICR 22,54619267,3.924840101579574,4.018181841229968
MDST8,9907093,2.778674083883115,4.239724613476187
P31/FUJ,11175137,-0.7372235608093404,1.6365492120463103
MDST8,36314,1.6029219233562175,-0.7829797869764968
PaTu 8902,2746,3.932313359375791,3.4696071868216745
P31/FUJ,3543504,4.167476980253382,3.2111151935083115
MOLM-13,selumetinib-decitabine (4-1 mol-mol),-2.0497039310535548,0.3483833415474688
HCC1500,2749,1.6972528944159595,2.307886340707702
HCC1500,2858523,2.9580940168196372,2.815075010547663
P31/FUJ,241158,2.9181679480161997,2.5255365139518404
IGROV-1,44202524,1.8303703172382677,2.33688271972947
COR-L95,24856436,0.3013384579313291,0.13613713176015232
Daudi,15983966,-4.480185591931726,-3.3342504571231135
MDST8,9903786,2.958137426904596,2.8445972806219255
SU-DHL-1,57519531,0.9649766396601452,2.4617122475111644
IGROV-1,25262965,-3.18785020602057,-1.2187312310954874
MOLM-13,135411,-0.7080955458923358,-0.15394944057821305
HCC15,24901704,2.315976175325417,3.436133811885605
SW1573,656346,0.5263129478884733,1.4405803852223449
SW1573,11238147,3.4967804964098517,3.131204075095889
MOLM-13,6918837,-5.322581124261525,-4.531087423085012
MOLM-13,444795,-0.8871401586886155,2.9765590664117765
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414,3.8660560859531166
SW948,44486219,4.202726475674803,4.193743011228481
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482,3.4145533204891096
SK-HEP-1,4259181,0.3926762831937545,0.3926069576169766
MOLM-13,11152667,-8.249378694414048,-1.8433722242571187
HCC15,46199207,3.454904957256138,3.1146208445318617
COR-L95,BRD-K55473186,4.076833088818027,3.9267092578801535
SK-HEP-1,11612883,3.763210558313423,3.0257740544690557
SW48,54619267,2.8192087316830587,3.843771697694874
COR-L95,448949,2.666065821382702,1.6888785257918664
SW1271,31703,-2.541706035799043,-0.9732365316665209
SW48,374536,2.9137455711630365,2.08738898062928
HuP-T3,25183872,-1.5149537087973208,-0.6854107581645517
BICR 31,71466578,6.11729815776394,4.72184825951004
PaTu 8902,JQ-1-UNC0638 (2-1 mol-mol),3.325968686418886,1.8630160263567719
SW48,135440466,-0.9616456131279733,2.122035807736512
Granta-519,322968,2.3569390760499234,2.1786939790256765
RCC10RGB,25227462,3.0929907596871646,0.8733308809427531
P31/FUJ,6917907,-6.201167718101803,-4.806358358892487
PaTu 8988t,49793307,-2.0749757720441164,-2.1175866454521888
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787,0.5480806923364511
Granta-519,12001922,1.093482575381039,1.5345872331235935
SaOS-2,54649381,4.670802712896813,3.8988121112245127
BICR 31,11213558,1.307666782243681,2.0220951777817535
NCI-H1568,crizotinib-PLX-4032 (2-1 mol-mol),1.1920351291695386,2.07501734603534
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553,2.7703677233260127
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982,-0.6420617503156228
SW1573,216468,2.7570678542174294,3.415309516522226
WM115,selumetinib-UNC0638 (4-1 mol-mol),-1.6649688708670054,2.5460179995827197
LCLC-97TM1,441298,2.906797889353979,2.1238793881290223
LS180,24753719,4.21554861148433,4.366133945823019
ALL-SIL,65064,2.797289094590348,3.4367837432243924
BICR 22,67291369,2.228219380635809,2.6106723268777188
RERF-LC-MS,168313200,3.896073258981905,2.928061206479364
SK-HEP-1,9444,4.343802313850578,4.3205681166102226
PaTu 8988t,5328940,1.37213408852796,1.7082082147348325
BICR 22,5311,1.9321946929787237,1.632607934337909
BICR 31,219104,4.339385963743166,4.0512479162044315
IA-LM,navitoclax-birinapant (1-1 mol-mol),0.9661669112911666,0.9961186075977647
ALL-SIL,4477,0.1906678465210559,0.2678601800142238
K-562,25154868,2.7747166739598264,4.120170355400687
SK-HEP-1,16065773,3.000790971898234,2.5120656620736517
PaTu 8902,11364421,1.1100050491651887,-1.4170402317464499
NCI-H1568,3081361,2.134244125445247,2.451248000140033
HCC1500,11640390,3.4842141291887234,3.443471274426238
BFTC-909,11626560,2.2197507332783735,2.0053427914550994
SW948,107970,1.650733689507072,2.1374245828115717
RKN,15983966,-2.847635435689191,-1.6994345940193505
P31/FUJ,11455910,0.7543092217738059,0.03352888281905516
MDST8,71466380,4.4925072325945825,4.334838585193443
HuP-T3,44185566,3.047929926499308,2.6841475113214592
WM115,24772860,-3.130789858430774,-1.657343772743776
COR-L95,327653,2.664763845896721,2.7087812407712466
BICR 31,46398810,2.284799792972812,2.5977532093997935
MDST8,46199207,3.2831338438462545,3.1451353673190914
P31/FUJ,54143018,-1.089453758548118,-0.20776952595186512
RKN,119607,5.106543735080002,5.263468346434246
COR-L105,5746,2.3338049438674933,1.7541768427943805
ALL-SIL,alisertib-navitoclax (2-1 mol-mol),-3.0899588817168286,-2.083017636773972
MOLM-13,5738263,2.9100103684660237,2.603731576229572
RERF-LC-MS,216345,4.25766275770173,4.115101707007602
P31/FUJ,10322450,3.023071845081992,2.8402025052501574
BICR 22,16065773,3.2562595111068933,2.5361252699018095
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848,4.463683715695499
RCC10RGB,2858523,3.1824977664847833,3.0372389753956615
HEL,3634881,2.3660153954756,2.604252389591455
BICR 31,4705,2.7587837218207194,3.2352556767784018
Daudi,16736978,-0.1290294552432643,0.9749845853174167
HCC1500,409805,3.5957056987066407,4.7250798327826615
COR-L95,11497983,3.7904455836505977,1.5986836751554825
NCI-H1568,erlotinib-PLX-4032 (2-1 mol-mol),1.5802949352112503,2.937107571632166
HuP-T3,123631,3.4682236131630213,2.3671291872792977
MOLM-13,6918736,-1.7098661921605196,-2.1390756913543107
MOLM-13,46943432,-0.154947866345158,1.1463132565304752
HCC1500,219104,2.0821347677363473,3.8316102240692094
WM115,salermide-PLX-4032 (12-1 mol-mol),1.9364726172790967,4.603273751416947
NCI-H1568,65064,3.2204713254113373,4.858305927502967
SW1271,16720766,0.8044088826386648,0.6940729914723023
Daudi,119607,3.8512151262400978,4.40075878993273
HCC1500,72193861,2.243893882523798,1.9284020711459824
K-562,5328940,0.7651330448756731,1.1795125410693454
SaOS-2,644241,2.5011234622868415,2.2119303639978254
HEL,60700,-1.2821695146150829,-1.899565904676715
RERF-LC-MS,25227462,0.8140348385016122,0.6119679907074572
COR-L95,4521392,4.944619543772989,4.215338936722556
KU-19-19,16720766,1.6427063989874335,0.42455942236344596
SK-OV-3,3025944,4.375754256809385,4.36747232473792
P31/FUJ,36314,-5.221113398603202,-2.1282191878683947
Panc 02.03,568763,0.7660787595735656,0.5776745484455316
PaTu 8988t,60700,1.4149082605005396,-0.6371504652036666
BFTC-909,421610,2.763760389372973,3.3118184140602436
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,2.916381592381822
RERF-LC-MS,123631,2.7610356359897104,2.6311500071952976
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.6807526122733254
RKN,10385095,1.0188882527918253,1.2730791322241055
K-562,carboplatin-etoposide (40-17 mol-mol),2.706166377048538,1.5403782118835037
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516,2.196269437715345
Daudi,44486219,3.679556481815833,3.4895844329734627
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647,2.126863772378351
P31/FUJ,159324,1.227532336429348,0.9761884039169647
SK-CO-1,6252,-1.3434891204218062,0.7906506174982638
LCLC-97TM1,656346,0.6605690440583806,0.7089795016205127
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835,-1.008759437740469
RERF-LC-MS,675434,4.646232548137413,4.6036305041129495
KU-19-19,123631,3.236221278135049,2.3662705744608217
MOLM-13,15983966,-4.417403089755366,-3.889094529717483
HuP-T3,4917,3.663340719397695,3.0699191355211854
LS180,44185566,1.7571027497277631,2.180772842797911
P31/FUJ,11228183,-0.9086595542209992,0.23149312829636115
WM115,9933475,1.7795579913266513,1.9363568330708776
RCC10RGB,445643,3.986839371383198,4.0894925658095485
LS180,11238147,1.5426585727528574,2.6741646938174735
SK-OV-3,6918328,0.3966751205296329,0.3472722531471908
SU-DHL-1,71466578,4.395132834723917,3.6221792258346626
ALL-SIL,135421197,0.8278001934093618,1.066353519945876
BICR 31,2858523,3.440938149330432,3.1152295653236424
NCI-H1568,72734382,4.159676082420196,4.684943199701821
BICR 31,10427712,4.26091650049326,4.354255122630902
K-562,5351362,1.2059406782397044,1.1616616131993371
HEL,44589607,2.8579344181758164,1.9415269733453135
RERF-LC-MS,89928392,3.2509495975064193,1.8523991076656767
K-562,4705,3.481256778033869,2.8285908541339477
SW948,400769,-0.4902020150535968,-0.7648701799955023
RKO,46199207,3.448070090368443,2.7843340633440703
HuP-T3,10410894,4.484643398072658,3.254351652719212
BICR 31,969516,3.644181632779252,2.8567503718924523
WM115,54618771,0.9043395114740442,1.668202897372807
MDST8,2749,2.5181508528519365,2.2361981802847506
SW1271,4378219,1.9495591217614856,2.543711897800547
RERF-LC-MS,12003241,-0.3897829713203344,-1.1620639204757952
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769,3.328446291015253
PaTu 8902,44620216,3.796821774118314,4.005627874282004
MOLP-8,4378219,3.751203523477959,2.3415508895798944
PaTu 8988t,11152667,-0.7220641758089987,-0.12085542122347169
SK-OV-3,navitoclax-gemcitabine (1-1 mol-mol),0.2321972175274424,-1.1506489209096586
SK-OV-3,60700,0.4435128165358443,-0.4205236133490885
LS180,168313047,2.515878081381246,2.5364656352790202
K-562,400769,-0.7978860959413716,-1.0880866941511378
Panc 02.03,126941,-0.7071805078882285,-2.0653241585168955
NCI-H1568,3634881,3.2529386900783024,3.418234945388314
LCLC-97TM1,24821094,3.5658031163211996,2.8977663732541554
LS411N,11485656,1.6093796612349578,1.6669880650404254
HCC15,16736978,2.153897232237977,1.8872425386392797
LCLC-97TM1,6610355,3.6494140877324273,4.368500916137432
IA-LM,serdemetan-SCH-529074 (1-1 mol-mol),2.9054360397422387,1.6721665523916545
IGROV-1,9911830,1.9130562323799436,2.378375699325675
LS411N,159324,3.2133975478450005,1.4039384938053845
COR-L105,selumetinib-PLX-4032 (8-1 mol-mol),2.5098576733785705,3.5364693363117614
SaOS-2,322968,3.970591848140582,3.9482683004990173
BICR 31,216345,4.54975912567895,4.12547595946043
HEL,3825829,3.033394475732853,3.2714844578171407
COR-L105,46191454,3.4168297701439223,1.9700009855257121
K-562,5113032,4.649240406472478,4.560271179895662
BICR 22,156414,1.4774483319728589,0.7853365272621987
SW1573,135875424,1.8143158468632437,4.068174952757005
WM115,12003241,-3.303596686294694,-1.154190806671413
RKN,11640390,3.613472996393559,3.592323958257565
HEL,23725625,2.914554844202699,3.438672776790095
COR-L95,36462,-0.8944975018350346,1.2027220354276364
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331,2.9168771338270325
HuP-T3,11977753,3.281021154274905,-1.4045548873775073
SK-HEP-1,400769,0.2777482831309371,-0.2447405448196195
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.144610574154712
SU-DHL-1,246676,5.693727803678488,3.9007486577589843
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012,1.8334114503355259
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075,1.7288687699325485
RCC10RGB,44507138,4.147954700367582,3.005713637298301
LS411N,123631,3.048490743589503,1.8788070752918251
MOLM-13,11213558,-2.3442824820578347,0.5562662411901238
MOLP-8,selumetinib-tretinoin (2-1 mol-mol),3.5259628447658495,2.6924812670774765
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766,-0.5843248355824495
PaTu 8988t,444795,4.288290341819835,4.729902179710269
SK-CO-1,66577038,1.9378658470267984,3.038461715099536
SW48,24771867,-3.897611921368264,1.9851594808963378
NCI-H2452,9907093,3.826391051371518,4.4137747620959455
SW1271,171352865,2.2565348875691624,2.56105381854325
SU-DHL-1,11152667,-1.9410189761528236,-0.5876746838986414
SK-HEP-1,148124,3.734435411699081,-1.0053926453252509
RERF-LC-MS,107985,-3.0933260647006215,-3.0995724831657334
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554,3.121457865117646
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653,-0.43164518386239
RCC10RGB,10184653,2.2305820416370965,1.2564547379884683
LS411N,17755052,2.4732315703899226,1.6076712178446018
Granta-519,decitabine-navitoclax (2-1 mol-mol),-1.3661382782873654,-1.1925374483790734
KU-19-19,24753719,4.40371401160258,4.2636579953887015
PaTu 8902,72376,-1.694582331183855,-1.7564091557489099
HEL,72376,-3.0304513894944933,-3.74249371104406
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486,2.650006278487192
SW948,9884685,3.1398548031465525,-0.12809226425892292
Daudi,24748573,1.578133478161721,1.2488230777972877
COR-L95,4917,3.3160135329409406,2.784138620847331
SK-CO-1,2708,2.7526164010571152,5.0069041861012185
Daudi,5479543,1.606221989903471,2.507385748490258
PaTu 8902,vorinostat-navitoclax (4-1 mol-mol),1.8599454099065449,1.3148635436043599
MOLP-8,44632017,0.8356757219547752,0.8564996450708265
SW1271,9868037,2.9396003878324857,3.288280320779373
COR-L95,11455910,1.0154509596480157,0.7577685596314417
IGROV-1,445091,5.8777802446160825,4.2808940324944595
IA-LM,107970,1.9308025720075177,2.1318842903761657
BICR 31,15953870,5.115358479555731,3.2961220796622293
HEL,135984461,1.7610482730169696,3.007645081158476
HCC15,vorinostat-carboplatin (1-1 mol-mol),2.4228610420151853,3.1322631857284886
PaTu 8988t,5311,3.6038975682992422,1.4854639257964302
MOLP-8,navitoclax-pluripotin (1-1 mol-mol),-0.3360266341011599,-1.8957770604356714
RCC10RGB,BRD-A02303741-navitoclax (2-1 mol-mol),1.3031528560505037,2.1357538607563042
SK-CO-1,11228183,0.9546983133897222,2.447985880324359
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.570509240579035
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759,2.2794943592808297
ML-1 [Human thyroid carcinoma],441298,2.939924630100921,2.4304144778231023
BICR 22,42642645,1.569820729256039,1.1904285772307495
RERF-LC-MS,387447,-4.351660250848144,-4.059779145819567
SU-DHL-1,carboplatin-etoposide (40-17 mol-mol),-0.8202872264800385,1.3026596346639383
RKO,676352,2.3070338313311547,1.8628988604260002
HEL,66577038,3.4935326109734217,2.5989855514196876
RERF-LC-MS,25062766,1.7296886540377192,2.112946245555986
RKN,52947716,-5.912196482956353,0.375686319027197
SW48,56973724,0.919295357428288,3.0173475588530834
LS180,66577038,2.8527700320727725,2.9324410575865425
K-562,7251185,2.894408284149289,1.767943943434728
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456,-1.297889287799035
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444,-0.6482188265086952
MOLM-13,6918878,-0.6248914400619264,0.5131559697193324
IGROV-1,135421197,1.96820638017286,2.077693702043087
RKN,11404337,0.6786980557761386,-0.4462460498698539
SU-DHL-1,6918878,1.5556600104975795,2.4852962985920386
MOLM-13,176870,1.4073018577806429,2.5543994584436063
SaOS-2,44566777,0.9896093397626105,0.6196886826617185
COR-L105,5470400,0.2171168006478052,-0.0457205233628892
LS180,44632017,0.4358481157568056,1.2661909318714633
RCC10RGB,16065773,4.176477311044804,2.706239159203526
BICR 31,156414,0.5699919561712937,1.1275170540099735
SW1271,tanespimycin-gemcitabine (1-1 mol-mol),1.3087817847802907,-0.3202244504176683
HCC15,JQ-1-navitoclax (2-1 mol-mol),-0.7343032708143507,1.2151151761970704
Daudi,54596490,4.948926549609605,3.997300136834369
NCI-H2452,11317348,1.7824301660124695,3.5899159544670107
IGROV-1,60700,0.4424479122017752,-0.4327437504685717
IA-LM,135421197,2.370501142960713,1.4810930417490789
NCI-H2452,135423438,1.816833708086427,2.433207945873646
NCI-H2452,6918837,-2.3246752526945413,-2.2109672672828924
HuP-T3,409805,5.703463345532586,5.159658376072457
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543,0.22720816047212058
WM115,3025944,4.015069634557516,4.2173716125579395
BICR 22,10127622,2.812639951672956,3.028911170392041
RCC10RGB,16741245,4.755009504271123,3.9532848050048646
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215,-0.328624613544411
BFTC-909,1641662,3.805506520632872,3.5311035726263382
SK-HEP-1,3136844,5.506062707172487,4.447780455423802
MOLM-13,5335621,3.915836728943439,4.067184119401489
ALL-SIL,6918736,-2.784980550106597,-2.594180544579589
NCI-H2452,selumetinib-navitoclax (8-1 mol-mol),2.20402438215903,2.0237127283795626
SK-OV-3,5311,1.582209129738937,1.6212306960452638
NCI-H1568,4378219,1.8995328874154,2.7415765238865784
PaTu 8988t,135440466,2.5529183901912456,2.639774052345445
P31/FUJ,208908,3.0114989034455415,1.958460429881547
MOLM-13,55508,1.530825081139479,2.782783319539583
ALL-SIL,15983966,-4.919474478826657,-4.415978842341822
ALL-SIL,72193861,-0.8088702984298154,0.10323564845492729
Granta-519,135875424,2.983761714085865,3.2108130087078326
Panc 02.03,25062766,3.7424097220448207,2.0125740335937734
LS411N,5282054,4.11513360382112,2.5960661016307167
WM115,9956119,3.8110537513046423,3.6972143910124062
Daudi,10077130,1.7104594990439606,2.1260175018819285
PaTu 8902,54618771,-1.3103145579416535,1.1691225468531259
LS411N,6610355,5.174673905344729,4.259081197757293
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006,2.6702920022403345
Daudi,11364421,-5.814557541528941,-3.92081743495072
SW48,10090485,5.377611493091081,3.8061783338737687
RERF-LC-MS,252682,6.464777279315186,6.4722733999618764
RERF-LC-MS,25195348,2.310586589861769,3.230488697105441
LS411N,57330099,4.386912904802011,3.8052655527702455
RERF-LC-MS,5351362,3.2669953777859493,1.6247348880031873
SaOS-2,5281321,-2.1045144226453134,-1.4976713325014017
SW948,navitoclax-gemcitabine (1-1 mol-mol),0.2837649103664914,-0.8521525329190578
HCC1500,15953870,3.698430879415157,3.1567001076616488
BICR 31,107985,-2.559614665868775,-3.1656038814554632
SU-DHL-1,5978,-4.006589870739168,-3.1910311964455427
SK-HEP-1,387447,-3.995016034956776,-3.750081959520911
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588,2.9077811198391856
BICR 22,44491742,3.912327775797625,4.316154765029431
NCI-H2452,10113978,2.1292579793865167,3.445685866543184
SW1271,selumetinib-MK-2206 (8-1 mol-mol),0.1264422257766406,1.8821410787071153
HCC1500,JQ-1-vorinostat (2-1 mol-mol),1.1801971963023554,1.2901614755033548
MDST8,JQ-1-vorinostat (2-1 mol-mol),0.5745237647612197,1.0628793021142824
PaTu 8988t,10074640,3.912219918984309,3.1663039664533694
RKO,25102847,3.0524897378806033,1.5878939854599416
K-562,446155,2.553560117982406,2.5788533615961713
HuP-T3,3062316,-3.5835263694309862,0.9560595871879116
BICR 31,selumetinib-piperlongumine (8-1 mol-mol),5.193629730371027,3.552163060031964
HCC15,selumetinib-MK-2206 (8-1 mol-mol),0.2516850341197869,2.05252306519614
COR-L105,9915743,-1.8659407955600968,1.1990488733308244
SU-DHL-1,676352,1.6127382742380425,2.13207835647822
SK-CO-1,15983966,-2.8914318783251733,-0.0743776068316388
BFTC-909,6450551,3.0302116860685886,2.687780670740854
HEL,salermide-PLX-4032 (12-1 mol-mol),3.70170985200322,4.443280729494405
LCLC-97TM1,6852167,1.822160840349085,2.5176401299450872
K-562,1716436,3.607306146681396,2.6659785410365657
ALL-SIL,6917907,-6.413711962559719,-5.555137404653659
SW48,44505237,4.455085659285412,2.3463534259462957
MOLP-8,4788,5.509648062033256,5.126338866244993
KU-19-19,49793307,-2.3409308252506777,-2.2328314628565193
IGROV-1,46843906,3.392503571349757,2.896333877313046
LS411N,selumetinib-navitoclax (8-1 mol-mol),0.3933540744124401,1.6474972968773889
NCI-H1568,23582824,0.2708211860244319,0.6625355851442865
P31/FUJ,156414,0.8249508749632878,0.6300205588974218
HCC1500,vorinostat-carboplatin (1-1 mol-mol),3.9041081325977616,2.9486204946005485
Panc 02.03,24951314,2.3006835537528585,1.5611784597791638
RERF-LC-MS,46199207,3.61094494328213,3.3269248225142376
MOLM-13,docetaxel-tanespimycin (2-1 mol-mol),-6.839014739935568,-4.672798892850005
IGROV-1,25102847,1.7007012555618253,2.4355691759406506
COR-L95,9884685,1.274087436172542,-0.07302783655237927
RKO,5738263,3.4166283525852523,2.913905212217468
BICR 31,446155,3.004688823756655,2.6726462531740514
MOLP-8,3081361,3.002632255231731,1.7585599965521925
KU-19-19,124202324,2.2262797687523266,2.7591562943554906
COR-L95,241158,4.468160037389037,3.142893485584971
PaTu 8902,selumetinib-UNC0638 (4-1 mol-mol),4.723826632745484,3.2888543359841536
SK-OV-3,9926054,2.1800400954819716,2.048059272487079
NCI-H2452,285033,-1.1649166052412432,-1.775604490603478
MDST8,SNX-2112-bortezomib (250-1 mol-mol),-1.5360671270430672,-0.8763715827051004
SaOS-2,3136844,3.967600163436525,4.223449963853459
Granta-519,36462,-1.2340392932323463,-0.24736521757231597
Granta-519,24785538,0.1958729752370936,0.22795879963737128
WM115,5566,2.8846390038255127,2.829405975283462
IGROV-1,31703,-1.792518264692263,-1.1787007036545836
HCC1500,3025986,-0.5847488606379614,-1.0651660029505097
K-562,2828334,5.968313970587813,5.669685581663755
HCC15,navitoclax-gemcitabine (1-1 mol-mol),-0.4507382221714274,-1.5757081564306257
LS411N,72193861,2.8187845663214848,0.6789841635252784
SU-DHL-6,11964036,-0.1529025297927845,0.5219188866672845
LS180,6918837,-2.789669873343886,-2.8143973643068976
Granta-519,445455,5.050402748491994,3.9121698352024445
LS411N,9926054,1.9376785020428349,1.7017154742514924
MOLM-13,135398738,2.371405234005272,2.143180927467068
BICR 22,53392493,3.288173891171126,2.5506755254402793
SU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),-1.5954357785960134,1.5482774452733201
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083,4.578169683614516
MOLP-8,9823820,3.862667538801475,2.797771218195028
SW948,219104,3.4463785749905886,3.03177066319591
Daudi,56649450,2.7731175257265757,2.372385232827921
RKO,446155,4.170579555483674,2.2784009978358015
COR-L95,2708,4.088828930735336,4.0583370398567675
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802,2.9845295465799975
SW948,6610216,4.184431800680971,3.998645206825212
SU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),1.2163104495485748,0.37859127500973117
MDST8,24978538,-1.5034064763640302,1.3321160275044404
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.5494081760604146
Granta-519,vorinostat-navitoclax (4-1 mol-mol),-1.0034104350750142,-0.21184698759141887
RERF-LC-MS,44607531,1.5104561529736475,1.6714931986093966
MDST8,16065773,2.461320056751215,2.4224088199361433
Daudi,11955716,-2.451420398730992,-1.9407039516461495
Daudi,44566777,-1.3909109996970672,0.006183892206631613
WM115,53495165,2.3633352174150155,0.6614648965436131
MOLM-13,10077130,2.656845569256352,2.504209957453846
LCLC-97TM1,11364421,-5.841421445385269,-2.555410822290602
MOLM-13,9887053,0.5396890830211841,2.576298924545548
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.1042905927681685
IGROV-1,46191454,1.3777495915525844,1.7074986504378173
Granta-519,5328940,0.7430401080732436,0.7714117404959856
SW1271,54618305,4.440463475812739,4.456805381292852
COR-L95,23725625,3.551891881441416,4.147059594529803
RCC10RGB,46843906,4.246883034106686,3.24752293734147
Granta-519,2945648,2.528276278220214,2.3068696672500044
Granta-519,11977753,-6.302388202708452,-2.552310637188599
SU-DHL-6,15953870,2.4587311871536315,2.959592082142824
MOLM-13,10322450,2.9930800125873045,2.85387652205994
LCLC-97TM1,6505803,0.2281876141434561,-0.5432376175495649
WM115,9967941,2.88500943866673,3.998113129706367
K-562,44202524,1.302888790519651,1.6515933976486874
K-562,252682,6.220409267483573,6.3824697696003465
HCC15,49867926,4.259454552862098,4.260402749900766
BICR 22,25183872,-0.1596442578279089,-0.7790738216841666
RKO,17755052,3.988455753476612,1.3788688530112554
IA-LM,selumetinib-piperlongumine (8-1 mol-mol),4.519292467442182,2.643938578548065
PaTu 8988t,5566,2.9380975134161553,3.0989706907014365
K-562,219104,3.3686951285077273,2.578337486656742
UACC-812,BRD-A02303741-carboplatin (1-1 mol-mol),6.034191295751065,3.7936723862583013
WM115,100016,7.477930972064711,6.25900544269584
BICR 22,serdemetan-SCH-529074 (1-1 mol-mol),1.6325628481893268,2.014728449466323
SU-DHL-6,46191454,-0.3846699961999978,-0.27595514173181085
LS180,124202324,2.088899784140079,2.4815629543671296
KU-19-19,navitoclax-MST-312 (1-1 mol-mol),0.8014531944430209,1.0753670862576241
K-562,4261,1.1039684536741017,0.7842484935367097
NCI-H2452,5282054,2.993265650723398,3.9628616673065302
MOLP-8,168312962,1.5743557083321402,0.7741456132887174
Granta-519,969516,1.9567849087702365,2.183008685857407
NCI-H1568,25062766,1.9660972036535989,2.2541055777368224
MOLM-13,448949,-0.3738099635599754,1.4037842318750255
SW48,11647372,-0.0986138935854908,0.8818078340131088
MOLP-8,selumetinib-piperlongumine (8-1 mol-mol),0.460809914604767,1.8925817356662926
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327,2.724364189226947
RERF-LC-MS,11977753,-0.575574044510787,-0.6543806152322064
LS180,49793307,-3.6014942577594415,-2.7205576071859396
SW948,3854666,3.050289300885683,1.3232692920181535
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803,3.0968701710859885
SW1271,navitoclax-PLX-4032 (1-1 mol-mol),5.386120495356167,1.7241105148656068
WM115,5278396,3.4301399168519153,3.680945464315131
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206,2.4215066584253333
HCC1500,11485656,2.6610961572019103,2.401569547344501
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992,0.020103782283271237
Daudi,2945648,2.1407869976239087,2.0331159778603776
MOLM-13,3689413,-2.8005667715254017,-1.5418884900009977
RKN,3543504,4.234888347098623,4.496503942931908
IGROV-1,24964624,0.5052308994941754,2.2693806284746127
PaTu 8988t,676352,1.787056590779638,2.158697619837887
RERF-LC-MS,10385095,0.7812016081678173,1.3533395410195406
WM115,4259181,1.0090630393378868,0.5144256772856186
MOLP-8,navitoclax-gemcitabine (1-1 mol-mol),-4.985488409488958,-1.6414007052664326
SaOS-2,1239801,5.3522865443092575,4.038661055152732
Granta-519,44137675,2.975150065736677,2.6419406255961686
Daudi,11455910,-1.173613913103254,0.17923524026759555
UACC-812,11152667,2.562952126743398,0.18012770361271221
SaOS-2,16219061,3.147835700454569,3.3885707727823684
P31/FUJ,erlotinib-PLX-4032 (2-1 mol-mol),2.316286260335057,2.6138103099611736
SaOS-2,71304818,3.198114510015862,2.441641168829099
IGROV-1,57330099,4.391385744785918,4.19494353298705
LCLC-97TM1,2729026,2.4668071198749555,2.7679605816086577
HCC1500,5281672,4.190998095776345,4.483128181059043
NCI-H1568,9884685,-0.6579514975056241,0.776823897143842
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801,2.7762609425739777
LS411N,107985,-2.091782559178726,-3.724402256654575
COR-L95,42642645,0.7279572059378924,0.33747472517274185
LS180,5566,2.7460265721966897,3.0236793398897497
COR-L95,104842,-6.859012992539376,-3.4883856420339794
K-562,702558,5.364922414830515,4.059368669617862
NCI-H2452,vorinostat-navitoclax (4-1 mol-mol),0.733087868835974,1.3877092570052567
LCLC-97TM1,9929138,5.774162864206733,5.448880193661637
LS411N,31703,0.7183186901084707,-0.4160060869645749
WM115,23725625,4.964211357698685,5.193149068426306
HEL,piperlongumine-MST-312 (1-1 mol-mol),1.46077164854103,1.1704021982878823
SaOS-2,24978538,2.44958290959275,1.3487604872800156
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359,1.6795038373387035
PaTu 8902,2858523,3.3217981805434196,3.074178352895158
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304,2.255073738486438
SW48,65628,3.988389614478155,4.165774103516963
Granta-519,9903786,1.2937892753152922,1.8312761326442444
IGROV-1,71304818,2.4878074097553378,2.6365421535047777
COR-L95,25105715,3.673741872436949,3.222972758816378
HuP-T3,6918837,-1.8626358392084263,-2.4992590305588225
PaTu 8988t,72376,-1.956580109455481,-1.6754749090827317
NCI-H2452,46907787,3.091101876271566,2.6149095008004606
SW948,23725625,5.544404993552476,3.988465319747649
K-562,25062766,2.5223735702376753,1.4698053799913342
SaOS-2,753704,5.53840358060444,5.011007735349524
NCI-H2452,56973724,2.8465784993073564,3.506204980659126
Granta-519,71466578,4.383489061930637,2.5493103010181475
SW948,11609586,2.9863433458317714,2.0315141766701483
HEL,71466445,1.5745300131733593,2.232136010710435
Daudi,5329102,1.2784768117884069,1.4947349967388686
HCC15,409805,6.461768980239098,5.130556054709516
Daudi,2871966,-2.2343916463272873,-0.5072875092511132
HCC15,selumetinib-piperlongumine (8-1 mol-mol),4.822467978355287,3.558468170746142
RERF-LC-MS,135421197,1.554065103888189,2.029289690970126
SW1271,selumetinib-tretinoin (2-1 mol-mol),2.7817516989696855,3.0101329473169205
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558,2.2200274662275756
PaTu 8988t,25150857,2.5954794764360343,2.6812724313565615
P31/FUJ,11152667,-2.5755274762926095,-1.8878255285764152
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282,0.820818446790421
BICR 31,2828334,6.263113325647995,6.301254403435159
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238,1.3405956306467275
IGROV-1,11507802,1.5049911819213722,1.7418438868568082
Daudi,11485656,1.7254760898020216,1.38149325779056
Granta-519,11152667,-3.975154363660797,-2.247316873041183
SW48,11640390,-0.422464249163724,3.5412281312987033
IA-LM,2828334,6.3387056990337705,5.846722359335709
HEL,36462,0.8349109175120154,0.2434473565874356
LS411N,4477,1.0450277541726452,0.6249359931779318
NCI-H2452,16219061,3.733701707144141,3.5583496233042125
RKO,16741245,1.399079485469943,3.6087677955692836
NCI-H1568,445455,4.330931204553833,4.787005024620753
K-562,15983966,-4.450185495623787,-3.814262005251257
HCC1500,4096211,2.7054358198440345,2.589425858593952
SU-DHL-1,46191454,-0.3713761809994262,1.0588311797585346
IGROV-1,387447,-3.9508602289798658,-4.1711251647710785
NCI-H1568,71751553,3.6437596116554887,4.512961271889295
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824,2.826110010430997
WM115,46199207,3.650123600055899,3.4180427358917207
SaOS-2,71680916,4.865393442781168,4.850842753712573
COR-L95,9823820,4.611798945344124,3.534840670461095
HuP-T3,44589607,2.433680498088492,3.0759710557020123
SK-HEP-1,vorinostat-navitoclax (4-1 mol-mol),1.9601053638256545,1.5990789168492787
IGROV-1,3634881,2.769147818550815,3.2229228367248557
COR-L105,54626689,5.0742986339862926,4.653431499375275
HEL,176870,2.3693727744318887,2.4588278866350373
LCLC-97TM1,9549297,2.332709006301325,2.4971502627871502
COR-L105,24180125,3.5925931777332676,3.2062811798592237
MOLP-8,89928392,0.1045876418070581,0.4567287221089561
BICR 22,3025986,-2.8899356497226756,-1.274975896525781
ALL-SIL,400769,-0.758162988868875,-1.7501079301847502
BFTC-909,71466380,5.267829049221599,4.601196668774656
MOLM-13,24951314,-0.2336633009541456,0.17568938654773766
MOLP-8,3038522,2.029025514425164,2.7736916651532124
RKN,16741245,1.555254881894904,3.8399726204735254
COR-L105,71751553,4.255827287979035,4.718515204886444
MOLP-8,60750,-8.573260651984995,-2.727184398318414
HCC15,navitoclax-birinapant (1-1 mol-mol),-0.4439511388855052,1.8615500544720205
BICR 22,24772860,-1.3590035600374548,-1.0833789846930915
LCLC-97TM1,5470400,0.2889153362640624,-0.1898446164515205
BICR 31,53232,3.653430995715962,2.811947753937082
BICR 31,8515,4.104799625743522,4.104980536468794
COR-L105,10127622,2.236200578684094,4.00789703065442
NCI-H1568,5328940,0.3466597705312412,1.7492233447747965
MOLP-8,135421197,1.7506124789909805,1.3565406005845047
SW1573,54454,1.176648172779268,2.5522905475340787
NCI-H2452,11964036,2.1879069513719087,1.6275261110962935
MOLM-13,44493528,3.9608078939228175,4.040109929342027
SK-HEP-1,11396600,5.84824704867975,3.6806888427010938
WM115,46215462,1.6800224060395437,1.9945339067918533
Granta-519,23939,5.101725753715152,3.226737944847164
BICR 22,46907787,3.4905986586009843,1.9665774826537872
HEL,10184653,1.0835446596032057,0.5064705003494685
LS411N,9903786,3.6806866285220017,2.8963171702525186
SW48,9840324,6.311735261945371,5.8001601336335815
HCC15,24753719,5.171121417544096,4.1769888194614895
SW948,11507802,1.163064588903486,1.2047722310205606
COR-L105,2733487,7.427108299628283,6.306690910345018
SaOS-2,439501,-2.8243657156627724,-2.251913027719262
UACC-812,5287969,-2.4803922230812527,-1.4802733035165472
Granta-519,66577038,2.6663435544296346,2.571440987343116
RERF-LC-MS,6918837,-3.051376318733669,-2.2395907358728593
NCI-H1568,11152667,-1.392140833696634,-0.43714213464799967
KU-19-19,49850262,4.263742487880845,3.8433545844741435
BICR 31,selumetinib-navitoclax (8-1 mol-mol),2.9853512378124023,2.452895041984989
SaOS-2,156414,1.509432711545826,1.48935116350247
KU-19-19,navitoclax-gemcitabine (1-1 mol-mol),-0.4466146105667509,-0.5667427421519784
Granta-519,216468,0.2159572219264565,0.6535609437827277
P31/FUJ,3136844,4.357504973194935,3.5741661976841614
MOLP-8,6918638,-1.572747132532541,-0.27343133339159825
LS411N,445643,4.311506480272609,3.788628281028184
MOLM-13,25126798,1.909946064109967,3.2194657035038934
BICR 22,9927531,5.395078942533075,4.733809905226974
SU-DHL-6,3385,2.96945431954736,2.59219230039156
SW948,49766530,-0.6875988061214425,-1.0489730120770104
MOLP-8,5287620,-5.023262566828496,-2.080491380293537
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994,1.3350821405162656
SW1271,5746,1.8306286254207629,1.2179125290156
SU-DHL-1,4788,5.095368657375766,5.050240359916128
UACC-812,44607531,-0.3950460021726514,1.280911060311206
SK-CO-1,10074640,3.0297361304753143,3.1720879706073624
IGROV-1,65064,4.920352624378345,4.740642021489295
P31/FUJ,9444,3.558733501871851,3.4379593487253883
MOLP-8,16722836,0.6223558214261112,0.8291487514767715
LCLC-97TM1,11647372,-0.3650454903758569,0.7402688007442212
COR-L95,9911463,4.18924595414168,3.4478616674153657
MOLM-13,3634881,2.324290549736021,2.4767245180977686
IGROV-1,1242560,3.902441161940491,3.4452827404162814
LS411N,702558,5.325144902608101,3.805331333898009
MOLM-13,969516,1.839627080728713,2.2196277890206777
IGROV-1,50905018,6.092412272559071,4.44937114132383
SaOS-2,5311,1.6246857228566176,1.4629528442473847
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816,-1.8976079160009198
BICR 31,11178236,-3.7191700347439176,-3.090675548532579
IGROV-1,16736978,0.1982875499977011,1.8999857577282335
HEL,54613361,-1.063581606127445,-1.3211546953890303
LS411N,409805,5.900990799691521,4.067578597954956
RKN,44819697,0.8547407464301948,-0.18148334476346695
SaOS-2,7326481,3.920515261577408,2.9655340122006386
HCC15,135411,0.5020362424433897,0.8118638215844284
SW1271,135875424,3.8663800475620542,3.8509700859518454
SW948,5281321,-2.986965028390854,-1.7842548713305881
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622,1.222691789688331
ALL-SIL,16722836,0.4684239096852854,0.6352101296271823
BICR 22,3384730,2.588423009806214,3.155490216473574
SU-DHL-1,5282054,2.781862093779865,3.650730985477829
COR-L105,10385095,2.1444085139831643,1.3727176913383388
Panc 02.03,409805,5.9877775932277615,5.097100047250385
RERF-LC-MS,11707110,3.327368501952155,-0.04647101799788961
Daudi,46199207,1.9328464692742409,2.5387111535202
SK-HEP-1,9907093,4.5474965014619455,4.310681171903352
NCI-H2452,6918736,-2.096990091914002,-1.7429203408797784
SW948,25062766,2.473025838261029,2.1637678720778792
SW1573,73707398,2.4757839790774123,1.5570746294136637
WM115,19582717,5.070140237856123,4.533430961981408
LCLC-97TM1,9926054,1.7367616025320842,2.158199333935375
Granta-519,46907787,0.1510211143130647,-0.44607562801133943
HCC1500,JQ-1-MK-0752 (1-1 mol-mol),3.680434993229653,1.0636010414891832
Daudi,9866186,0.2429325896096028,0.10407126223398824
HCC15,19582717,3.4575202036464665,4.286649121289035
BICR 22,3136844,4.306912771504561,4.165695934950532
PaTu 8988t,15983966,3.5024124287376477,-1.1865221561637143
WM115,24964624,1.5810045411950775,2.2648249731762298
Daudi,5335621,3.7832010435602568,4.010476639236172
KU-19-19,selumetinib-PLX-4032 (8-1 mol-mol),2.356754737959246,3.3012026644193355
HCC1500,67156097,1.177976655162538,-0.4565876150130801
LS180,6918878,3.4964027843545775,2.904470476688751
MOLP-8,4096211,1.580191863417666,1.1960727720911106
P31/FUJ,6252,0.489412050489878,-1.360552942400981
RERF-LC-MS,6505803,-0.6931241555509828,-0.43134102955592035
IGROV-1,24821094,1.720998716331183,2.2343519357935895
BICR 31,5311,2.2783252682939876,1.538924668799253
K-562,6438330,2.2742899368871123,1.8021872571705437
HCC15,71466578,3.4480874510133708,4.735922353121717
RKO,5566,3.2270609816668308,2.8508899169134416
MOLM-13,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0183785057987459,0.8612871465657419
Panc 02.03,24785538,2.724480470289088,1.7869131104624125
Granta-519,3025986,-4.58955813375105,-1.647259086416479
BICR 22,6918837,-3.531862368916405,-2.4870662964092505
MDST8,25262965,-2.668035259531665,-1.0240579909383336
IA-LM,5329102,2.7310604185474654,1.9240115084152796
SK-HEP-1,3385,5.476337571299632,4.251255549108053
LS180,16722836,2.063998190370722,1.6818156287970172
HuP-T3,tanespimycin-gemcitabine (1-1 mol-mol),2.6296169541858694,-0.5950777377100992
LS180,2749,2.025296960861402,1.8904172114966231
WM115,25262965,-0.2525217612691299,-1.2865557791113162
PaTu 8988t,5287620,-2.232870102756846,-1.9875160134120895
BICR 22,1641662,3.554805763515046,3.4379523076351344
HEL,11152667,-1.5416892011653274,-1.8337178942386914
COR-L105,doxorubicin-navitoclax (2-1 mol-mol),-0.4088475134066937,-0.6758630833027358
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386,4.0849454935567735
Granta-519,9907093,4.568904425758597,3.382225998192068
HuP-T3,56946209,-4.563482636842077,-3.931612250580853
COR-L95,2126,5.99033959567007,4.021665016784363
WM115,216239,1.6966934324307903,2.475878014056511
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837,3.2236822151588442
BICR 31,6918837,-2.993188010662521,-2.4616914469613262
WM115,3676137,5.1484929308777225,4.454942826529285
COR-L105,5113032,4.587192003158758,5.082073630858079
NCI-H2452,23635314,-2.1133256000938596,-1.8286218205206342
RKN,9887053,4.324470541002337,4.130454159781984
RCC10RGB,11427553,3.4421917630858387,2.8939625650193226
SK-HEP-1,3025944,4.243935374614092,4.329963174354523
HEL,613753,3.431831043675297,2.8344796495958233
LS180,navitoclax-birinapant (1-1 mol-mol),0.3756173230443141,1.6340943965867039
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642,0.8524616410419675
WM115,6450551,3.3231751041078086,2.8422830092688214
LS180,11178236,-2.7486494175863703,-3.039611313916343
SU-DHL-1,53232,0.8595699071174782,2.669065531712036
LCLC-97TM1,2742550,3.525188493197443,3.6037235114550814
Daudi,1716436,1.8661291896859675,2.289341277626042
SK-OV-3,11964036,1.753508425012185,1.4648308664720275
LS411N,10385095,1.4098978051841675,1.241196675926469
P31/FUJ,54613361,-1.6350280742113157,-1.0439560667612018
SU-DHL-1,638278,2.888532213305057,2.971385189091817
SW48,11228183,0.7765992306729816,2.4278704819769485
Daudi,54596558,3.73872893191344,3.9435626273685243
IGROV-1,44543605,3.88270235241076,3.6668230214493702
SK-OV-3,16722836,0.9083609759186712,1.69035390914045
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102,2.8928058863193358
P31/FUJ,168313047,1.7496121138347704,1.6230659797261606
RCC10RGB,969516,5.025939213907113,2.9481540567302598
COR-L95,tanespimycin-gemcitabine (1-1 mol-mol),-2.183473735098961,-1.5402108268224521
Daudi,selumetinib-MK-2206 (8-1 mol-mol),2.382051987434729,1.4683998586663358
HCC1500,crizotinib-PLX-4032 (2-1 mol-mol),2.666541156679824,1.9234408472586555
LS180,11507802,1.428529607587261,1.683651139370976
SW1271,2746,3.8382249001906814,3.1281729933920097
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417,-0.7720462835687631
SW48,6918328,-0.3603149144304291,-0.1261729961306205
RKN,11214940,-1.342915177510304,1.744913097601761
NCI-H1568,24180719,2.911739165396745,3.5158250566643146
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391,1.3872265528835093
K-562,11234052,2.2960989815513013,3.418933108662464
SU-DHL-1,107970,1.234326472603969,2.226053350963981
RERF-LC-MS,5280436,-0.2566098032119844,3.685348708842201
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814,3.1767598930292693
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482,1.6402276777110285
WM115,6184667,1.9705044508079528,3.3173504071474116
P31/FUJ,26596,-2.2448149587984836,-2.6226484181190144
RCC10RGB,216345,4.504390062805713,3.806313812396995
WM115,3634881,2.5774509186458183,3.136044884007888
COR-L105,5328940,1.3778120925573558,1.741577317943567
NCI-H2452,135440466,3.051805385291023,2.2554261251363723
P31/FUJ,51039095,1.7212337572708742,2.1666254220744867
Daudi,135398738,3.444692827115736,2.0563371110004325
MDST8,753704,4.923832713886697,5.10067643621775
Granta-519,23725625,1.8582588361990624,3.361567125597127
IGROV-1,6438330,2.7487580937365683,2.5352764823954432
BFTC-909,51037431,4.63288955594681,3.232652419692987
LS411N,262093,3.2594677855419456,2.178197943967446
Daudi,12001922,0.8334324910861088,1.5809389404952296
LS411N,10074640,3.3220574057236876,3.085278776432383
COR-L105,6438330,3.2365890454650867,2.6255185265259957
LS180,3689413,1.3392854552239355,0.20279582618347128
IGROV-1,53495165,1.3981720287668329,0.08994447760918821
RKO,10296883,4.075814636405189,3.0419902544524717
MOLP-8,24951314,0.5243645664323562,0.4407053943156764
IGROV-1,25126798,3.9275606774720817,3.756445003546894
BFTC-909,5281321,-1.6266730162675118,-1.3523017107207258
MOLP-8,123631,3.0356710048833446,2.191266409692636
LCLC-97TM1,selumetinib-MK-2206 (8-1 mol-mol),2.0492378318223508,1.9851381220149356
PaTu 8988t,72193861,1.5880501840541692,1.915602349941567
COR-L105,JQ-1-MK-0752 (1-1 mol-mol),0.9583306241234884,2.2280101236683962
MOLP-8,2742550,3.824247044326815,3.360892684255033
BICR 31,10074640,3.67367044204876,3.224711327179568
UACC-812,1750826,-1.5614417963348088,-1.2617406652526444
LS180,9907093,4.718701288752834,3.980187531712155
BICR 22,25062766,1.615874512669176,1.796939134734924
NCI-H2452,6852167,1.5258165813873172,3.1713079434266978
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155,1.7079281679923968
PaTu 8988t,52912189,2.515835026596807,2.5657050584896375
KU-19-19,9935249,4.318045076797651,2.9930896722706257
KU-19-19,57330099,3.159149106170822,4.465205779419392
SK-OV-3,17755052,2.097752569372091,1.8821584734006986
SK-OV-3,73707386,3.7899266428434233,2.4281563323224713
HEL,navitoclax-PLX-4032 (1-1 mol-mol),-1.2293549578890797,0.3211834586854364
SK-HEP-1,216239,1.5998975447874937,2.199873411215831
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488,-3.8257817489617474
RKO,3689413,3.093382349703003,-1.0757687066967976
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024,1.1832360502888386
K-562,44819697,-0.9868024060185686,-1.6241503869694656
LS411N,322968,4.732979049951269,2.7942997496573025
RCC10RGB,3689413,-2.0864832427963336,-0.38520687674816484
MOLM-13,BRD-A02303741-carboplatin (1-1 mol-mol),3.787495781999856,3.6997080759613516
COR-L105,409805,5.8843358134901775,5.169837571296274
ALL-SIL,11404337,-1.8413362349398936,-1.709512431854699
Granta-519,135398738,2.4818536310203587,1.9586308304651399
IGROV-1,10385095,1.0670946713416192,1.3194036582551225
KU-19-19,5311,0.9327005340349652,1.556022776215223
MOLP-8,6438330,1.5207659246126146,1.4566145062392786
SW948,5351362,1.282672018702937,1.4912351325553557
HuP-T3,54626689,4.821166418142214,4.676191756509857
HuP-T3,16013152,4.473149012747972,4.265618015254527
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054,1.0100878588005748
RKN,67156097,-0.5718675734992968,-0.9260124663933753
IA-LM,241158,3.7495123409873528,2.965019682677781
LCLC-97TM1,644241,3.02487415997038,1.878862536820173
NCI-H2452,9823820,3.552631474664052,4.305210064699988
BFTC-909,2749,2.0212973698927184,2.2030570951809603
Daudi,9956119,3.1347708383856827,2.782404920249972
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.18927059153970974
ALL-SIL,136227924,2.439460537978413,2.219192016010014
HEL,44507138,3.4784823626806296,1.6356083093506932
Panc 02.03,3634881,5.203302993958793,3.4521751665098592
HCC15,3038522,3.407637609998807,3.228221909788076
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834,1.3744511536762298
SU-DHL-1,5311,0.6388765020007606,1.5968836600167444
RKN,16038120,2.2721636156695357,1.1053395090608213
Daudi,6917907,-7.619939635694887,-5.110260844313668
MOLP-8,3385,2.1758430637220334,2.674387616899183
COR-L95,2749,1.0184502693195283,1.2790181924686213
BICR 22,56946209,-6.158851096198738,-3.81372277139662
SU-DHL-6,72193861,0.720057034069739,0.0832851596254147
RCC10RGB,122327,5.581829763733156,4.807781844738442
Daudi,5284329,2.65655795986699,2.110838342475114
WM115,72376,-0.2019485443349478,-1.3680389097367454
HCC1500,4378219,1.8377088226049565,2.470683646399482
SK-CO-1,246676,3.87632071272349,4.345577784482066
SK-HEP-1,docetaxel-tanespimycin (2-1 mol-mol),1.7150600920964667,-2.576364559578802
IGROV-1,57519531,2.639098862164858,2.6533642835309985
P31/FUJ,serdemetan-SCH-529074 (1-1 mol-mol),2.3029277371957884,1.1066298226529705
MOLM-13,1714884,4.557672503718371,2.499850518453575
MOLM-13,JQ-1-vorinostat (2-1 mol-mol),-0.8524574918693427,-0.48093356045165214
Granta-519,72193861,-0.9369484536210768,0.2572674143913043
RKO,5311,2.326095881991792,0.6924661501740269
SK-HEP-1,4521392,4.36382839215776,4.299142589819515
COR-L105,3062316,-0.8702764318143076,1.3286806719492632
COR-L95,387447,-4.370301659619954,-4.778457946089131
COR-L105,10231331,1.4114577114599935,2.54864075350301
SK-CO-1,637858,1.8597515079418403,2.1434696696343596
SW1573,5282054,2.2636648441362417,3.770723706634085
K-562,66577038,2.461713560075674,2.5884728359740183
Panc 02.03,984333,0.8671961837803726,1.0920306382502967
HCC1500,9967941,2.192170342398577,3.3709035101496125
NCI-H1568,5281672,4.0091617833462125,4.652918738669889
K-562,11640390,3.4084234644631244,2.4523530969346927
SW1271,60750,-2.442139934484719,-1.3551639587447621
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762,3.4190425424190094
MOLM-13,24889392,-6.717782140097413,3.2410141359953375
Granta-519,11364421,-8.40665244505035,-4.370082657804222
LCLC-97TM1,11612883,2.215690343731866,2.362880043529949
ALL-SIL,serdemetan-SCH-529074 (1-1 mol-mol),2.0214253699045392,1.3290742505066009
PaTu 8902,1566236,3.6887913704860535,2.3501076181796954
MOLM-13,16741245,4.189200129622084,3.4655457579219564
SW48,6184667,4.015043076320991,2.726583236687805
RERF-LC-MS,66577038,3.051572744120707,3.0399829245665244
K-562,71304818,1.450074212827562,2.175168082745226
RCC10RGB,44489675,4.041451654117508,4.177224623644942
LS411N,navitoclax-birinapant (1-1 mol-mol),3.012697957688565,1.3515204174391369
SW1271,10074640,2.938380325815859,3.167649761874507
RERF-LC-MS,11626560,1.1998891680987491,2.0891840959152574
PaTu 8988t,81146,4.470184859000855,4.676833042078684
HCC15,11178236,-3.9629964965138584,-2.9530148464069104
SW48,navitoclax-pluripotin (1-1 mol-mol),-1.096538281516441,-1.1330348282062481
HCC15,11317348,1.1767586352696475,3.1958424877246925
P31/FUJ,9903786,1.0734919883099745,1.9990322179705913
IGROV-1,23582824,0.3287266354391525,0.519073881444238
Granta-519,3465537,1.1430845598370274,2.294101922004368
PaTu 8988t,984333,0.9294993195358888,0.7848561669484188
HCC1500,11396600,2.707080690171913,3.797262935010545
NCI-H1568,6252,-1.964470857288188,0.7821628354225041
NCI-H1568,7251185,1.379011815458227,2.6643383753220458
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106,1.6871838301614361
LCLC-97TM1,55508,4.820744956173848,3.1786951182687364
PaTu 8902,9903786,4.041497343746548,2.7047867792923093
SW1271,12001922,2.1604198968714754,1.8874121738753666
HEL,6505803,1.212867497705534,-1.1384271148870793
SK-HEP-1,216345,4.108495190728752,3.900288242105142
WM115,4705,2.3860154683324897,3.131999749050973
NCI-H1568,JQ-1-vorinostat (2-1 mol-mol),1.325801474857881,1.3425322154349948
COR-L105,126941,-1.5036718028706904,-2.2024722432790695
PaTu 8988t,9926054,1.9241127892750265,2.057821096354002
SW48,tretinoin-carboplatin (2-1 mol-mol),4.556026920056554,4.643027726591707
NCI-H2452,navitoclax-MST-312 (1-1 mol-mol),2.3760907472780137,1.090473463068036
SK-HEP-1,374536,4.396616434658188,2.782128266725161
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.641996951577207
NCI-H2452,208908,2.397298909776284,2.067393866813798
SW948,24821094,3.757524617053942,2.4936037490255796
K-562,44491742,3.373435641850853,4.04060442701328
RKO,24180719,5.308193040989237,3.1833056674552216
MOLM-13,56946209,-5.150374128805616,-4.801448256041836
MDST8,54454,0.3151053774213321,2.449915222386998
Daudi,969516,2.18084937908482,2.0825555935347
COR-L105,44607531,0.2442604090297878,1.6537944267670681
SaOS-2,54619267,4.116373312960232,4.2001319993595025
MOLP-8,44607531,1.2227606502433142,1.092319345771481
ALL-SIL,11427553,-0.6859128537837271,0.9934902074483389
NCI-H1568,11427553,2.9296384487881166,2.851835096760217
SK-HEP-1,6918638,1.490993863020431,0.6404546069539729
K-562,11175137,2.6421325977097663,2.0059521496657244
MOLP-8,25126798,3.554030345273679,3.3752601235479402
MOLP-8,10427712,3.937375048887725,3.8893049086734504
BFTC-909,11404337,0.4468911705694049,-0.05454660008470483
Daudi,19582717,2.1579117268337975,2.9429220475091067
SW1573,9936388,3.0507391751654698,-0.5391867898430514
SW1271,156414,2.097129180606755,1.5803183374333658
Daudi,11213558,0.7122197709980888,1.2427534526360817
MOLM-13,135875424,3.721528356214304,3.171306949695229
LS411N,3062316,3.313525141236135,1.0813661572609106
Panc 02.03,6438330,3.381062774421129,2.3233441137808897
MOLP-8,4705,2.7848528520877727,3.0641607843519036
SW48,675434,5.164587034175743,4.48786123565439
NCI-H1568,46215462,1.5662565779678703,2.017723982422097
BICR 22,23635314,-3.9149935419765423,-1.2915723914805368
NCI-H1568,44607530,0.8979533446197012,1.7081146491121584
BFTC-909,89928392,2.1120581393996116,1.634915582941556
NCI-H2452,8515,2.9816658051225344,4.194148372229686
WM115,252682,5.883677253194902,6.56777247893117
SaOS-2,11507802,0.9759404440699744,1.2611172197785354
NCI-H1568,9935249,0.3822057580098375,3.1405765698911834
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321,1.866760136978819
SW1271,65628,4.408026608161547,4.264983905305378
MOLM-13,2742550,3.0943449980031845,3.3092505835214165
HuP-T3,56973724,4.820716068374067,3.3697448527803915
P31/FUJ,5328940,0.1000739186855886,0.6243289751131585
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747,0.620139236359243
KU-19-19,9967941,2.4242338826427794,3.839835327552326
COR-L95,selumetinib-decitabine (4-1 mol-mol),6.271791154986272,2.4501630115592636
SK-CO-1,5328940,2.280320557186381,1.5953894209232267
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128,3.0106252273895704
COR-L95,1716436,2.176954941746147,2.7137955226762687
MDST8,46398810,3.011862004714757,2.5350401850573734
SK-OV-3,654092,-0.1739817534251795,0.010760049898570484
SW948,54613361,-2.2535675944820084,0.12222071460196346
HuP-T3,25154868,5.141210696949765,4.546755639614364
SK-CO-1,selumetinib-PLX-4032 (8-1 mol-mol),0.4034815942312452,2.792648632544457
RKO,124202324,3.4391315101947386,1.2978407819721465
RCC10RGB,9444,4.509247284467684,4.176602856045639
P31/FUJ,135421197,1.0144502005310674,1.0296412362780563
MOLP-8,44487872,4.385798937588512,4.185956030381362
PaTu 8902,448949,2.6032868845304606,2.1143625466291156
MOLM-13,11427553,-2.505370137631637,1.4559379901739353
IA-LM,60750,4.549488262081028,-2.296699827091106
MDST8,3825829,4.752817875520721,4.209206350213405
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937,0.8966433289413994
BICR 22,navitoclax-MST-312 (1-1 mol-mol),0.8152867092510746,0.8576179303569359
COR-L105,51037431,3.876010066295024,3.26791270900535
RKO,31703,-1.8438289452025527,-1.6212187534452709
HEL,5978,-0.5240559956879017,-3.2643364220308233
SW948,168312962,3.6749765666335903,1.5602278071722073
IGROV-1,72734382,4.633226130326536,4.630833827302233
SW48,216468,-0.1130169029097753,2.9388627912150516
HuP-T3,216345,4.480282764347718,4.124717902565809
HCC15,439501,0.3030845703669018,-2.035260991087724
P31/FUJ,638278,2.9129004591727057,2.610121502309645
BFTC-909,676352,2.5282943369079818,2.1631677491574823
SK-HEP-1,60750,5.759979022694095,-1.7055879668931357
PaTu 8988t,4788,6.262210396704686,5.5472049086016115
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759,1.4996966971873706
NCI-H2452,doxorubicin-navitoclax (2-1 mol-mol),-1.0690798948484177,-0.9959515654822816
HEL,24951314,0.022330385445513,0.5242267725000871
MOLM-13,46907787,-1.536709398859376,-0.6107666525154746
SaOS-2,54626689,4.533352391847383,4.467677127172552
RERF-LC-MS,10410894,3.034247655874134,3.326228815662479
RERF-LC-MS,9903786,2.6182355767545213,2.868834737044454
IGROV-1,107985,-2.8971910842184516,-3.5631163357774773
WM115,10231331,-3.458943295987183,1.5022743678607453
Daudi,71466578,1.924283792281082,2.72027000818059
KU-19-19,6610216,4.876021689690227,4.383059255869078
COR-L95,6918736,-0.04136223528326,-1.3447350616040348
MOLM-13,11625818,3.232701320691832,3.458757068992197
Granta-519,16038120,-0.1772437220791911,-0.01209599644757637
BICR 31,46907787,2.190433361645711,2.473435516715886
Daudi,702558,3.2750017094913657,3.689137794474837
MOLP-8,24856436,-0.8263886484359759,-0.1680834185491654
MOLP-8,135440466,1.6989907480456066,1.791956919533122
SK-HEP-1,46843906,3.844316747572769,3.2495520288659376
RKO,54626689,4.750442055573677,4.511630578459473
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684,-0.5011145080021437
IGROV-1,11717001,4.394306548697183,4.031814091435114
Granta-519,5291,3.886616753428741,3.19059336841484
HuP-T3,vorinostat-carboplatin (1-1 mol-mol),4.326832101925159,3.2340947914679816
SW1271,262093,2.7991981503454495,2.8719649036230965
Granta-519,1566236,1.1036082649410253,1.406151359993709
BICR 22,24753719,4.1427183131543615,4.07335584923792
Panc 02.03,9926054,1.881153725115377,1.9421684494106202
HEL,selumetinib-UNC0638 (4-1 mol-mol),4.439373718009897,2.1936981822369335
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523,2.449884123078948
LS180,54619267,4.074522434074431,4.050019029998575
SK-OV-3,5281321,-0.7098099698865428,-1.0867472076655271
BICR 22,selumetinib-MK-2206 (8-1 mol-mol),1.8488971729777937,1.936586499683579
SK-CO-1,2729026,2.8886798476744246,2.5749085648743097
Granta-519,23582824,0.9303240666722092,0.4696025059655264
HuP-T3,JQ-1-navitoclax (2-1 mol-mol),2.3872748820971217,0.9836087934759888
WM115,24978538,1.155471911978994,1.4441572136160477
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147,-1.0021560305786137
NCI-H1568,11238147,2.925799577076833,3.1735139033064343
ALL-SIL,135398516,1.5622324093538014,1.2686251254671113
COR-L95,135659046,3.614564650544248,3.6905715345452488
SW1271,1285940,4.280510054640018,3.4883754861959995
SW1271,6505803,0.8186340021888412,-0.17549540519133638
SK-OV-3,SNX-2112-bortezomib (250-1 mol-mol),0.4595025269763413,-0.7950843482457869
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023,1.228567721854447
IGROV-1,11626560,1.7276653519578558,1.906434261660973
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467,2.4796451770965855
P31/FUJ,3552672,1.950832295752278,2.5728284533449592
P31/FUJ,67291369,0.7371006748241407,0.497336835368202
LCLC-97TM1,107970,2.3018486004849907,2.1142254332462507
SK-OV-3,44607531,1.947967745365508,1.4795961060945992
BFTC-909,9936388,1.702123766125507,-0.7376052335685181
ALL-SIL,8515,1.9161675301812888,3.291816983522151
LCLC-97TM1,25262965,-1.937189863749451,-1.4024271501501913
HuP-T3,ISOX-bortezomib (250-1 mol-mol),0.144245152578182,0.6388992822340247
MDST8,6914657,-1.2463021469195388,-3.5502758091252895
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481,-1.5045089114292378
HCC1500,53392493,1.8683885031226253,2.546060286967628
MDST8,135411,0.5541309628089411,0.8799817127251157
RERF-LC-MS,1750826,-0.5689233588179538,-0.8251376339683917
LCLC-97TM1,5328940,1.525932870405189,1.6626084502463547
NCI-H2452,25195348,3.541594611208225,3.458718797654397
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517,2.6189486153951185
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507,1.277823551992176
SaOS-2,53495165,-0.9847313398251484,0.24738962102270612
SW948,11626560,1.2721393744446543,1.1320053790711508
LCLC-97TM1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2417811136372243,-1.0408395943249833
HEL,25183872,-2.1054192111007657,-2.059290441608017
RCC10RGB,89928392,1.8749323034057075,1.7995284707488808
Panc 02.03,10074640,3.562403354758929,3.178853143811466
PaTu 8988t,57519531,4.351537289113079,2.5140658310564716
SK-CO-1,5281321,-2.128194299198524,-0.8197097699577256
RERF-LC-MS,5311,1.7201713868016182,1.8149103420838748
HuP-T3,11427553,3.1840600229712037,2.970860028786414
ALL-SIL,4259181,-1.3200126273341632,-0.6779170391232923
HCC1500,11214940,3.550811671890936,2.196725308788484
NCI-H2452,navitoclax-PLX-4032 (1-1 mol-mol),2.336639386671478,2.5450389936516427
HCC1500,25195348,3.452030504957034,3.3446736918905007
SW1271,52912189,0.6284206808713965,2.42121922687425
MOLP-8,984333,1.0413549547234568,0.22574602351708034
SW948,72734382,3.6940713099503473,3.983606279189713
IGROV-1,46943432,4.105714883822214,2.5151388106769543
BICR 31,25227462,0.4256700478941367,0.6331215415250612
SaOS-2,2126,4.6809882623674905,4.544286757821647
SaOS-2,11427553,2.020035940690151,2.675211136270683
MOLM-13,6914657,-6.22505002098335,-5.1461716460902664
NCI-H1568,24964624,2.125017418877952,2.43675492603021
HCC1500,11497983,4.502799578122533,4.035560894030431
K-562,23725625,5.2530061405843975,3.680884109766721
SaOS-2,salermide-PLX-4032 (12-1 mol-mol),4.26549663284579,4.899286915143019
RKO,136227924,3.256787131627037,2.661175342002855
IGROV-1,31703,-1.792518264692263,-1.1787007036545836
HEL,6438330,1.7062913765539824,1.2262863563817268
RERF-LC-MS,25126798,3.475546322259903,3.9575179054742846
LCLC-97TM1,409805,4.11204743963536,4.330237564261001
Daudi,2708,2.1654486353587266,3.2670695576433832
SK-HEP-1,6914657,-2.911576812343612,-3.656672747821968
MOLM-13,36462,-3.0478349617512466,0.1176396527934479
COR-L105,208908,1.1794902635628597,1.9714413552932288
MOLP-8,44491742,4.067907034019371,3.7009562160571106
Panc 02.03,89183176,4.957506748320777,4.739997735578785
Daudi,3025986,-1.684737909075286,-1.5669466727678871
PaTu 8902,10302451,3.9687769441396608,2.867292970730531
PaTu 8988t,9933475,2.2874108911255693,1.8716082650827692
SW1573,5281321,-2.072955292880288,-0.7406653465989714
IA-LM,2733526,5.6911514373146135,3.6543791577611007
Panc 02.03,6918837,-1.2317043962492993,-2.403668660403711
NCI-H1568,19582717,3.4209569673427342,4.284329712525228
WM115,55508,6.132181701054794,3.368715358143585
MOLP-8,2871966,-0.632569947519592,-0.2362003488210715
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216,2.4368533045304765
MOLP-8,decitabine-navitoclax (2-1 mol-mol),0.2255247501063145,0.0527337255204551
HEL,6918837,-4.248380638359999,-4.6016822364908565
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015,0.4184970468524113
BICR 22,136227924,2.105383482893856,2.9167287755221354
SW48,135875424,3.469184081134181,3.3413169188280665
COR-L95,10127622,5.649647064343883,3.5450408598740224
SU-DHL-1,60750,-4.603947913298721,-2.183910890530706
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117,2.6719357389325595
SaOS-2,446155,1.978878402700164,2.5009738984013694
Granta-519,tretinoin-carboplatin (2-1 mol-mol),6.438903911502162,3.572047226155932
SK-CO-1,11625818,4.187860927408271,4.418617454981893
COR-L95,676352,2.06388279354012,2.2112754821703833
RKO,11719255,3.406006587740275,2.360343209039621
NCI-H1568,135875424,3.0063280878885967,3.843208036747258
IGROV-1,25195348,3.0698662305180275,3.2873939011246556
RERF-LC-MS,16659841,3.453543705685564,4.0324886809686475
SW948,1641662,3.2658822910658905,3.192792063782447
BFTC-909,5351362,0.3148685714677321,1.5141079148706234
COR-L95,24771867,5.320672645408192,0.684330482311374
NCI-H2452,16725315,3.1677771909290184,4.288561558805192
WM115,9926054,3.0880179510914454,2.0657376043239672
IGROV-1,135875424,3.3275053166921347,3.4071676982335175
LS411N,4259181,-1.386635238211632,-0.19227952724102043
SK-HEP-1,24821094,3.809459846332286,3.4381360840539217
P31/FUJ,tanespimycin-gemcitabine (1-1 mol-mol),-1.9905845316732809,-2.0872086853990894
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326,3.746039618334296
HCC1500,11364421,1.8102576985092016,-1.7631216155914544
WM115,11647372,-0.748702419415335,1.2351840944565091
IGROV-1,374536,0.7022324251593053,2.441048546590101
K-562,5311,0.9288629076778604,0.6695964486077287
LS180,navitoclax-piperlongumine (1-1 mol-mol),3.251687407924036,1.3207712186086338
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088,-0.04013799826695374
Daudi,44607531,0.7322116783883826,1.1744878979860087
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564,5.748719033232784
SW1271,448949,2.9810988383972084,1.9753547381286038
SU-DHL-1,42642645,0.6641769458510169,0.8264734337304794
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582,2.456928298893128
SW48,53232,2.98078944705874,2.684107426282755
K-562,4096211,1.5585244853649294,1.0597787694954857
LS180,89183176,4.9114720653238315,4.275940398841307
SW1271,10427712,4.007366682408904,4.155540466687753
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008,1.573438289112414
SK-OV-3,72193861,3.227068856168802,1.766750151032426
K-562,148198,-4.073315546446919,-3.967599165073702
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564,-0.90625860935991
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331,-0.6721656229722954
SW948,2729026,3.020599067804879,2.524039927155375
SaOS-2,3552672,2.445112397338648,2.9036284943699555
K-562,6918638,0.0740833242167517,-0.1294393735912062
HCC15,67291369,1.6613409933263477,2.7739322089695464
LCLC-97TM1,11396600,3.6456493290211425,3.4596511290692864
HCC15,6438330,2.907250953014235,2.2754819944737594
SW48,123631,-2.3971553119638553,1.9567247624962858
RERF-LC-MS,6918638,0.4520678244574614,0.6429986241876641
HCC15,54619238,5.509074276782743,4.784912261229734
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716,3.148397820159171
Granta-519,5351362,0.2173676915670352,1.063802775863734
SW1271,219104,3.9142621703193625,3.7944666867454124
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984,1.5434980687428237
SW948,11497983,1.2110688984787443,1.2159010504117918
Panc 02.03,11404337,1.528571500956484,-0.3055487302597982
SK-OV-3,107985,-2.353051363092625,-3.3450301657332715
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333,1.664220536412121
HCC1500,56649450,4.199956636233384,2.868151058703183
MDST8,54649381,4.2434412709491385,3.7669686873135744
SK-CO-1,24772860,-2.764468608226056,-1.530714088419992
SW1271,2708,3.697662973501111,4.84832723220137
COR-L105,25062766,2.3512127388642865,2.165157300075452
BICR 22,9826308,0.9832071992526458,0.610283220990222
SW48,navitoclax-piperlongumine (1-1 mol-mol),1.2226780800612655,1.1209463625291114
KU-19-19,11404337,0.0275069311149896,-0.39721604991998155
LS411N,decitabine-navitoclax (2-1 mol-mol),1.6875581183367745,0.9866750467280793
LS411N,452548,1.178688753001054,-1.3698476632664913
COR-L105,3025986,2.299444367217184,-0.8109200783193695
IGROV-1,25102847,1.7007012555618253,2.4355691759406506
PaTu 8988t,24797083,1.3448554408655904,1.312372512265517
IGROV-1,46398810,2.003787621940583,2.597438564976159
SaOS-2,2749,2.484303950908632,2.0130386512552123
WM115,7251185,2.999080033015298,2.6287016975890674
IA-LM,151289,3.753931026261757,0.8341512737782943
SW48,60168763,3.2354609354554924,2.891946471730688
IGROV-1,168313016,4.807199318661473,4.995411869306033
MDST8,5351362,2.4401541198795726,1.5738386379020284
RKO,5291,3.391339544898264,3.330595167302127
LCLC-97TM1,23582824,0.7435680585464137,0.8845506236575699
BICR 22,16725315,5.207801943730372,4.163844960672439
HCC1500,44632017,4.723480031494906,1.3456912724484966
MOLM-13,219104,1.3929442819191806,2.3642964911619573
SaOS-2,44202524,1.4210473732360835,1.938318845192792
COR-L105,753704,5.105702577689745,5.143135464646811
BICR 22,216468,1.2752332856392885,2.95669691595161
RERF-LC-MS,445643,4.345437949323675,3.8363764511360863
BICR 22,selumetinib-UNC0638 (4-1 mol-mol),2.123491609761504,2.654588689269629
HuP-T3,44607531,1.7591062122540748,1.3888898484296446
NCI-H1568,9915743,-0.8427224057935273,1.038359192914814
ALL-SIL,126941,-2.455728969669062,-3.676573438305458
IGROV-1,168313047,1.93821625738322,2.410643652173757
LS180,100016,6.005443229591697,5.961884881209843
SaOS-2,60700,-2.625519230364934,-0.4708355554791303
KU-19-19,9907093,4.38040739031281,4.208217321689484
SaOS-2,9935249,3.097116977919543,3.2732109851233107
COR-L95,24821094,3.5692160345671335,2.809283006642559
Daudi,327653,2.694862581871668,2.3114985959832532
SaOS-2,65628,4.208345318362158,4.441673911226147
SW1271,navitoclax-piperlongumine (1-1 mol-mol),2.304332277449707,1.6545817711349773
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647,-0.17621738420872435
LS411N,24772860,-2.6286287692739587,-2.1039928149922122
HCC1500,15983966,1.4595203856942676,-0.7394716852790423
COR-L95,46907787,3.807595772412777,1.6390186199439927
BICR 22,24821094,3.82687279949815,2.0826628346350344
RERF-LC-MS,56946209,-3.4945734927118552,-3.6055993106256476
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,0.86556764818651
MDST8,49793307,-1.5088082080905487,-2.2650074829819347
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415,-0.6675700851142371
SW1271,159324,2.241950485620868,3.3029771008128193
LS180,doxorubicin-navitoclax (2-1 mol-mol),-2.003067068648065,-1.0394079159295988
HCC1500,135398516,0.4161092034804287,1.910489705382945
Granta-519,46901937,3.6488183223471022,2.090208669642876
RERF-LC-MS,5328940,2.240356815676024,1.7531363405074076
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062,1.5254621021175248
Granta-519,400769,-1.7592122365530554,-1.3032617704830236
BICR 22,135421197,2.0438055763788556,2.3054006834307286
BICR 31,9967941,4.3746614656618865,4.15135405905771
Daudi,89928392,0.010222000273875,0.24448159801119876
MOLM-13,151289,-0.2275053531847663,0.42302455930301086
IGROV-1,2874250,4.893662837169153,4.403043996446582
MOLM-13,4261,-0.2853779042398361,0.24098236439184803
MOLP-8,5280436,2.785612173209183,2.909355651383203
RKN,11427553,3.6372919842764424,2.614767159841204
LCLC-97TM1,2828334,6.057082646440782,5.939435441881273
Daudi,11640390,2.7767455060282873,2.5086847718693606
SW48,selumetinib-MK-2206 (8-1 mol-mol),-2.489387055809161,1.6498902967933224
RKN,51039095,3.7797830340785694,2.686264688955478
HuP-T3,46398810,2.968900053185397,2.6709010019506256
SW948,60700,1.1260701186231294,-0.5307239722704176
LCLC-97TM1,168313047,1.50715487575417,2.438365308626064
Panc 02.03,46174525,6.272327915554807,4.628894005366933
SW948,72193861,0.8788999866892542,0.7612811416523855
HCC1500,6918638,0.5709126385335386,0.2923918242725755
RERF-LC-MS,42642645,-0.4358765804877467,1.2714919169327716
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153,2.0484698880343517
ALL-SIL,12001922,1.676377280214729,1.5307729761611546
NCI-H2452,441298,2.247705741320954,2.763849540229261
BICR 22,46191454,1.6809351488377804,1.6702014969989787
COR-L95,16013152,4.05038947229277,3.531334812871117
BFTC-909,72376,-1.4314875177558029,-1.5345304380770783
SU-DHL-6,15983966,-6.405792257227171,-3.789433080250632
K-562,11497983,3.839483588328175,0.8446011475234488
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417,1.5061298974898438
IGROV-1,4477,1.1767656777594142,0.5740973329488179
SK-CO-1,9444,4.465837668270579,4.1204672112511265
SU-DHL-1,135999136,4.730243036337901,3.4741650108964772
IGROV-1,54619267,3.9701367924453455,3.916677424866417
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457,2.813157903467686
SW948,31703,0.6983000463207195,-0.7689312709505254
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028,-1.1968667197420695
SU-DHL-1,BRD-K03911514,2.3803066372148742,2.716715880040172
HCC1500,46398810,2.5427546617930905,2.533439689342703
LS180,tanespimycin-gemcitabine (1-1 mol-mol),-3.220136839114834,-1.4391838435321458
WM115,51039095,2.786212621210589,2.7056109334597185
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087,-0.15041144833235015
HCC1500,24772860,0.2838196702204312,-1.6881903976432835
SU-DHL-1,71304818,1.6958772786188914,2.2077772346259654
WM115,16736978,2.885535594388376,1.6341222638933532
NCI-H1568,54618305,4.1006341963066255,4.6350648177758105
RCC10RGB,11404337,1.763382313076518,0.210211654614666
BICR 31,navitoclax-MST-312 (1-1 mol-mol),1.028775915948256,1.0431470118823627
HCC15,17755052,4.876160174226561,1.6528734341667422
COR-L95,6610216,4.601423414679649,4.027601415861882
LCLC-97TM1,10296883,3.762301074740285,3.569936204983366
Granta-519,753704,4.381381177541046,4.213111891724821
COR-L95,3825829,4.2210058836960265,3.696269484403448
HCC15,51039095,2.370618956781999,2.7648493344695737
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.5442292916999816
SK-OV-3,crizotinib-PLX-4032 (2-1 mol-mol),2.8845128579100456,1.8995138032286325
K-562,9915743,1.457381054045144,1.1423512567301757
Daudi,644241,1.4114598324864769,1.020244689855856
COR-L105,6610355,4.615259996363044,4.734189613858301
NCI-H1568,400769,-0.2296701698466811,-0.6333157361762409
PaTu 8902,4096211,3.3878786245174917,2.165278495865324
IGROV-1,6610355,3.969940996770339,4.287475353715852
NCI-H1568,15547703,3.0519937502167744,3.3048591583773366
BICR 22,11609586,1.2076158919216122,2.537373266515253
NCI-H1568,6918736,-3.5744965026463893,-1.4115917759464631
Panc 02.03,2729026,3.1511226959620715,2.767284942568761
RCC10RGB,73707438,4.14323951901879,4.0375843899293935
SK-HEP-1,11609586,4.257559552037769,3.054008000965524
KU-19-19,piperlongumine-MST-312 (1-1 mol-mol),2.2377116602988187,1.9428318540222569
WM115,9935249,2.3950107716018465,3.159790784648777
ALL-SIL,9929138,4.286241964174987,4.229436803465574
SU-DHL-1,452548,-2.7499107831448257,0.15712557870996394
ALL-SIL,JQ-1-MK-0752 (1-1 mol-mol),0.2899712696196563,-0.5305085742366236
COR-L95,262093,1.2094317801688714,2.2489013729067078
LCLC-97TM1,4788,5.877974617736734,5.714964884252163
LCLC-97TM1,11455910,0.6647050862050086,1.008105453420238
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829,-1.7142138090932584
IGROV-1,3025944,3.9702787396819503,4.289926796126657
COR-L105,44486219,4.2268301570583,4.393360368255169
HEL,6852167,2.7971477189216207,1.7059915333744167
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308,-2.597052130019798
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636,-1.334572934233294
MOLP-8,24753719,3.861578571306771,3.501143424961396
RKN,54649381,4.194319964969153,4.026933889103474
NCI-H2452,5738263,2.391583749104638,3.5830679804850525
RERF-LC-MS,11612883,2.474683430971872,3.068721158456465
LS180,67156097,-0.3004464994297747,-0.7443276707562189
ALL-SIL,638278,2.4844738615144797,2.609844075165774
NCI-H2452,navitoclax-sorafenib (1-1 mol-mol),1.6826538344111892,1.9641581620750896
WM115,89928392,1.4475546317176564,1.459512764148479
NCI-H1568,4917,1.9457015565482707,3.032495762542543
Daudi,2746,0.9195319579001202,1.7000593879233117
RERF-LC-MS,136227924,4.560045704487339,3.2948335371382256
SK-OV-3,400769,-0.3757443057400228,-0.43989020884286556
Daudi,2742550,2.6022450411597764,3.2651113555191245
SU-DHL-1,1242560,3.2887270842989285,3.4937243589108267
IGROV-1,1750826,-3.124548162001242,-0.7400359222419632
IGROV-1,3025986,-1.046010021597061,-0.6909139640271128
SK-CO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.3873903217982155,1.8890270956930078
COR-L95,11178236,-1.511835887926392,-3.0020711128485114
MDST8,15953870,3.886262261351445,3.724252234130405
P31/FUJ,71466578,3.434376258750051,2.716673922227736
SK-OV-3,navitoclax-pluripotin (1-1 mol-mol),-0.7992901012574275,-0.6888829532583962
HCC15,16038120,-0.3287102193479797,1.1712740489483788
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094,1.0083515363050133
WM115,44607531,1.8052962391610108,1.6774043124046238
SK-CO-1,322968,3.708989182542924,3.8063940588633147
IGROV-1,1716436,3.2816872421007375,3.072483195237116
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.351017181259088
SK-HEP-1,15953870,5.227718988850451,3.6966085129448256
SW1271,10231331,-0.1974856956768426,2.170088253463384
HuP-T3,168312962,3.781886601468438,1.9066322254471983
Granta-519,11238147,3.49055902156802,1.8184199623933344
SW1271,54678924,4.1367056407476595,2.421767677036091
Panc 02.03,89928392,1.630028817710481,1.8242143538488256
BICR 31,148198,-3.2373882564770513,-3.2059766125140094
IGROV-1,104842,-1.6690343627553987,-2.837050359366107
K-562,erlotinib-PLX-4032 (2-1 mol-mol),2.919036789421011,2.998094432391072
HCC1500,10184653,1.0749855490236058,0.5275036900953347
HCC15,44202524,2.021204517823952,2.4557738233309805
COR-L105,9866186,1.0648092573013754,0.7413293411633505
COR-L95,285033,-2.430535969260308,-2.5131241740619568
COR-L95,23635314,-1.8010937940640896,-2.1811719106274077
SaOS-2,11364421,-5.8107581348158,-1.9671118586764171
BFTC-909,122327,4.590877432942681,4.62254138951971
IGROV-1,54618771,1.2456991772210466,1.4879441890915153
P31/FUJ,675434,4.075878142833804,3.961964385196738
HEL,tretinoin-navitoclax (4-1 mol-mol),-0.5211961958831923,0.8423934176198601
NCI-H2452,5328940,1.966899609603824,1.730681059405447
RCC10RGB,72376,3.207429090732714,-1.341956203127113
LS411N,selumetinib-tretinoin (2-1 mol-mol),1.6361357934026397,2.373432439125138
NCI-H2452,4917,2.7944300449003907,3.2019060878543244
BICR 31,1716436,3.7157300626912617,2.9524738987449557
MOLM-13,1239801,3.478439984806631,3.102816704801808
HuP-T3,10296883,4.266239948990751,4.089410277984763
PaTu 8988t,107970,2.530920724052233,2.43241716848425
ALL-SIL,675434,4.0400251875066715,3.883349867428074
PaTu 8988t,16736978,1.6582336139520693,1.7680248800564016
LS180,5460769,0.3293841533128088,2.317505142282149
MDST8,11612883,2.4942536836786635,3.141575434812867
COR-L95,46191454,2.009346014708409,1.27885540604614
MOLM-13,451668,-3.798095624109847,-0.40252496429421364
Daudi,168313016,3.9002026806644734,3.7316604952792507
ALL-SIL,135411,-0.5620485907345016,-0.18452356662909392
RCC10RGB,46215462,3.684591481140594,2.2415353363885995
KU-19-19,4917,3.607977283390518,3.052275190830987
Panc 02.03,71751553,4.925944110140211,4.589781445044704
HCC1500,5281321,-4.561246998431513,-0.9825387917174373
LS411N,44202524,4.412838675121289,2.287482261205534
LS411N,637858,2.7012095970179635,1.3147893575051848
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898,2.260264697013203
SK-HEP-1,24797083,1.0035545042427043,1.3328823309789937
ALL-SIL,navitoclax-gemcitabine (1-1 mol-mol),-4.146952784268296,-2.872394136446726
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659,1.3797475661957201
BICR 31,387447,-3.4745770631768553,-4.186799073832823
SK-CO-1,452548,-1.5551413224098238,0.6459295999173107
SW948,6914657,-4.288216532991124,-4.274574070381913
SK-HEP-1,216468,4.223762462623231,3.63847131394388
ALL-SIL,71466380,3.7861137397034255,3.821879239939206
ALL-SIL,66577038,2.592918053791083,2.413287378048696
K-562,46174525,4.631327159993839,3.212043765305371
SK-HEP-1,11404337,1.0852289139958715,-0.03336700336567672
SW948,tanespimycin-gemcitabine (1-1 mol-mol),0.3148339676626304,-1.0607339905675988
COR-L105,156414,4.037454349539868,1.7015995179248744
P31/FUJ,5351362,0.932451869978648,0.7597103477720915
BICR 22,57519531,2.122776388957543,3.026865614572374
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828,1.917161760229893
SW48,156414,-3.5613148313114293,1.179228195205313
BICR 31,24180719,3.9564262696237096,3.53988474575763
KU-19-19,11222830,1.7129831318158657,1.5760321096877419
HuP-T3,9911463,3.677427040789425,3.8593726813759752
Granta-519,56649450,2.820913380280981,2.434211189850064
BICR 31,5328940,1.2878315189706533,1.6246062330635294
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624,1.8821933078754918
IGROV-1,19582717,6.764352444432722,3.993266826804882
IGROV-1,24951314,0.9075718706849548,1.5840157073556511
Granta-519,9911830,2.3469616146388033,1.8172838926550818
RKO,3038522,3.342495330103654,2.88402672039488
P31/FUJ,135440466,3.423250795887436,1.5479549398231633
IGROV-1,6918878,1.6706182189896102,2.9137512619480965
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448,-0.4774529952470413
SW1271,136227924,3.2074421772411372,2.9072886470458865
IGROV-1,16722836,0.856484234547582,1.5958903130915807
WM115,piperlongumine-MST-312 (1-1 mol-mol),1.2080674757764085,1.819462631734192
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537,-0.8409698523565722
IGROV-1,168313016,4.807199318661473,4.995411869306033
Panc 02.03,9935249,3.920507280118285,3.20150504319477
UACC-812,19582717,5.3439559865445245,3.9908435809690896
SK-CO-1,54619267,3.100073010472608,3.9983475729289455
LCLC-97TM1,56973724,2.3842885859021985,2.7079298661935503
P31/FUJ,44185566,1.65624467652309,1.2852713033143488
BICR 22,erlotinib-PLX-4032 (2-1 mol-mol),2.8586424250405784,1.8865144238307672
LS180,568763,0.2796957344404436,0.6254595229500576
HEL,5281321,0.1504430999261452,-2.564374164819472
COR-L95,168313200,1.9910859109269063,2.5173551745642024
NCI-H2452,100016,6.6405878618594985,6.413248799921863
SK-OV-3,vorinostat-navitoclax (4-1 mol-mol),1.2421133926861518,1.1952949797706227
SK-HEP-1,71751553,4.559763777433237,4.6420278266624155
COR-L105,6450551,3.13458936271996,3.15381697950785
MOLP-8,227681,1.7901539797099055,2.6326435887520603
LCLC-97TM1,24951314,1.6929873886763296,0.826244434841724
LCLC-97TM1,20959075,-3.5903877814282836,-3.0924920786811385
Panc 02.03,11964036,1.263021853424522,1.5528804084179493
Granta-519,54596558,4.099782953798094,4.122965459868227
IA-LM,navitoclax-PLX-4032 (1-1 mol-mol),1.0143857311372344,1.7683139993819939
P31/FUJ,navitoclax-gemcitabine (1-1 mol-mol),-2.2174176001996626,-2.2487304129272
IGROV-1,246676,4.485924799339535,4.241413464389266
HCC15,25126798,3.760529318413009,3.8353488125506785
P31/FUJ,67156097,-2.27730723064269,-2.2697624273755848
KU-19-19,4788,5.856744699338042,5.573885197658923
MOLM-13,44507138,0.4726740823031857,1.4751690905426431
COR-L95,5281672,3.930459616892441,4.202060023526892
HEL,46191454,2.0114602406157487,0.11499106968542921
SaOS-2,25227462,1.0053365829052552,0.2757487166963423
NCI-H1568,327653,2.9538763640308403,3.155516088392012
MOLM-13,126941,-4.1996343959718665,-3.1100972800655136
SW1573,23582824,0.5044187481506299,0.7233576067563932
SW1271,selumetinib-UNC0638 (4-1 mol-mol),0.1676161732677231,3.1881124889217975
RKN,46199207,3.372714950884571,3.0668267536358083
MOLP-8,2113511,4.489524818659998,4.625443505944815
K-562,selumetinib-decitabine (4-1 mol-mol),3.3977333997002215,0.84116137542038
MOLM-13,9907093,2.467705892800055,3.2867193290440353
BICR 31,135398516,1.997761003126595,2.2359772414176504
SW1271,216345,3.992520329028928,3.8864584641268176
SW1271,49766530,-1.8216621121390524,-0.4904452336290308
BFTC-909,44819697,-0.8003395289407239,-0.02142529283550151
COR-L105,tretinoin-navitoclax (4-1 mol-mol),2.190606174961121,2.509531374660062
COR-L95,24951314,1.2848618182948477,0.8422555360470745
Panc 02.03,11427553,3.85172253134883,3.114903644496903
RERF-LC-MS,11955716,-2.426679724944883,-1.3974677468716592
LCLC-97TM1,168312962,4.14705930417905,1.841550368193238
LCLC-97TM1,984333,1.7706091320352773,0.9094182912566565
RERF-LC-MS,3689413,0.4263782886644774,-0.05279879187106019
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033,3.3985325855726285
HEL,72734382,4.138558929268269,3.3508772657761505
Daudi,5281672,3.0556000328651267,3.5728900991267
Granta-519,73707438,4.294812737502366,4.059214654560403
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031,-1.731081147964061
BFTC-909,3465537,1.8561429441463555,2.629705843904392
MDST8,53232,0.2243602329572143,2.593126661499626
PaTu 8988t,54618164,4.622822732421989,4.138836800204703
ALL-SIL,decitabine-navitoclax (2-1 mol-mol),-2.660613413513553,-1.632936562175319
BICR 22,241158,4.423333712203234,3.823675554133574
IGROV-1,25150857,3.031865110078871,2.6142505300947825
MDST8,2729026,2.783400494590182,2.665375405997205
IA-LM,56649450,5.159895082661475,2.763055187523498
RERF-LC-MS,44137675,3.373454428855253,3.7417264576403486
HCC1500,11612883,3.8728122953700113,2.8919428605350053
COR-L105,44491742,4.003695029376484,4.39736913995223
SU-DHL-1,17759555,3.5507610454949177,3.6134461620312988
PaTu 8988t,2828334,6.317024230854033,6.188363896787855
PaTu 8988t,168312962,3.961414669504744,1.9860788508560743
NCI-H2452,15953870,1.9726746369071917,3.8702862547928087
LCLC-97TM1,54626689,4.751501808909531,4.450180228959614
PaTu 8902,136227331,5.567107594748722,4.1307836005820695
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804,4.022325164413068
COR-L105,ISOX-bortezomib (250-1 mol-mol),0.2804376845822182,0.7298262850551958
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258,3.4292063508394826
Daudi,11317348,0.8828508555827204,1.176241191858745
IGROV-1,26596,2.910298792762654,-0.5359137703128236
K-562,2742550,1.8061055262772656,3.316367620104923
IGROV-1,25062766,2.144848161581278,1.9904663570097982
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094,-2.2905042578296473
IA-LM,navitoclax-MST-312 (1-1 mol-mol),0.5208691605540192,0.8423483499402268
SW948,123631,3.5700289871060327,2.1776105448208174
COR-L95,168312962,1.6965693753889812,0.9280448731852489
IGROV-1,9956119,3.7231415872817024,3.43815127391909
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706,-1.7345016570133955
HCC15,23725625,4.984445415553906,5.029180840797306
KU-19-19,JQ-1-vorinostat (2-1 mol-mol),1.2174768050309406,1.137826622392701
RKO,2708,5.0364138660049935,3.8471926178895677
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015,1.8218213034325612
IA-LM,148198,-11.384967135346804,-3.480233289812355
PaTu 8902,44202524,5.539571067533291,2.4784116137440613
SK-OV-3,10127622,6.3662035368843535,3.6163760978971062
PaTu 8988t,16038120,1.6913300198770496,1.0251892763220578
HCC1500,6610355,5.5539350619643395,4.588784079160317
RKO,9956119,3.3077949428120195,2.995935608076908
MDST8,8515,5.547245054967808,3.7065312466045395
HCC1500,5978,-3.1049031694332183,-1.7759132222421028
WM115,navitoclax-gemcitabine (1-1 mol-mol),-1.739473947075712,-1.3030029523028577
BFTC-909,262093,3.5924629632259792,2.9973431808143953
RKO,23635314,-2.140231911981244,-2.1846650920761
MDST8,11626560,2.2403804115384207,2.03593475982358
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316,0.922910896271703
COR-L95,44819697,-0.3616253875757693,-1.318805884576659
BICR 22,5351362,1.2051272382141311,1.6737670294548597
K-562,9967941,4.015535149970178,3.004890836027384
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385,3.149982087919753
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925,0.855329633228739
UACC-812,25102847,4.053875686762356,2.512898435622914
SK-OV-3,6610355,6.222226160480143,4.660786694968
IA-LM,11152667,1.0642318645878492,-0.9053949615260609
BFTC-909,6918289,3.427790661189136,2.6095467017551908
Granta-519,11167602,4.36712443545526,1.6926466399601239
BICR 22,60700,-0.4008092990404712,-0.30587908083583476
LS180,BRD-A02303741-carboplatin (1-1 mol-mol),4.457802595485306,3.8860856429906403
RERF-LC-MS,241158,4.36087401910034,4.1747172179832095
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658,0.644909413477432
HCC1500,24951314,1.2674136228128516,1.603804546063661
K-562,65064,5.606410384518605,4.02957784696289
PaTu 8988t,6852167,4.186106645973286,2.9728739569758122
NCI-H1568,BRD-A02303741-navitoclax (2-1 mol-mol),5.689804602568574,2.4348842226922107
RERF-LC-MS,25154868,3.293982375318642,4.47971591198806
Daudi,11719255,1.9605498566152704,2.0457779780975534
LCLC-97TM1,selumetinib-piperlongumine (8-1 mol-mol),3.449521534433945,2.4415242561588935
P31/FUJ,9907093,4.323796399268767,3.3661210814800584
SK-HEP-1,56649450,4.110961369423777,3.5793946109718644
SW948,11238147,1.5812364597614252,2.6450256228379407
MOLM-13,60700,-3.6931560077615337,-1.6038227302839845
SK-OV-3,54618164,4.236989567252486,4.181720284945047
WM115,53232,2.2909547616931243,3.00136918770073
Granta-519,11213558,2.214733921051264,1.3540868970360609
HCC1500,12001922,1.110118640671234,1.8441759770756756
MDST8,12003241,0.3559193403256231,-0.9986192972490794
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375,0.5112219404477111
MOLP-8,44819697,-0.0313402586892576,-1.280848263323844
COR-L95,136227924,2.879022500990784,2.4929820073499376
Granta-519,135421197,0.2234065586927925,1.3160880046074135
MOLP-8,SNX-2112-bortezomib (250-1 mol-mol),-3.1816176018347018,-2.543811294665361
SW48,6505803,-3.5264924347891897,-0.555349345380278
IGROV-1,8515,2.1861539315976053,3.784894226218016
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586,3.588529295642611
RCC10RGB,doxorubicin-navitoclax (2-1 mol-mol),1.2475465934468772,-0.6536955555121239
MOLM-13,25102847,-4.845176201807707,1.7959379557499253
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101,1.2146330392841747
SW1271,53481919,3.611390941951582,3.850976228736643
RERF-LC-MS,24964624,3.0594292113466515,2.367705411582511
LCLC-97TM1,969516,2.175595213634207,2.67356648170402
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876,2.303267950633516
RKN,49793307,-1.2643121180608,-2.52780619616775
K-562,selumetinib-tretinoin (2-1 mol-mol),3.758766106216507,2.381190338632767
SU-DHL-1,15547703,1.7605543364675147,3.057494688270107
COR-L95,11625818,4.182153411947424,3.6850661110467895
BICR 22,12003241,-0.4808187565312439,-0.9032941078569482
LCLC-97TM1,124202324,2.4863882679536133,2.0996728619650553
BICR 22,24797083,1.5794716057353129,1.5424322657509975
WM115,136227331,3.7917327546536983,3.657696445873376
MOLP-8,23725625,3.090240324780466,3.543985266980464
NCI-H1568,3552672,1.826953477138791,2.756905079441657
SU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),2.4518113927127754,0.9972755902936532
IA-LM,51039095,2.817946248906647,2.733170726331645
K-562,11964036,1.6077176524784418,0.5476524800323601
HCC1500,5470400,-1.7385310235308598,-0.49396305799903273
SU-DHL-1,11396600,2.533401176626175,3.6283700335045306
BFTC-909,216345,4.226804426652683,4.004009626092935
Panc 02.03,71304818,4.256945507775637,2.55612639892352
Panc 02.03,219104,4.2068478561753375,4.006714372226024
SW948,23582824,0.2041553679799947,0.8345253488315134
NCI-H2452,5287620,-2.107035322199283,-2.045255091415085
SW1271,15953870,2.918493523161381,3.5198581812543925
IGROV-1,119182,0.2112476135388779,-0.3198550710320196
SW1271,11656518,1.475105479065936,1.9025663148552154
Panc 02.03,49766530,0.9655059796360064,-0.10718800608808082
LS180,89928392,1.7442798189695845,1.447761733487195
SW1573,53495165,2.229023421141798,0.574897292481703
WM115,16659841,5.127619480623103,3.8697401194002286
SW1271,3552672,3.981050843991283,2.982162385143633
SW948,9926054,1.8406028662949705,1.7348567036641245
MOLP-8,JQ-1-MK-0752 (1-1 mol-mol),-1.2157281413611027,0.07752222091277801
RCC10RGB,71466445,4.397911896340776,4.1106669630617905
WM115,7326481,2.374260909001927,3.004619806686352
SW948,44202524,1.7116279237548724,1.8229556496571022
RCC10RGB,46907787,5.224507823938942,2.613469793201711
LS411N,9936388,1.997277136132151,-4.613751856849156
SW1271,135423438,1.1699634662635283,2.5208753054172712
SK-OV-3,ISOX-bortezomib (250-1 mol-mol),1.1042689402938264,0.618706460744334
COR-L105,123631,-0.3749766708664047,2.3810793299162234
MOLM-13,52947716,-3.8827491455655694,-3.0521806265288722
HEL,36314,-3.7348038354216593,-2.3667440698123987
KU-19-19,54454,2.6957608866389866,2.694307805984424
Granta-519,BRD-A02303741-navitoclax (2-1 mol-mol),-0.3585433064620935,0.6978129545566426
MOLM-13,71680916,4.890723285268907,3.8003190957811914
SW1573,65628,4.136448104244246,4.506974568240627
HuP-T3,11178236,-4.0067645508863174,-3.1453272802008208
WM115,11364421,-5.628114250516673,-1.3434126129558905
K-562,613753,3.252228295501032,2.7235610354401847
IGROV-1,24771867,1.9944882740161016,2.099055289458151
ALL-SIL,11152667,-2.075218964097288,-2.097411418444955
BICR 31,3081361,0.7844567898788304,2.374770518175836
SK-HEP-1,piperlongumine-MST-312 (1-1 mol-mol),1.9419225552023804,2.0861828684532444
RCC10RGB,4788,6.17872638158586,5.7800771761650775
Panc 02.03,11626560,2.1710424521283427,1.9530285729957229
IA-LM,11175137,3.357915620650256,2.2775947490995274
RCC10RGB,11626560,2.6825909392900376,2.1087853656268805
SW1573,168313200,1.7327341920391253,2.9488057514453594
Granta-519,2828334,6.191507302277889,5.646522783072305
SK-CO-1,selumetinib-piperlongumine (8-1 mol-mol),0.2146036861774908,2.406955157831558
MOLM-13,5460769,1.2989705913507943,1.902184321946861
SU-DHL-1,216345,3.4378126257341406,3.5018833469387203
WM115,vorinostat-navitoclax (4-1 mol-mol),2.428259860783612,1.3868780316385396
MDST8,9926054,1.8075400364112937,2.131108729336774
WM115,676352,1.7628184284101875,2.1164993511426022
BFTC-909,55508,3.078625314561866,3.5407866568388884
RKO,100016,5.817852214634293,4.989039724235646
MDST8,46943432,3.6174081091701886,2.7210806009239836
SW48,5978,-4.7084088584036525,-1.6951916814582038
ALL-SIL,44491742,3.700418914769662,3.848224360595442
ALL-SIL,navitoclax-piperlongumine (1-1 mol-mol),-1.3160613464557556,-0.617639138348598
SU-DHL-1,11178236,-5.1175240313736845,-3.4777597871564883
BICR 31,11955716,-3.162575487986667,-1.4204425714392912
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935,-2.291900268183206
MOLP-8,374536,-0.3332412159105151,0.8203854773069437
BICR 31,66577038,3.1838871840280745,3.011810228762635
MDST8,409805,3.941558883413243,4.903341160002664
K-562,6918878,0.8571724386049573,0.8339884797070889
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283,3.247159996610881
COR-L95,crizotinib-PLX-4032 (2-1 mol-mol),1.858262555354691,1.5111329853087958
NCI-H1568,5281321,-2.717480517336961,-1.1241503849669667
LCLC-97TM1,374536,2.574075324433214,2.0412571280169245
HCC1500,docetaxel-tanespimycin (2-1 mol-mol),1.2750885769824285,-1.6825090976452948
HCC15,66577038,3.417660968254761,3.1121962843957687
IA-LM,9911463,2.6703246121465436,3.207978251628776
SW1271,1566236,1.9677070098040983,2.462658711838187
IGROV-1,11238147,2.1723642292765084,2.7207574728359822
SK-OV-3,11364421,-1.984047807336832,-1.5268236352281206
SU-DHL-1,54613361,-0.1121754666598921,-0.3351698039782768
COR-L105,119182,0.6226208228567816,-0.5451642047140212
WM115,3384730,6.229532895174781,3.079474042671336
COR-L105,9967941,2.071649254258539,3.920898860417006
RKO,72193861,0.7735395045157347,0.34829803123347874
COR-L95,753704,4.781559661696253,4.433046396361134
IGROV-1,49766530,-0.195540678413639,-0.3756233468283263
BFTC-909,8515,4.73152093133166,3.8340298167655256
Granta-519,31703,-4.611611754102639,-2.44213356646201
SW48,19582717,4.381046957550593,3.8805253022883686
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148,0.7059246172051102
HCC15,15547703,3.515422457694346,3.1792535596428415
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826,-1.7264860863841698
SU-DHL-1,BRD-K58730230,4.384837032763104,2.7632310008830387
HuP-T3,2858523,3.211348955084378,3.1025342531400133
LCLC-97TM1,24901704,3.846855123751057,3.1450862480681616
NCI-H2452,44607530,1.9759156929339727,1.8151335398194137
HCC15,9936388,-3.3305479025951783,-0.2794669734540627
RKO,46191454,0.9841477576830012,0.8631905654446093
SW1271,3081361,2.248142117307072,2.484299348084696
HEL,100016,4.260371486080393,4.939791473017932
Panc 02.03,327653,3.634511095206161,3.3868822198237143
NCI-H2452,25062766,2.439590704022921,1.9475655741588411
SaOS-2,44607530,1.05170222821091,1.678097473079324
HEL,5335621,4.9483155198907225,4.054309737412773
BFTC-909,6852167,2.133526407129769,2.9881468867664602
MOLM-13,638278,1.880317910461832,2.6725346227370688
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225,1.3802115679599356
SK-CO-1,387447,-5.86001644251988,-3.9004326644174667
MOLP-8,10113978,2.697897563265303,2.2185321879625772
MOLP-8,216239,2.6519870661660803,1.8413438652074705
NCI-H1568,46174525,4.305444868539079,4.474199894001616
HCC15,navitoclax-pluripotin (1-1 mol-mol),-1.3512127688258049,-0.9081579637166781
LCLC-97TM1,44607530,2.097748917507136,1.6138866211395089
SaOS-2,9911463,4.168030006572111,3.900385257225541
Daudi,24889392,0.6157424479011876,3.2153913204725644
PaTu 8902,51039095,3.3801139171258976,2.7191090487284475
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216,1.9966210333152594
COR-L95,JQ-1-UNC0638 (2-1 mol-mol),1.8178477009164715,1.0378697075397028
Daudi,387447,-5.635352264179238,-4.750185991208765
IGROV-1,5702613,4.420745339537274,2.8853781858165757
LS180,375860,-0.0541765269880971,0.2719387532476791
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334,-0.46780489473706255
MOLP-8,241158,1.846975252387852,2.4184329725147635
SW948,44819697,-1.5719383449848416,-0.8275611991413377
NCI-H2452,5951923,4.988154330604512,4.6656140211692
MOLM-13,54613361,-1.833470941599732,-0.8154196952007142
SW948,148198,-4.802987893737634,-3.386090027516874
BFTC-909,4261,3.835594401773327,1.915587129026525
Daudi,45100481,4.914271492759253,2.45848164134288
MOLM-13,3384730,-1.9717967977442377,1.3173294887066092
IGROV-1,5566,3.174346862827938,3.0950961490949527
SU-DHL-1,10302451,2.2731723403274535,2.997342884365458
NCI-H1568,SNX-2112-bortezomib (250-1 mol-mol),1.539717951588267,-0.9283220362349596
RKN,24797083,0.944322820476056,1.3700707836079664
SK-HEP-1,148198,-3.434194259121147,-3.294410147713595
SW48,16736978,1.8227831775957584,1.3404865878312189
HCC15,2708,6.122532058448304,5.223258271365545
SW48,5335621,4.0461877603353855,4.588574726833925
SW948,JQ-1-MK-0752 (1-1 mol-mol),3.431430026033012,1.2695613496254832
NCI-H1568,71304818,2.2110745175145876,2.6536419439188377
COR-L105,5311,1.9211659995219237,1.6656346308074188
SK-OV-3,5328940,3.4311724872159903,1.7687436715124942
RCC10RGB,1716436,3.489109378341682,3.1334121026513606
MDST8,6918878,1.145593411739036,3.0865820194885605
RKO,11364421,1.233720517884939,-3.6255430847219396
P31/FUJ,65064,5.109694638799521,3.818801333622557
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727,2.3823048898689003
PaTu 8902,3025944,5.120505038776715,4.312080998961913
Panc 02.03,12001922,2.5444953584324193,1.971574679556943
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249,1.971953074861454
ALL-SIL,54454,2.130103786841792,2.118591093360435
Daudi,11238147,1.1945947480643642,1.7607788495204832
WM115,148124,-1.9357807696466565,-1.5759678510445738
PaTu 8988t,25262965,-2.4539636298097376,-1.3541663864783242
IA-LM,49766530,-3.412847117105243,-1.517405885377277
Granta-519,44185566,0.7632366174102183,1.5446795150642887
MOLP-8,44607530,1.0628729381864028,1.3004786187396593
K-562,409805,3.7514940654800064,3.8957913387726593
BICR 31,89928392,2.942196417475874,1.7233217067465707
SW48,23725625,4.606874242451815,5.001569495343917
RCC10RGB,16038120,1.536821218292656,1.080693675505923
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385,1.410486866785625
RKO,148198,-2.1467795088860875,-3.7007505464113204
SK-CO-1,409805,5.790109243945559,5.047333090271788
HuP-T3,7251185,1.9415241444855404,2.5516041614050646
LS180,11612883,2.759028826688456,2.5097872524667175
WM115,11507802,3.278245549501506,1.7564237578961774
IA-LM,168313016,4.257474229118996,4.216610314115951
ML-1 [Human thyroid carcinoma],5566,3.147714437598846,3.135488012064818
MOLM-13,crizotinib-PLX-4032 (2-1 mol-mol),0.492576617206884,0.9492413141612646
SW48,10302451,2.1638159560649157,3.0734450286481274
Daudi,65064,2.8809848507042095,3.4698741310641044
LS411N,11612883,3.0472980958623705,2.0317004992805243
NCI-H2452,11214940,1.2392722713501154,1.7573464917650259
ALL-SIL,984333,-1.3370961884574026,-0.9502647804362327
P31/FUJ,1641662,2.802136916275355,2.6996608288585495
MOLM-13,25183872,-2.142456248879295,-1.910140711338157
K-562,969516,2.7986550178028216,2.28260991651424
Granta-519,54143018,0.4327684951223574,-0.36328774439961103
SU-DHL-1,44819697,-0.3444138900100821,-0.3641661731257983
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231,1.535652550534959
Daudi,9933475,1.2993243126142855,1.409063832875815
SK-CO-1,10427712,4.208191107568486,4.210433652293631
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.6807526122733254
HEL,2841722,4.805306475973069,3.749348323116979
COR-L105,9926054,1.7310748902984938,2.037532979900204
RCC10RGB,15983966,2.263334704673794,-0.2662499354494782
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177,2.7149778492314374
IGROV-1,46174525,4.5083762186279595,4.467416865959895
BICR 31,11175137,2.7548462189262817,2.7146026330551107
COR-L105,11609586,4.426382611322312,3.1881639226361234
COR-L105,tretinoin-carboplatin (2-1 mol-mol),4.8464312209914056,4.998943593225332
IGROV-1,107985,-2.8971910842184516,-3.5631163357774773
SW48,selumetinib-tretinoin (2-1 mol-mol),-3.039219122646087,3.3042997270130856
IA-LM,71466380,4.547922152882383,4.4637515987481
Granta-519,navitoclax-sorafenib (1-1 mol-mol),-1.03945044820541,0.1856745517512425
K-562,11612883,3.292128537791773,2.1523894435519635
HuP-T3,15953870,4.533958601099395,3.570535094312487
NCI-H1568,219104,4.078417481216408,3.864416264133063
RKO,65064,4.5178366082525,4.4322513688793626
NCI-H1568,9911463,2.564901149372131,3.912901607435476
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.46540278587711575
ALL-SIL,6852167,2.025737624061405,1.4602247190080255
Daudi,16065773,1.627011760718674,1.9843015411706943
MOLP-8,10410894,2.1334782114390425,2.8935364597956355
RERF-LC-MS,73707371,5.9060077591992375,5.218727205743153
RKN,1566236,1.687441004968786,2.242833580897976
IGROV-1,439501,-2.1510551928674557,-2.2271923669229166
MOLM-13,57519531,1.2030375936335158,1.4496535262873287
Granta-519,11625818,4.458439944218401,3.2014819241028003
WM115,JQ-1-navitoclax (2-1 mol-mol),1.0904660510926631,0.9010641496446827
MOLP-8,3689413,-2.303477592076259,-1.4608911928372035
SK-HEP-1,54596558,4.485352352092043,4.581713790646984
SW1271,4705,3.86061099620112,3.137812383468581
Granta-519,9927531,4.885085469625254,4.1195467152375524
SU-DHL-1,11427553,0.3775832797434548,2.60227239418195
ALL-SIL,15953870,2.429039509996585,2.7790869211011944
COR-L105,4259181,2.2372065992854133,0.3519915929200322
HCC15,17759555,4.480266922784899,3.6669567619385357
COR-L105,10184653,-3.6529884694455608,1.583210358712179
RKO,72376,-2.4980018930037673,-2.9189371753494324
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187,3.340662580286089
RKO,613753,3.427719504210608,2.7999480936366687
LCLC-97TM1,10302451,3.3699574981481217,2.9557974945809242
PaTu 8988t,JQ-1-UNC0638 (2-1 mol-mol),3.720997870166264,1.7571903603021224
MOLP-8,3634881,2.730356562919761,2.5594828342355562
SW948,11612883,1.2539645440532456,2.1126241095244214
HCC1500,carboplatin-etoposide (40-17 mol-mol),4.564857215457985,2.2845745552287315
BFTC-909,10074640,3.0053798884123837,3.168136629834011
LS411N,24901704,3.828527152917887,2.3257474052977734
SW1271,51039095,2.010271277744507,2.832655120334304
K-562,9935249,0.8993678101188762,1.760747718660332
COR-L105,462382,1.111643181026989,0.7501397789921623
Granta-519,10385095,0.7144131323279258,0.8011930294712741
COR-L105,5281321,-2.635307184860664,-0.9796344231051767
KU-19-19,selumetinib-piperlongumine (8-1 mol-mol),2.2054937321135775,3.3210600979587377
LS180,11234052,4.148077533652898,4.245831994242916
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556,-1.2969705009434385
COR-L95,25154868,4.601001468087818,4.1823463365315074
Daudi,3025944,3.5610963405625267,3.5386710729070914
SW48,24180125,2.6937498240420457,2.931170204613837
SW948,navitoclax-birinapant (1-1 mol-mol),2.127959258569347,1.509063854799863
PaTu 8902,168312962,5.583922762984923,2.1383760482138516
COR-L105,5280436,1.8180108392693488,3.4389584104823605
SU-DHL-1,44507138,1.5242294298964132,2.0219423161891226
MOLM-13,10302451,1.7245492330691454,2.524859554337729
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083,-2.055904026069777
SK-HEP-1,44607531,1.6636821475505756,1.5995858031761896
IA-LM,15983966,2.169762444969255,-3.2783278704502252
IGROV-1,56946209,-4.416985130578084,-3.8501457410305253
P31/FUJ,25126798,3.55669651950966,3.5242621138165773
LS180,piperlongumine-MST-312 (1-1 mol-mol),1.6478111921038412,1.9079879352040683
BICR 31,15983966,1.7355748159582445,-0.6677211085941736
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765,3.385642570012463
NCI-H1568,135421197,1.29303587511011,2.218016768939026
HEL,374536,0.3200488785786777,1.1551234511150386
NCI-H1568,25161177,4.305259269080427,4.107132143431673
Granta-519,24951314,0.3336244464551668,0.32426010710986297
LS180,400769,-0.7559227838025858,-0.6517777710068158
MDST8,44607531,3.32682409463767,1.564592655789655
WM115,46843906,3.7194943725295992,3.333564538703886
RKN,24771867,0.8860225124393014,2.8369124425661805
HCC15,tanespimycin-gemcitabine (1-1 mol-mol),-1.7446538355575971,-0.9366740266845132
MDST8,72734382,4.130038178532864,4.559453259871119
SK-CO-1,1750826,-0.0283504159212216,-1.0518441733572281
MOLP-8,10184653,1.0374255182903005,0.8876339287641111
NCI-H1568,46398810,2.1853633940590966,2.688501555771942
PaTu 8902,6438330,3.32865710338655,2.42461303270031
K-562,60700,0.041873955903415,-1.299341109989649
KU-19-19,23725625,4.865374475902274,5.294242815114871
BFTC-909,6438330,3.0201113942824436,2.322046890763333
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788,1.229312861068706
HCC15,65064,4.883028365063005,4.793926721626449
HCC1500,285033,-0.4229420433590342,-2.293579207525806
LCLC-97TM1,navitoclax-pluripotin (1-1 mol-mol),-0.4086079898924854,-0.8167282459233169
LCLC-97TM1,5479543,3.538440111241957,3.398024925606423
PaTu 8988t,613753,3.3970334474933495,3.430489909089616
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346,-0.6411602194375837
SW1271,2949965,2.7362256869687895,2.8981594044583057
SaOS-2,4705,3.668938036329027,3.415232408513014
KU-19-19,11364421,2.01242470272022,-1.0325873791887001
SW1271,676352,2.2943086949623885,2.019018896170005
RKN,24856436,1.2279395925477072,0.16863721060007222
SW48,159324,-1.9628962598081805,2.4465821376403394
ALL-SIL,568763,-1.7129740739789223,-0.3689750632558789
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968,1.4704017079838005
WM115,9907093,3.0763750955907883,4.433360800760436
SW948,637858,1.5262532123254355,1.4012966663492383
PaTu 8988t,24901704,4.232615528659116,3.469748282281701
SU-DHL-1,11238147,0.4308170484254632,2.5141296283733654
BICR 22,alisertib-navitoclax (2-1 mol-mol),0.0230518675395602,0.5263423904172422
COR-L105,3634881,3.59150153069964,3.5289221445428627
BICR 31,49766530,2.6564815829329236,-0.4187557187861855
SU-DHL-6,439501,-2.4303946334698057,-2.736921321746721
SK-CO-1,6438330,2.884853035173295,2.5344558257936036
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526,-0.534141579629934
SW948,23635314,-3.685869994463448,-2.2505918184371003
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332,1.5048673747969554
RCC10RGB,24753719,5.18895385781671,4.403068070025852
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533,-0.5676638991798764
HCC15,53481919,4.945944641956239,3.7867740120810818
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622,-0.2683311030571015
BICR 31,11612883,2.9886930364048387,2.9769686088624905
HEL,20959075,-3.3486318540939535,-2.981149651336644
SU-DHL-1,24964624,1.891650824203322,2.342180817280447
K-562,11609586,2.0906528510972775,1.9097500583478189
KU-19-19,89183176,4.239044338938638,4.512516272226071
MOLM-13,9927531,3.44947203831576,4.253299455661761
COR-L95,10302451,3.773437494355592,3.197768554057319
SW1271,10385095,1.244878723840673,1.5566067330361988
SK-HEP-1,navitoclax-MST-312 (1-1 mol-mol),0.5798914619314417,0.940875794103511
IGROV-1,17755052,-1.0246415273055465,1.4541191896690517
Daudi,3634881,1.264969339465191,2.59500594055653
MDST8,46224516,2.508010817025431,2.600503405875371
SK-OV-3,65064,5.055886881526936,4.973598775450479
IA-LM,11364421,2.389092199855664,-3.6445277784664465
P31/FUJ,6918878,-0.2487475841908946,0.6305044933564318
SaOS-2,426756,5.396474834861055,4.487285353798682
MOLP-8,25150857,0.9011737742745826,1.512994722778494
BFTC-909,11167602,2.8757137848929006,2.6588213747724376
RKO,10302451,3.926970734642152,2.751122913408422
HCC15,6252,2.2097348223357396,0.9898681414569426
PaTu 8988t,135421197,1.788370067257354,1.893514138465064
SW48,42642645,-1.378549292450493,0.9873669528852063
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.8500108243304623
COR-L105,73707398,2.56355231698926,1.3986907627509728
Panc 02.03,3854666,5.373190444337423,2.7036820934956727
WM115,11404337,-2.7813606850874595,-0.19216478205153173
MDST8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9743607330604616,3.0837344924882473
K-562,9803433,4.389269041756261,4.4361075891423045
LCLC-97TM1,JQ-1-vorinostat (2-1 mol-mol),0.588169137305971,0.631680468807641
SW48,11152667,-1.5089069748808788,-0.30511711704137423
MOLP-8,BRD-K55473186,4.200306440270822,3.708267110072896
MOLP-8,3854666,0.8063321236158104,0.9276044415363575
WM115,156422,4.742483160763306,3.9415843709564786
BICR 22,10302451,3.218470138701286,2.2568948186860713
P31/FUJ,3815108,3.712799909664185,2.171802731122319
SK-CO-1,5280436,3.963354946284049,3.337959123742471
SaOS-2,11625818,4.3669462586555055,4.697728122452059
SaOS-2,serdemetan-SCH-529074 (1-1 mol-mol),2.337619260674083,2.0966285754833307
NCI-H1568,24856436,-0.7402646666066086,0.7868492977368662
MOLM-13,19582717,1.836192229041244,2.7472445420036324
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356,2.71012599229939
LS411N,65064,5.143309491248943,4.676061633835804
HCC15,selumetinib-PLX-4032 (8-1 mol-mol),2.5653564815538075,3.3963821510820686
SW948,1716436,3.337695569228523,2.842662810725288
HEL,60750,-4.342121097179363,-3.4824792303663576
SW48,5738263,2.8832489904283207,3.2304339680385463
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703,3.118778495515031
LS180,135984461,4.839780886141452,3.59738843347784
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025,2.5416109648250176
SW48,3634881,4.093042888484318,3.2638251664025035
WM115,82146,3.7974591517158,3.823931093643009
MOLP-8,24901704,2.731912612856625,2.358297097907475
SU-DHL-1,9826308,0.1808938529022712,0.49847265530244156
SK-HEP-1,60700,1.3088528574816594,0.33223719593216616
SW948,49793307,-5.1176222473357775,-3.284337009161949
BICR 31,selumetinib-decitabine (4-1 mol-mol),4.509241156469813,4.186917665204283
P31/FUJ,15953870,2.7000087530897776,2.907841600982237
SK-CO-1,24901704,3.265743022928408,3.3980671250209014
K-562,selumetinib-UNC0638 (4-1 mol-mol),3.2530488329097698,2.8304708582289577
Panc 02.03,100016,6.582809568040202,6.436116186689444
RKO,168312962,-2.5117583451491012,0.8892739675301855
RCC10RGB,25126798,4.759098567819552,3.96701036505086
SW1271,24964624,2.7126751219569147,2.2944474913622535
ALL-SIL,9444,2.1167841583667277,3.61331999702446
SW1271,1641662,3.842487885295187,3.4429051245277607
BICR 22,676352,2.452861704781308,2.047597928325935
K-562,54596558,4.166105900128149,4.3075840632332465
Panc 02.03,9933475,2.3025810529048205,1.8815129510276132
NCI-H2452,374536,-3.751500666928139,2.878667666016296
SW48,9825149,0.0451584979105152,2.1029639824753494
MDST8,3634881,2.8722303311625006,3.0847926602153084
SW1573,24180125,4.83914798243841,3.110245549911352
WM115,42642645,1.5932691238490415,0.8633023012020365
SaOS-2,24753719,4.762341084721446,4.501483136425917
SK-CO-1,25062766,1.7088187930933407,2.0537052616847813
Daudi,71466445,1.7957550148901065,2.6535092605848507
K-562,9903786,3.6050720376028105,2.4236326675234365
MDST8,5281321,-0.743993786053836,-1.3790014882303592
WM115,216345,2.152490626678771,3.9570205462914214
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333,4.230727665535049
Panc 02.03,44566777,1.8066319547984584,0.6795040990479838
Daudi,carboplatin-etoposide (40-17 mol-mol),-0.43265013296543,0.7707293989053932
SW48,1716436,3.2732206570492512,2.8429350523926384
KU-19-19,serdemetan-SCH-529074 (1-1 mol-mol),2.9806718783116337,2.038370755004187
COR-L95,5281321,-5.086788267908354,-1.865688609434508
ML-1 [Human thyroid carcinoma],2126,5.801287401499987,4.620657160903908
LS180,5287620,-2.159393408078438,-1.8576881687275795
HCC15,24856436,0.7194572205096856,0.9899147631695119
HCC1500,JQ-1-UNC0638 (2-1 mol-mol),1.6511332544763542,1.3683489124955608
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084,4.027751980629196
K-562,54613361,-1.429503199294265,-0.4994226515575903
PaTu 8988t,5311281,3.776140248734943,2.65492708771671
HCC15,10090485,4.457627969814505,4.178884290427501
LS411N,1242560,3.5784744482633526,2.9612136825319055
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174,-0.026572575327359953
MDST8,3854666,1.4298592595361392,2.243297661486576
HEL,carboplatin-etoposide (40-17 mol-mol),1.8930260059492108,0.56815411580477
BICR 22,doxorubicin-navitoclax (2-1 mol-mol),-2.5908889748637467,-0.9105850589737824
SaOS-2,448949,2.4147534872316916,1.8997201303944262
K-562,44607531,1.5533391017282614,1.3141233600967896
RKO,656346,1.2468664563159324,0.5142945675116886
SW1271,54619267,4.215254166837184,4.055865022957004
PaTu 8988t,107985,-3.7439330143768106,-3.5330686325086647
Daudi,107985,-4.311158471957254,-3.911452494238394
K-562,89928392,1.1726799483120014,0.44891544491973934
BICR 22,2828334,6.182973514514405,6.318166202987886
PaTu 8988t,462382,0.0850922030405946,0.6076624150111273
COR-L95,54619267,4.025082196689936,3.9642132424024203
SW48,44486219,4.521255071137468,4.178117341752604
MOLP-8,136227924,1.5113872866650588,2.345898678490359
SU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.1997073903631768,2.808390645452921
LS180,176870,3.0513508415646644,2.5774874815335522
ML-1 [Human thyroid carcinoma],409805,4.766723032315811,5.126308186839045
NCI-H2452,60700,-2.076184021255351,-0.24359511623624738
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878,2.383677879591257
Daudi,2749,-0.7661278600765006,0.9661970718894469
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985,-1.1102410343379554
HCC15,11364421,-3.377820549130246,-1.5115258817656403
ALL-SIL,135984461,1.7193250250744925,2.826937084566785
HCC1500,1750826,-2.1124887265082255,-1.0340531233151713
RKN,53392493,3.005817826052642,2.8871398489689337
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744,-0.08337583577581782
BICR 22,5287969,-2.619429839358568,-1.611574718942608
BFTC-909,24978538,2.589526114093726,1.2803229934734777
SK-HEP-1,2828334,6.264472809398218,6.250831540064304
Daudi,4705,2.565440722309658,2.7774879423509247
HEL,11485656,1.96241131365886,1.3728255183458722
BICR 22,23582824,1.0399288647056628,0.9873337906698403
Daudi,doxorubicin-navitoclax (2-1 mol-mol),-4.527956590288398,-2.0201189400217867
HCC1500,navitoclax-gemcitabine (1-1 mol-mol),-1.5596806456791137,-0.9626400835880218
MOLP-8,11364421,-5.744944118703229,-4.147018619560836
COR-L105,374536,-3.312479831607182,2.9428093068947283
SK-CO-1,56973724,0.9140094173628892,3.312264034647888
HCC1500,135440466,3.12374064827048,2.485104835780633
COR-L105,24978538,1.189273057385404,1.749955791581279
SK-HEP-1,45279963,4.052806603396004,3.8597683045520457
K-562,11317348,0.8853213314815674,1.2959635693141482
RKN,6918837,-0.6134153399361431,-2.466638140437774
LCLC-97TM1,285033,-3.3608842191269104,-1.661514328374075
HCC15,11455910,-0.3399110905288865,1.1981054891910115
SK-HEP-1,176870,5.630942733934813,3.524081822575582
RKN,23635314,-1.997093039658799,-1.731339180810589
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738,3.7398153598502324
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.1042905927681685
SW948,969516,2.384481795832599,2.4964647726158695
WM115,24180125,3.7433275341391057,3.0319342669140945
SK-HEP-1,135440466,3.4774178685499324,2.070241048251459
KU-19-19,11626560,2.7733848967135017,2.039855650940897
ML-1 [Human thyroid carcinoma],675434,4.374805668496918,4.61761953076617
LCLC-97TM1,44507138,1.7278080476353117,2.3944682560919293
SK-OV-3,25150857,2.8200349544845045,2.6964415128926924
HCC15,44491742,4.47716804785037,4.392081419472864
NCI-H2452,carboplatin-etoposide (40-17 mol-mol),4.403260682335101,3.105655069771258
LCLC-97TM1,25150857,2.1625900659079296,2.1209933905201983
P31/FUJ,124202324,0.9428129005296164,1.0322279051874934
IA-LM,BRD-A02303741-navitoclax (2-1 mol-mol),1.2493454608743932,1.9507293743598688
COR-L95,6505803,0.0712785503404296,-0.5243477689263956
HCC15,24964624,3.0755429715166063,2.3835591583714693
MOLP-8,11647372,0.2904161448795228,0.27957958451258935
BICR 31,11977753,-1.0341786941527915,-0.8595577791519573
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343,4.119949114072143
HuP-T3,5282054,2.779269170716028,3.8932772998838345
SW948,54618771,1.4567685239775812,1.0144919676032993
Granta-519,24797083,0.9051026865971544,1.0646623981593577
SW48,73707398,0.6331221198690845,1.3360201850403433
BFTC-909,135411,0.8518885281649031,0.9355408672271918
HCC1500,675434,3.977739266447536,4.642383967766759
SK-HEP-1,6918328,0.8938731782790444,0.3486802196881948
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286,5.625754878953114
LS180,159324,3.258862193159196,3.0688489322706305
HEL,168312962,0.5016152377841688,0.9349249193109531
SaOS-2,44607531,1.4975746891341548,1.5649292756042246
IA-LM,vorinostat-navitoclax (4-1 mol-mol),2.163605213189375,0.9964255616153193
MOLP-8,6610216,4.187822370904977,4.008027767464072
HCC1500,5278396,3.6802956879537856,3.604748904808787
K-562,445643,4.07029800941494,3.59875258406494
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781,-3.0726823114438218
Panc 02.03,5351362,2.6810485074832,1.6347085680523386
BFTC-909,23725625,7.000464253417552,5.1087562202683925
SK-OV-3,8515,5.143916520422132,3.899398744659401
RKO,24779724,5.847036108864024,3.1070097377013606
MOLM-13,65064,3.286890258414819,4.294357088944037
P31/FUJ,9868037,1.2869642230829814,1.8396601815238063
MOLP-8,52912189,-0.8757353744499203,0.35086814128853705
HCC15,2113511,6.327015395869061,5.678149688750145
IGROV-1,25183872,-0.4560099928976716,-0.7248625186464009
MOLM-13,44259,-1.8425758706378912,0.17839272657060487
P31/FUJ,9911830,2.020541196825024,1.6757257373836347
NCI-H1568,11455910,-0.0792581795853734,1.3041226344084367
Granta-519,409805,2.9966967612339417,3.672409185241063
IA-LM,7251185,3.003277248553597,1.9223996832048171
LCLC-97TM1,24771867,-3.13973757551719,1.1799932694365576
SaOS-2,387447,-3.480142635313653,-4.311975167841679
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522,2.8776672954418108
HCC15,71466380,4.492977556176778,4.477005971712907
KU-19-19,11178236,-2.578122805273377,-3.2912869870373522
SK-HEP-1,107970,2.7276242080982405,2.479104340497072
SW948,3503,2.019264798250741,2.241916057755611
MOLM-13,11455910,-0.3133362084586128,0.19069667504875035
COR-L95,216239,1.9606601522489808,1.860171777339088
MOLM-13,20959075,-3.627453597088981,-3.070795445795259
SW1573,3543504,3.864321270652805,4.602922881878323
NCI-H2452,16722836,1.367876124233394,1.7697163233227593
LCLC-97TM1,2949965,2.4577774402858203,2.8585508104819706
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199,3.6609805112687495
SK-HEP-1,9911463,4.3683168964450125,3.9160707922802254
P31/FUJ,11404337,-0.879305702132212,-1.2883668207125192
RERF-LC-MS,23725625,5.011639185934848,5.123780080313934
LS411N,alisertib-navitoclax (2-1 mol-mol),1.9281713469171404,-0.05945576977643286
SW48,126941,-4.535727103151088,-2.450643509777111
BFTC-909,6184667,3.207156937684644,3.1445092705709436
KU-19-19,2945648,2.475372674219151,3.086630222677505
HuP-T3,387447,-4.787053098216054,-4.076306387452243
Panc 02.03,44493528,4.298055948100647,4.381644353869931
Daudi,4788,4.597613323137637,4.839950653845076
K-562,46907787,1.0881737362577,-0.10136645929618998
HCC15,6505803,-2.813846830430111,-1.0037447047685706
MOLM-13,3503,1.2246558483585983,1.6396238102943925
NCI-H1568,136227924,3.032081072579533,3.0156747684206446
RKO,9444,4.448790979485227,3.6713379017962113
Daudi,107970,1.216737596928884,1.868757029212737
Daudi,5311037,3.4563783042396015,2.679519144614168
SW948,10184653,-0.1197105127119604,1.1775007209400687
HEL,89928392,0.5480178499310975,0.5214022034498466
SK-HEP-1,5566,3.210365271342881,3.1083269191865526
NCI-H2452,44493528,4.324080951064212,4.467106151148895
SW948,24753719,4.222068008445673,3.715249018583937
K-562,11717001,4.3318290739670555,3.9532597893816184
HCC15,11647372,2.6612404016221824,1.1868266199132036
COR-L95,11214940,4.129361910595318,1.9335017853030612
P31/FUJ,57330099,4.216278217816623,3.718246864964192
COR-L95,24889392,4.336996294263524,3.6994914748690166
ALL-SIL,16725315,3.2612856597636064,3.5808823929157514
SU-DHL-1,2749,0.1348057545057474,1.9649061389664402
IGROV-1,6918736,-0.950858733923241,-1.1172534603702202
HEL,46398810,0.908204113249262,1.6214900091330187
COR-L105,969516,2.680370673187369,3.039054306658201
MOLP-8,613000,0.7667530859484226,2.448534038728009
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434,1.178187954219092
SW948,375860,-0.5776308885037049,-0.026009967182910553
Granta-519,6438330,1.446800550416973,1.0272815532912911
SaOS-2,3384730,0.9471099210722488,2.927662427464891
COR-L105,navitoclax-pluripotin (1-1 mol-mol),-0.739242899323645,-0.4750224724686467
SW948,10127622,1.0689347689119728,3.420033941079917
SK-OV-3,104842,-0.359869843998673,-2.854437488601056
HCC15,2733526,3.237047771361035,3.8514798584487635
ALL-SIL,9884685,1.523019065964201,-0.4149699040877266
HCC1500,31703,-0.1591983874970776,-0.9545121361490527
MOLP-8,24785538,-1.5077289265748457,-0.027300728558390174
COR-L95,6918328,0.296514622397876,-0.5150719806080306
LS180,24964624,2.8898766327054153,1.9574940131897614
PaTu 8902,2945648,2.947030382730425,2.9684263569721554
IA-LM,16038120,1.0865848932778794,0.8107854536601076
Daudi,54619267,3.035333918034676,3.313056899764728
Daudi,5284373,1.725683673378691,1.9255835744042205
SW948,56946209,-4.45606402023299,-3.9545563066409746
SU-DHL-1,9956119,2.7884192993685666,3.456144212762545
PaTu 8988t,3689413,2.4784022576221836,-0.11897245311157223
WM115,44241473,4.443917717257507,4.739166927763597
HEL,11507802,0.749942791895586,0.8200238436218851
LS180,25150857,2.6595729662678846,2.453754027889813
ALL-SIL,11964036,0.9057184864624424,0.5363122943593294
SW1271,5351362,2.529410314371741,1.5445565829029593
KU-19-19,151289,4.45756440863607,1.235514436459791
MDST8,24785538,2.8042557252914597,1.7199102175063365
LCLC-97TM1,11228183,2.6499520646531254,1.8816201603607712
NCI-H1568,10127622,5.078058454742808,3.991505477724287
RKN,676352,2.5860960344205175,2.088774100217563
WM115,6505803,-4.475953396274594,0.009155910416177335
MOLM-13,5278396,2.870927952465231,2.948035806419873
SW48,1641662,2.4016053281737544,3.544751250454618
Panc 02.03,5329102,3.1751218779490404,2.06140307577097
P31/FUJ,136227924,2.3905530687579497,2.2138023298201004
LCLC-97TM1,5281321,-1.0764177966981967,-1.4348353833992191
SU-DHL-1,23635314,-2.2508595154996844,-1.371436534659563
SK-HEP-1,navitoclax-pluripotin (1-1 mol-mol),-0.7942291093316414,-0.7735286561122365
MOLM-13,44494015,-5.247330257185634,1.6848481291030912
SK-OV-3,carboplatin-UNC0638 (2-1 mol-mol),3.7911977444327034,3.3941644491461616
HCC1500,46199207,3.053954841618667,3.306743136116952
NCI-H1568,6610355,3.436001375430949,4.723253675069846
HCC15,54618164,4.329878027642837,4.010105391401436
RKN,969516,2.6409066030454804,2.862812985003802
COR-L105,71680916,4.738410817171978,4.877155580483617
SU-DHL-6,3634881,2.3700422517918653,2.761377997617142
Daudi,374536,1.069903440531545,0.7208642446986812
K-562,322968,4.0833948777840225,2.3943613534127266
HCC15,tretinoin-navitoclax (4-1 mol-mol),0.5454082454604786,2.3322206312508955
K-562,136227924,2.737847329779252,2.4189111433409516
HCC15,15953870,3.1000423449826275,3.5983640901972165
BICR 22,6505803,-0.8504421983690468,-0.7462301317014404
BICR 31,409805,3.7719372874267982,4.907103113719356
MOLM-13,navitoclax-pluripotin (1-1 mol-mol),-3.59227040291678,-2.4718780326680116
KU-19-19,71304818,1.8280747292346609,2.648414574402294
SW1271,6917907,-6.616351101315701,-4.758454111808519
SW48,44589607,2.4172125993075335,2.5308550878619873
KU-19-19,3854666,3.1161318305167995,2.324410071412385
MOLP-8,11404337,-0.9705317414577028,-0.9277669638005807
SK-OV-3,11152667,-0.6824217491873509,-0.15278488699079165
LCLC-97TM1,72199292,1.0139745528188595,0.5700477040182717
SK-OV-3,5566,3.179406871626594,2.8954453682008303
SU-DHL-1,11683005,2.624367478757415,3.2131714061192582
PaTu 8902,71466380,4.078142681912824,4.508018200341249
Daudi,56963564,0.012925039709307,-0.18155210349071726
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193,1.0503907148273741
SU-DHL-1,25195348,1.1859308431356896,2.596374891174843
RERF-LC-MS,11494412,1.0302757077826894,1.9836075464279213
IGROV-1,3634881,2.769147818550815,3.2229228367248557
SW48,445643,3.7110082204631545,3.8489461337901845
IGROV-1,3854666,2.3355254440561137,2.224181230453949
BICR 31,tanespimycin-gemcitabine (1-1 mol-mol),0.6260798256664765,-0.06292162770225984
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195,4.2713659247577445
PaTu 8902,387447,-3.44390255134181,-4.069715241825721
BICR 22,25150857,2.1797682691439233,2.300048688505363
SK-HEP-1,54618164,4.274964046269975,4.041252530364727
BICR 22,44493528,4.288893884195869,4.415941133327545
NCI-H1568,969516,2.3539842482072353,2.854712319361872
HEL,52912189,-0.3930066433927971,0.03502345424738761
BICR 31,53392493,3.0187901836288824,2.7431059420524515
Panc 02.03,6610216,4.56797737488032,4.334374750653731
PaTu 8988t,selumetinib-UNC0638 (4-1 mol-mol),4.596522805557342,3.3996174073744676
SaOS-2,445643,3.906030165734591,3.7306647912221598
SU-DHL-1,9967941,3.123701665105139,3.63148621066158
P31/FUJ,10113978,2.718593007254544,2.1885788057209776
K-562,54618771,1.1969173800987956,0.8271008786702992
SW1271,445643,4.255849699563793,4.08400306545546
SU-DHL-1,16741245,1.9818901112506189,3.7083440879969034
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422,0.6448239458093918
SU-DHL-1,9935249,2.376788737359572,2.439692638892274
HCC1500,doxorubicin-navitoclax (2-1 mol-mol),-1.8241267045237697,-1.0262237368782514
Daudi,11625818,2.088957631704298,3.157135406469047
IGROV-1,11213558,0.52356811652227,1.6566500002624296
HCC1500,selumetinib-MK-2206 (8-1 mol-mol),4.693148185456232,2.0700336473705327
SaOS-2,9907093,3.731287417721421,4.3764369182997065
COR-L105,54618771,2.0419110046350135,1.308516791118396
RKO,9935249,5.020114551473781,1.3931500963782744
RCC10RGB,54649381,5.891551456540707,4.121931581701018
RCC10RGB,11228183,3.0224846047699288,2.580341935748893
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868,2.0340428499981544
ALL-SIL,11683005,2.0727325774258794,2.9949940822770476
RKN,9935249,4.428036529076262,3.1697361474105143
SK-HEP-1,6918837,-2.2229066751457345,-2.489723146684403
Panc 02.03,36462,3.4500230117265933,2.3004277596322775
SU-DHL-1,9866186,-0.7631869517914462,0.8224186488796451
LCLC-97TM1,448949,2.0046135576158637,1.8480112209304245
SW1271,2858523,3.03244629786768,3.0822416244386854
SaOS-2,46398810,2.449640817433895,2.620384530926618
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677,1.9892551310766349
COR-L105,16013152,4.074366111138725,4.31241785232921
SW1271,10127622,0.8769341404821704,3.792506821781197
PaTu 8902,24951314,1.6215809376037376,1.5919700264324224
P31/FUJ,navitoclax-birinapant (1-1 mol-mol),-0.4716815446348188,-0.21440009864310752
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733,0.9818678687849131
Daudi,72199292,0.1565760694605324,0.27888319903778097
PaTu 8902,409805,5.142449436796194,5.174973660180629
BFTC-909,16115403,-3.993091010962378,-3.668715360833255
LS411N,serdemetan-SCH-529074 (1-1 mol-mol),2.4339981987212256,1.4756265023352324
NCI-H2452,6505803,0.3706171048891257,-0.40171332982589475
K-562,123631,1.7867714727142892,2.1866972061723526
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779,1.6779621132047873
SW948,56963564,0.1376223024943695,0.22832128932595488
P31/FUJ,doxorubicin-navitoclax (2-1 mol-mol),-2.963925883799113,-2.8222611789666576
KU-19-19,25183872,1.353604037781074,-0.7722141037367662
K-562,462382,0.6666012292356907,0.34550567473960503
BICR 22,216239,3.622359576149126,2.3898887949926846
SW948,72376,-2.235310823117723,-3.113155593342964
SK-HEP-1,16736978,1.840110323821058,1.7337417442580056
LS411N,135440466,2.8415058675889,2.1538314582336855
BICR 31,2871966,0.8542621552894032,1.128383381642677
NCI-H2452,5311281,2.597680352332147,2.109737113899976
HEL,25195348,3.2451646073619416,2.5670669664803785
MOLP-8,navitoclax-MST-312 (1-1 mol-mol),1.0636024254561756,0.36505630033311137
SW48,24856436,-0.3608375787119608,0.8803187842604672
COR-L95,23582824,1.713723586402061,0.5644400608460238
NCI-H2452,400769,-0.2625889565980605,-0.40297533656538576
Granta-519,6610355,5.056177796240837,3.6844111358928124
RKN,135984461,0.6080422026652917,3.8793522336348936
IGROV-1,9956119,3.7231415872817024,3.43815127391909
SU-DHL-1,24856436,-0.2626900450765423,-0.42461635485907023
BICR 31,9911463,4.617619725588035,4.0023050646050145
BICR 31,2742550,4.742856926113666,4.245066243559274
Daudi,6450551,1.0042642679666238,1.1479429762136262
HEL,57519531,1.593967479342305,1.4091271650482275
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638,0.6883781724664696
RKN,216345,4.602972623005823,4.173029105033394
SW48,46224516,2.362473255058207,2.536784127866799
RKN,10184653,1.939164173873933,1.495860509244782
MOLP-8,31703,-3.4249459011432912,-1.9057386297758838
HCC15,9911830,1.9028880277746671,2.5653475534527375
P31/FUJ,24180125,3.650250525491935,2.09476485860914
HCC1500,11427553,3.400784702269924,2.9487390623585394
WM115,4378219,1.986798403927216,2.5208056260879554
MOLM-13,445643,3.334033231716822,3.3495965594827313
HuP-T3,135440466,1.565116417651368,2.391852486696312
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175,4.298324585663067
SaOS-2,5284616,3.138246393599145,2.513313118240545
LCLC-97TM1,156422,4.251965697410575,3.5657930564829057
Granta-519,71680916,3.9040498639791226,3.940006358878587
SU-DHL-1,16725315,3.3729799888412257,4.0263549429251935
P31/FUJ,20959075,-3.3972839651855207,-3.2525654968983884
K-562,16720766,1.059873963232806,-0.1451197941906482
WM115,9915743,2.6223908273409515,1.3528750426907237
COR-L105,11238147,3.8255779395664065,3.094141173575706
HCC15,6918878,1.2461206152093485,2.8282197725766616
SK-OV-3,11427553,3.3243369937323877,2.6318477878584825
RKN,6918736,-2.1202784612128416,-1.2198740295409651
NCI-H1568,10385095,0.5241849666466598,1.2715614839023055
LS180,6623618,2.712323731600185,2.4968399770198597
COR-L105,BRD-A02303741-navitoclax (2-1 mol-mol),1.6973601808682428,2.629876793984412
COR-L95,5287620,-3.7742892062529183,-2.2452734380183124
Daudi,11977753,-5.803293235753203,-2.360519987995036
NCI-H1568,375860,-0.3746562160702436,0.015302940904021053
Daudi,1242560,2.7879344365615633,2.7516291427943975
RKN,2729026,3.0549768432694377,2.5937066073650383
SU-DHL-1,56963564,-1.155496663147979,0.8923592747142893
SK-HEP-1,42642645,1.5394057036271682,1.1449339007744799
COR-L105,9935249,3.5389604716579175,3.495554530532885
SK-CO-1,107970,2.4721550322855843,2.306501073559318
RKO,5113032,5.90165838842917,4.571877910824032
SW1573,135411,2.599466343128946,0.8845499165061961
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192,1.3831274506784217
RCC10RGB,6610355,5.214940260192328,4.6126485218776665
BICR 31,5287620,-1.513974949921974,-2.046771420851547
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734,4.331709554302926
RERF-LC-MS,72376,-2.3536044208150644,-1.6143303658636075
UACC-812,7326481,2.606201441290427,2.8344318733410434
MOLP-8,11717001,3.6554432811683824,3.9311187521690294
P31/FUJ,1317464,4.709019850634407,2.991753573271893
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101,3.755816496957954
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101,1.6961125020832128
SaOS-2,44507138,2.054017263478066,2.474120234824135
IGROV-1,445091,5.8777802446160825,4.2808940324944595
RERF-LC-MS,54613361,-1.445874788963763,0.0012340944003950693
RERF-LC-MS,72193861,1.0218744083195843,1.5767325270764159
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828,1.1446307234862925
HEL,56963564,-0.4081404928481738,-0.25390540117532934
PaTu 8902,136227924,3.2072125986231117,3.094194083476079
SW1271,25183872,-0.9123448839798644,-0.9730618036965827
LS411N,navitoclax-MST-312 (1-1 mol-mol),1.1524396159944978,0.7056214694927035
IGROV-1,25154868,4.833387840688245,4.259377862276962
LS180,107970,2.4480125060803077,2.288231350134991
RERF-LC-MS,9840324,5.508232790936476,5.708851032821517
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752,3.387735011809208
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843,-1.3484251921447596
COR-L95,60700,-2.695152938475503,-1.0757076477394516
HCC15,24785538,0.0662714662573936,1.7632907559572115
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.075005952505135
ALL-SIL,73707398,-0.324762560862376,0.4051505646873471
HuP-T3,23725625,5.187021863055133,5.282041054051254
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,2.916381592381822
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171,3.937829017169197
MDST8,6505803,-0.0816923181525763,0.09877771955165722
SK-OV-3,5351362,2.7626479495985765,1.691580891580827
IGROV-1,36462,2.313632721410001,2.157524946181313
BICR 22,54618305,4.315554591509874,3.802649901590074
MDST8,5311281,0.3396864368094036,2.2571668134072067
MDST8,9866186,0.4787443726889831,1.1360190478099015
COR-L105,9840324,5.89386509883338,5.828981475912462
SU-DHL-6,9887053,3.723065049771557,2.429105179972975
SU-DHL-1,10113978,2.4232665022526154,2.972470370872202
K-562,6610216,3.734328570580528,3.8594831781298895
MOLM-13,9936388,-7.059788369591511,-5.539485266481744
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824,1.4890693325672462
WM115,135659046,3.4373276092449667,3.6339574858747117
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322,1.923633863991307
RCC10RGB,2708,5.228545547030361,5.09853047578283
MOLM-13,JQ-1-navitoclax (2-1 mol-mol),-1.828604943394028,-0.8474010959247762
HuP-T3,969516,2.913535439683091,2.923342540609343
P31/FUJ,135398744,5.7727848933678,4.511584988800108
SaOS-2,168312962,3.518591614256865,1.9240036370911284
BICR 31,docetaxel-tanespimycin (2-1 mol-mol),0.9040464385667872,-3.0438390013850487
Panc 02.03,11364421,0.2085573081853932,-0.6251594136208631
SU-DHL-1,3385,0.1709309619587451,3.6107222267055534
COR-L105,3854666,3.5309487733662923,2.592314489772179
K-562,3025986,-1.372296763308674,-1.639821729566133
PaTu 8902,25183872,-0.4459453921876214,-0.6836730527462257
BICR 22,25022340,5.75714905141274,3.1042156977964273
SK-CO-1,71466445,5.862416915369376,3.976876688873542
HEL,159324,1.7687894675630291,1.0548051329534147
P31/FUJ,135411,-0.6620772647112111,-0.030695790767583483
K-562,11455910,-0.068399521398108,0.5136881122758534
BICR 31,doxorubicin-navitoclax (2-1 mol-mol),-0.8834140125072127,-0.6140895088951082
SaOS-2,135421197,3.6760992974277817,2.0380762270098525
RKO,54678924,1.753529637740366,1.8513411981298764
LS180,9926054,2.059729849775666,1.9864227312740552
PaTu 8902,3081361,4.091517551590367,2.2743578718602255
HCC15,54618305,4.644823264977023,4.503146851673746
SK-CO-1,135421197,1.070123520764916,1.905396159780657
MOLP-8,5282054,2.3704039128819603,2.660011650215894
Granta-519,2874250,5.483813332492178,3.7884810248541703
SW948,15547703,2.460178853059974,2.9440857946425836
RKN,11175137,3.1657803092866224,2.683027327001079
HCC1500,15547703,2.6330912213710693,2.9024864929328533
PaTu 8988t,3503,2.8268609009838706,2.3531489163516324
P31/FUJ,JQ-1-navitoclax (2-1 mol-mol),-0.8945725612384452,-0.6718766352067262
NCI-H2452,409805,5.262030999116563,4.994551733852403
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062,5.064548072696767
K-562,107985,-3.1543528536618175,-3.8756774979519695
RCC10RGB,6918837,-1.099435459858538,-2.0264011908419004
HuP-T3,2746,4.662800576379415,3.3771394819555622
Granta-519,135928012,3.1328015926823065,3.8842207311452728
HEL,2733487,3.1527152778808794,5.305882182321291
RCC10RGB,11175137,3.603105896683611,2.7833266147698645
RKO,51039095,3.7257826703811014,2.3128351373374385
WM115,3689413,-0.1044392328624619,-0.061700690316764374
SaOS-2,25154868,5.397428200613107,4.304574424882843
RKO,25195348,3.4491832635970585,2.7244525362924126
BFTC-909,49850262,4.237463012213885,3.675029833909739
SW48,168313047,2.500888470511616,2.131655475270964
WM115,444795,4.375682835505768,4.539717872479161
IGROV-1,5738263,4.037832478240785,3.45112555997276
MOLM-13,24748573,1.5626639761830592,1.1099348036975862
UACC-812,6917907,-5.293133909322777,-4.1904958982171685
IGROV-1,168313200,3.9938362637732983,2.916544782027707
PaTu 8988t,262093,3.2462588578894587,3.0059873242419
KU-19-19,selumetinib-navitoclax (8-1 mol-mol),1.098074451823129,2.1697089315268157
WM115,3543504,4.159835009416132,4.526305857514347
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272,2.3006877975922575
SU-DHL-1,9903786,2.5464454731205777,2.392627999642276
ALL-SIL,6438330,0.5772640537372373,1.0009855440040136
SK-HEP-1,322968,4.726859452680793,3.9918491297466483
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402,3.227517556979326
WM115,2874250,4.6839306454467975,3.7200777639191625
HEL,327653,2.969363674974165,2.8012136319327734
SU-DHL-1,11625818,3.655247454502854,4.202607004606869
UACC-812,49766530,0.2629782697340875,0.2835350493921818
SU-DHL-1,3815108,2.229733806447586,2.5438174293396836
IA-LM,71466445,4.189377103287156,2.90625668329877
HuP-T3,1716436,3.1901993610711092,3.2365630580121594
SW948,44566777,0.0218128389697893,0.5562752775620806
SaOS-2,24821094,3.1556587771151117,3.0017204248063445
Panc 02.03,135875424,4.996461687769912,4.078474442227603
COR-L95,3136844,6.4544258549997675,3.9653050652953628
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135,2.124352013567493
LCLC-97TM1,3385,2.7516430893834696,3.545800284101278
K-562,135875424,2.7247406179323055,3.4616504189856023
LS411N,5329102,2.797825403975713,1.688730968924415
MDST8,24964624,1.7196440159479949,2.3187664578864666
KU-19-19,10090485,5.355458016675434,4.154190216468626
HuP-T3,vorinostat-navitoclax (4-1 mol-mol),1.7749149652569187,1.40463523202786
RKO,89183176,-5.254565057669901,2.911581884086427
WM115,decitabine-navitoclax (2-1 mol-mol),3.441832187102982,1.659391595603989
Daudi,24775005,2.5651956502981093,3.409821425007047
SW948,46215462,1.7533079238953375,1.4823147583160965
BICR 31,6610216,4.499990209090508,4.352989310180971
ALL-SIL,89928392,-0.8842785165403505,0.2402650931240284
MOLP-8,carboplatin-UNC0638 (2-1 mol-mol),1.5821453597747015,2.8419721269268257
SaOS-2,9933475,1.7767718055197024,1.8056666564203994
LCLC-97TM1,16722836,1.3652485758433368,1.493441758753432
LCLC-97TM1,49793307,-2.6941720612695814,-2.8391270898618175
SW48,10127622,-3.686333454689576,3.1363002892022434
Daudi,451668,-1.5751627659840317,-0.454914680487305
NCI-H1568,135398516,0.1447365774963497,2.5227709419479956
MOLP-8,11178236,-5.22072808334844,-3.7250760439943797
NCI-H1568,46907787,2.5747387573296425,2.6590681001542533
PaTu 8988t,6914657,-5.535111189097384,-3.603361203593672
Daudi,vorinostat-navitoclax (4-1 mol-mol),0.7138664459313301,-0.07874855649191334
SW948,3025986,-0.0730103520402185,-0.518375123495437
IGROV-1,11612883,1.8715405446213529,2.5730529632977897
RCC10RGB,3081361,3.5981013353753464,2.482444802097509
MOLM-13,73707398,-1.293008226929777,0.3556802719423184
RCC10RGB,9915743,0.9759946846108524,1.5402479728240142
HCC1500,24771867,4.066345817331682,2.8998198559979524
K-562,44137675,5.346911467461658,2.8734997088171617
BICR 22,89183176,4.4276408454646,4.193321302516802
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305,-0.7862833173704538
BFTC-909,54619267,3.991913685478571,4.185310609598393
RKO,71304818,0.9175289508752972,2.2057267804549143
SW1271,selumetinib-navitoclax (8-1 mol-mol),0.9104447168636678,2.2678016929499147
BICR 31,25161177,4.144120396566418,4.260889180882602
SK-CO-1,6918328,0.4731277879927994,0.12950249695473146
RERF-LC-MS,6914657,-3.1593675222943896,-3.5781794320989064
NCI-H1568,44185566,2.743919877007031,2.568045801742013
BICR 22,navitoclax-pluripotin (1-1 mol-mol),0.259222956634469,-1.0812519835846819
COR-L95,6852167,3.112371536345172,2.273038568139183
P31/FUJ,5113032,4.875284905433655,4.4708994587372635
BFTC-909,24180125,2.699370118217823,3.2215804683716307
SU-DHL-1,6252,0.3334498529847555,0.6969086128233554
K-562,tanespimycin-gemcitabine (1-1 mol-mol),-1.5492083628260829,-2.2017078181838197
LCLC-97TM1,322968,2.924684365208183,3.2863617729563237
Daudi,60750,-4.624244800464318,-3.374380996496171
NCI-H1568,3385,5.30334090203815,4.2888903450050835
COR-L95,5978,-2.5997235685562026,-2.8615531116182042
Daudi,24856436,-0.3602858360333429,-0.39300601368460775
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635,1.2194307834198634
MOLM-13,445455,3.1473640199222386,3.993307441010069
SW1573,135421197,1.3915330004591782,1.9845728290217237
HCC1500,16065773,1.504426355167742,2.35372974866627
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564,2.7673005888725197
K-562,piperlongumine-MST-312 (1-1 mol-mol),1.115742811823549,1.111989329553762
Daudi,9826308,0.3207715704810925,-0.6718921281266477
RKN,17759555,4.047966260499275,3.658318015032143
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904,1.1522577400562053
PaTu 8902,9911463,4.390925153080421,3.864124852203826
LS180,54613361,-0.777399447336216,-0.03528522065755184
COR-L95,11396600,3.695258257335492,3.1198730388532026
SU-DHL-1,9911463,3.067527187401269,3.343436876972045
COR-L95,4477,0.8356196347588036,0.3283887335464854
SK-CO-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.065917743830426,3.680941267236286
COR-L105,12001922,2.476912212032941,2.013859329091053
NCI-H1568,25154868,2.392234118098981,4.415348678294453
P31/FUJ,24964624,0.604485461730223,0.8745461682726443
RKN,11507802,1.1392194525963166,1.6714030453900688
Granta-519,2746,3.996696473436098,1.692826752101879
BICR 22,6918736,-3.590209831667407,-0.4490917605591338
IGROV-1,135423438,0.764137689665023,2.4798559373188183
SaOS-2,5460769,2.263492155098724,2.690839688610376
MDST8,3025944,3.984610722170807,4.315826159109843
HuP-T3,9935249,3.692881062494191,3.103301105041702
BICR 31,54618164,5.999146696375086,4.227299216179829
MOLM-13,3552672,1.8354180523958712,2.8533047796654505
ALL-SIL,24889392,1.2675997647257198,3.2079390327261414
P31/FUJ,5470400,3.6840145170482383,-0.5954950954468887
RCC10RGB,68056272,3.770230744947895,3.570828170583314
K-562,135440466,2.878154323162211,2.167427070036194
KU-19-19,16038120,2.2784541929956563,0.9893796646034665
IGROV-1,969516,2.460805405371151,2.7675635093528204
RCC10RGB,54596490,4.957303932772775,4.841698193073691
SW48,54618771,0.2213541125267267,1.3618910980483037
SK-CO-1,56963564,-1.3743653333208103,0.8812782117716482
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657,3.095988813559486
SaOS-2,4096211,1.593922478920674,2.115968103196623
WM115,11317348,4.689716075377342,3.1110978714070385
LCLC-97TM1,ISOX-bortezomib (250-1 mol-mol),0.9661454802906008,0.7876930473977204
LS411N,387447,-3.952629374311597,-3.894994253544809
SK-CO-1,11396600,4.255124433433546,3.7421190330172895
RKO,2828334,5.934464187728916,5.648494943977044
NCI-H2452,6184667,2.981030320075281,3.456180481513046
MDST8,119182,-3.087899770061731,-0.4242876031344904
NCI-H1568,5282054,2.3545727551586744,3.8175956102507924
SK-OV-3,selumetinib-UNC0638 (4-1 mol-mol),4.410799167981822,3.6201045661035933
HuP-T3,navitoclax-sorafenib (1-1 mol-mol),3.5500030348393667,2.0813952540708214
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875,0.578351835003183
MOLM-13,5311,-0.2452037316548625,0.43334508794778126
Panc 02.03,119607,6.223236877281167,5.385703760101745
P31/FUJ,5566,2.621678413077409,2.7199180863975916
RKN,5311281,3.300248210659573,2.3302459384905987
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258,2.614698297264618
K-562,11152667,-1.0937594737206502,-1.517162122537104
WM115,241158,3.4880777915567496,4.037155457117857
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585,3.195140659397099
SW948,11707110,-5.12001559624384,1.2331233426528048
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308,0.07036187059991786
RKO,3503,2.683687073265507,2.044165131702671
SW48,tretinoin-navitoclax (4-1 mol-mol),1.442618908951043,1.7103398117415995
HCC15,3081361,2.87617011057776,2.4668800347776227
SW1573,25102847,2.4268351657646874,2.645775834648002
SW48,24785538,-2.175303706573729,1.2988396242766729
NCI-H2452,5329102,1.9284891088724192,2.0776260032829352
NCI-H1568,56946209,-4.312547212322036,-3.6157443499699493
SU-DHL-1,23939,4.934189555353841,3.6740494204628593
IGROV-1,2708,4.438419625543199,4.738814862114138
COR-L105,JQ-1-UNC0638 (2-1 mol-mol),-0.3865258904960421,1.877664747808914
K-562,44489675,3.6585617881709585,3.7667452721661676
SaOS-2,23582824,0.6839328831098858,0.5700508153021555
WM115,1242560,3.734530534800184,3.580967768457593
BICR 22,89928392,1.801349914013067,1.7031237400539105
MDST8,375860,-0.0509298762434446,0.1423794184625963
WM115,387447,-5.543981096917634,-4.048023545038445
PaTu 8988t,46215462,1.6929329300119484,2.050759687604125
SK-CO-1,25150857,2.4521914239487965,2.6150109506263615
RKO,46843906,3.289277038806309,1.786245595805908
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021,0.2983055614697819
SU-DHL-1,3062316,2.138301047480956,0.7922011253171712
LS180,31703,-0.5385699496513472,-0.6137989863965087
NCI-H1568,54619267,3.44714412714971,4.224332777579805
NCI-H2452,BRD-A02303741-navitoclax (2-1 mol-mol),3.2540850576086644,2.7140489277496256
SK-HEP-1,5351362,3.433378240202124,1.7376701928393197
Granta-519,119607,5.75770191278477,4.397120442702802
HCC15,2729026,2.745990777117554,2.5812003354244006
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816,1.5768732127105312
MOLP-8,24797083,1.4809895165463562,0.9066022201235184
MDST8,446155,3.7715450651151854,2.335627197004571
SaOS-2,11317348,2.7618337203443377,3.380959720656585
SW948,67156097,-1.6378764151549952,-1.8886755998770812
ALL-SIL,448949,0.3821166271144734,1.2707903026185474
SW948,5287620,-5.231918659547503,-2.0664394489510975
HCC1500,selumetinib-decitabine (4-1 mol-mol),6.513754829735322,3.1967778032535414
RKN,159324,4.081844329649501,3.1697361474105143
SU-DHL-1,6917907,-5.829381256855267,-5.027756595555441
BFTC-909,3825829,4.25128930140834,4.159329458332794
SK-CO-1,119607,5.49560679798916,5.161971167894077
LCLC-97TM1,6450551,2.230680139016655,2.4113771891496136
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.6989189323282723
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427,2.1216354307485306
HCC1500,54626689,4.657243866783195,4.585298743104096
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.4698336102755327
IGROV-1,9866186,0.4571266497661056,1.010325181710661
K-562,24772860,-2.920105669473321,-2.794745386521841
SW1573,9956119,4.0915863238100645,3.8452048056708077
BFTC-909,5280436,4.2143472852581025,3.5835860973042823
SK-OV-3,5282054,5.04615494272688,3.6700962585177836
SW1271,24180125,2.511417012575286,3.161541831422059
MDST8,doxorubicin-navitoclax (2-1 mol-mol),-1.1540260466133785,-0.676685915933497
LS180,46398810,2.878388522539818,2.504619247493406
P31/FUJ,2749,0.384854271149864,1.0295316926500004
NCI-H2452,5281321,-2.0767365956379944,-1.2159078947675737
SaOS-2,9927531,5.410264314347966,4.544389850840928
WM115,156414,1.595819692541897,1.57204204665258
COR-L95,15983966,3.7167583960216897,-1.7156208951758978
SU-DHL-1,10322450,2.9485372728674473,3.7609595317013254
HuP-T3,66577038,3.287519898796673,3.1423520820110684
Daudi,6505803,0.7229387165377155,-0.7304962739929592
COR-L105,46926350,-4.1614749205792565,-3.77556042635298
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034,2.419905580741604
MOLM-13,tretinoin-carboplatin (2-1 mol-mol),-0.195663512171335,3.056696547188443
MDST8,24901704,2.355370692316459,3.496915836607039
IA-LM,navitoclax-piperlongumine (1-1 mol-mol),0.8087427714288938,1.412323192116733
NCI-H2452,25126798,3.2665335299764298,4.006122308387821
ALL-SIL,107985,-3.6188373708521495,-4.05384635181342
P31/FUJ,5738263,2.6277017246063252,2.5661036110408215
HCC1500,2742550,3.2494473825713026,4.042689092308266
LCLC-97TM1,54618771,0.7707104681824843,1.005841774867908
MDST8,3062316,2.63216781392049,1.0730732809934904
K-562,100016,4.034095210213227,5.127731891615818
NCI-H2452,136227924,3.4253193575490695,3.22376862902091
IGROV-1,3025986,-1.046010021597061,-0.6909139640271128
IGROV-1,135875424,3.3275053166921347,3.4071676982335175
RCC10RGB,400769,0.8506758933165035,-0.18338546012315657
HCC15,44241473,5.510013950441446,4.8386886920210115
SK-CO-1,26596,-2.200264316257102,-0.344112391801997
HCC15,613000,1.6197134073445976,2.670970282335012
Granta-519,10427712,3.8202730219655496,3.7704857458936334
HCC15,5479543,3.813478020040636,3.5687476220909913
PaTu 8902,135423438,1.708930423466824,2.4582436102441703
Panc 02.03,24964624,3.328827283539013,2.486353147604555
LCLC-97TM1,25154868,4.98783448400422,4.32956113889541
RERF-LC-MS,5113032,4.48589538963195,4.87276481246601
SK-CO-1,168313016,6.229837204453753,4.902844397151767
SW1573,9926054,3.1618263718643513,2.0633652921524184
MOLP-8,451668,-1.0880279758209197,0.12130674007601669
Granta-519,doxorubicin-navitoclax (2-1 mol-mol),-4.791758111451553,-2.585510040636824
SW1271,46191454,0.8015154670027128,1.705054000969843
IGROV-1,156414,1.4212019235656712,1.240787372330667
IA-LM,vorinostat-carboplatin (1-1 mol-mol),4.059193114117947,2.3257122957051215
NCI-H1568,11647372,0.9090690740398496,1.4625515395673663
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188,-0.289413514789293
HEL,5394,4.33544579006292,3.3911097307438154
Daudi,23635314,-4.750280690911186,-2.92307932129584
SK-OV-3,3543504,4.529917197725731,4.260560371411857
NCI-H1568,51037431,4.33384460889792,3.4343077673992486
SU-DHL-1,2708,2.612747958759665,4.425994333852562
SW48,151289,-0.0884278513227002,1.1665127996375126
SW1271,24772860,-2.1080107772753607,-1.606958645168726
SW1271,675434,4.352597318848774,4.5365603983898195
Granta-519,44632017,0.2326960109936577,0.7139447471239465
SaOS-2,11955716,-1.373693500458253,-0.9812733063633547
KU-19-19,159324,4.255883770522122,2.9930896722706257
SU-DHL-1,4261,-0.6665613942828803,0.4396453049487347
COR-L105,10302451,1.2881684147693646,3.3541422717942204
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,0.86556764818651
ALL-SIL,4096211,-0.2650943934034739,0.925903765796805
IGROV-1,216468,0.5330864756407336,3.0305594637379145
Daudi,46907787,-0.707382985228944,-0.3491204617596885
ALL-SIL,11175137,2.2895463411974597,1.5892705915796725
HuP-T3,7326481,3.4338903427833674,2.9312317189876067
SK-OV-3,11626560,2.736987670099794,1.8418019973075561
NCI-H1568,5978,-3.194054905017319,-1.976336341132434
P31/FUJ,25062766,0.5108470478058419,1.498235740827658
LS180,4261,0.8191216854939201,1.310709759342445
HEL,71304818,2.1837189642761645,2.109316966631253
NCI-H1568,71466445,4.632148673172368,4.096484110245033
PaTu 8988t,5282054,4.412677005920707,3.875561325887868
SW1573,54686904,4.039437320121271,3.675650381873485
RKO,53392493,2.7606647137416616,1.930222035164456
PaTu 8902,156422,4.606541116596145,4.177546343287912
COR-L105,54454,1.772071227552003,2.6186922794668317
KU-19-19,9926054,2.3371072555508445,1.9648827303478011
IA-LM,3136844,4.47285753340146,3.5881271827990235
Daudi,3854666,0.3283534306514684,0.9196934858036068
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422,-0.13938226702414658
SU-DHL-1,72193861,-0.6645199564816581,1.4741043874178004
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972,-1.1328334457000364
SK-CO-1,44202524,0.5946445627983161,2.399464622302746
K-562,1750826,1.7671131923879069,-2.592702930627047
LCLC-97TM1,3854666,0.8191923722369518,1.5539818010205866
SK-HEP-1,4477,0.3599343153867445,0.6463685525754859
BICR 31,5282054,4.622453961920413,3.9250931948545156
ALL-SIL,3025986,-1.187507928097146,-1.586905957462387
BFTC-909,3062316,2.03384364484094,0.9719000176396239
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433,4.10754814035786
Granta-519,444795,4.599812836973149,3.110588818003188
UACC-812,piperlongumine-MST-312 (1-1 mol-mol),1.224354228260847,1.9745826110648357
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469,1.1964969845535354
RKO,1566236,3.4833841973625725,2.300735277620761
BICR 31,navitoclax-piperlongumine (1-1 mol-mol),2.358684882853314,1.5958986430075583
LS411N,carboplatin-UNC0638 (2-1 mol-mol),3.912215714956053,3.3711640890772396
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342,2.448925124637121
NCI-H1568,8515,2.0721444777555327,4.171122831056612
MOLM-13,24978538,-1.2743594434772367,-0.22804310267972558
SW1573,23725625,4.357604161446221,5.139442086524062
HEL,15953870,2.2428109686656295,2.833671083356731
Daudi,52947716,0.9938257746380776,-3.277727764120924
BFTC-909,44259,1.3269924163099676,1.1703429067876001
MDST8,selumetinib-UNC0638 (4-1 mol-mol),2.2725517612456416,2.6454524917142717
SaOS-2,6918328,0.1895131607356872,0.04460940970983817
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876,3.630876041540457
NCI-H1568,3503,1.1278876480867208,2.3447984293706043
IGROV-1,72376,-2.111352545322758,-1.8608142155205758
SaOS-2,selumetinib-piperlongumine (8-1 mol-mol),3.928507120342424,3.4512139429297366
SK-CO-1,654092,0.6285789884023978,-0.06776309569477056
SU-DHL-1,44589607,1.246014317818898,2.5754886357104305
PaTu 8988t,3552672,2.097731757890035,2.725883342639423
HCC15,5282054,3.6050373222028815,3.885686978223812
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058,3.424659227643442
WM115,16013152,3.8161355323039,4.172430484497218
ALL-SIL,54618305,4.365324809283883,3.30683834095497
SK-CO-1,25195348,3.743308569883415,3.422567715085186
BFTC-909,123631,2.8792987518934403,2.4707542481727587
NCI-H2452,25022340,5.0430378131248785,2.8146340079819323
BICR 31,11719255,5.311316415457661,3.545710916077976
BICR 22,JQ-1-vorinostat (2-1 mol-mol),0.486661425618767,1.0261937256680271
HuP-T3,568763,0.3762081962980199,0.47345153349653907
Panc 02.03,71680916,5.6819891784443595,4.923741651438172
SK-CO-1,44484440,3.788843022204708,3.0846824538094797
HCC1500,60750,4.75355506285403,-1.5773578969343647
SK-CO-1,44607531,1.475264767684201,1.3707460758597534
MOLP-8,1317464,4.425962710369034,2.976430630333022
BFTC-909,107985,-3.700699007813787,-3.356446754593015
SK-CO-1,3025986,-0.6416687634539443,-0.7996203695342597
BFTC-909,44493528,4.370300807083883,4.411642650700765
SW48,49850262,3.202043440642355,3.4458449020253106
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026,0.7274355777740787
MOLM-13,5746,-2.6320399073484633,0.02868480495762093
NCI-H1568,36462,0.6787379731584755,2.054519655028351
SW48,vorinostat-navitoclax (4-1 mol-mol),1.1280429303528072,0.9549571951221273
LCLC-97TM1,31703,-1.7062756219896058,-0.8528928408010789
BFTC-909,54454,2.6967031082973527,2.720585800606971
BICR 31,5351362,2.0722735669158876,1.581039130752028
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743,-2.7713702297694893
HEL,3543504,3.6690825601144064,3.323200827909208
IGROV-1,11178236,-2.8618715106425725,-3.294324520879388
SW48,176870,1.305545107688616,2.8770821007083303
LCLC-97TM1,3062316,0.5973926668956511,1.2940645550749936
HCC1500,6852167,3.541859976914812,2.8657547961769723
MOLM-13,54626689,4.673711949381485,3.8027192410254638
RKO,11175137,2.9264569639519906,1.923425886116081
SK-OV-3,carboplatin-etoposide (40-17 mol-mol),4.59219202218907,2.730515421944207
BFTC-909,73707398,1.325657316242966,1.2870302221785719
SK-HEP-1,11485656,3.3898088020096324,2.5867565637918504
SW1271,637858,1.8302889918552376,1.9398280627562088
P31/FUJ,151289,0.3376751835645198,0.511174624427682
MOLM-13,6918289,0.5846893448973186,0.08103271273397325
RKO,4096211,2.0568907070726397,1.2299975688720748
HCC15,42611257,3.545791426903468,3.354871153241985
RKO,51037431,1.443783779144223,3.16688521083335
RKN,1716436,3.648262431092988,3.1158633993688887
RKO,216345,4.0768365061219525,2.9271016905501153
MOLP-8,54454,2.3030156333842533,2.3635182308809575
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552,2.4201435579506305
SW1271,11719255,2.0964009449704335,3.533012432687612
SK-HEP-1,5328940,3.1706915881362097,1.814856649419096
HEL,6914657,-6.908409772348001,-5.375963572963306
LCLC-97TM1,6918878,3.384977217975284,1.9849697065067904
HuP-T3,46943432,3.2592232125577665,2.7181657994300767
KU-19-19,11152667,0.8748891502312,-0.4496077283918771
MOLP-8,5278396,3.6007551773478093,2.96765636000886
MOLP-8,71304818,1.8062780808091792,2.1197835486346652
BICR 22,selumetinib-navitoclax (8-1 mol-mol),1.8614529515345275,2.1572614622047634
SaOS-2,5280436,3.62212536353362,3.443480668961756
IA-LM,71751553,4.579394980470846,4.047731003709434
COR-L95,374536,2.031472802797221,1.4250775573398715
HCC1500,1716436,1.6304357372897462,2.910477262429016
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903,1.2753082896769063
SW1271,9967941,4.951865473173475,3.6377481685206066
KU-19-19,6918837,-3.3861016705907203,-2.412003085794341
LCLC-97TM1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.91566117969414,4.144933440705418
RCC10RGB,54626689,5.11978438920743,4.762943043591369
COR-L105,24964624,2.7213287093015848,2.738209615617391
RERF-LC-MS,10184653,1.661334722418144,1.525322794945428
COR-L105,9907093,4.049740181744662,4.404422312796082
WM115,4917,1.7802954819592542,2.7709342412628684
Daudi,25262965,-3.918146889356354,-2.339159185044698
RKN,9926054,2.8101544562472056,2.121043974241999
COR-L95,969516,2.641832541585458,2.613777449606055
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939,3.6087102959360595
LS180,60700,-0.831384616867798,-0.3835544922783598
HCC1500,25062766,2.7449885477672136,2.3218814190899657
COR-L95,11640390,2.478695805138082,2.780491198302582
HuP-T3,54618164,3.3933985234085755,4.185527903684501
SaOS-2,25105715,3.6317688538247968,3.284171432419216
SW1271,5335621,2.365445027841909,4.72357152020287
NCI-H1568,72193861,1.9818580959671683,1.9812285811768098
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006,1.5698464960729184
SW1573,10385095,0.5068001344623563,1.311862192955854
ALL-SIL,2841722,3.706104916487932,3.596026367875333
P31/FUJ,71466445,3.0287439983851225,2.430736720409172
IA-LM,JQ-1-UNC0638 (2-1 mol-mol),3.2694867389724744,1.4774325647557065
COR-L105,4917,3.658916006838,3.1718288510001362
RCC10RGB,9903786,5.708919982977709,2.884607506664302
HuP-T3,25161177,3.646148401953212,4.322747925112666
K-562,71466445,2.3693775657442373,2.5374909712022284
K-562,11977753,-1.2336845020581693,-2.5233921053482047
LS180,16725315,4.563180557999628,4.223457298017216
NCI-H1568,66577038,1.9593359628641709,3.011214854343586
SaOS-2,3465537,1.5281169625539155,2.6023887036883626
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235,3.849163655869317
MOLM-13,17755052,0.2343645648969551,0.43104347458461845
RERF-LC-MS,67156097,-1.006688958645714,-0.6252707072679725
SW948,5470400,-3.941225454290086,-0.6742424750609642
HEL,44185566,1.408371464536178,1.2585065913309794
RCC10RGB,3503,3.522457107356278,2.498911951210393
BICR 22,9866186,0.6641273098552615,1.0800510995100467
K-562,52947716,-5.609155633475852,-1.346060444610171
SaOS-2,1641662,3.0320316508312883,3.5187822265811945
SW48,5460769,-0.8804369809799648,2.1933055467336176
MOLP-8,11625818,3.354870459420626,3.3425417185787762
KU-19-19,3025986,-0.2897675094370045,-0.7801993707104456
K-562,9444,4.095192274458736,3.4036707094244245
IGROV-1,5329102,1.2794664511054334,2.0132615963717315
LS411N,11427553,2.839596649209722,1.885050394938797
SU-DHL-1,10385095,0.4695713178913991,1.2654455453600808
SW1573,124202324,3.209850220678193,2.9730889522991015
BFTC-909,2949965,3.0294119536880197,2.791820331680074
Panc 02.03,44589607,4.606435993835204,3.283186708630826
LS411N,25126798,4.124739072985443,3.4027472460811383
RKN,24785538,4.869460471506453,1.9436060688337826
SU-DHL-1,31703,-2.5255735182995203,-2.1826897528251203
KU-19-19,6505803,0.0199416611110358,-0.16432762271194132
MDST8,5281672,5.754114909876849,4.434509848832272
PaTu 8988t,9903786,4.140175125497243,3.026168412555439
SK-CO-1,11717001,2.027201802005241,3.93277253970599
K-562,navitoclax-sorafenib (1-1 mol-mol),1.3368563864105187,1.26212337794117
HuP-T3,54454,3.567661200928428,2.868318663323837
MOLP-8,262093,0.615798330418347,1.506850593770002
SW1573,6918328,0.8267852089643692,0.34553732743213866
LCLC-97TM1,73707398,0.638027637531153,1.0033234084474967
SaOS-2,11719255,3.097989779485228,3.6193552627336056
SU-DHL-1,73707386,2.8817783064824773,2.4898197109886104
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547,4.510004352511643
LS180,9915743,2.834892961755663,0.5421575981512567
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356,0.5695685026675694
BICR 22,4578,4.285603675470092,4.226907229121178
SaOS-2,24951314,1.4499530102948022,1.168944253569408
RKN,6918328,0.5495182279950256,-0.33519778499901404
IGROV-1,66577038,3.2148239132520455,3.0842289586396316
COR-L105,15547703,4.316721747481802,3.29711982951141
HCC1500,753704,5.032412058463686,4.982789035835506
RKO,44819697,-0.2126149769206573,-0.5382618854837184
HCC1500,16013152,3.952751911590144,4.139774695885666
SW948,89183176,3.757757719513151,3.369958597565294
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.8376842437211083
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593,2.6082427005041255
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823,2.961291788858363
IA-LM,44819697,3.529669119404179,-0.8377189784191218
PaTu 8988t,148198,-4.283282973565046,-3.4276474956602265
HCC1500,5287969,-0.1960949732639439,-1.6983785810583398
RERF-LC-MS,5460769,5.094680634820597,2.805724410458217
BICR 22,10113978,3.5652875556244923,3.421765279638482
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.3220039663456697
LCLC-97TM1,6184667,3.4160200622822736,2.576950093184647
SK-OV-3,44507138,1.930427516054787,2.548166680503953
SW1271,54626689,4.884226988721356,4.576758169388927
COR-L105,25195348,2.918205578273492,3.317852737880675
MOLM-13,49850262,2.0503909100702873,2.5800249907339694
LS180,104842,-3.608354535822108,-2.870476335222293
Granta-519,6184667,3.6411271735359207,2.1597928180737025
IGROV-1,49836020,5.658436828096057,2.4974169209720105
HuP-T3,54619267,3.893027602521098,4.191890959473174
SW1271,409805,4.993473873943069,4.755382615698904
NCI-H2452,2749,1.5209092727807076,2.1563472820851497
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918,-0.6399992830241769
SK-OV-3,119607,5.6958068077620405,5.317572256122098
Granta-519,JQ-1-navitoclax (2-1 mol-mol),-0.9470910727061151,-0.7490723873124666
SU-DHL-1,6184667,2.253300303827536,2.9135106664650654
WM115,2871966,2.231269661110087,0.8910300102780571
SK-HEP-1,219104,4.349330089087446,4.087746983358922
SW948,selumetinib-piperlongumine (8-1 mol-mol),0.6665506156446188,2.7588672380538077
SW48,8515,2.6507036204950256,3.7539121921849596
MOLM-13,241158,1.7093626682651633,2.551334676422198
RCC10RGB,71576739,5.1028364410536735,3.77942236120146
LS411N,54619267,4.196494516067777,3.5625152153749458
Panc 02.03,637858,2.766769284687194,2.177767218999009
P31/FUJ,25150857,2.053516150415863,1.4645270149721257
P31/FUJ,24951314,0.294555023880993,0.2013995397666812
SU-DHL-6,16736978,-0.092754907722646,0.722252354100641
RKO,151289,1.190219151105647,0.6002472307074475
NCI-H1568,1716436,2.664872339798973,3.0934818293456017
SK-CO-1,doxorubicin-navitoclax (2-1 mol-mol),-2.167378618505947,-0.7668868641193396
LCLC-97TM1,49836020,1.9924259842665932,3.76897753698718
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552,2.329500632750435
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011,3.603030630584995
SW948,11647372,1.3621251009964823,0.5958609872772981
LCLC-97TM1,selumetinib-UNC0638 (4-1 mol-mol),3.547341579124928,2.8143690830761323
LCLC-97TM1,56963564,-0.6229750501206363,0.21547753600288716
IGROV-1,11427553,2.926316692603687,2.9345320689945633
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019,4.353733150909353
SW48,24951314,0.6660870475429757,1.1741309136837264
RCC10RGB,46398810,2.467266718263722,2.6726698311293684
NCI-H1568,16720766,0.7309820541773976,0.5915620023631664
K-562,decitabine-carboplatin (1-1 mol-mol),4.43725246072026,0.14288443813048757
HCC1500,6918878,3.8452122267855544,2.87859219184839
MDST8,JQ-1-navitoclax (2-1 mol-mol),0.0958031568177067,1.0953480889160847
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245,2.4330496606551737
NCI-H1568,9840324,5.648333485386012,5.862096865710575
SaOS-2,24772860,-2.2454069761524416,-2.081925943597833
NCI-H1568,12003241,-1.4870303892505918,-0.7404486157032605
IGROV-1,135411,0.626702113064729,0.5540177980989789
SU-DHL-1,123631,2.2104669936854817,2.193770953292228
BICR 31,676352,2.5344425849235472,2.1343111237554337
WM115,2828334,5.840169576442124,6.233778096653914
BICR 31,16722836,0.993439631718574,1.7464772307211769
LS180,71304818,2.5144465721497573,2.21376383437088
HCC15,176870,4.3801450304989835,3.2589836295229975
SaOS-2,44137675,2.8908105588075537,3.5978415241751547
SW48,57519531,1.1891467216952898,2.757530004757437
LCLC-97TM1,46943432,0.977611384475134,1.8655094229225677
LCLC-97TM1,selumetinib-tretinoin (2-1 mol-mol),4.0009002077883755,3.174566164809603
MOLM-13,alisertib-navitoclax (2-1 mol-mol),-6.0299100304654365,-1.858102008888083
UACC-812,52912189,-0.0403441295384107,2.452120976453058
HEL,638278,3.1804055556137394,2.604606121956961
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824,2.415589557652517
UACC-812,45279963,4.1756281682233185,3.42747475423175
MDST8,12001922,2.1068751805520423,1.7590133389431717
HuP-T3,11626560,2.4663043755994094,1.9363482293914052
HCC15,9884685,1.2743229964902805,1.0257989831091536
Daudi,82146,3.751797413920901,2.818806596531819
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.144610574154712
BICR 22,969516,2.807563254821311,2.616108739641261
RKO,6917907,-7.36544436443182,-4.672830021615107
LCLC-97TM1,BRD-A02303741-carboplatin (1-1 mol-mol),3.5226633114065407,4.158021716956259
P31/FUJ,54649381,3.661627004097492,3.1238536621905473
P31/FUJ,15983966,-4.570279214878008,-3.3724148857208083
COR-L105,49793307,-0.7736136433109717,-2.153016720756216
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786,2.430649271654944
SK-CO-1,57330099,5.774767561552264,4.201024134353457
SW48,navitoclax-gemcitabine (1-1 mol-mol),-2.8390563906078543,-0.8803669606070847
Daudi,36462,-1.782907247885185,0.22369353230051878
SW1271,10077130,5.262255440725952,2.9587681718022254
PaTu 8902,124202324,2.5191853508509823,2.651226770744955
SW1271,4261,2.1417567232825157,1.741368787244598
SW1271,568763,-0.4148311333850545,0.7170937223341853
IGROV-1,44185566,2.2104732991243248,2.424391646793461
PaTu 8988t,piperlongumine-MST-312 (1-1 mol-mol),1.7723365960000816,1.975346844577867
RERF-LC-MS,54678924,1.4734481784853186,2.3804716867822253
SW1271,17759555,2.4829827438054104,3.6128269984896884
HCC1500,2871966,-1.8945265193529464,0.4711214732232033
RCC10RGB,119607,6.074674808773517,5.460263197743242
MOLP-8,5566,2.8349074996791295,2.84224645639843
K-562,24901704,1.0460453676907424,2.4204159761682367
SK-OV-3,44607530,2.4027946355264507,1.805439836244898
IGROV-1,44589607,3.0909001492794377,2.653358202721837
SU-DHL-1,44185566,1.07324922266726,2.3204411173043225
MOLM-13,navitoclax-gemcitabine (1-1 mol-mol),-4.310291489660192,-2.4608008639850785
SaOS-2,42642645,-0.01972406793895,0.7778101004703535
SaOS-2,327653,4.165382989627235,3.2265616891305173
RERF-LC-MS,44491742,4.380479941679622,4.4177195068720945
Granta-519,navitoclax-gemcitabine (1-1 mol-mol),-5.4729921992931665,-2.0803697013788627
K-562,3038522,1.918387146447148,2.5850524659022565
HuP-T3,702558,5.633624519144866,5.493298965038498
ALL-SIL,2858523,2.9846374491002376,2.46886373276817
WM115,44589607,3.0632481185375933,2.8501861756144318
LCLC-97TM1,11977753,-2.2409153175434953,-1.6583736074800235
Granta-519,7251185,1.138949301849667,1.5102948067233384
MOLM-13,446155,1.5984418257641329,2.1657449797112496
SW1271,11455910,0.4702460968788743,1.141756852512481
WM115,10184653,1.7306018843706388,1.442222470743212
SW1271,12003241,-1.4062779923685875,-0.9288773089472494
SU-DHL-1,3038522,3.3518104703058467,2.6215081930405755
RERF-LC-MS,44819697,-0.3406635094896507,-0.004724750180643237
SW948,tretinoin-navitoclax (4-1 mol-mol),4.012168549649723,2.117981796277918
SK-OV-3,piperlongumine-MST-312 (1-1 mol-mol),2.5779047815349627,1.8345730383321348
RERF-LC-MS,3825829,3.876424055067748,4.087540128053103
SU-DHL-1,208908,2.168834483257838,1.8021446821880063
COR-L105,4378219,1.9356703916494296,2.6698063617471974
SU-DHL-1,44489675,4.002710700308593,3.6830846872867915
BICR 31,5329102,1.5123342757929257,2.266874821639324
BICR 22,72193861,1.1787223619968317,1.5507171036338536
SK-CO-1,4259181,-0.2853622975740302,0.42444708943237147
RKN,5278396,4.050807510430523,3.809646542159776
LS411N,3543504,6.407278726964401,3.725076518588866
Granta-519,2749,-0.6711865738648753,0.8640513723776451
LCLC-97TM1,11222830,0.9756157307321038,1.4893654907313398
HCC1500,49766530,0.4188049276678212,-0.04973373161575404
BICR 31,24821094,2.272776200428542,3.0390316107390394
LS411N,15953870,3.79326986504028,3.4794029618730837
KU-19-19,15547703,3.5460273004695364,3.0786632044864723
IGROV-1,10410894,3.2660402181528263,3.0808623279266065
SK-HEP-1,9936388,2.725726666175631,-0.17324143098702016
SU-DHL-1,68056272,2.8441937668208297,2.8729628808986734
BICR 31,107970,2.625018410874988,2.4675687208555837
RCC10RGB,24978538,2.2083570886635258,1.521267026724032
MOLP-8,42642645,0.4027543307161444,-0.020139446219379856
IA-LM,6438330,0.5920782597943414,1.9761627201589205
HCC1500,25102847,3.871994319987046,2.623474014306277
SK-CO-1,9903786,1.8148473241522671,2.7729599606605104
SK-HEP-1,51037431,1.9503987957256583,3.2646871317494863
SU-DHL-6,15547703,1.663295720719241,2.5393621333030234
PaTu 8988t,42642645,1.5127014290808742,0.8146773355854929
Daudi,4578,4.14840859618435,3.6443976713087545
HEL,73707398,1.0006953763352662,0.3309046136193448
RERF-LC-MS,3634881,4.923247717838372,3.410873318393207
HCC15,9907093,4.55737056946543,4.302949809593443
IGROV-1,16725315,4.890680859998698,4.143152939705725
COR-L105,navitoclax-PLX-4032 (1-1 mol-mol),0.9673135251369994,2.4671915856435507
COR-L105,107970,2.936160881286492,2.3212978070783388
PaTu 8902,11485656,3.4031855994132663,2.5087302069343895
BICR 31,5287969,-2.0848564793948423,-1.80972294970225
SU-DHL-1,3503,1.2104794697541517,2.172540404630321
WM115,selumetinib-MK-2206 (8-1 mol-mol),-1.676879875544035,1.9631256607714844
RCC10RGB,107970,3.009214725762471,2.495591199664263
KU-19-19,51039095,3.4730458815699743,2.7518379527281835
KU-19-19,selumetinib-MK-2206 (8-1 mol-mol),2.230752575212941,2.331397406303538
IGROV-1,16038120,0.2864038103759729,0.9801423510508538
P31/FUJ,selumetinib-UNC0638 (4-1 mol-mol),1.8703414483738705,2.4704823990706064
SK-OV-3,1323703,3.751791158325908,1.6656918530713662
K-562,JQ-1-MK-0752 (1-1 mol-mol),2.296423482837328,0.2512084459141841
LS180,56946209,-4.291807545115399,-4.109470696623568
BICR 22,16741245,4.124711805224883,3.4878333076367496
Granta-519,11396600,3.399615682634249,2.4869506920910767
LCLC-97TM1,4378219,2.0431586025336332,2.464724868600505
COR-L95,piperlongumine-MST-312 (1-1 mol-mol),1.3307800151979865,1.4898950855687965
PaTu 8902,3062316,3.1999770976977966,0.8923460383360096
MOLM-13,9825149,-0.4975121245832732,1.672773522930149
PaTu 8988t,36462,2.8739750906545263,2.21671397370619
WM115,4261,1.0617223830766982,1.7967516061457358
BICR 31,54618771,0.3365869204450262,1.4174084010598655
IGROV-1,6918837,-2.9804518885508635,-2.4544872691238897
SK-CO-1,49850262,4.729060483840123,3.620185620154376
NCI-H1568,selumetinib-MK-2206 (8-1 mol-mol),2.137801357231392,2.344646801876703
SK-CO-1,49793307,-2.625714785229563,-2.7356652029868487
ALL-SIL,159324,0.7144692186053382,1.0589682923490655
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896,-0.8603736228433327
RERF-LC-MS,24821094,3.899392046553833,3.0207289645643325
NCI-H1568,selumetinib-decitabine (4-1 mol-mol),4.70224066359239,4.011562756213728
ALL-SIL,54613361,-1.2150310590443698,-1.0694446537782092
MDST8,54618771,1.2096098448968695,1.286302627226712
MOLP-8,26596,-2.4791577040777812,-2.646305003274267
RKO,4788,5.372325515812119,5.2106514956549175
P31/FUJ,44589607,2.3901798108348533,1.9428127618148932
SK-OV-3,613753,3.56222269809742,3.227101324682694
SW1271,navitoclax-sorafenib (1-1 mol-mol),2.5597569107989457,1.834375728556862
SW1573,2858523,3.1892649395611556,3.152543704451351
LS180,72193861,-0.0461725132802377,1.5808712294021605
RKN,25126798,3.956068538327861,3.7795379987581947
MOLM-13,6917907,-6.412365954060792,-5.38378173538195
WM115,50905018,4.954075896774319,4.248895978536988
HCC1500,54619267,3.954111090910006,4.100617185726867
IGROV-1,6252,1.1284141516966473,0.8065269008350997
Granta-519,49766530,-2.591856607816134,-1.9534212935589133
RKO,400769,-0.364727826621167,-0.8165218882308274
SaOS-2,5113032,4.015669070835574,4.982609955575661
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978,-0.38024923816765066
BICR 31,400769,0.3553213589698107,-0.5129781804903902
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249,0.4696318896773116
MOLP-8,JQ-1-navitoclax (2-1 mol-mol),-1.8736660374722776,-0.032451000607439134
RKO,24901704,3.90150667551114,2.2551974076780437
K-562,675434,4.134192231732703,4.210784405455968
PaTu 8902,vorinostat-carboplatin (1-1 mol-mol),3.3056109148195936,3.265485139338214
IGROV-1,60700,0.4424479122017752,-0.4327437504685717
RERF-LC-MS,439501,-1.3704502050640626,-2.142761998090764
PaTu 8988t,3081361,3.3861147832051004,2.4000232242709587
PaTu 8988t,11507802,1.1782523393568187,1.763315843027916
RKN,25154868,3.091821445991922,4.335223946745112
SK-HEP-1,3384730,4.617019540739567,3.1726641286770927
IGROV-1,135411,0.626702113064729,0.5540177980989789
RKN,44202524,1.6880658914716755,2.0571211490821892
MDST8,10127622,1.4568360900186117,3.0563167030609675
ALL-SIL,5978,-4.2912860791141725,-3.5954875625416816
LCLC-97TM1,25195348,3.14182472834864,3.306138467033023
MDST8,navitoclax-piperlongumine (1-1 mol-mol),-0.5700737020348542,1.3743700249305677
MOLP-8,2949965,2.304667717892232,2.133913666451007
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.18927059153970974
NCI-H2452,11485656,2.991875358712002,2.6282361463156843
Panc 02.03,2708,5.654354843286421,5.0894844897599185
SaOS-2,15953870,3.7774839542606617,3.6879684565159714
LS411N,11238147,4.220683195687341,2.552905463404684
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234,2.1920738171401766
COR-L105,11404337,0.9270352493146456,-0.1028138895891912
RKO,20959075,-2.9107192765247536,-2.459992545284077
IGROV-1,452548,0.0422661560146271,0.33527077791150167
SW1271,25062766,1.8071163488926476,1.8869294598013207
SK-OV-3,24180719,3.148638094054939,3.526792722034469
IA-LM,doxorubicin-navitoclax (2-1 mol-mol),-0.2967430289420483,-0.8673061745102035
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727,0.670434532056505
Daudi,selumetinib-PLX-4032 (8-1 mol-mol),4.542051250808824,3.2627537977903343
NCI-H2452,25150857,3.315566378385427,2.5551490590524124
P31/FUJ,carboplatin-UNC0638 (2-1 mol-mol),3.2617545834686155,2.489587647817834
LS411N,216239,2.6090534487015953,1.8887412371554497
SW948,2828334,6.27053385486612,5.736494845341516
HEL,25262965,-1.9607005706581808,-2.317914126005897
SK-HEP-1,46398810,3.2056962377986333,2.7625992585379953
P31/FUJ,46191454,0.7861082656977861,-0.15371124169682818
SaOS-2,11404337,-0.7935370479535776,-0.4338145589216607
LS411N,6918878,3.507421995092854,1.2274226495070983
COR-L95,5566,3.0030322186541754,2.8270057007886398
NCI-H1568,2729026,2.4592472427928795,2.7095018772222503
Granta-519,5566,3.1418180472473023,2.8213055126659077
SW948,15953870,3.980690301912255,3.4873621240096804
IA-LM,selumetinib-navitoclax (8-1 mol-mol),1.3709865001695822,1.9623986816887324
SaOS-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7775872222613356,-0.6690371863978908
COR-L105,decitabine-navitoclax (2-1 mol-mol),1.4499610580472069,2.110483039155661
PaTu 8988t,4096211,4.042256121680771,2.407220963257296
HCC15,638278,3.5096393014384346,3.2338545722320173
LS411N,44185566,2.59688005994845,1.744862549575835
WM115,15547703,2.53174585982074,3.352159419246966
RERF-LC-MS,46907787,3.883745984979501,2.503784656143422
RERF-LC-MS,49793307,-1.4864117200972382,-2.1704806213340264
LS411N,6918837,-3.511331359252859,-2.9896941457927078
HEL,2729026,2.9938268289747394,2.253505543178999
SU-DHL-1,9911830,2.4926956672938543,2.371048665139226
RKO,6505803,-0.9276151073099124,-1.0334844483211183
HEL,5351362,1.012542471793317,0.931322389460733
SW48,448949,2.118847083295334,2.1346769873338665
LS411N,3854666,3.592971008902542,1.0955093304197865
Daudi,55283,2.1333092426313143,2.259224598893584
WM115,568763,0.4176363376103466,0.5685394420645559
ALL-SIL,JQ-1-navitoclax (2-1 mol-mol),-1.241318632460125,-0.8683723675121258
K-562,54143018,0.8143265967368298,-0.1645869970574415
WM115,6914657,-1.139050920215431,-3.736353095076225
BICR 31,JQ-1-navitoclax (2-1 mol-mol),1.1041257622460865,1.1191526413049833
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982,3.282812083460409
Daudi,57519531,1.0816397392331083,1.5639667104797603
MDST8,9840324,7.1320098113776185,5.833472764320564
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234,2.0637212485394305
NCI-H2452,67156097,-0.4931697978204585,-1.0171056170244583
ALL-SIL,11507802,-0.6218585688390301,0.6736291285638601
MOLM-13,9926054,0.378361077880871,1.5765800752703667
LCLC-97TM1,676352,2.332754642745106,1.9509199667741377
SW48,6450551,-0.0066484474606689,2.2893551926926854
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169,-0.7043709490000858
MDST8,vorinostat-carboplatin (1-1 mol-mol),3.0562610561977004,3.097328408318394
ML-1 [Human thyroid carcinoma],53232,3.218931075380609,2.905677836866269
KU-19-19,46191454,1.4474607873871597,1.89400340092034
BICR 31,135440466,1.3506373291640237,2.3009948462213394
SW948,44632017,0.8619787858061628,1.1455961403015282
NCI-H2452,159324,4.677055932941875,3.528930134486276
WM115,60700,0.0008203329731028,-0.2066016424478714
HuP-T3,selumetinib-navitoclax (8-1 mol-mol),3.027921751084016,2.320259023598683
RKN,9936388,2.306220468641662,-0.9971203059482897
MOLM-13,2945648,3.0282797197343374,2.232723264665406
P31/FUJ,135875424,3.622681212031297,3.197812257660296
LS180,navitoclax-gemcitabine (1-1 mol-mol),-2.7206195218400007,-0.5842169749669796
BFTC-909,24964624,2.4776408698208003,2.5269424618539182
HCC1500,3825829,4.205963950909598,4.033887519705718
P31/FUJ,selumetinib-MK-2206 (8-1 mol-mol),-0.6510792771612892,1.6640387427292476
SU-DHL-1,135984461,1.9491307161872016,3.307664547687943
NCI-H1568,409805,3.8387714265583592,4.894762039075416
COR-L95,2945648,2.3261820103406183,2.4340282663175743
LS180,selumetinib-tretinoin (2-1 mol-mol),1.4682365811163622,2.6843419002536324
IGROV-1,5746,1.9055212643377857,0.8565857289935613
BICR 22,selumetinib-decitabine (4-1 mol-mol),2.485402962452582,3.128124026122015
HCC1500,104842,-2.1208898309536073,-2.5983087813627317
IGROV-1,148198,-2.659972993252853,-3.4912900206033246
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641,0.315599452053163
K-562,crizotinib-PLX-4032 (2-1 mol-mol),0.2702262717922032,0.9212122817876305
IA-LM,5746,4.310443233142937,1.1297414449554304
WM115,10427712,3.357641117907952,4.333884167224002
WM115,31703,-1.493876478932265,-0.9859083334416786
K-562,10296883,3.719487542859837,3.2982924679302004
UACC-812,JQ-1-navitoclax (2-1 mol-mol),2.277260275544626,0.6904789270394671
SW1271,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6288124556214316,3.8020382334117113
IGROV-1,10184653,0.79276129336756,1.208473366577402
K-562,5287969,-0.8630520858269013,-1.9539626073154097
MOLP-8,148198,-4.437033387624053,-3.9830221866396722
BICR 22,navitoclax-gemcitabine (1-1 mol-mol),-3.257857035264034,-0.36617890211478615
BICR 31,24951314,2.26082148142024,1.5459447326688263
COR-L95,9887053,2.0711365362831193,2.950141870409853
SK-CO-1,2841722,4.495379043063509,4.42649778403701
COR-L95,54618164,3.8157010413732406,3.9382695658498665
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025,2.405122509014811
SaOS-2,25262965,1.6840235781335875,-1.6412821886324303
MDST8,25150857,2.921484336528134,2.57949065375878
SK-HEP-1,984333,0.8474815446030621,0.8150989051171004
COR-L105,5311037,4.270584574919318,3.701589918096498
P31/FUJ,selumetinib-navitoclax (8-1 mol-mol),-1.1281624183387444,0.20366429572462597
LCLC-97TM1,3825829,3.858617243526108,3.5854532605062883
SK-OV-3,24951314,1.413681041410239,1.542718003037397
NCI-H2452,9903786,2.1501841215173396,2.7315816017957064
PaTu 8902,56963564,4.5637436248697565,0.5518296921772547
SaOS-2,262093,2.7398792490382244,2.918638419045181
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924,5.618961917922804
BICR 31,3854666,2.26793763186435,2.415542965220457
SK-OV-3,15953870,4.452396287203901,3.717157111665224
HuP-T3,serdemetan-SCH-529074 (1-1 mol-mol),2.447475280373413,2.1406725161011297
BICR 31,24785538,2.8976650742045127,1.8566367683015752
HuP-T3,9903786,4.0743016574038915,2.9342806579447376
Granta-519,11175137,2.0306520437568767,1.6677988308131169
Granta-519,25105715,3.663648488967505,3.0775664562773795
NCI-H1568,49867930,4.553956635433513,4.652911570357142
HCC1500,16038120,1.5738549040879308,1.219746949024654
LCLC-97TM1,227681,3.759896348853487,3.0721321461867563
BFTC-909,49867926,6.076136735210805,4.108980942135098
ALL-SIL,5278396,3.0589186731365814,2.8799731298375177
HCC15,2742550,3.2685764522673972,4.149198249742327
RERF-LC-MS,44486219,4.018485879154908,4.353107551508231
RERF-LC-MS,462382,0.9319597157341816,0.8399332689370076
SK-CO-1,selumetinib-UNC0638 (4-1 mol-mol),-0.0758878647184332,2.363832001653136
SW1573,3854666,2.927116287337192,2.3125613633811026
Daudi,9935249,-0.0031627785077317,1.049841128275562
MOLM-13,10231331,1.9024628033326092,0.6888207628207437
SaOS-2,6918837,-2.9214939411920593,-2.347680067851918
HCC1500,11507802,0.960722132601806,1.7499863656732844
WM115,doxorubicin-navitoclax (2-1 mol-mol),-1.5072575260972283,-1.294284320278972
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179,1.5462362593837313
LS180,9911830,2.83226076921101,2.426092242669437
RERF-LC-MS,11222830,1.7620759794741472,1.6411136519478557
MOLP-8,6252,-2.041702184925406,-0.6026877666187999
SW1271,5978,4.916909360273371,-2.0015643595045667
MOLM-13,5479543,2.5400848053862264,2.372432862419252
NCI-H2452,11612883,2.7546488169018963,3.054592603105165
NCI-H1568,44493528,4.1542795967274175,4.396114311534973
RKN,46398810,3.1612721401313792,2.5336058056167374
ML-1 [Human thyroid carcinoma],676352,2.608959843452948,2.159116132206666
MOLM-13,ISOX-bortezomib (250-1 mol-mol),-0.222539624438373,-0.2680658640041919
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605,-0.18533322378461736
SW1573,31703,0.7694714266266048,-0.7321885465545658
BFTC-909,11238147,5.503103761619835,2.763456024340614
SK-HEP-1,637858,2.866868896175592,2.192127564928196
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325,1.9137590971327882
KU-19-19,2828334,6.071698785304069,6.166264046975305
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108,2.160468785611846
RERF-LC-MS,2828334,5.9123201087220325,6.19421309095474
SK-HEP-1,vorinostat-carboplatin (1-1 mol-mol),4.117273876837617,3.381641440093052
PaTu 8902,54649381,5.340946431274584,3.965004890352459
RCC10RGB,11214940,1.429625683961422,1.9629093045871693
NCI-H1568,25195348,2.211268152441431,3.4210817899885653
COR-L95,10184653,1.5221413196357014,0.8699702257949113
BFTC-909,3634881,3.6308731463535704,3.4088030048288807
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.5494081760604146
SaOS-2,24785538,-0.4134197784310965,1.7181804567772758
RERF-LC-MS,4705,3.292681011259135,3.2895746292652333
MOLP-8,10127622,1.9499981558353492,3.04781702587516
Daudi,11626560,0.3779689739853294,0.6494052679815916
MDST8,168312962,1.677679532849221,1.5850802390679413
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.2226685318165216
MOLM-13,10113978,0.7724135376915046,2.371915880135419
PaTu 8902,selumetinib-MK-2206 (8-1 mol-mol),3.282015538774474,2.0364473805237524
HCC1500,216239,1.4805608336728902,2.4722322849977685
RKN,5281321,-0.4803497212669658,-1.3540786696890146
PaTu 8902,11175137,3.538788964844938,2.549751626124903
Daudi,10113978,1.6179427120332186,1.8936148162265
K-562,26596,-3.6076758496321832,-2.246766925231878
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158,-0.6034696356950924
Daudi,5291,1.8632614405000685,2.7677579732013866
NCI-H1568,2874250,4.364133169191667,4.57599365898883
LS411N,984333,1.2324204412799928,0.7570942931174318
PaTu 8902,11222830,2.39915227633331,1.6359438491539735
MOLP-8,54678924,1.6307832002497362,1.5350020864042173
COR-L95,49793307,-5.549400502924621,-3.504856509633992
HCC1500,45279963,3.5713917460093434,3.505684648126477
WM115,54765302,3.574934655958074,4.192136857599565
SaOS-2,136227924,4.496792726095474,3.0322565897451326
NCI-H2452,107970,2.3345640718356364,2.469450806839339
LS411N,16720766,1.2713952174238143,0.18919876038076602
MOLM-13,navitoclax-PLX-4032 (1-1 mol-mol),-1.1656285238385289,0.24818978146325296
MOLM-13,216239,-5.069803023561943,1.6442606287927026
RERF-LC-MS,44241473,4.536869636330491,4.891204757642411
LCLC-97TM1,10074640,3.2021543880531156,3.0185274133286133
Panc 02.03,10296883,4.297264305827386,4.037043738396239
IA-LM,3689413,-4.432004355370191,-1.107386343688549
RKO,375860,-0.2095842697906711,-0.43711170883891554
HuP-T3,676352,1.9029965224961456,2.080434328795924
SW1271,5470400,4.349220092525355,0.18794241499642939
NCI-H2452,656346,1.056906556032961,1.2675753784488
BICR 31,56649450,1.7574149169243078,3.3797941490046166
RERF-LC-MS,24785538,0.8057743011820994,1.9205096454293464
SaOS-2,9825149,0.8893885919981879,2.357786937231543
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573,2.8364227184513493
PaTu 8988t,carboplatin-etoposide (40-17 mol-mol),3.874190963823487,2.6780281277523983
SK-CO-1,638278,3.4780853527987854,3.203778051663274
WM115,4096211,3.685037910266886,2.167192920606732
RKO,126941,-5.081226966265268,-2.746765002564756
RERF-LC-MS,54618771,0.9955970244631366,1.540891124610953
Daudi,50905018,3.9297282000687312,3.2260713699021566
WM115,11609586,3.058244435077658,3.007525735151264
BICR 31,9926054,1.721382648019371,2.0484565832776958
RKO,24821094,3.7157598247146977,2.2514385576050877
IGROV-1,135440466,0.9791523710816318,2.283322810681581
NCI-H1568,44202524,1.0522971592210668,2.3997872295068796
HuP-T3,9933475,3.0776536859408807,2.0335357380875463
COR-L105,carboplatin-UNC0638 (2-1 mol-mol),4.035332544942737,3.372831716680125
BICR 22,11612883,2.729453217725868,2.5105537332421313
MDST8,25154868,3.4078840547236333,4.327966689850731
WM115,12001922,1.1273981641266086,1.9489083090673904
SW48,2742550,3.28553671385033,3.976516224151076
WM115,445091,3.8598878691820886,4.353158112474905
RKN,135875424,3.6230459419726526,4.0438889011961034
BFTC-909,2708,5.254338200716292,4.759603079397154
SaOS-2,2871966,1.7918423486815835,0.3619272351336381
SW1271,serdemetan-SCH-529074 (1-1 mol-mol),2.3446355759055684,2.200250156272219
HCC15,44632017,0.3758817607479284,1.450901920034639
COR-L95,2729026,2.664378744829576,2.5055184702914515
SaOS-2,1566236,1.7620742085681662,2.393441073965433
BICR 22,11955716,-1.4294009955010087,-0.9326350114025495
BICR 31,2729026,2.966794528433677,2.6641174415508497
COR-L95,119182,-1.6347192148686482,-1.1154351966730385
LS180,5328940,1.742567210928755,1.5111703681637738
Panc 02.03,46398810,3.420081587494409,2.7772509133616294
RCC10RGB,60700,3.171193268028763,0.400896597804423
SU-DHL-6,451668,-1.4332734905345434,-0.027428199359803184
Granta-519,16219061,2.116318709414125,2.1307595040975666
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784,1.0862061154899252
HEL,53232,2.5038982548529747,2.215645208988443
RKO,44507138,3.480554434186059,2.3227418422418267
NCI-H2452,3081361,2.98247650375621,2.4200674427880795
RERF-LC-MS,44202524,1.2785968032229695,2.2432815361170486
RERF-LC-MS,16722836,2.4162442447682193,1.8210035876747475
HCC15,637858,3.032734575357801,2.3296610305982504
IGROV-1,11396600,3.99372654279783,3.6005442436441903
BICR 22,44202524,1.658152527320416,2.457424809983843
MOLP-8,54618771,0.2679151571300236,0.669475841322622
NCI-H2452,navitoclax-gemcitabine (1-1 mol-mol),1.5021089136928458,-0.8941153963369923
LCLC-97TM1,54678924,1.535359034662644,1.957107790020606
BFTC-909,49793307,-2.946331542038894,-2.69350437345213
KU-19-19,5738263,3.812580710038467,3.492256491624186
PaTu 8988t,24821094,3.93253598055128,3.2470871861609822
LS180,148198,-2.644013472885731,-3.3657116580213273
HEL,409805,5.92709656224454,3.866464233756198
RKO,11612883,3.106052261550285,2.1533702696848946
SW1271,122327,4.37632222345113,4.740781573910149
MOLM-13,44241473,6.124350775268443,4.248251060036258
HuP-T3,2126,5.715410620657667,4.857501485314241
K-562,5291,-1.1872539047134878,2.275507889574919
RKN,5282054,3.624299707956654,3.75570160315918
BICR 22,613000,2.6534426018316277,2.898108199778909
HCC15,49850262,3.6300454046422774,3.8843548257434257
SW948,613000,2.5939391420023212,2.600014585543925
COR-L95,135440466,3.0574476104836914,2.124738761817494
SK-HEP-1,262093,3.158620019748703,2.8603329446259447
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967,0.5156921750926518
MOLM-13,123631,1.0914116119684203,2.008012599814532
BICR 31,4378219,2.049792351388142,2.772597228949443
LS411N,16722836,1.825979837410603,1.3767330773626267
SU-DHL-1,10074640,2.3568880289385654,2.689464443227054
ALL-SIL,6918328,-1.7903684912223865,-1.860273952260635
SU-DHL-6,3384730,1.0298608560692932,1.4785574631953582
SU-DHL-6,11485656,1.7981230616770194,1.7130757413008768
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346,1.9070645240447544
NCI-H1568,176870,1.641159934282528,3.3837231222149793
HEL,5280436,3.9989145330348896,2.831142366188578
BFTC-909,5328940,1.2290524134113243,1.8374330401158674
SK-CO-1,151289,0.7492352886663923,1.0814649058786994
RERF-LC-MS,104842,-3.024577047260716,-2.496534332799575
PaTu 8988t,46843906,4.444995617536364,3.1644768927972713
BICR 22,24856436,-0.0251718817877118,0.6376395031058429
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929,2.0442431218323076
IA-LM,67156097,4.3159050642226,-2.05074528510348
HuP-T3,6438330,2.3942211080747837,2.4235946155965804
HCC1500,10296883,3.843895309810077,3.807770550320862
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736,1.0703773829180425
SK-CO-1,56946209,-3.7989193199280016,-3.7976583330432345
Granta-519,148198,-4.763660659469611,-4.126023711953242
HEL,4917,2.9031193377759603,2.612229829076047
RCC10RGB,66577038,3.312011612499516,3.1025834786511086
Panc 02.03,3689413,0.2165954212360822,0.1797909186446648
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214,1.8662639161961911
SW48,241158,3.5185545260205364,3.883432435706323
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662,1.6516262875386252
HCC1500,navitoclax-birinapant (1-1 mol-mol),-3.387149505683513,1.0308894652496559
K-562,11167602,1.4540526159902811,1.8451402775337007
HEL,9911830,3.2406370139452134,1.3429975858961354
SW948,25150857,2.687963392787196,1.8524902548415398
WM115,44137675,0.4260207876885596,3.7305399384922904
SaOS-2,4917,3.064827494863108,2.8201696117038817
SaOS-2,3503,1.987605483793098,2.4000872837844045
LCLC-97TM1,9840324,5.858053248657865,5.627605179879247
RKN,11178236,-3.061903912386503,-3.1762518468134147
COR-L95,46843906,2.16387123849571,2.491128398941012
K-562,46191454,1.7723208241237427,0.9451974177271196
LCLC-97TM1,5746,2.627938158922912,0.9339209537821338
RERF-LC-MS,613753,3.34976336152667,3.2330590737780978
HCC1500,9823820,4.617789125102065,4.037326193447713
PaTu 8902,49793307,-1.5016152541437175,-2.3154315383753894
LS411N,24964624,2.837560916730962,1.406799958160506
Granta-519,42642645,-0.7384711962533689,0.023339863596735774
Daudi,156414,0.7854974484116999,0.6743998134193027
HCC1500,9840324,5.570797833564005,5.807918443278484
HuP-T3,6914657,-2.995276103152913,-3.721581901041633
SW48,11178236,-2.976969958039468,-3.2814175106921124
Granta-519,11214940,1.149911870185247,0.9343951131450148
Granta-519,72734382,4.317814968690637,3.4375781698338166
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697,1.9573018150588373
SK-HEP-1,15983966,0.8278271069258164,-0.997232058224548
BICR 22,6610355,3.5129220888937622,4.482776546950725
HCC1500,44489675,3.6836892776405854,3.991994147089711
IA-LM,3634881,3.385658224323674,2.8872613757090555
SaOS-2,JQ-1-vorinostat (2-1 mol-mol),0.950161902916163,1.0851807368994717
COR-L95,4788,5.892645370038274,5.352260230456619
NCI-H1568,11717001,4.19629869858104,3.923822291203821
RKO,46224516,2.430810450928805,2.5689360061869904
LS411N,6505803,-0.6536233604701492,-0.817079732717278
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986,2.7548962282030836
HCC1500,16725315,3.090868252599208,4.291434883445402
Panc 02.03,5287620,-2.132468814908427,-2.138334326504815
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485,0.04603714905908868
LS411N,5351362,1.130738510814583,1.2574282870339009
IA-LM,168312962,3.008218706470952,1.3191016994201428
SW48,9887053,1.6385742110161594,3.940097727350762
HCC15,2945648,3.8992008266513305,3.0079917524267654
WM115,10385095,0.3137764342063494,1.3890792062879262
SW48,11213558,0.38171338020492,1.5032145097732132
IGROV-1,9911830,1.9130562323799436,2.378375699325675
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277,-1.716893625396322
LCLC-97TM1,5284616,3.038958191933125,2.7583740623054145
SW948,5311,0.5245292911924586,0.8487481997393301
PaTu 8902,2949965,3.498586647815041,2.9801825455171693
PaTu 8988t,53232,5.050646647161413,2.8479880417779757
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367,-0.47579467485971094
P31/FUJ,2729026,1.895106624580685,1.9549624768128828
SW48,568763,-0.0201118962331156,0.6457078422921473
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646,1.103938190746082
SK-CO-1,docetaxel-tanespimycin (2-1 mol-mol),-5.721099284006835,-2.09078793545004
SK-CO-1,54454,2.352526453014332,2.6620150805360874
MOLP-8,tretinoin-navitoclax (4-1 mol-mol),4.347252260304068,1.4634642110738698
SW948,151289,0.9927868711009586,0.9352492795894243
RCC10RGB,676352,2.417271143726191,2.2855209910865413
LCLC-97TM1,15953870,3.316413299321368,3.5712949209833194
HCC1500,252682,6.335850466863892,6.539804446710252
LS411N,doxorubicin-navitoclax (2-1 mol-mol),-0.6349980356208603,-0.7799255746680676
SW1271,702558,5.67814751001827,4.89650083865757
HEL,3503,1.2339935625044716,1.7262485719629028
SW948,6918328,0.2458443826474451,0.03613363100531528
ALL-SIL,124202324,0.3755400921280209,1.1150018279716816
SW1573,2729026,2.4001203305493397,2.8938149047337807
SW948,57330099,4.403961221202979,3.82085726623235
UACC-812,42642645,2.375397400257474,1.259908018514982
LS411N,tanespimycin-gemcitabine (1-1 mol-mol),-0.1859317712708109,-0.8090617602277581
PaTu 8902,984333,1.3011106079808883,1.0448937192835148
P31/FUJ,135398516,1.7387657861081838,1.0195389748936285
WM115,46224516,3.0669076127990276,2.3551078780251267
SW1271,24771867,3.777194428597206,2.4617028959899137
HEL,73707438,4.0836720937600175,3.8588929115763175
MOLM-13,16038120,-1.7825288578452578,-0.4721235008257866
IGROV-1,10427712,3.944243047938238,4.536459987082317
LS180,3815108,3.93048377981505,2.7666250272056674
HCC15,1750826,-0.4775912601104041,-1.3287658240236697
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.4126910030873425
P31/FUJ,42642645,-1.1469220315427042,0.08779520729760291
HEL,1750826,-3.7677259179114047,-2.7914872236281316
NCI-H1568,25183872,-0.3156837582718859,-0.7203726687084031
SW48,54143018,-1.2192841502688678,0.8969868389131022
SaOS-2,441298,1.6833347099113902,2.36151495403969
SU-DHL-1,119607,3.7964753700545546,4.889553530700584
LS180,654092,0.275565618798522,0.009567167461451274
RKO,6918736,-1.762610939534952,-1.9819640038495705
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277,-2.335741663100446
SK-OV-3,168312962,4.003119281373622,2.0040233799977507
PaTu 8988t,3062316,1.6786738127042626,1.0120908226767515
P31/FUJ,5746,-1.0128835373821496,-0.3912889362020813
ALL-SIL,46943432,1.7359798293614472,0.8914507801390431
IGROV-1,119607,5.004384040905396,5.115816554887283
LS180,135440466,2.758543039731734,2.392271364320192
HEL,15983966,-4.130179752932702,-3.70099321395313
SW948,11228183,2.319596035574442,1.180492162531591
SK-CO-1,navitoclax-birinapant (1-1 mol-mol),0.739134837908099,1.5962313817307001
NCI-H2452,219104,4.089454197150707,3.9564505235179057
LCLC-97TM1,24856436,-0.9719468010392746,0.444360656918636
WM115,1716436,2.084402062067542,2.907627905790738
WM115,54596558,3.929397107249587,4.1184858116165355
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498,1.4289645987635953
SW48,2828334,6.103861625006206,6.19305118331021
Granta-519,5335621,4.386788840750005,4.055332828289362
NCI-H2452,25105715,3.487348959516136,3.423084702061434
LS411N,11152667,-0.1489697958567156,-0.7710240231533814
HCC1500,4259181,0.9827468065480526,0.3090933370572504
SW1271,1716436,3.164329770032204,2.944945001962448
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671,-0.5664860171884223
KU-19-19,637858,2.3404288739792314,2.113766533728238
SK-OV-3,3081361,2.5908903164469317,2.444061049302793
BICR 22,10322450,4.612637955736889,3.4697548434575514
ALL-SIL,44819697,-2.9345943950607136,-2.2094053560077125
LS180,4259181,0.5796574720850999,0.14706665414045764
IGROV-1,6918328,-0.5330006254346346,0.15790899945039044
RERF-LC-MS,11178236,-5.98494163410248,-3.1268669199547237
SK-HEP-1,SNX-2112-bortezomib (250-1 mol-mol),0.9629137048911888,-1.055318448291838
IGROV-1,11485656,1.900409616013456,2.1453319685172354
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167,-0.654792132468417
BICR 31,16065773,3.973194001978765,2.591575637965612
IGROV-1,6252,1.1284141516966473,0.8065269008350997
SaOS-2,135398516,5.990406168261382,2.139246569803675
RCC10RGB,11485656,3.364959979667133,2.5966492351742763
NCI-H1568,46926350,-5.085925204635643,-3.8643903841168066
LCLC-97TM1,123631,2.4246211789463445,2.330833161155364
BFTC-909,44185566,2.75887016136311,2.6463460994882224
BFTC-909,124202324,2.9321657702899295,2.7437584042225898
LS411N,4917,3.429074291339912,2.8114139815363637
BICR 22,135440466,2.8663984884678513,2.1771313403937715
HCC1500,10127622,5.201205269222406,3.2848935820326033
WM115,24748573,1.2650334763374356,2.2187443694926605
LS180,17755052,1.7669119525953814,1.497414617517484
HEL,5278396,2.941082820113368,3.060443963153093
K-562,6917907,-5.621792844351372,-5.599404245416648
WM115,11175137,1.8074191527620995,2.548026660820221
ALL-SIL,6610216,3.679901693613009,3.6980820814318265
IGROV-1,3815108,1.915722485757852,2.7103033177414
IGROV-1,44491742,4.406671418311328,4.173323265636984
NCI-H2452,11647372,3.7610160121318055,1.5671252792333628
Granta-519,25262965,-5.6090339200635375,-2.466384588323468
HuP-T3,5287969,-2.0305885584054693,-1.8668398333136895
Panc 02.03,4578,4.394890119629889,4.592581030293517
PaTu 8902,46199207,3.581196343990194,3.142405720614221
MOLP-8,5329102,1.1360795478534944,1.4250594588095427
SW1573,24797083,0.9725439959134782,1.3722579578417256
COR-L105,11507802,4.378208095645504,1.8886878095242614
SK-HEP-1,10385095,2.0924930980552148,1.3027319240779058
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475,2.6925329099148665
MOLM-13,54618164,3.841266236609366,3.3761519622250544
SW1573,5287620,-0.7347028317725576,-1.8236440809842716
Panc 02.03,24821094,4.183998590604807,2.9338034891889477
NCI-H2452,11977753,-3.0535753971711617,-1.8708044725737307
MDST8,selumetinib-tretinoin (2-1 mol-mol),2.2380074013059086,3.2231309100625576
K-562,5278396,3.2143611477277325,3.1473037340964978
MDST8,46907787,1.4338285439483007,2.284301339885783
MOLM-13,16219061,2.363003680724254,2.385274946552884
IGROV-1,3854666,2.3355254440561137,2.224181230453949
LS180,11175137,3.0855574956004506,2.654799444097332
PaTu 8902,24180125,3.5735575491444505,3.170835163617844
Granta-519,135440466,3.2501433765769097,1.7750287281349932
Granta-519,3634881,2.8250958488191533,2.5524655664237828
BFTC-909,24785538,3.0409365635840433,1.8353714756611146
Daudi,9903786,1.3988461789185107,1.800291742425596
IGROV-1,126941,-2.246216453812328,-2.4153467565108926
HuP-T3,327653,2.4979616286385573,3.246865481434649
KU-19-19,24785538,4.6207321752497545,1.7669191900265222
PaTu 8902,11238147,5.651020754323713,2.9233559467332704
P31/FUJ,24772860,-2.926152167827307,-2.762686174788046
SW48,969516,2.6010409472277303,2.6913165108344503
NCI-H2452,11656518,-0.3763326461825258,2.0911473115569748
LS180,156422,4.137124258725139,3.894511133447279
K-562,16038120,0.8140588279430221,0.3165304342184815
HEL,9956119,2.2634866876643924,2.7775518559251577
MOLP-8,16013152,3.9032026583920656,3.386727062560666
SaOS-2,7251185,2.1177882155213488,2.5324612648089366
SW1271,16722836,1.1489272284540188,1.6456244438229986
SW1573,1750826,-4.895155026964416,-1.6950186047339537
COR-L105,6918878,5.053406021852451,3.450114167063164
HuP-T3,44566777,1.596285673654969,0.8184783270860039
RCC10RGB,11167602,3.5267453541831695,2.87437989810576
KU-19-19,3689413,0.155027117273248,0.1159326197026325
LS180,262093,3.1953995116592826,2.9968086812078805
HEL,168313016,4.358661125075543,3.7221889724893082
LS411N,448949,2.5849168666236273,1.5492587916614116
RERF-LC-MS,11507802,1.168612691302407,1.8003849975707151
RKN,3025986,-0.1432368238740909,-0.6953274515478438
LS411N,5566,3.1552423609786153,2.8140850473668495
MOLM-13,168312962,1.173226591058953,0.6026050584814523
KU-19-19,16741245,1.8623441782077492,3.883372651284822
BICR 31,5746,2.9612823230829592,1.2235155863794414
RERF-LC-MS,448949,1.7883798522328354,2.0884412284171487
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114,1.9825596197650635
K-562,135411,0.731253239019591,0.24424482293191774
WM115,3825829,3.803690072721518,4.20520963956162
PaTu 8988t,1566236,2.792784501487116,2.5991545232034317
SK-HEP-1,25102847,3.375423501622406,2.6384911071538797
RCC10RGB,4378219,3.5112219508307017,2.5229941601484156
IGROV-1,46907787,2.182756719431072,2.0953961412153985
ML-1 [Human thyroid carcinoma],176870,3.163449715300446,3.652114148159126
COR-L105,9903786,2.948812050867326,3.1057550149129893
SK-HEP-1,5287969,-1.6185163943497696,-1.8801448218599817
LS411N,66577038,3.114674219164565,2.3410528079569635
LS180,11152667,-1.0678137233062412,-0.2479498803939954
SW1573,10322450,3.835483834832597,3.6088743873175866
ALL-SIL,4369359,5.632204520937589,2.29483812867338
P31/FUJ,6918289,5.395091759648689,0.15996265019501354
NCI-H1568,carboplatin-etoposide (40-17 mol-mol),1.7182211320205656,2.9201029238411733
BICR 22,54626689,4.975060177279609,4.6143932541818655
RKO,11455910,0.1271196393609195,0.6986138745105711
NCI-H1568,2749,1.8950065449811435,2.112692527399633
SK-HEP-1,2858523,3.173409588420467,3.1660190194733535
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214,1.9485191705730243
NCI-H1568,16736978,1.0202421307584555,2.158481746651325
NCI-H1568,11640390,2.883529605834316,3.615873138662693
SaOS-2,375860,-0.2844076074043694,0.09318624030354104
Granta-519,9549297,1.4990763156673828,1.5741522188863393
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837,-1.7944444671039712
MDST8,9915743,3.1722151191536607,0.9849743974131039
HCC1500,7251185,1.592161448601532,2.4438481994577326
PaTu 8902,654092,0.4014878659730266,-0.0011742555125128652
HCC15,36462,0.276886424919507,2.3116170654133295
HEL,11222830,1.7664464656365049,1.1107052981263839
LCLC-97TM1,6918328,0.5489211755624944,0.1493862198472735
SW1271,11427553,2.280233400826346,2.591399465588334
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673,-0.7536363091464167
SW1271,216239,2.3992651597700805,2.401438110272661
LS411N,52912189,2.124177170278397,1.1052710334008284
RKO,262093,2.7220373961576834,2.1192360692780086
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306,2.414792071328803
SU-DHL-1,24180125,2.3898229933344193,2.9682182590060795
P31/FUJ,10231331,0.360402840185862,0.593618757910112
COR-L95,navitoclax-PLX-4032 (1-1 mol-mol),-1.058390181093963,0.6215197206468875
HCC1500,4705,3.1720127097688073,3.496661004424414
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409,1.7109002123098218
ALL-SIL,49793307,-3.5976005593324607,-4.518524275245713
LS180,decitabine-carboplatin (1-1 mol-mol),4.499129095785504,3.911559100276591
BICR 31,selumetinib-PLX-4032 (8-1 mol-mol),3.623780948669338,3.7478476944232773
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001,4.857967562238521
ALL-SIL,44489675,3.868517697091687,3.5868202182962654
COR-L95,9825149,1.4009706639997015,1.843082398260143
SK-CO-1,25102847,2.4259034566713087,2.417499951648839
COR-L95,36314,-2.5383774872687743,-2.563202852347392
IGROV-1,1641662,3.5854177848263675,3.327716971284786
BICR 31,16720766,0.8786813091838682,0.6996121684786499
BICR 22,51037431,2.6213243445689254,3.266631929583371
BICR 22,2742550,3.9616050819266326,4.015718517866429
Panc 02.03,46843906,3.852893526574364,3.378221875147429
NCI-H2452,2708,3.4614923437122704,5.061364783535
RCC10RGB,15547703,6.556615668020641,3.4929697516027836
RCC10RGB,5311,2.218274000934613,1.8164424124461223
ALL-SIL,erlotinib-PLX-4032 (2-1 mol-mol),2.6221278423473446,2.869590580883115
LCLC-97TM1,24964624,2.5877637900313384,2.0504331791823933
KU-19-19,107985,-2.420790531142743,-3.292601487896554
PaTu 8902,67156097,4.866613623772486,-0.28615025378869147
KU-19-19,676352,2.681008284282423,2.153372589791476
NCI-H1568,67291369,4.628091486396258,2.7932401121562402
BFTC-909,54143018,0.6300785047889099,0.7986219517142021
BICR 22,5329102,1.9183442886017033,2.0119864024967433
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978,2.0390345997489714
SU-DHL-1,1641662,2.0867851207635044,3.326019122768974
SU-DHL-1,54143018,-1.2287450259829942,0.91907265282748
WM115,3552672,1.460151745141153,2.8588691013388763
Granta-519,6505803,0.3707466177802866,-0.850761214660984
BFTC-909,2733526,3.41724914482818,3.688899567621933
COR-L105,445643,5.447871607768224,4.048517755086302
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884,2.503028262714725
COR-L95,135421197,1.4504202802892363,1.7328754800969914
BICR 22,4096211,1.2113689067872688,2.3550700658238357
Daudi,241158,1.9180708700138325,2.2657506287779685
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714,-3.2375432536485547
COR-L105,44543605,3.798835657012519,3.9620581980014338
NCI-H2452,1641662,5.47511848960003,3.8267602369384552
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-0.9481542057234915
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258,0.5647287147244261
MOLM-13,44489367,5.70063080501961,4.251132397515002
MDST8,9936388,-2.5080849755955485,-0.9374915813097426
Panc 02.03,5311281,4.827416145020449,2.6113613480537303
MOLM-13,carboplatin-etoposide (40-17 mol-mol),-1.2909434999313618,0.5908163970367125
Panc 02.03,71466380,5.929652601038649,4.566739452908846
BICR 22,148198,-3.168643556299537,-3.128098219663297
LS411N,salermide-PLX-4032 (12-1 mol-mol),5.97516001818146,4.3653781728748235
SK-HEP-1,serdemetan-SCH-529074 (1-1 mol-mol),2.785522004432589,2.1828495636886283
MOLP-8,36462,-1.3356090090333852,0.6012874900725864
RKO,168313200,3.1169425006108455,2.8751488499280877
SK-HEP-1,24951314,2.4991128927954063,1.5969586924998331
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996,-0.02373056077886358
COR-L105,71304818,2.509036292239667,2.64084222523723
LS180,11485656,2.0322073649322716,2.2099859535764206
SW1271,44185566,2.531281599529394,2.643731079350102
P31/FUJ,49836020,4.674155414221834,3.2182022516917947
UACC-812,carboplatin-etoposide (40-17 mol-mol),1.4623710182991412,2.4970188263267796
SW48,selumetinib-piperlongumine (8-1 mol-mol),-1.6389231751651676,2.5592376235596457
RERF-LC-MS,9933475,2.253072026550434,1.8900109258840532
SK-CO-1,24964624,3.1718881088721735,2.339775131353936
Daudi,serdemetan-SCH-529074 (1-1 mol-mol),0.5315798853273473,1.6039410338584974
LCLC-97TM1,54619267,4.094508182091097,4.055100734281519
SW1271,53232,2.609582991635379,2.558813891027961
COR-L95,5282054,2.7623794331923293,3.2157200327830946
LS180,navitoclax-MST-312 (1-1 mol-mol),2.264329466995316,0.9799330530363393
ALL-SIL,2749,0.4174204822378836,1.0037051693472534
MOLP-8,11455910,0.4759456923848041,0.4604641897793265
SK-OV-3,5329102,2.1848030817162427,2.1629599746251404
IGROV-1,5978,-1.5618214380165825,-2.157515139010329
BICR 22,135411,0.5903998872112299,0.8144063037627823
NCI-H1568,6610216,3.52063980115584,4.365697583509835
SK-CO-1,176870,3.965368978694832,2.9658921858194476
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146,1.13693078695743
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383,-0.838640954447904
IA-LM,9936388,2.150111055311291,-3.834404189727437
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067,3.8373929961750872
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167,3.401790397888712
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132,0.8716147681533881
P31/FUJ,11214940,0.6332731592867608,1.4024518193622806
WM115,421610,3.513747492259629,3.3609721930501415
SaOS-2,227681,4.210698048028356,3.466046428776288
BICR 22,25102847,3.5270600092516444,2.4477761564995877
BFTC-909,46199207,3.2760821272908753,3.2610182469535895
IA-LM,25154868,2.8804249714329537,4.261654151197505
SaOS-2,5738263,2.656867973667437,3.3289604799062347
BICR 22,5738263,3.828959854789421,3.4925432133375756
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.9997538924915554
SW48,SNX-2112-bortezomib (250-1 mol-mol),-3.704667477676808,-1.629390923301569
Daudi,24771867,-1.2539165255857252,-0.4413498283692611
Daudi,446155,1.8075236258569949,2.3792761178722803
LCLC-97TM1,56946209,-4.83981355951691,-3.706710894800426
BFTC-909,702558,5.601571619782522,5.211884659856659
LCLC-97TM1,24797083,1.6672233423539589,1.4533888413425355
IA-LM,2945648,2.6647419367463794,2.490527580924682
LS180,11717001,4.39666521822979,4.031342907944906
LS411N,42642645,1.4293896003043414,0.39932637691676154
SaOS-2,16038120,-0.4228492368909831,0.8270632965130221
HCC15,387447,-3.5284625014182556,-3.3815415444310224
K-562,24785538,3.0712560410264436,0.7463971197777045
PaTu 8902,6918289,3.1585202712855196,2.558160340936753
BICR 31,11404337,-0.6318210319309021,0.03716282540392258
Daudi,navitoclax-PLX-4032 (1-1 mol-mol),2.817343533206949,0.2057302103690718
LCLC-97TM1,5460769,-2.8089441547625067,2.4389772362318736
IA-LM,25150857,2.846024040084871,1.9390439885462702
HCC15,56973724,1.575466068691269,3.385393803893523
ALL-SIL,3384730,0.9130815120154347,1.209007746566695
Daudi,426756,2.2442144831253383,3.714457031749407
NCI-H2452,6918328,0.3371182351616307,0.27537528055483973
SW1271,11364421,-1.228057709924225,-2.080614219383846
HCC1500,9911830,2.253316240952314,2.6439261184568643
COR-L95,60750,-4.239654973449372,-1.7676244801638432
COR-L105,675434,4.897128449999278,4.729685845163712
RKN,5978,-1.5379865785523688,-1.9916985362236155
BICR 31,1641662,4.3069637553272715,3.8125150212671004
SW48,5281321,-2.141746406212142,-1.025240992295271
SaOS-2,navitoclax-gemcitabine (1-1 mol-mol),-3.208051277471344,-0.9809065613271098
SW1271,vorinostat-navitoclax (4-1 mol-mol),2.219898250998274,1.1068660605720952
K-562,12003241,-5.632155645383806,-1.2085757965988735
IGROV-1,11455910,-0.2792640061206097,1.0510571848640542
COR-L95,10410894,3.9632969340699735,3.108388683712866
SW48,5351362,1.0988845715277948,1.5613826454898379
HuP-T3,9907093,4.467626530245781,4.400530058831502
IGROV-1,16065773,3.3717508464278585,2.5227662138697005
Panc 02.03,439501,0.4668648826805023,-2.088179187637347
COR-L105,11427553,3.315123926488956,3.0723107933509106
IGROV-1,119607,5.004384040905396,5.115816554887283
BICR 31,151289,1.9519908762907336,1.255637830660617
SK-CO-1,60700,-2.5556595153787915,0.055867093488413566
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732,6.26728718894633
BICR 31,3825829,4.543850483279072,4.146646203817082
SK-CO-1,65064,5.377201033407044,5.024298938583025
HuP-T3,613753,3.2946831222357233,3.385204839937251
SK-HEP-1,89928392,1.6602086186634375,1.7587598863927874
NCI-H2452,5291,3.747673065274588,3.797781676860046
NCI-H2452,24964624,2.8171716992687967,2.615759621457913
SU-DHL-1,654092,-1.6609972231677514,-0.07854941653472876
LCLC-97TM1,327653,3.202975625508304,3.02293566056249
LCLC-97TM1,11507802,1.3666879232460134,1.4561147017177873
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578,0.6954736790018322
BICR 31,selumetinib-UNC0638 (4-1 mol-mol),2.7430116861345977,3.0593972583592492
SK-CO-1,11222830,1.7982943188317977,1.6746167349004937
WM115,24951314,1.781657055553587,1.5516099926527311
WM115,135421197,2.9135607351561883,2.129032695061603
LCLC-97TM1,136227331,4.3740550996774745,3.8498294685763246
BICR 22,24951314,1.8959621159637303,1.6556726084565134
HCC15,15983966,-4.250826265389746,-1.2129503945686921
Daudi,24964624,0.5895170730703193,0.6693786409356539
SaOS-2,11257553,0.2323229130258903,1.1172462996310668
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885,-1.026384298788384
RKN,46191454,2.1430961760764897,1.7002576955258066
ALL-SIL,navitoclax-sorafenib (1-1 mol-mol),-0.9804805399961952,-0.17656315205882683
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534,3.2164378035915657
BICR 22,10410894,2.962619033825151,3.1219749317782517
NCI-H2452,168312962,2.634597095527088,2.708699660924355
MOLM-13,452548,-4.1979459883625045,-2.5351325478868527
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298,-0.7510462297742444
SW1573,44185566,2.872643000979188,2.713913817104766
SK-CO-1,5470400,-5.490738264790885,-0.5705277612895575
BICR 22,9933475,1.970614134756263,1.8199341786488206
BICR 31,24753719,4.233476426959058,4.274321880528378
HuP-T3,4261,3.8165819220848767,1.78563974635963
COR-L105,7251185,3.034502689275401,2.8315086140981833
ALL-SIL,selumetinib-MK-2206 (8-1 mol-mol),1.6757681784854677,1.429667871832056
SW948,crizotinib-PLX-4032 (2-1 mol-mol),1.0252435682890393,1.3869148951093022
SK-OV-3,49793307,0.1269396758315965,-2.0859698914181606
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049,1.4880092650991896
KU-19-19,216345,3.688803948438149,4.036821866008822
LS411N,638278,3.5631537252490917,2.983285599437537
SK-CO-1,374536,2.850215581982446,2.3577576412608203
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697,3.8834630356705815
P31/FUJ,11178236,-2.454576103037029,-3.6539697643687403
SW948,439501,-2.1692174321648174,-1.9667136465128536
NCI-H2452,9911830,3.1691750432917645,2.652712087039796
IGROV-1,9911463,4.195269991960018,3.936175854784387
PaTu 8988t,JQ-1-vorinostat (2-1 mol-mol),2.250446694675845,1.3784301155565182
KU-19-19,46199207,3.5920417522591723,3.229013498703145
IA-LM,25102847,3.5065737869109017,2.2007454316606347
SaOS-2,10385095,0.9171223668306429,1.162325075226383
SK-HEP-1,285033,-0.6546577384402199,-1.511710968777389
WM115,1566236,3.8332358430398847,2.165121321373551
LS180,3025986,-0.3657173630682503,-0.967247033732399
HCC1500,11625818,4.269459310239442,4.3248561313392875
HCC15,44259,1.006506996100477,1.3701697057111937
RERF-LC-MS,285033,-2.0574538896256587,-1.2676384982112072
IGROV-1,241158,3.288496474515495,3.6889187436206874
BFTC-909,6917907,-4.2174557642594035,-4.7126139071618205
BICR 22,375860,-0.6251605141105395,-0.030778406112290036
BICR 22,119607,5.438520616053313,5.13337459897371
RERF-LC-MS,676352,1.6328584527608256,2.109766293852332
HCC15,6918289,2.816502870816243,2.6515256347728884
RKN,241158,3.8611150596916577,3.7831706870416513
COR-L95,3634881,3.005165393659793,2.8346962849285693
IGROV-1,11626560,1.7276653519578558,1.906434261660973
LS180,3385,1.8718372753364907,4.052035782875169
SU-DHL-1,56946209,-5.3778659012875325,-4.492666371306217
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924,3.356952705655884
NCI-H2452,448949,2.771204919609998,2.0910933251885346
SW1573,5113032,6.532830278238065,5.044902308665363
SK-OV-3,11485656,3.3782074628341894,2.6217855977872904
BICR 22,81146,6.036644504914818,4.683821815273992
P31/FUJ,76446078,4.256026108364254,2.5768063838693958
Daudi,2113511,3.606563716227827,4.413590984713648
HuP-T3,5328940,2.3682781464336147,1.6598708266383955
RKO,6852167,3.601912647929868,2.210875013534262
SK-HEP-1,1750826,-4.478019715406424,-1.1250016482124232
SU-DHL-1,25102847,1.7846654255237482,2.0059813794138437
KU-19-19,2749,1.0704171129437314,2.233824066958371
COR-L105,136227924,2.729950058152846,3.182044405142402
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937,2.0606993578497175
RKO,25154868,3.654559992823761,3.9537576892979653
HCC15,5113032,5.023051877119823,4.887559319172342
LCLC-97TM1,3815108,3.2576294300862867,2.8536087085974713
SU-DHL-1,6610216,4.061950863639378,4.172861114346864
LS411N,136227924,3.1900427132689724,2.606688135174815
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057,3.308139879882873
KU-19-19,51037431,1.6044173216619535,3.379787026086969
MOLM-13,637858,0.5048034575879493,0.8135125600547728
SW948,5329102,1.476566645762777,1.790022234406229
NCI-H1568,tretinoin-carboplatin (2-1 mol-mol),4.637834792559274,4.839030874017768
K-562,serdemetan-SCH-529074 (1-1 mol-mol),0.9314801413999184,1.7105729509353658
SW1573,1566236,3.3872191513469025,2.247889313010388
IGROV-1,46174525,4.5083762186279595,4.467416865959895
SW948,9956119,4.230492181635778,3.2108621541162217
SaOS-2,100016,6.565789067704999,6.154408493355371
WM115,11152667,0.9737214532192616,-0.18130577609633647
HCC1500,439501,-1.4156205398968564,-2.1259435457890192
SU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),2.6727434521528894,2.5954012281526007
NCI-H2452,49793307,-1.217787389832333,-2.1559995847415894
BICR 22,208908,1.938925459708866,1.6665281147804507
KU-19-19,675434,4.307992798559183,4.524943444896411
SU-DHL-6,168312962,-0.817402334599034,0.7906401221897247
RKO,4705,3.750134101835121,2.7228710066988016
MOLM-13,72193861,-0.3301410770598842,0.2665286155441265
SU-DHL-6,11497983,-4.838706392617486,0.31663479252785204
IA-LM,6610355,7.432350505906943,4.477635424118842
SU-DHL-1,100016,4.0163007651424945,5.958778885089197
SW48,tanespimycin-gemcitabine (1-1 mol-mol),-4.429955017650206,-0.9646367361997137
BICR 31,11717001,4.942461846011657,4.282661173084029
MDST8,452548,1.517979290481689,0.32946319228611676
SaOS-2,vorinostat-carboplatin (1-1 mol-mol),3.1714498028608573,3.2319665445442842
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979,3.049062029469967
HCC15,216239,2.699139377969599,2.6040122407836477
SW948,54143018,1.1269042701713536,0.31361372538837123
PaTu 8988t,2871966,0.7913795837456433,0.8058606047342773
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008,3.8839224844647235
MOLP-8,702558,5.64086941386953,3.990239652794213
SK-CO-1,9926054,2.0008566323964576,1.9472511170989366
NCI-H1568,208908,1.6425276108518176,1.8494077177124304
BICR 31,11364421,0.6668909809197356,-0.8365636418241889
RKO,6438330,2.4839059464581785,1.7322466074208172
HCC1500,11717001,5.16685929391629,3.882564200928193
NCI-H2452,5335621,2.361346054519045,4.949740669278928
SK-HEP-1,168313200,3.8713243832650335,2.9416240953962483
MOLP-8,5281321,-3.090542457479921,-2.2128488603488092
LS411N,5287620,-2.7795044954925423,-1.883531813439315
BFTC-909,42611257,4.384387627976705,3.4050714823288843
MDST8,135421197,2.23565927197073,2.1622105702488197
LCLC-97TM1,navitoclax-MST-312 (1-1 mol-mol),1.32635815912294,1.2192436530109887
ML-1 [Human thyroid carcinoma],4261,2.09291450929782,1.9597723776049392
SU-DHL-1,136227924,2.1802521862386395,2.5620028188836352
HEL,9929138,6.278460484472286,4.490585837301123
BICR 22,100016,6.157225392196351,6.314324271944695
BFTC-909,6610216,4.898578232775107,4.442122437285131
ML-1 [Human thyroid carcinoma],327653,3.144384021244803,3.4230221882516387
P31/FUJ,2708,3.1798246734444535,3.4206214102321706
SK-HEP-1,11222830,2.864448489509693,1.6642749617239738
SW948,6450551,1.190778779915613,2.341260706549927
P31/FUJ,3503,1.1912257572322915,1.7153047921458071
SU-DHL-6,11214940,-0.480666123434414,1.161834931743541
Granta-519,3101542,4.848909880356854,1.9911091055279937
COR-L105,JQ-1-vorinostat (2-1 mol-mol),0.2989866544918393,1.2948270164397795
SK-OV-3,54613361,2.1799599530092597,0.12797039196068433
SaOS-2,navitoclax-MST-312 (1-1 mol-mol),0.5918912917357866,0.9089304369118554
PaTu 8902,9866186,4.760639543290191,1.0072960855885211
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559,3.382065465177796
MOLP-8,445455,4.348825488954634,3.860139919495163
LS180,327653,3.1909584751660973,3.2884153079428575
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672,1.2703033358140876
WM115,24889392,3.868386170167097,3.8528680737728336
SK-CO-1,54618771,-0.118181134306818,1.3085854426363444
SaOS-2,9868037,3.691858985861763,3.5971308801417066
Granta-519,navitoclax-PLX-4032 (1-1 mol-mol),-1.627997667174391,0.019082487178631685
HCC15,10385095,2.335943691067567,1.5314676802849576
MOLP-8,2874250,4.289349020932475,4.180463809984938
IA-LM,selumetinib-PLX-4032 (8-1 mol-mol),3.550842721167267,3.530822484505588
SU-DHL-1,44137675,2.905771721153928,3.279976462330299
SW948,16038120,-0.173493225813213,0.5229737426971961
SW1271,387447,-4.431171658059158,-4.211367860372491
HCC15,71304818,2.608087345638841,2.4675559506137215
HuP-T3,navitoclax-pluripotin (1-1 mol-mol),0.368847097693027,-0.8022915608582147
SW48,44259,-0.1330653223053438,1.3365852444436988
SK-CO-1,selumetinib-tretinoin (2-1 mol-mol),0.0609322450258742,2.5821110605903703
BFTC-909,216239,2.6603594422751136,2.520249421350353
MDST8,9825149,2.535214047656483,2.2092988359651513
BICR 22,11625818,4.758067302616356,4.2696235045909425
LS411N,6852167,3.3651093558735035,2.29072889361451
BICR 31,7251185,3.1852875333924415,2.860632685541463
ALL-SIL,25195348,0.8279476297727174,2.272290059434424
SaOS-2,73707438,3.8840228628110336,4.027484430306254
Granta-519,selumetinib-MK-2206 (8-1 mol-mol),2.927373885066516,1.4568313064760863
BFTC-909,17755052,1.7621152527207813,2.065956078220373
MOLP-8,vorinostat-carboplatin (1-1 mol-mol),1.858459936032215,2.215036391420498
SK-CO-1,3815108,2.810447278858876,2.762960061640877
COR-L95,3025944,4.2211844332657344,4.095261931005172
RERF-LC-MS,9825149,2.3136516136403595,2.4511740518957885
KU-19-19,72376,-1.7461965003174784,-1.5190767996835384
K-562,568763,0.3044566284292496,-0.16012187531564925
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941,4.38335714290836
Granta-519,6917907,-6.07944377191165,-5.586744373056368
SK-OV-3,4788,6.178998906779571,5.610624814165171
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533,2.266937896745406
RERF-LC-MS,6852167,1.8897499878184068,2.8683180915817545
RCC10RGB,2746,4.042085650474663,3.6313707365192096
SaOS-2,54143018,-0.9786223984268784,0.5410354986748951
HCC15,451668,4.7728580097586635,4.312257178109315
RKN,135999136,4.319110081529012,3.534428054555126
ALL-SIL,11228183,-1.4217334963731665,0.32773355061654685
RKO,568763,0.6942409100068829,0.1489398552458443
SK-CO-1,71304818,2.179260281615582,2.4194719032445047
SaOS-2,151289,0.9278405880660672,1.3061494219560579
BICR 22,tanespimycin-gemcitabine (1-1 mol-mol),-1.0672550933922087,-1.0192981356361979
MDST8,241158,1.799926141571129,3.979576602631451
BICR 22,11214940,1.8032425349242045,2.0749261488824353
BICR 22,navitoclax-birinapant (1-1 mol-mol),0.9663061977057198,1.023259913194134
LS411N,9825149,1.7370452341191267,1.9924220998610602
K-562,72193861,0.1570904811456113,0.24868377943365436
RKN,89928392,1.2442310560485252,1.6487706689070811
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058,2.560329081499501
RERF-LC-MS,44493528,4.358183394704722,4.427571003315308
COR-L105,5738263,4.054674337055045,3.5205923269336665
P31/FUJ,5280436,3.1830796623136832,2.7709279068865174
Daudi,JQ-1-navitoclax (2-1 mol-mol),-0.7335137922261505,-0.26982777198479435
LCLC-97TM1,135398516,2.1563049020997593,1.931680460625662
COR-L95,25102847,2.826830714185171,2.289418363729085
BICR 31,11427553,1.8414471938085448,3.130726854348041
P31/FUJ,navitoclax-MST-312 (1-1 mol-mol),-0.1859808943498902,-0.20019575555333102
IGROV-1,15547703,3.339928221860449,3.116359769216088
LS411N,navitoclax-PLX-4032 (1-1 mol-mol),1.1305163231038025,1.7113088508600525
LS411N,6918328,-0.170211770014818,-0.13034169799365755
Daudi,3136844,3.4483363469146098,3.656563324683002
MOLP-8,10302451,3.559537910744256,2.6024746946305117
LCLC-97TM1,24772860,-2.203105978452304,-1.801902288534006
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414,1.7751433355266966
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218,2.403318440190277
SW1271,119182,-0.4023310904747799,-0.22606891885368272
RERF-LC-MS,135398516,2.452363199699896,2.2670532088580773
SK-CO-1,44495899,4.504236306700641,2.936772257024172
IGROV-1,10127622,3.2581804056600165,3.622180030698976
SK-CO-1,44491742,5.1736211152382285,4.27774275484413
MOLM-13,4477,0.1750371811238646,0.5485907511822898
WM115,25183872,-1.8696572442850008,-0.8143450949779204
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152,0.868038643802893
LS180,JQ-1-MK-0752 (1-1 mol-mol),0.6783898145505391,1.5746484326563992
HCC1500,5335621,4.362965892261437,4.479121617282949
P31/FUJ,1716436,3.053886593694114,2.388292335724724
Daudi,9915743,0.3665260221427978,0.26964230499933173
UACC-812,selumetinib-MK-2206 (8-1 mol-mol),1.487616505543695,1.7259148933264459
SK-CO-1,5311281,1.7217135985324663,2.2278187900873285
IGROV-1,3503,2.453392942972796,2.443928277144516
SW948,17755052,0.6738246482480579,1.1959036826972265
Granta-519,5329102,1.3717145166802862,1.2350741855489746
HCC15,25183872,1.7330298559310635,-0.5231430026599082
IGROV-1,23635314,-0.611739968448912,-1.1678303411437583
HuP-T3,46174525,5.4457837824532245,4.580986071506646
IGROV-1,46199207,3.293579955374855,3.2356812673003064
NCI-H1568,11656518,0.902462789439692,1.945870612542729
SW1573,12001922,2.294011710402099,1.9105317057159181
HCC1500,navitoclax-sorafenib (1-1 mol-mol),-0.1825981932609776,0.9312295463076709
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917,3.0728885045909617
SW948,2871966,1.833559506117821,0.19576643492663398
RKO,42642645,1.3055497818976145,0.35585157367746667
NCI-H2452,6450551,2.947106204512916,3.111850502840004
P31/FUJ,10302451,4.186780329312711,2.541010018040914
P31/FUJ,6918837,-4.676526715032863,-4.4257579275442644
HuP-T3,3552672,1.4793505278318,2.9764310985025015
BFTC-909,25105715,3.3944682152224455,3.4982498540307603
HEL,44197249,3.8651368484410056,1.800056256090372
HCC15,JQ-1-MK-0752 (1-1 mol-mol),3.1823820949476564,1.6181721512270673
BICR 31,46215462,1.6669957894505008,2.1721510299226323
HuP-T3,9866186,1.729562359157257,0.8592029904004406
HuP-T3,11717001,4.25253085122872,4.05327635207109
NCI-H1568,54618164,3.652866089784218,4.191229878663167
WM115,441298,3.225500618866892,2.4624509221163646
LS411N,71304818,3.0616651991102697,1.9969945835699041
NCI-H1568,navitoclax-sorafenib (1-1 mol-mol),1.4784994486098395,1.8850352162377368
SK-HEP-1,10184653,3.249474772070569,1.550908478544368
BICR 31,12003241,-1.4237270953299652,-1.1847563563658197
RERF-LC-MS,25150857,3.1332692975488934,2.639217840470682
COR-L95,24964624,2.1587115359420994,1.9266393170833032
SU-DHL-1,44241473,4.633491620971472,4.645891432151118
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419,1.7635276914427447
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393,-0.31342696571077827
MOLP-8,6918878,0.495059053850733,0.6953549248182347
RCC10RGB,448949,3.406339167429426,1.9618985073693656
HCC1500,148124,1.3380754252474834,-0.40932506805580926
HCC1500,5280436,1.8565158203383687,3.474606140935376
IGROV-1,10302451,0.4135234554742116,2.861754716070282
Granta-519,285033,-4.09305161448312,-3.4178747722255878
HEL,JQ-1-navitoclax (2-1 mol-mol),-0.660921199279695,-0.4192033341320315
Granta-519,71304818,1.7993370678919798,1.9821718909208237
NCI-H2452,3689413,1.184555113675537,-0.10518949023453975
IGROV-1,2708,4.438419625543199,4.738814862114138
SW1271,49850262,4.063818012025616,3.5996825035483253
LS180,6918736,-2.1262365465987907,-0.8353465589960669
PaTu 8902,10127622,6.3250626499292295,3.4130854958315267
SW1271,57519531,1.4534695216386555,2.6197692564441706
HCC15,57519531,1.9577451103636032,2.633304204338155
SK-HEP-1,navitoclax-PLX-4032 (1-1 mol-mol),2.657614017988428,2.214881938457685
SW48,44185566,0.7812235367324193,2.3726310807456286
Granta-519,navitoclax-birinapant (1-1 mol-mol),-1.2889388818955343,-0.20372072315099843
KU-19-19,241158,4.34083218708613,3.8752246933022603
NCI-H1568,11404337,-0.63897934294681,-0.1952406873396871
Granta-519,219104,2.15431657191886,2.273470769763631
SK-CO-1,5746,-2.8271360432483035,1.1169358461726835
WM115,6918837,-2.450050091846588,-2.3196640860990887
SK-CO-1,11152667,-1.1935109806009474,-0.5355231250690745
SW1271,9825149,2.2012182796133084,2.514691291473143
SaOS-2,208908,2.5337103611164893,1.938260151322251
SW48,5470400,-1.7303817372543355,-0.21918228159693853
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172,2.0316512776507363
SW48,15547703,3.0370188863847414,3.097495728104285
SW948,46907787,2.3709287142369555,0.13613758449724453
Daudi,5113032,4.739966647777949,4.4943701670377445
SaOS-2,135984461,4.8186429168984475,3.6281088678214
MDST8,168313047,3.800021027786958,2.510603840854446
RCC10RGB,11964036,2.4986740771219673,1.523703239215243
SW1271,24785538,1.505278847517323,1.6364896558442517
BFTC-909,3676137,5.055523871435828,4.579875685847998
SW48,9868037,2.459515994210572,3.2274881092719827
KU-19-19,10231331,0.2937024112037242,1.9213667508996748
ALL-SIL,54619267,3.6744484896003713,3.3401870115268433
BICR 22,selumetinib-BRD-A02303741 (4-1 mol-mol),2.600469012399248,2.9591372014543618
RCC10RGB,24951314,2.138755705452886,1.5575145060598574
SU-DHL-6,26596,-1.882707371112463,-2.460886462647932
COR-L105,46843906,1.9821208299636863,3.2816987152643033
RERF-LC-MS,4477,-0.1141702320643991,0.46439736519635283
MOLM-13,49766530,-2.4914272268054107,-1.7479688761416556
SK-CO-1,4917,2.9299888563447163,3.148556435973914
Daudi,72734382,3.17690285998388,3.4278217876972694
LCLC-97TM1,11625818,5.063433550011292,3.9599694236747593
LS411N,vorinostat-navitoclax (4-1 mol-mol),1.2590657469614004,0.5859625616470384
ALL-SIL,451668,-1.1904263441284522,-0.9570226645272828
SK-CO-1,219104,3.537047767593632,3.824271191970513
NCI-H2452,65064,5.258935158123576,5.152329407768154
BICR 31,25062766,2.0025728701089904,2.24682656561647
LCLC-97TM1,4261,1.8883571230172835,1.4484711909227306
BFTC-909,54618164,4.281231487810877,4.17693238522763
NCI-H2452,16736978,0.9447398024439234,1.526634073102839
NCI-H2452,selumetinib-BRD-A02303741 (4-1 mol-mol),6.449127799684226,4.5108253242059195
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202,3.9417822079445957
WM115,6917907,-5.049795628811172,-4.976927218248898
HuP-T3,5746,1.6464242063318688,1.1176851021240943
MOLP-8,327653,2.384727852533787,2.5277669765743007
SW48,72376,-3.1415011638088144,-1.9131373155112792
SK-HEP-1,23582824,1.0257570544783106,0.7854165364964543
K-562,12001922,1.1213264373636214,1.7327556897461687
WM115,10410894,3.2188686198907743,3.3030039537523326
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.3220039663456697
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245,3.905311066854354
KU-19-19,44819697,-2.543386759740491,-0.21468706079195152
LS180,46199207,2.9384583216685023,3.0819421638518882
LS411N,56946209,-3.80128700519076,-3.9807344039541324
LCLC-97TM1,6918289,3.014261251605047,2.7779896303640244
KU-19-19,107970,3.004209688555129,2.43562942984856
MOLP-8,72376,-3.958595065171294,-3.4325589767153764
IGROV-1,5291,3.6852809555447985,3.7878187115136797
Granta-519,46191454,0.5060764897707477,-0.07450154762802685
COR-L105,24901704,3.8942422617258714,3.5092656872720402
NCI-H2452,24797083,2.030715286150645,1.4780696440588859
NCI-H2452,124202324,3.032884210730814,2.7968122552004133
LCLC-97TM1,4259181,-0.2611730486969081,0.1635496051082453
KU-19-19,73707440,5.592820593626321,4.034241046236765
RKN,5460769,5.79272629497122,2.7624343790456867
RKO,10184653,1.6814092199651305,1.073244926492914
PaTu 8988t,24180125,3.300808715406375,3.171346276846837
COR-L105,2858523,3.082532365215724,3.0925538664502312
BICR 22,decitabine-navitoclax (2-1 mol-mol),1.4331437420597166,1.934212774802206
LCLC-97TM1,16065773,3.044024356255971,2.1868210692607977
MOLM-13,16115403,-5.622868208190141,-4.445095110846691
Daudi,104842,-7.567274671559235,-4.076009822318026
PaTu 8988t,3825829,4.270364787448243,4.098228699138068
HuP-T3,227681,2.514870644267688,3.5501672246535945
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524,1.8591679311055436
COR-L105,11964036,1.2117851204645589,1.3867840697015614
SW1271,135659046,3.922158232881772,3.6021118793864555
IGROV-1,4917,2.985904350427039,3.224999838761337
HCC15,9826308,1.2579647962340863,0.5504637091321185
SK-OV-3,46199207,3.479599233509405,3.2793847043280153
KU-19-19,2729026,3.069520174525383,2.7162107789959156
COR-L105,25102847,1.810865395215699,2.558602472311328
SW1573,9935249,2.8664920450292852,3.0793547448731475
COR-L95,1714884,3.7968274989469992,2.7654822425469803
PaTu 8988t,7251185,3.286029674356028,2.7512680037845945
SK-CO-1,24856436,0.7128954142297991,0.6476476026975697
HCC1500,5738263,2.955373895930653,3.4987612213988233
SU-DHL-1,6914657,-4.020831804674196,-4.579798562674083
SW48,638278,3.16751315896482,3.1576424926194555
LCLC-97TM1,135421197,1.517750954289076,1.6304849628836866
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295,-0.07159621352598777
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631,3.8655607442472704
NCI-H1568,6914657,-5.120590256929669,-3.7452389902622594
NCI-H2452,3676137,5.703513737309888,4.654244528452315
PaTu 8988t,11238147,3.9795465318298526,2.9768871613830528
RCC10RGB,5113032,2.807854627845623,5.123820444519058
IA-LM,44607531,1.5934898700442923,1.635669714150908
MOLP-8,BRD-A02303741-carboplatin (1-1 mol-mol),5.885720002784475,4.26160867559768
SW1271,docetaxel-tanespimycin (2-1 mol-mol),1.954654024202385,-3.1343627923463426
RKN,3815108,2.827407220517517,3.112914063444714
IGROV-1,448949,2.098499309472767,2.149839136295482
BICR 31,5426,4.483861121335425,3.973704056210222
SK-OV-3,322968,3.987773865251791,3.9013615930510457
BFTC-909,15953870,3.192835350037467,3.5867570573469396
BFTC-909,4378219,4.497242068417329,2.7300708091706394
COR-L95,54143018,1.379812266453913,0.32888034396462923
SU-DHL-1,11612883,2.467580560997241,2.3827861054320434
COR-L105,alisertib-navitoclax (2-1 mol-mol),1.2187125492955395,1.2376752026073616
LS180,5978,-1.0800938866172374,-1.8525606108098602
NCI-H1568,44566777,1.438409258191859,0.8677016557457158
BICR 31,42642645,1.5553576315566706,0.8743751304406508
MOLM-13,654092,-2.113392174262404,-0.9259836808541166
LS411N,124202324,2.3656166654970137,1.5017140318031394
SU-DHL-1,5329102,0.4187283879213827,1.9027149203651854
Daudi,51037431,1.7669670215364446,2.8087201696314645
RERF-LC-MS,45279963,3.7797867340420215,3.791618710440385
IGROV-1,49850262,4.068828647042517,3.6702588512290584
BICR 31,12001922,2.662375748901725,2.0266912971139917
IGROV-1,49793307,-2.5291790820063538,-2.4173239019530564
PaTu 8902,2828334,6.440933390339598,6.194542315312403
SU-DHL-1,24951314,0.6018835624310062,1.480332057109145
MDST8,676352,2.6149374435458643,1.9607868586108979
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624,2.0580081080421007
MOLP-8,44185566,2.3020252385384747,1.7304195018342057
RKN,44137675,5.459450119186335,3.7083378983539252
SU-DHL-1,216239,2.4334915471860064,2.2851631475290004
RCC10RGB,5328940,2.5920229504771264,1.7973643448962255
MOLP-8,5351362,0.578803181676615,0.9764932080217404
KU-19-19,4521392,6.281175440463305,4.345705929242281
HuP-T3,219104,4.090562015064086,3.87517245341444
BICR 22,16722836,2.37465920140225,1.5655852750800223
Granta-519,54678924,3.4908303220152512,1.3911658284790582
SW948,5738263,3.889172676108031,2.9937234806701998
SW1271,9549297,2.1335240165820606,2.701290678557832
MOLM-13,5280436,3.611781786093365,2.68262256425036
BICR 22,3062316,1.4778056821676904,0.009641029738431943
HCC1500,46191454,2.281809335685502,1.566929225094459
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661,4.873161840233197
SW48,9549297,0.4487326680785643,2.2312317033753812
SK-OV-3,46843906,3.785109660734252,3.2398339847863746
NCI-H2452,5351362,1.571040634520482,1.3868928187229914
RKO,56946209,-3.445993729976747,-4.135697490854811
SaOS-2,56649450,2.657103116813459,3.7075155662317116
KU-19-19,doxorubicin-navitoclax (2-1 mol-mol),-0.7241135755509572,-0.8819472066870913
LS411N,23725625,5.218761480016774,3.858258255262056
RERF-LC-MS,4578,4.625372786711685,4.63229457735797
MOLM-13,11507802,1.0337656748409854,0.8425344139765986
SW48,65064,5.106206142410259,4.758966134886485
HCC15,2828334,6.579413009448801,6.221403158041153
SaOS-2,4378219,3.572923749570723,2.5816656960778563
BFTC-909,23939,4.493588141952023,3.698551790335862
RCC10RGB,439501,-2.548266242367821,-1.9105045490464436
SW1271,3815108,3.2377532103389832,2.9582028714174924
P31/FUJ,5287620,-2.889875327880449,-1.947939294893355
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039,2.0249365541323257
LS411N,5281321,2.872375461605106,-1.9403159875656406
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184,3.144410565514747
MOLM-13,16736978,-0.7178102164081313,0.49689721257380093
HuP-T3,24964624,2.5347495437600753,2.4446858976528647
SW1271,3038522,2.6397404309625574,3.186483516683392
SK-OV-3,6852167,3.0870556066687076,3.0827297252206023
PaTu 8902,25262965,1.559985123462204,-1.5340073319410783
PaTu 8988t,89928392,1.7442497788257625,1.525502585552752
RCC10RGB,5494449,5.764110819730859,2.962937320279895
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951,0.31428665076193785
Daudi,5282054,2.334684985175564,2.5530468650218965
SW1573,9866186,2.2605214925080035,0.9375426807981596
SK-HEP-1,16013152,4.2454363352103925,4.2311668980656645
IGROV-1,11647372,-0.6595372928368528,1.1615664816991116
RKO,60700,-0.2024014556335324,-1.0127362254083054
SaOS-2,66577038,3.461550546017496,3.0834513534954806
BICR 22,6918638,0.0558003797401064,0.42387391783893164
NCI-H1568,6918878,3.5715267618547832,3.1755910970146393
RKN,17755052,4.615024850417848,1.9262216417268232
RKO,10385095,1.2981289243482117,0.8364236257647424
NCI-H1568,25227462,1.3523005990409367,0.5242604288891871
IGROV-1,168313200,3.9938362637732983,2.916544782027707
LS180,52912189,2.5201251776162454,2.084695600883022
SK-OV-3,446155,4.068831864004445,2.8701910498982484
SaOS-2,2729026,3.0079080963172573,2.8280062242934427
COR-L105,24785538,1.9787344511962284,1.8180090942595402
WM115,9549297,1.875565618317202,2.3730049941225055
COR-L95,53392493,1.7864953470488698,2.0785076708184267
SaOS-2,219104,3.933074432676362,3.7553169471566292
WM115,3854666,2.6196721416111024,2.2574352268761784
PaTu 8902,11626560,1.9806688551606229,1.9550713910309008
P31/FUJ,24901704,1.8625310117446785,2.346541862932981
IGROV-1,9911463,4.195269991960018,3.936175854784387
LCLC-97TM1,216468,0.7418366776466117,2.4819959103985694
MOLP-8,387447,-5.214034261316855,-4.668808044519994
RCC10RGB,16722836,2.017391543442539,1.784500852122178
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,1.1248425552903007
SW48,5311281,1.5627745937535438,2.304114547399179
MOLM-13,11497983,-4.003769607545663,-0.7977236265244527
KU-19-19,2858523,2.990442019675252,3.174292880903084
COR-L95,11626560,1.5180153972734145,1.240979756869713
WM115,123631,1.7981952102566006,2.351144383565251
RERF-LC-MS,2874250,4.628157945253743,4.608937963722966
MOLP-8,65064,3.020382379730844,4.102523751235853
RERF-LC-MS,3854666,0.8294073497518095,2.2104658707794638
HCC15,3689413,0.3467742153458734,0.19984961544574464
HCC15,25150857,2.8177810894811786,2.6221898857006694
LCLC-97TM1,46174525,4.403281113181967,3.9350430205034828
SK-HEP-1,31703,0.3185055118054912,-0.9272675087666016
BICR 22,123631,2.0553358195001383,1.5993654719288397
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163,3.232485772487925
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403,1.2611737436764756
COR-L105,11213558,1.6245415685033464,1.9105469199596898
COR-L105,3689413,-2.1605707630353708,0.07834754438158557
MOLP-8,4917,1.932746630984224,2.8849139117968807
HEL,11238147,1.9261110470981635,1.9519118316369053
HCC15,46907787,1.7788170946404287,2.435422579328513
HCC1500,3062316,2.994925150114549,1.0979422102911969
MOLP-8,9935249,-5.983061984872936,1.4453013403039665
IA-LM,135398516,1.3190430503048431,1.5804351680473128
NCI-H1568,6917907,-6.013699668749745,-4.268581185571131
PaTu 8988t,25062766,2.121196656552597,2.152142109607343
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797,-2.470277332072141
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125,2.2385403350434543
HCC15,3825829,3.261310602619802,4.117534179874465
SaOS-2,36314,-6.649536011740597,-2.2092366302587885
BFTC-909,54613361,0.5481358040879688,0.4220077475412317
HCC1500,navitoclax-MST-312 (1-1 mol-mol),-1.0378024218006647,0.8099831541459074
KU-19-19,135999136,4.912207411852192,3.9795792995826393
HCC15,126941,-2.714458984381298,-2.4481239864546676
K-562,387447,-4.172741798582805,-4.834502106868509
BFTC-909,400769,-0.3884900564724624,-0.35559955845970465
SW948,serdemetan-SCH-529074 (1-1 mol-mol),2.314613339768124,1.6781463632509637
K-562,19582717,3.29667086675107,3.02794344785259
LS180,676352,2.815097827506973,2.1498213940126916
SK-CO-1,5278396,2.886619996042885,3.554396226182226
SW1271,654092,-0.6724961197062129,-0.25766588233043697
BICR 31,984333,1.688597902845401,0.845050847266759
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644,2.46348253147271
PaTu 8902,6918328,0.0837665640709721,0.21585091376221527
KU-19-19,25126798,3.8528221502524262,3.7718461650348165
SW48,BRD-K27188169-navitoclax (2-1 mol-mol),2.506636688150973,1.9181279168305274
K-562,984333,1.160515473081413,0.17709341442982487
BICR 22,4261,1.6582900308021409,1.5207079808921302
P31/FUJ,24753719,3.279397605233023,3.286528517141443
RKO,89928392,1.6264666324972337,0.3845380983334876
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723,-0.9757498921566953
MOLP-8,2746,0.9128995235322724,1.8372177850503604
PaTu 8988t,44589607,3.069724280166482,2.931992342495635
Daudi,55508,3.074140286884227,2.7185329394877624
IGROV-1,53232,2.4872106086763393,2.8598711974991757
HCC1500,11178236,-0.8618797474299623,-3.043176098382765
SW1573,11228183,1.3544411199442492,2.3371183727719145
ALL-SIL,docetaxel-tanespimycin (2-1 mol-mol),-8.351495985477111,-5.483533704494756
HCC15,151289,0.5818248951012718,1.1795964300076014
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073,1.8867321044525882
LCLC-97TM1,9956119,3.701469228999412,3.336850419077017
LS180,65064,5.333283055182179,4.884322925602403
Panc 02.03,1566236,1.9322803720882225,2.5857787136872328
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783,1.734516123925998
COR-L105,5311281,2.5909348271223833,2.6288922186932866
COR-L105,4261,1.037866526492344,1.8784389401674506
MOLM-13,6505803,-3.0527041000310255,-1.034416114112255
SaOS-2,24797083,1.1743557883271736,1.40550250765414
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435,1.7140767227416578
PaTu 8988t,44819697,-1.4855632158782932,-0.8727129316880625
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,1.1248425552903007
MOLM-13,136227924,1.704251401840426,2.3658483345412114
K-562,11955716,-2.44804051648688,-1.9419013552977769
PaTu 8988t,119607,6.161307312166748,5.342215099692911
COR-L95,71466380,4.385390307812106,4.152182100861538
SW48,400769,-1.161678790289576,-0.7456789008939846
SK-HEP-1,54618771,0.9570801540222316,1.4588924499242537
Daudi,10410894,2.7348964142664096,2.74901686104478
P31/FUJ,8515,2.4023085754769133,3.4009248989548286
MOLP-8,12001922,1.340541943266141,1.4782886425191268
SaOS-2,24180125,2.5037581025896896,3.224848903564856
LCLC-97TM1,11497983,-3.4928977535107872,2.6706786792960795
KU-19-19,54618771,0.4920305765445359,1.4009162057227542
BFTC-909,9826308,0.9467806471528852,0.6366128581142193
HEL,6252,-2.3526628041976547,-1.6138267855312551
PaTu 8902,1750826,3.002378182351502,-0.8312962265668973
HEL,375860,-0.4243086466742362,-0.7195973841475866
SK-CO-1,erlotinib-PLX-4032 (2-1 mol-mol),3.6761827416716737,2.5054871083341483
LCLC-97TM1,44137675,2.6535109564984403,3.175742837484183
BFTC-909,4096211,2.208598833058293,2.1822932083129007
SW948,piperlongumine-MST-312 (1-1 mol-mol),2.3670131047839496,1.7839909951036717
MDST8,serdemetan-SCH-529074 (1-1 mol-mol),2.3277787595180417,1.881270256859611
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604,2.0472385049489232
SK-CO-1,10231331,-0.7210930575000714,1.4107914113791296
RERF-LC-MS,9908783,5.63449812951243,4.894100377431667
SW48,BRD-A02303741-navitoclax (2-1 mol-mol),2.3907101942881392,1.9946025954562294
SaOS-2,navitoclax-birinapant (1-1 mol-mol),2.783475564423097,1.412613890328095
SaOS-2,54618795,3.185724709117328,1.1918080628933092
PaTu 8988t,637858,2.5993481939897314,2.0813454019818747
HEL,984333,-1.1600295079037413,-0.057091078852113626
HCC15,2841722,4.4106331963661285,4.501157941220285
SW948,676352,1.6772543111300298,2.096640123511654
BICR 31,24964624,2.1782924417506235,2.591791429185295
MDST8,984333,1.6302493723588198,1.0140512881197892
SaOS-2,25102847,2.0054521503393956,2.6936999223292166
NCI-H1568,11396600,3.496587037401377,3.747689191120477
SU-DHL-1,25126798,1.813712960287442,3.6154489633224127
MOLM-13,445091,4.269392983422825,3.8958776434884546
IA-LM,6918328,0.468629569752011,-0.003972851968475033
RKO,16038120,2.1201165412688385,0.30686811562548777
Daudi,3689413,-4.376822515219121,-1.0360532428916716
LS411N,1750826,2.0365622567800985,-2.3979884428117173
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258,0.6090403354727312
LS411N,11640390,3.2208706785393972,2.4989852726804167
SK-OV-3,2729026,2.529477515357917,2.7116773932867364
BICR 22,1317464,3.72634745746102,3.0127394393114653
PaTu 8988t,6917907,-5.027469783550181,-4.288556592448581
BICR 22,168313200,4.032164885313491,2.7515395603149186
WM115,24180719,-0.1236916700903925,2.81311759980472
WM115,2708,4.839353437835411,5.0237248767994425
Daudi,erlotinib-PLX-4032 (2-1 mol-mol),2.269531504347571,2.5606571274349426
SW948,135398516,1.5329637117305952,1.6613798614181954
SK-HEP-1,15547703,3.182423809990023,3.378591964061069
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797,1.734359317767968
SW1271,400769,-0.393739366900267,-0.5334872534977794
COR-L95,11657048,4.451680892653422,3.1728702589735884
KU-19-19,5470400,0.4514058362673593,-0.11061525713103898
SU-DHL-1,46199207,2.2603615990150803,2.7651733174117936
LCLC-97TM1,452548,-0.620032222833134,-0.4467548971462356
COR-L105,216345,3.681753487249753,3.8710015560806563
SK-CO-1,6918736,-2.135863333000623,-0.9509162917952614
SK-CO-1,5351362,1.1244803572081656,1.7126434328455564
Granta-519,451668,1.0102660805443675,-0.6866475946274855
RCC10RGB,71751553,5.18764953581067,4.7113795878481275
SW948,44137675,3.8395253943289553,3.0725525351237275
SaOS-2,JQ-1-navitoclax (2-1 mol-mol),0.6153479757572562,1.0553520829773415
LS411N,654092,0.6196619744838121,-0.6585727098148402
HCC15,11222830,1.5967166138936082,1.6427490902275934
RERF-LC-MS,54143018,1.1379926617289184,0.6670574318074789
HuP-T3,107970,2.2315719384591133,2.395325610903873
MOLP-8,462382,0.932516774133838,0.43682638607116253
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712,4.1353929018888245
COR-L105,448949,1.923777772079977,2.1396187714316115
SU-DHL-6,5311,0.0847535344452709,0.37595314323012224
COR-L105,65064,5.250674314711081,5.126477276978921
RKO,9908783,5.5436232623995805,3.992664102540206
BICR 22,1566236,3.7080344976190434,2.45705095085226
SK-OV-3,2708,5.531711784720637,4.961131340942316
RERF-LC-MS,148198,-3.5927713028936834,-2.9804310755725867
K-562,10127622,4.587499993681003,2.874077651090413
MDST8,3543504,4.366917593553272,4.394954923655132
NCI-H2452,675434,4.57874791360699,4.640122719929143
BICR 22,vorinostat-carboplatin (1-1 mol-mol),3.8807496375646937,3.1783955715379695
K-562,73707398,1.1020172598138147,0.5429086120099733
BICR 22,11178236,-2.3138277354389176,-3.1845561575967594
KU-19-19,53232,3.650570649303299,2.8107203535918073
COR-L105,2126,5.6436039579971045,4.625788931608151
MOLP-8,alisertib-navitoclax (2-1 mol-mol),-4.498852011390448,-0.7465967412092164
WM115,984333,1.7219326558446977,0.5649855923514704
Daudi,6918878,-0.3078198284611306,0.5169686199942253
HCC15,16725315,4.804384009366738,4.339809675176682
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398,-0.5445651338866832
ALL-SIL,56946209,-4.755076906810128,-5.01061738822664
P31/FUJ,25195348,1.3039046822632598,2.369001482076285
NCI-H1568,4261,1.7177455985107426,1.677235854497277
BICR 22,11238147,2.160553784520482,2.7408302904455297
SW48,decitabine-navitoclax (2-1 mol-mol),-0.1693110303669234,1.289635240387889
LCLC-97TM1,25126798,4.007107372760091,3.8569576453222267
PaTu 8988t,11612883,3.2937262662044424,3.008262720198372
SW48,44507138,1.5733509414979852,2.4136615164517377
SU-DHL-1,66577038,2.452346655400699,2.9740390208469747
ALL-SIL,60168763,4.204461937910143,2.433918261017845
Daudi,25227462,-5.495402710114509,-2.858532681604253
LCLC-97TM1,613000,2.0466318432711708,2.575555036400368
LS411N,2828334,6.327786282136184,5.5046955240750925
IGROV-1,9866186,0.4571266497661056,1.010325181710661
SU-DHL-6,72376,-4.568822946856545,-3.611298034183663
P31/FUJ,984333,-0.8646677641211812,-0.41986638968693996
COR-L95,123631,2.8240072692867915,2.305154583587157
IGROV-1,11497983,4.37450324471555,3.551788650510249
BFTC-909,5281672,4.401358042981416,4.710696785419603
PaTu 8902,44607530,2.9609228636650826,2.0187243030467115
HuP-T3,5566,3.0002994658008935,2.952673365265777
NCI-H2452,JQ-1-UNC0638 (2-1 mol-mol),2.3308008637008837,1.8389377182120301
IGROV-1,2729026,2.3541792737160296,2.4830337918811507
COR-L95,11222830,1.53452681839189,1.389558634596834
LCLC-97TM1,66577038,1.6013450181273698,2.935384420237771
IGROV-1,24772860,-3.2892316801587835,-1.4613410986351665
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-0.7405340349346616
HCC1500,navitoclax-pluripotin (1-1 mol-mol),-1.6377620908642292,-0.8348465493262068
NCI-H1568,54678924,1.274078635657008,2.3027992753323745
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495,1.1299439464125036
RCC10RGB,9908783,5.908182650801537,5.11111177643999
IA-LM,66577038,3.3956332242260765,2.6810255761246236
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172,0.9394449463246284
COR-L95,9935249,2.976260244275784,2.1011800076865024
SU-DHL-6,9868037,3.231553190440303,2.1524203159362254
RCC10RGB,11640390,5.2605770793622275,3.9619027891194194
Daudi,285033,-6.062056136351362,-3.035323557923425
BICR 22,11626560,2.057582050988773,2.041954778839756
NCI-H1568,60750,-4.838669884752028,-2.0219462151467673
MOLM-13,2708,1.6215518677504634,3.5499043912787225
LS411N,crizotinib-PLX-4032 (2-1 mol-mol),1.3060638395576354,1.2197983077662535
K-562,10385095,0.5975872383647969,0.964202740885461
P31/FUJ,tretinoin-navitoclax (4-1 mol-mol),0.2737114955755992,0.3848264633221489
ALL-SIL,9887053,2.3955838154567703,2.431336229851593
RERF-LC-MS,151289,1.06337646711186,1.2270245112322693
LCLC-97TM1,71466445,2.7974721848465025,3.2866390669439998
RKO,15983966,1.976330033309676,-2.861546888355898
SU-DHL-6,54143018,-0.9166021499884252,-0.2747712258819998
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992,0.7387724011532711
MOLM-13,vorinostat-carboplatin (1-1 mol-mol),0.7090489644750352,2.1467814508811696
IGROV-1,49793307,-2.5291790820063538,-2.4173239019530564
COR-L105,crizotinib-PLX-4032 (2-1 mol-mol),2.1629523176516248,1.9390750640824341
SW48,9866186,-0.0602537260044697,1.0679771704712302
ALL-SIL,24753719,3.3195109491118635,3.1745731207799084
PaTu 8988t,409805,3.676693079768219,4.90117216788823
BICR 22,11175137,1.6412636442827269,2.5142268582301828
PaTu 8988t,vorinostat-navitoclax (4-1 mol-mol),3.0451026382172732,1.1369172991972598
MOLP-8,9887053,1.3364969406129874,2.4466364531154463
Daudi,81146,4.468898659357518,3.602573018817535
NCI-H2452,6438330,4.066979701794873,2.3345043897862556
SU-DHL-6,73707438,4.161722925172636,3.9906727651254768
SU-DHL-1,9825149,2.3972801394012415,1.8435466884243197
LCLC-97TM1,1242560,3.1698209685240832,3.317046628666952
RKO,44632017,0.9673312213076444,1.0487220772708203
ALL-SIL,10184653,0.3156525087572682,0.6871881668955133
MOLM-13,15953870,2.45012914744678,2.920121963746745
WM115,docetaxel-tanespimycin (2-1 mol-mol),-3.9058848396527464,-2.717342828077325
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045,3.00422935969599
Daudi,9908783,4.64363842559646,4.0237211051972706
BICR 22,2746,3.5358057095338404,3.3013408544413267
SK-OV-3,9903786,2.611217845094376,3.0666377047434166
Granta-519,446155,3.3236756015859266,2.271048745001586
HuP-T3,46843906,1.6260119885378777,3.2736318836900358
RCC10RGB,25102847,4.4790627708666255,2.64255187705795
SW1573,119607,3.675967979424282,5.351676238121072
NCI-H2452,36462,2.3648017756260327,2.471560976600292
RKO,9926054,1.883626680074333,1.7676009201683736
UACC-812,11396600,4.679415745859403,3.701886850299877
LCLC-97TM1,67291369,2.1623476689900527,1.9388059099325092
SaOS-2,9926054,1.5065280757428428,2.128504667972447
SW1271,11485656,2.5257448561020053,2.643098387961717
SU-DHL-1,65628,3.0805404655500843,4.121395748758374
RERF-LC-MS,24889392,5.73600211591012,4.073559471352703
IGROV-1,16720766,-0.0562020789376145,0.4707013608439095
SaOS-2,53392493,1.7453499080757628,2.4313454240532995
BICR 31,JQ-1-MK-0752 (1-1 mol-mol),2.163474213011291,1.63724258049774
LCLC-97TM1,71466578,4.4967812415195025,3.6688423720624312
MOLM-13,135440466,-1.1165614244178856,1.6729631659102437
IA-LM,1566236,2.064855820915055,2.452001696790384
SW948,3825829,4.076553662425885,3.5339932224705404
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361,4.33784307909623
WM115,322968,4.566671406107956,4.147233828373874
RKN,637858,2.0099352926359533,2.061396984243733
COR-L105,135398516,1.4567379833558207,2.184612400195048
LS411N,15547703,3.407600768992332,2.675418521094575
SW948,6918878,-0.2941800388813576,1.4470424318199877
SK-OV-3,31703,-0.6007067740148971,-0.7687222727486411
BICR 31,16038120,0.7865824758597759,0.9912324371675263
SW1271,46943432,0.8939870827443378,2.5149796959589286
Daudi,67291369,0.2775886597323658,0.40679253483477756
WM115,SNX-2112-bortezomib (250-1 mol-mol),-3.3081919953178507,-1.2250623033286132
BICR 31,11455910,2.0785566961581186,1.2165813209858463
MOLM-13,25150857,2.0975264071969075,1.6100735481068207
COR-L105,46174525,5.553907170062061,4.640877529831297
COR-L105,piperlongumine-MST-312 (1-1 mol-mol),2.3163882961547086,2.1336399085292466
SW48,serdemetan-SCH-529074 (1-1 mol-mol),1.5320240627835209,1.7366389775100428
IGROV-1,135398516,1.9751898057484376,2.2229824683205717
PaTu 8902,3689413,3.662647678116459,-0.44507917279804987
Daudi,31703,-5.42156315939604,-2.3893084084671306
IGROV-1,24785538,1.106246320450551,1.5298150893727835
Daudi,navitoclax-MST-312 (1-1 mol-mol),0.6762626360352524,0.3346694963025839
PaTu 8902,676352,2.5672836386659625,2.1004599805381092
MOLM-13,426756,3.5583078181784504,3.976865868814995
WM115,64971,1.594754361798162,2.5174094865975642
SW1271,4521392,3.9428497415690713,4.091738216905306
HCC1500,19582717,3.689290387765622,3.9994634139295364
BICR 22,71680916,5.5411632888305755,4.710032057492212
IA-LM,462382,0.6444148679919928,0.4591001429962761
P31/FUJ,24856436,-2.072993507389728,-0.5856454618820313
LS180,135411,0.2951252953722391,0.6800006687344883
MOLM-13,72376,-3.7215877343251456,-3.7774293514949653
RKO,6610216,3.958403220086871,3.8587556351214984
RKN,452548,0.7515073582009456,0.03928075724655218
P31/FUJ,navitoclax-sorafenib (1-1 mol-mol),0.3998417690889591,0.05777017068226927
SaOS-2,3038522,3.0360203721983257,3.0430271189896585
SK-HEP-1,409805,5.808157500863876,4.907614641308654
BFTC-909,44137675,3.23817368119839,3.798359329905064
SW1573,25183872,-2.56928333929943,-0.5281431380267823
HCC1500,23582824,1.5666293035108128,0.6767079597449688
MOLM-13,11612883,-1.8374573083034769,1.7955742959989323
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189,0.46656673653135305
ML-1 [Human thyroid carcinoma],445643,4.241689590807037,3.9145716438061235
KU-19-19,135421197,1.2163789616721166,2.006659289588255
SK-HEP-1,49766530,-2.8567737760804324,-0.1074480618012101
Daudi,46843906,1.1534141628569738,1.4817080359034491
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316,3.911734613538014
IA-LM,11494412,5.732457488131999,0.7314649597917573
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826,0.8002999703210891
Granta-519,selumetinib-piperlongumine (8-1 mol-mol),3.4654025033242712,2.056038210797295
Granta-519,46943432,2.0409318821812477,0.7326277807487357
MOLP-8,46174525,3.423634821116614,3.1633017779287407
RCC10RGB,19582717,5.580606305911862,4.325541930968078
NCI-H1568,71680916,4.3779497666633915,4.900577842610818
SW948,3689413,-2.2648112033429824,-1.0880943045923397
RCC10RGB,252682,6.528801566934436,6.4578281060877964
Daudi,135875424,2.734623655159311,2.998841732690595
K-562,4788,4.09681667300412,5.207199129716414
BFTC-909,66577038,2.856590203747272,3.0168771464504154
BICR 22,56649450,1.894872176339528,2.664521854296829
LCLC-97TM1,23635314,-2.2617116518456792,-1.950791837485359
SaOS-2,16013152,4.240825830990255,4.012777932774715
MOLP-8,5738263,2.3540234006064424,2.7977531345554483
IGROV-1,3552672,2.134472496867482,3.047149937925773
BFTC-909,6505803,-2.7076869289136147,-0.1413554996630854
NCI-H2452,9952709,3.912471204941481,3.2343249071512377
SW48,4477,0.2937974315698831,0.36857784512057945
IGROV-1,10113978,2.874171865860951,3.0392499285631622
Daudi,3465537,3.6729414318228697,2.495081586770178
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842,-0.5802060207435545
WM115,60750,-0.3155979924811316,-1.8353479088445352
LCLC-97TM1,3552672,1.9872160910848609,3.023079188459803
P31/FUJ,16720766,-1.2973124396101832,-0.5587475121817441
PaTu 8988t,16722836,1.7927006401716397,1.7307316741880936
RCC10RGB,24785538,4.443576486987547,2.05134929118596
LCLC-97TM1,54454,2.264936650655555,2.737535646379891
BFTC-909,44202524,2.4582417316930916,2.0310411376358446
NCI-H2452,9956119,4.089312834038711,3.8811568745082337
LCLC-97TM1,44589607,2.470818031732135,2.7780451235636736
K-562,9911463,2.5078915917546336,3.1369509018589827
RKO,12003241,-0.2410566552434749,-0.6712204178148271
SK-CO-1,9887053,2.665990529661509,4.10690347791321
HEL,9444,3.6260707724362113,3.342714920397782
RERF-LC-MS,54618164,3.9158352593779377,4.163461485916113
SW1271,vorinostat-carboplatin (1-1 mol-mol),3.5487525185295774,3.098687442099514
MOLM-13,400769,-1.4398892181534526,-1.5703959041323834
RKO,54454,4.6965621210229225,2.738066327518676
HEL,3815108,1.7280464955300685,2.2345084778648734
HuP-T3,400769,-0.02490432142157,-0.44023773233599883
COR-L105,439501,-1.395093001857319,-1.8336261508028142
P31/FUJ,11717001,4.27266863837082,3.7039614360385347
WM115,44566777,1.1755609042254629,0.5297496465040178
Daudi,9823820,1.816535221490948,2.39849728119436
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233,3.4142873117340264
SaOS-2,11178236,-4.192404287761835,-3.538789922838134
RKO,107970,2.3673735748138265,2.0533149503339896
Granta-519,3384730,1.8851059301538475,1.5327847010873732
Daudi,3081361,1.2348545680767924,1.7868729371630758
COR-L105,11656518,2.8708923278875846,2.05979381363437
SK-HEP-1,4261,2.0689452694586596,1.9406878846795395
IA-LM,4261,0.3595729013120086,1.5331169637818183
SW1271,5282054,4.135247135343962,3.6869494344566704
NCI-H1568,44491742,3.692908194165655,4.387211052987023
K-562,10074640,1.329135681779355,1.9911930277836283
IGROV-1,9908783,5.873270433212515,4.767042103654517
MDST8,24951314,1.0921901869172437,1.2023628112937585
ALL-SIL,3081361,0.1962192778787347,1.3673402999625026
SaOS-2,4578,4.61303870633514,4.496600944827262
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031,0.10296968824419256
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248,2.209551602988438
IA-LM,25227462,1.9658589227885097,0.3216278961676706
MOLP-8,71466578,1.6771539715617054,2.409825343514016
HCC1500,11977753,-0.4307765862265268,-1.096356608606266
BICR 31,vorinostat-carboplatin (1-1 mol-mol),4.357832771492993,3.216734723646847
BFTC-909,568763,0.745825262149274,0.6104918149039539
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955,4.159296842573125
RCC10RGB,613753,3.3201179844199498,3.404564248934106
BICR 22,421610,1.881248812005912,3.354684695899195
COR-L95,55508,1.7090560645840305,2.832772640735946
SaOS-2,2945648,3.259308629519986,3.0092473696362934
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845,1.4342570108263002
RKO,409805,3.580644131410829,3.9964147440301905
COR-L95,53495165,-2.3377393798516395,-0.7690220189126313
SK-HEP-1,25154868,3.1824362497542182,4.517367835710655
NCI-H2452,tanespimycin-gemcitabine (1-1 mol-mol),1.9681737644651764,-0.36863270414715293
SaOS-2,5978,-3.9287237947590494,-2.472124708997447
COR-L105,4096211,2.67395928769434,2.1982212293418346
LS180,15953870,3.325208983942858,3.4659835992552384
Daudi,66577038,1.2731684674623205,2.529609738462624
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278,2.9199065553375116
RKO,6918328,0.803085247134139,-0.5293636993243307
SW48,4259181,-1.8199657809061969,0.08551451713282626
SK-CO-1,44185566,2.2410285456889176,2.392887753211261
K-562,5978,-3.1400031562505393,-2.8222924111346583
SaOS-2,613000,1.0847199338514617,2.7079644698717846
LCLC-97TM1,9826308,0.172966057550933,0.22992587448341728
Granta-519,5311,0.5114694341413046,0.3708176034978966
SaOS-2,carboplatin-etoposide (40-17 mol-mol),1.667562518729443,2.3102191668466023
SW1573,4788,4.2029613497215195,5.666054329288466
PaTu 8988t,vorinostat-carboplatin (1-1 mol-mol),4.263432325084182,3.2773388152289096
WM115,2729026,3.0250773642114175,2.627048136794524
IGROV-1,23725625,5.712368491237602,4.9174610170418
ML-1 [Human thyroid carcinoma],8515,2.907082200923046,3.9822035836462875
SK-OV-3,24964624,2.562140083880341,2.5408639017638053
HCC15,navitoclax-PLX-4032 (1-1 mol-mol),0.321962590188161,2.3160096113830786
MDST8,5278396,3.853168516309647,3.582187606826537
RKO,119607,4.75876667689532,4.362172578856297
MDST8,65064,4.754326425577863,4.812328405548577
MOLP-8,54596558,5.109397009340411,4.153791015929731
WM115,9911830,1.4636751787761997,2.3072874442641123
SK-HEP-1,44486219,4.3977685724309215,4.291123343466613
BFTC-909,15983966,-4.834157449814871,-0.7815661335288496
SU-DHL-1,24901704,2.0463171426909086,3.0853069946742773
NCI-H1568,3025944,3.938114410703908,4.373330595806923
LS180,selumetinib-PLX-4032 (8-1 mol-mol),2.448756445045049,2.8605705597958164
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289,0.662516527750288
RCC10RGB,16725315,5.2458056955252275,4.195635581661678
RKO,53495165,0.8925500623489324,-1.252582232128536
HCC1500,71304818,1.489157695167493,2.365479927132628
COR-L95,135398738,4.3251787986630195,3.4673189876899477
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263,2.897308093216138
SaOS-2,56949517,5.721423210410403,4.417514601791129
ALL-SIL,644241,-6.056766449232899,0.25352378878498993
MOLM-13,42642645,-6.876168570605093,-0.2787993174141997
RCC10RGB,51039095,3.636696049778912,2.8938496902266797
ALL-SIL,60700,-4.240130526526249,-2.1574059346719285
PaTu 8902,15547703,4.581249636071297,3.2343375760814954
BFTC-909,11609586,2.9417391320909134,3.0353982703883045
SW48,11455910,-0.1633281652990052,0.9398155300882216
LS180,selumetinib-MK-2206 (8-1 mol-mol),1.4028786728536926,1.4887895314178832
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963,1.5101231325868367
MDST8,11364421,1.2673702676732186,-1.1799345768946374
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991,1.6323617974884
IGROV-1,23939,4.412541857664819,3.691798047383603
HCC15,11626560,0.3588759938830249,2.123507102726289
MOLP-8,1750826,-2.6273703880538166,-2.8560789744153943
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314,2.0921452171375092
SaOS-2,3634881,3.4478485283346454,3.263047401302994
KU-19-19,65064,5.4276979548790285,5.060169151439266
SK-OV-3,53392493,2.9853646548342767,2.7795872298771456
BFTC-909,44607531,1.7004331217528663,1.6924282502862522
RKO,9915743,2.8851858618766957,0.47564968512318573
WM115,969516,2.5733075045080405,2.9064960242484004
MOLM-13,navitoclax-MST-312 (1-1 mol-mol),-0.7732876947237494,-0.31310326873182315
HCC15,1641662,2.7903081608832743,3.576608633884234
PaTu 8988t,24856436,-1.0780184146975675,0.6733893144064997
BICR 22,151289,1.1052603945032196,1.1745882885041277
RKN,10302451,3.971829298943927,3.141711963531583
Daudi,9840324,5.326423492349393,5.460392510544406
Granta-519,24978538,-1.4483375486726318,-0.30586194529435273
IA-LM,969516,4.593397144463051,2.346260539747163
LS411N,16741245,4.421981695824733,3.42723766956521
SaOS-2,241158,3.6917409878316136,3.725250545155684
HCC1500,49846579,-4.075833194843517,1.1236084022877237
LS411N,11626560,1.8283516183370416,1.0804433274980632
NCI-H1568,2746,2.7741418395417163,3.326305900054876
PaTu 8988t,375860,0.0559535091713014,0.252704638230616
BICR 22,613753,3.418897622092284,3.2179883148713198
ALL-SIL,52912189,0.8155728349845486,0.2295259834353084
BICR 31,erlotinib-PLX-4032 (2-1 mol-mol),1.9143994783784697,2.9973108721919743
BICR 22,3634881,3.8771660288779457,3.24187872721693
RKO,3543504,4.836700902585943,3.6862722239496137
Granta-519,6918837,-5.331886820340028,-4.706217678533489
SW48,56963564,-0.9893979738252238,1.0130013510966918
Daudi,4259181,-0.0890599021012781,-0.31778313876079173
Granta-519,7326481,2.8185757173328927,2.773776828878474
SK-OV-3,4096211,3.632564776557465,2.080276651294741
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417,3.361327714429241
SK-OV-3,24856436,1.946601057004947,0.6904709118778257
Daudi,613753,2.7401651571031618,2.472905687113951
ALL-SIL,navitoclax-pluripotin (1-1 mol-mol),-6.100095381264916,-2.5221860569260515
BFTC-909,452548,0.7682850038212578,0.31117085282349977
P31/FUJ,409805,3.653161003579303,3.937121264141672
IGROV-1,11404337,-0.7659238947812715,-0.47097365279673686
SU-DHL-1,24753719,3.670729792524347,4.066529387009844
BICR 22,24901704,3.9299918475898408,3.2521526362269917
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436,3.9854174105547986
NCI-H1568,135411,0.4069452326541798,0.5972676857785981
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309,-0.7654755213540466
K-562,126941,-4.461586339574126,-3.06017629540974
Panc 02.03,2113511,6.868929428825361,5.607910165638855
NCI-H2452,44241473,5.273016525632626,4.936837600202615
RERF-LC-MS,135984461,4.284403636339015,3.959288298446114
KU-19-19,5329102,2.6076401407195355,2.1374123462573764
SaOS-2,49867930,4.412008076102657,4.7752673372462064
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555,2.0477826962206245
IGROV-1,54618771,1.2456991772210466,1.4879441890915153
BICR 22,7251185,3.2802016727508105,2.444369967987223
WM115,11178236,-3.130587173648645,-3.0767570199053678
BICR 31,168312962,4.404506435623785,2.381355828293975
BICR 31,135421197,2.236076370585341,2.0507522690897186
K-562,72734382,4.39493075447737,3.5177666101172234
Daudi,4521392,3.754955104648716,3.907835901531787
NCI-H1568,9903786,2.4011050725962115,3.1047188273055717
Panc 02.03,1242560,3.876690059869664,3.527074315371577
SaOS-2,24771867,1.911103494547597,2.6967208376222236
NCI-H1568,46224516,1.8217130718981496,2.542212099950866
HuP-T3,637858,1.096014734488476,2.085574521117654
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931,1.0479376966953855
HCC15,9825149,1.99442718669858,2.2419749607432276
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004,3.730506723472372
LS180,9967941,3.3265068520356227,3.431011766982467
BICR 22,15953870,4.283514914534557,3.574400832592037
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842,2.807419206584117
P31/FUJ,49766530,-2.577046245506879,-1.7635493177376174
COR-L95,erlotinib-PLX-4032 (2-1 mol-mol),3.78665088959685,3.188823579233481
IGROV-1,5470400,-0.2457809435208252,-0.14900179441584188
K-562,3025944,3.938999685525622,3.9922435613257075
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238,4.0209547158275845
Panc 02.03,1641662,3.717230762709902,3.663071754017669
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874,1.6494079376587651
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858,-0.2754742140590501
SK-CO-1,613753,3.569116813952151,3.270816035261404
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196,-1.357299528256187
LS411N,73707398,1.3643081745247092,0.7306290318473804
RKN,60700,0.8209474049972991,-0.1437303244847961
P31/FUJ,52912189,-0.0654684439378525,0.2949425427713359
Granta-519,49793307,-5.0235824363471675,-4.6800272785419335
LS180,439501,-1.9142457865624176,-2.0068854205789948
BICR 22,19582717,3.5857042125142247,4.381965398246665
P31/FUJ,11612883,1.4537759753270971,1.8065324576992208
RCC10RGB,135423438,4.4299924289236055,2.842622008886086
HCC1500,piperlongumine-MST-312 (1-1 mol-mol),1.4293216638390454,2.0622042452199247
IGROV-1,24797083,1.5319862293819655,1.3454469056061729
WM115,11657048,4.298694485616108,3.6251746800896627
SaOS-2,5328940,1.8581375817896455,1.7994919430021383
K-562,11427553,0.716330793964625,1.6034755114265433
BFTC-909,60700,0.4554202898414442,-0.08180776048425514
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229,2.5869699495405185
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438,1.1121259242242427
HEL,656346,0.4971755704716853,0.2922024274820461
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425,3.055004370580337
SK-HEP-1,25126798,3.9918710327668503,3.9866373717274035
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933,0.7445381313659086
HCC1500,568763,-0.919346546730658,0.6039242231423841
SW948,selumetinib-tretinoin (2-1 mol-mol),-0.8554904901249896,2.7754197838019707
NCI-H2452,71466578,5.120149615089657,4.8313479131558505
COR-L105,2871966,0.4959639880090196,1.0518106725850058
SW948,5746,1.511438037719251,1.1776315002980162
WM115,10172275,3.759074377781229,3.523037083646654
PaTu 8988t,11964036,2.992263460840089,1.4947823222825836
SW948,16219061,3.499504842183279,2.7656183216033248
LCLC-97TM1,53495165,-0.6427926162361222,-0.556652827953514
UACC-812,3081361,1.9829916627298712,2.371213062916341
SaOS-2,5287969,-1.655987163162804,-1.7241065146614787
IGROV-1,25183872,-0.4560099928976716,-0.7248625186464009
IGROV-1,44607530,1.2936443589937894,1.8271391413737998
BICR 31,salermide-PLX-4032 (12-1 mol-mol),5.564689341846323,4.893515717584812
SK-HEP-1,57519531,4.12625544642691,2.6951706147976715
BICR 22,119182,-2.736639797021525,-0.5128894146788755
PaTu 8902,4521392,4.129468839379376,4.1761100896932986
LCLC-97TM1,60700,-0.7670870439402468,-0.3705422866827549
ALL-SIL,44607531,0.7892287314343482,1.0449630322216295
SW48,16720766,-1.213948450866439,0.39871320314345937
LCLC-97TM1,9911463,3.937478558519083,3.6091788590534883
SW1271,6918289,2.985913038733717,2.286613135250244
SK-HEP-1,25183872,-0.6604608842788147,-0.7257661717914455
P31/FUJ,5311281,0.8046363155731003,1.8214392787620373
MOLM-13,107970,2.204740997332017,1.9977922576841214
PaTu 8902,44607531,2.4953979740561136,1.711749315432348
BFTC-909,5978,-2.385180460490498,-1.4118444854168606
IGROV-1,9926054,1.8111808945519428,1.9581098809236983
MOLM-13,JQ-1-UNC0638 (2-1 mol-mol),-0.7004023711482303,-0.32953726979336373
SaOS-2,44632017,0.980304929421305,1.3455649667753626
WM115,23582824,-1.5173797182891284,0.7340184121115846
RKO,5746,2.147448518007633,0.714805719432497
SU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-2.528242404368283,-4.109506299260169
COR-L95,11234052,4.796206825131301,3.7285017893612995
HuP-T3,navitoclax-gemcitabine (1-1 mol-mol),2.4880623143443965,-0.9305616416011734
MOLM-13,46199207,1.8343479247638497,2.776067547052341
SK-CO-1,216345,2.2578794962248403,3.7699512482090722
LS180,24951314,1.284825385865239,1.4389723283175337
SW1573,71680916,4.0865163925225385,4.792315068743892
LS180,11427553,3.214146965067504,2.9426761094431115
HuP-T3,17755052,3.4304742988115366,2.054756318858314
IGROV-1,44607530,1.2936443589937894,1.8271391413737998
HCC1500,11964036,2.769497384705972,1.3653938303997193
LS180,446155,1.950458971830876,2.890728182468976
SK-OV-3,10385095,3.0219456492917485,1.4660411165889813
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096,2.0032370427592077
LS180,23635314,-2.728761007932067,-1.1717968863836499
ALL-SIL,25262965,-0.0785584741633136,-2.569664158408133
MOLM-13,9956119,3.465056755214706,2.8204722142672995
Panc 02.03,54619267,4.6873070757127335,4.162659146615595
MDST8,45100481,5.670163105184411,4.4255003529817545
P31/FUJ,11427553,0.2126015278922564,1.2175407722066345
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983,1.254728817810923
SW1271,123631,1.9601206845091983,2.4075254858362465
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825,3.6695671326838317
SW1573,11626560,2.096503053081923,1.9660769400104818
COR-L105,11717001,4.401406695561914,4.085468199761438
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765,1.6620098195519741
IGROV-1,135984461,4.285945029851472,3.7105518460418327
HuP-T3,16725315,3.145396972494799,4.376232513003977
SK-OV-3,5278396,4.0115131897954175,3.7392368274182557
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973,4.27729696139312
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252,1.8808107980057014
HCC1500,7326481,2.1911838281348897,2.6588188276846445
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542,0.12350880549803209
RKO,11485656,2.16906736756012,1.4972489375392237
HCC1500,17755052,3.708779056995352,1.523542671626109
RKN,16720766,0.5941206863048918,0.2673661941735806
SK-OV-3,49766530,0.1985460846164677,-0.4311177091293109
NCI-H1568,11178236,-4.756412327662482,-2.7768165880529883
K-562,613000,2.5009117496842292,2.1350560996964996
SK-HEP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.2519782158989084,-0.8132346170024348
Daudi,49867930,3.141108082189553,3.645991554414918
P31/FUJ,451668,0.4769801026955246,-0.1567661521859406
SU-DHL-6,2708,3.434249932793118,3.357268154630471
RKN,11497983,4.544575984994342,4.519399180242271
IGROV-1,23582824,0.3287266354391525,0.519073881444238
HCC15,2858523,2.7763462118547833,3.1273717231287823
RERF-LC-MS,3025986,-0.71270364092759,-0.3630449399576365
LS180,984333,1.4840791700280882,0.4684328199235004
COR-L95,24901704,3.9540534266274183,2.8833344469310163
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083,2.058287074991326
MOLM-13,piperlongumine-MST-312 (1-1 mol-mol),1.1119295359137316,1.1273751577247353
COR-L95,409805,3.71634228772174,4.109643240560289
PaTu 8902,9823820,4.420414335239228,4.1273049870506995
Granta-519,24821094,2.4908648032560183,2.1499716604225547
SU-DHL-1,26596,-2.3613305357908625,-0.8071152273813555
RKN,285033,-0.0275118271199953,-1.8885144784131327
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505,0.2723930217602027
WM115,ISOX-bortezomib (250-1 mol-mol),0.2831832229570691,0.5108870661840248
NCI-H2452,9936388,2.1806204942966803,0.06662308322752514
LS411N,54618771,1.0517408544895162,1.210041889197248
RKN,72193861,2.3331130274465313,1.6372904543027094
MDST8,46843906,2.4704071908178844,3.1579722138639865
HCC15,11485656,2.480533785053976,2.487449349013495
MDST8,11977753,-2.9914432786855305,-1.4627606327874556
PaTu 8902,168313047,2.1566405666580963,2.1710664928520726
MOLP-8,135928012,3.056644501758044,3.855815708791105
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775,2.15089386193422
MOLP-8,10074640,3.1436066614625173,2.7280090179175924
HCC15,12001922,1.9087360775911748,2.0193534382517075
LCLC-97TM1,3025986,-2.553955076787079,-0.950012846773589
BFTC-909,2842253,5.585220688564769,5.307542475799031
RKO,216239,1.9979551619375524,1.866146873902647
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157,3.8069679019896454
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872,2.4206770488506493
Granta-519,135398516,2.1425852334349575,1.1017160656400018
KU-19-19,10385095,1.1563887024661463,1.4166532292453733
LS411N,navitoclax-gemcitabine (1-1 mol-mol),0.4425335439188313,-1.0698371744595665
SU-DHL-1,9803433,4.734138876460479,4.342167571080714
HCC15,135999136,4.472611779685761,4.019748417241076
SW48,11238147,3.1100916590750045,2.781571567507921
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784,-0.8611534100311341
BICR 22,409805,3.8456212820768214,5.032745309861308
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956,0.7795175498942176
P31/FUJ,24785538,-0.2737810661065927,0.29991908175553594
Panc 02.03,176870,4.923826321280428,3.327814660531299
RCC10RGB,322968,3.1449149812629877,4.107265207773938
HCC15,107970,2.678547076190946,2.40041124205962
SW1271,71304818,2.7682192858067385,2.563466049262055
LS180,3634881,3.5372782333734696,3.268691040001577
COR-L105,11214940,1.6414587299435788,2.1542580853655955
SW1271,5287620,-1.7165830209074355,-1.8185881667189507
HCC1500,navitoclax-piperlongumine (1-1 mol-mol),-1.489158158277352,0.7747036632472121
COR-L95,49766530,-0.268325836176492,-0.804596175819492
P31/FUJ,6450551,0.3392586382091512,1.1657643277119087
PaTu 8902,5566,3.0665407385312182,2.931287055730772
SW1271,6610216,4.395476769861187,4.378582431242585
IA-LM,4477,0.1872236957364025,0.3980807939589295
BICR 31,6917907,-2.0849244140580683,-4.541079955486874
Daudi,56949517,3.615784656128556,3.903652048531469
SW948,selumetinib-navitoclax (8-1 mol-mol),-0.0800083599001994,1.44923767704994
Granta-519,156414,1.3767921664113123,0.6654638238969595
SW1573,60700,0.5293530759970745,-0.027079412372610114
PaTu 8902,11404337,0.5155229173062875,-0.23006587725489983
BICR 22,52947716,-3.710960782083666,-1.0296027876787122
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184,1.556087052679426
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852,2.4336505344450385
SW48,216239,2.7420558854204105,2.3337150840840453
HCC15,136227924,3.0147456858017923,3.04722346931559
MDST8,400769,0.2052239388954162,-0.4339820065156114
IA-LM,navitoclax-sorafenib (1-1 mol-mol),0.7106711881893861,1.4689096857809942
RCC10RGB,4917,3.4531775579708044,3.0633572989637803
RERF-LC-MS,73707398,2.0319367406190483,1.6189348032983295
LS180,4917,2.9590600733191272,3.1245429932342534
Granta-519,46926350,-4.5411361861126,-4.517650400035689
BICR 22,1716436,3.778329286476686,2.9599694989991696
LCLC-97TM1,55283,2.725406070596606,2.661086713459525
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901,1.8358536450701166
RKN,168312962,-2.199105388969794,2.1136900011077806
MOLM-13,54619267,3.3881439662249657,3.2564063963294854
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711,-1.2955238401155424
COR-L95,1239801,5.40725658561935,3.837367144795299
IGROV-1,10184653,0.79276129336756,1.208473366577402
HCC1500,16741245,3.4170657459529865,3.773244361303364
LS411N,44491742,5.693616041532359,4.086011272753289
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148,3.768788276487167
Granta-519,24753719,3.151565571990212,3.6150148031215985
MDST8,decitabine-navitoclax (2-1 mol-mol),-0.200661322464638,2.036208804158086
RKO,107985,-4.24085601271806,-3.736513010815264
HEL,322968,3.0393820993226535,2.257228299047353
Granta-519,46224516,0.9242838162777752,2.130791479388543
LCLC-97TM1,9823820,4.2474508710721315,3.5452604262535026
MOLP-8,23582824,0.4015956903029024,0.35247067813158767
NCI-H2452,60750,1.245026450810127,-2.581600782186939
NCI-H2452,piperlongumine-MST-312 (1-1 mol-mol),2.5229701837483263,1.7151575980110103
COR-L95,54596558,4.049100773357865,4.2718519724111035
SW948,135398738,3.916695667859345,3.052781132725028
SK-CO-1,9936388,-6.4137542305703015,-0.9875448653370706
Daudi,60700,-3.752408099295295,-1.8324911297625184
COR-L105,11612883,3.356288934915157,3.1042842965597344
PaTu 8988t,10302451,4.044762571435361,3.4706240150390353
SK-CO-1,44507138,1.8454813707467936,2.4299267787318297
COR-L95,44486219,4.398500193784116,4.312932837382825
LS180,1242560,3.670855291471482,3.416656805659524
PaTu 8988t,25102847,3.84691315859083,2.6688743048893526
SU-DHL-1,1750826,-3.9186889861650713,-0.9742565886161235
IGROV-1,4261,1.934016649932683,1.662837627863512
IGROV-1,9903786,1.7387584479757865,2.9585727721700534
IGROV-1,9935249,3.330117761231163,2.9720913651531258
COR-L95,446155,4.383849487789403,2.3723845161637778
COR-L95,9967941,2.195306027237361,3.1030564707757495
BICR 31,49793307,-0.900639036765476,-2.4050867280488633
Daudi,52912189,-0.5619081020202099,0.49124469070420423
MOLP-8,9911463,4.2009596294807245,3.0779515980583785
LS180,44589607,3.154958497437342,2.7106236613206622
Daudi,24821094,0.7293316215174883,2.283012507069965
RKN,12003241,-0.3350096455718494,-1.4084738797827874
LS411N,148198,-2.2204558676981576,-3.6497543548005638
RERF-LC-MS,446155,1.000000375050646,2.6109803979246493
MOLM-13,10127622,2.24693559354045,2.2082159146605336
SU-DHL-1,decitabine-carboplatin (1-1 mol-mol),1.7663528844174463,3.598103659996726
P31/FUJ,72734382,3.508076038929844,3.381777908481066
SU-DHL-1,568763,-0.4525318049600722,0.6475472881770185
SaOS-2,11977753,-0.3684170228919589,-1.7159818011383043
SaOS-2,969516,2.4754458532868067,2.826651381388138
SU-DHL-1,54619238,4.649416356939895,4.143316946738804
SK-OV-3,6623618,3.404966669354166,2.4125305198332962
WM115,9952709,2.366340614566085,2.93301133107662
Panc 02.03,10184653,2.526680989613479,1.2661651404142507
SW1271,3634881,2.897813479014186,3.223936412773676
P31/FUJ,72376,-3.3088434861533704,-3.5068694898191834
P31/FUJ,46907787,-0.8407426122417735,-0.3629545295879176
IA-LM,5351362,3.020488284300014,1.3186619574889278
NCI-H2452,676352,2.443862996701222,2.2183959365526627
SU-DHL-1,56973724,1.0008411647005613,2.924960626255595
PaTu 8902,1716436,3.3992265902353425,2.96007858195064
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812,3.2083490905248566
MOLM-13,11717001,3.6418982852877457,3.769737748796511
MOLP-8,613753,2.6774354597179,2.66137326244245
IGROV-1,44137675,1.8406125640672395,3.247209208502524
P31/FUJ,6914657,-6.361388893160888,-5.051436182727077
LS180,60750,-4.478139976515186,-1.4174380227410455
SW1271,3062316,-1.9256219632112692,1.1882706067248179
RCC10RGB,219104,3.453227771477981,4.035507232788363
HuP-T3,6917907,-1.7519392074642692,-4.819528250419628
SU-DHL-1,11656518,1.4392799669460994,1.1225683047748345
MDST8,54626689,6.955475194588027,4.513380466368892
SW48,10410894,3.4061289364485794,3.278048292872334
HEL,72193861,0.4910118925931417,-0.07669486323147044
Panc 02.03,65064,5.367712415574159,5.0804274444634725
BFTC-909,984333,1.0937084793466407,0.8717764724918472
IGROV-1,426756,6.142776526139055,4.385713100416311
RKN,11152667,0.0617927102225113,-0.24210531817646636
BICR 22,3025944,4.210034761741456,4.231742816908565
SU-DHL-1,11640390,4.597120644825806,3.2624129935351296
RKO,44589607,3.597229089573096,2.0136753783647956
IGROV-1,56963564,1.8260986108097368,0.830227194106924
Daudi,24180719,3.437659555986817,3.1812796482389105
BICR 31,45279963,4.353781648061694,3.88829819086989
KU-19-19,445455,4.442962740031222,4.695373654705161
Panc 02.03,5281672,4.500820026656837,4.585759454360266
Granta-519,675434,3.9057117034292976,3.7678480850365337
WM115,46398810,3.009678027858605,2.663506998000348
BICR 31,119607,5.814089022953436,5.343634838161979
IGROV-1,23635314,-0.611739968448912,-1.1678303411437583
HEL,44819697,-3.010940469478465,-1.9313853940694088
ALL-SIL,5282054,2.788902246408387,2.681567089783641
WM115,5328940,2.031963430852867,1.7788745243578359
BICR 22,11455910,2.0554057071158303,1.4534436949484963
COR-L105,serdemetan-SCH-529074 (1-1 mol-mol),2.960742836944571,2.2220120957080445
P31/FUJ,4259181,-1.476581151251805,-0.30632376337270467
MOLP-8,54619267,3.766514987830834,3.62631563327065
P31/FUJ,44489367,5.126164790260484,4.294736207001859
RKN,11625818,5.974552631000589,4.50723599023288
SK-CO-1,alisertib-navitoclax (2-1 mol-mol),-2.923852550533504,0.6186191199880465
BICR 31,5470400,2.045329114611378,-0.16667786781928093
LCLC-97TM1,5738263,3.894572665100205,2.999891330073545
SW48,2729026,2.3283979545053155,2.562211316798348
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635,2.3668217121543695
COR-L105,11167602,4.878993593502554,2.5143017134262236
HCC15,9549297,1.5760835884765407,2.689529474836215
HuP-T3,448949,2.1685596620814565,2.0749837892376974
Granta-519,9915743,0.9460784198503543,0.29904866458878904
MOLP-8,51039095,1.4019996450160122,2.01363127758953
COR-L105,56649450,3.0558986692826595,3.6676705413080266
WM115,16038120,1.6321211746217177,1.1762757731719158
K-562,31703,-1.219746708928784,-2.1215971760827332
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729,2.1799664725164734
SU-DHL-1,11609586,1.5538406664396571,2.3627994598271274
BICR 31,3025944,4.108701914406302,4.303178399318863
SW48,66577038,3.1598846844687545,2.9329141585573346
Daudi,24180125,1.1000611971852634,2.0488406643664847
SK-CO-1,6184667,4.676967004326267,2.964525226339235
Daudi,SNX-2112-bortezomib (250-1 mol-mol),-4.343389130323972,-2.6151235649230573
SU-DHL-1,67291369,2.039504043535649,2.3471083031662667
IGROV-1,3815108,1.915722485757852,2.7103033177414
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633,5.171086606648341
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703,1.6783091237513006
LCLC-97TM1,68056272,3.7652459105524585,3.598772009458118
NCI-H1568,9926054,1.8156743035592564,2.026023779670001
SU-DHL-1,2113511,3.6581551041454823,4.782706147206262
HCC15,3503,1.8764785687467953,2.3634859132667048
SaOS-2,3062316,2.2990980703822115,1.3588253920468227
K-562,16736978,2.075477087199636,0.900128752394772
SU-DHL-1,selumetinib-decitabine (4-1 mol-mol),2.598187269312087,2.824122025111148
RKN,135440466,3.1815161125023033,2.516220019643935
SK-CO-1,89928392,1.2451759556756246,1.8138759850283082
NCI-H1568,54596558,4.146513733670967,4.5110782283844175
LCLC-97TM1,4477,1.1810793422928998,0.6678747523164015
LS180,16741245,4.152630132762677,3.6717515539033747
SK-CO-1,decitabine-navitoclax (2-1 mol-mol),-0.6610169057545121,1.6644843137319065
BFTC-909,159324,4.114702101808939,3.21168700813813
PaTu 8988t,2113511,6.37119394515457,5.520734666783884
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045,0.9086321535631596
IGROV-1,5291,3.6852809555447985,3.7878187115136797
PaTu 8902,16038120,1.215016097060631,1.0768638687763825
ALL-SIL,10302451,-1.1728976190372558,2.6026943335882193
UACC-812,tretinoin-navitoclax (4-1 mol-mol),2.4411364981876043,1.744496623335969
LS180,vorinostat-navitoclax (4-1 mol-mol),1.6395407762655403,1.1347407668979586
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.8500108243304623
P31/FUJ,vorinostat-navitoclax (4-1 mol-mol),-0.3847698718995038,-0.23753783021238672
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645,2.7882845314526565
SW948,7326481,3.486606738365962,2.9036559363520302
HCC15,44507138,1.6295786006094204,2.685031709442933
RERF-LC-MS,16725315,4.583339442818838,4.508114660760129
P31/FUJ,148198,-3.664233852608881,-4.074683003292619
HEL,49850262,3.2265871136708997,2.5734050855825985
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935,3.7182484529320607
BFTC-909,60750,-1.7298046099952136,-2.1900053611453867
SW48,doxorubicin-navitoclax (2-1 mol-mol),-4.619867397585904,-1.2846418532384682
NCI-H1568,675434,4.067969537829177,4.631603404994604
COR-L95,19582717,3.635233206850296,3.618144577049909
COR-L95,148198,-4.800055382400855,-4.003176409660439
BICR 22,44819697,0.2156040754176,-0.02606800804530516
SK-OV-3,46224516,3.444215787907748,3.00338483563032
HCC15,5281672,5.6563329698974965,4.444085140791397
HEL,6918328,-0.4966077251990671,-1.6240441415223545
NCI-H1568,24785538,0.5698046292147018,1.7353447037797929
RKN,23582824,1.7370647325872666,0.8095075455892897
PaTu 8988t,navitoclax-gemcitabine (1-1 mol-mol),-0.4570432900108468,-0.8448161595571909
SU-DHL-1,322968,2.585334286015635,3.5115011562863447
BICR 31,24797083,1.8361324304615187,1.4608155234008846
SK-HEP-1,3062316,3.432714145613195,1.6156143946254813
PaTu 8902,2729026,2.7803221257085884,2.7872777627826455
SK-OV-3,11609586,4.251063762376387,3.136099369618666
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333,4.36037821689079
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202,1.7801736161512511
Granta-519,44607530,1.7224857333943702,1.3264364584145971
NCI-H1568,15953870,3.42403550557497,3.626122923577959
RCC10RGB,carboplatin-UNC0638 (2-1 mol-mol),3.3801418218563337,3.332460939702939
MOLM-13,erlotinib-PLX-4032 (2-1 mol-mol),1.7877509525982431,2.7626510955132835
MOLP-8,252682,6.161004481234046,6.221653671714925
SW1573,126941,-1.0305779796426808,-2.2637285158928027
BICR 31,9927531,5.661036072082279,4.885402131401076
RCC10RGB,441298,3.7731685554529384,2.2863075700590936
MOLM-13,387447,-5.119095777855545,-5.0198669367529325
Granta-519,216345,1.0997896286755158,2.6308647113619306
LCLC-97TM1,107985,-4.222636663811031,-3.587859510425967
LS180,3384730,2.894746509752001,2.888502089643653
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233,-1.9861835674451185
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885,3.645254878084613
KU-19-19,44493528,4.383684457454455,4.33245197113978
LS411N,53232,4.5193815700089655,2.9099197973464355
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804,2.5394003154741402
LS411N,6438330,3.3380693145982816,1.8484058225783933
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737,2.3373066472149047
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457,2.558577057924384
BFTC-909,16725315,4.495652912061774,4.204490784943795
RKN,124202324,3.704376342602573,2.8560470757954515
LCLC-97TM1,10127622,3.458194652659875,3.2418205796991537
SW948,vorinostat-carboplatin (1-1 mol-mol),1.7834644899516086,2.3024556981606903
SaOS-2,5494449,1.7356769079300427,2.8574541687987067
HEL,702558,3.166026376934585,3.7565764955882344
KU-19-19,11612883,2.975593545287462,2.929465463878332
BICR 31,6914657,-2.1990076047646703,-3.886688002232333
PaTu 8988t,2858523,3.414247843041017,3.105268919934367
SW48,9911830,1.5953282800372102,2.489506117631604
Daudi,11178236,-7.583909031047052,-4.259488660777615
Granta-519,44819697,-1.094231558387569,-1.994371440909279
MDST8,2828334,6.077771510152207,6.262137464694729
RKN,9911463,4.114615883902867,3.842928035945342
RCC10RGB,JQ-1-vorinostat (2-1 mol-mol),1.4034358595851535,1.2968343943553817
SaOS-2,9903786,2.3206358959344264,2.645383100058366
RKO,44607530,2.6096687798301677,1.6140893694483056
SK-CO-1,11455910,1.152685438196598,1.3148772241739661
SK-OV-3,25183872,-0.070614613180641,-0.4559815884982086
WM115,25227462,1.5125525407178182,0.26747370929919834
HCC15,2126,5.047391044285817,4.577033186674945
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693,4.047238558323943
HuP-T3,11238147,3.6375005285241033,2.921169118555041
SU-DHL-1,168313047,2.0629090722275945,2.0141868403490264
BICR 22,5335621,5.24838502551373,4.319738903981143
SK-OV-3,135398516,2.140261030425796,2.083612391237677
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316,3.1709235399897517
RKO,11214940,1.6564081526645635,1.3460418249575918
SW948,9935249,-1.8483271913214137,1.925527521206998
NCI-H1568,2871966,-1.5477941874243064,0.5976741562786053
WM115,54626689,3.4845925362433,4.6061748725361875
IGROV-1,46398810,2.003787621940583,2.597438564976159
NCI-H1568,alisertib-navitoclax (2-1 mol-mol),0.1984676648447771,0.4054940081844792
RCC10RGB,selumetinib-UNC0638 (4-1 mol-mol),4.208062457345683,3.416285044572138
SW1271,selumetinib-PLX-4032 (8-1 mol-mol),0.5021040652093107,3.505840075137039
BFTC-909,3025944,6.464154930724253,4.366315615273193
BFTC-909,10113978,3.8739618499623094,3.382898297082088
LS180,docetaxel-tanespimycin (2-1 mol-mol),-5.0888233311005795,-3.3711529628786208
BFTC-909,24748573,2.672786285704278,2.2640016332748196
MDST8,23582824,0.3553467044538872,0.7974124535596409
MDST8,navitoclax-MST-312 (1-1 mol-mol),0.0883996467230522,1.0033874454187663
SW948,53392493,1.921137473015096,1.9909215341703472
LCLC-97TM1,5287620,-2.537847801025228,-2.2298113996021955
HCC1500,3552672,1.623977684405255,2.8118403888619143
SW1271,2113511,4.856200971437617,5.500624666485115
RKO,11238147,3.3996395604326977,2.335514375982983
MDST8,56963564,1.9609696235744132,0.998160921927587
HEL,JQ-1-vorinostat (2-1 mol-mol),-0.5678151706430512,-0.7443933440001659
MDST8,73707398,0.930898424190815,1.315662742914117
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403,1.9226168009247695
COR-L95,serdemetan-SCH-529074 (1-1 mol-mol),-0.7704324455951623,1.756451154563454
HCC1500,107970,1.6380228058856745,2.340666261533891
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911,3.001721602849638
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933,4.718499930307387
MDST8,11222830,1.739834123793711,1.7156694847977816
MOLM-13,11364421,-4.614262921489179,-4.595072235452367
MDST8,89928392,1.3331112546959425,1.6545473459825228
SW1271,doxorubicin-navitoclax (2-1 mol-mol),-1.1619625703073235,-0.9723302962652542
RERF-LC-MS,148124,-5.592640359076286,-1.5659834224529336
PaTu 8988t,219104,4.30352428274638,3.8836687907811607
SaOS-2,16659841,3.6368059645085737,3.8833233282152912
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157,2.44364366494763
ALL-SIL,25183872,-1.1896517316661384,-2.3327683934237737
HuP-T3,3503,2.6961085729175465,2.4027262576088924
SaOS-2,148124,-5.379251304292956,-2.8055724633064822
SW48,25102847,1.5289459974072863,2.4304514957840526
PaTu 8902,6852167,4.282216220168943,2.729429579726239
ALL-SIL,11396600,2.960335319566646,2.9362153177262265
LS411N,54649381,4.0879656113234315,3.0155874527284925
LCLC-97TM1,56649450,1.9268896253969057,2.927780799820222
Panc 02.03,42642645,1.4849485241267697,1.2129909481388648
PaTu 8902,5328940,2.100447742300893,1.6123444989893958
Daudi,10127622,5.05479511248997,3.4050533201439155
SaOS-2,15983966,-4.612114381732812,-1.2419131245678179
SK-CO-1,selumetinib-decitabine (4-1 mol-mol),0.410871863589865,2.841046582939522
MOLP-8,11214940,2.188017762346292,1.5253304143048287
SW48,44607531,-0.0703962424187993,1.335295619976368
IA-LM,637858,2.795809218533269,1.2655325005795062
LS180,119182,-2.2864715680735603,-0.6607471470288826
SK-CO-1,135411,-1.9906675184189948,0.8483108241593571
SW1271,15983966,-1.9627382742922743,-1.468900652247096
LCLC-97TM1,11485656,2.4293249862604913,2.1225856660181734
Daudi,135984461,3.9990978127252728,2.851170178892908
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662,1.2479150299180035
SW1271,24180719,4.447587763279296,3.431191157224612
RERF-LC-MS,4917,3.617944790726347,3.1193211554903155
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943,3.5084197463894604
COR-L105,44185566,3.03526972595121,2.6947827585146626
MOLP-8,8515,3.727464051425151,3.181116738644256
Daudi,11656518,1.0836561052202376,0.7026793185136843
MDST8,10302451,4.267643132743765,3.162029652938441
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559,2.8028972399980883
MOLP-8,135398738,4.11621412508813,2.318416255720747
RCC10RGB,568763,0.4218853975706897,0.715164936774121
SW1271,285033,0.340737243750418,-1.857557014187823
Granta-519,67156097,-3.3327998752636483,-2.3772302583445875
WM115,11964036,0.4423113132234746,1.4911988787288337
SK-CO-1,156414,0.1991331726980137,1.0015511246045197
BICR 22,568763,1.1340411223212885,0.9144976532730807
P31/FUJ,176870,1.9707243184949097,2.5858155973926724
SW1271,24748573,2.5868513601661336,2.1644799503964514
MOLP-8,72199292,1.2541603744267094,0.6759919948155251
RKO,5282054,3.8735499096789856,2.86313904732715
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643,1.0130347680628242
HCC1500,16722836,2.402902940836366,1.769408538023545
Panc 02.03,46199207,3.8452319744534886,3.231569166087402
PaTu 8988t,71304818,2.8353343090304257,2.652755650094635
IGROV-1,241158,3.288496474515495,3.6889187436206874
Daudi,71751553,3.830487233171358,3.7587166351550234
COR-L95,46174525,3.763282126483136,3.6907256381690186
NCI-H2452,2126,4.762499509878762,4.782488531361263
HCC15,11228183,0.6025691709173914,2.446326632269594
HCC1500,11404337,-1.1638452247583002,-0.33215520074513477
PaTu 8988t,16725315,5.4103858057829095,4.048301023882353
MDST8,4378219,1.9480435949418269,2.227865327248667
IGROV-1,5351362,1.961059142684053,1.4831654191620565
HuP-T3,44489675,3.6946366435409352,4.057809609039305
SW1271,4259181,0.7411137136724786,0.054586135980648924
RKO,5978,-3.7617282032773582,-2.480979546079782
MOLM-13,11485656,-3.968420003132376,1.6824061269701158
K-562,24821094,1.908113699718487,2.5167555007681273
SW1573,89183176,3.862510153781557,4.612858625607266
K-562,24180719,3.2747438118023533,3.3405589000298557
LS411N,4788,5.997281207159956,5.526248547957801
IGROV-1,66577038,3.2148239132520455,3.0842289586396316
SaOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),7.165298435960504,4.44498169234392
Daudi,9549297,1.403366421117492,1.5062437597493712
UACC-812,11427553,3.574449796486334,3.0621537903611142
MOLM-13,52912189,-1.0667663091505395,-0.11263295436390827
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826,1.3527873113055937
SW948,erlotinib-PLX-4032 (2-1 mol-mol),3.457135081619971,2.9729023066542486
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802,1.9904795028977187
IGROV-1,24821094,1.720998716331183,2.2343519357935895
Granta-519,11427553,-0.9723301484726812,1.1691949796265177
MOLM-13,208908,2.7636340376000317,2.0462536655073107
IGROV-1,9915743,-0.4757488934941289,0.562821725359728
Panc 02.03,241158,4.402915180139186,3.995849562700182
IGROV-1,24748573,-1.0654275876710166,2.1876101612261345
COR-L105,5287969,-1.8496230723467,-1.663272627088973
MOLP-8,10296883,2.725727750190508,3.0494575911357016
SW948,241158,4.5321951743877005,3.094811530526303
ML-1 [Human thyroid carcinoma],216239,2.965937740464059,2.4744847057767654
MOLM-13,navitoclax-piperlongumine (1-1 mol-mol),-1.0908841522604569,-0.02131777757548825
SU-DHL-6,10302451,3.370117636140473,2.5806659680506083
IGROV-1,9936388,2.10108466287406,-1.4638110917399119
HCC15,72376,-1.512462057486854,-1.2421499464411618
COR-L95,6450551,2.8920154707175776,1.8130200388501196
NCI-H1568,5738263,3.2402226460817323,3.4977779548686185
RKO,54619267,4.028311361432676,3.5821920593107035
RERF-LC-MS,4261,2.068565192175152,1.9743481540051013
K-562,73707371,5.645446798773975,3.8516168898158383
SK-HEP-1,carboplatin-etoposide (40-17 mol-mol),5.6878657292744075,3.1210404194507824
P31/FUJ,ISOX-bortezomib (250-1 mol-mol),-0.0400156428773503,0.00011335667622812253
WM115,122327,3.780637240577924,4.816099121857556
WM115,25150857,2.4679229997528394,2.39669585892869
SK-CO-1,11178236,-3.2010052407962215,-2.688205555657293
RKN,753704,4.966407297087677,5.047587377708309
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714,3.6284375954649604
SW1271,227681,3.2917347097405725,3.596476741967678
MDST8,568763,0.1407924711645573,0.7191906260190086
BICR 31,5566,3.2898773587253096,3.1032201035986393
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164,4.139754592523604
RERF-LC-MS,6450551,1.967154760545028,2.958201966574366
IGROV-1,2874250,4.893662837169153,4.403043996446582
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896,0.7722447833400727
HCC15,56946209,-3.385198311974778,-3.8544187162015793
BFTC-909,136227924,2.3418993883842134,3.086348845638028
Granta-519,1750826,-3.7858867937492984,-3.2986284655718476
P31/FUJ,11625818,3.2136174191857174,3.1860474887594807
COR-L105,10322450,4.112392966182136,4.118242653153885
HCC1500,5566,2.905130044911903,2.829777690195323
SW48,51039095,1.7096770563148074,2.758043998743525
SW1271,8515,5.208985199998064,3.9335975909884784
KU-19-19,73707398,1.7453733414385195,1.313975840763098
K-562,11707110,1.6681367726124623,1.1526809003072789
COR-L95,16065773,1.8842547212847705,2.1446870115711683
LS411N,docetaxel-tanespimycin (2-1 mol-mol),0.1660438979420715,-3.535998985085273
IA-LM,11178236,-6.720771550362321,-3.409817774332356
MOLP-8,54596490,4.413151323823571,4.324665696779335
ALL-SIL,44202524,-0.4119558263455749,1.2275771007953746
WM115,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6716900719045018,3.024874189916025
MDST8,6918328,-0.3527629143091293,0.26559393907455997
BICR 31,104842,-0.0442586507462943,-2.756853075266453
BICR 31,6852167,2.001013365002547,2.7423437201049694
MDST8,vorinostat-navitoclax (4-1 mol-mol),-0.0959848783200281,1.2831760855772247
IA-LM,24821094,3.0699000024292293,2.7005153137029962
IGROV-1,73707398,0.8848064516600974,1.2422793991487897
SaOS-2,46191454,1.8159544721998524,1.5908191732173216
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343,1.862870242702512
LS411N,25150857,2.959758413524705,1.7546505602753242
HuP-T3,11175137,3.603877049706456,2.6973918130927994
LS411N,135984461,5.061110843141604,2.8557471169573088
IGROV-1,4261,1.934016649932683,1.662837627863512
SK-CO-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.3228586557967312,2.4165244763592235
HCC1500,9952709,2.298703589628035,3.3397315989935277
SK-OV-3,176870,3.5610869734905255,3.2882865676485062
PaTu 8902,9952709,4.3707417693645745,3.172040857619178
P31/FUJ,56973724,0.796880831995934,1.661890810823402
RKO,2729026,2.3662843020346753,2.147583663037933
RKO,387447,-4.452540898932811,-4.385776384314039
SK-CO-1,135398738,3.5773200936681584,4.5470835963303315
BFTC-909,3552672,4.498195948808332,2.8148854010394495
Panc 02.03,7251185,3.0530850004567767,2.7742386402990507
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024,-0.5911823215074347
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992,2.2078696138685188
Panc 02.03,53392493,3.617637281515077,2.8185765070448614
LCLC-97TM1,446155,3.780165105352184,2.816451607825645
BICR 31,23725625,6.004496967521932,5.089239924550659
RCC10RGB,11612883,4.41570881394896,3.0626617350448053
WM115,5280436,2.216411919293008,3.4701889427519577
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096,0.49183810091230984
NCI-H1568,10184653,1.3826991243685076,1.2988840708845726
LS180,10427712,4.740953715848998,4.361939523835493
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577,2.0221347092993582
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888,0.734331457645709
HuP-T3,12003241,-0.2833744856936582,-1.0087859847732223
Daudi,9884685,-1.7998414591903729,-0.3040173149206253
SK-CO-1,44259,0.6005082969424771,1.2370501972353083
MDST8,10231331,0.2022855962524302,1.4169040687163945
SK-CO-1,4261,0.7789911540114764,1.5757279446302408
P31/FUJ,10074640,2.9862675466657764,2.410613652502613
SK-CO-1,12001922,1.782153173177779,1.9790558609199098
SaOS-2,16720766,-1.9505026731708328,0.651782946916707
RCC10RGB,216239,3.3222265979679375,2.706665869391323
BICR 31,navitoclax-pluripotin (1-1 mol-mol),-0.5418229135264367,-0.7003133490457966
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133,1.0698173688251729
COR-L105,72734382,5.425179503032161,4.836162646240959
LS180,11640390,3.36619781023128,3.1696388898912096
K-562,25262965,-1.232298297425116,-2.1716696775377913
IA-LM,piperlongumine-MST-312 (1-1 mol-mol),2.1673101171047513,1.6344578217934926
LCLC-97TM1,135411,0.5874500365845237,0.5192297676931351
SU-DHL-1,46398810,1.696894130738712,2.113116153974671
P31/FUJ,6610216,4.336076332167018,3.844169671217061
BICR 22,5291,3.723640910280853,3.7397072802763476
HEL,44632017,1.0842639602191189,0.6549110458696156
Granta-519,4261,1.1412453306659267,0.23131614561279576
Granta-519,56963564,-0.5609340564012296,-0.3382542932188661
MDST8,53392493,2.9375507482716334,2.687605291607285
LS411N,44819697,-0.923326266781905,-0.9372264281448159
NCI-H2452,selumetinib-decitabine (4-1 mol-mol),5.979248786857892,4.260623618852311
NCI-H1568,5291,3.770643134542437,3.6510610859009422
BFTC-909,11612883,3.5324782187628827,2.9747395802807626
RCC10RGB,11955716,4.4260489213830425,-1.0232958733009359
SW1271,11626560,1.376954486231794,1.7712275816765564
SW48,46943432,0.8743166493146273,2.611014924811075
HEL,3062316,2.2727573444408633,-0.08539254196626506
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483,2.480522174451435
RCC10RGB,5329102,2.357265375302505,2.225317548318571
ALL-SIL,9866186,-0.4181259896802407,0.18307830620536172
NCI-H1568,selumetinib-navitoclax (8-1 mol-mol),2.553812274921004,2.351879065778675
HEL,23635314,-2.6594801266287154,-2.9846355338401827
Daudi,10074640,1.7373836938395748,2.5004889253182223
RKO,26596,-1.341584325458414,-1.9053030940126225
WM115,11167602,1.5239005360441813,2.436850143472478
IGROV-1,2746,2.8413672686351212,3.0979599659057744
Daudi,24978538,2.467871482925033,-0.07360824811709744
RKO,2858523,3.1569923390566332,2.936267660068305
LS411N,15983966,2.6804451752833978,-2.3667772177958786
SK-OV-3,452548,0.7579906967862455,0.2917070672294723
MOLP-8,25262965,-4.805551534468427,-2.021619142112542
LCLC-97TM1,46215462,1.4949685345148778,1.611436617862732
BICR 22,439501,-2.4052901035443,-1.862398658857053
SW48,10184653,-2.0074491437034094,1.0852367685400857
P31/FUJ,168313016,4.690131242833582,3.8126112940155967
NCI-H1568,selumetinib-tretinoin (2-1 mol-mol),5.145646184067631,3.490956861644149
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199,1.94888254836785
LS411N,54613361,3.867376577775082,0.3604808848549279
COR-L105,24772860,-1.435746068442861,-1.5992912215027937
K-562,11222830,1.892206265748428,1.1695879717362971
Daudi,10385095,0.347773175212431,0.9256851107787974
HCC1500,44137675,4.199849963716895,3.561628119650598
SW1573,11404337,-1.3449252751203844,-0.12188103467473116
SK-HEP-1,46191454,1.8876467264614776,1.8906035549479092
P31/FUJ,135999136,4.068676884464422,2.4832378707156515
RCC10RGB,25150857,2.370598483016253,2.5466111883426867
NCI-H2452,57330099,4.302779847582817,4.3294596802364325
IGROV-1,10127622,3.2581804056600165,3.622180030698976
COR-L105,5282054,3.9571885951378505,4.001310764296942
LCLC-97TM1,53481919,3.8027519676947232,3.424636805555176
NCI-H2452,3025986,-0.5496531660815697,-0.49145027874219216
WM115,11955716,-2.4505472507691013,-0.8560355187195665
BFTC-909,637858,2.264716830291231,2.1182135556806383
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839,1.7715116481810766
Daudi,1641662,2.995591169153073,2.787513631308716
MOLP-8,446155,0.367312642153156,2.3608540583487083
RERF-LC-MS,135999136,4.400683337930441,4.009890328872715
WM115,5738263,3.851280366828244,3.697692161526021
MOLM-13,65628,2.9573007313246924,3.106596523239941
HEL,9936388,-3.337900467930123,-5.413640516351035
SW48,104842,-4.777281812432541,-2.5954883300828135
MOLP-8,ISOX-bortezomib (250-1 mol-mol),0.0006851036189058,0.11327583711734722
Granta-519,11626560,0.2073830225530282,0.6686202055729228
SK-CO-1,969516,2.7975557975376035,2.886698312711792
SW948,11640390,3.051257470103826,2.5211355325290494
HCC15,10302451,3.767869991537956,2.8043434357940145
MDST8,crizotinib-PLX-4032 (2-1 mol-mol),1.604281792595084,1.9435900523458474
PaTu 8988t,46943432,6.478561461465468,2.812160405969583
K-562,208908,1.7214906675478436,2.1957611683633598
NCI-H1568,11612883,2.467781963295413,3.032738975577104
LCLC-97TM1,9884685,-0.6945268748645868,0.4492279425165096
Granta-519,6918328,-2.2526378564537355,-1.9727822703775328
Granta-519,5470400,-3.2597420844446163,-0.24099384349613653
LS180,10231331,0.7625893939503741,1.6108958101179665
SW1271,46199207,3.134892747913181,3.0512613620425713
HEL,11404337,-0.835651629585067,-1.1157790264390948
Daudi,216345,1.872370108624604,2.562297846251294
MOLM-13,decitabine-navitoclax (2-1 mol-mol),-5.337552823003331,-0.486284731396083
RKN,54613361,0.2026815444056028,0.1528087325095722
LS180,452548,0.7544699085550369,0.31298527722183156
RKN,44493528,4.408823872302737,4.39733683121829
SK-HEP-1,11238147,2.1467729161342524,2.9401296796508047
MOLP-8,tanespimycin-gemcitabine (1-1 mol-mol),-4.944533339092102,-1.760120984304998
COR-L95,11364421,1.7062947816433405,-2.6700839845074076
KU-19-19,452548,1.4010535434747853,0.6556277939884312
COR-L95,tretinoin-carboplatin (2-1 mol-mol),4.531796019532578,4.054659361266827
IGROV-1,44819697,-0.8326420176056434,-0.09713419646305495
MOLM-13,salermide-PLX-4032 (12-1 mol-mol),4.733891503361179,4.385574592163604
RERF-LC-MS,2729026,3.1361811776879644,2.7873806618995087
RKN,4788,5.902938799554125,5.745974760784775
K-562,216239,1.6121414929675577,1.7511253342202349
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788,2.8022941050834023
IGROV-1,2746,2.8413672686351212,3.0979599659057744
IGROV-1,637858,1.814476597989254,1.7828075770557112
HuP-T3,11214940,1.8541641961456377,2.013605614931583
IGROV-1,46907787,2.182756719431072,2.0953961412153985
P31/FUJ,445643,6.117258311867223,3.3125411235784292
Granta-519,3854666,0.1662242620713641,0.7391602337839681
MOLM-13,tretinoin-navitoclax (4-1 mol-mol),-1.997886556177749,0.6107748712006795
LCLC-97TM1,135440466,1.105929023295497,2.33932758372344
RERF-LC-MS,56649450,3.38813984116235,3.7060926148387385
SK-CO-1,11612883,2.4661452350243493,2.496601569621054
SK-HEP-1,44137675,4.549525792934436,3.6177999582202274
HCC15,72193870,4.3690783386047025,2.311743089731086
HCC1500,2746,2.6069735713089006,3.182851113112109
MOLM-13,decitabine-carboplatin (1-1 mol-mol),-2.1020710624228833,0.10048380625901204
Daudi,11222830,0.8543881776084605,1.0046016621614358
WM115,2749,6.3303951951253445,2.116782854625381
K-562,9840324,5.675524269237515,5.577475157288608
MDST8,10113978,3.624916965791189,3.0805702994515896
NCI-H2452,44507138,2.753685109279225,2.6216324963367414
MOLM-13,5282054,3.1361279245897857,2.8112863827672148
BICR 31,9911830,2.2138272662609064,2.5213745264320786
HEL,6917907,-5.38656193144065,-5.438695885795527
IGROV-1,2858523,3.196384505087132,3.09519315657488
MOLP-8,322968,-1.2094679469942695,1.9890008187611634
BICR 22,3503,2.960513829073252,2.454779176569355
ALL-SIL,10113978,1.6173510565910796,2.2061602055962464
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606,1.9737476822432125
RERF-LC-MS,119182,-0.645974794966856,-0.41822272582107284
LS411N,4261,1.591263829932159,1.6003392466288553
SW948,4096211,1.12279899109382,1.366283798005117
K-562,11485656,1.7795111963017332,1.7736499549617704
MOLM-13,53232,2.182263698942312,2.513869180293288
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423,-0.47688973777514976
IGROV-1,3689413,-0.3633634632064185,-0.05287243807235151
RCC10RGB,12001922,2.277970650057297,2.1496754303124246
RERF-LC-MS,246676,4.480243243269967,4.459523565885928
HCC15,374536,0.7951987879889547,2.6421362725967485
MOLP-8,11977753,-4.876868381891939,-2.3333033626664763
Panc 02.03,2874250,4.438896474206821,4.522341486144555
COR-L95,613753,3.031049367391043,2.982048265756538
SW1573,9840324,5.095993559480237,5.7907867133400535
SW48,24901704,1.780712261537264,3.0734218264587914
BICR 22,6918328,0.5113628660513942,0.06315125500375571
Daudi,54613361,-0.5183638298018372,-1.0692716253915318
LCLC-97TM1,25102847,2.141917897082315,2.165192396377986
HuP-T3,3081361,3.872954779649628,2.2479909530149937
LS180,969516,2.6818241036299275,2.95877558717784
SW1271,2945648,2.4921907486938646,2.989613153842254
BICR 31,25126798,3.691910729857057,3.935443642415625
KU-19-19,SNX-2112-bortezomib (250-1 mol-mol),-1.0111363937138018,-1.1304147440177756
Daudi,262093,0.7533038243356376,1.4590000691137766
RKN,20959075,-2.033811748726601,-2.768543392808397
KU-19-19,702558,5.449368171937104,5.335936044717746
SaOS-2,2842253,6.143936300195383,5.538584873735885
RERF-LC-MS,26596,-1.2372341703529914,-1.232091166755461
PaTu 8988t,5329102,3.3339986936080717,2.240255667715324
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447,1.515567112201479
SaOS-2,73707398,0.8491853151273433,1.1243139302257026
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991,0.05242888684204514
SaOS-2,984333,4.259432573695519,0.6432977633149213
LCLC-97TM1,53232,3.007779101776312,2.71746468206787
KU-19-19,3503,3.0769201112014803,2.379971251141224
WM115,57330099,5.984461482923693,4.398528537052857
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928,3.8851213302654783
LCLC-97TM1,44491742,4.237702230509644,4.143855070749383
SK-CO-1,9915743,2.0474134916136184,0.3219423124646296
HCC15,73707398,1.6988346513711203,1.6324158697654505
HCC15,4477,-0.3802251277588812,0.5180647748899027
BICR 22,26596,-1.8883514509946957,-1.0020130715888085
SaOS-2,445091,4.479630914494518,4.429492929998945
HCC1500,3503,2.0705498046235817,2.318787412805759
SK-CO-1,salermide-PLX-4032 (12-1 mol-mol),5.553578625312618,4.82965250003506
RCC10RGB,71304818,3.488257335656729,2.8056985594606276
RKO,241158,4.5302703569847305,2.798679635715984
SW1271,168313016,5.582938604018868,4.881084857295685
SW948,10385095,1.3660359707166476,1.2334054088948099
RERF-LC-MS,3543504,3.1700226881436193,4.581794445489098
LS180,5311,1.1738972820475675,1.3469140593226507
RERF-LC-MS,5291,3.9873816513243785,3.6837795791560537
RCC10RGB,53481919,4.9196370953200805,3.7444707702091544
Daudi,44241473,5.233980827552566,3.7980134215629193
Panc 02.03,10127622,3.4148938287456776,3.493304933115307
BICR 31,49836020,4.313223650735915,2.965260062659585
Daudi,54618305,3.9105424608095847,3.3524912338680752
SK-HEP-1,5746,3.319924463812582,1.5286810866007898
ALL-SIL,67156097,-2.3407546390754037,-2.130085168164878
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168,1.5836420852853481
P31/FUJ,613753,2.9305719806169432,2.640329590582859
PaTu 8988t,1641662,3.634680635371761,3.5519400733714828
SU-DHL-1,15953870,1.992339234699044,3.122616281139606
COR-L95,decitabine-navitoclax (2-1 mol-mol),-0.2234984214129892,0.25270691711284926
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667,1.7478008942886047
P31/FUJ,navitoclax-PLX-4032 (1-1 mol-mol),0.0164871875305551,-0.5168402584690422
Daudi,vorinostat-carboplatin (1-1 mol-mol),1.6612162447966572,1.9885537639312372
SK-CO-1,11364421,1.7180407971266538,-0.9577434738396442
COR-L105,16722836,1.79329711252707,1.7556380954262738
IGROV-1,439501,-2.1510551928674557,-2.2271923669229166
ALL-SIL,50905018,3.9646846974495418,3.4451916263851894
SW48,25126798,2.5731969050098993,3.622331887685363
PaTu 8988t,10113978,4.3652834043747335,3.2046278818702394
SK-OV-3,12003241,-1.2313805329375749,-0.708510107309462
Daudi,1317464,3.6966432302020817,2.5749934859554657
WM115,5978,4.185238310426041,-1.4306263614147356
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625,2.652591918363679
ALL-SIL,24785538,-0.5874123218373029,-0.04423230013949908
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034,1.1055540741222512
IGROV-1,9967941,2.9735049794712545,3.7727462684070914
SK-HEP-1,11977753,-1.1270659898133608,-1.1292483227075185
COR-L105,676352,1.9469411585028615,2.173605186417555
MDST8,11485656,2.867381561993162,2.5480887428088463
SW1271,selumetinib-piperlongumine (8-1 mol-mol),2.3808052258502705,3.1708830671774426
SW48,6918736,-2.164113269607571,-0.9920361775527341
SK-HEP-1,445455,4.37046727572682,4.644709765453581
Daudi,4096211,1.4831417361144643,1.0611691152833655
LCLC-97TM1,16038120,-0.9192372639718316,0.6271129202767985
BFTC-909,3384730,4.46542670181497,2.9766322739558873
K-562,36462,1.3855340321895664,1.2340323242381803
SK-HEP-1,5329102,2.506246240472525,2.2102458937520435
WM115,25161177,2.874219730459086,4.017245355080897
HCC1500,119607,4.730010050453825,5.156113628904006
IGROV-1,24964624,0.5052308994941754,2.2693806284746127
HCC15,421610,3.960173561996767,3.4487083426654754
ALL-SIL,4788,4.920956242868583,4.668487936968822
IGROV-1,49766530,-0.195540678413639,-0.3756233468283263
SK-HEP-1,11175137,3.0126176485486114,2.7522868078385936
MOLM-13,selumetinib-piperlongumine (8-1 mol-mol),2.118239948342191,1.7127378034680547
K-562,54678924,1.7343444538293111,1.4837116063230495
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764,-1.028753958503196
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923,2.6049454612577536
COR-L105,6505803,1.059348129706536,-0.21139565696019655
P31/FUJ,25183872,-2.108478877482417,-2.3573670183827478
Daudi,navitoclax-birinapant (1-1 mol-mol),2.1928151248147194,0.5573287528230515
NCI-H1568,9444,4.259676436179719,4.20899267626048
NCI-H2452,selumetinib-MK-2206 (8-1 mol-mol),2.148853035614541,2.5956489720459905
KU-19-19,19582717,2.992815973528006,4.405202095997541
RKN,36462,2.460575122343829,2.152104829411441
P31/FUJ,3062316,2.2346133515561415,0.3970581837192815
MOLM-13,36314,-7.769941141611737,-2.079554460009578
HEL,44484440,3.2564839193688524,2.649041422513358
RERF-LC-MS,168313016,4.277512101574917,5.141862965449157
HCC1500,637858,1.1010846881251866,1.973046644023376
COR-L105,11178236,-3.064044900311784,-3.0925336261154475
IGROV-1,44202524,1.8303703172382677,2.33688271972947
LS180,alisertib-navitoclax (2-1 mol-mol),1.1962644272537857,0.274082951686793
MOLP-8,11175137,1.914718066408171,2.0039201148282975
LCLC-97TM1,1641662,3.5570250788057187,3.371818086916518
SK-HEP-1,46199207,3.772137058295689,3.2754365893046535
SW1573,6917907,-6.296104468024424,-4.874144453346469
HEL,89183176,1.9576500820122449,3.0353683616048523
SU-DHL-6,49793307,-4.306431914357451,-4.518076946514525
K-562,6918837,-4.262812875828109,-4.245059727560935
Daudi,44493528,3.680262260756896,3.9247739567941964
RERF-LC-MS,5311281,3.366561586065275,2.4136373424676867
IGROV-1,675434,4.336225379212549,4.348769585933863
NCI-H1568,216345,3.8344110950672823,3.9030833644088796
SU-DHL-1,9926054,1.6936537424309908,1.7598564473864777
Panc 02.03,9911830,3.8856260346392903,2.7130368397675007
HCC1500,2729026,1.749867272011919,2.6108824814260525
ALL-SIL,42642645,-2.33031271995146,-0.12827019930889827
Daudi,9911463,2.4252044126403915,2.8527591361262905
NCI-H1568,45279963,3.534456091536717,3.599167885006206
RKO,135999136,6.045591123054076,2.8809249964280594
SW948,JQ-1-UNC0638 (2-1 mol-mol),0.5184819522178918,1.296356048559745
SW948,9903786,1.6902329933335576,2.6405424915714035
RCC10RGB,9956119,4.44093701823858,3.5829887301566874
SW1271,25154868,5.0403607075499375,4.4418371647043156
K-562,65628,4.517417686157834,3.588659784101898
SU-DHL-1,613753,2.797885663964736,3.0619930861892835
SW48,ISOX-bortezomib (250-1 mol-mol),0.0957852828937709,0.4281812556570265
HCC1500,44566777,0.0909506116020526,0.892648612556795
NCI-H1568,54454,3.61375646412465,2.6363331720826775
SW948,44507138,2.949706410080911,2.3425690524891873
SK-CO-1,17759555,4.047587343089958,3.444681793717835
HEL,568763,0.2288469977463405,-0.1885106526143163
BFTC-909,3815108,3.5118939741133075,2.9554860644948353
ALL-SIL,24901704,-0.1489296834412312,2.066848735901592
MOLP-8,piperlongumine-MST-312 (1-1 mol-mol),0.7424689739493265,1.12969644547696
KU-19-19,24772860,-1.0696999794461075,-1.768216816004027
MOLP-8,9866186,-0.5209158528959533,0.1032641674202836
NCI-H1568,JQ-1-MK-0752 (1-1 mol-mol),3.5105249308751363,2.075242649101042
HuP-T3,71304818,3.5647709327393287,2.635551456555431
MOLM-13,11683005,2.7238157220539345,3.0306629919185353
HEL,54618771,0.7283869495698151,0.3932998606668355
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854,3.5075244975597983
WM115,selumetinib-PLX-4032 (8-1 mol-mol),-2.130332393585934,2.426136230525155
NCI-H1568,25150857,2.4294918673251416,2.6192405539279418
RKN,6438330,1.1013294242613172,2.1285656403935547
HCC15,644241,2.326085716096255,2.3711871829773212
LS180,2708,3.937371430907984,5.03235230514378
LS180,51037431,3.4786862718788747,3.1836568195398787
K-562,16741245,3.9224206604880583,3.333661169978771
RERF-LC-MS,44185566,3.014427147988128,2.714220056241174
SW48,navitoclax-MST-312 (1-1 mol-mol),0.8806321220589545,0.3185050855767137
RKN,5566,3.4992110401170944,3.068702313915379
LS411N,navitoclax-piperlongumine (1-1 mol-mol),2.36008373550467,1.032031398974745
MOLP-8,216345,2.155670358283386,3.0209363471451915
HCC1500,BRD-A02303741-navitoclax (2-1 mol-mol),0.0071603230581946,1.79407428386809
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494,0.7966136326388251
PaTu 8902,46224516,2.4477060426075723,2.5498239968159004
RCC10RGB,241158,4.984223152954295,4.25681836805921
HCC15,11612883,1.9950389922708311,2.6427566124074686
HCC15,969516,3.14053560758236,3.020879141888569
LS180,9866186,-0.1716689837079009,0.8363934074235014
Granta-519,decitabine-carboplatin (1-1 mol-mol),2.1725621434549582,-0.08039129847022258
RCC10RGB,24964624,2.93015987785669,2.643951733451367
MDST8,216345,3.5638732818875094,3.594757605763498
RCC10RGB,10302451,3.839480938635774,2.870347947543859
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084,6.247887565847012
WM115,44491742,3.78432787650886,4.278265294870287
SU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),2.378072265787347,2.8218196208556576
KU-19-19,262093,2.7281718696395303,2.9218791008885456
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344,3.1777016875430375
COR-L105,1242560,3.3237423881291233,3.527736011360791
MDST8,16736978,0.980275670291684,1.6910224404372334
NCI-H1568,16722836,1.2045551605263336,1.890421464263372
WM115,5282054,2.577591804396212,3.7186084603188387
IGROV-1,25195348,3.0698662305180275,3.2873939011246556
PaTu 8902,148198,-2.774580136562139,-3.2725117700197246
HEL,26596,-1.8679385890512872,-2.49380679926244
Daudi,25126798,3.548189682848153,3.23229442931002
PaTu 8902,selumetinib-piperlongumine (8-1 mol-mol),5.497989392681889,3.008688007704551
SaOS-2,decitabine-navitoclax (2-1 mol-mol),2.350842092351968,1.9240439640456697
PaTu 8988t,56946209,-4.946927234389905,-3.6839864456668368
SK-CO-1,2945648,3.4071568821077993,3.1242173640746995
SK-CO-1,JQ-1-navitoclax (2-1 mol-mol),0.4682346666935782,0.8038854890816978
BFTC-909,3136844,3.2427360302120403,4.391499630889202
IA-LM,71304818,3.3887828048220094,2.324421215699322
NCI-H2452,122327,4.606448802646307,4.856635084705018
LS180,12003241,-0.6460664270988897,-1.200688992862644
SK-HEP-1,16741245,3.65273757252914,3.7629851645014476
RCC10RGB,6918638,2.235907203261483,0.40162761252864276
WM115,16065773,1.4979025411384967,2.193887022331717
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411,2.443017572649178
Daudi,54678924,0.8831010429483725,1.490981978649404
MOLP-8,9903786,1.299688823902182,2.2715000062307977
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187,3.622702448914369
WM115,219104,4.514482202684108,3.8486233608616702
Daudi,25150857,0.8259987709661276,1.597924347692327
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379,3.756072059242661
BICR 22,25262965,-4.220207088048826,-1.1554724452109655
BICR 22,25126798,3.759096897040898,3.627653240981727
HCC15,11717001,5.339668805105819,4.009835180789834
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918,1.791534427987543
BICR 31,6918328,1.2499033439512497,0.23665101642735953
COR-L95,25150857,1.208080540357677,1.9167714119790498
ALL-SIL,104842,-6.679847729141338,-4.762949374098647
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622,3.092731179567136
MOLP-8,crizotinib-PLX-4032 (2-1 mol-mol),0.0452912472141007,0.9332641628341706
IGROV-1,11612883,1.8715405446213529,2.5730529632977897
HEL,9926054,1.596813412273358,1.535597981571743
HCC15,11404337,-0.219975280966356,-0.2917628693793046
LS411N,168313047,3.2811764574410893,2.2166837830001613
HuP-T3,168313200,4.289513738947004,3.0074547944636185
RKO,216468,3.08027711257304,1.3522741781342342
HCC15,5566,3.133848096057735,3.0766161472946236
SaOS-2,2130404,2.752105467907615,3.1561898835947004
PaTu 8902,6623618,2.257974787323956,2.1884016854069483
Granta-519,45279963,2.8131243875516097,2.8258842695409383
BICR 31,6918638,1.4401869695378149,0.809676352431578
IGROV-1,2729026,2.3541792737160296,2.4830337918811507
SaOS-2,decitabine-carboplatin (1-1 mol-mol),4.9062736540715735,4.280925458107037
PaTu 8988t,126941,-4.347732149803542,-2.6788701761304567
BICR 31,44607531,1.4420456412349776,1.471391458633183
RKO,227681,3.9032876810461814,2.8271978583728257
Granta-519,5278396,3.331153353007608,2.918200171096342
MOLM-13,11214940,0.2452206847669268,1.285547974924381
Granta-519,6914657,-5.464946920891912,-5.115186511953131
SW1271,72199292,4.741032264194907,0.35011030355666056
LCLC-97TM1,3676137,5.47833794075875,4.574048913716281
BICR 31,6505803,0.2507928346620714,-0.22376323699734577
NCI-H2452,9927531,4.529523169776047,5.005219359987377
HEL,107970,2.2652057864285893,2.049514216938597
P31/FUJ,73707398,-0.9687174770786582,0.5216255908878797
SK-CO-1,3634881,3.2176217097393867,3.1254875351532
ALL-SIL,71680916,4.0231197218666015,3.6201063760704697
IA-LM,carboplatin-etoposide (40-17 mol-mol),4.857587432381165,2.4928801122131703
NCI-H2452,54678924,3.78052585603054,2.243917856894327
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657,-2.680290809930837
RKN,9840324,5.059199694090175,5.830055169376825
LS411N,25195348,3.7393125277208608,3.116174600196721
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435,3.0428684835000035
BICR 31,11497983,4.106423080888053,4.708843103037439
RKN,3825829,4.2934517576030276,4.012677777825205
Panc 02.03,104842,-1.6275579890051994,-2.539048046162533
SK-HEP-1,4378219,1.9889575503272792,2.415522924380922
NCI-H1568,11609586,2.169671625299293,2.7539818448980293
NCI-H2452,24772860,-2.067021978185303,-2.0968311483217494
HCC1500,2828334,6.090675120485649,6.165205100882206
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473,-0.44756249731748793
HCC15,selumetinib-navitoclax (8-1 mol-mol),-1.9070047094364015,2.3967738330705144
ML-1 [Human thyroid carcinoma],5291,4.042812106600411,3.7706237844025474
SK-CO-1,426756,3.753929508081783,4.4310847638942
SaOS-2,46215462,2.3169135098646483,1.79473803114743
IGROV-1,216468,0.5330864756407336,3.0305594637379145
RERF-LC-MS,25262965,-1.1343637554659964,-1.4366884085026128
NCI-H1568,53392493,1.829675716879907,2.807864656609285
WM115,6438330,2.009543324889134,2.280458817057279
P31/FUJ,9908783,6.361014450142155,3.7700582773804023
HCC1500,5291,3.388112901698238,3.5451623474169924
HCC1500,216345,2.2086555393223293,3.6689332267674257
SK-CO-1,16722836,1.1930735523198912,1.650403294287078
MDST8,2858523,3.149165485885388,2.889411015523332
IA-LM,44486219,4.346993548383093,4.3197079500702875
P31/FUJ,10427712,4.089067276268696,3.765660687564217
K-562,24771867,1.7261535062160185,-0.8529632374171797
SW948,2742550,2.6149964231270166,3.3505335685257633
COR-L95,2113511,4.880906118348224,5.096234737282723
BFTC-909,82146,3.493415453952883,3.7676118674154337
BICR 31,4261,2.904745052497421,1.6830011900037827
BFTC-909,119607,6.015893315993201,5.325338214771161
MDST8,JQ-1-MK-0752 (1-1 mol-mol),1.445543393100169,1.8872565959552532
Granta-519,262093,1.5974758737964725,1.6647614122314696
COR-L105,4521392,4.261553030698096,4.428950846948751
HuP-T3,52912189,2.4400429797195065,2.5704058940574073
HCC15,168313016,4.627209757330862,4.939198329930405
MDST8,15983966,1.9809932367095728,-0.5922590957927522
Granta-519,9866186,-0.14818829969678,-0.016449279185724367
SK-HEP-1,462382,1.018219313736715,0.763951103669719
Daudi,7251185,0.6493905196982933,1.3918815870882069
HEL,3385,2.274300648457042,2.4278658241427773
NCI-H2452,44185566,2.4757676958398824,2.7935867214140107
SW1573,9884685,-1.2788581073527363,0.947187271024117
RKN,6505803,1.4092626649390017,-0.3594503974145059
COR-L105,selumetinib-piperlongumine (8-1 mol-mol),1.184006147072735,3.4047225041440266
RERF-LC-MS,11427553,2.91041132641442,2.9440566457596855
SW948,107985,-3.1361927230844255,-3.497804031618435
IGROV-1,24951314,0.9075718706849548,1.5840157073556511
IGROV-1,753704,6.461140333581179,4.951316208300307
LCLC-97TM1,54143018,-1.232378656007133,0.17394187416350224
SU-DHL-1,16038120,-4.191759239414132,0.611761204510551
SK-HEP-1,65064,5.472205201006758,5.0598155317698446
COR-L105,2733526,5.6711261994322,3.683258953872452
HuP-T3,56649450,4.499318873015619,3.372366443517534
SW48,16741245,3.865069024996995,3.9529395490151766
HCC15,89183176,3.7013914070621903,4.462623867228238
SU-DHL-1,135928012,2.7237506411412427,4.0704085309264375
HCC1500,24901704,3.772063812557438,3.335773115192923
K-562,6505803,-1.797722788015983,-1.140194891781037
P31/FUJ,docetaxel-tanespimycin (2-1 mol-mol),-5.9377835284500895,-4.1397817730217366
ALL-SIL,9936388,-6.364749169872344,-5.429967185183523
P31/FUJ,5284616,2.141886646431612,-0.39564148811706146
RKN,654092,-2.299209260296745,-0.34090140269285746
SW48,piperlongumine-MST-312 (1-1 mol-mol),1.3077982167208542,1.807923620147782
Panc 02.03,462382,1.1832417961450334,0.5399704084429184
P31/FUJ,11609586,2.709581392176905,1.2279225493388002
COR-L105,322968,4.452130073523545,4.122329886002369
RKO,135398516,4.318914396092429,1.52303245140633
Panc 02.03,44185566,3.1312758482446976,2.708755261346293
NCI-H1568,72376,-1.5373297187690371,-1.6789394148983527
Daudi,11494412,-0.3802447608890573,0.2668415410902445
SW48,erlotinib-PLX-4032 (2-1 mol-mol),3.2399078814474924,2.5952826318583293
SW1271,2126,5.27764055734565,4.466635111716888
RERF-LC-MS,10296883,4.230661493555322,3.9802112929094413
SK-CO-1,53232,1.9491581074450712,2.9275642134540307
HCC1500,11222830,1.0956735100670385,1.6976610547548998
SK-CO-1,vorinostat-navitoclax (4-1 mol-mol),1.5116374119241311,0.9930215438225397
LCLC-97TM1,16219061,3.747043694071086,3.1071196902571336
HCC15,3543504,4.297283358198234,4.459475620121628
SW1271,6918837,-1.9255423784418917,-2.4371998579274936
SaOS-2,53301938,5.583232766578932,3.9181440146440507
UACC-812,9866186,1.6792636289805696,1.1318023275099802
RKO,5278396,3.510721289362286,2.9000118878636143
K-562,16722836,1.308803334400655,0.9746716280567007
HEL,selumetinib-tretinoin (2-1 mol-mol),7.234386750467808,2.083888867141603
P31/FUJ,9935249,2.700947453739227,0.9761884039169647
IGROV-1,5351362,1.961059142684053,1.4831654191620565
IGROV-1,44819697,-0.8326420176056434,-0.09713419646305495
HCC1500,5746,0.8617369744590151,0.8107659766283599
BICR 31,15547703,3.2095649219178006,3.1887533099650205
P31/FUJ,72193861,-0.3659416399435479,0.13393189582161014
PaTu 8902,24964624,3.11499425545507,2.3229826075343896
BICR 31,vorinostat-navitoclax (4-1 mol-mol),1.4356739307232549,1.0439492057303623
SK-OV-3,24901704,3.989938255280614,3.2285762071792776
LCLC-97TM1,2113511,6.012866888022406,5.703325946238504
SaOS-2,3081361,3.085781742119062,2.455050223555145
IGROV-1,15983966,1.7101486625531308,-1.6646425410632844
MDST8,6852167,1.3374988720553735,2.4333007626970486
MOLM-13,67291369,-0.0488061328139809,0.6486878747633527
K-562,JQ-1-vorinostat (2-1 mol-mol),0.1257253367868581,-0.1494810542390489
MOLP-8,9926054,1.7939353525170396,1.591871961137791
SU-DHL-1,168312962,-2.257405592485961,1.0195717264929787
LCLC-97TM1,219104,3.650486733954163,3.3083422791071233
HuP-T3,984333,1.5721860041126483,0.8362395545903115
Panc 02.03,4477,0.984097917718396,0.8136749245513473
Daudi,selumetinib-piperlongumine (8-1 mol-mol),2.587128104626929,1.8576131302951728
IGROV-1,9929138,6.483056540257463,5.280534831654023
SaOS-2,11175137,1.9690729540796783,2.6894332287833858
LCLC-97TM1,9915743,-0.0836077976930932,0.8008777744645147
PaTu 8988t,9907093,4.39010034793255,4.229007666156183
LS180,73707398,1.191690395470446,1.0516877581661914
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898,2.750494930066863
Daudi,11960529,3.700971671461623,3.2825115000553673
RKO,4259181,-0.4049041326260317,-0.12972701473823212
MOLM-13,31703,-4.683228669920675,-2.362439615341501
SW1271,4477,0.3648589081307944,0.5614219089128448
HuP-T3,216239,2.9976543037230665,2.3988788329946256
HCC15,9903786,1.5576741113339283,2.8804056040366492
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544,0.9097756566743656
Daudi,1239801,3.0112900662314717,2.8481707018167315
PaTu 8988t,25126798,4.088623680113087,3.89775937932786
RKN,227681,3.7901732699912585,3.5854524768987397
K-562,216468,1.7844503846326911,1.0995377740112755
NCI-H1568,11234052,4.07711650557102,4.129884958215351
RERF-LC-MS,17755052,1.8057357372617977,1.8845884609900536
HEL,135999136,1.6019096984193502,2.340820894057088
HEL,9887053,3.0781159437380974,2.4764147650895216
RKO,11625818,4.5581118700811105,3.354291791702017
HuP-T3,322968,2.6241189840020787,4.141197790020609
BFTC-909,11317348,4.568727931072339,3.330794292782028
SW48,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5460315373913385,3.356378475580984
MDST8,1716436,1.1500764778734351,2.479088914730602
ALL-SIL,16741245,1.8101156107911176,3.6009793732283795
Granta-519,16722836,1.0937584859115594,0.5389878323982306
PaTu 8902,10385095,2.391345219233966,1.411142619033475
WM115,3038522,1.9104775831242309,2.9189417556672543
HCC15,decitabine-carboplatin (1-1 mol-mol),4.946381859305088,4.370377619729859
RKO,11497983,5.954072388877685,0.7816309792122809
BICR 31,46174525,4.37434163277974,4.429805022685619
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.583978337786103
PaTu 8902,73707398,2.5949502925816397,1.3930485995448725
MOLP-8,1641662,3.485304007232308,2.8111353836196566
HuP-T3,11640390,3.629059315953643,3.7428604977598625
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802,3.9180109855952634
LS411N,49850262,4.021647044836445,2.8257480254692395
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269,3.1208102010266185
SW1573,24951314,1.273840217876839,1.5292536693965877
RKO,441298,2.3183923582018107,1.91871576026035
COR-L95,5335621,4.389010810876702,4.348239274951494
MOLM-13,selumetinib-UNC0638 (4-1 mol-mol),2.1826018630699746,1.9142561554763102
MOLM-13,24785538,0.0261170120397283,0.17252573047254421
Granta-519,374536,-1.3755413186728007,0.9645109547294796
HuP-T3,9911830,2.533690069517969,2.6774739692418565
HCC15,11640390,4.25082988279064,3.790354479937118
Daudi,375860,-0.7416229308895455,-0.5343418517594344
BFTC-909,16722836,1.424017650466323,1.8845605716938962
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966,1.5988807040009088
BICR 31,crizotinib-PLX-4032 (2-1 mol-mol),1.5274046089824267,1.9837708275014878
LS411N,46398810,3.253541487295017,2.002963039097009
SW948,carboplatin-etoposide (40-17 mol-mol),4.008054530018911,2.195164271688491
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587,2.101842792598612
BICR 31,136227924,2.8140968842668923,3.07873694377006
SK-CO-1,24753719,4.51149350773187,4.189729406780404
LS411N,JQ-1-MK-0752 (1-1 mol-mol),1.615286960946078,1.2035203202967457
SW1271,57330099,4.656552081384507,4.122723870327905
ALL-SIL,60750,-4.149254188873004,-3.183604160483306
MDST8,42642645,1.1052716804296012,1.055680749709834
ALL-SIL,25062766,1.575972356073685,1.5286579622895753
LCLC-97TM1,salermide-PLX-4032 (12-1 mol-mol),6.666218718302321,4.594895922374634
SW948,11455910,0.6774609071475187,0.9157169983613075
SK-CO-1,11485656,2.076616779710352,2.2717979318969435
P31/FUJ,387447,-5.269499156732966,-4.855089583932649
SaOS-2,54765302,6.138432086002101,3.8650651513840844
KU-19-19,3384730,2.4463371108200995,3.4093360328010216
SW48,56946209,-4.8342224094221455,-3.680693356968716
RERF-LC-MS,71304818,2.1402027844306986,2.5171947556183722
SaOS-2,5351362,1.054118918695375,1.323008775788045
SW1271,60700,-2.0966401571631805,-0.5425466006807762
SK-OV-3,12001922,2.3689117655248197,2.070389891447577
BICR 22,11222830,2.7513096778080293,1.6126596675788687
HEL,637858,1.821308587756956,0.9375036788057594
LS411N,11609586,3.7769222068832384,1.7369054485797417
PaTu 8988t,crizotinib-PLX-4032 (2-1 mol-mol),2.4555083865109197,1.9410765368658178
SW1573,53392493,3.256582971351183,2.7691690251869803
IGROV-1,71466380,4.863636874274779,4.269614038310135
SK-HEP-1,119607,5.888068080296772,5.39884160478766
K-562,5329102,1.5928854941533903,1.3397297398726837
RERF-LC-MS,24901704,2.6292316786888295,3.539302697271004
RKO,54649381,4.449908747747005,3.2330169849797943
KU-19-19,6438330,3.038685724131264,2.3757986660625616
RERF-LC-MS,6917907,-5.461995819879327,-4.336992832371116
Daudi,6852167,0.8630196090584432,1.8540046048881167
RKN,2708,5.19327789915259,4.9768447131724205
SK-CO-1,51039095,2.6345691844177006,2.8214764675171033
HEL,9935249,3.1121102066484827,1.0548051329534147
Daudi,6184667,1.7615544136572183,2.0740813943651726
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913,2.6727981005039076
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312,2.9403586220897693
LCLC-97TM1,5978,-5.540378308178224,-1.6726014850579074
SaOS-2,135999136,4.306712196094447,3.703437708775795
IGROV-1,5311,1.0068816368200209,1.4471634589531788
PaTu 8902,10184653,3.3664490630517023,1.276388852133245
IGROV-1,54678924,1.4704159748793169,1.933058995294996
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742,-0.0071917856709693305
IGROV-1,16720766,-0.0562020789376145,0.4707013608439095
RCC10RGB,31703,2.24368059098483,-0.1483896092535493
SW48,4261,1.3708847234833408,1.3623441690437148
LCLC-97TM1,navitoclax-gemcitabine (1-1 mol-mol),-2.1258188281402757,-0.6739519766866792
Granta-519,11494412,-1.422706675432074,0.21842782421022858
BFTC-909,10302451,3.622269240471498,2.9785042579186607
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969,0.06862423829886581
SU-DHL-1,11497983,5.985793176782232,3.8376908268195793
HEL,44486219,4.241945120616936,3.8981224387497924
HuP-T3,9926054,1.9266750805140576,1.967586410209355
Granta-519,5281672,3.715092894597705,3.9656228913102676
NCI-H2452,568763,0.2251625503779925,0.5791540713798123
Daudi,15547703,2.9729250708388815,2.44511244812503
RERF-LC-MS,1566236,3.687566928717542,2.714447184732228
SW48,3689413,2.066117060158584,-0.023111953879982338
RKN,11396600,3.670395083293249,3.739004830516074
COR-L95,25227462,1.0954609187473372,-0.022928783187918328
P31/FUJ,11497983,-3.9754433923569295,-0.06531801708428663
COR-L105,11977753,-3.381629820862821,-1.4199403233132757
SaOS-2,10302451,5.268852772808677,3.3480287208479624
WM115,25126798,4.207732195436686,3.839253764362354
HEL,6918736,-2.4872933380365483,-2.118034039012556
ALL-SIL,vorinostat-carboplatin (1-1 mol-mol),1.2348853562201922,1.9480619341265748
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526,1.3124887075362588
BICR 31,11626560,1.5769037831027732,2.0626466065519473
SaOS-2,53481919,3.9662352208904,3.9640084071016672
NCI-H2452,4378219,4.095695943124218,2.3579435346834225
RKO,135440466,3.093117295091816,1.913347989212831
ALL-SIL,selumetinib-decitabine (4-1 mol-mol),-0.1840409792284095,0.9652578887059191
IGROV-1,4521392,5.131794979216607,4.196224175305276
WM115,6610355,3.646348527159068,4.60801627536891
IA-LM,46199207,3.643614442277753,3.243539746608551
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367,0.9500295326380305
RERF-LC-MS,4259181,-1.273108977623296,0.34002637105126643
COR-L95,selumetinib-PLX-4032 (8-1 mol-mol),5.035796466628604,3.8638656299468352
LCLC-97TM1,9866186,0.636434294421894,0.5287351560686956
LS180,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497004756461055,2.9216196579014984
BICR 31,285033,-1.6333817403557132,-1.5975711760158182
SW1573,24821094,3.391149888356164,3.3597952110005935
RERF-LC-MS,984333,0.876742343627688,1.0287314194052453
SW1573,2828334,5.538488922798482,6.241982007484779
BFTC-909,11214940,1.666026285351028,2.323872748556774
MOLM-13,SNX-2112-bortezomib (250-1 mol-mol),-3.9385993868290665,-2.840857360706563
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248,3.630069373170161
MOLM-13,16722836,-1.8349401857846608,0.8189692616926714
MOLP-8,135398516,0.6877200142840878,1.1879347634088555
NCI-H1568,56649450,2.3390116545362956,3.100366343394066
COR-L105,5329102,2.9490674090485007,2.1760021196503674
BICR 22,104842,-5.460039616101889,-2.573717268973781
ALL-SIL,44507138,0.0905903694215729,1.5591473847550703
COR-L105,navitoclax-piperlongumine (1-1 mol-mol),1.1506089120324992,1.9231155260991972
Daudi,252682,5.82526834825694,6.3967899958150225
SK-CO-1,24785538,-2.301834394825824,1.503774800182602
HCC15,4788,6.208189927463216,5.6436686852334015
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886,3.394520139811767
SK-HEP-1,5282054,5.2464488654660935,3.8722366746781627
K-562,2729026,2.90327889883348,2.387252550496377
HEL,docetaxel-tanespimycin (2-1 mol-mol),-3.324993936619335,-4.593487221361975
IGROV-1,135398744,6.402844237905131,6.379096425809272
Panc 02.03,44819697,-0.6097657869730747,-0.20627647133329194
COR-L95,6252,1.2572884944075156,-0.3893034369943558
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108,2.575195642733379
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934,0.4725721705618966
RKO,135411,0.3039750611139232,0.08194772857516354
SW1271,5284616,3.4240840801047825,2.2232610913469064
Daudi,9803433,4.921870042846492,4.258668148950325
HuP-T3,1566236,2.433067651410228,2.4648368061341874
NCI-H1568,11364421,1.3511041801335055,-1.2998808029524722
SaOS-2,54678924,2.353285364311993,2.220328656326971
NCI-H1568,6438330,1.052967118553252,2.2515596857231825
SaOS-2,56946209,-2.927880316628738,-3.684404902831761
MDST8,71304818,3.102141708789901,2.5176782385250007
MDST8,16722836,1.8236379945665244,1.7425030478456527
COR-L95,5460769,3.3963309413836815,2.3897423522788093
SW1573,5328940,2.8151731448483424,1.9692005663223668
P31/FUJ,44486219,4.066329818545256,3.5299880734154847
SK-CO-1,44819697,-0.0659450585917303,0.3455352431698337
NCI-H1568,3689413,-2.0602171008804935,0.11652942524501465
SW48,4788,5.795432827385499,5.420586242237175
IGROV-1,11625818,2.877471533668122,4.639095978662588
HEL,5282054,3.8014373831294073,2.684008297692906
Granta-519,2858523,3.0573334835342725,2.5566092968814456
Granta-519,2708,2.6467102550113357,3.0387898228383476
SaOS-2,10074640,3.1546787022314264,3.244432567311196
Granta-519,alisertib-navitoclax (2-1 mol-mol),-1.8552810437041576,-1.6035851891566424
NCI-H1568,462382,0.4864277786958156,0.5133539010214748
PaTu 8902,6450551,4.419968438595772,2.840724435355851
NCI-H1568,89183176,4.755399227223714,4.400587564052585
SK-HEP-1,89183176,6.199387598364303,4.6634143811668505
COR-L95,3689413,-1.01311028513846,-0.7804384488363197
SW48,322968,2.620984302451229,3.5146618346654903
NCI-H1568,2113511,4.994259934049027,5.522117964528268
RERF-LC-MS,10074640,3.277461458690314,3.169673769386463
P31/FUJ,11485656,1.9746673234827223,1.3180588223380707
NCI-H2452,24978538,1.4440845227299357,1.6314714430387016
SW948,46398810,1.81837356763434,2.148096950446526
SW948,navitoclax-pluripotin (1-1 mol-mol),-1.6002032912556945,-0.6853830899316898
SW48,5280436,3.9386259808510737,3.1864047642656845
NCI-H1568,16013152,3.794215458313736,4.260641271041837
K-562,JQ-1-navitoclax (2-1 mol-mol),0.4672607120603991,0.1735419026257079
SaOS-2,72193861,0.3662001709486771,1.4675989678628962
SW1271,6623618,2.240401111492455,2.28526958836015
BICR 31,11964036,0.7129684858082154,1.6367576582055614
MOLM-13,71466445,2.28410988708537,2.2279337370827235
SW1271,5280436,5.166796757102748,3.4805512228010316
Daudi,crizotinib-PLX-4032 (2-1 mol-mol),0.8611087114550048,0.934811893868361
SK-HEP-1,5470400,0.5577708849126581,0.12993757276643525
SW1271,73707398,1.637161284255629,1.1674277010790803
Panc 02.03,24771867,4.320948526904658,2.868397437962532
K-562,11494412,-0.907204058397288,0.5454266308856054
HuP-T3,4477,0.7500067469313434,0.6864709782541943
WM115,44489675,3.6522428576041888,4.012850324944371
IGROV-1,10074640,3.2681490579824426,3.1625051790981447
LCLC-97TM1,387447,-4.752686001320434,-4.192387270727688
NCI-H2452,136227331,4.192235498443636,3.9975917668552894
BICR 22,44566777,0.9464577594296588,0.9124420991820288
Daudi,44462760,2.2846011846998184,2.624322394377914
HuP-T3,11222830,1.7699584455080513,1.639242247847603
BFTC-909,10184653,1.6906150005550105,1.4761004895557834
COR-L105,navitoclax-sorafenib (1-1 mol-mol),1.5234919165461795,1.9619259722717592
SK-CO-1,5460769,-0.7722931098274061,2.4918072012357633
IGROV-1,9884685,-0.088911709267569,0.540235778141885
SW948,10074640,3.6458957710098927,3.0915325714470385
RCC10RGB,2729026,3.187414345119047,2.7726344460711583
SU-DHL-1,25105715,2.6102250612439857,3.2209323479743683
SaOS-2,2708,4.307882235107384,5.022500290509191
SW48,11485656,-1.6768123952056315,2.113603652329216
LS411N,5738263,3.6843208102291127,2.8772720503744074
LCLC-97TM1,89928392,0.9843618500255806,1.066818324707169
IGROV-1,5328940,0.347812751869877,1.6919335441483232
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505,3.620401066168288
MOLP-8,6184667,3.7618917164892296,2.0961791699656076
HEL,9907093,4.271492923268933,3.465762638754443
SU-DHL-1,409805,5.150132871505728,4.489194869362127
IGROV-1,5287620,-1.5394168430569777,-1.9703421548359026
HCC15,6184667,2.403880665872793,3.191574392922068
ML-1 [Human thyroid carcinoma],119607,6.010030667993389,5.481112205584926
BFTC-909,11152667,-0.3524603871752078,-0.3125060261876493
BICR 22,10427712,4.255154443676342,4.054796607458902
RCC10RGB,73707398,3.9170227295506304,1.4249601701620631
SK-HEP-1,4788,5.857315027837397,5.783891671936139
SaOS-2,11167602,3.026359974607451,2.5670627774954733
IGROV-1,3825829,4.144093606877803,4.089634186682881
Daudi,53232,2.2893399383043116,2.525053401320461
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115,6.135150470791125
LS180,5470400,-3.6342626980574657,-1.1469443486588624
NCI-H1568,322968,3.6220797151302673,3.7268651095245677
SU-DHL-1,25150857,1.7165355924738273,2.030519438612676
NCI-H2452,9926054,2.7849990975548726,2.1382826260467844
RKO,5280436,4.655813696583822,2.9741786386151285
Panc 02.03,25126798,4.246913180768056,3.8915889965433443
BICR 22,5460769,-1.4539525700949456,2.3102952355951967
RERF-LC-MS,4521392,4.229663793191115,4.307645230216398
COR-L95,65628,4.016533332946612,3.6416186383478233
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634,0.45395775760494206
BFTC-909,11507802,1.7199271215311116,1.7267548359681961
HCC15,16115403,-5.315255617661217,-3.519668004014431
Panc 02.03,24797083,1.7288458125332262,1.67732219975388
Granta-519,16065773,1.8580334509866892,1.9658004278468448
MOLP-8,67291369,0.6739245689833524,0.7978745597908798
LCLC-97TM1,71304818,2.70820846116735,2.311139599342483
COR-L105,10113978,3.5062120769458907,3.393005755185815
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017,1.6898895574064152
ALL-SIL,5460769,0.8731159867521163,1.6655629422727949
MOLM-13,89928392,-0.0278317389216686,0.22053682174204844
ALL-SIL,selumetinib-PLX-4032 (8-1 mol-mol),4.528203505983491,3.759051193045341
SaOS-2,6852167,2.181246544986129,2.9544092180367625
SK-CO-1,135999136,4.853872243910513,4.007687157618064
LCLC-97TM1,5329102,1.5800226001590805,1.8892063278486178
RCC10RGB,3825829,4.92777419243283,4.329003045584696
WM115,16722836,2.5522609953991577,1.78238052110219
KU-19-19,6610355,5.477302473020379,4.548214735730275
HCC15,5311281,-0.1593612251340344,2.5881919990785156
WM115,11656518,-0.7680829336702796,1.9592283359520861
IGROV-1,675434,4.336225379212549,4.348769585933863
BICR 31,322968,4.229982613329669,4.126096147444446
LCLC-97TM1,serdemetan-SCH-529074 (1-1 mol-mol),1.7773916595129422,1.8884966818373945
MOLM-13,409805,3.504188648592109,3.670175179610317
NCI-H2452,68056272,5.088176766324353,3.8172987824289497
HuP-T3,JQ-1-vorinostat (2-1 mol-mol),0.3185506624165122,1.2221437911541666
RERF-LC-MS,25102847,0.6953191965745218,2.5897181570627787
SU-DHL-1,5278396,2.36959409949266,3.4911962522066484
HCC1500,9935249,2.2800833668468266,3.0740484093284355
HEL,46907787,-1.2802643066913908,-0.6629775909938312
Daudi,64971,1.9256728094608813,2.074365184567366
KU-19-19,168313047,3.3084179069540696,2.32769214427598
HCC1500,9903786,4.21203406645071,2.821727462833165
BFTC-909,3689413,0.9841636034152118,-0.05436455816154884
MDST8,9911830,3.786562744766562,2.2532485086355383
WM115,262093,2.5199436905866905,3.024497715253601
IGROV-1,5311281,3.3250623444804206,2.5510222373111615
ALL-SIL,4261,-0.4593745111072439,0.3391704417453986
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556,-0.5420561104247651
NCI-H1568,25105715,3.512540774448481,3.370854219325024
COR-L95,12001922,1.5177554079359803,1.9119917386949905
Granta-519,25154868,5.041568583050757,3.8723344832615862
MOLP-8,navitoclax-piperlongumine (1-1 mol-mol),0.7236562214911971,0.7875991446093464
SK-HEP-1,3503,1.99172511033101,2.4664772708031215
BICR 22,2749,1.4483580801045477,2.3027942401274264
SU-DHL-1,10231331,2.149159497852676,1.2807464212357507
SU-DHL-1,132496,3.861580575323874,3.2865952451744618
NCI-H1568,11955716,5.84501437277453,-0.7796207092722889
COR-L105,11647372,1.8386560750541856,1.4716997075764424
PaTu 8988t,702558,5.248840045640507,5.33329320156043
RKO,219104,3.7756995047121658,2.618404130679844
RERF-LC-MS,119607,4.38818595494476,5.354916449901922
SK-OV-3,969516,2.624811361400939,2.9096978106240083
SU-DHL-1,67156097,-2.1897423830418155,-0.5909166502764767
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604,-1.6318905902914562
MDST8,10296883,3.644541291105843,3.9392363774566155
BICR 31,135411,1.1842135795155395,0.8828483286842587
NCI-H1568,17755052,1.5920713080731803,1.8417857850204487
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653,0.2431845929933539
Granta-519,3062316,1.222650334372554,0.27818124775336184
MOLM-13,11609586,0.2693262849825738,1.8014454697094349
MDST8,65628,4.39024768664476,4.449092724300057
LS411N,11222830,1.85641131377126,1.4124932226000402
P31/FUJ,5278396,3.2564464707559786,2.999480249897526
NCI-H2452,selumetinib-piperlongumine (8-1 mol-mol),3.871574708601934,3.805438813446404
HCC1500,11228183,-3.1075364778620544,2.293598930368161
Panc 02.03,3503,2.8594786206641514,2.3683565305596432
MOLM-13,12001922,1.648284949914827,1.552100525827804
Daudi,decitabine-navitoclax (2-1 mol-mol),0.1880854613737136,-0.5917885738031551
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179,-0.7945666587905517
KU-19-19,selumetinib-UNC0638 (4-1 mol-mol),2.3716952230277313,2.9065910863546236
RCC10RGB,135875424,5.859031260595621,4.0734017908028015
LS180,44491742,4.531352051294965,4.062361511509221
Daudi,salermide-PLX-4032 (12-1 mol-mol),4.83725960729828,4.274096902587832
SW948,5460769,-0.6640669541383749,2.4419717931954508
BFTC-909,9866186,1.150003196853964,1.2671957335565105
KU-19-19,docetaxel-tanespimycin (2-1 mol-mol),1.4200175787881737,-2.8636179291513684
Daudi,322968,1.8489038189519929,1.9548086401652676
LS180,135999136,4.321194581518088,3.8066051337122855
MOLP-8,4259181,0.2540996075245788,-0.018394224820154362
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676,1.6341806250739994
BICR 31,17755052,0.616652074058669,1.9896777480220478
Daudi,10427712,3.475831712716563,3.5182930892555406
ALL-SIL,6252,-2.462384672511242,-1.4471320578541453
IGROV-1,57330099,4.391385744785918,4.19494353298705
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955,1.6156500405039245
LS411N,5746,2.615146419652584,0.9880623658988879
WM115,11625818,2.666283825244439,4.629830741856447
SK-CO-1,17755052,1.6143754050867285,1.6002301621145887
BFTC-909,4788,5.986704833543041,5.759917368417857
BFTC-909,613000,3.1980696015333137,2.9080296642813166
RCC10RGB,9933475,1.608288384582936,2.098265162380421
COR-L95,11964036,1.1862097811542611,1.0153248310656449
IGROV-1,12003241,-2.0122972114546904,-1.0724594763195507
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136,-0.466473593422471
SK-CO-1,navitoclax-PLX-4032 (1-1 mol-mol),0.9904814430420492,1.763818171101047
LS411N,676352,3.0047981548436873,1.8630689526702202
NCI-H1568,6918638,-0.3782949656582497,0.36254457569647724
HCC15,654092,-0.5163256778254894,-0.18015614756771434
MOLM-13,72193870,3.075841334601934,1.4510999479296145
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263,3.2594597381368886
SK-HEP-1,1716436,3.791424957504218,2.9020085224530123
IGROV-1,637858,1.814476597989254,1.7828075770557112
IA-LM,44137675,5.685431340913792,3.2029855908092135
RKO,49793307,-1.4433237106321422,-3.231270830266456
Panc 02.03,1750826,-0.0877771412327358,-0.7723261347161633
P31/FUJ,216239,3.114152508734425,1.6744991981447246
BICR 22,9911463,4.403388511465592,3.558012188854702
LS180,3503,2.1233569957286673,2.3895843318938
NCI-H1568,135440466,1.9451121966001212,2.3429571368025224
LS180,6917907,-5.898955627831861,-4.4359390543190145
NCI-H2452,3503,2.8949427881039367,2.1594672881651116
LCLC-97TM1,9952709,3.284131025623194,2.758590939063
MOLM-13,168313047,1.872191765635252,1.4919963380857166
RKN,65064,4.855719732775604,4.657679106912443
SK-CO-1,1716436,3.109025551437123,2.9294700686523703
Panc 02.03,322968,4.613737356937267,4.021610120786017
SU-DHL-1,16115403,-5.307217729681928,-4.084069026613424
Daudi,5738263,2.220866513982768,2.5271368921343407
SW48,10074640,2.891302128524984,3.043512009300193
SW48,3552672,5.820012420560967,2.960171742361372
Daudi,568763,-0.9358982895655849,-0.3457877070074218
HCC1500,11234052,4.300499145525321,4.13718881979471
WM115,16741245,4.109793610684897,3.764335037516145
SK-CO-1,6917907,-6.103253673111458,-4.9701685386270995
SW48,100016,6.031440310304127,6.158619761165082
SW948,12003241,-1.7903806895013192,-0.8149202840132476
SK-HEP-1,9840324,5.848573782723059,5.86568961932305
ALL-SIL,5328940,-0.9694628184696558,0.6237555126767089
BICR 22,2858523,3.373464702278958,2.9633240400674326
NCI-H2452,17755052,2.4746667711045514,2.045066738747869
HEL,tanespimycin-gemcitabine (1-1 mol-mol),-4.465092392275179,-2.421387152313407
P31/FUJ,654092,-2.277731190350674,-1.0747847676281115
HCC15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.266961603535723,3.8430590025207585
BICR 22,16736978,1.4452527998079976,1.85326099164788
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494,-3.3370287609925438
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797,-1.4898959929452757
ALL-SIL,9843750,4.4328493438561845,2.9997039789947384
IGROV-1,168313047,1.93821625738322,2.410643652173757
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967,2.119643470245083
RCC10RGB,24797083,3.688734393817597,1.5573858824097164
IGROV-1,67291369,1.8066430555976296,2.6228122764139217
SK-HEP-1,135875424,4.97106166770821,4.064789508595168
SK-OV-3,676352,2.4999853996447423,2.150167289222351
IGROV-1,3689413,-0.3633634632064185,-0.05287243807235151
MOLM-13,2126,3.944929409626795,3.8620753587765337
SW1271,25150857,2.216244024484901,2.5028777541771565
P31/FUJ,piperlongumine-MST-312 (1-1 mol-mol),1.5235846843184453,1.238588199078776
Granta-519,3689413,-2.6080640580656977,-1.8280005058653046
UACC-812,11955716,-3.4049141440551765,-0.9006778440962254
WM115,6918638,1.2765614986990457,0.7678767844701064
MOLM-13,119182,-3.013346002661584,-2.7028364737059536
HuP-T3,25150857,2.779922499061356,2.5556450642274786
RKN,400769,-0.3685197718994141,-0.5547918775545476
RCC10RGB,navitoclax-birinapant (1-1 mol-mol),2.5525116990099015,1.1265134513009738
COR-L95,9927531,5.207677506691081,4.5052484165424165
RKO,439501,-1.8401322759847645,-2.2051657229842934
COR-L105,135875424,4.584511127602178,4.050535168047958
MDST8,67156097,-2.036194319435593,0.226258542973831
SK-CO-1,11640390,3.1287755311468715,3.3591902959431184
NCI-H2452,9915743,1.4140850498548845,1.5163848849980324
COR-L95,54626689,4.626807564914302,4.3865566363511315
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887,1.0187006426656016
SW48,15983966,-4.810478602921179,-1.0455667805549054
RERF-LC-MS,53495165,1.4938275665549956,0.30559125028628764
SW1573,10026128,4.237670104162456,3.9520583789172763
BICR 22,5328940,1.2238467278980267,1.3360089120788359
IGROV-1,25150857,3.031865110078871,2.6142505300947825
SW48,54649381,3.6753624817280706,3.748113455090244
RKN,11485656,2.343665915939472,2.4526742486776825
IGROV-1,216239,2.21703825410177,2.5403342687126824
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272,-0.015528057849355322
SaOS-2,675434,4.709862103920263,4.485178531037041
WM115,439501,-0.2667789802830004,-2.1106118356420978
RKO,11152667,-2.010180339323448,-1.127399899361518
BICR 22,702558,5.841545864846151,5.27911862628023
SW948,navitoclax-piperlongumine (1-1 mol-mol),1.2480624926894286,1.2536199024822123
IGROV-1,52912189,2.3966568144845666,2.4522768054746447
SU-DHL-1,219104,2.7039031158758395,3.6008030859609295
SW1271,19582717,5.373754052547774,4.162797038581285
IGROV-1,119182,0.2112476135388779,-0.3198550710320196
SW1573,25150857,3.3863948467965717,2.5299533453196967
LCLC-97TM1,1566236,1.804143498427706,2.3965338311602107
SW48,6252,-1.782590172996294,0.3826170650527541
MOLP-8,168313200,3.062868142984741,2.7837244297865396
SU-DHL-6,969516,2.321858620209541,2.366361602558237
K-562,44632017,0.5936262556123562,1.1988431244414606
BFTC-909,56973724,3.22598802973391,3.319212212148614
NCI-H1568,24180125,3.319632294157453,3.2619953025636685
HCC15,JQ-1-vorinostat (2-1 mol-mol),0.768732947542672,1.315547914606397
RKO,15547703,3.988071110220001,2.6176069870405523
COR-L105,446155,1.2274898824574871,3.095628578377383
WM115,25062766,1.993857010637035,2.1758037800071977
HCC15,42642645,-0.8684016042996798,1.0610378211727107
IGROV-1,3136844,5.214591389089975,4.392178372451829
COR-L95,16659841,4.2643844802603725,2.926389088047137
NCI-H1568,107985,-3.6136890416333665,-3.428258540653553
HEL,9967941,3.646907071964301,3.0019372742124233
NCI-H1568,5311,0.289477139532769,1.5376579305098124
HCC1500,24964624,2.92457410282952,2.407928646342699
LCLC-97TM1,44185566,1.2712415312804253,2.2155085093298355
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529,0.06735401532409895
RKO,135421197,1.472175761257966,1.4841178404209152
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725,1.2371432799523046
WM115,vorinostat-carboplatin (1-1 mol-mol),3.7982137973374104,3.3691928166801905
K-562,docetaxel-tanespimycin (2-1 mol-mol),-6.155798984221324,-3.8056437013138935
P31/FUJ,119607,5.165578068786105,4.314551539250176
SW1271,44507138,3.04083255973368,2.6237789722326
MOLP-8,72734382,2.92105223846654,3.3868737164893195
COR-L95,selumetinib-tretinoin (2-1 mol-mol),5.25273224867287,3.356811614455832
RKN,12001922,2.582060834791438,2.075550604230291
MOLM-13,3025986,-2.268401268397509,-1.7386423698171194
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395,0.2872164500098464
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789,4.950403879302842
BICR 22,387447,-3.632542993789297,-3.2988854498763787
SU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),0.447892144567538,-1.836097412775667
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594,2.601909656268069
MDST8,44819697,0.5968481057166135,0.18489602639346592
COR-L95,54613361,1.8571878459944453,-0.2640372629805623
PaTu 8988t,25183872,-1.065851307698322,-0.572149848447892
HCC1500,969516,2.5012208253247374,2.8982911291722457
LS411N,51039095,3.380080993968732,2.6793243714168984
IA-LM,10385095,1.8174613436578264,1.1712703880520356
Daudi,JQ-1-vorinostat (2-1 mol-mol),-1.994208072819334,-0.6671246337766519
MOLP-8,44589607,1.928632926439859,1.925032021539903
UACC-812,JQ-1-UNC0638 (2-1 mol-mol),0.7883661966359787,1.6752992950742571
SK-HEP-1,5311,2.3418360503567386,1.713313599337758
NCI-H2452,24889392,3.037712354939189,4.236062536382324
SU-DHL-1,4378219,1.8683369375684944,1.773384436597255
NCI-H2452,2858523,2.6943426896823284,3.045708775581726
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496,4.563132060796138
IA-LM,119607,5.918153428689206,4.577591543133518
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482,2.0313836180889906
COR-L105,46224516,3.053099263199949,2.8891781280776034
SW948,3062316,3.151526592835161,1.7030125091507884
BICR 22,6610216,4.672862717569176,4.131642680928381
SW948,16736978,1.371465793072688,1.500084561360426
IGROV-1,2828334,6.070696247039626,6.1181813078833205
RCC10RGB,44185566,3.1564704709707856,2.6197550488532113
Granta-519,135999136,4.28714374371566,2.5403815613488505
BFTC-909,654092,0.6323398211983356,-0.3484586519598997
SW48,selumetinib-PLX-4032 (8-1 mol-mol),-2.238777477327049,2.631983025472673
P31/FUJ,17755052,1.7010190253681206,0.6528631877127431
SU-DHL-1,2945648,2.120687124348465,3.071518971868812
LCLC-97TM1,16720766,-2.0806199642234704,0.6248046270623848
HCC15,3025944,3.8616867083103648,4.360886579285341
LCLC-97TM1,53392493,1.9813066602409652,2.345662504786675
WM115,selumetinib-piperlongumine (8-1 mol-mol),-2.154986024806584,2.843888294057283
COR-L95,675434,4.0325297307826125,4.241673656440882
SaOS-2,11213558,1.0641156085827448,1.812218862709859
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236,-0.04263326184051341
KU-19-19,1716436,3.531012736022478,2.9354668260273082
SU-DHL-1,11485656,1.6397040363022437,2.169916897874718
SK-CO-1,16736978,2.1510378918389415,1.758444501781887
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037,1.9202920656894076
HCC1500,136227924,2.675203690625814,3.071267959022978
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557,0.902516800624846
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509,4.199609598330171
PaTu 8902,selumetinib-PLX-4032 (8-1 mol-mol),5.82901614817581,3.421151571843923
Daudi,219104,1.6178665476553538,1.976132541508344
WM115,5284373,2.6004259651165644,2.898400130013323
SU-DHL-6,216345,3.116690602340157,3.095750813879792
HuP-T3,5460769,4.291069487745317,2.484566734145025
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144,4.787699947026701
Daudi,8515,3.193004700442435,3.207700522851098
HCC15,3815108,3.1337581441750277,3.0562517520877948
IGROV-1,5280436,3.2616766817665086,3.0794214574849685
COR-L95,107970,2.0048060228155333,1.9715983801582346
BICR 31,25150857,2.3687059872087217,2.622746156699157
IA-LM,6918837,-2.975709639111599,-2.991835910347222
WM115,3025986,-1.3268545497049868,-0.5008545837831889
WM115,BRD-A02303741-navitoclax (2-1 mol-mol),3.3998938295257632,2.5343537733342254
SW48,17759555,2.861947497664063,3.449572651200221
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368,1.9120962553092773
SW1271,9956119,4.3828310926576375,3.480968656972765
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103,2.180044506339243
MDST8,24772860,-2.900176299695688,-1.1682764575444318
SaOS-2,4259181,-0.1317601722396107,0.2416443769489793
PaTu 8988t,5746,3.0775825889142543,1.2801387914289857
SaOS-2,4521392,4.5837419847316845,4.442211601465042
SaOS-2,445455,5.662681927298568,4.74832359092918
IGROV-1,148198,-2.659972993252853,-3.4912900206033246
SK-CO-1,11404337,-0.5084033800481932,-0.05047285465181198
Granta-519,4578,4.680400709321271,3.756407002004326
RKO,4261,2.924548439505643,1.140915923931103
MOLP-8,54618164,3.908946135671936,3.6141690667135613
HCC15,24978538,-1.0517559532383662,1.6204742782978476
COR-L105,2945648,3.0602962908492386,3.0865290882553853
RCC10RGB,salermide-PLX-4032 (12-1 mol-mol),5.5053951487435775,5.009038859559563
NCI-H2452,4705,3.641149380662554,3.5334092625382483
SK-CO-1,54143018,-0.6826828748975821,0.8994929198884575
MDST8,26596,-1.25574590011264,-0.6308740819687935
NCI-H2452,54454,2.511734775409603,2.3842856856994428
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487,1.3410173023921277
RERF-LC-MS,16038120,1.5599846769821624,1.16684942142276
SK-OV-3,44185566,3.1295797630764266,2.7670379041871667
BICR 31,148124,2.7085675831815292,-2.1422846749533204
P31/FUJ,439501,-2.3575947617146475,-2.254589322035638
BICR 22,11152667,-1.8276171650012312,-0.7372305128467801
COR-L95,56973724,4.268430703602559,2.731836146102313
RERF-LC-MS,54626689,4.221264321270605,4.604718654710841
IGROV-1,1641662,3.5854177848263675,3.327716971284786
MOLM-13,613753,2.871004682812888,2.647318569850629
IGROV-1,11404337,-0.7659238947812715,-0.47097365279673686
SW48,219104,2.280685064057957,3.542630710066813
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245,2.0741506819702056
Granta-519,9935249,0.0212855082517002,1.1069132416947767
MOLM-13,2749,0.3899767988765278,1.0468253380694117
WM115,1750826,-0.9273267035114736,-1.057953343310442
SK-OV-3,2858523,3.2787147644650716,3.1490582563688245
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809,0.983966693273269
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923,2.8998140562746033
SW948,25183872,-1.604238480901096,-0.896289097945818
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568,2.4254625921222517
IGROV-1,6914657,-4.141311308759326,-4.0693288077486764
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315,4.586880293762627
HCC15,6610216,4.23435184261858,4.348554339182103
NCI-H1568,10074640,3.1711026687004855,3.079814740147879
SW48,4917,2.351047632498956,2.805740704702272
MOLP-8,46215462,1.266580776259001,1.150214015736094
WM115,erlotinib-PLX-4032 (2-1 mol-mol),0.1999561238865428,2.7174348789921208
COR-L105,387447,-4.5302496546864885,-3.886414412440176
MOLP-8,44462760,3.111101001788515,3.115780262659628
BICR 31,44819697,0.4590360698509347,-0.45385922275714
HuP-T3,9956119,4.370077084995815,3.888164500360196
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585,0.6789068982541303
KU-19-19,66577038,3.864819378735941,2.9854625960384187
BICR 22,5746,-1.0393569299451335,0.9419639541702232
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211,2.358510256841602
SW48,67156097,-2.150931452918296,-0.4569735711799015
SaOS-2,25150857,2.491525195617086,2.3947700754659347
NCI-H1568,613753,3.056586098825006,3.296308133667476
LS180,44137675,2.850653785387247,3.417322249399942
RKN,11364421,-3.590581417405073,-2.17230579880552
HuP-T3,23582824,1.5911146583975455,0.6947754699216041
SW48,446155,2.2181780639059907,2.6358067872208966
SU-DHL-1,44202524,0.8334918459072751,1.7527415899293808
RERF-LC-MS,11404337,1.609147033115388,-0.1502404514919823
K-562,44486219,4.057183894108205,4.094507036500504
PaTu 8902,serdemetan-SCH-529074 (1-1 mol-mol),2.396607903766339,2.083617195857326
PaTu 8988t,46199207,3.796589685342678,3.2144462932477507
LS180,11964036,0.9251272605785624,1.1456980567614554
SW948,8515,3.759025323790885,3.5133498619469794
SaOS-2,374536,3.743747938767685,2.4745538952156583
SW948,135875424,4.663257041681152,3.5833615220342665
SK-HEP-1,72376,-0.6035227354554765,-1.697025943953929
SK-CO-1,1242560,3.64748499205759,3.528933124344763
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724,2.0973216451485155
MOLP-8,3025986,-4.599162344151263,-1.213858670629561
SW48,25150857,2.2099211562472125,2.3544612136198255
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173,4.065869405836422
LCLC-97TM1,3465537,1.1142431298706064,2.3052026817910716
NCI-H1568,9887053,3.9549233487650666,4.127173109941637
SW48,5746,-2.6538895977275745,0.8147750064573924
LS180,44484440,3.4848015178596343,3.1099066826492923
Daudi,25183872,-3.2629659020313393,-1.6384769359697924
IGROV-1,984333,0.6618578113050116,0.6354090225640696
COR-L95,135999136,4.28146486500778,3.186686314269131
RERF-LC-MS,4788,5.0822281264538365,5.621202517264817
HuP-T3,2828334,6.159425491986346,6.192653573976426
RKN,3854666,2.132003481112045,2.007676317680934
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515,2.1491443278650872
PaTu 8902,54639665,4.483683562011812,2.900102003832576
ALL-SIL,24180125,1.6553840753953686,2.453102259682521
SK-CO-1,12003241,-0.9578793579943758,-0.9603751928268401
BFTC-909,104842,-1.584917163766509,-2.7282005251538535
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629,-2.3187380805180084
MOLP-8,24772860,-3.493237790177901,-2.825872178271014
SK-OV-3,49836020,-5.2191550029019025,2.384094698360413
K-562,46199207,1.8646546122938352,3.0080577291753956
SaOS-2,BRD9876-MK-1775 (4-1 mol-mol),1.220945840769529,0.4992271268242775
MOLM-13,6450551,0.4092106163446157,1.2470380476169167
BICR 31,1566236,4.637821170940002,2.8110912529275836
SW1271,54454,2.1914366041236204,2.7101068443430143
HCC1500,selumetinib-PLX-4032 (8-1 mol-mol),4.771751115117369,2.7171051085820026
SaOS-2,9952709,3.1448975558697545,3.1412154048280665
HuP-T3,54618771,0.8132197250487964,1.0615901538262311
IGROV-1,6918736,-0.950858733923241,-1.1172534603702202
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673,0.04173293004579943
Granta-519,53392493,1.7904738197895116,1.6382597672428423
NCI-H2452,445643,4.078319116283011,4.106104153654131
HuP-T3,5281321,0.1098786391841839,-0.8762602896787621
NCI-H2452,654092,0.1220899319284023,-0.2005236215591286
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983,2.604252907002997
MOLM-13,56973724,0.5307136138302019,1.79240984552264
BICR 31,439501,-2.4499261286992007,-2.144627778398371
MOLP-8,44495899,4.403173191891281,2.6746685829109746
Daudi,44632017,0.5148090574579154,0.8471295034199374
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755,2.0778418207997307
SU-DHL-1,10077130,2.6641926349973875,2.7117379168060602
SaOS-2,9549297,2.000544043325996,2.722504102857179
LCLC-97TM1,24785538,-0.7280489014481334,1.3251544483730762
HuP-T3,10302451,3.3244038223924868,2.9233834279184254
Panc 02.03,73707398,1.687012904299387,1.6693012868569255
SW948,25161177,4.032512886861284,3.5542968135966095
COR-L105,17755052,1.2153053156846572,1.9362552593524984
HCC1500,11719255,2.4435237001116685,3.5129565326220455
RERF-LC-MS,5287620,-3.2415128958876123,-2.015164051653025
WM115,72193861,3.0084505907765795,1.7666595988677218
K-562,2113511,5.3605896450220785,5.011492615787817
RERF-LC-MS,24772860,-2.3078196081029136,-1.7596701428272268
SK-CO-1,navitoclax-gemcitabine (1-1 mol-mol),-3.3609230620799595,-0.6719426328477885
HCC15,piperlongumine-MST-312 (1-1 mol-mol),2.732022929511258,2.0563188635770424
MOLP-8,15547703,2.3372930335131663,2.575130669908851
LS180,4378219,2.066313424484697,2.090698029541695
SW1271,168313047,1.8206519834924395,2.2865043787575474
RKO,123631,2.6120370559458155,2.1743949572050947
NCI-H2452,3011155,5.255477653901917,4.212872154173164
Daudi,16722836,0.8830828668869325,0.7741767061543454
PaTu 8988t,6505803,-0.6279165545759258,-0.6559700661619093
SW1573,5280436,3.0542460563059253,3.7345374053517277
MOLM-13,262093,0.9014616367149992,1.8216970763975653
IGROV-1,BRD-K55473186,4.387806234483854,3.848113223987608
SU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),2.1944562589821226,2.228694405115835
SW948,5287969,-2.4513180825948515,-1.6588297812115422
P31/FUJ,54619267,3.5260071244925575,3.568997476296959
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.9997538924915554
SW1271,11396600,3.626770708484224,3.666038450184268
IA-LM,676352,2.5463710414635696,2.009181738863837
SW48,148198,-2.7635683141359277,-3.3665145290946095
K-562,6918328,-1.3297822316036851,-0.998813454776426
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966,3.4872670372180665
Daudi,135423438,1.6157885595086947,1.3424303077238406
Daudi,6438330,0.2626238759101729,1.0082028889536476
Daudi,44543605,5.193449926403497,3.601297522855246
SaOS-2,71751553,4.337892909522829,4.461782167538479
MOLP-8,23939,4.352572888875192,3.3015420767957493
SW48,2858523,2.8468158768410965,2.93318386060046
SK-HEP-1,selumetinib-piperlongumine (8-1 mol-mol),4.719630045140052,3.286685084230162
COR-L105,9911463,4.222864246171191,4.002045345131867
SW1271,11167602,2.369450835450289,2.542235209700447
SW48,135928012,3.696922095661256,3.982316171974185
Granta-519,53232,4.0944047749373915,2.5463116317693126
COR-L95,2871966,-0.8178907803151099,0.1635097523063401
MOLM-13,17759555,3.648246486561575,3.33867923739721
COR-L95,tretinoin-navitoclax (4-1 mol-mol),0.626714074175952,1.1757252241492908
SK-OV-3,44589607,4.1377534493712265,2.943084470814711
RERF-LC-MS,44543605,4.169252612552019,4.1496578138512215
Granta-519,49836020,3.8229564713378057,3.0117625878876675
SW948,5278396,3.777624651516773,3.257244311771544
HCC15,400769,-0.8695567043490428,-0.5173924464796451
ALL-SIL,3038522,2.34327176020718,2.454931913570163
SW948,135440466,1.4177296224023617,2.298539070018046
PaTu 8902,400769,0.6580342998730634,-0.469811242047659
IGROV-1,5746,1.9055212643377857,0.8565857289935613
COR-L95,25195348,4.044301101066811,3.1522353189124117
BICR 22,24180125,3.296229177015365,3.0389867051489152
SW1271,carboplatin-UNC0638 (2-1 mol-mol),2.98870654666586,3.580200878494895
RKO,73707398,0.9128481241529548,0.6868172106004566
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936,2.333933136933906
HCC1500,decitabine-navitoclax (2-1 mol-mol),-0.2719438923490784,0.8792534250404261
IGROV-1,15953870,2.712793598656007,3.638670784638731
WM115,71466445,4.303064097958205,3.9561835307796933
COR-L105,9956119,4.279642090153805,3.9876999240740236
BICR 22,168312962,0.5954564951508424,1.4903417603301572
SK-OV-3,navitoclax-piperlongumine (1-1 mol-mol),3.1171344026711147,1.358853594634259
LCLC-97TM1,46843906,2.6060669508648675,2.563804094001414
HCC15,9840324,6.2076616503129,5.973611204022399
RKN,24964624,2.2448388370498704,2.3996864725172165
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,2.1526901472097055
K-562,10410894,3.650757753763785,2.654201370880498
SW48,124202324,1.4616392816877528,2.528409828592998
IA-LM,15547703,3.104636726250569,2.8458178545659143
SU-DHL-1,decitabine-navitoclax (2-1 mol-mol),1.6803027957585963,0.7516761263671881
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004,3.359981184095366
MDST8,49850262,3.692937134795778,3.598984152334737
UACC-812,52947716,-6.767186414102593,-1.2876783314448954
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615,2.720487291685004
HEL,11427553,2.263048189869726,0.9969316938951054
IGROV-1,5281321,-1.4962463697398798,-0.7891091126965071
IGROV-1,135421197,1.96820638017286,2.077693702043087
LCLC-97TM1,104842,-3.469971777740615,-3.1207937452809937
RCC10RGB,374536,3.743226525407361,2.688210800487454
COR-L95,107985,-2.989419812710682,-3.701932159298761
RCC10RGB,72199289,4.762339751475906,3.496520093434525
NCI-H1568,11485656,1.8106242285910237,2.5720562463204373
MOLP-8,9549297,1.4376511571672042,1.7699529282401532
Daudi,24951314,0.2263717121921743,0.0072725442887883384
BFTC-909,7326481,3.4905195575106527,3.1356980206141043
BFTC-909,6623618,2.802037410677928,2.3631927248622286
HuP-T3,5287620,-3.5836939395445913,-2.3130988367233356
COR-L95,568763,-0.4949329271490838,0.10169527340106616
SaOS-2,216239,3.028726771334262,2.3662700915899957
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292,1.6975607084381137
Daudi,5311281,1.0302556341787754,1.9255654899474646
LS411N,3503,3.033347172376105,2.1032656767366937
BICR 22,4705,3.4365696424802477,2.2653311117733987
Granta-519,6918638,-1.0102021398050984,-0.6291586664621169
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418,2.7671807612409896
SW48,54618164,3.7830586534540616,3.8808951493474972
MOLM-13,25105715,3.5182090361281326,3.1510902979494153
Daudi,11175137,1.084300991963852,1.7784828023321066
SW1573,42642645,1.1024283721976142,0.8334036108154734
P31/FUJ,11364421,-5.080526011220062,-3.9110169945683646
MOLP-8,12003241,-1.4499361325619826,-1.2117433891169667
Granta-519,10410894,1.4137063553430784,2.570274118095317
RCC10RGB,57519531,5.003664553369681,3.00625159459413
HEL,11625818,4.404342627749774,3.4377356429359702
SK-HEP-1,1242560,3.752923936287399,3.698597133828422
SW48,3062316,-0.5038339303633423,0.6986096669776782
HEL,219104,3.0071408108258253,2.1728893146955794
SK-CO-1,3025944,4.807689572392986,4.2046501838886705
SK-OV-3,52912189,0.2062426244094619,2.4782494267335893
COR-L105,51039095,3.4251018662752073,3.141201513758741
HEL,65064,3.1933308972510113,3.9582305583888466
Daudi,9929138,3.458684768924583,3.830564592926168
SK-OV-3,11404337,1.4011927232423718,0.017638288620157597
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037,2.860488654865718
MDST8,11178236,-3.494725666780331,-3.034169450458695
HCC1500,ISOX-bortezomib (250-1 mol-mol),0.4566996929358766,0.471331883236482
WM115,119182,-0.4924283039006125,-0.1627996880834598
COR-L95,56649450,4.0191520211736895,2.8442710601397083
HCC15,5278396,3.283293724206623,3.6156382341422817
LS180,54143018,-0.5111931850291043,0.7245305898874466
MOLM-13,10427712,3.427914513597021,3.673383758012451
NCI-H2452,1566236,3.5735792412039022,2.1621060708180706
ALL-SIL,452548,-3.3771532504793194,-3.337840872439116
KU-19-19,409805,5.730069773001202,5.04585377889482
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407,0.7158503734013736
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847,3.4505150491537098
SW948,11955716,-2.1355637415890323,-1.769497450508587
RERF-LC-MS,11609586,3.546222239883878,2.953711823315174
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.4126910030873425
WM115,5311,1.988201906885666,1.637352173352767
HCC1500,5311,1.250436307916732,1.4700102998691513
KU-19-19,5282054,4.451216911386669,3.7774308399427152
PaTu 8902,4788,6.453607861068675,5.662983393556168
PaTu 8902,4261,2.3507697687761224,1.8138599595430986
SW48,68056272,2.992212540747962,3.460739840798377
HCC1500,56963564,1.3630245510511625,0.9833830896140827
Panc 02.03,25183872,-0.079390979301081,-0.5433210658498335
LS411N,11964036,1.3999141622104765,0.8433587495320881
BFTC-909,135440466,2.535274686795805,2.2326209905516134
SW48,selumetinib-UNC0638 (4-1 mol-mol),-2.2763178570350857,2.6752511524160787
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484,4.111815613912563
LS180,25183872,-0.6080839156226316,-0.3947436068978228
PaTu 8902,71304818,2.9919229428361263,2.4506011347547947
BICR 22,216345,4.525930969601246,3.9418886979737664
NCI-H1568,374536,1.2941902477204823,2.4327315362497557
LCLC-97TM1,135423438,1.8911988038183152,2.2877329096949834
NCI-H1568,56963564,0.2273202395709376,0.7877689491653294
K-562,9927531,3.3022164605184763,4.318679095410361
SW948,2858523,3.1308292618704905,3.052075035339735
COR-L95,ISOX-bortezomib (250-1 mol-mol),0.3297770164947888,0.18326665856051094
SK-OV-3,5287620,-0.5544150043477152,-1.993267040409595
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591,4.66392062715402
NCI-H1568,5311037,3.1621369524545155,3.644776159090635
WM115,15953870,3.7155207356015207,3.5959575475358347
Daudi,445643,2.8458589584694307,3.378928613452357
BICR 22,navitoclax-piperlongumine (1-1 mol-mol),2.368049525679639,1.394986312536511
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164,-0.12868642873396988
NCI-H2452,156414,1.7996451609117237,1.5380953569511249
Daudi,53301938,4.372641532954565,-0.7051979879782347
PaTu 8902,9907093,4.385383441203628,4.273930644894848
SW48,136227924,1.7122170056378203,2.9367153870751217
P31/FUJ,4096211,0.7441609883240002,1.0129029982929205
IGROV-1,6610355,3.969940996770339,4.287475353715852
PaTu 8902,4917,3.0649190232675525,3.0459871477749196
IGROV-1,613753,3.483244781428779,3.1423778947211973
SU-DHL-1,3136844,3.883215489826005,4.066860230787344
HEL,446155,2.11086977892158,2.3861212159743195
HuP-T3,46907787,1.2763139172323097,2.3911455229617293
ALL-SIL,2729026,2.163276094007301,2.197142134970227
NCI-H2452,54613361,3.2620625907056744,0.2176965777537703
BICR 22,448949,3.2035793217055124,2.02375407392058
SW948,5280436,1.724516723779293,3.139236900072291
BICR 31,25154868,5.458998944130281,4.451490853986948
LCLC-97TM1,44632017,0.6758650901814578,1.2758357962962645
PaTu 8988t,docetaxel-tanespimycin (2-1 mol-mol),-5.646992799561264,-3.056240837989315
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551,3.7434155636270043
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322,1.8302083488140253
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764,4.924653627408136
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657,0.8674585080541205
SW948,409805,5.995103866916248,4.259814078792015
P31/FUJ,16736978,2.2012912480094444,0.5574689891464357
SK-CO-1,crizotinib-PLX-4032 (2-1 mol-mol),1.4696043946454187,1.8353412029638398
PaTu 8902,19582717,4.67665303596855,4.4246221006458555
SaOS-2,24775005,3.5680490412807555,3.613900277269445
Granta-519,327653,2.833903719231272,2.5215157221212956
ALL-SIL,446155,2.369103686447931,2.2235896361784033
HCC1500,445643,3.796669497386567,3.9369329878276393
COR-L95,7326481,3.0640813007839105,2.760170988089634
Granta-519,selumetinib-navitoclax (8-1 mol-mol),0.4649117531552323,0.2654544818272451
LS180,53232,2.536426383073758,2.9465380262586995
P31/FUJ,10127622,1.4388313131004449,2.8753535969211117
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493,3.36006631952587
WM115,alisertib-navitoclax (2-1 mol-mol),1.935725956121268,0.40997445511837205
SaOS-2,11214940,4.2656495802712735,1.8454659809309764
RKO,637858,2.400395947377078,1.213299217131141
NCI-H2452,3552672,4.527548939486843,2.857340452626287
Daudi,168312962,0.2834059413422853,0.5633955674863949
P31/FUJ,216468,2.1049028903625673,0.6704853982369938
MOLP-8,11656518,1.844531268869525,1.004739069496958
MOLP-8,5426,4.334733303826167,1.9369734707655142
SW48,54454,2.31662951125423,2.475774676636136
K-562,4521392,4.220123235241678,3.87313773883029
SU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),2.801448892460394,2.953328765030418
RKO,1641662,3.3091455873155367,2.8479146035238716
BICR 31,135875424,5.0736941678127945,4.1632243260329105
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959,2.168455067386692
Daudi,44607530,0.9746569917988196,1.0830235475044863
SK-HEP-1,25150857,3.0587845310763297,2.5208128716761133
COR-L105,tanespimycin-gemcitabine (1-1 mol-mol),0.318019061549867,-0.5118673094429074
Granta-519,23635314,-4.977140911540282,-3.098755633161686
LCLC-97TM1,24753719,4.6973214087473405,3.9422318674748476
P31/FUJ,11640390,3.1324724534083277,2.1564033648259815
HCC15,navitoclax-MST-312 (1-1 mol-mol),-0.227842438558318,1.1786358447787566
K-562,6450551,-0.0734681627771844,1.4801023723878666
Daudi,56946209,-7.191237665956405,-4.768188042140171
Panc 02.03,25154868,5.464083731960118,4.517853104164024
P31/FUJ,5311,0.3390662723443479,0.4203320916862061
SaOS-2,11485656,2.155652122560971,2.4606626495742794
IGROV-1,3025944,3.9702787396819503,4.289926796126657
COR-L95,docetaxel-tanespimycin (2-1 mol-mol),-3.340788273550256,-3.613892095787108
PaTu 8988t,11494412,2.1257430484232525,1.7910615761271154
IGROV-1,53495165,1.3981720287668329,0.08994447760918821
LCLC-97TM1,42642645,0.0997949580151915,0.4001198557228539
HCC1500,36314,3.7134374865247017,-0.6039280045083867
NCI-H2452,3815108,3.5712952235347455,3.2300851517701115
WM115,11214940,3.8761690772861126,1.889582515324995
SW48,676352,1.4830170410483523,1.9366642877453828
MOLM-13,25262965,-3.0495150612642465,-1.9657304561620899
ALL-SIL,tanespimycin-gemcitabine (1-1 mol-mol),-4.457360880270642,-2.184308369759861
Panc 02.03,148198,-4.053337817942692,-3.3776265998735755
SW1573,71466380,3.629171273590213,4.7512751506822415
SU-DHL-1,151289,-1.0536473601541108,1.3414016127254087
SK-OV-3,JQ-1-vorinostat (2-1 mol-mol),1.4863340037373012,1.21500055399179
COR-L105,285033,-1.0049053408998423,-1.364463803169253
SU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.738100295775396,-2.2139122236432267
Daudi,135440466,1.490781603812653,1.6029521399959705
NCI-H2452,6918878,3.5446658281374277,3.3904841415335296
PaTu 8902,123631,3.453096327622384,2.1964478956918203
COR-L95,15547703,3.222652754514603,2.9821599829059204
NCI-H1568,123631,1.2596294102093508,2.3622546106830082
P31/FUJ,216345,2.9363986514954203,2.881723917148686
HEL,4261,0.4865008011530605,0.47068087231433714
SK-HEP-1,5280436,-0.1709015599208282,3.7787437632438934
SaOS-2,25062766,1.5016836694759386,1.991742823157311
RERF-LC-MS,51037431,2.0455212647735364,3.1299876502800186
HCC15,11656518,2.9308462534519024,2.1086760638373274
RKO,10127622,3.209405126939437,3.386047528843174
COR-L105,9927531,5.197941564874311,4.9091327447101465
NCI-H2452,6623618,2.534886377212576,2.3902899948451433
SK-HEP-1,16725315,5.326615386804391,4.37216397142111
SW1271,11152667,-1.5987482479879582,-0.43692797007320777
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424,1.2197809125742365
SU-DHL-6,3825829,3.5283611337160155,3.211143128280696
RCC10RGB,11656518,3.9855029209510215,2.103677491272704
SaOS-2,67156097,-1.585481519484996,-1.0387608635334762
BFTC-909,5566,2.8568699448622263,3.061222445171913
SW948,4788,6.033471365822279,5.733189048333437
LCLC-97TM1,1750826,-2.0890062190589544,-1.6168677719632336
MDST8,3689413,-1.6812703512916511,-0.33897655189284154
SW48,9926054,0.5681768331785455,1.7736212852050204
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401,0.005045767100777298
SU-DHL-1,262093,1.7952973078733698,2.7600023720418223
BFTC-909,439501,-2.4866456286351095,-2.1162127699724365
HCC15,123631,2.7523193051058974,2.2113132743530652
P31/FUJ,60750,-3.4241008025920396,-2.995123567192527
Daudi,9927531,3.2507934675389447,3.796069640194952
MOLM-13,5281672,4.456656164404507,4.170030906313553
IGROV-1,11222830,1.5703285223102077,1.5396462893834306
SK-CO-1,5311,2.0479844637297617,1.3678958822830614
COR-L105,15953870,3.0827686267342957,3.65863477761284
PaTu 8988t,9866186,1.4965239773376473,0.9624187074897981
IGROV-1,124202324,2.2563058955522157,2.1628348600216594
PaTu 8988t,9936388,-7.900053622036252,-0.6103455395223313
HCC1500,11152667,3.4439033763408644,-0.06895385778615935
MDST8,54618305,4.422279328619345,3.975059041687299
MOLM-13,3825829,3.189823245525434,3.27170592189353
BICR 22,3081361,1.798482521796042,2.0544790160697493
SW1271,3854666,4.252835819462087,2.011625997170587
HuP-T3,285033,-3.1273004056463916,-1.651575916884549
COR-L105,navitoclax-birinapant (1-1 mol-mol),1.1502985438361142,2.0025555847086256
SK-OV-3,6610216,4.5015440272840275,4.366726617381794
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523,-3.7919396433132215
SU-DHL-1,10090485,4.45721233802345,3.3454704364440357
COR-L105,54765302,4.547071050564395,4.069129337070111
SaOS-2,44491742,4.263847553999534,4.293793833626282
RCC10RGB,BRD-K55473186,4.42890698658841,4.107003200408897
SW1271,2742550,3.530952260660614,4.036657308730743
Daudi,148198,-7.679285276133229,-4.214938227348269
RKN,104842,-2.3241286690000265,-2.832401410250419
SK-CO-1,3689413,1.2567954519757167,0.641122189956709
Panc 02.03,24180719,3.694319415808187,3.4186557829848754
MDST8,637858,1.7716899628344815,2.010327490680929
BICR 22,11404337,-1.5250786338229352,-0.18961042360144303
NCI-H1568,82146,4.486561599154294,3.991395882268062
LCLC-97TM1,52912189,1.3140510236946998,1.858554248554353
BFTC-909,6918328,0.6354681535452512,-0.0607471567271988
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,2.1526901472097055
SW48,10385095,0.7767009249070084,1.2911519709697847
RKO,56649450,4.8662264096692684,2.495669809031754
SW948,45279963,3.8052773477912782,3.0821466932403565
RCC10RGB,3038522,2.595581097335362,2.9812949566529166
BICR 31,3689413,0.760898743899782,-0.0466748631686768
RERF-LC-MS,5282054,4.065617468844444,4.005519329364086
K-562,selumetinib-PLX-4032 (8-1 mol-mol),4.219594820991848,3.530865652357335
K-562,25161177,2.405708421255354,3.5236142016021126
ALL-SIL,11497983,-4.396279985993102,-0.9371848840904435
SW1271,446155,1.3369653200346725,2.5163528534026356
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196,0.4767434497975782
Daudi,10296883,2.545577320776033,2.774136197551619
COR-L105,52912189,0.1952406080619365,2.3910682820616476
RERF-LC-MS,36314,3.6884025033565897,-0.7174067890420257
SU-DHL-1,25062766,2.372674975426994,1.9045449258556857
BICR 22,126941,-2.054722221433598,-2.300277839010774
P31/FUJ,46398810,1.6622931867453647,1.8050580541385455
K-562,15953870,3.5143251027161613,3.0279438415686877
MOLP-8,89183176,2.6780353354925706,3.0376068143826274
MOLM-13,9967941,3.903949930542719,3.120689496099264
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082,2.8638488260451966
SW1271,5291,3.239071539524422,3.8640487509536143
K-562,56963564,-0.0263606087054764,-0.007951142305748074
LCLC-97TM1,54613361,-0.0023609252607709,-0.11210149180071945
Granta-519,24771867,-1.6352261980607803,-1.199057086702098
RERF-LC-MS,5287969,-2.0564845219287555,-1.647857634853965
SW48,alisertib-navitoclax (2-1 mol-mol),-4.705705243079418,-0.0972552612736694
IGROV-1,168312962,3.022863957843741,1.6536811668986993
SaOS-2,6505803,-1.001039194104569,-0.2403007049988801
Panc 02.03,5460769,1.6540560754425335,3.094265569859374
RCC10RGB,vorinostat-navitoclax (4-1 mol-mol),1.2015093799520282,1.4524277760916167
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735,2.833631299107538
Granta-519,crizotinib-PLX-4032 (2-1 mol-mol),0.3086247100875356,0.8488628943571237
HCC15,135440466,1.473766152733558,2.4305550689574535
Panc 02.03,448949,3.46549633046868,2.174327351520796
SW48,119182,-2.1563748503052103,-0.45267515945277237
SK-OV-3,36462,2.5052417836250496,2.036204498729526
LS411N,46199207,3.2917214979820506,3.03996371405868
Daudi,71466380,2.956949879575845,3.74080197658164
RCC10RGB,44566777,1.0790521939265936,0.9459319141328594
P31/FUJ,446155,2.867326521256313,2.1325090651952943
SW948,navitoclax-PLX-4032 (1-1 mol-mol),3.63435849770784,1.7748356071984295
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736,0.7865388175261181
BICR 31,71576739,4.400142576070014,3.5934512159927174
SW1573,6623618,2.3278245092002936,2.473805849239571
ALL-SIL,969516,2.19071597716798,2.1803126066502894
COR-L105,241158,4.618729119434587,4.212920165792697
Daudi,24797083,-0.0937737057199073,1.074074031046928
HEL,5566,2.9283259495001133,2.713199772211798
BICR 22,44137675,4.05989667865121,3.276548399328974
Granta-519,3503,1.8528122642218805,1.620194708524953
WM115,5287969,-2.3112325385791093,-1.771528777921001
NCI-H2452,3062316,-0.5574526988915461,1.173502222922897
PaTu 8988t,12003241,-0.7673639150441187,-0.96538693312416
SK-CO-1,44589607,2.7511810771029213,2.780437041986622
RKN,23939,4.640348748177221,3.9446098191447776
IGROV-1,72734382,4.633226130326536,4.630833827302233
BICR 22,46215462,1.5294433170369757,2.2553688016380913
MOLM-13,2949965,3.7040534246432624,2.217137567592606
HCC1500,46215462,1.5254849350202837,2.0208065638751718
K-562,25183872,-1.1768480549542706,-1.6547084615188838
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037,-0.3704712918746935
IGROV-1,3081361,0.99973562532788,2.337253718044572
NCI-H1568,9908783,4.863315848037401,4.838209627725946
HEL,vorinostat-carboplatin (1-1 mol-mol),1.771793472925216,1.9965604234432064
SW48,25195348,3.355247289110599,3.363574085961348
HCC1500,135411,2.801194317933856,0.8701553224973434
BFTC-909,10410894,3.671861694905457,3.4294475532068454
COR-L105,2708,5.5167338716905885,5.159537785528337
SW1271,9927531,4.558020454092029,4.670645622845662
NCI-H1568,44462760,4.02669785413772,4.212612378058936
COR-L95,11612883,2.9601999054336106,2.351173354174481
KU-19-19,selumetinib-tretinoin (2-1 mol-mol),2.7257099010203047,3.210968450240717
SaOS-2,46199207,3.779046434903352,3.099934957211787
MDST8,15547703,1.8320295844693912,2.9937502646246164
SK-HEP-1,23725625,4.972795252846745,5.22902958866259
HuP-T3,JQ-1-MK-0752 (1-1 mol-mol),1.9324342474715044,1.776101846006737
SaOS-2,doxorubicin-navitoclax (2-1 mol-mol),-1.9339656168793864,-1.2574767978919186
HCC1500,24797083,1.1358144177435396,1.2880414528989679
MOLM-13,11647372,-0.8512376057901615,0.13409584109572342
Daudi,navitoclax-sorafenib (1-1 mol-mol),1.4462190868370148,0.38136140292251164
K-562,5335621,4.97915810125604,4.23953110412766
COR-L95,2858523,3.028185885315027,2.964391010065816
HCC1500,9911463,3.4774936591741703,3.6195405118209423
RKO,452548,0.942587279069954,-1.7349852618532815
MOLP-8,126941,4.086011311839599,-3.055011680354599
P31/FUJ,3384730,-0.5934712638177775,1.2376858139241207
LCLC-97TM1,16725315,3.732120983026874,4.085946772986145
HuP-T3,60700,1.2793809884126126,-0.2873271412394396
SaOS-2,9956119,4.053594307296879,3.731768613275658
HEL,alisertib-navitoclax (2-1 mol-mol),-1.6663288612486489,-1.2421199614798242
SK-CO-1,46199207,2.9466484543003197,3.2240888825720035
SK-OV-3,11175137,3.182781765506491,2.804570448951085
LS180,11222830,1.8684195070218452,1.6060666276798576
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029,2.349613408963105
K-562,23582824,1.4169931108164455,0.5362926921502382
COR-L95,3025986,-1.3264557881304966,-1.1026713869107334
NCI-H2452,16065773,1.9140766169124153,2.3946479813967483
MOLM-13,54454,1.7928295036604598,2.228894661359593
LS180,119607,5.442141379439383,5.1603385957937595
Granta-519,644241,4.377614733152813,0.7720796787808344
IGROV-1,46199207,3.293579955374855,3.2356812673003064
IGROV-1,3038522,3.6829378423722416,3.092157756807584
HuP-T3,135875424,4.261865095251217,4.066310805926496
IGROV-1,89928392,1.4824233552493276,1.4310066296703057
KU-19-19,5280436,3.7375704611092657,3.329637121872852
SW1573,54678924,1.9184875438403524,2.180564035159361
K-562,selumetinib-MK-2206 (8-1 mol-mol),2.367030654184624,1.798257622244145
SK-HEP-1,11364421,3.0648019303900624,-1.0062401738613655
P31/FUJ,11507802,-0.4015560413947272,0.6283675191576559
MDST8,selumetinib-PLX-4032 (8-1 mol-mol),6.148002129111475,2.524429756601502
NCI-H1568,89928392,1.1949851991515912,1.6445295589820799
WM115,11222830,1.2308018153574234,1.5446806633243413
SU-DHL-6,9908783,5.938767725153886,3.8732063126605114
HCC1500,25150857,1.1801270031504156,2.453714690106379
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912,1.3710421731333562
NCI-H1568,4521392,3.7910777113602303,4.1828131435927
COR-L95,25183872,0.0728708482253017,-1.1442756062018784
IGROV-1,227681,3.5439813498262347,3.4424002319720803
PaTu 8902,6918878,3.691618711508776,3.155754071412945
K-562,1242560,3.4884556471232293,2.84139442442243
BICR 31,53495165,2.344314514368125,0.3998184150738395
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874,2.6571226037689377
BICR 22,17755052,1.4011116930942769,1.3124605819134376
Daudi,17755052,0.1512024273398794,0.41565913352418626
HEL,67156097,-1.6398778776875675,-2.3786290026251518
BICR 31,44486219,4.3544536670303025,4.328711631262991
SU-DHL-1,119182,-1.9070320733957784,-0.3774694698454415
WM115,135440466,3.0586385090162085,2.445375371684081
IGROV-1,11152667,-1.4116509977729443,-0.47513339005627614
BICR 31,10385095,1.3759128494100044,1.512010481387836
RKO,969516,2.537841036798478,2.1652774826281753
Granta-519,123631,2.886011281362197,2.1592120285388536
HEL,4477,0.140225607998234,0.36928368111956883
HCC15,568763,0.562622735167329,0.4533328313699458
HCC1500,9926054,1.7367797854287812,2.005372955262795
HCC15,vorinostat-navitoclax (4-1 mol-mol),-0.4329287763165494,1.4693803827745668
SW948,444795,4.960330673315111,3.562282017760703
SW948,119607,5.410714093672246,4.543034760339242
RERF-LC-MS,9936388,-8.273067767637817,-0.28587141950831524
SW1271,alisertib-navitoclax (2-1 mol-mol),1.9083065334137317,0.16829183032678924
KU-19-19,4261,0.7367611445661113,1.8112825103762802
SU-DHL-6,387447,-5.553627026103078,-4.9701867127295
SK-HEP-1,3825829,4.395950359013269,4.204834605607599
COR-L95,9903786,3.7357721387912513,2.4114892879223673
SK-HEP-1,44185566,3.236949395761265,2.7000389812203713
COR-L95,73707398,1.0347493154641954,0.8158606081781159
SW1271,66577038,2.7134536861777807,3.1960245001430474
RERF-LC-MS,36462,1.1230283698314445,2.170953025867182
LS180,5278396,3.460947025625347,3.3336197915813623
Daudi,3062316,-6.775500959037878,0.49207180819323293
K-562,107970,1.9304513771469212,2.12272731124948
HCC1500,3854666,1.4433352503078565,2.342078221112575
LCLC-97TM1,JQ-1-navitoclax (2-1 mol-mol),0.3092105032557149,0.9991683981713578
HCC1500,11455910,0.2448151005088887,1.3285660672016584
MOLP-8,46907787,-2.434163875600539,-0.9052966419692168
LS180,crizotinib-PLX-4032 (2-1 mol-mol),2.1034358212812867,1.8175019982302814
RERF-LC-MS,53392493,1.949934555719578,2.8282161268632513
MDST8,6610216,4.3863838734153,4.190018428237948
COR-L105,navitoclax-MST-312 (1-1 mol-mol),1.0518954464197996,1.1589975325047612
LS411N,216345,4.369072592416217,3.0553863487797246
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352,0.3034264784486826
SW48,2841722,4.762546821441249,4.485690233104635
SW48,9956119,3.393025538441131,3.415543209500975
PaTu 8988t,44607531,1.764787957031886,1.5321292823635175
HCC15,16741245,4.574628343563009,3.8928662207786173
SW948,89928392,1.4444572178844948,1.002765487603608
SK-OV-3,25126798,3.9960730178767,3.8854532210837562
RKN,54143018,1.3184566027416504,0.5631131591786509
NCI-H2452,24180719,2.8480667171601852,3.8149805353031057
COR-L95,9915743,0.942320604231091,0.5252395438680841
LCLC-97TM1,decitabine-navitoclax (2-1 mol-mol),2.9245922441873717,2.227599071335712
LS411N,selumetinib-PLX-4032 (8-1 mol-mol),1.7092095935664802,2.8895908579651235
ALL-SIL,387447,-4.904935645240703,-5.041817501538271
SW1271,54649381,4.56488530045006,3.8085726603327625
KU-19-19,4259181,2.3072251676522835,0.5433412142117557
SW948,25105715,3.628389782970242,3.2049615087089505
SK-CO-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.470227169685732,-0.5999850145976385
LS180,19582717,2.9052461851112565,4.202101952370078
Daudi,676352,1.3635905677607614,1.7209197709018753
SW948,SNX-2112-bortezomib (250-1 mol-mol),-2.424265268462928,-1.330803996805095
ML-1 [Human thyroid carcinoma],375860,0.003862862725961,-0.005811551934794402
SW48,9915743,2.691515978939234,0.8124849835002089
MDST8,BRD-A02303741-navitoclax (2-1 mol-mol),1.0671280155352338,2.263048585053788
P31/FUJ,navitoclax-piperlongumine (1-1 mol-mol),-0.4738069202441977,-0.20511580941837618
SK-CO-1,navitoclax-piperlongumine (1-1 mol-mol),0.7177098692298883,1.2276831774956358
Granta-519,3025944,4.149663954634143,3.689846415906174
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125,4.482930660021559
SW1271,2841722,4.036476035404804,4.3091573660689075
SW948,53232,2.3961531254319466,3.1370864313634375
SK-CO-1,25183872,-2.2315902989777725,-0.4354089804983074
KU-19-19,vorinostat-navitoclax (4-1 mol-mol),1.414230786423441,1.2277412045093339
SK-CO-1,selumetinib-MK-2206 (8-1 mol-mol),-0.5781899978856783,1.9317641661759588
P31/FUJ,6918328,-1.424420935100909,-1.7743833274192409
HuP-T3,71680916,4.329506074723249,4.766081730541997
P31/FUJ,262093,1.035147161622815,1.7501484605470963
SaOS-2,11228183,2.7080984165628754,2.4634411957159355
NCI-H1568,6852167,2.376266672184036,3.054694313090102
RKO,4477,1.7070595719756474,0.4454903584782348
Granta-519,46199207,2.493616790778817,2.6701439824354805
IGROV-1,5470400,-0.2457809435208252,-0.14900179441584188
IGROV-1,409805,5.990596261907717,4.658136259646809
PaTu 8902,15983966,2.4191743534269463,-0.9714526469292517
RERF-LC-MS,31703,0.0184985959907658,-0.776930229395154
NCI-H2452,SNX-2112-bortezomib (250-1 mol-mol),-1.5822620251622193,-1.3482686561263568
P31/FUJ,46224516,2.421293495972869,2.350183843635882
BFTC-909,10127622,5.216996592058982,4.036254484824867
HuP-T3,55508,4.397520768584908,3.5444986647264938
HuP-T3,10385095,0.7178899916931367,1.3693314329882385
RKO,16013152,4.038378204585466,3.024690158880225
RCC10RGB,6918328,1.0053978601828475,0.5594297938801577
SW948,9444,4.221430823371368,4.015717931161338
WM115,53392493,1.845382538513501,2.744180778824948
HCC15,44185566,3.08334642122707,2.566941509672587
LS180,JQ-1-navitoclax (2-1 mol-mol),0.8160001924760493,0.8514429422754607
UACC-812,25262965,-4.249514707304517,-0.9148178115205238
WM115,51037431,2.6247692404465868,3.345349273550159
SW948,5311281,0.0185560472432188,2.53264299761561
HCC15,44607531,1.6724658843452191,1.690274150273544
MOLP-8,6450551,1.973885798572914,1.6235437948645741
MOLP-8,7251185,0.7855879803762651,1.6065581776556426
SaOS-2,5479543,4.655800274360292,3.6081362555469387
IGROV-1,4917,2.985904350427039,3.224999838761337
Daudi,3825829,3.2006002080342544,3.0232047229641115
UACC-812,148198,-2.7739066615342236,-3.667579750124471
Granta-519,1242560,3.55554960326222,2.8392342943698
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207,-0.2164159644752872
HEL,17759555,4.966386069896687,3.0975191341456862
SW1271,119607,6.141140067390372,5.108154035996039
Daudi,3038522,1.648170780235362,2.5224390230138294
PaTu 8988t,969516,4.442820223092304,3.0140718715458923
HuP-T3,4521392,4.351966444408677,4.321483167726717
BFTC-909,2113511,5.65564772398506,5.547787550401023
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731,3.1169096542881904
SW1271,24856436,1.0602186643720275,0.7910000182810734
HEL,24180125,3.3188099636510495,2.1759537784795273
WM115,10077130,4.784184630126653,2.9295224749402315
SK-HEP-1,5281321,-2.075735756673856,-1.0742428905000727
UACC-812,10184653,-4.111635019949291,0.7469724552331981
BICR 31,55283,4.60336009153674,2.9524233592474127
MOLM-13,11178236,-3.317575610691226,-3.651150918282086
COR-L105,57519531,4.553300256365288,2.8729247390080657
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723,3.222947804396093
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997,1.1414890020770114
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587,3.3569619951636334
ALL-SIL,11317348,-1.373590167325895,1.100034659565806
LS411N,6914657,-4.299110458286086,-3.9152646592729328
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476,-1.0443802668274071
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324,2.997175715636703
LS180,57519531,1.9809210286085912,2.3295376390747746
LCLC-97TM1,60750,-0.9490237417659374,-2.136681813894017
SU-DHL-1,49850262,3.2383746822480384,3.72267659745742
SK-OV-3,9911830,2.8997016876614863,2.5939599875919974
PaTu 8988t,alisertib-navitoclax (2-1 mol-mol),4.265397677389301,0.6189916175163895
RERF-LC-MS,15983966,-4.090154567310139,-0.6989597339752099
SK-HEP-1,selumetinib-MK-2206 (8-1 mol-mol),4.11054762578972,2.6012689783219334
RERF-LC-MS,24951314,1.4075693116182684,1.7464800259445965
SK-HEP-1,11494412,3.332434654266433,2.046454423083179
BICR 31,51039095,3.0794813668201546,2.9255548441559847
Panc 02.03,11178236,-2.8028080099743624,-3.1730253347906414
SU-DHL-1,24772860,-2.736237819232434,-1.9724057009604699
Daudi,6610216,3.2134188501838494,3.927007759486956
NCI-H2452,53392493,2.782389188766079,2.8225850046594143
NCI-H1568,445091,4.097432324473231,4.519435946535464
K-562,9926054,1.8612748023096723,1.831567158629169
HCC1500,24978538,-1.6021545775061432,0.5911370698025786
COR-L95,25126798,4.203058281978897,3.598466057700229
LS180,44819697,-0.9723932292423276,-0.17614980938794134
BICR 22,5281321,-1.7077192732848236,-0.7278350994611167
PaTu 8902,656346,4.145274855759625,1.0233854369028665
BFTC-909,42642645,1.561027146692027,1.0423441223284848
IGROV-1,49836020,5.658436828096057,2.4974169209720105
Daudi,168313200,1.4988300519601074,2.5752861588109455
MOLM-13,24779724,4.7751629548446894,2.8227275762873902
IA-LM,docetaxel-tanespimycin (2-1 mol-mol),3.5360773084497494,-3.031952902633875
K-562,doxorubicin-navitoclax (2-1 mol-mol),-1.4702798280033291,-1.7628083376676345
RKN,2828334,5.965623907482328,6.1045882163288745
NCI-H2452,5280436,4.838161671645799,3.542036263263887
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263,1.9956001384400446
BICR 22,637858,2.779101364791116,2.070637648153337
RERF-LC-MS,56963564,0.3267097404636779,0.6761650643862613
RCC10RGB,2949965,2.9970768068045577,2.871594483667353
WM115,10074640,2.7921613557017473,3.1062846170953806
KU-19-19,25154868,3.204596310046931,4.509127464896087
BICR 22,49793307,-5.020228152199773,-2.3371432079566032
SU-DHL-1,5460769,-0.475427190707336,2.304385135721213
NCI-H2452,9868037,3.199558399493599,3.5404752790730503
SaOS-2,9823820,4.1201217228566565,4.184936143820121
SU-DHL-1,9444,2.825333870881758,3.8190211014679187
HCC1500,53495165,1.6495193303321407,0.7301963129961813
RCC10RGB,9952709,4.37754893062567,3.279305969376783
Granta-519,73707398,-0.348610297970246,0.48484455815990146
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276,1.373816725150456
MOLM-13,26596,-2.2068545341754295,-2.4399551879891117
K-562,52912189,0.5484446218637569,0.43438614756672517
MOLP-8,doxorubicin-navitoclax (2-1 mol-mol),-3.5664947897809207,-1.7650827913437956
IGROV-1,375860,0.7731558163124775,-0.027256983078158433
IA-LM,11964036,4.998383188027045,0.8798695844319058
MDST8,387447,-2.914953377887094,-3.634403913213636
IA-LM,9915743,1.455667571666015,1.430697973703569
LS180,6918328,-0.1069758097146191,0.13957195504710287
PaTu 8988t,6610216,5.064895456595333,4.326928271940672
SU-DHL-1,104842,-6.410970225096146,-3.7680694254580995
P31/FUJ,56946209,-4.67609529352027,-4.602596357145641
SW948,6917907,-5.884345700630281,-4.9099470472913875
BICR 22,53232,4.030024483575548,2.5361343577667457
PaTu 8902,568763,1.8312011651342244,0.7129409744474842
ALL-SIL,6505803,0.7073572306495796,-0.7884625151150635
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607,2.2055825756839385
LS411N,10302451,4.220534629483678,2.2556374383783626
RKN,11238147,3.9265768628415487,2.6758297652815206
PaTu 8902,135440466,3.176809791892748,2.413868548985201
MOLM-13,119607,3.836878131829583,4.3856021403098655
HEL,11612883,1.9962168488272864,1.8136107716299923
COR-L95,11485656,1.8696119642586884,1.8684985938194745
MDST8,675434,4.4652962141660595,4.5111134476325985
IGROV-1,11507802,1.5049911819213722,1.7418438868568082
SK-HEP-1,2708,5.260013220141412,5.02222137244245
LCLC-97TM1,BRD-K27188169-navitoclax (2-1 mol-mol),5.367919613117806,2.212289826740535
SU-DHL-1,5738263,2.757121948334044,3.1168554176631362
Granta-519,54626689,4.523537450364534,3.887417399139455
SW948,135421197,1.7477185084776832,1.5519078171635565
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054,0.6106189038262194
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561,-0.16633819976811806
BICR 22,4917,3.6655313291566327,2.99968957908147
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246,3.4746491072457353
MOLP-8,16736978,0.6033273838828506,1.1313567258683155
SW948,11396600,3.556168564723583,2.9611087174299233
IGROV-1,2113511,5.982902824257526,5.636842023568634
Panc 02.03,16725315,5.289216895099664,4.5180169021715635
K-562,9549297,1.810271401171294,1.575354181171066
SU-DHL-1,60700,-3.861884777487788,-0.9384147944329975
MDST8,89183176,5.515733421140453,4.20745082315236
PaTu 8988t,selumetinib-decitabine (4-1 mol-mol),5.718429611668687,3.884047013219925
WM115,10113978,3.3670712397266698,3.285216332413465
SW48,25154868,5.084018259884556,4.275063732737658
Granta-519,107985,-5.079154139769343,-3.7171974418100917
IA-LM,15953870,4.160803294534019,3.4134005244890293
RKO,19582717,4.345992572306107,2.9167134580905407
WM115,selumetinib-decitabine (4-1 mol-mol),-1.8184529973078083,3.0104008282218917
ALL-SIL,2742550,3.1857763586562577,3.2418477792912204
COR-L95,375860,0.21091681928276,-0.28890791844878727
Daudi,JQ-1-MK-0752 (1-1 mol-mol),-0.2875395851345496,0.1623148215008623
COR-L95,702558,5.203109308170341,4.389365537568519
ALL-SIL,5329102,0.5818325089631969,1.2764391432979025
MDST8,9911463,4.372295154952754,3.7285612090253037
LS411N,44607531,1.9881484499388475,1.186167158316912
Daudi,68056272,2.8001037652797818,2.9483703391335028
MOLP-8,4521392,3.737637773211522,4.003465856970714
MDST8,20959075,-2.855250986095604,-2.5148358077268744
IA-LM,400769,-0.2498086542393983,-0.619030224752413
IA-LM,16722836,2.5380745713557893,1.2542011250080027
HCC15,445091,5.451686926059382,4.285527110986788
HCC15,11507802,1.1916077520331714,1.886587575348652
MOLM-13,9903786,0.7109980532390177,2.143304695500765
SW948,24901704,3.213341299668661,2.575408380124514
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883,2.8055484363441594
SU-DHL-1,10427712,3.576020229714379,4.191362815179414
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204,-3.234258055114802
SK-CO-1,piperlongumine-MST-312 (1-1 mol-mol),2.091052840490691,2.092584422827259
Granta-519,51039095,1.7779321154646133,2.0332269435935055
RERF-LC-MS,65628,5.693639897620667,4.4792633392387815
SaOS-2,2828334,6.074749772556143,6.105004673554724
SW48,3815108,2.5063295630391806,2.7641935997990976
SK-CO-1,11626560,0.3943389380121196,1.7742179199062025
HEL,107985,-3.965696416470184,-4.140622793132727
KU-19-19,60700,0.8700483452505813,-0.20594226052370973
Daudi,5280436,1.0789231424034973,2.2381654559767794
MOLP-8,54613361,-0.8734170036218252,-0.3949110563499154
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844,-1.8422464554748337
SK-CO-1,24978538,-0.5683899539074425,1.4307203996980062
SU-DHL-1,54649381,3.644517842316546,3.4007944318206755
SU-DHL-1,44493528,3.922242735424854,4.204609718012886
P31/FUJ,5282054,2.945149434876345,2.5856014408073538
SK-OV-3,49850262,4.3958011115665006,3.6480219007932613
IA-LM,10184653,0.8510906912410041,1.2805613374390388
NCI-H1568,36314,4.092621701538515,-2.1067198313698174
BICR 22,46843906,2.889476079217857,3.413237558753786
SU-DHL-6,9444,3.111459322097769,3.518759528327874
ALL-SIL,10410894,2.969142576372873,2.6524343868353135
ALL-SIL,9549297,0.2429486516660708,1.4664007639957517
Daudi,46926350,-6.041265180126537,-4.51821434499815
RKO,1750826,1.760307875609834,-2.635205773302522
PaTu 8988t,4477,0.4312443696129938,0.771235296828658
Granta-519,5282054,2.5814189459390957,2.5274056444707202
SaOS-2,carboplatin-UNC0638 (2-1 mol-mol),3.570952437368873,3.28004539139742
IA-LM,16065773,2.795317455347302,2.1456338161551027
RCC10RGB,156422,4.423389512885201,4.097317864163311
IGROV-1,11214940,1.360660548899077,2.271828951228982
Panc 02.03,16720766,4.473005389666903,0.925799144009305
Granta-519,3081361,1.7559432073327723,1.6629096701654036
MOLP-8,52947716,-7.872176911001468,-2.1847093737494028
KU-19-19,5281321,2.871465791170073,-0.7185046664724402
IGROV-1,5282054,3.614574021382022,3.687556865905678
MDST8,4261,1.8348924416255383,1.7988144598124374
MOLP-8,100016,7.090961588333011,5.025011146080476
Granta-519,168313200,2.290121636997186,2.585876257604944
HCC1500,462382,0.0787876699821948,1.198070203384217
IGROV-1,10113978,2.874171865860951,3.0392499285631622
IGROV-1,BRD-K55473186,4.387806234483854,3.848113223987608
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042,3.8047411376205207
P31/FUJ,10410894,5.368264014178215,2.609130839584172
BFTC-909,3025986,-2.0399601309440336,-0.5837295176372361
MOLP-8,24771867,-5.187641849515016,-0.996117313359133
BICR 31,11214940,4.966543096658616,2.24157372741302
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617,1.5025176583906843
UACC-812,9936388,-5.022392750910281,-0.6036009361048722
ALL-SIL,24772860,-3.38763553354356,-3.2893932897521547
MOLP-8,11626560,-0.689912231097504,0.7261176781512839
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015,1.3612526543165766
BICR 22,navitoclax-PLX-4032 (1-1 mol-mol),4.097608134933257,1.5326697369157296
SW948,262093,3.1804911198162036,2.4484149942813542
SW948,216239,1.8650010893863176,2.189093911494168
SW948,11364421,-5.809742751249139,-2.965163394899869
HEL,10302451,3.814274659252608,2.2237194901596133
K-562,46398810,1.812730009869126,1.6991082138669866
Daudi,216239,1.5780166370194677,1.8944422538163521
LS411N,10231331,0.2083934704449227,0.6937249979702836
MOLP-8,46926350,-5.986975596425451,-4.764197934108265
SK-HEP-1,11964036,3.325100881793091,1.728347351698342
Granta-519,11485656,1.6660529916447626,1.5361248933596112
K-562,2871966,0.96376622724181,-0.13932411423516605
P31/FUJ,54454,2.7341923640247123,2.3079229499805454
SW48,54613361,-1.8010952783890095,0.10094620738480613
NCI-H2452,46843906,4.012061875028764,3.2816192298846754
HEL,135875424,2.9448279330391927,3.2363337437294843
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005,4.25250231594041
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322,2.1447337741875416
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616,3.0011055889170977
P31/FUJ,decitabine-navitoclax (2-1 mol-mol),-1.2834649241305407,-1.167264109709915
HCC1500,54678924,1.846277418486191,2.2694839708466
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971,0.7746043734927431
MOLP-8,9927531,5.438833274000949,3.9227631325091243
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403,2.5100649700028965
HCC15,9952709,3.084010703088348,3.3063133561439595
K-562,3503,1.244026999465694,2.141802515503264
SaOS-2,3689413,0.0712794264513353,-0.3752606113628347
MDST8,10427712,3.921886084986449,4.3402856091168145
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126,2.9394047898426066
SU-DHL-1,1716436,3.093009546519781,2.903888604327597
PaTu 8902,25105715,3.5553172149604375,3.3556455281805864
HuP-T3,24771867,4.228511460696379,2.8365106136483975
RKN,31703,-0.7196573309741882,-0.8811418687214766
MDST8,60700,1.1908209554887386,-0.19748184871249144
SW948,carboplatin-UNC0638 (2-1 mol-mol),3.7515115045005913,3.328255501652232
HEL,54454,2.1583735480761437,2.4189360121167685
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301,1.7712352593645844
BICR 31,alisertib-navitoclax (2-1 mol-mol),3.3923193563221257,1.0416688794383544
SU-DHL-1,135875424,2.8587183873170847,3.7520803096635778
SU-DHL-1,36462,-1.6063137198477124,0.7658940238627254
MOLM-13,73707386,2.881964792667641,2.451847414957345
P31/FUJ,3854666,0.6136756098719494,0.6363245759343957
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029,0.28758795772804197
MOLM-13,159324,-0.2587959593058327,1.264876561396391
SW948,19582717,2.742329976582949,3.2819022446180086
SK-CO-1,444795,5.109688629113172,4.742137522507036
Daudi,400769,-1.3686052359334673,-1.4524791164796058
SK-HEP-1,10296883,4.4971190241998835,4.0135405098067345
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688,-1.351168847836562
LS180,17759555,2.746757712453425,3.222011954816214
MOLM-13,156414,-0.1970532812518614,0.5885474856559337
ALL-SIL,72376,-2.2514410459425043,-3.7885299214259924
BICR 31,selumetinib-MK-2206 (8-1 mol-mol),1.335551689205146,2.2809873873058204
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683,-0.7998001601745122
HCC1500,51039095,2.9997605815390935,2.7844043707050417
WM115,44185566,3.0030021210520794,2.666126627253492
COR-L105,4705,0.5312031062005766,3.223175919090283
Granta-519,8515,3.731909716775835,3.1873267897943687
ALL-SIL,11234052,3.5011978223530926,3.040214566399973
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636,-0.3315995949347279
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626,1.3565993184216456
Granta-519,613753,3.0344429390603493,2.767115909066803
HuP-T3,5329102,2.4996480668272527,1.9320712511245615
SU-DHL-1,2828334,5.462697908299577,6.066308669422569
SK-OV-3,51039095,2.3576173335626147,2.965363164651535
UACC-812,5470400,-2.2578344499942418,-0.44587644920419217
HCC15,9935249,4.091947122155354,3.1554818763114376
UACC-812,JQ-1-vorinostat (2-1 mol-mol),-0.5213031534169104,0.9065544074761782
SW1271,322968,3.7653444240208263,3.7035461703422516
COR-L105,54678924,1.4327429630461548,2.4152035772950917
Panc 02.03,31703,0.91391851070637,-0.7024530106926923
NCI-H1568,5329102,1.5348278867114138,2.165207487423386
Granta-519,9887053,0.035640336798207,2.2099189129746715
IA-LM,6610216,4.173583896241699,3.922761983066029
NCI-H1568,119182,-0.8732650634834633,-0.6068214885700911
IGROV-1,159324,2.8766947154825044,2.9720913651531258
NCI-H1568,5566,2.911706555521376,2.977377512463001
Granta-519,ISOX-bortezomib (250-1 mol-mol),-0.0076351128807997,-0.21474139082001728
NCI-H2452,10385095,2.425738192808243,1.2549788751454676
HuP-T3,16065773,2.155269900494742,2.573699081933336
SW948,448949,1.5714288146717783,1.6674444454079207
NCI-H2452,107985,-2.625758680845612,-3.3429493124479843
RCC10RGB,1750826,-3.277944046627699,-1.9948786266152703
Granta-519,16736978,1.0160166250823044,0.7033891595827945
HEL,104842,-4.135712202151618,-3.786143162899469
MOLP-8,71466445,1.892906464336944,2.5228379263650527
MDST8,262093,2.389063867163299,2.4954593114035957
COR-L95,4259181,0.8580425806970188,-0.09127433310201416
Daudi,45279963,2.6753649589319854,2.763963968177103
IGROV-1,656346,1.6285470744333117,1.197888545417862
SK-HEP-1,10427712,4.527720982072863,4.479510010922071
SaOS-2,11647372,0.6261520317366223,1.4119209708475637
COR-L105,53495165,0.9627099148057476,0.6908123405648601
Granta-519,11404337,-2.8078628280004048,-1.1815890414111343
SW1573,25154868,3.281093993360062,4.518979710049486
RCC10RGB,crizotinib-PLX-4032 (2-1 mol-mol),2.89623675646366,2.033889451616831
BICR 31,3503,3.4488620791118993,2.537585947377018
SK-CO-1,3062316,0.5910144260309655,1.526714591208878
RKN,6917907,-6.438038185084336,-4.83587314638013
LS411N,23635314,4.011909681168236,-1.855650138660067
WM115,11234052,4.1182935305671435,4.23806407839863
Granta-519,tanespimycin-gemcitabine (1-1 mol-mol),-7.490554088908799,-2.3197274755366313
SW948,JQ-1-navitoclax (2-1 mol-mol),0.5901277786092829,0.47881596688543016
RERF-LC-MS,11485656,1.5190166417661397,2.5128821659421168
PaTu 8988t,46224516,2.924922546378164,2.6004238990310897
Granta-519,JQ-1-vorinostat (2-1 mol-mol),0.0738956362017292,-0.462000176028333
SK-CO-1,5287620,-2.837552470898679,-2.041179754468316
PaTu 8988t,24772860,-1.5593380796956875,-1.8476277361484172
PaTu 8988t,6184667,3.5063575702163345,3.139639901497757
BICR 22,36462,0.4717839486114671,2.300995201910257
RKN,16722836,2.340122812915413,1.6447164602117887
Panc 02.03,54618164,4.482290203520866,4.133356726440111
BFTC-909,2841722,4.3094465275997536,4.313001363732193
COR-L105,2746,3.1035280268076217,3.522787774595877
IGROV-1,9929138,6.483056540257463,5.280534831654023
HCC1500,2708,5.151987441269929,5.06783490648949
MOLM-13,11238147,1.4582306649534449,1.964334731177527
RERF-LC-MS,11364421,-3.8493036468537265,-1.3616090811971893
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015,6.449744294026147
RERF-LC-MS,16736978,2.30801467798398,1.9242525932202499
LS180,44241473,4.435457667187811,4.806997373161335
SW48,16722836,0.2197322523934369,1.5629003921249986
NCI-H2452,9444,3.5242093703527697,4.351772701063866
SU-DHL-1,5284616,2.4488241799592143,0.4370838792725636
K-562,54454,3.689215856042272,2.5431325086353325
HEL,2945648,2.719646445320408,2.2259383361444334
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996,1.7029513666188647
HuP-T3,9936388,0.6940852338085793,-0.49257302433163264
LCLC-97TM1,10427712,4.124790087544491,4.095914025655287
SK-CO-1,navitoclax-sorafenib (1-1 mol-mol),1.5561836215711824,1.6881360556173595
SW1271,135398738,5.657599080768866,4.074052908033266
RKN,216468,4.351451769225332,3.120569615657942
SW1271,46224516,1.263100640010589,2.7064334467248763
SK-OV-3,60750,-4.210978436614257,-1.6503879120287481
SU-DHL-1,11455910,0.1271925880707346,1.303236272977964
Granta-519,25161177,3.429453868131532,3.4378401385980037
PaTu 8902,SNX-2112-bortezomib (250-1 mol-mol),1.6303309640570394,-1.3419342870377193
COR-L105,erlotinib-PLX-4032 (2-1 mol-mol),-0.0740461614956173,2.9508333609991837
UACC-812,16065773,1.9582746458630844,2.0308162761420108
MOLP-8,2858523,3.112163707938977,2.927537504772838
ML-1 [Human thyroid carcinoma],6252,2.036085666454029,1.0235418655886253
IGROV-1,6505803,-0.2382223795960626,-0.7995475613560213
HEL,24772860,-2.0205510075596425,-3.020090676618497
HCC15,4917,3.2753021602409267,3.1384481618319184
HEL,ISOX-bortezomib (250-1 mol-mol),0.0125517502363375,0.08367647388571883
P31/FUJ,6184667,2.9500590386465393,2.1540240087527938
MOLP-8,46843906,0.174682801852784,1.5113393698380104
NCI-H2452,54618305,4.302077073898344,4.638428541859198
BICR 22,8515,4.348804794701894,3.7686846392916715
COR-L105,24821094,-1.121187296223131,3.04459524701177
HCC1500,4788,5.676843976237076,5.459875183946171
SK-HEP-1,2746,4.04921422913523,3.5606873856872157
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791,-0.5699516600049577
COR-L95,46199207,3.11604668311128,2.9637915567999875
MOLM-13,1641662,2.418131669664625,2.747873768362015
WM115,135984461,4.094268409164816,3.9297454891375967
LS411N,10127622,0.4126946340819594,3.185538179018776
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333,4.213165002199154
ALL-SIL,11364421,-5.245070547120315,-4.656764246357042
NCI-H1568,44607531,1.2688225542701184,1.332795327460262
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317,-0.7668864548404167
SW948,104842,-0.6555530305877334,-2.5657521346805354
SK-CO-1,46907787,4.316773762169295,2.034237481898008
HuP-T3,104842,-2.1883971380944054,-2.8013914044186072
IGROV-1,11178236,-2.8618715106425725,-3.294324520879388
HCC1500,71751553,4.671922723370954,4.475754775767757
SW1271,54618771,-0.1319273231055389,1.5815372315567664
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816,3.225859820720593
IGROV-1,654092,-1.340387623873854,-0.005734850945298391
HCC1500,44819697,2.691999336982048,0.025153470998082773
HEL,44137675,4.224171499328968,2.9650814276768807
MOLM-13,tanespimycin-gemcitabine (1-1 mol-mol),-4.499081483016427,-1.979064295936436
COR-L95,5328940,2.113977806947162,1.6820405734223243
SK-OV-3,3825829,4.139200001280225,4.073939599543984
Panc 02.03,216468,3.8655539989600176,3.4484065344684574
SW948,25195348,3.534636067330416,3.5015707093102013
MOLM-13,9444,3.2439366633039426,3.5516497937733424
NCI-H1568,24821094,1.7576462865100984,3.0863218937007035
MOLP-8,1566236,0.7132031003128095,1.884112182278057
HuP-T3,11455910,1.0919804440303738,1.2243476607128303
MDST8,44185566,3.0590843033834116,2.705981425446907
NCI-H2452,216345,4.1608899350266615,4.330000348385717
SaOS-2,23635314,-2.530968731721941,-2.0267781824702973
MOLP-8,selumetinib-MK-2206 (8-1 mol-mol),0.6863734484808788,1.4287145611244907
LS180,168312962,-1.039638615515642,1.4945474534366971
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906,1.9702001759294612
BICR 22,322968,4.6496227244818416,3.757377698069492
NCI-H1568,vorinostat-carboplatin (1-1 mol-mol),1.5719417416558872,3.200153147304542
RKO,6918837,-1.4612228483082623,-3.3592579192457994
MDST8,selumetinib-navitoclax (8-1 mol-mol),0.5901837965573531,1.535531230230093
SW48,613753,3.5910736246612323,2.981931561238506
IGROV-1,44507138,2.359177395411688,2.5845051771022396
WM115,52947716,-6.8465929822900815,0.7075851580226431
RKN,73707398,1.136221501718042,1.3670435340522586
HCC1500,4477,0.2789780560390432,0.6276687460225147
Granta-519,11719255,2.4006867045586953,2.256117236784589
HCC1500,6918736,0.2919336581768246,-0.9278559838758355
IGROV-1,4477,1.1767656777594142,0.5740973329488179
IA-LM,11609586,4.073174168632335,1.8971561380341497
NCI-H2452,11404337,-0.3859535574072682,-0.016919685888266155
Daudi,136227924,1.3476403322374937,2.3684573599776098
SK-OV-3,387447,-3.0618968905277164,-4.0211818694976875
MOLM-13,3854666,0.5101644656521153,0.791860748829817
RKN,46843906,3.906010302389018,2.8244842642110437
ALL-SIL,1641662,2.105441320822025,2.551506388056689
MOLP-8,46199207,3.622115707782432,2.681135976439233
HEL,17755052,2.5427584711612554,0.9448668749155648
MOLP-8,9915743,0.5160575940701332,0.09917854256212685
NCI-H2452,135398516,0.2354885350790482,2.2408167542678594
NCI-H2452,JQ-1-vorinostat (2-1 mol-mol),1.361868366541758,1.405778308298111
SW1573,9911463,3.734935340044018,3.959472273405408
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421,1.3130537945112655
IGROV-1,23725625,5.712368491237602,4.9174610170418
IGROV-1,54143018,0.8385018685685798,0.9305437908012698
WM115,135875424,2.968517855352779,3.882041795124779
SW948,16659841,2.968981271202921,2.6932493818995926
SW48,25183872,-1.521332471338628,-0.8277914696652761
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236,0.5702029653119488
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323,1.7300759969801252
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363,1.7295955447525184
WM115,5284616,2.9108529677003565,2.4402764917181687
SW948,4705,1.720002028261835,2.9410534037270706
HCC1500,71680916,4.362866442203444,4.681890049975771
PaTu 8902,17755052,3.1533076581920936,1.4226835382183562
COR-L95,11427553,2.745819698220539,2.0974672056915624
MOLP-8,11707110,-0.9708482925672104,1.0109105772140994
HCC15,5351362,1.1207822529279785,1.6624002410802645
SaOS-2,11234052,4.364959006359101,4.097468555822473
SK-OV-3,6918837,-1.7709381590236568,-2.3737494265576817
RKN,10113978,4.430129932581481,3.2533678360532963
Panc 02.03,5566,2.8367562997211815,3.0498836195760783
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.9739085260517184
Granta-519,4096211,0.4087245803445845,1.0152935947975272
SK-HEP-1,72193861,3.0367238048594603,2.160962311002085
SW948,9933475,1.7222383900333498,1.862943607657651
SW48,9936388,-6.68623848822316,-2.012554096433484
NCI-H1568,11222830,1.5738139714037271,1.5307158012927815
IGROV-1,24856436,0.4840146383282276,0.6141350144842619
SW1271,25105715,2.9104912505007143,3.3097882303605375
IA-LM,11238147,3.064975348903814,2.4035472346796514
PaTu 8988t,23635314,0.3317794086663004,-1.5252364412915238
Granta-519,3136844,3.153984140395424,3.591672086343466
COR-L105,24951314,2.139685821030411,1.4849671603817667
IGROV-1,135398744,6.402844237905131,6.379096425809272
LCLC-97TM1,156414,1.5907536031970133,1.1936003921166198
BICR 22,46926350,-6.042960620867506,-3.781452523414757
Granta-519,387447,-5.4996124066637435,-4.915757735189238
BFTC-909,51039095,2.7594177275421403,2.6977673061209217
Panc 02.03,5746,2.615751109567445,1.3804500360310954
SW948,71466380,3.8629020707603914,4.210078947428546
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815,-0.41144496896363286
COR-L105,24856436,1.5602990639828938,0.638920341391904
K-562,327653,3.3038748071855175,2.6568785431709006
Daudi,16725315,3.035985748437892,3.486022534147042
LCLC-97TM1,6917907,-8.098980466082804,-4.984338810303924
NCI-H2452,4261,1.8682088943565944,1.7949789488461951
SU-DHL-6,241158,1.5794519300851928,2.481427776903884
IGROV-1,9840324,5.720969888694302,5.792507729260499
COR-L95,10074640,3.0551355702246292,2.9150155720705353
ALL-SIL,navitoclax-birinapant (1-1 mol-mol),-2.9890180212020265,-0.6720027207803239
BICR 31,5460769,3.9433617709959696,2.641376998196058
WM115,navitoclax-pluripotin (1-1 mol-mol),-1.858334672155358,-0.849810468622731
ALL-SIL,171352865,4.1926931777749346,1.8789663445775773
PaTu 8988t,5351362,2.286773409161727,1.4249786731107448
COR-L105,54618164,4.149947168538197,4.159294055050939
K-562,168312962,1.3008721680360658,1.0535444290519005
NCI-H2452,3634881,3.1517111283550854,3.431262122090936
SW48,crizotinib-PLX-4032 (2-1 mol-mol),0.8715368349247399,1.7283257228810973
LS411N,2858523,3.1062955336512603,3.048967771046549
NCI-H1568,65628,3.926137474064237,4.510871801494731
SW1573,25126798,4.147065453172024,3.90995439906468
SU-DHL-1,9868037,1.568771805047012,2.807158534381051
HCC15,46174525,4.292402667650191,4.460163753580795
HCC15,54626689,4.436341034968849,4.726796448411719
K-562,241158,3.183928650435804,2.5927500114571638
HEL,400769,-1.0010167847558078,-1.5347470798936065
MOLP-8,24180125,2.8280981087253605,2.235292751707566
LCLC-97TM1,6918837,-2.241539398034031,-3.1409830801298404
SW948,52947716,2.6983492764143984,-0.2438511621188596
HuP-T3,11609586,3.0975126346448056,2.996652107038605
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079,3.0581685441958126
K-562,9911830,-1.954559593888618,1.7815243335006183
Panc 02.03,54454,5.027619058009229,2.8735198000943227
Daudi,9967941,1.9498714635628245,3.1175442803494633
SK-CO-1,46224516,2.9108482414820833,2.578224980751738
IGROV-1,56963564,1.8260986108097368,0.830227194106924
PaTu 8902,119607,6.110313748168657,5.441573730273353
SK-OV-3,1750826,-0.3132155362058529,-1.7246695219548096
NCI-H1568,11507802,1.223292685938289,1.6929378502584616
SU-DHL-1,6918736,-2.1290482192432396,-1.5248538016428543
MOLM-13,6252,-1.803091878000868,-1.3897003467866273
HuP-T3,16659841,4.694527425679891,3.954030067041732
COR-L105,135440466,2.282908830244017,2.393591416102375
COR-L105,36462,5.237060103367249,2.791853268623311
LS180,16038120,0.768362963165676,0.8633888147415674
COR-L95,11719255,2.8113582651389684,2.8617266537181645
K-562,71466380,4.109476883218819,4.120512354737494
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205,1.3814813853648702
LCLC-97TM1,65064,4.239331302053654,4.8096426643369625
ALL-SIL,11626560,-1.2475078800938888,0.6351925672649731
IGROV-1,9903786,1.7387584479757865,2.9585727721700534
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734,5.183461726531199
UACC-812,3025944,3.7003704595595894,4.286026085131355
HCC15,52912189,2.9796194932949875,2.62195749673685
SK-CO-1,24951314,2.193758155281627,1.3752486944826632
IGROV-1,208908,2.822483792004996,1.8249590634002573
BICR 31,2945648,3.0787524499283023,3.157256161411703
WM115,11485656,3.738489726762909,2.6593009041297533
IGROV-1,126941,-2.246216453812328,-2.4153467565108926
KU-19-19,135411,0.3258457054887789,0.8495146431642232
PaTu 8988t,tanespimycin-gemcitabine (1-1 mol-mol),0.132721029617077,-0.9763482055758536
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694,0.8691333963628857
MOLP-8,25105715,3.7016775455761968,3.2267122261577357
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.14249234774721
NCI-H1568,25126798,3.633705991567496,3.8279457834845623
LCLC-97TM1,3689413,0.1289764847745495,-0.4120746821276346
SW48,5311,0.4861581581750583,1.3924325435091935
LS180,409805,6.164182483443964,4.8816787169992635
ALL-SIL,17759555,3.7861470032844418,3.13875875910901
K-562,7326481,2.6072018104551824,2.830380814518892
SK-CO-1,8515,5.207883928071115,3.9727588828068394
NCI-H1568,439501,-2.6831567396736022,-2.251146934907825
BICR 31,3634881,3.594506321194918,3.2936446431760142
KU-19-19,656346,4.826208082880011,1.0399186735524266
SW1271,10410894,3.9794007270318903,3.2697090567933524
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163,-0.14535491875713638
SK-HEP-1,16722836,2.576451725849178,1.8445886874378465
RERF-LC-MS,10113978,3.210216765519601,3.4329859849474507
LS180,54454,2.0147485365690945,2.6905746128087276
NCI-H1568,9866186,-0.23967308205821,1.0877506379544648
IGROV-1,10302451,0.4135234554742116,2.861754716070282
PaTu 8988t,9935249,3.4642640806067897,3.1303587577626497
HuP-T3,65064,5.168937665689206,5.128813357947347
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942,2.1033676835006077
LCLC-97TM1,44543605,5.020704141539917,3.7282342461541917
KU-19-19,3062316,3.300727237006398,1.282673641195848
IA-LM,54143018,6.360653223606267,0.31448421601387344
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477,2.4719886963822373
PaTu 8988t,11497983,4.771256524847766,4.4894072304961075
IA-LM,7326481,3.2597510497719964,2.9099106861283706
MOLP-8,57519531,1.794840771759573,1.4562733657692082
Panc 02.03,387447,-4.21908064053878,-3.9764420525397486
Panc 02.03,9866186,1.4364847380387245,1.1038537988386252
BFTC-909,56946209,-2.8280109825858943,-4.030087523957242
K-562,46843906,1.6079735978006011,1.6586487146369384
IGROV-1,3038522,3.6829378423722416,3.092157756807584
COR-L95,9933475,1.8209744616881691,1.8200011554199196
NCI-H1568,54613361,-1.9115789745186575,0.11132520150850707
PaTu 8988t,11178236,-5.843883599227575,-3.3087576778099166
IGROV-1,24856436,0.4840146383282276,0.6141350144842619
HEL,5746,-1.0378501544368317,-0.2899287220355708
LS180,216345,2.343571728213523,3.6512226620902233
MOLM-13,11234052,1.8885372726820036,3.343372902679757
IGROV-1,656346,1.6285470744333117,1.197888545417862
IGROV-1,613753,3.483244781428779,3.1423778947211973
RERF-LC-MS,44632017,0.7768655843829712,1.39021307584708
LCLC-97TM1,10113978,4.598206277837053,2.9250825869552175
LS180,136227924,2.415770069388299,3.047075481898566
Granta-519,5978,-7.678617575463935,-3.707231869156175
MOLM-13,2828334,5.861258184508348,5.670396243516202
ALL-SIL,3815108,1.81429533281988,2.162345414424608
NCI-H2452,serdemetan-SCH-529074 (1-1 mol-mol),2.3569369644908535,2.3246846803969596
LS180,10385095,1.937933801431244,1.3781251317437715
SW1271,7326481,3.1173859417421985,2.9474817982583428
COR-L105,176870,-0.2151307909405896,3.4282652745509834
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.351017181259088
HEL,6918878,-0.4197772532459504,0.5324721495265269
RCC10RGB,44589607,3.0966280095343777,3.091475404679918
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995,0.6090601813038303
SW48,89183176,5.513741245898386,3.9598461283301645
KU-19-19,168312962,-2.211081322704064,2.3992623439304994
LCLC-97TM1,11656518,-4.424964199082896,1.8428548561592686
ML-1 [Human thyroid carcinoma],426756,5.157831333984941,4.5039250351647615
SW48,decitabine-carboplatin (1-1 mol-mol),4.347409294464919,3.8030002766941813
WM115,6918328,0.4200257259119496,0.12401785717429893
RKO,44491742,4.905526099010324,4.124309094071725
SU-DHL-1,5280436,3.4353188558540895,3.2463787479430226
SW1271,BRD-K27188169-navitoclax (2-1 mol-mol),3.98136464619854,2.2291484419306684
P31/FUJ,702558,3.294053878414949,3.8409720459746137
MDST8,322968,3.292336134337166,3.717598113993294
MOLP-8,66577038,2.4807994544381997,2.548962050740378
NCI-H2452,216239,2.289885444542123,2.456631424432393
LS411N,24951314,1.1768436480242177,0.5465091063756884
HCC15,5291,3.948819619575577,3.7198693719691716
RERF-LC-MS,11152667,0.0782441689403026,-0.41105595746711876
NCI-H1568,285033,-1.965656578387781,-1.9702522841599461
K-562,119607,4.708269214175102,4.37237297254803
MOLM-13,6918328,-1.6668605659600593,-1.361218692831241
HuP-T3,51039095,3.318948357155543,3.0144081661615907
COR-L105,3025944,3.915005293474353,4.3640849864116005
SK-CO-1,carboplatin-UNC0638 (2-1 mol-mol),2.9632424574107157,3.5241009361707984
NCI-H2452,42642645,0.8357005775142816,0.9271440282568991
PaTu 8988t,67156097,0.822255948885768,-0.5407466170312092
P31/FUJ,44507138,1.0120664141515707,1.5569928037685425
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623,0.8573810766286204
COR-L95,vorinostat-navitoclax (4-1 mol-mol),-0.3281165082224372,0.44107060496186257
HCC15,10074640,3.1199478074334106,3.1312365409223752
IGROV-1,53392493,2.352084848618059,2.5716803691717147
SK-HEP-1,135398516,1.8011759760648425,2.322992899584042
HCC1500,tretinoin-navitoclax (4-1 mol-mol),-0.6846797821009611,1.7566173915043484
IGROV-1,1242560,3.902441161940491,3.4452827404162814
IGROV-1,24901704,3.0789156375765936,3.2583830733961268
RERF-LC-MS,23635314,-3.639251677232653,-1.3044191401550873
KU-19-19,56946209,-3.434845070293707,-4.001159928789506
SK-CO-1,11427553,2.3636745936222177,2.939339829860424
SU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),3.622151043319632,2.756515561256346
Panc 02.03,6852167,4.143336119644561,2.943527888615021
NCI-H1568,26596,-1.690126811671561,-1.0384462096651423
ALL-SIL,100016,4.099229681419155,4.981420369520613
SW1271,navitoclax-pluripotin (1-1 mol-mol),-0.6532328489926583,-1.145720831785093
BICR 22,219104,4.618531153522784,3.7223298063087618
HuP-T3,4378219,2.0668857590794767,2.522909651437011
IGROV-1,11647372,-0.6595372928368528,1.1615664816991116
BICR 31,46843906,2.802485697538939,3.273979110218278
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854,1.9468488325061435
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863,2.2551426232564613
PaTu 8902,65064,4.553320484088526,5.049122273854998
NCI-H1568,10410894,1.924104691976128,3.363990823680479
SU-DHL-1,72376,-3.386078956410557,-1.656550196791419
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112,1.931562562052892
NCI-H1568,16659841,3.88074746768202,3.9531590898752897
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822,1.8511191943250767
LS411N,54618164,4.167426775220608,3.628464230133095
MOLP-8,5287969,-2.4943575090146903,-2.2919330512799156
Granta-519,24856436,-2.399051702227432,-0.7481322612558856
SK-OV-3,JQ-1-navitoclax (2-1 mol-mol),0.6239682404577798,0.9979639833181715
BICR 22,3689413,1.1307119933583345,-0.3380052942465552
SW948,11494412,0.3616963479580831,0.7444685002153729
RCC10RGB,3552672,3.073432883089278,2.9962915103179597
LCLC-97TM1,72376,-4.375427192181232,-2.4451092809682713
SW948,11234052,4.776317924055416,3.4605026863096087
P31/FUJ,89928392,-0.2575535361410093,0.5039888349243643
SK-HEP-1,ISOX-bortezomib (250-1 mol-mol),0.2987916672751671,0.7590868906589529
MDST8,piperlongumine-MST-312 (1-1 mol-mol),2.167739236118489,2.2213110509459986
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232,1.3539921675945652
NCI-H2452,2742550,5.209305166760603,4.207313163916893
SW48,9884685,-1.5395746259931604,0.7431980482016236
SU-DHL-1,16722836,1.4294085247204618,1.4154371998864559
MOLP-8,11640390,2.6566405323234057,2.142470430757573
RKN,5113032,5.131058822839954,5.034968613323759
Panc 02.03,5311,2.7910052639268415,1.5820666818574936
HuP-T3,36462,3.380707637397105,2.351091323970556
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.9804258170851865
K-562,6852167,3.2696177089982807,1.9531671437128955
KU-19-19,16725315,4.810213458660102,4.3180530448595364
Daudi,44819697,-3.048561633253287,-1.6325539020509796
NCI-H2452,73707398,1.4673083704761625,1.4745824636099498
SU-DHL-1,6438330,0.8462618394668467,1.6000694757528504
PaTu 8902,carboplatin-etoposide (40-17 mol-mol),6.0931927841576385,2.8887402915122236
IGROV-1,400769,-0.5589612210030486,-0.47957617837387084
PaTu 8988t,6918736,-0.015847459349983,-1.43290080474781
NCI-H2452,12003241,-1.7557808561862691,-1.1281146910910689
SW48,89928392,0.7467993581529679,1.4264962461943338
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203,3.9426197625464625
NCI-H2452,71466380,5.164331301376758,4.4706120535088925
Panc 02.03,4917,3.7856869354758342,3.1051847888691926
SW48,25062766,1.0755009410821956,2.1720563790818894
IGROV-1,4259181,0.1937358171291443,0.22252156091263828
BICR 31,46926350,-4.294934659479777,-3.71393725117827
Granta-519,72199292,2.8103945289975623,0.48702113745387765
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256,2.3245906221094366
MOLM-13,11222830,0.9845802392597008,1.0043906887112772
SK-HEP-1,676352,1.798347685811885,2.2005731585091923
SK-CO-1,36314,-5.371942323616045,-0.4629593193259759
P31/FUJ,71466380,4.574945433624961,3.664804085950936
PaTu 8988t,11427553,3.005069211450264,2.8931296553272556
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783,2.525456947633862
NCI-H1568,151289,0.8908355813530987,1.1009399070232917
SW48,216345,1.323366684487305,3.3924983040599357
SK-HEP-1,44819697,-0.1381867301228731,-0.40577508443609056
BFTC-909,24951314,2.3445794180209565,1.5944777129202752
SK-CO-1,107985,-2.728069079888901,-3.5110649139055723
BICR 22,168313016,4.910867780923905,4.793185183376636
SW48,3025986,-2.1875732043663048,-0.5722479436021554
HEL,SNX-2112-bortezomib (250-1 mol-mol),-2.046606544409741,-2.749378959278523
UACC-812,erlotinib-PLX-4032 (2-1 mol-mol),1.674253271447935,2.637447874521996
HCC15,446155,0.1844871361320988,2.5831067632337805
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512,0.35342508303726206
BFTC-909,56963564,-0.1720168824982637,0.6628327571592934
MOLP-8,151289,0.9447515089929442,0.5998271038944877
HEL,11609586,2.7821230127549663,1.5599586849309472
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513,3.037795399039652
SW948,46174525,3.747184504681747,3.5037111754265733
HCC15,11964036,0.8100768326008368,1.414568380785681
SK-OV-3,53232,3.610813443380856,2.958917055911686
NCI-H2452,9884685,3.2183676658345868,0.717241942628509
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402,0.5965826099932557
K-562,44241473,4.342180714885996,4.187580348214205
HCC1500,65628,4.452955395596753,4.514845552607076
MOLM-13,24771867,-2.755307399303063,-1.7041597718607735
RERF-LC-MS,168312962,0.3496483928324376,2.2401245794378464
SU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),2.541711165237938,2.72904640211426
NCI-H1568,44589607,2.521775448277625,2.879223557298643
ALL-SIL,selumetinib-UNC0638 (4-1 mol-mol),2.881146238835363,2.1845743191585227
Granta-519,5280436,1.7342596657129103,2.547760908659853
NCI-H1568,72199292,0.3941551729128716,0.46867989760343515
SK-CO-1,439501,-2.410857533331093,-1.7657830389094846
Daudi,selumetinib-decitabine (4-1 mol-mol),-0.4974612156096017,0.6978421477097497
PaTu 8902,3038522,3.855914834510199,3.1192274037238303
SU-DHL-1,159324,0.2044468524757833,2.439692638892274
BFTC-909,46398810,2.674147192871529,2.5351274992239228
LCLC-97TM1,148198,-1.8422045751990368,-3.5086404651060605
MOLM-13,selumetinib-MK-2206 (8-1 mol-mol),0.4118015123896347,1.3080446384602695
LS180,5351362,1.0497784443121565,1.4430262527717397
NCI-H1568,5311281,2.6261557759532974,2.5847207686394813
SW1271,44589607,3.6432775089048888,3.1169409483538146
RKO,54143018,-0.3751060369564643,-0.03332881642141504
COR-L105,44607530,0.5885750535327339,1.9789909981219054
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563,-1.1110065745258735
Granta-519,serdemetan-SCH-529074 (1-1 mol-mol),-1.751418488769959,1.2976266026596033
SW948,387447,-4.931777613053621,-4.353242953659506
BICR 31,168313016,4.3680397842259095,4.952920569278829
LS411N,36314,3.823716751686664,-1.4389491854054262
IA-LM,JQ-1-vorinostat (2-1 mol-mol),1.5927237168826456,0.12565747244804515
MDST8,67291369,1.5579520311273356,2.925789252664204
RERF-LC-MS,3062316,3.070306969339253,1.0713699611046514
COR-L95,doxorubicin-navitoclax (2-1 mol-mol),-3.6271325367233977,-2.0673702350636205
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459,-1.2519695912380862
WM115,JQ-1-vorinostat (2-1 mol-mol),1.1090035526940631,1.2322749292256239
MOLP-8,11964036,0.2292639686830329,0.30392369779794876
RKN,66577038,3.4891743358782104,2.889394170380427
PaTu 8988t,5978,-2.779195325360685,-1.7825992179984198
RKO,8515,4.32265921632429,3.277720606262167
SU-DHL-1,46907787,0.92481130470373,1.8552201443777419
COR-L95,216468,4.837628080392179,1.8348240757120442
SW948,462382,0.505941174695894,0.6796467553983493
NCI-H1568,448949,1.6827994040181535,2.1896112747331147
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123,1.8196410120659747
NCI-H2452,10184653,1.4868368660739673,1.6482294688909567
NCI-H2452,1285940,4.318373702463549,3.7933828265169973
SW48,52912189,0.0060801339095902,2.3423507519521083
RERF-LC-MS,46926350,-4.177207395055215,-3.7062516576253284
P31/FUJ,5978,-3.805650321394954,-3.2379336084230306
Daudi,4917,1.6956741153412938,2.7727195124892035
LS411N,44507138,1.8249335905604152,2.35829938327449
RERF-LC-MS,10231331,0.9954911948227504,1.984607631669783
HCC15,4261,-0.2961876318733478,1.6322792969789774
P31/FUJ,16722836,0.3472605187822769,0.763649589967671
MOLP-8,45279963,3.839697844480557,2.940555699166663
NCI-H2452,446155,1.665772886963468,2.406141219692461
NCI-H2452,11609586,3.752552997604344,3.1466887359825857
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105,1.6823733681509614
IA-LM,9933475,1.89794527933904,1.8038878522169828
MOLP-8,4477,0.6768027916096236,0.48816733122433936
IGROV-1,42642645,0.3750175292659389,1.1560339403199644
IGROV-1,6852167,1.5305143027352028,2.8760236503936234
Daudi,5287969,-2.32062356362434,-2.0479755992919677
WM115,44607530,1.3586937130527126,1.728588559813253
SU-DHL-6,5291,3.0098231219330422,2.9893379781177583
IA-LM,53392493,3.818463276064527,1.9307974620482367
MOLP-8,5328940,1.3442597724286955,1.0952485432420083
NCI-H1568,11626560,1.7284579168385834,1.92156661881025
NCI-H1568,9967941,2.084939505363619,3.7340367699222963
BICR 31,24856436,1.9770307243044476,0.8691369412909363
LS411N,6918289,4.168112514533401,2.3798489198467063
SK-CO-1,49766530,2.416603727276247,0.023760171684345462
LS180,15547703,3.0095925001469577,3.0632761938619746
SK-CO-1,24771867,2.6665073598645086,2.5234146297806337
MOLP-8,17755052,-0.3093261728985458,0.8914006637789734
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292,-1.4181593177643526
NCI-H2452,6610216,4.12804282735119,4.48942285336515
RERF-LC-MS,16065773,2.958049600168222,2.3798710481496603
SaOS-2,6610216,4.351676798413151,4.276510865960722
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731,1.934100734314888
COR-L95,BRD-A02303741-carboplatin (1-1 mol-mol),4.777626447761979,4.014308270527524
NCI-H1568,3854666,0.7326561551321923,2.2923852915029195
SU-DHL-1,11404337,-0.9851913382580488,-0.5816603422961693
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034,4.931118081432778
K-562,2746,2.4328857060914797,2.1467208680720646
Daudi,16038120,0.2901991168563289,0.4606271974394117
MOLM-13,71466380,3.777949844495899,3.5668222262412086
Panc 02.03,11955716,-1.8470517927785437,-1.4849329743500623
LCLC-97TM1,2858523,3.382646598163124,2.941029327163426
SK-HEP-1,11234052,4.66363668535284,4.173444360447986
HCC1500,322968,2.559368987278369,3.7053825204802213
COR-L95,24772860,-0.7858558168975444,-1.7273473350073283
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914,2.1407488198287625
SW1271,89928392,3.428275427880058,1.3702688145417192
RCC10RGB,24821094,3.8097926200280225,2.8172849858886555
HEL,24753719,3.7144242054355985,3.3840581190952554
K-562,445091,4.14956176193418,4.056252584312321
HEL,136227924,2.725456875957553,2.4273713945040596
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.641996951577207
LCLC-97TM1,159324,3.194316902825419,2.536879519813442
RERF-LC-MS,57519531,1.5399611647939,2.5714780457637767
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295,0.25142324423293855
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645,1.4445429055447334
HCC1500,51037431,2.242858518427135,3.0815736536764153
ALL-SIL,12003241,-5.746631994241774,-1.6518544450536377
P31/FUJ,44819697,-1.8374306821299025,-2.1237919156813554
SU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.4382165085850405,-1.5023188495171356
MDST8,107970,2.8941750874079744,2.222733915623104
SK-OV-3,3503,3.0304882575129497,2.410691959783013
HuP-T3,selumetinib-piperlongumine (8-1 mol-mol),4.093853736240695,3.1115090271850874
HCC1500,9927531,5.051014893697188,4.473465866630033
NCI-H2452,selumetinib-tretinoin (2-1 mol-mol),6.004763322543325,3.875805221329494
HCC15,5328940,2.162982624771584,1.7101706105210708
Panc 02.03,11626927,4.481877662185247,3.2851564607621566
SU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-3.283553666087357,-1.5565400703544763
SU-DHL-6,2749,-0.5951367082815587,1.1539313855940576
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633,3.344614126675616
MDST8,135398516,1.8788362071916904,1.9776001752989318
MOLM-13,5328940,0.1532905912336842,0.8647473633753914
WM115,4477,-0.2872762876800434,0.4283840037940476
ALL-SIL,5746,-1.6673474530311534,-0.7769244834927254
PaTu 8902,25150857,2.644837375624729,2.4929917478216033
MDST8,219104,3.7181204954875864,3.7140903486930252
Daudi,11228183,2.4864875823277557,0.7889234716500786
ML-1 [Human thyroid carcinoma],613753,2.773006926215127,3.3384385532006813
Daudi,984333,-2.2486456844128333,-0.2646911418415899
Granta-519,12003241,-2.1147517064841925,-1.2487748300577841
Granta-519,BRD-A02303741-carboplatin (1-1 mol-mol),4.5159158584764745,3.92435987895944
SW48,387447,-4.885505238560258,-3.822799914957843
COR-L105,36314,4.185071185075879,-0.7312810828240357
HuP-T3,4705,2.7233440783632608,3.2213712460016772
Panc 02.03,54678924,2.4878586568917536,2.370232347486886
SW1573,16065773,3.287625611468905,2.2827186302554443
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016,3.6323157535469806
COR-L95,10385095,1.3959867651371194,1.0510007963148977
P31/FUJ,2945648,2.3869646223252365,2.1891146849260905
PaTu 8902,55283,3.4956890773009097,2.8033995489200767
COR-L105,89183176,5.033590250009003,4.498362841439058
HEL,navitoclax-MST-312 (1-1 mol-mol),-0.4450786060493964,0.15186980588853968
HCC1500,445091,4.393350110080019,4.255716109660095
SK-CO-1,11175137,2.477148698701912,2.7447290292929694
SK-CO-1,navitoclax-MST-312 (1-1 mol-mol),0.863563965470539,1.0119734134334606
BFTC-909,54618771,2.8225313881877545,1.2218211965194339
HCC1500,73707398,0.9868057798362108,1.4768892680095866
WM115,135398516,0.1940094116062491,2.147239062479623
SW948,11977753,-4.015233583581633,-2.076270101771145
KU-19-19,446155,2.785852834205258,2.826010652070954
BFTC-909,3854666,1.1654585644167257,2.48545233042471
ALL-SIL,327653,2.0915878780614623,2.4895829154207387
RERF-LC-MS,2749,2.1448012118135176,2.203423944515804
SK-CO-1,3503,2.662166466999906,2.360177657619553
IA-LM,60700,0.8821511316384938,-0.07445534691152743
Panc 02.03,10302451,3.706546166543765,2.982621730866307
SaOS-2,45279963,3.893370234288743,3.7830327268339614
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042,3.081688610830469
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836,-1.427237073208821
K-562,11626560,-0.7477726232652755,0.8548026598922144
PaTu 8902,252682,7.782026892174048,6.6390293404187295
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684,0.6765887413224432
HCC1500,9887053,4.8738692747205175,4.063582209640845
IGROV-1,11717001,4.394306548697183,4.031814091435114
NCI-H2452,9911463,3.657985193851277,3.9638438196157946
HuP-T3,11707110,2.782188957571083,-0.40671104144222836
COR-L105,5287620,-2.2558017577268665,-1.8687618631154046
K-562,9907093,4.115761716505682,3.4459461909947184
SW1573,53245473,3.5468633352222287,3.1639384666374166
COR-L95,100016,6.620829555802918,5.4188774803999875
Granta-519,11178236,-5.517610268531398,-4.0072644470569765
IA-LM,3503,2.293282991199797,2.3841478972221313
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943,-0.3038982849387888
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-0.7405340349346616
MOLM-13,23635314,-2.1464398793300408,-2.9566194459778017
WM115,45100481,5.666571363096329,4.5242081533831735
ALL-SIL,doxorubicin-navitoclax (2-1 mol-mol),-2.2880067679034526,-3.1368257355393876
COR-L105,5351362,1.5942690709113274,1.5670886375756492
IGROV-1,6610216,4.310938387105607,4.106228975424988
SK-CO-1,4521392,4.292734672993078,4.067481065030111
RERF-LC-MS,53232,1.207294902086358,2.829116421157026
NCI-H2452,16038120,1.767482091574877,1.135836928162842
LS180,107985,-4.080313435814333,-3.444549406620797
SU-DHL-1,24785538,0.8988368126388477,1.3395670912270103
IGROV-1,11977753,-2.2284230058029433,-0.9636030774763291
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686,2.4134900780486337
SW48,24964624,1.8073600797801577,1.9593670555801412
RKO,9911830,2.9376280530386123,2.077558006559011
SU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),4.469831301175806,0.8964389777227058
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919,-0.5337393983132817
HEL,5287620,-1.51108604946339,-2.0754462671340796
MDST8,11964036,-0.5107320494490124,1.4896312929795479
HCC1500,10385095,0.8648832931247582,1.5705263263018094
SW48,702558,4.851481027043998,5.1883301366490775
BICR 22,15547703,3.054989624104991,3.1680743518789996
LCLC-97TM1,375860,-0.9613247940016756,-0.25760711169636463
BICR 22,5566,3.0896765386345244,2.7013930033277256
SW948,36462,2.9711779559511604,1.611865037878182
SaOS-2,135411,0.7043200334589346,0.5689225615728919
SW1271,24889392,3.729104653817525,3.756550284370698
K-562,4917,1.7461656699737091,2.809201800875677
MOLM-13,11964036,-0.3903680086882432,0.33010282554042747
SU-DHL-1,9907093,3.802209526559384,4.078675264548016
MOLP-8,44507138,3.0437239609683515,1.9028177302651894
HCC15,441298,2.404091830829315,2.7716154786545646
IGROV-1,246676,4.485924799339535,4.241413464389266
IGROV-1,3136844,5.214591389089975,4.392178372451829
Daudi,119182,-1.0022442636317743,-3.1964593803865013
SK-CO-1,2742550,3.074063089907043,3.999072889105209
COR-L95,5291,3.794551144961864,3.373077081758514
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379,3.1812245939768697
WM115,16219061,2.9198343751130036,3.417617383434779
RERF-LC-MS,2871966,0.0193381278585586,1.1221315953803745
SW1271,44607531,2.0262821909932964,1.4320664015614089
NCI-H2452,53495165,2.6100799702143824,0.9803933492064284
SaOS-2,3825829,3.573326366415088,4.1092649076382735
HEL,1242560,2.170830105823081,3.0100776579172437
SU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.6823534410792318,3.1372468374517863
MOLM-13,135423438,-5.2048777869707035,1.2051563906774256
RKO,3815108,2.4813915623878264,2.321414038205448
SK-CO-1,57519531,1.3464743023672243,2.5805193924139673
SU-DHL-1,2729026,1.1961155288156848,2.6221066964844915
MOLP-8,57330099,4.408814311331857,3.8610905276269785
SK-HEP-1,25262965,-1.9202339310426983,-1.0109696236210748
HCC15,71466445,3.952377160133232,3.971090904297231
Daudi,49793307,-5.375388093698208,-4.265378503210117
RCC10RGB,52947716,3.397847809230189,0.5322273111048302
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724,2.2278185756725133
MOLM-13,10074640,2.6694741782411975,1.3543926016205692
HCC1500,16736978,0.2362509616809698,1.7237474695842412
WM115,11228183,1.7654096487865938,2.404126406291445
Granta-519,25150857,0.8022216450857215,1.6809026768620847
RERF-LC-MS,2858523,3.0171071482923826,3.042086798688128
K-562,71466578,3.85538032532176,2.8935098028186754
RKO,135875424,3.829354185480349,3.2587105943839716
HEL,4096211,2.9626104821001524,0.7067197130419832
LCLC-97TM1,67156097,-2.339870774569048,-1.350921535159077
COR-L95,3503,2.5200783295079834,2.071871094182718
SW48,11609586,2.634017068041322,2.642812648611998
SU-DHL-1,375860,-0.8487932986720208,-0.027949085261659998
SU-DHL-1,5351362,0.9282229173955964,1.7960191579384412
SK-OV-3,6917907,1.1533351492785058,-4.75930518832448
PaTu 8988t,65064,5.1728218990125,4.841610246264256
RKN,3503,2.6546301780010144,2.3809419079641416
IA-LM,23582824,0.7235929041173603,0.8522948311906207
IGROV-1,54143018,0.8385018685685798,0.9305437908012698
Daudi,11214940,1.5157277988308535,1.076567031650011
SW948,4261,0.2066749270482282,1.0140280877897296
HuP-T3,15547703,4.355520728687953,3.230458618284032
NCI-H2452,24748573,1.1942514329138498,2.5016994003574498
IGROV-1,159324,2.8766947154825044,2.9720913651531258
MOLP-8,JQ-1-vorinostat (2-1 mol-mol),-1.65297675500665,-0.8552965026938917
MOLP-8,navitoclax-birinapant (1-1 mol-mol),3.3062400198752195,0.6558155421602505
SU-DHL-1,3465537,3.713885766889003,2.3041087330815406
NCI-H1568,60700,-0.8736945480852499,-0.4556281150705299
P31/FUJ,3689413,-2.495432751898851,-1.5093572014676102
PaTu 8902,16722836,2.3982166809874768,1.6439709239815634
SW1271,452548,-0.0979853591066759,0.4537021758948809
HCC1500,9444,4.370086947523025,3.969552364251602
IA-LM,navitoclax-pluripotin (1-1 mol-mol),-1.626939018948189,-0.9066111105959248
MDST8,44137675,1.8173250203578384,3.4340028119919084
IGROV-1,5460769,1.6083174601829917,2.869405595440461
SK-CO-1,10302451,2.4520332675877605,2.8688726470656087
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386,0.38644536594761547
SU-DHL-1,3384730,1.173741268518712,2.282256810517766
LS411N,11178236,-2.533537215148808,-2.788433594871892
COR-L105,216239,2.81147830727615,2.3943335607841747
MDST8,1750826,-3.2078848487443716,-1.3134877183019023
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726,-0.9780617355424901
SW1573,3025986,2.659291536752942,-0.5912335949271326
SK-OV-3,73707398,1.4890038437616029,1.5743883289601934
LCLC-97TM1,12003241,-0.8351557307101188,-0.8330991748511833
BFTC-909,1750826,-0.1726466566192349,-1.3098265675126461
WM115,44819697,0.4217395821242636,-0.19097213625995546
Daudi,57330099,4.348234162675926,3.6145785121312075
HCC15,6852167,3.485797740848402,2.9341532793441623
IGROV-1,23939,4.412541857664819,3.691798047383603
Daudi,carboplatin-UNC0638 (2-1 mol-mol),1.637238274504332,2.819864247870279
MDST8,159324,4.143261975826356,2.8759781798361796
IGROV-1,9840324,5.720969888694302,5.792507729260499
LCLC-97TM1,36314,-6.600382606146434,-1.020831228812783
UACC-812,11494412,1.976870257251046,2.1546692625466473
LS180,24785538,2.36344296814186,1.5369787524441951
SW1271,46398810,2.1181317502001864,2.657932446685113
COR-L95,8515,4.297389552329342,3.4656865867508584
HEL,67291369,-0.0398574366947598,0.44235854791970214
WM115,65064,5.519507799834776,4.623718304142987
K-562,11178236,-5.937287665657859,-3.785704494691767
MOLM-13,46398810,-0.3461491770759903,1.8383701764446356
Daudi,49836020,3.49644839546437,2.6788481035504814
SaOS-2,135659046,3.828911922642458,3.6860103053576534
MOLM-13,156422,2.6570896066322054,3.0859497712432318
IGROV-1,11222830,1.5703285223102077,1.5396462893834306
MOLM-13,3062316,-0.5121609334560062,0.5410732763839236
RCC10RGB,24775005,3.7293513155953737,3.7882325153821137
Daudi,135411,0.411387979123234,-0.1588936394986372
HEL,6623618,1.8836955043929509,1.7570659264332391
IGROV-1,5702613,4.420745339537274,2.8853781858165757
BICR 31,3025986,-1.7152493432112506,-0.7293671894305868
ALL-SIL,crizotinib-PLX-4032 (2-1 mol-mol),-0.8453908934030238,0.9067362665270698
HuP-T3,46926350,-3.9956296104835447,-3.845188686060528
SW948,11964036,0.9329377934210036,0.7261554570886264
HEL,navitoclax-pluripotin (1-1 mol-mol),-0.6457207254934652,-2.5247120026655514
BICR 31,168313200,4.293337148285007,2.9802878145553273
LCLC-97TM1,613753,3.2994086878019693,3.1200732289828688
NCI-H1568,2858523,2.9099207435493306,2.8547634764270216
K-562,selumetinib-piperlongumine (8-1 mol-mol),3.695022326832345,2.192859241553412
WM115,168312962,-0.8720769549309708,1.8406554882349948
COR-L105,3136844,4.323289843330604,4.515549253699519
SaOS-2,24964624,2.194529135867758,2.5126507931306943
IGROV-1,322968,4.140599241163106,3.728338389891758
SU-DHL-1,44259,0.9870469643742532,1.0593702887310164
HuP-T3,erlotinib-PLX-4032 (2-1 mol-mol),4.371591161861475,2.9771573317655826
Daudi,7326481,2.37278983949268,2.6942398446368623
HCC1500,5284616,3.2143502285360395,1.8905143938860833
Granta-519,6918736,-3.0470654964091346,-2.2952485652616677
K-562,53232,2.317344808959498,2.8301541614161594
KU-19-19,6914657,-4.990300196809823,-3.940289716044779
Granta-519,72376,-3.0273971733074463,-3.6013123601877033
SW948,54678924,1.3690911042909353,1.6900003881040022
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179,3.953202944284072
SU-DHL-1,2858523,2.096941494706986,2.7618565002195106
HCC15,11427553,0.4296382841284133,3.001621360639719
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503,1.4052742603018225
PaTu 8902,9444,4.223556509018044,4.218162772114272
Granta-519,10074640,3.4462174196318864,2.485410748107166
NCI-H2452,11213558,2.927858740250081,2.2152288083172587
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322,3.1113912087458444
SU-DHL-1,17755052,1.573040093702568,0.8301571471723878
HCC1500,44185566,2.7833515387265435,2.453404167374994
BFTC-909,107970,2.2861723254681774,2.3499694310479753
WM115,46191454,1.770414974730312,1.8226934081152983
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948,3.5954008319821242
SW948,JQ-1-vorinostat (2-1 mol-mol),0.5761489017255973,-0.023622020852102906
SW48,984333,0.702746968378095,0.5481567490741225
MOLM-13,4378219,1.3750720877022855,1.360039044758513
SK-CO-1,104842,-6.47047720162668,-2.2564745650842837
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165,2.359429108075814
SU-DHL-1,753704,3.8222320630358344,4.676136998018327
NCI-H2452,11640390,3.686004280320225,3.8082912937238143
IA-LM,44185566,3.1900951690600596,1.8806680152997801
SW948,24748573,3.0928652753553685,1.56822215759187
HCC15,16722836,0.9313515315756092,1.7884379361826226
SK-CO-1,2858523,3.0692168261278345,3.1909723383209556
BICR 22,984333,1.5288435331300914,0.8605670585345325
WM115,46907787,1.8634039559333693,2.464488257652139
K-562,135398516,2.1877631842117315,1.454302187025816
PaTu 8988t,navitoclax-pluripotin (1-1 mol-mol),-0.085365931635351,-0.9003507220201754
SW1271,56649450,5.123918884487689,3.3457163497307265
MOLM-13,73707438,4.222752629567675,4.07216570831512
BICR 31,navitoclax-PLX-4032 (1-1 mol-mol),3.597223758742863,2.0566828292743233
IGROV-1,9908783,5.873270433212515,4.767042103654517
COR-L105,100016,7.1590039780101895,6.4730272362896075
MOLP-8,2733487,6.371854996101937,5.398027624168875
HuP-T3,40482356,5.071639396405957,3.762793026778821
Daudi,10231331,6.134507235467236,0.361997016870328
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.8376842437211083
ALL-SIL,135398738,2.8388897343309214,2.199478184350224
Granta-519,15953870,3.078322892664931,3.1424179781240498
SW1573,16722836,2.4665820842388606,1.8183797070560856
RKN,262093,2.5285063130840344,2.9325903245106275
COR-L105,16736978,0.0668136597141226,2.0961292717579503
SU-DHL-1,3854666,0.5155348387571919,1.9274216029896092
SaOS-2,docetaxel-tanespimycin (2-1 mol-mol),-4.954749121249774,-3.0469180126406807
HCC15,1242560,4.141842055686159,3.585667384466687
Daudi,227681,2.3413610492173533,2.2741168767959365
BICR 22,9825149,1.9632507246672848,2.078700946745183
KU-19-19,57519531,2.7709295903751987,2.5579618365806835
HEL,675434,4.82305615478698,4.034892374283067
LCLC-97TM1,9927531,5.703886109604247,4.679497100138762
HCC1500,60700,0.3261825799377537,-0.15165417871723322
SK-HEP-1,3025986,-0.7748266135658505,-0.614107455632491
LS180,5281321,-2.3743222213125703,-0.8837119315881
RERF-LC-MS,11234052,4.094456859515875,4.363909914323239
COR-L95,JQ-1-navitoclax (2-1 mol-mol),-0.0986281743436248,0.22086161464905055
RERF-LC-MS,753704,5.128075002459309,5.1759437140650535
ALL-SIL,71304818,1.8469641946240791,1.9259549940684477
LCLC-97TM1,2733526,4.142341185184233,3.790548454325054
SW1271,6918328,0.5991052607451842,-0.38057880215072937
SW1271,24901704,3.681572165465946,3.2699798808872402
Granta-519,11656518,1.6452745070498538,0.20395768808731854
NCI-H2452,3025944,3.797054601848671,4.380287811486111
COR-L95,navitoclax-sorafenib (1-1 mol-mol),-0.3721439158461418,0.9329825349488432
RKN,24951314,1.3743916622304369,1.4690683244660827
SW1271,25126798,3.686543071113652,3.7352728384029312
IGROV-1,6450551,2.579641476451469,2.777602567511325
IGROV-1,54454,2.453541831966438,2.742562064281504
COR-L95,9936388,1.0197606854481494,-3.3832082157142076
Daudi,42611257,3.0497080994784307,3.154848282837067
BICR 22,54618771,-1.5156377594303725,0.7442028464600619
LCLC-97TM1,23939,4.339779460008714,3.899403128965401
NCI-H2452,46191454,2.4313233431346366,2.0007315023211447
COR-L105,42642645,1.1549939076973508,1.2014146493686912
MOLP-8,11609586,0.3617141221652126,1.8780206078136492
BICR 31,613753,3.1747241586791772,3.2733084205184486
SU-DHL-1,5328940,1.3431964509037,1.5590523608807247
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793,-1.7320042785531757
SW48,carboplatin-UNC0638 (2-1 mol-mol),2.888292790339682,3.1073878738593295
BFTC-909,11455910,1.958059547603208,1.0176522840659272
RERF-LC-MS,322968,4.758979615786181,4.106937551981448
KU-19-19,5351362,1.814646406429004,1.5513503289095325
MOLM-13,54649381,3.864277780400009,2.952154553342891
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337,1.6747775402449405
NCI-H2452,72199292,1.1345413256627164,0.41583964286131575
MOLP-8,676352,1.5936675202889017,1.9231757546189723
HCC1500,676352,1.5631676801704226,2.0401172222236235
COR-L95,51037431,4.395819234826154,2.9208664064669314
Daudi,5328940,0.4604914818199462,0.9238646636432998
SU-DHL-1,ISOX-bortezomib (250-1 mol-mol),0.1782734065105105,0.19876127210734623
IA-LM,168313200,3.804941602819176,3.053385476847782
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026,-1.251519404314029
RKO,119182,-2.4803685643523,-1.757336767388112
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715,2.4538153216521748
PaTu 8988t,25227462,0.2940996568558364,0.4232121113632927
SU-DHL-1,9929138,3.6810672504095385,4.523667767693491
SU-DHL-1,12003241,0.0778318253848937,-1.4837263084685954
RKN,15547703,3.1395613683678287,3.257728933521725
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752,1.916743187839031
MOLP-8,375860,-0.9263291950812266,-0.4568215227224905
PaTu 8988t,11234052,5.58672838892775,4.240708646973956
LS411N,piperlongumine-MST-312 (1-1 mol-mol),2.10220496247882,1.4052633587475851
SK-CO-1,126941,-2.257482818819106,-2.3445654575826276
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617,1.6315022656274567
LS180,3038522,3.8311766422201727,3.2240536417150567
SW948,1566236,2.0550116218076235,2.135900844249482
Granta-519,89928392,0.2978525114312038,0.2623540266353167
MOLP-8,19582717,2.2376953494036624,2.81951900658662
HCC1500,vorinostat-navitoclax (4-1 mol-mol),-0.8820209164506474,0.46381694874402213
K-562,2874250,4.395305106833161,4.320270644305389
SU-DHL-1,11234052,1.0073590907004168,3.8037443996570004
BICR 22,73707398,1.4183060149157571,1.3009391385234677
COR-L95,46926350,-4.41571269577794,-3.9496225716463123
Daudi,25154868,2.925803317483448,3.982853776928786
HEL,16725315,4.4825385691379145,3.39646405951217
IGROV-1,67291369,1.8066430555976296,2.6228122764139217
PaTu 8988t,11404337,-0.5897258437911538,-0.2839438608695586
SK-CO-1,9911463,3.850014047184169,3.8219542520344936
LS411N,89928392,2.6081309937571655,0.6855921075585788
SW948,374536,1.478775672326772,1.500475621168051
Daudi,3543504,2.1992036346279997,3.4547133169779265
NCI-H2452,5746,2.2152642195731818,1.4204684016676055
K-562,451668,2.928523807666895,-0.5638361700900375
RERF-LC-MS,71680916,4.2559060280924665,4.902424757642118
BFTC-909,5311281,3.2468587214362175,2.401628471206388
HCC15,54649381,3.779002151510325,3.9221527810397303
SaOS-2,6252,5.899001284083339,0.9708087956090445
SK-CO-1,2828334,6.603893313093487,6.165476031115653
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265,4.020540555001606
RKN,56946209,-4.407104587623599,-3.6262523995193647
P31/FUJ,54618164,3.783909273991047,3.6206439652402236
P31/FUJ,46943432,0.8368365469264624,0.974057297486704
SU-DHL-1,24180719,4.350105317542874,2.8986809233595308
SK-CO-1,10113978,3.831664495659769,3.2121715036362395
Granta-519,16659841,3.0104726191973756,2.466389131052767
HCC15,5329102,1.9423862085433257,2.123527946370055
RKO,9903786,4.184024439899693,2.5472037605459725
Daudi,76446078,6.274042769130843,2.8093718813589015
SU-DHL-1,5113032,6.615586057729586,4.79507822810521
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623,3.0572354567579834
IA-LM,219104,4.299166533144503,2.652568548223926
P31/FUJ,5329102,0.6917422477571054,1.1818612393325856
PaTu 8988t,5278396,4.086122365965545,3.4069230653182556
LCLC-97TM1,8515,3.105500626842055,3.56408547050733
ALL-SIL,36314,-6.574209880787115,-3.6008388099730166
HEL,JQ-1-MK-0752 (1-1 mol-mol),-0.9106796249442436,-0.2825684567235936
SU-DHL-1,252682,6.908372017357921,6.369785488094892
MOLM-13,24753719,4.086009941734247,3.546969307582093
LS411N,119607,5.818355117504778,4.510164133404797
MOLM-13,66577038,2.3893764671204853,2.6222738891265127
HCC1500,25183872,-1.4621663438631347,-0.8748410160878504
KU-19-19,6917907,-4.52253618895935,-4.987883394829294
MOLM-13,11396600,-0.7885098330267027,2.7409946134050425
SW1271,25195348,2.4923805554625407,3.1620533637600956
NCI-H2452,15983966,-3.826639310361129,-1.3893930996607549
BICR 22,6184667,3.547514920621151,2.965245781631134
IGROV-1,11396600,3.99372654279783,3.6005442436441903
PaTu 8902,24748573,3.607230896648149,2.422483498844229
MDST8,54613361,0.3905773320508885,0.2675990362180107
SW948,136227924,2.9576701343794145,2.874259949626865
HEL,135411,-2.1892340188273836,-0.21505461908239226
RKN,322968,3.2277505791227776,3.8651270756905665
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005,3.563327448367391
RCC10RGB,alisertib-navitoclax (2-1 mol-mol),1.3902469753656497,0.9183753060972331
COR-L105,444795,5.02091820523187,4.8538304126586365
RERF-LC-MS,11175137,3.6286013190581503,2.7186290632733763
RKN,54619267,4.894700718514424,4.187658617219129
MDST8,54143018,0.2489025697900608,1.1754857383736579
LCLC-97TM1,4917,2.8423920861921803,2.7971595103548372
Granta-519,60700,-4.015034522335836,-2.087625030159779
MOLP-8,56649450,1.2499213171679169,2.564399722343162
RERF-LC-MS,11719255,3.775646564562419,3.6621308372563077
BFTC-909,12001922,1.803559970478093,2.0147857046848703
MOLP-8,3384730,1.892166165987978,1.6297520163516703
RKO,176870,5.862868084879783,2.74819106463453
HCC1500,SNX-2112-bortezomib (250-1 mol-mol),0.5561082321817433,-1.2441286745145825
PaTu 8988t,navitoclax-MST-312 (1-1 mol-mol),1.1129030049458837,0.8449321065925652
IGROV-1,24772860,-3.2892316801587835,-1.4613410986351665
IA-LM,6450551,2.2909353415785403,2.0118664805086732
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055,2.2251137298513672
BFTC-909,6252,5.031852570794812,0.7372983418943759
BICR 31,9907093,4.585915925811977,4.271250053769398
MDST8,285033,-1.9150900594470792,-1.5673534408002616
MOLM-13,375860,-1.005106987112833,-0.5187276523737854
P31/FUJ,16725315,4.109597365862544,3.424882224372605
IGROV-1,216345,3.498629789107092,3.4890272552306065
SW1271,208908,1.7498569635536685,2.0212131824325983
COR-L95,11507802,0.9381723124038672,0.8194210688424858
RERF-LC-MS,6918328,0.3946668064090056,0.4508360606545251
NCI-H1568,426756,4.294080241318686,4.3582190557246605
K-562,67156097,-2.769244311294464,-2.281241177190383
LS411N,2729026,2.9791300415919646,2.1065093739380623
SK-HEP-1,2729026,3.094345392685322,2.751300825794698
Panc 02.03,54618771,1.0884531427161812,1.4206718563272747
MDST8,5282054,3.0885738072945776,3.7247664002372165
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486,-0.824534278276659
HEL,54143018,-0.2807045945993052,-0.357005030213275
COR-L105,5278396,3.038896363429305,3.697829867705193
SU-DHL-6,6450551,1.9173550036200224,1.3854556197129408
LCLC-97TM1,1716436,2.9898763561132276,2.8700431676410103
K-562,54619267,3.679496217482672,3.81383432965306
Granta-519,1641662,2.857235389717828,2.792283822288199
PaTu 8902,219104,4.25826825351418,3.8458273253195148
NCI-H2452,24779724,6.409137734448782,4.527691741325203
RCC10RGB,2126,5.809199309072596,4.9018342890801705
HuP-T3,24753719,4.122061219367772,4.388013544827409
RKN,44197249,3.9607888926275217,4.237030600103042
SU-DHL-1,44543605,4.013392575246718,3.813826557837872
HEL,11455910,0.7002369428142345,0.09650046008831606
SK-HEP-1,5281672,4.68841423543723,4.595194095402053
SW1271,navitoclax-gemcitabine (1-1 mol-mol),-0.9038417813496232,-0.9857554740618858
BICR 31,23582824,0.6119811525421108,0.7896187723731518
SW48,57330099,4.121753491452113,4.099677070969186
MOLP-8,3825829,4.0673932001437,3.0997115479793447
Granta-519,5746,-3.467826904777232,-0.4920145743743977
K-562,46215462,1.6076592131491731,1.3953379868519105
Daudi,alisertib-navitoclax (2-1 mol-mol),-1.1022910082635888,-0.7530572541670931
MOLM-13,6852167,0.0474303723036755,1.7532253299547285
PaTu 8902,44819697,-0.6077719001286086,-0.15686002209700742
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257,3.608886714432397
HCC15,135875424,4.57405525423842,4.009573769887609
BFTC-909,6918736,-1.9066217610366931,-1.6708592115288479
MOLP-8,25195348,2.8158250690550215,2.5188546722802165
KU-19-19,11175137,2.6409229524549858,2.8902800528059798
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199,1.7567063089601838
SU-DHL-1,15983966,-4.109397573586815,-1.139386941049971
Granta-519,4705,3.4024179319436483,2.8994003662044343
SaOS-2,6450551,2.5324870379200113,2.822143600557668
SU-DHL-1,6918837,-2.995399398295858,-4.120973306392596
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143,3.9047949957686865
SW1573,159324,2.9705070550476274,3.0793547448731475
LS180,11625818,4.457813695022962,4.446056128426182
Granta-519,10296883,3.749738066673353,3.0034375614741093
Panc 02.03,285033,-1.023489563814438,-1.7912530389909218
SU-DHL-1,11175137,1.828860424721981,2.5030907783028487
HEL,124202324,1.0355607531680788,1.2282111200331653
NCI-H1568,702558,5.469457182473135,5.114476534244213
IGROV-1,46191454,1.3777495915525844,1.7074986504378173
WM115,55283,3.7426713954425415,2.4840014635673056
SW948,7251185,1.827873481109932,1.7903290059488728
MDST8,4521392,4.294685623216763,4.218296475905747
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392,1.5684245331573472
LS180,11455910,2.088798844266998,1.1786251886864678
NCI-H2452,151289,3.721937933525537,1.2630824509287548
LCLC-97TM1,11214940,1.4536772193180694,1.7546104155232083
RKO,25062766,2.7314931301361476,1.531569807795624
SU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),1.5701555779120346,1.071982418173131
COR-L105,3385,6.244906352702261,4.395649896692479
IGROV-1,375860,0.7731558163124775,-0.027256983078158433
SU-DHL-1,9936388,0.846879508636978,-1.538563161081499
MOLP-8,11955716,-2.2423093620343666,-1.9834407847250068
IGROV-1,11455910,-0.2792640061206097,1.0510571848640542
HEL,216468,1.594172428774628,1.057820058609191
K-562,216345,3.9110155346915088,3.2064729226915203
SK-HEP-1,6450551,3.663777137244395,3.097937943609697
Daudi,5460769,0.2326576177581661,1.5279492860170987
BICR 22,1750826,0.8880077925102622,-1.2196756020662713
RERF-LC-MS,11238147,2.4729298726299147,3.2876724574643954
BFTC-909,54649381,4.487285574329416,3.830310707328006
RERF-LC-MS,9926054,1.8051014319834384,1.9570134501763636
IA-LM,1750826,-4.675530321169698,-2.1603423354543945
BICR 22,46398810,2.733805979632988,2.390983138422204
WM115,445643,3.76443753653658,3.9594198508460408
LS411N,3689413,2.701640891749041,-1.0523323860752352
SW48,71304818,2.1411626536950323,2.329873779371428
HuP-T3,5291,4.150853397708747,3.8017395683461195
SW48,9911463,3.374803590447597,3.624229878328386
Daudi,16219061,1.2860438148144782,2.0851850693618594
SaOS-2,9911830,2.995519789289086,2.664676509843436
BFTC-909,5329102,1.9658448878596055,2.18359758788046
NCI-H1568,53495165,-0.6133813456223128,0.3949526373158156
BICR 22,6918878,1.3704913724877863,2.9250851106394866
SK-OV-3,4259181,0.9080230343390464,0.22484725151780968
HCC15,BRD-A02303741-navitoclax (2-1 mol-mol),0.3796712498058268,2.83721457102258
BFTC-909,445091,4.3207806819680625,4.2516719179073
WM115,2130404,3.451007656106494,3.144259314028371
RCC10RGB,11152667,2.8531679730856268,-0.41046415825707816
HEL,5460769,3.63888115942649,2.0242091508153552
HEL,969516,2.4495484774391296,2.3173053479103998
MDST8,11152667,-1.6082048518025778,-0.3944355239410093
WM115,54596490,4.400808012137458,4.171818348999256
NCI-H2452,1716436,2.783046357832639,3.254162012878473
MOLM-13,4917,2.9272389210025955,2.74254544265541
ALL-SIL,119182,-4.503247338331098,-3.08678426439551
MDST8,3552672,1.9687663546279843,3.023253777611865
HCC15,16720766,-0.3160262480808965,0.7237131734734764
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916,2.051064573337672
MOLM-13,12003241,-3.578107028375036,-1.3408507185852787
SW948,24856436,-0.402936098482521,0.36089499455634366
HCC1500,44202524,3.676243999694772,2.008761940942452
Daudi,4261,-0.6156785773872924,0.4747205864959043
MDST8,11507802,0.9258202338292296,1.8691685373691995
BFTC-909,54626689,4.365294423210906,4.672504877716079
NCI-H1568,16741245,4.262204040009308,3.7129891370166352
HCC1500,25154868,1.8923567203600569,4.197862458195689
HCC15,navitoclax-piperlongumine (1-1 mol-mol),-0.4364560874228035,1.8976570473820054
COR-L105,3825829,4.424164708702568,4.1780186016151
HEL,10074640,3.098757234686198,1.560430431358079
RKO,44202524,1.4476976505001866,2.1670771709436254
SK-HEP-1,6852167,5.53454213252302,2.89785222880225
